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SCIENCE IN MEDICAL PRACTICE 
Robert W. Berliner, M.D. 
The following article is based on a talk which Dean 
Berliner gave to the Council of Academic Societies at the 
annual meeting of the Association of American Medical 
Colleges in November. The theme of the session was 
“Basic Science Education as the Foundation for 
Advanced Medical Practice. 
There will be new things in the practice of medicine that 
future physicians will need to cope with. It is important 
that they have sufficient background in science to be able 
to understand these and sufficient critical judgement to be 
able to make reasonable decisions about what they will 
read or hear. 
So, what should our students be taught in their pre- 
clinical science curriculum to prepare them for this future? 
The specifics of what they are taught are far less important 
than the generalities. 1 doubt that any of us know what 
specific areas are going to be the important ones of the 
future. Our problem is to give students a background that 
will make it possible for them to assimilate and utilize new 
developments in any one of a number of fields of knowl¬ 
edge. What is needed for that is not a mass of details at the 
edge of present knowledge, but a broad understanding of 
basic principles upon which to build, along with develop¬ 
ment of the habit of and faculty for applying those princi¬ 
ples to problems. Students must learn early the importance 
of independent study and self-education. That is what is 
going to be required of them for the rest of their profes¬ 
sional lives. They must learn to examine what they read 
critically so that they can reach reasonable decisons about 
the value of new things that appear in the medical literature. 
These are the principles which, at least in theory, guide 
our present curricula. But, in practice, we are not very 
successful in following them. In the basic sciences, and in 
the clinical years as well, there is a tendency to load the 
students with details. Each member of the faculty acts as if 
every member of the class was going to spend the rest of 
his life in the field in which the faculty member is expert. 
Often the result is that the student is loaded with a confus¬ 
ing mass of information that he has great difficulty not only 
in retaining, but in assembling into an orderly system upon 
which he can draw conclusions when faced with a problem 
that may not fall precisely in a form that has previously 
been presented. The examinations to which students are 
subjected too often depend on the recall of specific facts 
rather than requiring the application of more basic princi¬ 
ples to the solution of new problems. 
Our curricula generally do not prepare students ade¬ 
quately to evaluate the validity of new developments. It is 
often the case that, in medical school, the student for the 
first time encounters material whose interpretation is con¬ 
troversial and uncertain. In general, what students have 
previously been exposed to in their earlier experience will 
have been fairly well established. In medicine, they must 
learn to live with uncertainty not only in the sense of 
probabilities, but in the form of unsettled controversy as 
well. At the same time, it is important that they learn to 
question the certainty of others and to doubt, possibly for 
the first time, the written word. 
An important element in preparation for critical evalua¬ 
tion of new information is, of course, an adequate ground¬ 
ing in statistics. This does not mean simply to understand 
tests of statistical significance, how to calculate a standard 
deviation or a standard error. Probably more important is 
the ability to seek out and find possible flaws in the design 
of studies, which in modem days is such more often the 
source of faulty conclusions than simply inadequate statis¬ 
tical analysis. The literature these days is full of tests of 
statistical significance and p-values so that it is unusual 
that differences that could be attributable to chance alone 
are interpreted as meaningful. However, it is not uncom¬ 
mon that these tests have been misapplied, and even more 
frequently there are problems in the study design that make 
the differences found questionable of interpretation. It is 
the latter problem that lies behind many of the most con¬ 
troversial issues in present day medical practice. 
There is nothing that can make an individual more 
aware of the problems of experimental design and the 
interpretation of data than personal involvement in carry¬ 
ing out a significant research project. It is difficult to make 
such experience a regular part of the undergraduate medi¬ 
cal curriculum. It is demanding upon resources and, if 
adequately supervised, on faculty time and attention. Even 
more of a problem, however, is the perception that stu¬ 
dents do not have time in their already crowded schedule to 
take on additional activities. At Yale, a school that has for 












based on original research, we are continually faced with 
complaints from our students that they do not have enough 
time. Often, I'm afraid the complaint is justified, although 
those students who make adequate plans early enough do 
not have serious problems. But all of them must deal with 
the wasteful clinical years of medical school. 
The wastefulness of these years is fostered by a number 
of factors — historical, parochial, and psychological. His¬ 
torically, medical schools turned out graduates fully 
prepared to engage in the practice of medicine. As the need 
for additional training and experience became recognized, 
the post-graduate years have been added, and it is now 
generally held that the medical school years are to be 
looked upon as preparation for several years of supervised 
experience in a residency. Little adjustment has been made 
in the clinical years to take this change into account. 
One of the reasons that change has been resisted is that 
each department jealously protects its share of the availa¬ 
ble time: in part, in an attempt to attract students to a future 
in its own discipline; in part, out of enthusiasm for its own 
activities; and in part, simply to make sure that its own 
importance does not appear diminished relative to that of 
another. If what is needed, however, is a broad founda¬ 
tion. an understanding of fundamentals, and the ability to 
draw upon this foundation for the solution of problems, 
equal time is not the appropriate division. Some areas have 
broader application than others. I may be accused of 
parochialism given my own background in internal medi¬ 
cine, if I say that internal medicine — and here I mean 
internal medicine generally and not the great detail of its 
individual sub-specialties — provides a greater opportu¬ 
nity for solidifying the student's grasp of how to apply the 
principles of science to the solution of individual problems 
of health and disease than most of the other clinical disci¬ 
plines. Undergraduate medical education is not the place 
to make the student into a surgeon, an obstetrician, or a 
psychiatrist. Hours spent holding retractors in the operat¬ 
ing room may add glamour to the medical school years, but 
they do not contribute much to the ability of students to 
deal constructively with new problems — unless he or she 
is going to be a surgeon, which only a fraction of the 
students will be. 
But departmental parochialism is not alone in its respon¬ 
sibility for this type of misspent time. The students them¬ 
selves, and the house staff, fall easily into the pattern. 
Students are all too ready to do those things that make them 
feel like they are behaving as doctors, and nothing gives 
them that feeling more than being involved in carrying out 
procedures. The introduction of hands-on clinical experi¬ 
ence even into the first year of medical school, — either at 
the insistence of the students or to stimulate their interest, 
- is a reflection of the urge of students for identification 
with the routines of medical care. Unless they are guided 
with a strong hand away from these activities, they will 
follow this urge only too readily. But the strong hand is 
seldom there, or rather, it is there and pushing the students 
in the wrong direction. The faculty, happy to see the students 
in their own image, and the house staff, happy to share 
what they now recognize as drudgery, are quite ready to 
allow the students to take on as much of the routine as they 
are capable of and willing to do. The students become 
heavily involved in doing those things that would be better 
reserved until their own house staff years, and things that 
they will be doing the rest of their professional lives, rather 
than those for which the medical school years are a unique 
time — to study in depth, to think problems, even to make 
mistakes while there are presumably wiser heads around to 
correct them. 
Fortunately we don't hear as much about relevance as 
we did five years ago. At that time, the question was 
directed at the basic sciences. Were they really relevant to 
clinical medicine? Does the subsidence of that wave of 
questioning represent a recognition among our students of 
the true relevance of the sciences basic to medicine? I'm 
inclined to think the answer is more “no” than “yes”. 
Rather, I believe it reflects the behavior of a less rebellious 
cohort of students more willing, if necessary, to put up 
with the ideas of their elders even if unconvinced of their 
validity. I think it is time for us to raise the question of 
relevance. Perhaps we are better qualified to identify what 
is really relevant and what is not, having been exposed to 
the full range of school, post-doctoral education, “and 
more”, as they say in the advertisements. The “more” in 
this case is what has happened in medicine in the last few 
decades and what is likely to happen in the next few. 
What is really irrelevant to the future is much of the 
detail of what now goes on in clinical medicine. Many of 
the diagnostic procedures now in use, the specific pharma¬ 
cological agents that are prescribed, the surgical opera¬ 
tions that are performed, will be supplanted by others — 
better ones, we may hope. Many of the things that now 
seem to our students to be most relevant, in which they 
most eagerly involve themselves, will not be out of date, 
discarded. What will remain the same is the patient and his 
or her problems and the physiology and biochemistry and 
the psychology that underlie them. What will remain 
relevant is the science that provides the basis for under¬ 
standing those problems, for appreciating the reaction of 
the patient to his situation, and the rationale of the means 
for dealing with them. The important part of the teaching 
in the clinical phase of medical school is to emphasize the 
application of those sciences to clinical problems and to 
habituate the students to thinking about them in an orderly 
and logical fashion. That process will never be irrelevant. 
Well, here I am in a session supposedly concerned with 
the teaching of basic science, and if I've said anything, it 
has been largely in criticism of the teaching in the clinical 
years. I would not want to leave you with the impression 
that I don’t think there is anything to criticize in the 
preclinical curriculum. It is often too crowded, too much 
directed at the acquisition of detailed factual information, 
and insufficiently concerned with the assembly of those 
facts into a coherent system so that they can be used for 
thinking out new problems. 
The most important message to the basic sciences is that 
they need not, indeed should not concern themselves with 
emphasizing what is relevant to today’s clinical practice, 
because tomorrow's will be different. They also should 
recognize how wasteful of the student’s time much of the 
clinical curriculum is, and should not hesitate to suggest 
that some of it might be better used by them. Why should 
new courses — genetics, immunology and the like, be 
jammed into the limited time devoted to the basic 
sciences? Only if it can be shown that the time occupied by 
clinical exercises is better spent than what would be dis¬ 
placed from, or further crowded in, the preclinical 
curriculum. 
You may rightly ask whether the Yale curriculum 
reflects what I have been saying. Well, my father used to 
tell me, “Do as I say, not as I do.” 
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A MATTER OF TASTE 
' 'Jack Sprat would eat no fat; his wife would eat no lean. Between them both, they licked the platter clean.' ’ When it comes 
to food tastes, there are almost as many variabilities as there are people. Although there are many cliches on the subject, 
psychophxsicists are beginning to uncover some of the basic chemical and genetic reasons for differences in taste 
perception. Their findings have implications for discovering causes of taste and smell disorders as well as for the future of 
the food industry'. 
To some people, rich sweet desserts are the epitome of 
gustatory delight. Others prefer a tart apple or sour cherry 
pie. Ardent coffee drinkers relish cups of strong, bitter 
black brew. Those less enthusiastic, dilute theirs half and 
half with milk and add plenty of sugar. Millions of calorie 
counters drink diet soda and notice little difference 
between it and the non-diet drinks, yet others find the 
after-taste of diet drinks bitter and extremely unpleasant. 
Why? Research scientists in the field of taste sensation 
have found that although learning and culture are factors, 
food preference is also affected by complex chemical and 
genetic influences. Their findings have implications for 
discovering underlying causes of taste and smell disorders 
and for the future of the food industry. 
‘ ‘Taste” is generally thought of in hedonic terms — the 
pleasure or displeasure of flavor, aroma, texture, color, 
and whatever else that gives a particular food or drink its 
unique quality. In fact, taste is the sweet, sour, bitter or 
salty quality of a dissolved substance as it is perceived by 
cell receptors concentrated on the edges and at the back of 
the upper surface of the tongue. Flavor — chocolate, 
vanilla, lemon, beef, chicken, and so forth — has three 
components: taste, smell and texture-temperature. When a 
food enters the mouth, these three sensory modalities are 
all independently stimulated to produce a distinct flavor. 
More than two million American adults suffer from loss 
or impairment of gustatory or olfactory senses, according 
to a recent report of the National Advisory Neurological 
and Communicative Disorders and Stroke Council. The 
condition itself is not life threatening, and in comparison to 
loss or impairment of vision or hearing, it is not generally 
considered to be a serious loss. Scientists are beginning to 
realize, however, that the chemical senses have consider¬ 
able medical significance. 
Taste and smell disorders not only prevent people from 
enjoying eating and drinking — a deprivation of a certain 
quality of life — they may also have potentially dangerous 
consequences. For example, anosomic patients (those 
with an olfactory disorder) are unable to detect escaping 
gas and other dangerous fumes as well as fires; smell and 
taste often provide the only means of detecting rotten or 
rancid foods. Chemosensory defects can signal serious 
conditions such as cerebral tumors, temporal lobe epilepsy 
or endocrine disorders. They can also be related to indus¬ 
trial pollutants, viral infection, congenital anomalies, 
nutritional deficiencies and diabetes. 
Although many patients consider taste or smell dis¬ 
orders disabling and serious enough to seek help, the 
medical profession, for the most part, has viewed the 
conditions as a mere inconvenience, frequently going as 
far as to describe them as “neurotic”. Furthermore, since 
there is little known effective treatment for these prob¬ 
lems, physicians who do take these complaints seriously 
often dismiss their patients to “live with” the problem. As 
a result, many consult psychiatrists, and a few even con¬ 
sider suicide, according to Dr. Linda Bartoshuk, associate 
professor of epidemiology and psychology at Yale, and an 
associate fellow of the John B. Pierce Foundation 
Laboratory. 
Dr. Bartoshuk is also associate director and co-principal 
investigator with Dr. Frank Catalanotto, of the Connect¬ 
icut Chemosensory Clinical Research Center, a collabora¬ 
tive endeavor of the University of Connecticut, Yale 
School of Medicine, the Worcester Foundation for Experi¬ 
mental Biology and the Pierce Foundation Laboratory. 
The Center, one of only four in the country specifically 
directed toward understanding taste and smell disorders, is 
funded by a three-year grant from the National Institute on 
Neurological and Communicative Disorders and Stroke, 
to study, diagnose and treat disorders of taste and smell. In 
addition to clinical studies of chemosensory impairment 
related to illnesses such as multiple sclerosis, kidney 
failure, neurological disorders, diabetes, and problems 
related to radiation therapy for cancer, the Center will be 
involved in basic scientific research on the physiological 
and psychological basis of taste and smell. 
Dr. Bartoshuk’s research is aimed at describing taste 
sensation. Why do substances taste sweet, sour, salty or 
bitter? Why do some people have stronger sense than 
others of a particular taste sensation? The answers to such 
questions are fundamental to an understanding of chemo¬ 
sensory disorders. 
One of the difficulties in determining taste perception is 
that there may be significant differences even among 
“normal” populations in taste ability. Recent research in 
Dr. Bartoshuk’s laboratory and others have revealed a 
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genetic basis for some of these differences. 
Taste researchers have noted that there is more variation 
among individuals for sweet and bitter than for salty and 
sour. Salty and sour substances produce relatively little 
individual variation in taste because the chemical stimulus 
for both — a tiny positively charged ion — is relatively 
simple in structure. In contrast, sweet and bitter substances 
are usually large and complex organic molecules that have 
varying effects. 
Not all bitter substances act on the same receptor mech¬ 
anisms on the surface of the tongue, but rather, we taste 
“multiple” bitters, according to Dr. Bartoshuk. One bitter 
substance, phenylthiocarbamide (PTC), is a hallmark of 
sorts of genetic determination of taste. Family studies 
indicate that the inability to taste PTC in foods is a simple 
Mendelian recessive trait; individuals who carry two 
recessive genes are relatively insensitive to PTC and are 
called “nontasters”; while those who carry one or two 
dominant genes are much more sensitive and are called 
“tasters”. 
About seventy percent of Americans are tasters, and 
tend to experience a bitter taste from saccharin in diet 
sodas and potassium chloride, the most common substitute 
for salt. Thus, reactions to PTC provide a test for gauging 
reactions to salt and sugar substitutes. This finding is 
important for research leading to new and better substitutes 
than are currently available for sugar and salt. 
Early studies on the structure of PTC seemed to suggest 
that a certain very specific part of the PTC molecule was 
responsible for the variation in bitterness. The only other 
molecules containing the same structure were not often 
encountered, so the effect was of more interest then to 
geneticists than it was to taste investigators. 
However, in 1975, Dr. Bartoshuk and her colleagues 
discovered that caffeine, a bitter substance which does not 
have the required structure, tastes more bitter to tasters 
than to nontasters. “Interestingly enough, the concentra¬ 
tion of caffeine in an average cup of freshly brewed coffee 
is below or near threshold for most nontasters, but it is 
above threshold for most tasters,” she observed. “As our 
studies continued, we found that the perception of the 
bitterness of the saccharin was also related to PTC status. 
At the concentration of saccharin used in most diet sodas, 
the average taster of PTC perceives two to three times as 
much bitterness as the average nontaster.” 
Dr. Bartoshuk and one of her students, Bathsheva 
Rifkin, have extended this research to potassium chloride 
and to sodium benzoate, a preservative often used in 
canned foods. They now assume that further study will 
turn up many more bitter compounds related to PTC. In 
addition, although it has not yet been statistically con¬ 
firmed, the research indicates that PTC tasters may be 
particularly sensitive to certain types of chemotherapy. 
This may account for taste problems in leukemia patients 
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undergoing therapy, for example. 
Early in the 1970's a group of medical science writers 
and public relations people attending a meeting to learn 
more about taste research from Dr. Bartoshuk, were some¬ 
what astonished when she passed a perfectly cooked arti¬ 
choke and a glass of water to each of them. After they had 
eaten the artichoke and drunk the water as instructed, she 
asked, “How many of you found that the water tasted quite 
sweet?” Several, mostly women, had. The “artichoke 
effect”, she explained, is another example of the genetic 
implications of taste. It may also be sex-linked, hence the 
reason more women than men at the meeting experienced it. 
She and her colleagues happened on the taste differ¬ 
ences in artichokes while working on a series of projects on 
taste modifiers — substances, including detergents, the 
Indian herb Gymnema sylvestre, the African berry known 
as “miracle fruit”, and one’s own saliva, — which, when 
applied to the tongue will change the basic taste of another 
substance. For example, if you brush your teeth before 
eating breakfast, you will notice that orange juice tastes 
unpleasant. Some toothpaste, and some mouthwash, con¬ 
tain sodium laurel sulfate, a detergent which produces 
temporary effects on the sense of taste. 
“Understanding these effects is the foundation for the 
rest of the work in taste research. We don't know, for 
instance, if two groups that are behaving differently 
towards a food, are in fact, having the same sensory 
experience,” Dr. Bartoshuk pointed out. 
Laboratory studies have demonstrated that individuals 
may be sensitive or insensitive to each of the four basic 
tastes. Dr. Bartoshuk’s studies further suggest that sweet 
and bitter substances can themselves be subdivided so that 
a given individual may, for instance, be insensitive to a 
particular bitter stimulus, and very sensitive to other kinds 
of bitter stimuli. The same may prove true for sweet 
substances. This permits a great deal of potential varia¬ 
bility in taste both among individuals and across species. 
Artichokes, caffeine, miracle fruit, saccharin and the 
like may seem rather frivolous research material to hard¬ 
line bench scientists, but they contribute to a thorough 
understanding of the environmental and hereditary factors 
necessary to distinguish normal reactions to taste percep¬ 
tion from those produced by illness. The Connecticut 
Chemosensory Clinic is staffed by taste and smell experts 
as well as physicians from the medical specialties associ¬ 
ated with sensory function. One purpose of the clinic is to 
provide expert diagnosis of abnormal taste and/or smell 
function by comparing patients' taste/smell abilities with 
normal function established by laboratory research such as 
Dr. Bartoshuk’s. “It is our hope that we will not only be 
able eventually to help these patients but that we will also 
learn valuable lessons about taste and nutrition from 
patients with disordered taste function,” she explained. 
M. B. Noyes 
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DAVID MUSTO: a man with a sense of history 
“This brings back keen memories of a childhood fascination 
with all the sciences,’’ Dr. David Musto commented when 
he learned he had been invited to membership on the Council 
of the Smithsonian Institution. He is the first physician ever to 
serve on the council of prominent scholars and scientists who 
advise the Secretary of the Institution about its programs. 
For David Musto, the invitation to serve the nation’s 
historical and cultural center was not only an honor and a 
delight, it was also an affirmation of his scholarship on the 
history of the development of the sciences and social policy in 
the United States. His research is recognized as an important 
contribution to the understanding of legislative decisions in 
these areas. It has also resulted in several significant appoint¬ 
ments including Historian to the President’s Commission on 
Mental Health, and Historical Advisor to the Chairman of the 
United Nations Commission on Narcotic Drugs, as well as to 
membership on the White House Strategy Council on Drug 
Abuse Policy during President Carter’s administration. He 
also served as a member of the National Academy of 
Sciences' Panel on Abuse and Alcoholism, whose final 
report was released last fall. 
Dr. Musto is professor of psychiatry (Child Study Center) 
and histoiy of medicine, as well as head of the Section of 
History and Social Policy of the Bush Center in Child 
Development and Social Policy. A glance at his curriculum 
vitae confirms that this combination of science and the 
humanities has been consistent throughout his academic and 
professional careers. 
After graduation form the University of Washington, 
where he majored in classical languages, he entered medical 
school there. When he had completed two years of medical 
school, he came to Yale for a master's degree in the history of 
science and medicine. He returned to the University of 
Washington to complete his medical education and received 
his M.D. degree in 1963. 
Following internship at The Pennsylvania Hospital in 
Philadelphia, and a psychiatric residency at Yale-New Haven 
Hospital Medical Center, he served as special assistant to the 
Director of the National Institute of Mental Health from 1967 
to 1969, and at the same time, as visiting assistant professor 
of history at Johns Hopkins University. He joined the Yale 
faculty in 1969 as assistant professor of psychiatry (Child 
Study Center) and of history. 
In addition to his book. The American Disease: Origins of 
Narcotic Control, which received high praise, Dr. Musto’s 
extensive bibliography covers such diverse subjects as the 
biochemical genetics of glucose-6-phosphate dehydrogenase 
deficiency; the theory of hereditary disease of Luis Mercado 
(1525-1611); the support of basic sciences in 19th century 
America; and an historical perspective on the freedom of 
inquiry and subjects’ rights. It also includes insights into the 
lives of notables such as John Quincy Adams, Sigmund 
Freud and Sherlock Holmes. His article in 1968 in the 
Journal of the American Medical Association on Holmes’s 
and Freud's involvement with cocaine provided a basis for 
the novel and film “The Seven Percent Solution’’. 
It was as special assistant to the Director of the NIMH 
that Dr. Musto first became interested in the history of 
public policy making. “One day, the director. Dr. Stanley 
Yolles, called me into his office and asked if I would help 
him with a ‘historical problem’. Apparently, every time 
public health officials suggested providing heroin main¬ 
tenance programs for addicts, the opposition, which in this 
case was the Federal Bureau of Narcotics, would point to a 
decision by the American Medical Association in 1920, 
completely opposing heroin maintenance. Dr. Yolles 
wanted me to find out why, so the next time the subject 
came up at a Congressional hearing he would have a better 
response,” he explained. 
In both the National Archives and the Library of 
Congress he found masses of materials on the history of 
drug abuse policy dating back to before World War I, 
which essentially had never been consulted. “I became 
intrigued with the history of narcotics policy in the United 
States because it was so different from what I had absorbed 
in medical school and during residency. It was more com¬ 
plicated, and in many ways, more interesting.’’ 
In researching the assignment from Dr. Yolles, he 
became aware that social problem solvers in Washington 
and elsewhere in the country, could refer to the history and 
evolution of the problems they deal with more often than 
they do. ‘ ‘There are many simple facts about the history of 
some of our policies, such as that regarding drug abuse, 
which if better understood, would provide a different per¬ 
spective on how to approach the problem, and on what 
kind of goals might be set with the likelihood of some 
success,’’ he said. “The same might be said about the 
profession of psychiatry, which has been particularly 
susceptible to the social mores of its times, and is liable to 
expressing in rather more complicated medical language 
what might otherwise be called simple biases of the 
moment. One of the dangers of being in the psychiatric 
profession is that one might think that it is invulnerable — 
that you can securely take a stance that is extremely objec¬ 
tive and separate from the social context in which you 
live,” he explained. “However, any profession that has to 
have one foot in the real world, and one foot in research, is 
very vulnerable to strong pressures from society. It is 
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important to look at history in order to be humble, to 
realize that distortions can happen.” 
To illustrate his point. Dr. Musto cited a few examples. 
In the 19th century, “documented” claims by pro-slavery 
polemicists of the inherent inferiority of blacks and the 
dangers to them of emancipation were matched in the 
north by psychiatrists’ studies of Irish immigrants who 
were claimed to suffer from an ethnic “constitutional 
inferiority.” These examples merely confirm the contem¬ 
porary social attitude of that time in history when the vast 
numbers of immigrants to this country seemed to threaten 
its moral, social and economic structure. 
A more recent and professionally disturbing example 
occurred during the McCarthy era of the 1950's. It 
involved a serious encroachment on the very basis of 
professional ethics — preserving patient confidentiality. 
In an attempt to learn what attracts people to com¬ 
munism, an academic project called “Appeals of Com¬ 
munism Project”, based at Princeton with operations all 
over the world, turned to psychotherapists for the answer. 
Therapists were selected by reputation, position, or pub¬ 
lished papers in social science research. Although half of 
them declined to reveal information about their left-wing, 
communist, or ex-communist patients, 35 cases were pro¬ 
vided by those therapists who agreed to participate. The 
purpose of the study was to determine the family constel¬ 
lation that bred communists and the defensive role of 
communism in their lives, according to Dr. Musto. Each 
patient’s history was studied intensively and in great 
detail. 
“It is doubtful that the patients had consented to the use 
of their histories or were even aware of this sharing of 
information, although the published checklist of informa¬ 
tion requested from their therapists includes categories that 
would easily identify the patients to anyone knowledgeable 
about their party careers or public accomplishments,” Dr. 
Musto observed. “This is a good example of how history 
can be important to the profession, and how any of us, 
under stress, can be led to do things we might later deeply 
regret. 
“The nation appeared to be in great danger from Com¬ 
munism at that time, and this may have justified to the 
therapists an apparent grave breach of patient confidential¬ 
ity, that at a later time might seem strange. Still, good 
history doesn't encourage one to laugh at the mistakes of 
the past, but rather to appreciate the humanity and frailty 
we all share, past and present,” he cautioned. “If we take 
this incident merely as another example of how we have 
progressed, we conveniently ignore the humbling continu¬ 
ity we have with the past.” 
Dr. Musto’s work in the history of drug policy also 
reveals a national susceptibility to social pressures of the 
time. “It seems to me that drug policy is like a cork 
floating on an ocean. The forces that move it up and down 
are social perceptions of deviant groups; our attitudes 
toward foreign nations, and what they may be doing to us; 
and our faith in international law and diplomacy,” he 
pointed out. “There are so many factors involved other 
than the actual effect of drugs that it's hard to imagine a 
field more plagued by being affected by attitudes about 
many, many other topics and subjects.” 
Although drug use in the United States today is a matter 
of considerable concern, it has been a part of the American 
scene from the earliest settlers who drank heavily, not just 
for inebriation, but also, they believed, for personal 
health. Crude opium was imported then, mainly for medi¬ 
cinal purposes; later in the 19th century, both morphine 
and codeine were isolated from it — again, mostly for 
medical use. 
It was not until the last third of the 19th century that 
narcotics use began to be widespread. A year after it 
developed Aspirin, the Bayer Company successfully man¬ 
ufactured heroin from morphine and introduced it com¬ 
mercially as a cough suppressant, sold over the counter. At 
about the same time, advances in technology made pure 
cocaine more readily available, and soon its stimulating 
and euphoric qualities were highly recommended for 
athletes, workers and students. Bottlers of popular soda 
drinks and over-the-counter “tonics” added cocaine to 
their products. By the turn of the century, both heroin and 
cocaine were as available as wine and liquor. 
“We had a totally free economy in drugs in the United 
States up until around World War I. There was no restric¬ 
tion other than an average tariff on the importation of crude 
opium and coca leaves, and their products could be pur¬ 
chased at grocery stores, through mail order catalogs and 
elsewhere. The result of a free market in drugs was that 
people used more and more of them,” Dr. Musto said. “I 
find that of interest today, when some advocate the elim¬ 
ination of drug laws and predict that then drug use would 
decline because the public would not feel compelled to use 
a forbidden product. ” 
With the widespread use of drugs came a fear of the 
consequences. Drugs were frequently associated with 
specific groups which were seen as a locus of difficulty. 
For instance, before World War I, hostility of southern 
blacks to whites was linked in the public mind and in the 
minds of legislators as well, with cocaine. “In fact, it was 
thought that cocaine was an especially dangerous drug for 
southern blacks, because, unlike alcohol which damaged 
your aim if you were shooting someone, cocaine was 
thought to enhance your aim,” Dr. Musto said. “The truth 
is, Americans were using cocaine in the north and south — 
both whites and blacks, but given the social climate of the 
times, the focus was on southern blacks. As the drug era of 
the 60’s and 70’s progressed, I became amused at modem 
studies that indicated that cocaine was a ‘naturally’ white 
drug, and that heroin was a ‘naturally’ black drug. Before 
World War I, the opposite connections were asserted, 
‘naturally’. We have cliches in the history of drug policy 
which are simply unexamined, but have a powerful affect 
on what we decide to do, what we are after, and who we 
are after, in the process.” 
Before World War I, as now, some segments of the 
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population believed that drugs were the cause of violence 
and social disintegration in society. “Drugs like heroin 
and cocaine are not good for society, and 1 am not in favor 
of their use. However, the cause and effect of those drugs 
at times did get a little mixed up. Perceptions of the way 
drugs seem to affect people can be influenced by social 
climate, the context in which the drugs are taken, and what 
consumers expect those drugs to do after they have taken 
them.” 
Coincidental to the increasingly widespread use of 
drugs at the turn of the century was the rise of the Progres¬ 
sive era, closely associated with Theodore Roosevelt. 
According to Dr. Musto, in many ways the reform move¬ 
ments that characterized the Progressive era have much in 
common with activities in this country during the 1960’s 
and 1970's. 
“Many federal activities which seem modem — the 
battle against water and air pollution, legislation for pure 
foods and drugs, mine safety, meat inspection, etc., came 
from the Progressive period, in which even the word 
ecology became a byword of conservationists and health 
reformers alike,” he explained. 
By the close of the Progressive period, the effort to 
improve public health had gone a long way toward control 
of dangerous substances, including the prohibition of 
alcohol. Eventually, not only “prohibition” but even the 
term “temperance” acquired a bad name, suggesting 
over-righteousness and excessive governmental interfer¬ 
ence in private life. The final rejection of Prohibition and 
the image it achieved have spread beyond the details of the 
18th Amendment to include wariness at almost any state¬ 
ment or proposal to fight alcohol's damage to society. 
“Neo-prohibitionist” has become a convenient label to 
discourage open debate about alcohol's role in contempo¬ 
rary America. 
“The taint the anti-alcohol movement received from 
Prohibition led to a disassociation between what we might 
call broadly the ecology movement — campaigns against 
carcinogens, atomic wastes, air pollution — and that con¬ 
cerning alcohol. From a progressive, informed and 
responsible public stance, attracting in 1900 the kind of 
concerned people now in the ecology movement, those 
alarmed over the abuse of alcohol have slipped from 
leadership to the, so to say, arriere-garde.” 
“Yet, the two campaigns for reform are not that far 
apart in fundamental concern about public health and 
safety, a reliance on scientific research, and a desire to 
improve the common environment. The perception of 
what we might call the temperance movement may 
change, just as there has occurred a revolution in our 
attitude toward cigarette smoking as a social activity and 
health hazard. If this does occur, there will be a powerful 
re-association between old allies with undoubtedly strong 
effects on our social mores and policies,” he reasoned. 
“Not that prohibition would be reinstituted, but consider 
how significant a change would have taken place if we — 
and those around us — began viewing a drink the way we 








































A Sense of the Ending 
By a departing light 
We see acuter, quite, 
Than by a wick that stays. 
There’s something in the flight 
That clarifies the sight 
And decks the rays. 
Emily Dickinson 
“A Sense of the Ending” is a television production about 
terminal illness as seen from the quite different perspec¬ 
tives of two women who had cancer. It was directed and 
produced by William Guth, director of Media Communi¬ 
cations, Yale School of Medicine. 
Richard Sewall, professor emeritus of English at Yale, 
relates with compassion and poetry “the very remarkable 
experience” of his wife Mathilde’s death. Mrs. Sewall, a 
potter and weaver, was a woman whose spirit and sense of 
humor remained until the day she died at their home in 
Bethany, Connecticut. 
“The countryside was beautiful: the October coloring 
has never been matched. She was surrounded by friends 
and family and all the conveniences we could assemble,” 
Professor Sewall remembers. “It occurred to me, though, 
that this is all too seldom true of such cases, and I won¬ 
dered about those people who have to go through such an 
experience in the lonely hospital room in a big, crowded 
city hospital.” 
Charlotte Barnard spent the last six months of her life in 
the hospital, conscious, — reading and "thinking about 
things” — and attached to an intervenous, hyperelemen- 
tation life care pump, with a tube out of her nose. She, too, 
was a woman of tremendous courage and a sustaining 
sense of humor. She had hoped to be able to die at home, 
but circumstances of her death necessitated hospitalization. 
During those six months, Mrs. Bernard did a great deal 
of thinking about her situation and what she could do to 
improve similar experiences of other patients. She agreed 
to be interviewed for a short videotape prepared for a 
seminar on medical ethics for Yale medical and law stu¬ 
dents. Her physician and friend. Dr. Howard Spiro, pro¬ 
fessor of medicine and well-known gastroenterologist, 
conducted the provocative and moving interview. 
“A Sense of the Ending” was conceived from the 
response of the students to this interview, according to 
William Guth. “The videotape of Mrs. Barnard's reac¬ 
tions to her situation focused on the issues in a way that the 
written word cannot, or does not do. We were impressed 
with the students’ responses to it, which ranged from 
almost complete withdrawal or denial of her situation, to 
feelings of great compassion for her. In the discussion 
which followed that and subsequent presentations to other 
groups of students and health professionals, we became 
A REVIEW 
William Guth, left, the director, confers with Dr. Howard Spiro and 
Professor Richard Sewall on location in Bethany. 
Mr. Guth and Philip Garvin, the photographer, prepare for a scene at a 
patient’s bedside. 
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aware of the need for more of this kind of material.” 
Parts of the interview are incorporated into the 40-minute 
program produced by Guth. In various settings including a 
ward in the V.A. Medical Center, the cardiac unit at 
Yale-New Haven Hospital and the Sewall homesite. Dr. 
Spiro seeks reactions to it from Patricia Neil, a nurse who 
had cared for Mrs. Barnard; Dr. Harvey Berger, Class of 
'77 and assistant professor of diagnostic radiology; and 
Professor Sewall. 
In the interview. Dr. Spiro asks Mrs. Barnard what she 
sees the future as bringing her. "Well, obviously nothing 
but death, but the big questions are when and how grace¬ 
fully, and how much can I be prepared and can my loved 
ones and friends be prepared?” she responds. “I think if 
more people were frank, we’d get a lot farther in the 
treatment of fatal illness — just in the comforting side of it 
to the patient, day by day. This experience has taught me 
that the touch of a hand, holding hands, can be the most 
comforting thing in the world,” she continues. 
"Doctors and others in the hospital may not be as aware 
of that as they should be,” Dr. Spiro notes. 
"A pat on the way by, holding a finger for just ten 
seconds, gives the patient something he can carry with him 
when he’s thinking about the fact that he will never again 
eat a peanut butter sandwich,” she tells Dr. Spiro. 
To at least one viewer, this is the lesson of Guth’s 
program. It is not whether one spends one’s last days at 
home surrounded by family and friends or hooked up to a 
life-support system in a large city hospital — often, there is 
no choice. The feeling of love and caring expressed to the 
patient not only by family and friends, but also by doctors 
and nurses determines the difference between experienc¬ 
ing death as a part of living or experiencing death as a 
lonely ending to life. 
Perhaps the answer lies in an observation nurse Patricia 
Neil makes. "We must remember that a dying individual is 
a living individual.” Often, this is extremely difficult. 
"When you come into a patient’s room, as I did into my 
wife's, with a lump in your throat as big as an orange, it’s a 
little hard to be constructive. It’s just too hard to keep the 
tears back,” Professor Sewall remembers. "If I could do it 
over again, I certainly would see to it that I made a good 
deal more explicit than I did, my love for her, my feelings 
for her.” 
"Mrs. Barnard’s experiences are a lesson for all of us,” 
according to Dr. Berger, a young physician specializing in 
the high-tech of nuclear medicine. As he talks he is adjust¬ 
ing a huge machine which looms over an elderly patient, 
who looks very small in comparison — and quite appre¬ 
hensive. "The coronary care unit is a particularly scary 
environment. The burden falls on us as physicians, as 
investigators, clinicians, to be the person behind the 
machine. It’s very important that patients realize and are 
confident that there is a physician, that there is a person 
behind all the new technology . . . We’ve got to reach out, 
touch them, become part of their lives.” 
As a health professional, Patricia Neil clearly has 
wrestled with the question of involvement — of becoming 
a part of the patient’s life support system. "Sometimes 
there is limited choice in that for us as well. What comes to 
mind is the issue of involvement or abandonment. It's hard 
to get that involved,” she admits. "Out of my experience 
and exposures here I see death more as a part of life. There 
is a journey towards death, a wandering, a waiting. We, as 
health care givers, must not abandon the dying patient. We 
must not avoid involvement for our own protection.” 
Dr. Spiro expresses the same sentiment in another way 
in a conversation with his son, Philip, a fourth-year medical 
student. "I’m your father. I’m my father’s son. I’m a 
doctor. I will someday be a patient. You will be a doctor, 
and alas, someday a patient. I think one of the things that 
does seem to happen is that doctors don't always see 
themselves and their friends and relatives as patients. In 
that sense, the sense of the ending, knowing what is yet to 
come, ties it all together for me.” 
“A Sense of the Ending”, produced in color, was 
funded by a grant from the Connecticut Humanities 
Council. The title was taken from an essay adapted from a 
convocation address delivered by Professor Sewall at 
Williams College, Williamstown, Massachusetts. The 
production was taped by Philip Garvin, an independent 
public television producer and film maker. It is being 
prepared for distribution to medical centers and schools, 
and there are plans for showing it on public television as 
well. 
Asked if it was produced specifically for medical stu¬ 
dents, producer William Guth responded, "It was pro¬ 
duced for people who have to deal with death — which is 
everyone.” M.B.N. 
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One of Yale’s most distinguished graduates 
offers a challenge 
Dr. Leona Baumgartner (’32 Ph.D., '34 M.D.) is recognized worldwide as an authority on public 
health. Among numerous achievements and honors, she has been New York City's Commissioner 
of Health, an Assistant Secretary of State and a Professor at Harvard Medical School. 
Already a major benefactor of the School of Medicine, Dr. Baumgartner is especially concerned 
about the rising cost of becoming a Yale doctor — now $ 17,000 a year for tuition and living 
costs. Therefore, in addition to her generous previous gifts, she has just offered to give $75,000 in 
new money to the Student Revolving Loan Fund, provided that a further $ 150,000 in new money 
is given by other medical and public health alumni. 
Every dollar that you give to this year’s Alumni Fund above what you gave last year will be 
matched one-for-two by Dr. Baumgartner. If you made no gift last year, she will match your entire 
gift one-for-two. 
Currently at least three out of four Yale medical and public health students need significant 
amounts of financial aid. Although ninety-five percent of all loans are repaid on schedule, there are 
still not enough funds to meet students’ needs. If Leona Baumgartner’s challenge is fully met, 
funds for student loans will be significantly increased. 






A MESSAGE FROM THE DEAN OF STUDENTS 
Howard Levitin, M.D. 
Recent publicity has focused much 
attention on the problem of financing 
higher education As you are undoubt¬ 
edly aware, rising costs and decreasing 
money for financial aid create serious 
problems for medical students and for 
those considering a career in medicine. 
In spite of the large amount of money 
involved, our students have been will¬ 
ing to assume responsibility for their 
education, anticipate a large debt, and 
fully expect to pay back the money bor¬ 
rowed. This is attested to by the excel¬ 
lent performance of Yale students in 
repaying loans. 
In order for a loan program to meet 
students' needs, it should make money 
available on terms that make repayment 
compatible with income during post¬ 
graduate training and the early years of 
professional practice. Therefore, in 
addition to having the necessary 
amount of money available for loans, 
repayment must be at a reasonable 
interest rate and have a deferment 
option that postpones the burden of 
repayment to a time when income will 
be commensurate with the repayment 
schedule. The immediate crisis facing 
students in higher education today is 
the decreasing availability of money 
with these desirable characteristics. 
It is fortunate for the Yale School of 
Medicine that at this crucial time, Dr. 
Leona Baumgartner has made a substan¬ 
tial gift to the Student Revolving Loan 
Program, and that she did this in a way 
which encourages others to join in the 
support of our students. Adequate 
financial aid is imperative so that we 
can continue our current admission pol¬ 
icy based on scholastic achievement, 
not on the ability to pay. It is also 
important that our graduates be able to 
choose the specialty and location of 
practice uninfluenced by the magnitude 
of their debts. 
Over the years the Yale Medical 
School Alumni Fund income has been 
designated by the Dean to be used for 
student financial aid. The current 
Alumni Fund annual giving will be 
added to our Student Revolving Loan 
Funds. The Leona Baumgartner chal¬ 
lenge provides an exceptionally fine 
way to support this effort. I can assure 



















Dr. Lerner is Honored 
Dr. Aaron B. Lerner, professor and chairman of the 
Department of Dermatology since 1958, received the 1981 
Lita Annenberg Hazen Award for outstanding contribu¬ 
tions to clinical research. Dr. Lerner is well known for his 
research in pigment cell disorders. 
The Award cited his important contributions to immu¬ 
nology, endocrinology and neurobiology. “Dr. Lemer's 
research on pigment cells has advanced our understanding 
of disorders that involve the color of skin and eyes and has 
taken science closer to finding a treatment for patients with 
melanoma," the announcement said. Melanoma, a fre¬ 
quently serious type of cancer, usually involves the 
melanocytes, or pigment-forming cells in the skin. 
Dr. Lerner has also been among the leaders in research 
in the study of vitiligo, a disorder involving loss of pigment 
cells. It may also be related to immunologic abnormalities 
involving the eyes, thyroid, adrenal glands, blood and 
sometimes, the development of cancer. 
Dr. Lerner, who was bom in Minneapolis, received his 
advanced education at the University of Minnesota, earn¬ 
ing a B.A. degree cum laude in 1941, and a Ph. D as well 
as M.D. degree in 1945. Prior to joining the Yale medical 
faculty in 1955, he had been assistant professor of derma¬ 
tology at the University of Michigan Medical School, and 
associate professor of dermatology at the University of 
Oregon Medical School. In 1961-62 he was a Common¬ 
wealth Fellow at the Laboratory of Molecular Biology, 
England. 
The Lita Annenberg Hazen Awards were established in 
1979 to honor physicians whose “investigative studies 
have changed the medical profession's knowledge and 
consequent treatment of disease." Half of the $100,000 
award is given to the scientist whose work is honored; the 
remainder is subsequently given to the investigator’s insti¬ 
tution for support of a research fellow or fellows to be 
chosen by the Award winner. The awards are administered 
by the Mount Sinai School of Medicine. 
The following was excerpted from an article written by Dr. Lerner 
which appeared in the December 1981 issue of Clinical Research. 
Our research in the pigment field has covered much 
ground, yet our projects are carefully focused and oriented 
toward well defined goals. One of my most recent con¬ 
cerns has been to obtain adequate funding to keep intact the 
best group currently working on the biology of pigment 
cells. This group is important because I have long felt that 
the problem of melanomas can be solved and we all want 
to help with the work that has to be done. Good support 
from the American Cancer Society and the National Insti¬ 
tutes of Health has been and continues to be essential. 
Much of our work was initially of real interest only to those 
few people concerned with the biology and chemistry of 
pigment cells. It was only after we used melanocytes in the 
isolation and characterization of the melanocyte stimulat¬ 
ing hormones from the intermediate lobe of the pituitary 
gland and melatonin from the pineal gland that numerous 
investigators realized the great value of these cells for 
research in neuroendocrinology. Pigment cells arise from 
neural tissue and are responsive to factors from the inter¬ 
mediate lobe of the pituitary gland and the pineal gland. It 
is remarkable that our work on pigment cells has provided 
the handles that were so necessary for the study of these 
elusive structures. There has been an explosion of useful 
knowledge of both glands and in neuroendocrinology in 
general. Melanocytes were also used by Sutherland, 
Bitensky, Pastan, Hadley, ourselves and others to advance 
the “second messenger" concept of hormone action. 
A satisfactory treatment for melanomas may arise from 
general advances in oncology or from an unexpected 
source, but until that happens we shall continue on our own 
long march. Our present efforts combine three approaches. 
14 
We are seeking a full understanding of the receptors for the 
melanocyte stimulating hormone; the cytotoxicity of prod¬ 
ucts from reactions catalyzed by tyrosinase; and the 
immunology of pigment cells. These projects may appear 
overwhelming but I believe that the only important miss¬ 
ing link is a strain of mouse that develops vitiligo, to be 
used for the immunologic work. While it was indeed 
strange that melanocytes provided the leads for research 
into the pituitary and pineal glands it is still more surprising 
that knowledge of vitiligo may bring us to the solution of 
melanomas. There is hardly a disorder that has attracted 
less attention than vitiligo, and yet the association of 
depigmentation with autoimmune disorders of the thyroid, 
parathyroid, adrenal and thymus glands, as well as with 
pernicious anemia and melanomas, appears to be the 
Rosetta stone that holds the clues to a useful therapy for 
patients with melanomas. Years of clinical and laboratory 
experience have brought me to this conclusion. 
Vitiligo occurs in dogs, cats, pigs, horses, elephants, 
fish, chickens and other animals. All animals with pigment 
cells should have the potential to develop vitiligo. Chick¬ 
ens of a certain genotype, a year after hatching, lose all 
their pigment, become blind and develop thyroiditis. 
Removal of the bursa, the source of B cells, decreases the 
incidence and delays the onset of these changes. We need a 
mouse model similar to the chicken. When we are able to 
examine the growth of melanomas in mice that develop 
vitiligo we may be in a position to understand the role of 
immunologic surveillance in the spontaneous regression of 
tumors. Combining this understanding with information 
on the nature of receptors for MSH and the cytotoxic 
intermediates formed during melanin biosynthesis, we 
shall have all the basic knowledge required to develop a 
useful treatment for patients with melanomas. The cost of 
obtaining all this information is large but finite — between 






Appointment of Three Faculty Mem¬ 
bers to Named Chairs Announced 
Three members of the School of Medi¬ 
cine faculty have been appointed to 
named professorships. Dr. Lawrence 
S. Cohen has been appointed Ebenezer 
K. Hunt Professor of Medicine; Dr. 
Robert M. Donaldson, Jr. has been 
appointed David Paige Smith Professor 
of Medicine; and Dr. Paul Greengard 
has been appointed Henry F. Bronson 
Professor of Pharmacology. 
The Ebenezer K. Hunt Professorship 
was bequeathed to Yale by Mrs. Mary 
Crosby Hunt in 1896 in memory of her 
husband. Dr. Hunt, who was an alum¬ 
nus of Yale College Class of 1833, re¬ 
ceived his M.D. degree from Jefferson 
Medical College. He practiced medi¬ 
cine in Hartford for many years and was 
president of the Connecticut Medical 
Society in 1863-64. 
The David Paige Smith Professorship 
was established in 1912. It honors Dr. 
Smith w ho was professor of the Theory 
and Practice of Medicine from 1873 to 
1877, and professor of the Principles 
and Practice of Surgery from 1877 until 
his death in 1880. 
Originally designated as a chair in 
comparative anatomy, the Henry F. 
Bronson Professorship was reassigned 
to the Department of Pharmacology by 
recent action of the Yale Corporation. It 
was established in 1889 through a gift 
of Dr. Bronson, a member of the Yale 
medical class of 1827. 
Dr. Lawrence S. Cohen. 
Ebenezer K. Hunt Professor of Medicine 
A noted cardiologist. Dr. Cohen has 
been professor of medicine here since 
1970, and was chief of cardiology from 
1960 to 1970. 
A graduate of Harvard College, he 
received his M.D. degree from New 
York University School of Medicine in 
1958. He first came to New Haven as 
an intern at Yale-New Haven Hospital, 
where he also served his assistant resi¬ 
dency. From 1962 to 1964, he was a 
research fellow in cardiology at The 
Peter Bent Brigham Hospital in Boston, 
and assistant in medicine at Harvard 
Medical School. He was senior investi¬ 
gator and head of Clinical Service, 
Cardiology Branch of the National 
Heart Institute for three years prior to 
his appointment in 1968 as chief of 
clinical cardiology and professor of 
medicine at the University of Texas 
(Southwestern) Medical School at 
Dallas. 
Active for many years in the Ameri¬ 
can Heart Association. Dr. Cohen was 
named "Man of the Year" in 1980 by 
the South Central Connecticut Chapter. 
He is a member of several professional 
and honor societies and is a fellow of 
the American College of Cardiology, 
the American College of Physicians, 
and the Council on Clinical Cardiology 
of the American Heart Association. He 
serves on the editorial boards of the 
American Journal of Cardiology, Pri¬ 
mary Cardiology, Cardiovascular 
Medicine, and American Heart Journal. 
Dr. Robert M. Donaldson, Jr., 
David Paige Smith Professor of Medicine 
Dr. Donaldson, who is vice-chairman 
of the Department of Internal Medicine 
and chief of Medical Services at the 
Veterans Administration Medical Cen¬ 
ter in West Haven, is a leader in the 
field of gastroenterology. He came here 
in 1973 from the Boston University 
School of Medicine, where he had been 
head of the Gastroenterology Section 
and professor of medicine. 
After receiving a B.S. degree with 
high orations from Yale University, Dr. 
Donaldson studied medicine at Boston 
University School of Medicine, where 
he received an M.D. degree, cum laude, 
in 1952. He was an intern at Montreal 
General Hospital and a resident in in¬ 
ternal medicine at Boston Veterans 
Administration Hospital. From 1957 to 
1959, he was United States Public 
Health Service Fellow in gastro¬ 
enterology at Peter Bent Brigham Hos¬ 
pital and assistant in medicine at 
Harvard Medical School. He was 
appointed to the faculty of the Boston 
University School of Medicine in 1959. 
A member of a number of profes¬ 
sional societies. Dr. Donaldson served 
as president and is a member of the 
governing board of the American Gas¬ 
troenterology Association. The author 
of numerous abstracts and papers on 
gastroenterology, he served as editor of 
Gastroenterology from 1970 to 1977, 
and is a member of the editorial com¬ 




















Dr. Paul Greengard, 
Henry F. Bronson Professor of 
Pharmacology 
Dr. Greengard, a leading authority on 
the pharmacology and biochemistry of 
the nervous system was appointed to 
the Yale faculty in 1968. Prior to his 
appointment to the Bronson Professor¬ 
ship, he had been professor of phar¬ 
macology and psychiatry. 
A pioneer in the field of cyclic nu¬ 
cleotide research. Dr. Greengard is 
well known for his investigations on the 
phosphorylation of membrane proteins 
and its potential role in nerve transmis¬ 
sion. His work has been recognized by 
numerous awards and honors, includ¬ 
ing election to the National Academy of 
Science, as well as to the American 
Academy of Arts and Sciences in 1978. 
In 1980, he received the New York 
Academy of Sciences’ Award in Bio¬ 
logical and Medical Sciences, and last 
year he was appointed an Andrew D. 
White Professor - at - Large, one of the 
most distinguished professorships 
offered by Cornell University. 
Prior to his appointment at Yale, Dr. 
Greengard has been director of the 
Department of Biochemistry at Geigy 
Research Laboratories in Ardsley, New 
York. A graduate of Hamilton College, 
Clinton, New York, he received a Ph. 
D. degree in neurophysiology from The 
Johns Hopkins University. In addition, 
he did research at the Institute of Psy¬ 
chiatry, University of London; the 
Molteno Institute, Cambridge Univer¬ 
sity; the National Institute for Medical 
Research, London, and the National 
Institutes of Health, Bethesda, Maryland. 
Dr. Greengard is a member of a 
number of professional societies in¬ 
cluding the American Society for Bio¬ 
logical Chemists, the American Society 
for Pharmacology and Experimental 
Therapeutics, and the American College 
of Neuropsychopharmacology. He is 
on the editorial board of several journals 
including The Journal of Biological 
Chemistry; Drug and Alcohol Abuse 
Research; and Current Topics in Mem¬ 
branes and Transport, and is the 
founder and series editor of Advances 
in Cyclic Nucleotide Research. 
Two New Lectureships Established 
by Alumni 
Through a gift of an alumnus, a series 
of annual Sanfurd G. Bluestein Lec¬ 
tures in Diagnostic Radiology was 
inaugurated at the School on February 
1 I. Dr. M. Paul Capp, professor and 
chairman of the Department of Radi¬ 
ology at the University of Arizona 
College of Medicine, spoke on “Medi¬ 
cal Imagery- 1990”. 
The lecture series was established 
through a contribution to The Cam¬ 
paign For Yale by Dr. Bluestein, a 
member of the Class of 1946. A pioneer 
in the field of radiology, he was one of 
the first physicians in the United States 
to use cobalt in the treatment of malig¬ 
nant disease. In the 1950’s, he pio¬ 
neered in the use of radioisotopes as a 
diagnostic procedure. 
Dr. Bluestein, who is attending radi¬ 
ologist at Chilton Memorial Hospital 
and Bamert Memorial Hopspital in 
New Jersey, is assistant professor of 
radiology at Mt. Sinai Medical School. 
A former member of the Hospital Plan¬ 
ning Council for Northern New Jersey, 
he is a member of the Board of Direc¬ 
tors and of the Executive Committee of 
the New York City Opera. 
A lectureship honoring Dr. Jack R. 
Cooper has been established in the 
Department of Pharmacology through a 
gift of Dr. Mohandas M. Kini. The first 
annual lecture was given on February 
19 by Dr. Jon Lindstrom of the Salk 
Institute in San Diego. 
Dr. Cooper, who is professor of 
pharmacology, is well known for his 
research in the field of neurochemistry, 
and especially for his contributions to 
new knowledge of the neurotransmit¬ 
ter, acetylcholine, and of the role of 
thiamine in nervous tissue. He became 
a member of the Yale medical faculty in 
1956, and has been a Special Fellow of 
the U.S. Public Health Service in 
London, England (1965-66), and 
visiting professor at Hebrew Univer¬ 
sity, Israel (1973). 
A graduate of Queens University, 
Kingston, Ontario, he received both his 
M.A. and Ph.D. degrees in biochemis¬ 
try from George Washington Univer¬ 
sity. From 1952 to 1954, he was Smith, 
Kline and French Research Fellow of 
the National Heart Institute. He is a 
member of the Advisory Board of the 
USA-Israel Binational Science Founda¬ 
tion. The co-author of Biochemical 
Basis of Neuropharmacology, now in 
its fourth printing. Dr. Cooper serves 
on the editorial boards of Biochemical 
Pharmacology, Neurochemical Re¬ 
search, and the Journal of Neuro- 
Neurochemistry. 
Dr. Kini, who received his Ph.D. 
degree from McGill University in 1960 
and M.D. degree from Yale University 
in 1965, is chief of Retina Services at 
Boston University Medical Center, and 
assistant professor of ophthalmology at 
Boston University School of Medicine. 
He did research in Dr. Cooper’s labor¬ 
atory while he was a postgraduate stu¬ 
dent at Yale. 
Dr. Brieger Delivers 
Fulton Memorial Lecture 
The fourth annual John F. Fulton 
Memorial Lecture was given on Octo¬ 
ber 30 by Dr. Gert Brieger, professor 
and chairman of the Department of the 
History of Health Sciences, University 
of California, San Francisco. The lec¬ 
ture was entitled “Early Ambulation: A 
Case Study in the History of Surgery”. 
Dr. Brieger received his M.D. degree 
from U.C.L.A., his M.P.H. degree 
from the Harvard School of Public 
Health, and his Ph.D. degree in history 
from Johns Hopkins University. He is 
president of the American Association 
for the History of Medicine. 
The lecture is named for the late John 
F. Fulton, Sterling Professor of the His¬ 
tory of Medicine at Yale, and is funded 
by a gift from Dr. Bern Dibner, Direc¬ 
tor of the Bumdy Library, Norwalk, 
Connecticut. A committee of the 
Beaumont Medical Club selects a 
Fulton Fellow annually. 
17 
Faculty Notes 
The 1981 C.E.-A. Winslow Award 
was presented to Dr. Robert W. 
McCollum, who is recognized interna¬ 
tionally for his research on hepatitis. 
The award, which is presented annually 
by the Connecticut Public Health 
Association, is given to an outstanding 
professional in the field of public 
health. It was established to honor the 
memory of the founder of the Depart¬ 
ment of Public Health at Yale. Dr. 
McCollum retired as Susan Dwight 
Bliss Professor and chairman of the 
Department of Epidemiology and 
Public Health on January 1, to become 
dean of the Dartmouth Medical School. 
The National Academy of Sciences 
presented the 1982 U.S. Steel Founda¬ 
tion Award in Molecular Biology to 
Dr. Joan A. Steitz, professor of mo¬ 
lecular biophysics and biochemistry. 
Established in 1961 to recognize nota¬ 
ble discoveries by young scientists in 
the field of molecular biology, the 
award cites Dr. Steitz's contribution to 
the understanding of how RNA mo¬ 
lecules are recognized and synthesized 
by enzymes, and discovering the roles 
played by small ribonucleoprotein mo¬ 
lecules in RNA processing. 
Among the first delegation of the 
American Psychiatric Association to 
visit China, were Dr. Donald J. 
Cohen, professor of pediatrics, psy¬ 
chiatry and psychology, and Dr. Boris 
Astrachan, professor of psychiatry 
and director of the Connecticut Mental 
Health Center. In addition to visiting 
major psychiatric centers in the People’s 
Republic of China, they presented 
papers at the first Chinese symposium 
on schizophrenia. It was their impres¬ 
sion that ideas about psychiatric dis¬ 
orders in China generally are similar to 
those held by psychiatrists in the United 
States. 
The 1982 Kappa Delta Award for out¬ 
standing research in orthopedic surgery 
was presented to Dr. Gary E. 
Friedlaender, associate professor of 
surgery (orthopedic). The awards are 
given annually by a joint committee of 
the American Academy of Orthopaedic 
Surgeons and the Orthopaedic Research 
Society. Dr. Friedlaender was recog¬ 
nized for his development of guidelines 
for the safe and effective banking of 
musculoskeletal tissues and for concepts 
for clinical application of bone allografts 
following traumatic, degenerative or 
neoplastic diseases of the skeleton. 
Seven members of the faculty were 
named American Association for the 
Advancement of Science Fellows at the 
Association’s annual meeting held in 
January. They are Dr. Alvan R. 
Feinstein, professor of medicine and 
epidemiology; Dr. Robert E. 
Handschumacher, professor of phar¬ 
macology; Dr. Kenneth K. Kidd, 
associate professor of human genetics; 
Dr. Frederic M. Richards, the Henry 
Ford II Professor of Molecular Bio¬ 
physics and Biochemistry; Dr. Leon 
E. Rosenberg, professor and chaimian 
of the Department of Human Genetics; 
and Dr. Sherman M. Weissman, pro¬ 
fessor of human genetics, medicine, 
and molecular biophysics and bio¬ 
chemistry. A fellow of the AAAS is “a 
member whose efforts on behalf of the 
advancement of science or its applica¬ 
tions are scientifically or socially 
distinguished.” 
Dr. James L. Boyer, professor of 
medicine and director of the Liver Study 
Unit, and Dr. Joyce D. Gryboski. 
professor of pediatrics, have been 
appointed to the National Digestive 
Diseases Advisory Board. Dr. Boyer 
was also named vice-chairman of the 
Board, which was established in 1980 
to recommend to Congress and the Se¬ 
cretary of Health and Human Services 
ways to combat digestive diseases, a 
leading cause of death and disability in 
the United States. 
The 1981 Macomber Lecture at Harvard 
Medical School was delivered by Dr. 
Philip M. Sarrel, associate professor 
of obstetrics and gynecology and psy¬ 
chiatry. His topic was “The Psycho¬ 
sexuality of the Menopause”. The 
Macomber Lecture was established to 
provide lectures by guest speakers to 
undergraduate students on subjects of 
sexuality in the field of human repro¬ 
duction and reproductive biology. 
Dr. Gilbert H. Glaser, professor and 
chairman of the Department of Neurol¬ 
ogy, has returned from a fall term leave 
of absence spent mainly conducting 
research as a visiting professor at The 
Park Hospital, Oxford, England, the 
National Centre for Children with 
Epilepsy in Great Britain. He also was 
designated a Fulbright Distinguished 
Professor during the month of October 
in Yugoslavia, where he gave a series 
of lectures and conferences in the 
University Departments of Neurology 
and Neurosciences in Zagreb and Rijeka. 
Dr. John A. Kirchner, professor of 
otolaryngology, delivered the Semon 
Lecture at the Royal Society of Medi¬ 
cine in London in November. Sir Felix 
Semon was well known for his work in 
laryngology, and in 1881, “Semon’s 
Law” of laryngeal paralysis was pub¬ 
lished. In his lecture. Dr. Kirchner 
examined this disorder as seen a cen¬ 
tury later. 
Dr. George A. Silver, professor of 
public health and Institution for Social 
and Policy Studies, has been elected a 
senior member of the Institute of Medi¬ 
cine. Chartered in 1970 by the National 
Academy of Sciences, the Institute of 
Medicine enlists distinguished mem¬ 
bers of medical and other professions 
for the examination of policy matters 
pertaining to public health. 
New Books by Faculty 
“Skin Signs of Systemic Disease”. 
Second edition. By Irw in M. Braver- 
man, M.D., professor of dermatology. 
W.B. Saunders (Philadelphia) 1981. 
“Clinical Psychiatric Medicine". 
Julian Lieb, M.B.B.Ch., associate 
clinical professor of psychiatry; 
Andrew Slaby, M.D., PhD.; and 
Lawrence Tancredi. M.D., J.D. 
Harper and Row (New York) 1981. 
Yale Medical Historians Contribute 
to Classics of Medicine Library 
An English translation of “The Etiology, 
the Concept and the Prophylaxis of 
Childbed Fever” by Ignac Semmel- 
weis has recently been privately printed 
for the members of The Classics of 
Medicine Library. The elegantly bound 
volume also contains translations of the 
Semmelweis “Open Letters” prepared 
by Dr. Sherwin Nuland, assistant clini¬ 
cal professor of surgery, and Ferenc 
Gyorgyey, medical historical librarian 
at the Yale Medical Library. Dr. 
Nuland's article, “The Enigma of 
Semmelweis — an Interpretation”, 
from the Journal of the History of 
Medicine and Allied Sciences is also 
included. The Classics of Medicine 
Library is a division of Gryphon Edi¬ 
tions, Ltd., Birmingham, Alabama. 
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Robert Holt Green, M.D. 
Dr. Robert H Green, clinical professor 
of medicine and formerly professor of 
pathology and medicine, died at his 
home in Madison, Connecticut on 
December 25. He was 70 years old. 
A native of Charleston, South 
Carolina, he received his B.A. degree 
from the University of the South in 
1933 and graduated from the Johns 
Hopkins University School of Medi¬ 
cine in 1938. Following an internship at 
Strong Memorial Hospital in Rochester, 
New York, and post graduate training 
in internal medicine at Western Reserve 
University Hospital in Cleveland, he 
was appointed a National Research 
Council Fellow in the medical sciences 
at the Rockefeller Institute. Dr. Green 
served four years in the U.S. Navy dur¬ 
ing World War II and was discharged in 
1946 with the rank of lieutenant com¬ 
mander. He returned to the Rockefeller 
Institute for a year prior to joining the 
Yale faculty in 1947 as an assistant pro¬ 
fessor of medicine. He was promoted to 
associate professor in 1950. 
In the ntid-1950’s Dr.Green was 
engaged in practice of internal medi¬ 
cine in Madison; however, he returned 
to the full-time faculty at Yale in 1957 
as an associate professor of preventive 
medicine working with Dr. John R. 
Paul. From 1960 to 1967 he served as 
associate professor and professor at 
New York University School of Medi¬ 
cine. During this period he was asso¬ 
ciate scientific director of the Health 
Research Council of the City of New 
York and later chief of the medical ser¬ 
vice at the Manhattan Veterans Admin¬ 
istration Hospital. He returned to 
Connecticut in 1967 as associate chief 
of staff for research at the West Haven 
Veterans Adminstration Hospital and 
professor of medicine at Yale. 
Then in 1969 Dr. Green responded to 
a call from his homeland and served as 
dean and professor of medicine at the 
Medical University of South Carolina 
until 1970. When he came back to Yale, 
he was appointed professor of pathol¬ 
ogy and medicine and resumed his posi¬ 
tion at the Veterans Administration 
Hospital. In 1974 he joined the staff of 
the Middlesex Memorial Hospital in 
Middletown, Connecticut as chairman 
of the Department of Medicine and 
continued his association with Yale as a 
clinical professor of medicine. 
During his career as a medical scien¬ 
tist, Dr. Green did extensive research 
on the epidemiological and clinical 
aspects of a variety of virus diseases, 
especially rubella and intluenza. He 
also studied the effects of virus infec¬ 
tions on persons suffering from bron¬ 
chitis and emphysema. He was a mem¬ 
ber of the American Association of 
Immunologists, the American Society 
for Clinical Investigation, the Infec¬ 
tious Diseases Society of America and 
various other professional organizations. 
In speaking of Dr. Green’s service as 
chief of medicine since 1974, the 
Middlesex Memorial Hospital presi¬ 
dent said, “Dr. Green was one of the 
most outstanding physicians this insti¬ 
tution has known in terms of his contri¬ 
butions to the quality of patient care 
here ... He worked in quiet, effective 
ways, offering unique and special con¬ 
tributions too extensive to be 
innumerated. 
Dr. Green is survived by his wife, 
Audrey Johnston, two sons and a 
daughter. 
Theodore Sehlosser Evans, M.I). 
Dr. Theodore S. Evans, clinical pro¬ 
fessor emeritus of medicine, died on 
Januray 25, 1982 at the age of 86 fol¬ 
lowing a long illness. 
A graduate of Phillips Exeter Acad¬ 
emy, Dr. Evans received his B.A. 
degree from Yale College in 1917 and a 
B.S. Degree in 1919 from Columbia 
University. In 1921 he received his 
M.D. from the Columbia University 
College of Physicians and Surgeons. 
He interned at the House of Mercy 
Hospital in Pittsfield, Massachusetts 
and then served as a resident physician 
at Roosevelt Hospital in New York City 
from 1922 to 1924, when he located in 
New Haven. 
He joined the Yale School of Medi¬ 
cine faculty in 1933 as a clinical 
instructor of medicine. He was pro¬ 
moted to assistant clinical professor 
and subsequently to associate clinical 
professor. In 1952 he was promoted to 
the rank of clinical professor. He was 
given an emeritus title when he retired 
from the active faculty in 1964; how¬ 
ever, he continued to be active profes¬ 
sionally until 1976. 
Dr. Evans was one of the first physi¬ 
cians in this area to specialize in hema¬ 
tology, and he won wide acclaim in that 
field. For many years he was chief of 
the medical service at the Grace Unit of 
Grace-New Haven Hospital and director 
of the Hematology Clinic. He also had 
been chief of medical services at the 
Hospital of St. Raphael in New Haven 
and the Griffin Hospital in Derby. He 
was a fellow of the American College 
of Physicians, a member of the Inter- 
natinal Society of Hemotology, and 
had served as president of the New 
Haven Medical Association. 
Throughout his medical career in 
New Haven, Dr. Evans was a dedi¬ 
cated teacher of medical students and 
house staff. On his retirement from the 
active faculty. Dean Vernon Lippard 
wrote as follows: “Your loyalty and 
support of the highest ideals in medical 
education and medical care have been 
demonstrated on many occasions, and 
the position you have held in the medi¬ 
cal community has made your support 
effective.” 
Cyrus Robert Friedman, M.I). 
On November 27, 1981, Dr. Cyrus R. 
Friedman, associate clinical professor 
of pyschiatry, died suddenly following 
a brief illness. 
Dr. Friedman was bom in New York 
City in December 1923. After receiv¬ 
ing his B.A. from Cornell University 
and his M.D. in 1946 from Cornell 
Medical College, he interned at the 
Sinai Hospital in Baltimore, Maryland 
and then served for two years in the 
Army Medical Corps. 
He began his residency in pyschiatry 
in 1950 at the Winter Veterans Admin¬ 
istration Hospital in Topeka, Kansas 
and was simultaneously a fellow at the 
Menninger School of Psychiatry. In 
1952 he moved to the Austen Riggs 
Center in Stockbndge, Massachusetts 
to complete his training. From 1955 to 
1959 he was a member of the staff at the 
Austen Riggs Center and had a private 
practice in Pittsfield, Massachusetts. 
In 1959 Dr. Friedman was appointed 
chief of the Department of Psychiatry at 
Mount Zion Hospital in San Francisco, 
a post which he held until he came to 
New Haven in 1961 to engage in the 
private practice of psychiatry and psy¬ 
choanalysis. He was appointed to the 
part-time faculty at Yale in 1963 as an 
assistant clinical professor and was 
promoted to associate clinical professor 
in 1971. He was also an attending pys- 
chiatrist at the Yale-New Haven Hospital. 
continued, next page 
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A graduate of the Western New 
England Institute for Psychoanalysis 
and a fellow of the American Psychiat¬ 
ric Association, Dr. Friedman was a 
highly respected member of the New 
Haven psychiatric community. He was 
regarded by his colleagues to be a very 
competent clinician and a challenging 
and effective teacher. 
Dr. Friedman is survived by his 
wife, Carolyn Jaffe Freidman, and their 
daughter, Margaret, and son, David. 
Anil N. Jayawardena, Ph.I). 
Dr. Anil N. Jayawardena, a research 
associate in epidemiology and public 
health, died suddenly, apparently of a 
cardiac arrest, on December 20, 1981 
at the age of 35. 
Dr. Jayawardena came to Yale in 
1975 as a postdoctoral associate in the 
Department of Pathology. Born in Sri 
Fanka, he attended the University of 
Ceylon and graduated with the B.Sc. 
degree with honors in Zoology in 1969. 
He then went to England and received 
his Ph.D. in 1975 from the University 
of Fondon, where he had served as a 
Commonwealth Scholar. Prior to com¬ 
ing to the United States, he worked as a 
postdoctoral research fellow in the 
Department of Immunology at Middle¬ 
sex Hospital Medical School in Fondon, 
From 1976 to 1978, Dr. Jayawardena 
held a James Hudson Brown Memorial 
Fellowship in pathology at Yale and 
worked with Dr. Byron H. Waksman 
on the role of suppressor T-cells in an 
animal model of trypanosomiasis. In 
1978 he was appointed as a research 
associate in pathology, and in 1980 his 
appointment was in epidemiology and 
public health. Throughout this period 
he continued his immunologic research 
in experimental trypanosomiasis and 
received support from the National 
Institutes of Health and the Rockefeller 
Foundation. 
Dr. Jayawardena was considered by 
his colleagues to be an exceptional 
individual and a profoundly competent 
investigator. The sudden unexpected 
death of this extremely promising 
young scientist was a great shock to all 
those who knew him. 
RENOVATION OF THE JANE ELLEN HOPE BUILDING: 
an historic place updated for new uses 
The intenor of the Hope Building, when the central area on the first 
floor was used as a waiting room for the clinic — circa 1925-30. 
Sitting squarely on the comer of 
Congress Avenue and Cedar Street, the 
dark red brick and rough stone building 
is the oldest structure on the medical 
school campus. Built in 1902 as the 
clinic for the School it was considered 
at the time to be one of the largest and 
most thoroughly equipped clinical 
buildings in the country. The Jane Ellen 
Hope Building is of historical as well as 
architectural significance to Yale and to 
the surrounding neighborhood. 
While its exterior is important as a 
landmark, it is not exceptional architec¬ 
turally. The original interior of the 
Hope Building, however, was a 
masterpiece of architectural space and 
detailing, typical of the times. 
Designed around a central interior 
court, three stories high, surrounded by 
galleries leading to small rooms, with a 
monumental stairway to the second 
floor, it was crowned with a magnifi¬ 
cent skylight which filtered sunlight 
throughout the central space. Tucked 
behind, were a small lecture hall, and 
perhaps the building's greatest treas¬ 
ure, an amphitheater. 
Beneath the dismal hodgepodge of 
subsequent clumsy and ill-conceived 
partitioning and other intrusions on the 
space, many of the elegant architectural 





and its balustrade, terrazzo from the 
first floor, wood detailing and brackets, 
and marble slab counters. Some of 
these, as well as the lecture hall and the 
amphitheater, are incorporated into the 
renovation plans. 
By the late 1960’s, it was evident 
that the building, as it was originally 
designed, was impractical for modem 
use in a medical school where space is, 
to put it mildly, at a premium. Further, 
the open design, however appealing 
esthetically, did not meet contempo¬ 
rary building fire and safety codes. 
Fortunately, suggestions for demo¬ 
lition of the Flope Building were 
rejected in favor of renovation to create 
much needed new teaching space. The 
final design by architect Alexander 
Purves reflects a fine sensitivity both to 
the historical and architectural qualities 
of the building in a design that is a well 
executed adaptation of the interior to 
more practical use as an educational 
center. 
When work is completed sometime 
this summer, two new auditoriums, one 
on the first floor, the other directly 
above, each with a capacity for 150 
people; ten seminar rooms and the 
existing small lecture hall will be avail¬ 
able for use by medical classes, as well 
as for conferences and convocations. 
Exhibition galleries, lounges, a snack 
canteen and a catering kitchen to serve 
day-long events, will add much needed 
amenities to the facilities at the School 
of Medicine. 
There are also plans, temporarily 
shelved for a lack of funding, to reno¬ 
vate the amphitheater. These plans are 
described here by Mr. Purves. 
The historic amphitheater is both the 
symbolic and the architectural heart of 
the Hope Building. It is the oldest sur- 
ving teaching space at the School of 
Medicine, and it forms the core of the 
renovated building. Over time, as the 
room ceased to be used for its original 
purpose as a surgical amphitheater, it 
fell on sad days. Previous renovations 
to other areas began to encroach on the 
space, and mechanical ducts were run 
through it as they would be through any 
other unused abandoned space. 
The amphitheater, with its steeply 
rising curved tiers of seats — like a 
small Greek theater — was the most 
unusual and architecturally striking 
space in the old building. The current 
renovations will retain the unique char¬ 
acter of the room and will restore it to 
its appropriate place as a vital teaching 
space at the center of the building. Cer¬ 
tain minor modifications to the original 
room will be made to make it safer, 
more easily accessible, and more ser¬ 
viceable as a teaching space. A new 
entrance at each side will lead directly 
from the first floor to the lowest tier of 
seats. The floor of the pit will be 
slightly raised so that it will suitable for 
lectures. A chalk board will be inserted 
within the old window frame on the 
front wall, and the original skylight, 
which had been partially destroyed, 
will be replaced by a new one in the 
same location. Enough of the original 
seats survived so that they may be 
reconditioned and reinstalled. 
The room itself is of such a strong 
architectural character and creates such 
a dramatic ambience that it is likely that 
a greater variety of uses will be found 
for it in addition to that of a lecture 
room. It would incidentally, be ideally 
suited to small stage productions or 
chamber music performances. But the 
intention of the renovation is to modify 
the room only as necessary to make it 
serve as a teaching space while retain¬ 
ing its unique architectural character as 
well as its unique place in the history of 




The Alumni in Medicine Column 
Notes from the President 
Nicholas P. R. Spinelli, M.D. 
Welcome to a new column. We intend 
in future issues to present subjects for 
discussion which are of interest to you, 
ones which hopefully many of you have 
suggested. 
Our purpose is communication, 
among ourselves and for ourselves. A 
first and pertinent question is who 
“ourselves” may be — Who are the 
Yale alumni/alumnae in medicine in 
1982? Across the span from our oldest 
graduates from the Class of 1906 to 
those of 1982, there is great profes¬ 
sional, geographic, and ethnic variety. 
Our alumni ranks began with physi¬ 
cians, but with the growth of our organ¬ 
ization we have added to the roster pub- 
lic health professionals, house staff and 
fellows, and recently the physician 
associates. 
Lastly, but so importantly, the cur¬ 
rent Yale medical student deserves 
attention, and perhaps some orienta¬ 
tion, in this context. We are students so 
briefly, and alumni forever thereafter. 
Students should be viewed as the em¬ 
bryo alumni they are, and we probably 
owe them an orientation to the sense of 
responsibilities and opportunities which 
the alumni status provides. Of particu¬ 
lar interest to all of us would be the 
portrait of the Yale medical student in 
1982. Does their experience parallel 
those of the generations of graduates 
who remember the Yale system of med¬ 
ical education so unique and so extra¬ 
ordinary? A future column or article 
should be devoted to them so that they 
can present their self-portrait. 
Most of the many graduates who 
elected to remain active in alumni 
affairs are involved in the fund-raising 
process which addresses various needs 
of our School and especially those of 
our current students. Who are these 
dedicated people and what gratification 
do they derive from their effort? Ros 
Gallagher (’30), for example, has for 
the many years since its inception 
chaired, in a low-key way, our Medical 
School Alumni Fund’s Bequest and 
Endowment program. Aided by Sam 
Kushlan (’35), why did he last year 
pursue this effort in a more high-keyed 
way? What are the implications of such 
activities concerning the future of 
American medical education? In a 
forthcoming column, we shall have you 
meet Ros and Sam and let them state 
their case. 
We visualize communication in this 
column as a dialogue. Since a dialogue 
does not flow in one direction, we shall 
need your suggestions, reactions, and 
volunteered expertise to make this 




The third edition of “Hand Surgery” 
by J. Edward Flynn has recently been 
published by Williams & Wilkins. Dr. 
Flynn is clinical professor of surgery 
emeritus at Tufts University School of 
Medicine and chief. Hand Surgical Ser¬ 
vice at the Veterans Administration 
Hospital in Boston. 
1940 
Crawford Campbell wrote recently: 
“We have semiretired, although I spend 
five months a year at the Mass. Gen. 
Hospital in the Department of Ortho¬ 
paedics working in the field of patho¬ 
physiology of the bones and joints, and 
another three months in other universi¬ 
ties teaching in the same field. Our ma¬ 
jor home is on Squam Lake in New 
Hampshire and we have a condominium 
on Commonwealth Avenue in Boston.'' 
1941 
Robert Areson has been appointed full¬ 
time corporate medical director of Un¬ 
ion Camp Corporation in New Jersey, a 
position he has held on a part-time basis 
since 1969. 
Dr. Areson will develop company 
health policies and coordinate the activi¬ 
ties of other company physicians, while 
continuing to provide medical services 
at the Wayne (N.J.) headquarters. He 
will also serve as the company's repre¬ 
sentative on industry health committees. 
Dr. Areson has published several arti¬ 
cles on diabetes and serves as chairman 
and president of the Camp Nejeda Foun¬ 
dation, which operates a camp for dia¬ 
betic children in Stillwater, New Jersey. 
Among his professional honors are cita¬ 
tions from the New Jersey Diabetes 
Association and from the Board of Trus¬ 
tees and medical staff of Mountainside 
Hospital, Montclair, for his service as 
president of the medical staff. He resides 
in Little Falls, New Jersey. 
1944 
Laurence Roth, in private practice in 
Batavia, New York, has been elected to 
a three-year term as chairman of District 
II (New York State) of the American 
College of Obstetricians and Gynecolo¬ 
gists. From 1976 to 1978, he was a 
member of its Committee on Patient 
Education; in 1979, he served on its 
Committee on Nominations; and from 
1978 to 1981 was secretary of District II. 
Dr. Roth is assistant clinical professor 
at State University of New York at 
Buffalo School of Medicine and clinical 
instructor at University of Rochester 
School of Medicine and Dentistry. In 
addition, he is affiliated with Genesee 
Memorial Hospital in Batavia. 
Dr. Roth is also a Fellow of the Amer¬ 
ican College of Surgeons and a member 
and past president of the Buffalo Gyne¬ 
cologic and Obstetric Society. 
1950 
John Strauss, professor and head of the 
Department of Dermatology at Univer¬ 
sity of Iowa College of Medicine has 
been selected as president-elect of the 
American Academy of Dermatology. In 
addition to having held many positions 
in the Academy during the past 25 years, 
he is also an assistant editor of the 
Journal of the American Academy of 
Dermatology and has served on the edi¬ 
torial board for the Journal of Investiga¬ 
tive Dermatology. 
Dr. Strauss' activities extend into 
many aspects of medical education and 
health care. He is on the Committee on 
Continuing Medical Education for the 
Council of Medical Specialty Societies 
and the Accreditation Review Commit¬ 
tee for the Accreditation Council for 
Continuing Medical Education. He is 
also an associate director of the Com¬ 
mission on Cutaneous Diseases for the 
Defense Department and a consultant 
to the Surgeon General of the United 
States. 
1952 
Karel Absolon’s recently published 
book, “The Surgeon’s Surgeon: Theodor 
Billroth (1829-1894). Volume II (The 
Middle Years, 1867- 1879)’’ is now 
available in addition to Volume I. Vol¬ 
ume III is in preparation. The publisher 
is Coronado Press in Lawrence, Kansas. 
In a review of this work it was noted 
that “it is important to recognize that 
Professor Absolon was himself an edu¬ 
cator and busy surgeon during this 
writing ... He uses facts, anecdotes, 
epigrams, conversations, and docu¬ 
ments of historic importance, some of 
which are reaching the outside world 
tor the first time, in a singularly precise 
way, delivering essentially Billroth the 
person and surgeon first, and then with 
less priority, the broad sweep of history. 
. . . The sterling quality of Professor 
Absolon’s Surgeon’s Surgeon is that 
his subject was, and is, first and fore¬ 
most a human being 
The reviewer of this work. Dr. Stacey 
B. Day, comments further: “. . . Few 
surgical scholars are so well fitted as 
Karel Absolon to undertake the trans¬ 
lation of so much original background 
information, or to evaluate and appre¬ 
ciate the life of Theodor Billroth as 
evident in the work of Professor 
Absolon. This Life is a magnificent 
endeavour, and it is convincing.’’ 
1953 
Donnell Etzwiler. pediatrician at St. 
Louis Park Medical Center and director 
of the Diabetes Education Center in 
Minneapolis, has been honored by 
election to membership in the National 
Academy of Sciences, institute of 
Medicine. Dr. Etzwiler is also a past 
president of the American Diabetes 
Association and is currently a vice pres¬ 
ident of the International Diabetes 
Federation. 
Jose Ramirez Rivera, Director of the 
Western Consortium of Medical Edu¬ 
cation and professor of Medicine at the 
University of Puerto Rico has received 
an award as ‘'the highest value in Medi¬ 
cal Education” for 1981 from the West¬ 
ern District of the Puerto Rico Medical 
Association. Dr. Ramirez is Chairman 
of the Department of Medicine of the 
Mayaguez Medical Center and Director 
of the Rincon Rural Health Initiative 
Project. 
1954 
The Uniformed Services University of 
the Health Sciences has established a 
Section on Medical History in the 
University's School of Medicine, and 
Robert Joy has been appointed the first 
chairman and professor of medical his¬ 
tory. Dr. Joy, until his retirement from 
the Army in October 1981, had served 
27 years in the Medical Corps. He held 
the rank of colonel and had most recent¬ 
ly served as Commandant of Students 
at the School as well as chairing its 
Department of Military Medicine and 
History. 
A lively and vivid lecturer. Dr. Joy 
in 1980 received the first William P. 
Clements Award which is given annu¬ 
ally at the University, as it is at the 
service academies, to the uniformed 
faculty member considered by the stud¬ 
ents to be their best teacher. 
At a retirement ceremony on October 
30, Dr. Jay Sanford, Dean of the 
School of Medicine, referred to Dr. 
Joy’s retirement as a “transition” rather 
than a goodbye. Then, as Dr. Joy’s 
mother, wife, and daughter looked on 
Dean Sanford presented him with the 
Army's Distinguished Service Medal, 
the highest award that an active duty 
military officer can receive in a non¬ 
combat role. 
1956 
William Hindle wrote recently from 
Honolulu. He has been elected for a 
third term as treasurer of the Hawaii 
Medical Association. 
1960 
John Davis, state director of research 
for the Illinois Department of Mental 
Health and director of research at the 
Illinois State Psychiatric Institute in 
Chicago, has been appointed the first 
Gilman Professor in the College of 
Medicine, University of Illinois at the 
Medical Center, Chicago. He has also 
been named a research professor in the 
College’s Department of Psychiatry. 
Internationally known for his work 
in the fields of psychopharmacology 
and psychiatric depression, he has 
served as consultant to the Food and 
Drug Administration, the National 
Academy of Science, National Institute 
for Mental Health, the President’s 
Commission on Mental Health, and the 
National Commission on Marijuana 
and Drug Abuse. 
1964 
An impressive health care system is 
being developed in Bogota, Colombia, 
South America by the Fundacion Santa 
Fe de Bogota (F. S. F. B.). Of the six 
founders of this Colombian Institution, 
two are Yale medical school alumni; 
Alfonso Esguerra and Jose Felix 
Patino, (’52). Dr. Esguerra is the gen¬ 
eral director of F.S.F.B. Dr. Patino is 
the chairman of the Department of 
Surgery at the medical center being 
developed by F.S.F.B. 
The medical center will open in mid- 
1982. Its 200-bed hospital will provide 
a full range of in- and outpatient ser¬ 
vices. All full-time physicians and 
those clinical physicians actively par¬ 
ticipating in the teaching programs of 
the medical center will have academic 
appointments at the University of the 
Andes. 
1965 
William Grossman, formerly director 
of the cardiac catheterization labora¬ 
tory at Brigham and Women's Hospital 
in Boston, has been appointed director 
23 
of the cardiovascular divison at Boston’s 
Beth Israel Hospital and promoted to 
professor of medicine at Harvard Medi¬ 
cal School. He is particularly interested 
in new developments in the treatment 
of patients with acute myocardial in¬ 
farction. Dr. Grossman is the author of 
the textbook, “Cardiac Catheterization 
and Angiography" which is now in its 
second edition and is the standard of 
reference in his field. 
1966 
Arne Youngberg, an attending radio¬ 
logist at Waterbury (Conn.) Hospital is 
vice chairman for the Medical Staff 
Division of the Waterbury Hospital's 
1982 Annual Appeal. The Annual 
Appeal seeks support each year in 
Waterbury and surrounding towns to 
help fund the purchase of new and re¬ 
placement medical equipment. 
1970 
Daniel Dedrick is an assistant profes¬ 
sor of anesthesia at The Pennsylvania 
State University College of Medicine at 
The Milton S. Hershey Medical Center 
in Hershey. Pennsylvania. His wife, 
Dr. Carolyn Dedrick, a former member 
of the class of 1973, is an assistant 
professor of radiology at The Pennsyl 
vania State University College of 
Medicine. 
1972 
John Foster is now practicing diagnos¬ 
tic radiology at the Westerly Hospital in 
Westerly, Rhode Island. He and his wife, 
Barbara, are living just across the border 
in Mystic, Connecticut with their two 
children, Ainslie and Jonathan. 
John Fulkerson is assistant professor 
of orthopedic surgery and director of 
the Sports Injury and Knee Clinic at the 
University of Connecticut School of 
Medicine in Farmington. 
In January, Fred Hyde participated in a 
two-day seminar in Washington, D.C. 
on “Capital Financings and Refinanc¬ 
ings for Health Care Facilities” spon¬ 
sored by The National Health Lawyers 
Association. Dr. Hyde spoke on “The 
Future of the Capital Markets and How 
to Survive it’ ’. Dr. Hyde is vice presiden 
and National Health Care Manager at 
Smith Barney, Harris Upham & Com¬ 
pany Incorporated in New York City. 
1973 
In a letter received from Richard 
Boland in May, he mentioned that he 
has “recently run into several former 
classmates in the past few months, and 
upon comparing notes, it appears that a 
very large segment of our class has 
stayed on (at least this far) in academic 
medicine.” 
He notes that he is now assistant pro¬ 
fessor of medicine at the University of 
California, San Francisco, where he 
has been funded to study glycoprotein 
biochemistry in gastrointestinal cancer; 
that John Stratton is doing research in 
cardiology at the University of Wash¬ 
ington where he was recently appointed 
assistant professor of medicine; and 
that Richard Young became assistant 
professor of pediatrics at Hershey 
Medical School (The Pennsylvania 
State University College of Medicine) a 
year ago and is doing research in pedi¬ 
atric neurology. 
Dr. Boland listed twenty-four other 
classmates who, “as far as can be as¬ 
certained, currently hold academic 
appointments and are actively involved 
in research. This list (compiled from 
the softest of data bases — rumor and 
recollection) is in excess of one-third of 
all those we could recall. It may be 
somewhat overinclusive, and some 
others may have been overlooked.” 
He’d be interested in having corrobo¬ 
rating information about this. 
1974 
Richard Pasternak, director of the 
Coronary Care Unit at Pacific Medical 
Center and clinical instructor in medi¬ 
cine at the University of California in 
San Francisco has been elected to Fel¬ 
lowship in The American College of 
Cardiology. 
1980 
Steve Rosenfeld writes that he and Lisa 
are enjoying life in St. Louis, Missouri, 
and that he is pleased with his ophthal¬ 
mology residency at Barnes Hospital. 
Public Health 
1965 
Elliot Segal, staff director of the Over¬ 
sight Subcommittee of the House 
Commerce Committee is leaving Capi¬ 
tol Hill to become manager of health 
care cost containment programs for the 
William Mercer subsidiary of Marsh 
and McLennan, insurance brokers. 
1979 
Lisa Rosenfeld is now the director of 
planning for the Jewish Hospital of St. 
Louis (Mo.) which is one of three hos¬ 
pitals comprising Washington Univer¬ 
sity Medical Center. Her husband, 




Richard Norton has been promoted to 
professor of medicine at Tufts Univer¬ 
sity School of Medicine. He is in the 
Section of Gastroenterology and is 
located at the New England Medical 
Center Hospital in Boston. 
1976 
Louis Wang announces his association 
with Drs. Howard Smith and David 
Roberts as a member of the Connecticut 
Ear, Nose and Throat and Facial Plastic 
Surgery Associates for the practice of 
otolaryngology, facial plastic surgery 
and head and neck surgery, with offices 
in Middletown and Essex. 
IN MEMORIAM 
OscarS. Proctor, M. D. 
August 12, 1981 
ex med ’19 
Barnett Greenhouse 
October 24, 1981 
M. D '21 
Herbert C. Soule, Jr. 
July 22, 1981 
HS ’21 
Chester E. Hurwitz 
May 15, 1981 
M. D. ’22 
Dexter M. Bullard, M. D. 
October 5, 1981 
ex med '23 
Spafford Ackerly 
September 24, 1981 
M. D. '25 
Felix F. Tomaino 
August 28. 1981 
M. D. ’29 
Dana L. Blanchard 
December 29, 1981 
M. D. '31 
Morris F. Heller 
October 11, 1981 
M. D. '31 
Charles E. Trihble 
August 10, 1981 
M. D. '31 
John James Head 
(date unknown) 
M. D. '39 
Arthur N. Springall 
October 4, 1981 
M. P. H. '50 
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MEDICAL SCHOOL ALUMNI WEEKEND PROGRAM 
FRIDAY, June 4, 1982 
Alumni Registration 
Rotunda, Sterling Hall of Medicine 
8:00-4:00 Yale School of Nursing Annual Alumnae/i College 
"Tomorrow’s Issues Today in Nursing" 
Registration, 855 Howard Avenue 
8:30-4:30 Yale Alumni in Ophthalmology 1982 Annual Meeting 
"Current Concepts in Glaucoma” 
Registration, Brady Auditorium, 310 Cedar Street 
10:15-11:00 Department of Epidemiology and Public Health Symposia 
I. "The Impact of Management and Labor on the Health Care System in the Eighties" 
11 :(H»-11:45 II. "Nuclear Warfare: The Role of the Medical Profession” 
Winslow Auditorium, LEPH 
1:55-3:00 Department of Epidemiology and Public Health Seminars 
I. "Do We Really Need Infectious Disease Epidemiology?” 
II. ‘ ‘The Statistical Needs of the Biomedical Researcher: Some Observations and Suggestions from 
Director of a University Biostatistics Consulting Center” 
III. "Problems in Conducting Epidemiologic Research” 
IV. "Yale Graduates Look at Occupational Health” 
(Locations to be announced) 
3:15-4:30 Department of Epidemiology and Public Health Lecture 
(To be announced.) 
2:00-5:00 Guided Tours — New facilities of the Yale-New Haven Hospital 
5:00 Dean’s Reception 
Beaumont Room, Sterling Hall of Medicine 
SATURDAY, June 5, 1982 
Alumni Registration 
Rotunda, Sterling Hall of Medicine 
9:00-11:00 Coffee Service 
Beaumont Room, Sterling Hall of Medicine 
9:15-9:45 Special Alumni Symposium 
"Yale Today” 
A. Bartlett Giamatti, President, Yale University 
Historical Library, Sterling Hall of Medicine 
10:00-11:45 Seminars 
I. "Gene Splicing in Biomedical Research” 
II. "Efforts at Yale in Caring for the Elderly” 
III. "The Graying of America: Implications for Health Care” 
IV. "From the Bench to the Clinic: New Treatments for Depression and Opiate Withdrawal” 
(Locations to be announced.) 
10:00-12:00 Guided Tours — Yale Center for British Art; Historic Section of New Haven 
11:45-12:30 Meeting of the Association of Yale Alumni in Public Health 
Winslow Auditorium, LEPH 
12:00-12:30 Annual Meeting of the Association of Yale Alumni in Medicine 
Harkness Auditorium 
12:30-2:00 Sherry and Buffet Luncheon 
Harkness Lounge and Dining Hall 
2:00 Guided Tours — New Facilities of the Yale-New Haven Hospital 
3:00-4:15 Guided Tours — Yale Center for British Art; Historic Section of New Haven 
4:30-6:00 Social Hour 
Beaumont Room, Sterling Hall of Medicine 
Yale Medicine 
333 Cedar Street 
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Immunology at Yale 
The following articles were coordinated and edited for 
Yale Medicine by Dr. John Dwyer. 
The Human Immune System: 
A Very Personal Survival Kit for the 1980’s 
and Beyond 
By John M. Dwyer, M.D., Ph.D. 
Human beings are, among many other things, efficient but 
complex compilations of biological machinery. As with all 
mechanisms that substitute intricacies for simplicity, 
increasing sophistication is associated with increased 
fragility and vulnerability. As is true of many human 
endeavors, the biological systems of most individuals do 
well in isolation; delicately poised mechanisms, allowed 
the luxury of total introspection, perform with single- 
minded efficiency. Trouble comes, however, when these 
biological systems must contend with a hostile environ¬ 
ment. While all of the above generalities are true at a 
psychological level, we are here concerned with aggres¬ 
sion that is very definitely at the physical level and most 
frequently posed by man’s most ancient and constant 
enemy — microbes. Virus, fungi, bacteria and parasites 
abound in our environment, and were it not for a very 
active protective (immune) system, we humans, despite 
our superb intellects, ingratiating sociability and advanced 
knowledge of how our body works, would be extinct. 
Our protective or immune system has been subjected to 
intensive basic and clinical research in the past two 
decades. What has been learned is of the greatest practical 
importance as it allows physicians, among other things, to 
make better vaccines, transplant organs, improve the cure 
rate for cancer, understand and better manage allergies, 
and, for the first time, approach scientifically many of the 
chronic diseases of mankind. Altogether apart from its 
practical importance, however, the details of the evolution 
of a protective system that can handle the microbial enemy 
and the manner in which it does so makes a fascinating 
story for anyone remotely interested in biology. 
Let’s approach the requirements for an adequate 
immune system by analogy. Imagine that you are hiring 
night watchmen for the world’s largest and most sophisti¬ 
cated computer operation, programmed to support systems 
involved in life and death decision making. Going through 
Dr. Dwyer is associate professor of medicine and pediatrics and chief of the 
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a checklist of the essential attributes for candidates you 
may hire to guard this vital establishment, you would be 
certain to include the following. Firstly, your night watch¬ 
man must be sufficiently educated so that he identifies with 
complete accuracy a true problem when it arises. An 
intruder into his complex must be distinguished from, for 
example, other watchmen who superficially may look 
very similar to the unauthorized entrant. What a tragedy if 
our watchman made a mistake and shot a fellow guard. 
Yes, the first attribute sought would be maturity and 
education sufficient for accuracy in problem identification 
(recognition). 
The second desirable, even essential, attribute for our 
candidate would be the ability to learn on the job. If the 
domain under his protection was attacked and our watch¬ 
man prevailed only after a considerable struggle, we 
would wish that the memory of his “close encounter of the 
first kind” would lead to the development of expanded 
mechanisms capable of more efficiently handling the same 
invaders should they be foolish enough to attack again. 
Memory of the inadequacies of the first response would 
lead to a more efficient secondary response. 
Our watchman is of no use to his employers if he cannot 
respond decisively to any threat to the computer complex. 
He must be armed so that he can repel the danger. The 
weapons at his disposal, however, must be used judi¬ 
ciously. The appropriateness of his response will distin¬ 
guish the really well programmed watchman. No use firing 
off lots of bullets in all directions. Even if he hits the 
enemy, the damage to innocent bystander computer 
mechanisms might be horrendous. Certainly if you were to 
find a watchman whose every action was appropriate and 
reliable, you would be likely to make him a supervisor of 
less well trained individuals. His job would then be one of 
supervision or regulation of armed but relatively inexperi¬ 
enced (and therefore potentially dangerous) recruits. 
The human immune system, of necessity, specializes in 
accurately recognizing the enemy (antigen), attacking him 
powerfully but appropriately and using a highly developed 
memory system that will insure that adequate preparations 
are made for more efficiently handling second encounters. 
As the inflammation that can be initiated by the immune 
response is so powerful, such a weapon system is very 
tightly controlled by all important regulatory mechanisms. 
The cast of characters that provide us with our immune 
system is large, but the stars are small white blood cells 
known as lymphocytes. There are two major classes of 
lymphocytes; B lymphocytes, so called because they are 
educated in the bone marrow and T lymphocytes which 
mature in the microenvironment of a remarkable gland, 
the thymus, that lies in the chest over those great vessels 
that enter and leave the heart. Apparently the evolutionary 
pressures exerted by microorganisms on lower species 
aspiring to evolve into higher species was of sufficient 
magnitude and complexity to require the development of 
two cooperative but distinct weapon systems. It is the job 
of one to fight bacteria (the B cell system) while the other’s 
function is to fight viral, fungal and parasitic infections 
(the T cell system). 
Humans are armed with about 400 billion of these little 
“pac-men-like” lymphocytes. Some lymphocytes con¬ 
stantly patrol around the body seeking antigens that may 
have entered our environment. Others remain stationed in 
lymph nodes and the spleen, waiting for antigens to be 
delivered to them in the lymphatic fluid that runs in the 
specialized lymph vessels that travel throughout the body 
with our arteries and veins. 
The antigen recognition capacity of lymphocytes is 
individually programmed. Unlike our night watchman 
who should be able to recognize any and all intruders, any 
individual lymphocyte is capable of recognizing only one 
antigen. Cells that can recognize streptococci can't recog¬ 
nize staphylococci. By the time we are bom we already 
have enough lymphocytes to recognize upwards of a 
million different potential invaders. Like our watchman, 
these B and T cells are “armed”. When a B cell binds 
antigen to a surface receptor that is designed like an 
expensive lock that will accept only one very specific key, 
to bind one specific antigen, it responds by manufacturing 
and secreting remarkable chemical molecules known as 
immunoglobulins or antibodies. These molecules can bind 
to antigens, whereupon they indicate the destruction and 
removal of this material by harnessing a number of 
inflammation producing mechanisms that rely heavily on 
the properties of a none too specific scavenger cell known 
as a polymorphonuclear cell. T cells work similarly, 
although the chemicals they secrete are not antibodies but 
rather lymphokines; reagents that harness another non¬ 
specific cell (the monocyte or macrophage) to attack 
antigens bound by the T cell. Unlike B cells, T cells are 
themselves pretty good at directly killing many antigens. 
Since at any given moment we have to be able to 
recognize any one of a million different enemies and we 
are not composed of huge masses of lymphocytes, we do 
not have many cells that can recognize any one of these 
antigens. As a result the primary immune response is slow 
to develop. During the primary encounter with an antigen, 
however, those cells that do recognize the antigen will 
divide many times to expand geometrically the population 
or clone of cells capable of recognizing that particular 
antigen. The result is a disproportionate accumulation of 
cells that have been involved (sensitized) in a particular 
battle. The expanded recognition capacity represents 
immunological memory and insures a much more potent 
and rapid secondary response to antigen. 
One of nature's biggest immunological mistakes was to 
program humans with lymphocytes possessing the capacity 
to recognize their own body constituents as antigens. 
Thus, apart from having lymphocytes that carry receptors 
for nonself, we also have both B and T lymphocytes that 
carry receptors for those structures that represent our own 
constituent antigens. For most of us this never presents a 
serious problem because of the presence of supervisory 
cells that continuously regulate the immune response. 
There are cells that develop in the thymus, but instead of 
producing an inflammatory response on encounter with 
antigens, they control effector cells. They act as an 
immunological thermostat, constantly insuring the 
appropriateness of all that is done by the cells that can 
produce inflammation. Among the chief responsibilities of 
these immunoregulators is the maintenance of a state of 
nonreactivity amongst those lymphocytes capable of react¬ 
ing with us. Usually these cells work quietly and efficiently, 
but occasionally (disturbed by drugs or viral infections or 
because they were not so well educated in the first place — 
second rate genetic information) they fail to control these 
potential attackers of self, and autoimmune disease results. 
Rheumatoid arthritis, systemic lupus erythematosus, 
thyroid disease, multiple sclerosis, pernicious anemia and 
myasthenia gravis are but a few of the diseases that can 
result. 
Lymphocytes are rapidly giving up their secrets to 
scientists, and the results are being felt in everyday medi¬ 
cine. There is, however, still much to be learned about 
these “night watchmen” and the supporting players with 
whom they have to interact. It seems reasonable to predict 
that the explosion of interest in immunology will continue 
to be a profitable one if as much progress is made in the 
next 20 years as in the previous two decades. Many scien¬ 
tists and clinicians believe that it will be improvement in 
our understanding of the immune system and the applica¬ 
tion of this knowledge that will provide us with our best 
chance for the next great advance in improving both the 
quality and quantity of human life. For improvement in the 
latter, one further major disadvantage of our immune 
system will have to be overcome. Individual T lymphocytes 
live for upwards of 60 years and then slowly fade away. As 
the thymus works for only a few years of post-natal life, we 
have within the immune system nature’s classic example 
of inbuilt obsolescence. Most people reading this will have 
their biological T cell clock fully wound and ticking nicely 
but definitely finitely. The eternal elixir of life (when 
eventually we find it) is certain to contain a good measure 
of extract of young T cells. 
The more one learns about immunology the more 
fascinated you are likely to become with this subject, and 
more articles on this subject follow. But apart from 
intellectual satisfaction, the future of immunology may 
relate very personally to your own future. After all, the one 
inescapable disease we all suffer from is aging. You would 
do well to keep an eye on scientific efforts to unravel the 
mechanistic prowess of Methuselah’s T cells. 
Transplantation Antigens: 
Markers of Individuality, Love and Disease 
By Robert E. Cone, M.D. 
In the early 1900’s, tumor biologists were surprised to find 
that tumors developing in some laboratory mice would not 
grow when transplanted in other mice. This was quite 
puzzling. Why should some mice be resistant to the tumor 
while others were not? Did some mice have the ability to 
recognize the malignant nature of cancer cells and destroy 
them, while others lacked this capability? If so, under¬ 
standing this phenomenon would be an important clue to 
understanding cancer in humans. 
It was subsequently found that resistance to the growth 
of the transplanted tumor is due not to recognition that the 
cells are malignant, but rather, to recognition that the cells 
come from another mouse and are “foreign”. (Studies 
have shown, in fact, that tumors transplanted from one 
genetically indentical mouse will grow). Animals dis¬ 
criminate “self’ from “non-self” or foreigners by 
examining antigens on the surface of the transplanted cells 
known as histocompatibility antigens. Over the years, 
these have been shown to be defined by an area on the 17th 
chromosome, known as the Major Histocompatibility 
Complex. 
As a result of several events in the last thirty years, the 
study of histocompatibility in mice and humans has 
become an important area of research in many laboratories 
around the world. For instance, when human organ trans¬ 
plantation became feasible, surgeons in the field experi¬ 
enced some of the same frustration felt by the early mouse 
tumor transplantation biologists: the immune system of 
recipients of organ transplants defended itself against the 
foreign intruder. In 1958, the French immunologist, Jean 
Dausset, discovered antibodies which detected a human 
leucocyte antigen (HLA). It was then found that disparities 
in HLA antigens correlated with rejection of organ trans¬ 
plants and the science of histocompatibility testing in 
humans began. 
HLA antigens have now been studied and defined in 
many ethnic and racial groups throughout the world. An 
example of the quality and spirit of cooperation in the 
world-wide scientific community can be found in the 
degree of information sharing between laboratories work¬ 
ing in this field. 
Eighty-two different HLA antigens have been defined 
so that their position on chromosome 6 in humans can be 
mapped. The genes which determine these antigens can be 
grouped into at least four positions on the chromosome and 
the maximum number of combinations of these genes 
Dr. Cone is associate professor of pathology and surgery 
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approaches seven billion. With this many possible com¬ 
binations, it is easier to draw a royal flush in poker than it is 
to find two unrelated individuals with identical HLA 
genes! 
For this reason, the immunological problems in organ 
transplants are considerable. That some individuals who 
receive an organ transplant from unrelated donors retain 
the organs for one or many years can be attributed to “the 
luck of the draw” in histocompatibility matching; or more 
likely, it can be attributed to the steady improvements in 
therapeutic modalities which suppress immune rejection 
of the organ. While the immune response to the graft must 
be suppressed for successful organ transplantation, there is 
also great danger of infection if the immune system is 
completely suppressed. The problem will be solved when 
methods are refined to suppress only the response to HLA 
antigens on the transplanted tissue. Research to develop 
such immunosuppressive “smart bomb” treatments is 
being done in many laboratories. 
The discovery and elucidation of the complexity of 
HLA antigens has important applications other than those 
of providing jobs for transplantation immunologists, and 
frustrations for the transplant surgeon. As a marker for 
human biologic individuality, histocompatibility testing 
has important genetic and even legal application. HLA 
typing of racial and ethnic groups worldwide is of great 
value to anthropologists. Inclusion of HLA-typing has also 
been extremely useful in settling legal paternity suits. 
In addition to their importance to organ transplantation 
as well as for markers of human biologic individuality, 
HLA antigens are also crucial to human well-being. An 
integral relationship for Major Histocompatibility Com¬ 
plex genes to the immune system was demonstrated first in 
studies with inbred mouse strains. It was found that certain 
mouse strains would make a strong immune response to 
synthetic amino acid polymers while others would not. 
Genetic studies demonstrated that the relative immune 
response of mice to these polymers was determined by 
genes which were “mapped” to the Major Histo¬ 
compatibility Complex (MHC). These regulatory genes 
were termed “immune response” (Ir) genes. Moreover, 
the ability of immune cells to kill cells infected by viruses 
appears to be restricted by other gene products of MHC. In 
extrapolating these results with mice to humans, it appears 
that genes of the MHC can determine how strongly the 
immune system responds to infectious organisms and, 
once it responds, how effectively it deals with the foreign 
invader. 
Is such extrapolation warranted? The susceptibility to a 
number of diseases appears to be associated with MHC 
genes. The prototype example of this HLA-disease 
association is the rheumatoid disease, anklylosing 
spondylitis. Almost 100 percent of patients with this 
disease possess the HLA antigen B27, although only about 
25 percent of the total population carry this antigen. This 
does not imply that B27 positive individuals are destined to 
be affected by anklylosing spondylitis, but they are 
certainly more prone to the disease than B27 negative 
individuals. 
Other diseases demonstrating an HLA-susceptibility 
association include hayfever, asthma, multiple sclerosis, 
coeliac disease, and juvenile diabetes, to name a few. 
Every month new associations, or non-associations, are 
reported. Many of the diseases showing an association 
with HLA antigens have in common an inflammatory 
and/or immune basis. In many, and perhaps all, the actual 
cause of the disease is unknown. 
What are our HLA genes telling us? If the extrapolation 
of mouse studies to humans mentioned earlier is valid, it 
may be that the HLA-disease associations are due to an 
improper response and/or lack of response to our immune 
system to infectious agents. At least, it is clear that there is 
a genetic basis for susceptibility to many, and perhaps all 
disease processes. Understanding the genetic basis for 
HLA-disease association could help clarify the nature of 
the complex diseases linked to these genes so that more 
appropriate therapies can be developed. As the list of 
HLA-disease susceptibility associations grows, it seems 
possible there might come a time when the population 
would be typed for MHC genes. There would then be a list 
of diseases to be on the alert for and preventive steps could 
be taken. 
Finally, one very recent observation, again made in 
mice, should be mentioned here. Inbred strains of mice 
exhibit a preference for strains to which they will mate. 
This mating preference has been found to be determined 
by genes mapping to the MHC. It is suspected that females 
present an odor, possibly a pheromone, which excites, or 
turns off a male. 
In this way, nature uses histocompatibility antigens to 
help insure the best continuing association of new genetic 
formulae. For instance, it is much more difficult to pro¬ 
pagate animals by inbreeding than it is by outbreeding, 
because implantation of a fertilized egg is greatly facilitated 
if the histocompatibility antigens associated with the 
seminal fluid are very different from those of the mother- 
to-be. She will make an immune response to these antigens 
that will cause inflammation in the fallopian tubes or 
uterus, thus providing a hospitable environment for 
implantation. 
The possibility that human MHC genes may decide 
whether or not a blind date will succeed has yet to be 
determined. Perhaps it shouldn’t be. Somehow ensuring 
“love at first sight” by genetics and/or chemistry would 
take all of the fun and mystique from one of the most 
basic of human responses. Is nothing sacred anymore? 
Clearly, the romance (forgive the word) with histo¬ 
compatibility genes is not over. New traits governed by 
these genes are still being described. The demonstration of 
precisely how these genes work, and perhaps ultimately, 
the isolation of the genes will further the understanding of 
how the immune system works, and how it can be 
modulated to our advantage. Perhaps genetic engineering 
may someday be used as a method of prevention for certain 
diseases. 
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The Helper T Cells^ 
By Charles A. Janeway, M.D. 
The initiation of the complex cellular cascade known as the 
immune response involves recognition of foreign materials, 
called antigens, by lymphocytes. The principal cells 
involved in the initiation of these responses are known as 
helper or inducer T cells. Our research involves an exten¬ 
sive characterization of these cells, presently at the single 
cell level, using T cells grown from a single progenitor 
cell, or T cell clone. 
Antibody responses can be characterized either quanti¬ 
tatively or qualitatively; that is, the amount of antibody 
produced can be measured but so too can the class of 
antibody be determined. Antibodies come in eight distinct 
forms, each with a different effect or function. We have 
found that there are two classes of helper T cells, one of 
which is principally involved in increasing the quantity of 
antibody produced, while the other modulates the quality 
of the antibody produced. These cells differ in other prop¬ 
erties, and these differences allow us to separate them and 
to study them as independent entities. 
We have focused on three different aspects of recogni¬ 
tion by helper T cells; recognition of specific foreign 
antigens; recognition of antigens encoded on the major 
histocompatibility complex, the genes that control anti¬ 
gens on tissue cells that serve as the targets recognized by 
lymphocyte causing rejection of foreign tissue grafts; and 
recognition of determinants found on antibody molecules. 
Our studies of the precision of foreign antigen recogni¬ 
tion by T cells demonstrated that individual T lymphocytes 
are uniquely specific for a particular antigenic determinant. 
Such cells readily discern very minor changes in antigen 
structure. 
We next turned to a consideration of the role of the major 
histocompatibility complex (MHC) in antigen recognition 
by T cells. The MHC consists of a cluster of genetic 
information that produces not only cell surface antigens 
that determine our immunological identity, and supply the 
targets for recognition in the transplant situation, but also 
produces many influences that regulate immune response. 
For example, we found that helper T cells are influenced 
by a region of the major histocompatibility complex that 
also controls the magnitude of antibody responses, the 
so-called immune response or Ir genes. These genes have 
now been shown by our laboratory to encode cell surface 
antigens expressed in B cells. The helper T cells recognize 
not just the foreign antigen we inject into the animal but 
their own Ir gene products as well. 
Since only B cells express these Irgene products, only B 
cells bear antigen in a form that is recognizable by the 
helper T cells, and thus T cell help is directed exclusively 
to such cells. This mechanism is very important in con¬ 
trolling the quantity of antibody produced. Interestingly, 
genes that encode transplantation antigens recognized as 
non-self in graft rejection, also encode self recognition 
markers that are critical to communication between cells in 
the immune system. The mechanism by which antigen 
associates with the Ir gene product to control immune 
responses is now a central focus of our research. 
In performing functional assays of helper T cells in 
mice, we discovered that there are two helper T cell 
populations that act synergistically. Subsequent studies 
have shown that one of these is antigen-specific and 
recognizes antigen on B cells in association with self Ir 
gene products, but the second cell, while also specific for 
the foreign protein antigen, is specific for self immuno¬ 
globulin or antibody determinants. This cell does not 
develop in mice deprived of B cells experimentally, and 
we have therefore termed such cells immunoglobulin 
dependent helper T cells. It would appear that such cells 
play a critical role in the regulation of antibody quality, 
such as the type of antibody produced (e.g. allergic 
antibody versus neutralizing antibody). Thus, the helper T 
cell system can be divided into those that recognize Irgene 
products and those that recognize immunoglobulins. Only 
the former also respond to non-self transplantation 
antigens encoded by the Ir genes. 
By preparing cloned helper T cells, it has been possible 
to show that a single T cell can be specific for a foreign 
antigen recognized in the context of self Ir gene products as 
well as for non-self Ir gene products. This finding, which 
has been made in several systems, provides a potential 
explanation for the intensity of graft rejection reactions 
directed at antigens encoded in the major histocompatibility 
complex. T cells specific for any antigen would also be 
specific for some non-self transplantation antigen; thus, all 
antigenic contacts also immunize an animal against major 
histocompatibility complex encoded antigens of the species. 
Hence, an animal is immunized for graft rejection by 
encounter with conventional environmental antigens, 
presented to T cells on the surfaces of self cells. 
In summary, our studies have shown that helper T cells 
are highly specific for foreign antigens. These antigens are 
recognized on self cell surfaces in the context of self major 
histocompatibility complex encoded antigens, and the 
same cell can also recognize non-self transplantation 
antigens encoded by allelic variants of these same 
polymorphic genes. There is a second set of helper T cells 
that do not recognize major histocompatibility complex 
encoded antigens at all, but rather recognize self antibody 
molecules. The precise chemical nature of the recognition 
process, and the relationship of these cells to regulatory T 
cells that in turn control the activity of helper T cells forms 
the focus of our current research effort. 
Dr. Janeway is assistant professor of pathology 
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Immortalization of the Thymus Derived 
Lymphocyte 
By Nancy H. Ruddle, Ph.D. 
The body’s defense against foreign invaders is accom¬ 
plished in part by substances produced by many different 
kinds of cells. These substances include antibodies or 
immunoglobulins produced by members of the bone 
marrow derived lymphocyte (B cell) family and lympho- 
kines produced by members of the thymus derived 
lymphocyte (T cell) clan. 
B cells recognize foreign invaders called antigens, such 
as viruses and bacteria, by means of their surface antibody 
and the chemical nature of this class of molecules is well 
understood. The T cell’s mechanism for recognizing anti¬ 
gen is much less clear, as is the biochemical nature of the 
factors they produce. 
These problems have entertained and frustrated 
immunologists for many years and will probably continue 
to do so for some time to come. It is important to under¬ 
stand T cells intimately in order that we may direct them in 
their already well-known roles in defense against viral and 
fungal infections and against malignancy, through their 
direct killing of tumor cells and mobilization of other 
defense systems by means of factors called lymphokines. 
One impediment to our understanding of T cells is the 
plethora of different subsets which can be categorized 
according to their functions. T cells can act as regulatory 
cells. They help B cells to differentiate into antibody 
secreting cells called plasma cells. Suppressor T cells 
inhibit the differentiation of B cells into plasma cells and 
inhibit effector functions of other T cells as well. Other T 
cells act as effector cells killing virus producing cells of 
manufacturing lymphokines which in most cases act on 
other "nonT” cells. These factors, to name a few, include 
migration inhibitory factors (MIF), immune interferon 
(IFN-Y), lymphotoxin (LT), macrophage activating factor 
(MAF), osteoclast activating factor (OAF), T cell growth 
factor (TCGF, also called interluken 2) and B cell growth 
factor (BCGF). 
Because it is difficult to obtain enough T cells of one 
particular subset with the ability to recognize a particular 
antigen, a major goal of my laboratory has been to isolate 
individual T cells and then transform the normally non¬ 
dividing T cell into a continually proliferating line which 
can be grown and cloned in tissue culture. When this is 
accomplished, the progeny of an individual T cell repre¬ 
sentative of a particular subset can be isolated and studied 
providing basic information at the single cell level. 
Because T cells do not normally grow in culture for 
extended periods of time, we have to trick them so they 
grow, divide, and maintain their function in tissue culture. 
Dr. Ruddle is associate professor of epidemiology 
One method we have used to prepare continual cell lines 
is to isolate T cells from antigen immunized mice and 
culture them in the presence of growth factors, specific 
antigen, and irradiated spleen cells from mice of the same 
strain. Spleen cells act as feeder cells and antigen present¬ 
ing cells for the T cells. Many lines derived in this way do 
grow and divide in the presence of specific antigen and 
produce lymphotoxin (LT) and immune interferon (IFN- 
G). Some lines can be stimulated to produce factors at 
concentrations 500 times higher than those produced by 
cells immediately after removal from the animal. These 
cell lines are already providing quantities of lymphokines 
sufficient for biochemical analysis and use in biological 
experiments. 
The marvelous technique of cell hybridization can also 
be used to immortalize T cells. The antigen specific T cell 
is taken from the animal and fused with a proliferating T 
cell tumor called a lymphoma. This fusion is accomplished' 
by means of an agent such as sendai virus or polyethylene 
glycol, which perturbs the two cell membranes in such a 
way that holes are formed and repaired when the two cells 
stick together. Information from both parents is con¬ 
tributed to the resultant hybrid. 
The tumor cell, with its capacity for unlimited growth, 
rescues the antigen specific properties of the T cell and 
provides the proper environment for that cell to flourish 
and proliferate. The result is a clone of hybrid cells with 
the antigen specificity and lymphokine producing capacity 
of the T cell and the unrestricted growth and replicative 
properties of a tumor. Even in the face of occasional 
instability, we have been able to detect expression of many 
functions in T cell hybrids which are characteristic of both 
individual parents. These include expression of particular 
surface antigens characteristic of T cells and traits typical 
of individual T cell subsets. 
Thus, when we used as parents a T lymphoma and 
suppressor T cells enriched by their adherence to antigen 
coated plates, we have obtained hybrids which bind anti¬ 
gen when it is presented on a cell and produce suppressor 
factors. Other hybrids have been prepared from T cells or 
T cell lines (described above) which produce lymphokines. 
Many such hybrids express LT, and we are presently 
screening for one that expresses IFN-V. 
The dissociation of LT and IFN in some hybrids 
suggests that they are separate molecules and demonstrates 
an important use for hybrids in allowing us to distinguish 
between molecules which can only be monitored by 
biological assays. We are also using hybrids to isolate 
individual cells which interact in complex immunological 
phenomena. The perpetuation of particular subsets which 
may make a profound contribution to a reaction, but which 
comprise only a very small segment of the population, is 
also affected through the preparation of T cell hybrids. 
In recent experiments we have analyzed the nucleic 
acids of T cell hybrids and tumors and have made the 
startling observation that mouse T cells can excise frag¬ 
ments of DNA from a segment of chromosome 12 that 
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codes for immunoglobulin heavy chain. By analogy with 
information concerning the generation of diversity in B 
cells which produce antibodies, it appears that a similiar 
mechanism is operative in T cells and may be involved in 
generating the specificity of the T cell antigen receptors. 
Now that cloned T cell lines and hybrids that produce 
lymphokines have been developed, it is possible to isolate 
messenger RNA and by recombinant DNA techniques, 
clone the genes for the lymphokines. This will permit the 
production of vast quantities of homogenous T cell 
products such as LT and IFN-Y which are of such pro¬ 
found immunotherapeutic potential in tumors and viral 
diseases, particularly in the compromised host. 
Immunology at Yale has kept pace with recent develop¬ 
ments in molecular biology and genetics. The tools of 
these disciplines are being applied to ever more clearly 
defined questions that have always plagued the 
immunologist. With these approaches, T cell immunology 
has emerged as a serious but still intriguing discipline. 
Students of T cells can move beyond phenomenology and 
descriptive studies and begin to understand mechanisms. 
By applying technical advances of molecular biology to 
cultures of cloned T cell populations, it is finally possible 
to study T cells at the most basic levels which ultimately 
elucidate the most complicated interactions at the level of 
the whole animal. 
Immunology: An Approach to Health 
Problems of the Third World 
By Frank F. Richards, M.D. 
About 80 to 90 percent of the research into disease cure and 
prevention in the world is carried out in the United States. 
This research is largely directed against diseases such as 
cancer and cardiovascular disease which are serious 
threats to only about 10 or 20 percent of the world’s 
population; yet most of the population does not have the 
luxury of worrying much about the diseases of advancing 
years. The old enemies of poverty, malnutrition, infection 
and insect-borne diseases take their toll in youth and the 
middle years. In many parts of Africa, for instance, old 
age is revered because it is still a difficult and rare 
accomplishment. 
Some of the most formidable diseases which face man 
in the tropics, and sometimes outside the tropics, are the 
parasitic diseases. Both animals and people can become 
infected and infested with a wide range of other animals 
which range from microscopic single-celled creatures 
such as amoeba or trypanosomes, to large many-celled 
creatures such as tape worms. In the West, we are used to 
making clear distinctions between animal and human 
diseases, but often in the third world, these distinctions are 
either blurred or lost. For instance, where protein malnu¬ 
trition is the most important human disease, parasitic 
infections of domestic animals are in fact a serious cause of 
human sickness. 
There is nothing new in the process whereby one animal 
makes its home within another for at least a portion of its 
life cycle. This arrangement has gone on since the dawn of 
life, and it was certainly well established before our primi¬ 
tive ancestors left the sea to crawl on land. It has to be 
recognized that while another animal’s body is a friendly 
environment, rich in food and protected from the ele¬ 
ments, in another sense it is hostile, since most vertebrates 
have developed chemical and cellular systems of 
immunity designed to rid themselves of unwanted 
parasites. 
To become established in a hostile world of antibodies 
and cells designed to engulf and kill invaders, the parasites 
have developed an audacious array of dirty tricks to fool 
the body’s defenses. Some may cover themselves in 
sheep’s clothing of host proteins, so that the body’s 
defenses cannot distinguish the parasite from its host. 
Others, such as trypanosomes, cover themselves in an 
easily recognized protein coat, but as soon as the body 
produces antibodies to that coat, the parasite changes coats 
and assumes one which is not recognized by the first 
antibody. In fact, a single trypanosome has been shown to 
produce more than 100 different coats. 
Dr. Richards is professor of medicine 
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These parasites seem to have explored very thoroughly 
the working of the immune system in man as well as 
animals. They appear to have learned stratagems which 
can interfere in the complicated body cell interactions 
which constitute the immune system. It was shown in 
studies at Yale that an African trypanosome, a close rela¬ 
tive of the organism that causes sleeping sickness, can turn 
on cells which suppress the body’s immune responses. 
The implications of such a discovery are profound, 
because on reflection, one can see the difficulties that such 
biological phenomena may have in the development of 
vaccine. In recent years, a number of antigens associated 
with parasites have been grown in tissue culture. Usually, 
not long after we learn to culture an organism we can 
prepare a vaccine by extracting harmless antigens from 
such material. However, if the parasite has learned to 
stimulate the immune system in such a way that immune 
responses are turned off rather than on, as in the case of 
trypanosomes, it is possible to give an extract of dead 
antigen to millions of people with good intentions of 
preventing parasitic disease, only to have the vaccine turn 
off their immune response, rather than turn it on. For this 
reason, it is extremely important that we understand how it 
is that organisms such as the trypanosome and the parasites 
that cause malaria are able to activate suppressor mecha¬ 
nisms that supply these parasites. 
As the study of parasites develops, it becomes clear that 
their survival devices are based on some novel and 
interesting genetic and biochemical mechanisms. It is this 
flamboyant biology which continues to attract skilled 
young molecular biologists, immunologists and chemists. 
There is also the added attraction of the very real potential 
for making discoveries which can be applied directly to 
human welfare. 
Immunology has a great deal to offer third world 
countries because of the nature of their problems. It is very 
important that we train physicians willing to look to these 
problems. Ninety million people in the world suffer from 
malaria, which causes untold suffering. Malaria, as well 
as protein malnutrition and parasitic diseases clearly are 
major factors in preventing the third world from entering 
modem society. 
To this end Yale has begun to develop a Parasitology and 
Tropical Medicine Program which spans many depart¬ 
ments in the School of Medicine. A clinical program is 
being designed to enable Yale physicians to be trained in 
Africa, Central America and in the Caribbean. In turn, the 
School will enable physicians working in the field to come 
here for further training and research. Further plans being 
discussed include a Ph.D. program in parasitology and the 
possibility of a Center for the Study of Parasitology and 
Tropical Medicine. 
No longer can we isolate ourselves from the troubles of 
the world. We have learned that drug-resistant malaria 
acquired in the Far East is not uncommon among New 
Haven veterans who served in Vietnam. Refugee popula¬ 
tions from Indochina have brought exotic diseases to 
regions where such diseases were never seen before. Many 
United States industries have operations in Africa, 
Indonesia, South America and increasingly, in jungles and 
inaccessible regions. These industries are faced with 
combating tropical diseases, yet few American physicians 
are trained in their management. Yale is learning to 
collaborate with industry in the solution of such problems 
and the community of interests created, may provide a real 
industry-academia bridge for the future. 
All of the research on parasitology now under way in 
laboratories here or planned for the future, is based on the 
solid understanding of the immune response of the human 
body. It is now almost a hundred years since the science 
and art of immunology was bom. We are beginning to 
apply it to some of the world's most urgent problems. 
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Medical Illustration: a picture is worth more 
The woman at the front desk was conferring with a well- 
known scientist about illustrations for a book he is prepar¬ 
ing. People came and went in steady procession to deliver 
or pick up projects. In an adjacent room, five technical 
artists worked diligently at their drafting boards, while in 
the darkroom beyond, a photographer processed prints for 
delivery later that day. An illustrator was putting finishing 
touches on a beautifully articulated anatomical drawing. 
The phones rang with frenetic insistence. 
It was a typical morning in the Office of Medical 
Illustration. “Spring is our busiest time of the year, but in 
fact, it is always pretty hectic here,” Virginia Simon, the 
director, acknowledged with a wan smile as she answered 
requests from a faculty member in need of a last minute 
illustration, conferred with her staff, and politely granted 
an interview, almost simultaneously. 
She has been director of the Office for almost twenty 
years, and the activity of the place is a tribute to her skills 
not only as an illustrator, but as an administrator as well. 
“It was a one-person office in 1963, when I succeeded 
Armin Hemberger, a very fine artist who had been medical 
illustrator here for many years. But as the demand increased 
for the charts, graphs, drawings and photographs necessary 
to illustrate research being done in the School, the staff 
grew. There are three medical illustrators, three photog¬ 
raphers and five technical illustrators, and several more on 
call for times such as this, when the workload is more than 
we can handle,” she reported. 
According to Arlene Resnick, who was the first person 
to join the staff, and is now senior administrative assistant, 
the Office serves more than 250 faculty, research staff and 
students, and produces an average of 500 to 600 projects 
each month. The variety of illustrative style and media is 
as impressive as the volume of work. Perfunctory charts 
and graphs, typical of textbook and lecture illustrations, 
are of course a part of the work, but the Office also 
produces fine four-color and black and white slides and 
prints as well as drawings of exquisite detail and artistic 
merit. The Office also designs and produces exhibits and 
posters. Orders range from a simple chart or graph to 
detailed anatomical drawings and photographs to illustrate 
an entire textbook. 
Illustration by David Bo! insky of the horizontal section of a head, looking down 
on the tongue, a rear molar, and tonsils. It was drawn as a reference. 
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An illustration by Linda Seigneur 
depicting the successive stages and 
core of the nursing program at Yale. 
Diagram for Dr. P Barash of the Department ofAnesthesiology, was drawn by 
Suzanne Kendall. 
The placenta of the first twin monkeys known to be born in 
captivity was photographed by Mildred Satterfor 
the late Dr. van Wagenen 
Medical illustration and medical photography were 
originally handled in two separate offices, but after 
Howard Reynolds, the photographer retired, the work was 
gradually assumed by Virginia Simon’s staff. In fact, 
photography has become an important factor in the pro¬ 
duction of much of the work that comes from the office, 
and photographers on the staff frequently work closely 
with the artists and illustrators on projects. 
As medical illustrators from Vesalius down through 
history have recognized, nowhere is the old proverb, “a 
picture is worth a thousand words”, more true than it is in 
medicine. Description of a complex new research finding 
or an intricate surgical procedure would be almost 
impossible without some kind of graphic assistance. In 
addition to traditional methods of illustration, modem 
technology has made possible a fantastic array of tech¬ 
niques to capture on film or paper tiny organisms or remote 
and hitherto inaccessible sections of anatomy. 
With these sophisticated methods for precise replication 
available, isn’t the age-old art of medical illustration 
passe?” Not at all,” Mrs. Simon replied. “There are many 
instances when a drawing is preferable. For instance, in 
Cartoon for a slide presentation about 
anesthesiology drawn by Anita Mullin. 
Beverly Pope illustrated for Dr. D. Cuono the design of a new skin flap 
procedure to resurface rhomboid skin defects produced by removal of skin 
tumors. 
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Photograph of a pleridium rhizome, enlarged many times, was made by Thomas 
Coughlan. 
describing a surgical procedure, a camera might capture 
too much detail. The artist, on the other hand, can ‘peel 
away’ unnecessary elements and concentrate only on the 
most significant parts, so that the drawing is much easier to 
read than a photograph would be,” she replied. 
There is more to medical illustration than merely artistic 
ability. ‘ ‘It requires as much knowledge of anatomy to be a 
good medical illustrator as it does to be a medical anatomist 
who is also a doctor. It also requires very particular kinds 
of drawing skills and great precision,” Mrs. Simon 
explained. In addition to constant reference to anatomical 
texts, the medical illustrators on the staff sometimes find 
themselves in the operating room alongside surgeons, 
nurses and anesthesiologists, watching the procedure 
closely, and taking many rolls of film for reference. 
Recently two members of the staff took turns recording 
step by step a very delicate surgical procedure which took 
almost twenty hours. 
Some members of the faculty are more experienced than 
others in their knowledge of graphic representation and 
know precisely what methods will reflect best the content 
of their work. Usually these same people have very real 
Photograph of functional neck dissection performed by Dr. Clarence Sasaki by 
Randall A. Smith. 
Drawing by Wendolyn Hill of superior venacava common pulmonary artery 
shunts, executed for Dr. William Glenn. 
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Virginia Simon 
Schematic rendering by Virginia Simon of seven vertebrate nephrons drawn to a 
single scale adapted from references to illustrate an article by S. Long and G. 
Giebisch, which appeared in the Yale Journal of Biology and Medicine 
esthetic judgement, and as a result, are a real pleasure to 
work with, according to Mrs. Simon. “Others bring in 
work without realizing the problems of translating their 
pen or pencil scratches into a finished product. We are 
frequently faced with the problem of presenting vast 
amounts of information in a very small space,” she said. 
Still other members of the faculty and some students are 
“first timers”, and require considerable counsel and 
advice. “Actually, this may be my favorite part of this job. 
I really enjoy sharing the experience we have gained in this 
office with them. The exchange of knowledge between the 
client and members of the staff about presenting scientific 
information has been one of the most rewarding aspects of 
working here,” Mrs. Simon said. 
A former student of the Art Students League in New 
York, Virginia Simon started her career as a painter and an 
architectural and technical draftsperson. She first worked 
as a medical illustrator for Yale on a free-lance basis from 
her home in Rhode Island. One of her most frequent clients 
then was the late Dr. Nicholas Giarman, professor of 
pharmacology. 
When Armin Hemberger announced his intention to 
retire in 1962, she applied for the job and was accepted. 
The question then, she said with a laugh, was, “is there 
enough work to keep her busy full time?” In no time at all 
she was indeed very busy. “I was so excited about the job 
— I still am.” 
OGCE at 
YALE 
“This is a superior program. The School’s support for 
continuing medical education, the productive relationship 
between clinical departments and the Continuing Medical 
Education Office, the substantial formalized on-going 
community hospital interaction, all lead to the expectation 
of continued growth in providing superior educational 
activities.” These words of praise were included in a letter 
from the Accreditation Council for Continuing Medical 
Education, announcing that the School of Medicine’s pro¬ 
gram for continuing education had received accreditation 
for a new term of six years. A standard interval of accred¬ 
itation is four years; one of six years is given only to 
exceptionally stable and meritorious programs, according 
to the Council. 
Established in 1975, the Office of Graduate and Con¬ 
tinuing Education extended programs of the School’s 
former Office of Regional Activities. They were based on 
the federal Regional Medical Programs legislation (PL 
89-239) of 1966, which expired in the mid-70’s. It 
expressed Congressional concern about the translation of 
federally funded basic medical research to the improve¬ 
ment of patient care in the community, and provided funds 
to accomplish this goal. 
Dr. James D. Kenney was appointed associate dean for 
graduate and continuing education in the fall of 1978. 
There hasn’t been a dull moment in the Office since. 
In spite of a busy private practice in rheumatology and 
internal medicine in New Haven, Dr. Kenney’s interest in 
continuing medical education runs deep. On being 
appointed associate dean, he literally rolled up his sleeves 
and began applying his incredible energy and creativity to 
its operation. 
“When the regional medical program began, 1 as a 
devout practicing private physician had an interest in 
Yale’s relationship to the private medical community,” he 
explained. “As such, I was invited to sit on some of the 
committees involved in setting up the regional activities 
program here.” As time went on, he also helped to 
develop the four Professional Standards Review Organiza¬ 
tions in Connecticut, and for about ten years, he has 
headed the Internal Medicine Review Course. 
“I had one foot in the region and one foot in continuing 
education, and I had watched the OGCE grow from its 
early days as an Office for Regional Activities through the 
development of an associate deanship for graduate and 
continuing education. I was very interested in becoming a 
part of it.” 
Under the federal regional medical legislation, the 
Connecticut Regional Medical Program established a 
system of affiliation of community hospitals either with 
the Yale School of Medicine or the University of 
Connecticut School of Medicine. Yale already had long¬ 
standing relationships with several community hospitals. 
With the new regional medical program, these ties were 
formalized, coordinated and gradually expanded. 
A major undertaking since Dr. Kenney’s appointment 
has been the review and renegotiation of five-year agree¬ 
ments with each of the regional hospitals in Yale’s 
program. (Hospital of St. Raphael in New Haven; 
Bridgeport and St. Vincent’s Hospital; Danbury Hospital; 
Greenwich Hospital; Griffin Hospital in Derby; Lawrence 
and Memorial Hospitals in New London; Norwalk Hospital; 
and St. Mary’s and Waterbury Hospitals). The general 
objectives of the affiliations include continuing education 
of medical staff, graduate medical education of house 
staff, undergraduate medical education, recruitment of 
faculty and medical staff, and multi-hospital research 
programs and referral networks. 
After moving cautiously at first, the Yale affiliated hos¬ 
pitals program is proving attractive to all parties. “The 
chiefs of services and others in the hospitals who interact 
with our faculty have become increasingly prudent plan¬ 
ners, so that the teaching provided by Yale to the regional 
hospitals is not simply a matter of talking heads, but 
instead, includes bedside rounds, special conferences, 
grand rounds, clinic review — whatever the chief at the 
hospital feels will be best for a program that is underway 
there,” according to Dr. Kenney. 
The OGCE staff has given a great deal of attention to the 
organization and standardization of the mass of informa¬ 
tion involved in the agreements with each individual 
hospital, in an effort to facilitate access and review by 
outside agencies such as the Accreditation Council for 
Continuing Medical Education. In addition, they keep a 
census of continuing medical education events in the 
various hospitals. “This is essential,” Dr. Kenney pointed 
out, “so that Yale, as an institution, does not appear to be a 
landlord who signs an agreement, and as he leaves says, 
‘Call me if anything interesting happens.’ We specifically 
solicit and keep records of most, if not all, of the CME 
programs that take place in each hospital. ” 
One of the most innovative programs Dr. Kenney has 
brought to the office provides physicians the opportunity to 
acquire 26 Category 1 CME credits a year without ever 
leaving home. It consists of objective open-book examina¬ 
tions given twice a year, based on the contents of THE 
MEDICAL LETTER in the preceding six months. THE 
MEDICAL LETTER, published by a non-profit organiza¬ 
tion, is a widely circulated and well-known source of 
information about drugs and therapeutics. 
Developed in the latter part of 1979, the examination 
program took off like a rocket, and there are now about 
10,000 subscribers. “Extremely valuable. Researching 
the answers constitutes a most valuable review.” “It is 
excellent. Taking the exam compels me to study THE 
MEDICAL LETTER. This improves my expertise in 
‘medicine’ which helps me as an orthopedic surgeon and 
professor.” “It’s the most attractive of the good quality 
CME correspondent courses in terms of cost per CME 
credit unit.” “Excellent. Would like to see more like it. 
Every physician should participate,” have been some of 
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the many favorable comments from participants. 
The program was developed to permit physicians, and 
when possible others who subscribe to THE MEDICAL 
LETTER, to acquire the CME credits conveniently and at 
a very low cost of $15 per year. The examinations are 
written by a committee of Yale physicians, including 
senior and junior faculty with skills in teaching, research 
and clinical practice. They prepare examinations made up 
of multiple choice, true/false and matching questions not 
only with scholarly intent, but with a touch of wit as well. 
One participant noted, “Excellent education excercise,” 
and added “I enjoyed the humorous aspects of several 
anecdotal ‘cases’. The exam was a pleasure to take.” 
In addition to the affiliated hospital programs and THE 
MEDICAL LETTER exam, the OGCE makes all of the 
arrangements for continuing education workshops, 
seminars and conferences held throughout the year and 
attended by physicians and other health professionals from 
all over the state. Generally sponsored by a department or 
section in the School of Medicine, these programs reflect 
the interests of faculty here, and as such augment activities 
at the Medical Center. According to Dr. Kenney, “In all 
of its endeavors, the Office tries to operate in such a way 
that it can be seen as an extension of the scholarly life 
proper to the Medical Center.” 
In response to a question of whether a medical school 
was the proper agent for graduate and continuing educa¬ 
tion, Dr. Kenney left little doubt about his feelings about 
the subject. “To provide continuing medical education is, 
as 1 see it, a proper endeavor of the university. Whether or 
Janice Gore, front row center, is assistant to the associate dean for 
graduate and continuing education. According to Dr. Kenney, she 
manages the Office, doing everything from balancing the budget to 
making arrangements for the many conferences sponsored by the 
Office, and administering the postdoctoral fellow program — and she 
does it with easy grace. 
Helen Kosack, front row right, is the Office secretary. In addition, she 
does all of the administrative work involved in the production of THE 
MEDICAL LETTER EXAM, including the test scoring, analysis, 
reporting of results, and awarding of certificates. ‘ ‘An absolute marvel 
with detail, she is the perfect person for the job, ’' Dr. Kenney said. 
Patricia Soderberg, front row left, is the liaison between the Office and 
the affiliated hospitals, arranging for lecturers and the like. 
Mary Ellen Levy, in the back row with Dr. Kenney, produces the 
Medical Center Weekly Schedule of Events, one of the Office’s many 
subsidiary projects. 
Dr. Kenney, a professor of clinical medicine, has been the associate 
dean for graduate and continuing education since 1978. “One of the 
unique privileges of practicing medicine at Yale-New Haven Hospital is 
to be part of the most unusual organization here, in which we have 
people of basic scientific expertise, people who are straight-forward 
practitioners, and all shades in between. There are lots of vigorous 
minds and an extraordinarily good house staff. It’s a nice vigorous 
climate in which to work. ’ ’ 
not there are laws mandating CME, and whether or not 
there might be a conflict, either for legal reasons or 
psycho-social reasons with state medical societies, it is 
still the proper business of the university.” 
This philosophy is evident in the direction of activities 
the OGCE has taken over the past few years. “My own 
instincts are those of a practicing physician with some 
minor scholarly pretensions. I am not an educator or an 
educationist. I lament the entry into this field of those 
educationists who are long on the quantification of what 
there is to be learned, or how much time it takes to leam it, 
or how great was one’s satisfaction with what had been 
learned and how that was expressed in one's life. I don’t 
think the business of becoming cultured in any way — 
whether in medicine, the arts, or hard science — is pro¬ 
perly dealt with that way,” he explained. “After all, the 
population of people with whom we deal is bright, and the 
approach to measuring what has been achieved by them 
has to be more general. ” 
For that reason, he sees the Office of Graduate and 
Continuing Education as a mediator between the people 
who make demands for quantitative reportage on the one 
hand, and the people in the School of Medicine, who are of 
professional merit. “Our job is to interpret and make easy 
a transference between the vigorous, difficult-to-define 
life of a university, and the bureaucratic mind, which seeks 
principally a report of what was done. We stand between, 
trying to make things satisfactory for the critic, and easily 
presented by the person of skill.” 
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Letters to the Editor 
A View From The Other Side of the Retractor 
I read with interest the article entitled “Science in Medical 
Practice” which appeared in the last issue of Yale Medicine. 
Who could disagree that an important part of under¬ 
graduate medical education should be the teaching and 
development of critical thinking? What intellectual skill 
more surely defines the excellence of both investigator and 
clinician than the ability to critically evaluate new 
information? However, isn’t our mission as medical 
educators broader than this ? We are here not only to nurture 
inquiring minds; we are here also to train the next genera¬ 
tion of health care professionals — men and women who 
will be responsible for the lives of the infirm and insecure. 
Where in the curriculum are we to breed and evaluate the 
integrity and empathy that will insure against abuse of this 
responsibility — and the humility and humor to carry this 
responsibility gracefully? Where in the curriculum are we 
to assess the students’ ability to respond to stress with 
equanimity and effectiveness? Where and how are we to 
teach these students about priorities and decision-making? 
Where are we to evaluate how maturely and sensitively 
they are able to work with others? Where are we to teach 
and assess their ability to take initiative when it is indicated 
— and to ask for help when it is needed? My guess is that 
most of these qualities are fostered and refined during 
those “wasteful clinical years of medical school” to which 
the article referred. And unless this interface with the 
clinical faculty remains good and meaningful we will have 
abdicated one of our most important academic roles: 
career development and counseling. This is not 
“parochialism”; it is helping future physicians decide 
what to do with their lives. 
I believe that a relevant, integrated medical school 
curriculum requires an environment which values inquiry 
and emphasizes the need to utilize basic science instincts 
and insights in approaching and solving clinical problems. 
We are teaching students who have come to a professional 
school, not a graduate school. We are here to provide 
guidance in approaching both problems and patients — 
and to help our students acquire the skills and stimulation 
necessary for continuing self-education. Our role, it seems 
to me, is to clarify the relevance of the basic sciences to the 
clinical sciences, to require the same intellectual rigor in 
both, and to expect that these intellectual skills be balanced 
by maturity and compassion. 
I believe that there are some specific ways in which 
surgery (as compared to other clinical disciplines) is 
particularly relevant to the development of these problem¬ 
solving skills, whether or not the student has any interest in 
surgery as a career: surgical problems tend to be better- 
defined (with a clear-cut beginning and end) and usually 
evolve over a shorter time-line; decision-making and 
intervention are central to altering the course of these 
problems (and intervention decisions cannot be made 
without a consideration of priorities); the consequence of 
the intervention is usually clear (as is the feedback as to its 
effectiveness). Clinical problem-solving implies both an 
evaluation of the problem and a plan for treatment. 
Surgical problems not only require an early decisive 
assessment but also are more likely to result in a clear and 
tangible solution. The surgeon who is called to see a 
patient who is septic with an acute abdomen or hypo¬ 
tensive following an automobile accident or exsanguinat¬ 
ing from a gastric hemorrhage must be calm, 
compassionate, thorough, and decisive. The student who 
is there in the operating room when the perforated colon is 
resected, the lacerated liver is repaired, or the bleeding 
ulcer is oversewn, is seeing the impact of anatomy, 
pathology, and physiology on the solution of a clinical 
problem. The student who participates in this process is 
learning about problem-solving skills that are fundamental 
to his future. 
This is a case not for “departmental parochialism” but 
for medical education. 
Richard J. Gusberg, M. D., Assistant Professor 
of Surgery, Director of Medical Students, 
Department of Surgery 
This letter from Dr. Gusberg is the only correspondence received 
by Yale Medicine in response to the article ‘ ‘Science in Medical 
Practice’ ’; however, Dr. Berliner has received several personal 
letters from alumni, all but one of which enthusiastically supported 
his views on curriculum as expressed in that article. Editor. 
Erratum: 
An error in Dean Berliner’s article 
“Science in Medical Practice” 
published in the Winter 1982 issue has 
come to our attention. 
In the first column on page 3, the 
word “not” was erroneously included 
in the next to last line. The sentence 
should read: “Many of the things that 
now seem to our students to be most 
relevant, in which they most eagerly 
involve themselves, will be out of date, 
discarded”. 
We apologize for this error. 
Letters to the Editor continued on next page. 
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Letters to the Editor, continued 
Associates of the Yale 
Medical Library 
In 1948, a small group of senior mem¬ 
bers of the faculty joined together to 
form the Associates of the Yale Medical 
Library, an organization of people who 
are devoted to developing not only the 
quality, but also the accessibility of the 
great collection of books found here. 
Since that time, members of the 
Associates, by their dues or contribu¬ 
tions, as well as, in many cases, by 
their active participation have been 
instrumental in maintaining the high 
standards of scholarship which the 
Library makes possible. 
Each year in the spring, the Library’s 
outstanding event is the annual meeting 
of the Associates, at which a distin¬ 
guished visiting scholar or public figure 
speaks on a topic of bibliophilic 
interest. This year's speaker was Dr. 
Lawrence K. Altman, Science Editor 
of the New York Times, who spoke on 
the topic “Medicine and the Press- 
A Historical Overview”. 
At the time of the annual meeting, a 
special exhibit is arranged in the 
Cushing Rotunda for our members and, 
as a souvenir of the occasion, each is 
given a facsimile of a manuscript which 
has had an important place in medical 
history. A reception follows the lecture 
to allow members the opportunity to 
meet the speaker and greet one another. 
It is my pleasure to invite all Yale 
Medical Alumni to membership in the 
Associates. This can be yet another 
way of identifying with the goals and 
aspirations of Medical School and 
Hospital, encouraging the Library, and 
helping to define its philosophy and 
direction. Become an even closer 
friend of your medical alma mater — 
we need all the help you can give. 
Sherwin B. Nuland, M.D., ’55 
Chairman, Board of Trustees, 
Associates of the Yale Medical Library 
Note: 
Membership dues are $25 for contribu¬ 
ting member, $100 for sustaining 
member, and $1000for life member. 
Checks payable to Yale University 
should be sent to the Associates of the 
Yale Medical Library, 333 Cedar 
Street, New Haven, Connecticut, 06510. 
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Two on Faculty Elected to National 
Academy of Sciences 
Two members of the faculty have been 
elected to the National Academy of 
Sciences. Dr. Charles F. Stevens, 
professor of physiology, has been 
elected a member; and Dr. Tsuneo 
Tomita, senior research scientist and 
professor emeritus of ophthalmology 
and visual sciences, has been elected a 
foreign associate of the Academy. 
Election to the National Academy of 
Sciences is considered one of the 
highest honors that can be accorded to a 
scientist or engineer in this country. 
Dr. Stevens is well known for his 
research on the molecular basis for 
nervous system function, and in parti¬ 
cular, for his studies on the role of pro¬ 
teins in transmission of information 
between nerve endings and the nerve 
impulse. A graduate of Harvard 
University, he received an M.D. 
degree from Yale in 1960 and a Ph.D. 
degree from Rockefeller University in 
1964. Prior to his appointment to the 
Yale medical faculty in 1975, Dr. 
Stevens had been professor of 
physiology and biophysics at the 
University of Washington School of 
Medicine in Seattle, where he had been 
a member of the faculty since 1963. In 
1969-1970, he was guest investigator 
at Lorentz Institute for Theoretical 
Physics, Leiden University, The 
Netherlands. He received the W. Alden 
Spencer Award from Columbia 
University College of Physicians and 
Surgeons in 1979, and was the Grass 
Lecturer for the Society of Neuro¬ 
science in 1981. 
Dr. Tomita made a major contribu¬ 
tion to the understanding of the visual 
process when he first described the 
electrical signals produced in the 
photoreceptor cells of the eye. Further, 
with his colleagues, he has been able to 
describe the way in which the nerve 
cells of the retina process these photo¬ 
receptor signals. Formerly professor of 
physiology and dean of the Keio 
University School of Medicine, he has 
been associated with the Department of 
Ophthalmology and Visual Sciences at 
Yale since 1971. He received both an 
M.D. degree and a Ph.D. degree from 
Keio University, where he was a mem¬ 
ber of the faculty for thirty-five years. 
Dr. Tomita is the recipient of a number 
of honors including the Purple Ribbon 
Medal of the Japanese government, the 
Proctor Award of the Association for 
Research in Vision and Ophthalmology, 
and the Japan Academy Award. 
Two Professors Retire 
Two distinguished professors at the 
School of Medicine will retire at the 
end of this academic year. 
Dr. Dorothy M. Horstmann, John 
Rodman Paul Professor of Epi¬ 
demiology and Professor of Pediatrics, 
and a member of the faculty for 39 
years, is recognized throughout the 
world for her research on poliomyelitis 
and rubella. She received her B.A. and 
M.D. degrees from the University of 
California at Berkeley, and first came 
to Yale as an instructor in preventive 
medicine in 1942. In 1969, she became 
the first woman ever to hold an 
endowed chair at Yale, when she was 
promoted to the Paul professorship. 
She is a member of American Academy 
of Sciences, and a Fellow of the 
American College of Physicians. 
Dr. Joseph S. Fruton, Eugene S. 
Higgins Professor of Biochemistry and 
Professor of the History of Medicine, is 
one of the nation’s leading scientists in 
the field of the biochemistry of 
proteins. He received a B.A. degree 
and Ph.D. degree from Columbia 
University, and after ten years on the 
staff of The Rockefeller Institute for 
Medical Research, came to Yale in 
1945 as an associate professor. 
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Pharmaceutical Firm Establishes 
Visiting Professorship in 
Pharmacology 
The School of Medicine has received a 
grant of $50,000 from Sterling Drug 
Incorporated to establish a Sterling 
Drug Visiting Professorship in the 
Department of Pharmacology. The 
grant was made in honor of Dr. Alfred 
Gilman, a distinguished research 
scientist and educator in the field of 
pharmacology. 
The Sterling Drug Visiting Profes¬ 
sorship is intended to promote the 
interchange of knowledge in pharma¬ 
cology between colleges and universi¬ 
ties. Visiting professors will deliver a 
major lecture to faculty and students, in 
addition to participating in seminars 
and workshops. 
Dr. Gilman, who has been a lecturer 
in pharmacology at Yale since 1973, is 
co-author with Dr. Louis S. Goodman 
of “Pharmacological Basis of Thera¬ 
peutics”. The book, published by 
MacMillan & Company and now in its 
8th edition, is considered one of the 
most important texts in the field of 
pharmacology. 
Before coming to Yale, Dr. 
Goodman had been professor and 
chairman of the Department of 
Pharmacology at Albert Einstein 
College of Medicine since 1956. He is a 
graduate of Yale College and received 
his Ph.D. degree in biochemistry here 
as well. In addition to being elected to 
membership of the National Academy 
of Sciences, he is a fellow of both the 
American Academy of Arts and 
Sciences and the American Association 
for the Advancement of Science, and a 
member of a number of other pro¬ 
fessional societies. In 1979, he 
received an honorary Doctor of Science 
degree from Dartmouth College. 
The endowment to establish the 
Sterling Drug Visiting Professorship in 
honor of Dr. Gilman was presented to 
Dr. Alan C. Sartorelli, professor and 
chairman of the Department of 
Pharmacology, by Dr. W. Clarke 
Wescoe, chairman of the board and 
chief executive officer, and Dr. 
Monroe E. Trout, senior vice-president 
for medical and scientific affairs of 
Sterling Drug Inc., in a brief ceremony 
on March 24. 
Leading Geneticist was Fifth 
Caldwell B. Esselstyn Fellow 
Dr. Charles R. Scriver, one of 
Canada’s most distinguished medical 
geneticists and educators, delivered the 
Caldwell B. Esselstyn Lecture on 
Monday, April 26, at the Yale School 
of Medicine. The title of his lecture was 
“Genetics and Medicine: an Evolving 
Relationship.” Named the Fifth 
Caldwell B. Esselstyn Fellow of the 
Department of Epidemiology and 
Public Health, Dr. Scriver also held 
informal meetings and participated in 
seminars with faculty and students. 
The organizer and leader of the 
genetic screening and health services 
program in Montreal, Canada, con¬ 
sidered to be one of the most outstand¬ 
ing in the world. Dr. Scriver is also 
widely recognized for his research on 
the role of amino acids and phosphate 
transport in inborn errors of metabo¬ 
lism. He is a professor of medicine, 
biology, and human genetics at McGill 
University, Montreal, where he 
received a B.A. degree, cum laude, in 
1951 and M.D.C.M. degree, cum 
laude, in 1955. A Fellow of the Royal 
College of Physicians and Surgeons 
(Canada), as well as of the Royal 
Society of Canada and the Canadian 
College of Medical Geneticists, he is 
the recipient of numerous honors and 
awards including the Queen’s Jubilee 
Medal (1977), the Gairdner Interna¬ 
tional Award (1979), and the 
McLaughlin Medal of the Royal 
Society of Canada (1981). 
The Caldwell D. Esselstyn Fellow¬ 
ship was established by the Esselstyn 
Foundation in 1978 in honor of the late 
Dr. Esselstyn, Class of 1925, to bring 
to the Yale community the opportunity 
for dialogue on social and ethical issues 
as they affect health and the quality of 
life. Fellows are selected from among 
those whose work has influenced 
present public debate on health care 
policies, whether or not they are 
directly concerned with the delivery of 
health care services. 
AWARDS 1982 
The Francis Gilman Blake Award is 
presented annually by the graduating 
medical school class to the outstanding 
teacher of the medical sciences. The 
award this year was presented to Dr. 
Edwin C. Cadman, associate pro¬ 
fessor of medicine and pharmacology. 
Dr. Caroline Ryan, an intern in medi¬ 
cine, and Dr. David Podell, a second- 
year resident in medicine, received the 
Samuel D. Kushlan Awards. Estab¬ 
lished in 1969, the awards recognize 
the intern and second-year resident who 
have contributed the most to patient 
care during rotation through the 
Memorial Unit Medical Service. Selec¬ 
tion of recipients is made in consulta¬ 
tion with the clinical faculty and the 
nursing service. 
The Benedict R. Harris Award, estab¬ 
lished in 1967, was presented to Dr. 
Samuel D. Kushlan, clinical professor 
of medicine and associate chief of 
medicine at the Yale-New Haven Hos¬ 
pital. The award is made annually to the 
private physician who has contributed 
the most to the teaching of the house 
staff. Selection is made by first-year 
assistant residents. 
The Betsy Winters House Staff Award 
is presented annually to the member of 
the house staff of the Yale-New Haven 
Hospital who made the most significant 
contribution toward the education of 
medical students. The selection is made 
by the senior class, who this year 
presented the award to Dr. David 
Braun, resident in pediatrics. 
17 
“THE MOVE” into New Patient 
Care Facility: fanfare, flowers and 
festivity 
The first patients moved into the Yale- 
New Haven Hospital's new seven-story 
patient-care facility on April 21, 
culminating nearly 20 years of planning 
and three years of construction. The 
enormous task of moving patients, staff 
and equipment from the outmoded New 
Haven Unit and parts of the Memorial 
Unit was launched amid balloons, 
flowers and a spirit of festivity in the 
pristine, attractive new facility. 
Each patient moved received a 
commemorative coffee mug marking 
the occasion, and every patient in the 
Hospital was given a red carnation as a 
token of the event. Patient moves are 
expected to be completed by June 10. 
“This is an exciting, landmark day in 
the history of Yale-New Haven Hos¬ 
pital,” noted President C. Thomas 
Smith, who presided over a brief 
ceremony before the first bed was 
wheeled onto the fifth floor. “It marks 
a major advance in our ability to deliver 
the best possible patient care.” 
The $73 million project replaces 
outdated facilities located across the 
street in the New Haven Unit with a 
modem, comfortable and integrated 
patient care area. The project also 
includes renovation of the childbirth 
facilities in the Memorial Unit. 
The building has enabled the 
Hospital to consolidate the departments 
of radiology, pediatrics, the operating 
rooms, admitting and discharge offices 
and the cafeterias. The new emergency 
room located on the first floor has 
doubled in size. Patient rooms on floors 
five through seven have been designed 
with privacy and comfort in mind. 
Fulton Award Presented to 
Jed Gorlin 
Jed Gorlin, a fourth-year medical 
student, was awarded the John F. Fulton 
Memorial Award in the History of 
Medicine. The award was established 
in 1966 by a group of Dr. Fulton’s 
former students and alumni of the 
Nathan Smith Club, an organization of 
students interested in medical history. 
The award, which perpetuates Dr. 
Fulton’s work of fostering student 
interest and enjoyment in research in 
medical history, is given annually to 
the student who submits the best 
manuscript of a talk presented before 
the Nathan Smith Club. 
Mr. Gorlin’s paper entitled “The 
Doctrine of Difficult Dentition” is based 
upon his study of medical concepts 
concerning teething in childhood. 
Faculty Notes 
At a ceremony on May 20, the Univer¬ 
sity of Wisconsin Medical Alumni 
Association presented Dr. Leon 
Rosenberg with the Distinguished 
Alumni Citation Award, the highest 
award conferred by the Association. In 
February, Dr. Rosenberg, who is pro¬ 
fessor of human genetics and pediatrics, 
and chairman of the Department of 
Human Genetics, was the UCLA 
Annual Lecturer, and in April, he was 
Pfizer Lecturer at the University of 
Minnesota. 
The National Board of Medical 
Examiners has appointed Dr. Philip 
Felig, professor of medicine, as chair¬ 
man of the National Board’s Part II 
Medicine Test Committee. The distin¬ 
guished corps of examiners of the 
Board, which includes individuals 
selected from among the most promi¬ 
nent members of medical faculties 
throughout the United States and 
Canada, has the responsibility for the 
development of National Board exami¬ 
nations and for assuring the quality and 
integrity of the overall evaluation 
system of the National Board of Medi¬ 
cal Examiners. 
Dr. Donald Cohen, professor of 
pediatrics and psychiatry in the Child 
Study Center, has been elected a 
member of the Board of Trustees of 
Brandeis University. 
The John Simon Guggenheim Memorial 
Foundation has awarded fellowships to 
two members of the faculty. Dr. Arthur 
Broadus, associate professor of medi¬ 
cine received the award for his work on 
isolation of the factor responsible for 
the hypercalcemia of malignancy; and 
Dr. Frederick Naftolin, professor and 
chairman of the Department of 
Obstetrics and Gynecology, was 
recognized for his research on the struc¬ 
ture-function relationship in neuro¬ 
endocrinology. They were among 277 
scholars, scientists and artists chosen 
from 3,200 applicants in the Founda¬ 
tion’s 58th annual competition. 
Dr. William H. Prusoff received the 
1982 AS PET Award from the American 
Society for Pharmacology and Experi¬ 
mental Therapeutics. Dr. Prusoff, who 
is professor of pharmacology, is recog¬ 
nized for his work in the development 
of nucleotide analogs as potential anti¬ 
viral and anticancer agents. 
Two members of the faculty were 
recently honored by the American 
College of Physicians. Dr. Howard 
Spiro, professor of medicine and well- 
known gastroenterologist, has been 
made a Master of ACP. The Richard 
and Hinda Rosenthal Foundation 
Award “to that scientist or scientific 
group whose recent innovative work is 
making a notable contribution to 
improve clinical care in the field of 
internal medicine” was presented to 
Dr. Alvan R. Feinstein, professor of 
medicine, and epidemiology. 
In addition to being elected president of 
the American Association of Patholo¬ 
gists, Dr. Vincent Marchesi has also 
been named editor-in-chief of the 
American Journal of Pathology, the 
official publication of the Association. 
Dr. Marchesi is Anthony N. Brady 
Professor and chairman of the Depart¬ 
ment of Pathology. 
The Greater New Haven Chapter of the 
University of Connecticut Alumni 
Association honored Dr. Robert B. 
Hurowitz with its Distinguished 
Alumni Award at the Association's 
annual award reception in June. Dr. 
Hurowitz is assistant clinical professor 
of pediatrics. 
18 
Dr. Mary Swigar, associate professor 
of psychiatry, has been named “Distin¬ 
guished Alumnus’’ by Muhlenberg 
College, in Allentown, Pennsylvania. 
She is one of four women ever to receive 
this award, which is given annually by 
the college. 
Dr. Ira V. Hiscock, Anna M R. 
Lauder Professor Emeritus of Public 
Health, celebrated his 90th birthday on 
May 7. Among greetings he received 
was this telegram from Hector Acuna 
(’51 MPH), director of the Pan-American 
Health Organization: “Please receive 
my heartiest congratulations on the 
occasion of your ninetieth birthday. As 
a former student of yours, I would like 
to express once more my deep affection 
not only for your thoughtful lectures, 
but especially for your warm and wise 
guidance that you have provided to 
myself and hundreds of others to better 
serve the cause of public health. On 
behalf of the Pan American Organization 
Regional Office for the Americas of the 
World Health Organization and myself, 
we feel pleased to honor you in this 
way.’’ Dr. Hiscock resides at the Pine 
Run Community in Doylestown, 
Pennsylvania. 
Richard Schweiker, Secretary of Health 
and Human Services has invited Dr. 
Adrian Ostfeld to join the National 
Advisory Council on Aging. The 
council is the senior advisory group on 
aging research and training in the 
National Institutes of Health. Dr. 
Ostfeld is Anna M R. Lauder Professor 
of Epidemiology and Public Health. 
Dr. Gary Schwartz, professor of 
psychology and psychiatry, has been 
busy on the lecture circuit this spring. 
On March 2, he delivered the second 
annual Kate Ellen Polachek Memorial 
Lecture on Behavioral Medicine at the 
University of Wisconsin Medical 
School; and the next day he gave an 
invited workshop on research in 
psychophysiology at a meeting of the 
Society of Behavioral Medicine. He 
recently gave an invited series of lec¬ 
tures at the Skinner Institute on Bio¬ 
feedback and Behavioral Medicine in 
Rome. 
The 22nd Annual Herman Beerman 
Award was presented to Dr. Frank 
Ruddle, professor of biology and 
human genetics, by the Society for 
Investigative Dermatology. The award 
is presented to a scientist outside the 
specialty of dermatology for significant 
contributions in developing a new 
biomedical technology with applica¬ 
tions in dermatology. Dr. Ruddle 
delivered the Beerman Lecture entitled 
“Reverse Genetics: A New Approach 
to Human Genetic Analysis.’’ 
On March 31, Dr. Bernard Gee, pro¬ 
fessor of medicine, gave the Dr. Owen 
Clarke Memorial Lecture at the 
University of Western Ontario, 
London, Ontario, with the title of 
“Sarcoidosis: Current Concepts in 
Pathogenesis, Diagnosis and Manage¬ 
ment.” Dr. Gee was also an organizer 
and director of the International Con¬ 
ference on Occupational Lung Disease 
sponsored by the American College of 
Chest Physicians and held in Chicago 
in March. 
Dr. Frederic L. Holmes has been 
appointed Master of Jonathan Edwards 
College for a five year term. Dr. 
Holmes is professor of the history of 
medicine. 
New Book by Faculty 
“Narcotic Analgesics in Anesthe¬ 
siology”. Edited by L.M. Kitahata, 
professor and chairman of the 
Department of Anesthesiology and 
J.G. Collins, assistant professor of 
anesthesiology and pharmacology. 
Williams & Williams (Baltimore) 
1982. 
David Andrew Balia, Ph.D. 
Dr. David A. Balia, associate professor 
of psychology in the Child Study 
Center,- died on February 16, 1982 at 
the age of 42. 
A native of Pittsburgh, Pennsylvania, 
Dr. Balia received his B.A. degree 
from DePauw University in 1961 and 
the M.S. and PhD. degrees in 
Psychology from Yale University in 
1965 and 1966. He was appointed a 
Research Staff Psychologist in the Yale 
Department of Psychology in 1967 and 
in 1970 was promoted to Research 
Associate in the Department of 
Psychology and the Child Study 
Center. In 1977 he was appointed to the 
rank of Associate Professor in the Child 
Study Center. 
Dr. Balia made major contributions 
in the fields of developmental 
psychology, mental retardation, and 
juvenile delinquency. He was an 
associate editor for Applied Research in 
Mental Retardation and a consulting 
editor for the American Journal of 
Mental Deficiency and Clinical 
Psychology Today. Dr. Balia was also 
the author of more than 60 scientific 
publications including both journal 
articles and books. 
In addition to his wife and parents, 
he is survived by three daughters, a 





The following endowed lectures were given at the School of Medicine during the academic year 1981-1982: 
The Paul B. Beeson Memorial Dr. Anthony S. Fauci, National Institutes of Health, “Human B Lymphocyte 
Lecture Function: Activation and Immunoregulation in Normal and Disease States.” - 
January 27. 
Sanfurd G. Bluestein Lecture Dr. H. Paul Capp, University of Arizona College of Medicine. “Medical 
Imaging-1990.”-February 11. 
Phyllis T. Bodel Memorial Lecture Dr. Margery W. Shaw, University of Texas Health Center. “Prenatal Medi¬ 
cine and Selective Abortion: Legal Issues Confronting Physicians.” - 
November 11. 
Philip K. Bondy Lecture Dr. David J. Weatherall, John Radcliffe Hospital, “The Clinical and Molecular 
Diversity of the Thalassaemias: A Model for Genetic Disease in Man. ” — April 
4. 
The Jack R. Cooper Lecture Dr. Jon Lindstrom, The Salk Institute, “Use of Monoclonal Antibodies to 
Study Acetylcholine Receptors and the Autoimmune Response to Receptors in 
Myasthenia Gravis. ” — February 18. 
Clyde L. Deming Memorial Lecture Dr. Vincent O’Connor, Jr., Northwestern Memorial Hospital, “Experience 
with Vesicovaginal Fistula Repair.” - November 30. 
Caldwell B. Esselstyn Lecture Dr. Charles R. Scriver, McGill University, “Genetics and Medicine: An 
Evolving Relationship.” - April 26. 
Harold Fink Memorial Lecture Dr. Ernest Beutler, Scripps Clinic and Research Foundation, “Bone Marrow 
Transplantation in the Therapy of Acute Leukemia.” - May 12 
John P. Flynn Memorial Lecture Dr. Eric R. Kandel, Columbia University College of Physicians and Surgeons, 
“Cell Biological Approaches to the Study of Anxiety in Simple Animal 
Models.” - March 5. 
John F. Fulton Memorial Lecture Dr. Gert Brieger, University of California “Cooperation Between Medical 
Historians and Clinicians.” - October 28. 
“Some Aspects of the History of Therapeutics” -October 29. 
“Early Ambulation - A Case Study in the History of Surgery.” — October 30. 
Samuel Clark Harvey Lecture Series Dr. Howard A. Pearson. “History of Pediatrics in New Haven. “-February 8. 
Dr. Franklin C. Wagner “Spinal Cord Injury from Imhotep to Present.” - 
February 15. 
Dr. MarkM. Ravitch, University of Pittsburgh, “Development of the 
Resection of Chest Wall Tumors.” - March 8. 
William Barriss McAllister Jr. 
Memorial Lecture 
Dr. Steven Silverburg, George Washington University Medical Center, 
“Hormones and Endometrial Cancer.” - March 24. 
John Meyer Visiting Professor 
Lecture 
Dr. Andrew W. Bruce, University of Montreal, “Prostatic Acid Phosphate - 
Current Status.” - March 8. 
Louis H. Nahum Memorial Lecture Dr. B. Sakmann, Max Planck Institute, “Measurement of Single Channel 
Currents Activated by Putative Transmitters in Muscle, Spinal Cord Neurons 
and Heart.” - April 28. 
Leon E. Sample Lecture Dr. William R. Drucker. University of Rochester Medical Center, “Metabolic 
Basis for Defense of Homeostasis During Shock.” - March 20. 
Henry E. Sigerist Lecture Dr. James H. Cassedy, National Institutes of Health, “A Medical Calculus of 
America’s Foreign Mission Enterprise 1830-1860. ’ ’ - February 26. 
Arnold D. Welch Lecture Dr. Frank M. Huennekens, Scripps Clinic Foundation, “Three Roads to 
Tetrahydrofolate - Implications for Chemotherapy.” - April 16. 
Dr. Samuel and Kathryn Yochelson 
Lecture 
Alan M. Dershowitz, Hazard Law School, “The Cage, the Couch, and the Cat 




The Alumni in Medicine Column 
Introduction by Nicholas P. R. 
Spinelli, President 
Among many alumni, working for the 
School with constancy but quietly and 
with low profile, has been Ros 
Gallagher (’30 Med). He has been 
Chairman of our Medical School 
Bequest and Endowment Program 
since its inception in 1960. In these 
times when private educational institu¬ 
tions are experiencing financial 
hardship, remembering our alma 
mater among our heirs, in some 
fashion, has become a more urgent 
necessity. This effort has been most 
successful in the Yale College Alumni 
Fund as well as other Yale graduate 
schools, most conspicuously the Law 
School. In recent years, Ros has been 
ably assisted by Sam Kushlan (’35 
Med) in this task. Following is their 
description of what B and E are all 
about. 
Why a Gift to “Endowment”? 
“. . . Kissing your hand may make you 
feel very good but a diamond . . . lasts 
forever.” So, too, does a gift to the 
Yale Medical School Alumni Fund 
Endowment. “Endowment” to many 
of us spells permanence, “a gift in 
perpetuity”, “a gift that keeps on giv¬ 
ing” — those are what a gift to 
“Endowment” is all about. 
It is the permanence of a gift to 
Endowment that appeals to so many of 
those whose circumstances permit 
them to consider making a substantial 
gift. Unlike the Parisian’s kiss, it is not 
for the moment. Year after year after 
year the income it generates will help to 
maintain the School’s quality. 
The “giving” also has permanence. 
Like “The Brook” of Alfred Lord 
Tennyson, it will ‘‘go on forever’ ’. The 
total amount of a donor’s gift to 
Endowment is credited in his or her 
name and class in the year it is received 
and its income will be similarly credited 
each year thereafter. It is impossible to 
know how much this way of recogniz¬ 
ing a donor’s gift to Endowment may 
influence the donor’s decision to make 
a contribution. But is it not true that 
there is more than a little of “. . . this 
pleasing hope, this fond desire, this 
Other donors like the variety of ways 
a major gift can be made to Endowment. 
For one, a Life Income gift best fits his 
or her circumstances; for another a 
Deferred Annuity gift, a Bequest, a 
Capital gift or a gift of a Life Insurance 
policy whose protection is no longer 
required will be appealing and 
appropriate. 
The fact that the gift’s capital is 
managed so as to compensate for 
attrition by inflation must impress 
every prospective donor; no one likes 
the thought that a gift’s real value will 
gradually (these days rapidly) diminish. 
To counteract this the Fund adds a 
fraction of each year’s income to the 
capital amount of the original gift. 
These brief speculations of why 
alumnae and alumni choose to make 
gifts to Endowment suggest another 
fundamental question: why does a 
graduate desire to make a substantial 
gift? Like many basic ones — there is 
no single, definitive answer. 
You, no doubt, have thought of more 
than one reason. There are many: 
“divers dive for diverse reasons” — 
and so do people who give. Some of the 
reasons are homely, familiar; others. 
equally valid, may be obscure. It’s a 
wise donor who knows his own motives. 
Warm feelings, fostered by happy 
memories of his or her own School 
experiences, or of one or more teacher’s 
encouragement, inspiration or friendli¬ 
ness, must be high on everyone’s list of 
reasons. An uncomplicated, simple 
feeling of obligation to repay the 
School for at least the difference 
between the tuition paid and the amount 
his or her education cost the School is 
another. Or a mix of empathy with 
succeeding generations of students and 
the memory of one’s own struggle may 
serve to breed a desire to make these 
younger people’s journey as beneficial 
as — and less grueling than — the 
donor’s. 
Then there are the complex, more 
intimate reasons: the need further to 
feed a still hungry ego, or to bolster a 
still less than solid identity. Not all the 
processes of adolescence reach their 
destinations before the thirties! 
And, often intertwined with one or 
more of those, is a reason that might 
better have been mentioned first; the 
fact that many donors previously had 
learned that giving is a rewarding 
experience, that it is “ . . . more blessed 
to give than to receive”, and frequently 
more satisfying. 
Ros Gallagher, Chairman 
Sam Kushlan, Co-Chairman 
Yale Medical School 
Bequest and Endowment Program 
Class Notes 
1932 
Myron Wegman has been elected 
president of the American Association 
for World Health for the biennium 
1982-83. From 1952 to 1961 Dr. 
Wegman served with the Pan American 
Health Organization, first as chief of 
the organization’s Training and Educa¬ 
tion Division, later as secretary 
general. He was dean of the University 
of Michigan School of Public Health 
from 1961 until his retirement in 1974. 
The AAWH is a private non-govem- 
mental health agency whose function it 
is to carry out programs of public 
education relating to the objectives and 
21 
programs of the World Health Organi¬ 
zation and to encourage citizen support 
for WHO in the United States. 
In addition, Dr. Wegman was the 
recipient of the first Distinguished 
Alumnus Award for Outstanding 
Service in Public Health from the Johns 
Hopkins University School of Hygiene 
and Public Health. The selection was 
based on a recent alumni survey in 
which 50 were nominated for the 
honor. Dr. Wegman received his mas¬ 
ter’s degree in public health in 1938 
from Johns Hopkins University. 
1940 
Secretary, Donald G. Johnson 
Box 116 
Bar Mills, Maine 04004 
Dear Classmates, 
It would be inaccurate to categorize my 
secretarial efforts as productive. In 
fact. I’ve had nothing about which to 
write since nothing has been brought to 
my attention. You will be pleased 
perhaps to learn that I do now have 
something to report, most of which is 
through Jim Ferguson. 
Bill Oakes writes from Los Alamos, 
N.M. that he is now truly retired and 
has been travelling about the Southwest 
in his recently acquired trailer, visiting 
parks and thoroughly enjoying it. 
AI Merendino has written to Jim 
Ferguson to say he has left the Univer¬ 
sity of Washington and is now back in 
Riyadh, Saudi Arabia as director of the 
Cancer Therapy Institute and acting 
director of operations of King Faisal 
Medical City. Al’s “new career’’ 
sounds challenging. More power to 
him. 
Mirabile dictu!! a letter to Jim dated 
last November from Joe Sokol. Joe’s 
career has taken him from medical 
school to training in medicine in New 
Haven before and after W.W. 2 with 
interim Army service in the Pacific. 
Then back to New Haven on the faculty 
at Yale, military service again 1950-52 
in Europe, then back to New Haven. 
Joe went to Roswell Park in Buffalo in 
1955 and became research professor of 
medicine at State University of New 
York. He left Buffalo in 1979 for Duke 
University and is a full professor 
“without responsibilities, less teach¬ 
ing’’, but with time for research pro¬ 
jects dealing with chronic myeloid 
leukemia. Joe is married to a native 
Floridian, and has two sons both of 
whom are M.D.’s; one of his sons is 
now in Upper Volta, Africa and the 
other, in Dallas after a residency there 
in medicine. 
A letter also to Jim Ferguson from 
Crawford Campbell outlined plans 
for a six week lecture tour in March and 
April of this year to Japan, Thailand, 
South Africa, and finally to Rome 
where Kay will join him for three 
weeks in Florence. We are all glad to 
learn Kay has recovered from her 
Spring 1981 illness. Crawford and 
Kay’s younger son has decided to make 
a fantastic change from ballet to medi¬ 
cine. I wish him well in his new career. 
Communication from Champ 
Taylor mentions a recent trip to France 
for a month last fall. His son, Reid, is in 
his third year of medical school and is 
interested in surgery. 
Both Jim and I received letters from 
Jack Blaisdell. Jack went into ortho¬ 
pedics, and following discharge from 
the Army in 1947, he went into practice 
in Santa Ana, California where he 
remained until 1975. It appears Jack 
truly got involved in organized medi¬ 
cine through participation in numerous 
medical societies. He has received on 
two occasions the A.M.A.’s Physician 
Recognition Award in Continuing 
Medical Education. Having “tired of 
the rat race” in California, Jack and his 
wife, Famie, moved to Northern Idaho, 
still practicing, but in a relaxed manner 
and in the pleasant surroundings of 
Lake Pend Oreille in Sandpoint, Idaho. 
On Saturday, March 20, 1982 Jack 
Wells had a group of us 1940ers at his 
home in Wethersfield, Conn. Present 
were Eddie Martin and wife Marty; 
Eddie is still practicing in New Britain 
and believe me, he doesn’t look his 
age. Jim and Izzy Ferguson, now 
retired, are enjoying tennis and life in 
general. Jack and Eunie Wells are still 
up to their necks in civic activities. 
Jack’s current practice is limited by his 
own choice to former old patients. Ron 
and Betty Beckett, with whom I stayed 
for the week-end, were there. Ron is 
“retired” but still works in the 
Hartford Hospital in pathology and is 
involved in his nomenclature and 
computers. And who showed up?? Bill 
Lee, whom we all consider a classmate 
even though he didn't graduate with us. 
Bill now works in the Employees 
Health Department at Hartford 
Hospital, having given up practice after 
a brush with vascular problems. He 
plays tennis actively and frequently. 
Your secretary completed the group at 
Jack’s soiree. I am still retired in 
Maine, not engaged in any way in prac¬ 
tice , but working in a vague sort of way 
with the Red Cross Blood Services, 
Northeast Region (Maine and 
Massachusetts). The party was a great 
success and I hope many of you had 
burning ears from our reminiscences. 
If you welcome this column for the 
next issue of Alumni news, I would be 
delighted to do it again with support 
from those long since silent. 
Best wishes to all. 
1943 
Announcement has been received that 
Robert Furman, vice president for 
corporate medical affairs at Eli Lilly 
and Company, has been named to the 
Union College Board of Trustees at 
Schenectady, New York. Before join¬ 
ing Eli Lilly and Company in 1970, Dr. 
Furman held a teaching position at 
Vanderbilt University and a research 
position at the University of Oklahoma 
School of Medicine. He has been pro¬ 
fessor of medicine at the Indiana 
University School of Medicine since 
1970. He is the author or co-author of 
more than 170 scientific papers in the 
fields of endocrine, cardiovascular and 
metabolic disorders and has served on 
the board of editors of several scientific 
publications in addition to being a 
member of numerous professional 
organizations. Dr. Furman is also a 
very active alumnus of Union College. 
1951 
Robert Hamburger, professor of 
pediatrics and head of the Immunology 
and Allergy Division at the University 
of California at San Diego, was elected 
in January to a three-year term as a 
member of the Board of Regents of the 
American College of Allergists. 
1956 
Announcement was recently received 
that Captain William Narva, MC, 
USN, has been appointed by the Presi¬ 
dent to the position of vice president of 
the Uniformed Services University of 
the Health Sciences, and that upon 
Senate confirmation, he was promoted 
to the rank of rear admiral. Since 1978, 
Dr. Narva has served as professor and 
acting chairman of the Department of 
Dermatology at the Uniformed Services 
University School of Medicine, a posi¬ 
tion which he will retain with his new 
assignment. Also since 1978, he has 
served as special assistant for reserve 
affairs in the Bureau of Medicine and 
Surgery, and from 1970 Dr. Narva has 
been staff officer to the chief of Naval 
Operations. 
1958 
Robert Neuwirth has been named 
director of obstetrics and gynecology at 
St. Luke’s-Roosevelt Hospital Center 
in New York City. His appointment 
marked the merger of Ob/Gyn patient 
care, teaching and research activities 
into a single department in the Hospital 
Center’s three divisions: St. Luke’s, 
Roosevelt and Woman’s Hospitals. Dr. 
Neuwirth, noted for his research in 
non-surgical techniques for female 
sterilization, has coordinated numerous 
such projects internationally and has 
consulted on many in emerging and 
Third World nations. He pioneered the 
use of laparoscopy and is widely 
recognized as an authority on 
hysteroscopy. 
1959 
Mark Bitensky has resigned his pro¬ 
fessorship at Yale to join the Los Alamos 
National Laboratory in New Mexico, 
where he is Division Leader of the Life 
Sciences Division. He recently wrote to 
say that the demands of his new posi¬ 
tion are awesome. The functions of the 
division include toxicology testing of 
shale and other synfuels, mutagenicity 
and carcinogenicity testing, genetics 
and cytogenetics research, environ¬ 
mental science and waste management, 
flow cytometry, experimental pathol¬ 
ogy, and radiobiology. 
1970 
Daniel Dedriek is an assistant profes¬ 
sor of anesthesia at The Pennsylvania 
State University College of Medicine at 
The Milton S. Hershey Medical Center 
in Hershey, Pennsylvania. His wife. 
Dr. Carolyn Dedriek, a former member 
of the class of 1973, has been named 
assistant professor of radiology at The 
Pennsylvania State University College 
of Medicine. 
Bruce Reitz wrote recently that he is 
leaving Stanford University School of 
Medicine where he has been associate 
professor of cardiovascular surgery to 
become professor and head of the 
Division of Cardiac Surgery at Johns 
Hopkins University School of Medi¬ 
cine, a position which "has been held 
for the last 18 years by another Yale 
medical school graduate, Vincent 
Gott, (’53).” 
1971 
Steven Moffic has recently been pro¬ 
moted to associate professor of 
psychiatry at Baylor College of Medi¬ 
cine and has edited the book "A 
Clinician’s Manual on Mental Health 
Care: A Multidisciplinary Approach”, 
(Addison-Wesley, 1982). 
1973 
A letter received from Richard Boland 
in May 1981 was unfortunately omitted 
from the previous issue. He mentioned 
that he had "recently” run into several 
former classmates in the past few 
months, and upon comparing notes, it 
appears that a very large segment of our 
class has stayed on (at least this far) in 
academic medicine.” 
He notes that he is now assistant pro¬ 
fessor of medicine at the University of 
California, San Francisco, where he 
has been funded to study glycoprotein 
biochemistry in gastrointestinal cancer; 
that John Stratton is doing research in 
cardiology at the University of 
Washington where he was recently 
appointed assistant professor of medi¬ 
cine; and that Richard Young became 
assistant professor of pediatrics at 
Hershey Medical School (The Pennsyl¬ 
vania State University College of 
Medicine) a year ago and is doing 
research in pediatric neurology. 
Dr. Boland listed twenty-four other 
classmates who, "as far as can be 
ascertained, currently hold academic 
appointments and are actively involved 
in research. This list (compiled from 
the softest of data bases — rumor and 
recollection) is in excess of one third of 
all those we could recall. It may be 
somewhat overinclusive, and some 
others may have been overlooked.” 
He’d be interested in having corrobo¬ 
rating information about this. 
1974 
Richard Pasternak, director of the 
Coronary Care Unit at Pacific Medical 
Center and clinical instructor in medi¬ 
cine at the University of California in 
San Francisco, has been elected to 




The Houston Academy of Medicine- 
Texas Medical Center Library has 
honored John P. McGovern in naming 
the library’s history of medicine collec¬ 
tion for him. At a reception in April, a 
portrait of Dr. McGovern and a bronze 
plaque commemorating The John P. 
McGovern History of Medicine Collec¬ 
tion were presented to the library. 
1969 
Michael Rosner wrote in April: "I was 
recently elected chief of medicine at 
Holyoke Hospital in Holyoke, 
Massachusetts. I continue in private 
practice in Holyoke with three other 
associates including Robert Seaver 
who was a Gastroenterology fellow 
(’71) at Yale.” 
IN MEMORIAM 
Matthew Griswold 
March 7, 1982 
M. D. '25 
Moses Cooperstock 
January 30, 1982 
M. D. ’26 
Richard M. Starr 
(date unknown) 
M. D. ’26 
Harold A. Flynn 
January 30, 1982 
M. D. ’27 
J. Merriman Lynch 
February 20, 1982 
M. D. ’30 
Dana L. Blanchard 
December 29, 1981 
M. D. ’31 
Frederick A. Wies 
January 19, 1982 
M. D. ’33 
Charles W. Cashman, Jr. 
February 8, 1981 
M. D. ’41 
Gabriel A. Saviano 
December 15, 1981 
M. D. ’48 
Allen R. Traurig 
February 12, 1982 
HS ’66 
Ronald M. Holloway, 
M. D. M. P. H. ’67 
December 20, 1981 
Class of 1982 
First-Year Postgraduate Appointments 
Arizona 
University of Arizona Affiliated Hospitals, 
Tucson 
David Goldstein — Medicine 
California 
Cedars-Sinai Medical Center, Los Angeles 
Albert Ungricht — Surgery 
Kaiser Foundation, San Francisco 
Eric Wells — Pediatrics 
Stanford University Affiliated Hospitals, 
Stanford 
Mary vander Velde — Pediatrics 
University of California Hospitals, 
San Francisco 
Cathleen Belden — Obstetrics & Gynecology 
Gabriel Escobar — Pediatrics 
Howard Jaffe — Medicine 
Kathleen Nolan — Pediatrics 
University of California/Irvine, Irvine 
Louise Connolly — Obstetrics <£ Gynecology 
Gary Garshfield — Pathology 
University of California/Los Angeles 
Keith Gladstien — Pediatrics 
Colorado 
St. Joseph Hospital, Denver 
Jonathan Amow — Surgery 
University of Colorado Affiliated Hospitals, 
Denver 
Kenneth Huttner— Pediatrics 
Connecticut 
Norwalk Hospital 
Alfred Harrington — Medicine 
University of Connecticut Hospital, 
Farmington 
Stuart Gardner — Pediatrics 
Waterbury Hospital 
Carol Pilbeam — Medicine 
Yale-New Haven Medical Center 
Deborah Blair — Medicine 
Paula Braverman — Pediatrics 
Thomas Brennan — Obstetrics & Gynecology 
Fred Drennan — Medicine 
Laune Katz — Pathology 
Teresa Massagli — Pediatrics 
Christopher Otis — Pathology 
Mark Piccinllo — Radiology 
Carrie Redlich — Surgery 
Robert Rohrbaugh — Psychiatry 
Stephanie Rosenblum — Medicine 
Philip Sager — Medicine 
Paul Sylvan — Medicine 
Lynn Tanoue — Medicine 
Patrick Toth — Surgery 
Laurence Turka — Medicine 
Ronald Voit — Obstetrics & Gynecology 
Georgia 
Grady Memorial Hospital, Atlanta 
Craig Lewis— Medicine 
Illinois 
Rush-Presbyterian-St. Luke’s Medical 
Center, Chicago 
Juan Larach — Medicine 
Iowa 
University of Iowa Hospitals, Iowa City 
Muriel Cyrus — Medicine 
Maryland 
Johns Hopkins Hospital, Baltimore 
Rise Chait — Psychiatry 
Sinai Hospital of Baltimore 
Henry Jampel — Medicine 
Massachusetts 
Beth Israel Hospital, Boston 
Sylvia Beck — Medicine 
Boston City Hospital 
Don Stromquist — Medicine 
Brigham & Women’s Hospital, Boston 
Michele Masi — Medicine 
Donald Regula — Pathology 
Robert Rizzo — Surgery 
Cary' Sennett — Medicine 
Cambridge Hospital 
Alan Brown — Flexible 
Children's Hospital Medical Center, Boston 
Jed Gorlin — Pediatrics 
Lewis Rubin — Pediatrics 
Massachusetts General Hospital, Boston 
Joyce O'Shaughnessy — Medicine 
New England Medical Center, Boston 
Paula Schlesinger — Pediatrics 
Michigan 
University Hospital, Ann Arbor 
Seyms Cartwright — Medicine 
Minnesota 
Mayo Graduate School of Medicine, Rochester 
George Gaunt — Pathology 
Missouri 
Barnes Hospital, St. Louis 
Jeffrey Gimble — Medicine 
Michael Katz — Radiology 
Peter Namnum — Medicine 
New York 
Bronx Municipal Hospital 
Charles D Wright — Psychiatry 
Brookdale Hospital Center, New York City 
Kamu Kokayi — Family Practice 
Harlem Hospital, New York City 
Carola Greengard — Medicine 
Highland Hospital, Rochester 
Beth Connors — Family Practice 
Montefiore Hospital Center, New York City 
Dan Odenheimer — Surgery 
Henry Stem — Surgery 
Ellen Tattelman — Family Practice 
New York University Medical Center-Bellevue Hospital, New York City 
Jerrold Levine — Medicine 
Presbyterian Hospital, New York City 
Daphne Hsu — Pediatrics 
St. Vincent's Hospital, New York City 
Liba Goldblum — Flexible 
The New York Hospital, New York City 
Jeffrey Tepler — Medicine 
University of Rochester Hospitals, Rochester 
Evangeline Franklin — Medicine 
24 
New Zealand 
Dunedin Hospital, Dunedin 
David Menkes — Flexible 
Pennsylvania 
Hospitals of University Health Center, Pittsburgh 
Michael Carty — Medicine 
Richard Doan — Psychiatry 
William Sikov — Medicine 
Hospital of the University of Pennsylvania, Philadelphia 
Lisa Crossley — Medicine 
Andrew Fox — Surgery 
James Michelson — Surgery 
James Reinprecht — Medicine 
David Wright — Psychiatry 
St. Christopher’s Hospital, Philadelphia 
Jane Cross — Pediatrics 
Temple University Hospitals, Philadelphia 
Ratal in Roth — Medicine 
Rhode Island 
Miriam Hospital, Providence 
Lila Inouye — Medicine 
Rhode Island Hospital, Providence 
Christopher Roberts — Medicine 
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Commencement Address: 
Yale University School of Medicine May 24, 1982 
This is an auspicious day. We are here to celebrate the 
conferring of the Doctor of Medicine degree on 28 women 
and 56 men who constitute the class of 1982 of the Yale 
University School of Medicine. I congratulate each of you, 
confident that I speak for everyone in attendance and for 
family, friends, and teachers who are not. Your achieve¬ 
ment testifies that young (and a few not so young) people 
in our society can still set their own goals and have the 
discipline, dedication, and patience to reach those goals. 
At a time of national doubt and introspection, this is 
reassuring. Your presence here signifies, too, that the 
unconditional love which your parents have for you, their 
children, and the sacrifices they have gladly made in 
expressing that love are rewarded. That is beautiful. More¬ 
over, this commencement ceremony proclaims that this 
venerable institution of learning, whose architecture can 
most charitably be described as eclectic, whose educa¬ 
tional trappings run the gamut from outmoded to antique, 
and whose faculty structure most closely resembles that of 
an anthill, can manage to pull itself together for your 
benefit. That is amazing. 
This is a day, too, of thanksgiving: of children thanking 
their parents for the tangible and intangible support essen¬ 
tial to reaching this milestone; of parents thanking their 
children for taking a large step toward independent, self- 
sufficient lives; of teachers and students thanking each 
other for shared experiences conferring mutual stimulation 
and sustenance. I wish to add my personal thanks to the 
class of 1982 for selecting me to speak here today. To be 
recognized by one’s students is always a special reward for 
a teacher. To be recognized by you at this unique moment 
in your professional lives is a singular honor, and one, I 
can confidently say, that I (the recipient) will remember 
far longer than you (the bestower). I say this because it is 
precisely 25 years since I received my M.D. degree on a 
day and at a place something like this, and listened to a 
commencement address. Sadly. 1 must confess to remem¬ 
bering nothing of the message delivered on that occasion. 
Sadder still, I cannot even recall who uttered those 
unmemorable words. Fortunately, however, I do remem¬ 
ber quite a lot about what ensued in the years subsequent to 
that blotted out ceremony and it is those reflections I will 
use in trying to say something that someone of you may 
remember sometime. 
I suspect there are two things on your mind today. One is 
the hope that this ceremony will be mercifully brief so you 
can clutch your diploma, kiss your spouses and parents. 
I 
hug your classmates, and have a glass of wine. Fear not for 
I have taken my cue from Muriel Humphrey who liked to 
remind her loquacious husband. Hubert, that for a speech 
to be immortal it need not be eternal. 
The other matter, only slightly less immediate, concerns 
your internship, now called many things but still meaning 
the same thing. When you leave here today some of you 
will stay in New Haven, others w ill scatter to every comer 
of the United States and one of you w ill go as far away as 
Dunedin. New Zealand. For most of you choosing an 
internship has been the major occupation and preoccupa¬ 
tion of the past year. Among the rationales given for the 
enormous amount of time and energy devoted to this 
process, two stand out. 
The first contends that internship marks the rite of 
passage from student to physician, and with that status 
change a quantum jump in responsibility and independ¬ 
ence. That assessment is correct. I believe. Being an intern 
is not like being anything else. It is an idiosyncratic year in 
which extremes become the norm: greater exuberance 
from medicine than many of you will ever again expe¬ 
rience coupled with greater fatigue; an absolute commit¬ 
ment to your work which pushes nearly all other commit¬ 
ments to the background; a time of triumph and of being 
sorely tested. It is a year for which I envy you. knowing 
full well interning should not be done more than once. 
The second rationale for all the angst associated with 
internship selection derives from the belief that this 
choice, more than any other, sets in motion a elear, 
orderly, even inexorable chain of career events. My expe¬ 
rience says otherwise. I chose an internship in internal 
medicine blithely convinced that I wanted a career largely 
devoted to clinical practice with some time, perhaps, for 
teaching. Research was not a serious consideration; 
specialization in medical genetics was not even imagined 
since the specialty didn't exist. If anyone had suggested to 
me at my medical school commencement that laboratory 
research and teaching in medical genetics would, in fact, 
be the major pursuit of my next 25 years, or that I would 
one day become board-certified in internal medicine only 
to devote the vast majority of my limited clinical effort to 
the care of young children with inherited metabolic 
diseases I would have been incredulous. 
Let me explain how this total career flip-flop came 
about. My internship experience was rewarding and 
important because I was exposed to teachers who believed 
that scientific rigor and humane understanding were 
equally important ingredients for sound medical practice. 
But my exposure to fellow house officers with quite 
different career orientations may have been even more 
important. Most of my colleagues were headed for 
research fellowships at the National Institutes of Health, 
because they were embued with the notion that the rapid 
progress being made in biochemistry, pharmacology, and 
physiology would have a great impact on medical practice, 
and they wished to participate in this surge. So 1 tagged 
along, in part because I was vaguely curious about my 
interest in and ability for research, but more because, in 
candor, it was the thing to do. Remember, those were the 
halcyon years of biomedical research in this country and 
NIH was Mecca. My experience there began disastrously. 
I found myself participating in metabolic balance studies 
aimed at understanding the cachexia of terminal malig¬ 
nancy. Caring for a large number of patients dying of 
cancer was difficult enough. Trying to do detailed met¬ 
abolic investigations on these debilitated, uncomfortable 
people was excruciating. 
There was, however, one child on the service with a 
puzzling syndrome characterized clinically by progressive 
skeletal muscle wasting and chemically by a markedly 
exaggerated excretion of amino acids in urine. He was a 
pleasant, bright lad, and caring for him was a welcome 
respite from my otherwise depressing chores. He was 
being studied because someone believed that his muscle 
wasting might, in some way. be likened to that observed in 
patients with cancer. That idea, for which there was no 
logical foundation and from which nothing materialized, 
did not catch my attention. What did fascinate me was the 
fact that two of this boy's brothers had an identical clinical 
and biochemical picture. Each of these boys died of 
respiratory muscle failure, without definition of the 
mechanism for muscle wasting or the renal tubular defect. 
What did not die was the interest that these children's 
illness ignited in me concerning the biochemical and 
genetic basis of disease. Months later, this spark of interest 
exploded into a dazzling sense of well being when I carried 
out some related laboratory experiments which gave 
interpretable, but by no means, earth-shaking results. 
Thus, I literally caromed into the emerging field of 
medical genetics, and have resided there happily ever 
since. 
I am convinced that the series of accidents, chance 
occurrences, and serendipities which redirected my pro¬ 
fessional aspirations are not unusual, and feel certain that 
many of you w ill be surprised by the unexpected turns your 
careers will take, and by your inability to anticipate 
currently what lies ahead. So be open to the year-long 
happening your internship will be. View it as a rocket 
carrying you to uncharted space, not as a bow designed to 
propel you straight toward a target. 
Whereas some of your careers will be nudged and 
deflected by chance, all of your careers will be revolu¬ 
tionized by change. Here again. I will use my past to 
project your future. 
It is impossible to overstate the magnitude of the change 
the field of medicine has undergone since my graduation. 
Entirely new biomedical sciences such as molecular 
genetics and cell biology have appeared, and with them the 
solution of such fundamental problems as the structure of 
chromosomes, the nature of the genetic code, and the 
significance of subcellular organelles. Clinical diagnostic 
capability has been transformed by such techniques as 
cardiac catheterization, radioimmunoassay, and comput¬ 
erized axial tomographic scanning. No less dramatic are 
the therapeutic advances made by the cardiovascular 
surgeon toward the correction of certain congenital and 
acquired heart defects, by the oncologist and radiother¬ 
apist in the treatment of certain forms of Hodgkin’s 
Disease and leukemia, and by the pediatrician in the 
prevention of mental retardation caused by phenylketo¬ 
nuria. Major diseases such as poliomyelitis, diphtheria, 
and small pox have literally or virtually disappeared 
through population-based immunization and surveillance 
programs. 
This too abbreviated synopsis of the march of progress, 
sometimes beginning at the bedside and other times in the 
laboratory, sometimes initiated by clinicians and other 
times by basic scientists, is part of the medical fabric for 
you the class of 1982. I refer to it neither to make you. the 
physicians of the future , feel puffed up by the tools at your 
disposal nor to make us, the preceding generation of 
scholars, smug in our accomplishments. Rather I mention 
what has happened in slightly more than two decades to 
remind you of what is certain to happen in the next two. 
The power of recombinant DNA technology, of mono¬ 
clonal antibody synthesis, of in vitro fertilization, of 
nuclear magnetic resonance spectroscopy, and of other, 
yet undiscovered modalities will be directed toward 
patient care. You will very likely witness the eradication of 
malaria, the cure of sickle cell anemia, the understanding 
of oncogenesis, and even the elucidation of some of the 
fundamental rules governing nervous system develop¬ 
ment. You will see more than new medical science with 
which to embellish your clinical art. You will see radically 
different systems of computerized medical communica¬ 
tion and of preventive services. Lest you fear that these 
changes will fall on you like an avalanche, let me empha¬ 
size that they will occur gradually and that you will 
participate in and preside over them. They will be part of 
the natural evolution of your careers provided you develop 
the critical judgment to distinguish what is truly novel 
from that which is merely new, the flexibility to embrace 
rather than recoil from change, the wisdom to discard 
deeply ingrained but faulty dicta, and the courage to 
grapple with uncertainty and controversy. 
By now, you have probably guessed that I consider you 
most fortunate to have chosen a career in medicine. Your 
profession is not constrained by geography or national 
boundaries. It speaks a worldwide language. Your profes¬ 
sion has a continuum which runs from the laboratory bench 
to the bedside, from hard science to compassionate 
humanism, from the broad arenas of international and 
public health to the intimacy of private practice, and from 
the classroom of the school to the board room of industry. 
Moreover, you alone are free to determine where along 
this spectrum you stake your claim and when you see fit to 
move from one vantage to another. Physicians are 
rewarded by our society with a degree of economic 
security unknown to virtually any other group, and with 
societal approbation that remains unusually strong, despite 
some selfish and arrogant stances on our part which seem, 
at times, intent on diminishing our collective esteem. This 
societal embrace is a token of mankind’s commitment to 
health and of humanity's thanks to those who comfort the 
sufferer. 
Nor is your good fortune diminished by the increasingly 
large shadow that health concerns and health expenditures 
cast on our world. Rather your opportunity to serve is 
enhanced because you will have even more ways to 
express your individual talents and beliefs. For example, 
doctors of medicine will be found in increasing numbers as 
elected legislators and appointed executives where they 
will act as spokesmen and women on public issues whose 
understanding, even resolution, will depend on the physi¬ 
cian's critical perspective. This will be good, I believe, for 
both society and medicine. We do have a unique perspec¬ 
tive which is as important to the public dialogue on matters 
like occupational safety and reproductive options as our 
responsibility for expressing that perspective is large. 
Let me close by drawing on my ethnic rather than my 
medical roots. At celebrations like this one, Jews say two 
things. We say “Mazeltov” which means good luck, and 
you will need luck in the years ahead as much as any of the 
technology or compassion in your possession. Perhaps 
more to the point, Jews toast celebrants with the word 
“l’chaim” which means to life. It is, after all, to life that 
your formal medical education has been directed and to 
which your careers will ever be devoted. And so, to each 
member of Yale Medical School's Class of 1982 I say 
“l’chaim” — to your lives, to the lives of your loved ones, 
to the lives of the people who will be entrusted to your 
care, and to the lives of all humankind poised so fragilely 
on this vulnerable, little star. 
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THE GREYING OF AMERICA! problems; research; care 
By Marjorie B. Noyes 
While Madison Avenue is waging its multi-million dollar 
campaign to keep Americans forever young, the hard fact 
is that in spite of cosmetics guaranteed to melt away 
wrinkles, dozens of books with instructions on how to 
have a fit and youthful body and $ 100 designer sweat suits 
to wear while doing so, a large portion of the population is 
getting old. The over-75 year old group is now the fastest 
growing segment in the nation. Twenty-six million 
Americans are 65 years and over; the population 85 and 
over is 2.4 million. Census Bureau projections indicate 
these figures w ill nearly double by the year 2025. 
There are implications in these statistics for students of 
health care. While some elderly people are truly enjoying 
the Golden Years, others are in poor health and many are 
disabled by severe arthritis and skeletal disorders, chronic 
obstructive pulmonary disease, diabetes, peripheral 
vascular disease, congestive heart failure and other dis¬ 
orders associated with old age. 
THE WORST OF ALL DISEASES 
By far the most pervasive and debilitating problem of 
aging is senility or senile dementia. An estimated 2.5 
million American adults suffer some sort of dementia. 
The most prevalent form. Alzheimer’s disease, affects 
over a million people. They occupy over half of the 1.2 
million nursing home beds in the country at a cost now 
exceeding $10 billion and expected to increase to $40 
billion or more within a few years. 
Dr. Lewis Thomas, former Dean of the $chool of 
Medicine, now Chancellor at Memorial Sloan-Kettering 
Cancer Center, has described Alzheimer's disease as the 
"worst of all diseases, not just for what it does to the 
victim, but for its devastating effects on families and 
friends. It begins with the loss of learned skills, arithmetic 
and typing, for instance, and progresses inexorably to a 
total shutting down of the mind." he wrote. "It is, un¬ 
mercifully, not lethal; patients go on and on living, essen¬ 
tially brainless but otherwise healthy, into advanced age, 
unless lucky enough to be saved by pneumonia." 
Changes most commonly associated with Alzheimer's 
disease occur in the protein of nerve cells in the cerebral 
cortex, causing accumulation of abnormal fibers, which 
when viewed under a microscope, appear as a tangle of 
filaments. Scattered throughout the cortex, groups of 
nerve endings degenerate and disrupt the passage of 
electro-chemical signals between the cells. These areas are 
called plaques. The larger the number of plaques and 
tangles, the greater the disturbance in intellectual function 
and memory. Research has also revealed that Alzheimer's 
patients have a reduction, often as much as 90 percent, of 
the brain enzyme choline acetyltransferase. which is in¬ 
volved in the passage of nerve signals and is crucial to 
memory function. 
What causes this devastating condition? It is not, as has 
been assumed for centuries, the consequence of the natural 
process of aging: nor is it due, as was once thought, to 
hardening of the arteries. The cause remains a mystery. 
Dr. Elias E. Manuelidis, professor of neuropathology 
and neurology, and his colleagues. Dr. Laura K. 
Manuelidis. associate professor of neuropathology, and 
Dr. Jung H. Kim. assistant professor of neuropathology, 
are among a small group of scientists working on the 
hypothesis that Alzheimer's disease is caused by a slow- 
virus of the type recovered from brain tissues of victims of 
the fatal but rare form of dementia, Creutzfeldt-Jakob 
disease. 
Dr. Manuelidis has devoted most of the last seven years 
to the study of dementias, and was the first to transmit 
Creutzfeldt-Jakob virus to small laboratory animals such 
as guinea pigs, hamsters and mice. Because it has not been 
possible so far to transmit Alzheimer's disease to labora¬ 
tory animals, he and his research team use these animal 
models for their slow-virus research. 
The slow-virus hypothesis is based on a few significant 
similarities observed between Creutzfeldt-Jakob (C-J) 
disease and Alzheimer's disease. Although C-J patients 
usually lapse into a deep coma shortly after the onset of the 
disorder, and die within a year or two. while Alzheimer's 
patients can live for quite some time, patients of both 
experience the dramatic personality change, memory loss 
and dementia noted by Dr. Thomas. The two diseases are 
characterized by degeneration of nerve cells in the brain 
and an increase of supporting cells called glia cells, and 
there is a marked deficiency in choline acetyltransferase 
enzyme in the cortex. 
According to Dr. Manuelidis, lesions in the brain 
characteristic of Alzheimer’s disease, have been found in 
up to ten percent of patients who died of C-J virus; while 
spongy areas in the nerve cells characteristic of C-J virus, 
have been found in the brain of persons w ho have died of 
Alzheimer's disease. The literature notes that some 
members of the same family have had C-J disease while 
others have had Alzheimer's disease. The symptoms were 
so similar that only post-mortem examination could clarify 
which member had C-J disease and which had Alzheimer's 
disease. 
Dr. Manuelidis and his colleagues will study the 
mechanisms and progress of C-J disease in laboratory 
animals and compare them with symptoms observed in 
patients with Alzheimer’s disease. The ultimate goal is to 
learn about the structure and function of the enigmatic 
slow-virus and to apply this knowledge to a better under¬ 
standing of Alzheimer's disease. 
This fall, two significant grants underscored the impor¬ 
tance of the research. The Commonwealth Fund awarded a 
grant of $225,000 in support of a full-time investigator in 
the study, for five years. The National Institutes on Aging 
awarded the School of Medicine over $1.3 million in 
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support of Dr. Manuelidis’ research for a period of five 
years. 
This type of long-term support is extremely valuable to 
this research. Studies of slow-viruses take a long time and 
are painstaking. When injected into susceptible laboratory 
rodents, the virus produces no evidence of the disease for 
eighteen months or longer, after which there is rapid 
destruction of the brain. To begin with, it requires an 
enormous amount of funding just to maintain a colony of 
laboratory animals in good health for a year and a half or 
two, but that is not the only reason. 
Scientists working on slow-viruses, are essentially 
working in the dark. Unlike other viruses, slow-virus does 
not seem to consist of particles visible by electron micro¬ 
scope or detectable by chemical methods; and although it 
multiplies itself thousands of times over in the affected 
brain, no one has discovered nucleic acid in slow virus. It 
may well be that it is self-replicating with its own DNA or 
RNA, or it may be similar to a class of very small viruses 
found in plants. There is not even the slightest knowledge 
of how it functions. 
Dr Elias Manuelidis 
As Dr. Thomas noted, the work requires more time and 
more money than most biomedical scientists believe they 
have at their disposal these days. “If you were planning to 
inject samples of a suspect virus into an array of experi¬ 
mental animals, the thought of an interval of a year-and-a 
half or two years before you could reasonably expect even 
a preliminary, tentative answer would stay your hand . . . 
By the time you finished your first experiment you would 
be near the end of your first grant, most likely with nothing 
to show for it.” 
These obstacles have not discouraged Dr. Manuelidis, 
who continues his research with enthusiasm and optimism. 
“There are two reasons," he stated simply. “First and 
foremost, there is the possibility for finding the cause and 
maybe a way to treat the most terrible disease in humans. 
Then there is the tremendous challenge to unravel the 
mystery of this incredible virus, which so far has eluded all 
attempts by the most sophisticated scientific investigation. ’7 
Dr Andrea Schaffner and Dr. Leo Cooney pause during morning rounds to give 
an encouraging word to a patient in the Continuing Care Unit. 
THOSE WHO CARE 
As her husband watched, a woman in her early sixties 
shuffled aimlessly around the garden, talking incoherently 
to herself. “It's so hard to believe," he said sadly. “She’s 
a Phi Beta Kappa graduate with a Ph D. degree in chemis¬ 
try. Not only did she have a brilliant career, she also 
managed our household — we used to give wonderful 
dinner parties. Then she began losing hold. We noticed it 
first when she became more and more illogical over even 
the smallest matters,” he noted. “Then, gradually, she 
became like a little child, unable to take care of herself. 
Incontinence is a big problem.” 
Like many families of Alzheimer’s patients and patients 
with other dementias, this man is reluctant to put his wife 
in a nursing home while he is able to care for her, but the 
mental and physical burden of coping becomes over¬ 
whelming. “Why me?” a daughter designated by her 
family as caretaker of an elderly mother asked. “I love my 
mother, but sometimes I get so frustrated and lonely taking 
care of her that I come close to putting her in a home. Then 
I suffer terrible guilt for weeks. It doesn’t help. ” 
A year ago, the Geriatric Assessment Clinic was 
established in Yale-New Haven Hospital to offer support to 
families such as these. The program was over-subscribed 
almost from the day it started. It was developed by Dr. 
Andrea Schaffner, assistant professor of medicine, who 
believes that in geriatric medicine it is extremely important 
to treat the whole person instead of merely symptoms. This 
includes consideration of the patient's home environment. 
"Taking care of an elderly parent can put severe stress 
on even the best family relationships,” Dr. Schaffner 
explained. “Social contacts often are greatly curtailed 
because families are embarrassed to entertain in their 
homes when an elderly person with problems symptomatic 
of dementia are around, and at the same time, they cannot 
go out as often as they once did because they can't leave 
the patient alone, and it's difficult and expensive to have 
someone in to take care of them. These people feel isolated 
and frustrated. They need almost as much help and support 
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as the patients themselves.” 
The Clinic helps patients and their families deal with 
chronic disorders, long-term disabilities and general 
psycho-social problems that leave elderly patients unable 
to care for themselves. A majority of the patients have 
Alzheimer’s disease. Thorough physical examination by 
Dr. Schaffner, and if necessary, a psychiatric examination 
by Dr. Frances Baker, assistant professor of psychiatry, is 
given each patient. The staff, including Nan Scholhamer, 
a social worker, then meet with the family to discuss 
treatment of physical and/or mental problems and to assist 
in making arrangements with various community-based 
social services to provide home care or arrange for 
institutional placement if it becomes obvious that the 
family can no longer cope. 
Records are kept of each patient and follow-up is a part 
of the program. Through this, the staff is attempting to 
determine which medical, mental, environmental and 
social factors best predict a patient’s ability to remain in his 
or her own home. In addition, they are undertaking studies 
on the effectiveness of various drugs for treating 
Alzheimer’s disease and other organic mental conditions. 
Although the Clinic has been in operation for only a year, it 
is becoming a model for multi-disciplinary care for the 
elderly. 
Today's medical students are mostly interested in the 
more challenging aspects of the profession. In contrast to 
specialties such as cardiology, immunology or cardiology, 
geriatrics might seem pretty low-key. Dr. Andrea 
Schaffner disagrees. "There is something quite challeng¬ 
ing and rewarding about trying to improve a person’s final 
years,” she said. 
A graduate of Columbia University’s College of 
Physicians and Surgeons, Dr. Schaffner came to Yale- 
New Haven Hospital as an intern in internal medicine. In 
1981, she was awarded a fellowship in geriatrics, working 
with Dr. Leo M. Cooney, associate professor of medicine 
and director of the Continuing Care Unit, and this year she 
was appointed assistant professor of medicine, as well as 
medical director of a local nursing home. 
The Geriatric Assessment Clinic is an outgrowth of the 
Continuing Care Unit, which is dedicated to returning to 
their homes as soon as possible, elderly patients hospital¬ 
ized with acute problems such as amputation, cardio- 
thoracic surgery, rheumatoid arthritis, and hip fracture. 
Many of these patients would otherwise be at risk for 
long-term placement in nursing homes. The 13-bed Unit, 
where the average patient stay is about two weeks, is as 
well, an educational resource for residents and medical, 
nursing and physical therapy students. 
Dr. Cooney and Dr. Schaffner are very interested in 
improving education in the care of the elderly, and have 
developed electives in geriatrics for house staff as well as 
medical students. They treat the subject not as an extension 
of internal medicine, but as a sub-specialty in itself. 
Speaking at the 1982 Gerontological Society's annual 
scientific meeting. Dr. Cooney said, "The clinical years in 
medical school and throughout house staff training mold 
our clinical judgement and form the basis for much of our 
clinical strategies . . . Clinical strategies must often be 
altered in the very old patient. The standard "work-up” 
must be altered in view of the often fragile physiologic 
reserve ot the elderly person. A simple contrast gastro¬ 
intestinal work-up can have significant side effects in the 
elderly, in that the patient can become quite dehydrated 
and debilitated from the preparation and completion of 
these studies. Blind adherence to normal serum levels and 
rote work-ups of abnormal findings can often have 
disastrous consequences. 
"There is much research to be done to answer many of 
these strategy questions,” he continued. "What is the 
value versus the morbidity of various diagnostic evalua¬ 
tions in the elderly? Should the elderly patient with a 
myocardial infarction be moved from a skilled nursing 
facility to an acute coronary care unit? What are the 
‘normal’ serum drug levels in the elderly?” 
“Physicians are extremely important individuals in 
their patient's long-term care decisions,” he told the 
audience. "Families and patients turn to physicians for 
advice regarding the site and type of care that will be 
given. In addition, physicians must certify most types of 
institutional and home care. This role must be recognized 
and the young physician must be prepared to assess the 
functional needs of the patient and to help organize the 
provision of resources to fill these needs. The student must 
be taught simple methods of assessing a patient’s ability to 
care for himself and to recognize that the ability to get out 
of bed and walk to the toilet may be much more important 
to the elderly patient than the level of the serum calcium.'' 
In conclusion, he emphasized, "Substantial progress in 
the care given to the dependent elderly patient requires a 
strong geriatric force at each medical school and center. 
Full-time faculty physicians must have as their major focus 
research, service, and teaching in care of the elderly. The 
scholarly efforts of these physicians must be supported and 
their research efforts nurtured if geriatric medicine is to be 
well taught to students in their clinical years.” 
6 
WOMEN IN MEDICINE 
r 
CLV A R T V S. 
LIBER Q^VARTVS, 
D £ VARIETATIDVS NON N A T V- 
ralu partus, & car undent cum. 
This illustration and the one on the following page are from Ein Schon Lustig 
Trostbuchle by Jacob Reuff f 1554), courtesy Yale Medical Historical Library. 
An Exhibition Portrays the History of Women in Medicine 
Women have practiced the healing arts since the earliest 
times, according to a concise exhibition of “Images of 
Women in Medicine" on view in the Cushing Rotunda of 
the Yale Medical Library through December. Prepared by 
Dr. Diane Puklin, a medical historian, with Susan Alon, 
secretary to the Medical Historical Library, it traces the 
perceptions of female anatomy and concepts of women's 
contributions to reproduction as well as the role of women 
as healers, from Biblical times through the 18th century — 
a period not often dealt with in women's studies. 
Unusual anatomical engravings made three dimensional 
with layers of lifting paper shutters; an exquisite ivory 
mannequin, probably 17th century German, with the 
abdomen open revealing a finely carved fetus, and other 
beautiful illustrations show the slow progression through 
the centuries to an accurate understanding of female 
anatomy. 
Equally engrossing and well documented are early 
perceptions of women's contributions to reproduction. 
This section traces the evolution of Aristotelian and 
Galenic concepts of reproduction from their original 
sources through their medieval expressions and culminat¬ 
ing in their faithful reiterations in treatises of the 16th 
century. It also contains drawings by Andreas Vesalius 
and the 17th century physician, Jan Swammerdam, who 
successfully challenged these early theories. 
For women practicing and studying medicine, however, 
the most important section of the small exhibition may 
well be that part describing early women healers using 
texts from Biblical acknowledgment of midwifery (The 
Book of Exodus) to post-Renaissance obstetrical treatises 
written by women. "Legends abound of famous female 
healers, whose identities are not sufficiently supported by 
historical evidence," according to the introductory narra¬ 
tive. "These legends are important not only for the 
historical figures they name, but also for the attitudes 
towards women healers they reveal." 
Legend tells of Agnodice, a young Greek woman of the 
4th century B .C., who, in order to study medicine, dressed 
in male clothing. She attended the lectures of Herophilius 
of Chalcedon (Alexandria), and learned to tend and teach 
other women. Rival physicians, jealous of her skills, 
dragged her before an Athenian council, where she 
revealed her true identity. The wives of the councilmen 
defended her good offices, according to the tale. The 
councilmen heeded their appeals, and Agnodice was 
allowed to continue her practice. 
Most of the information about women healers in ancient 
times is based on treatises, according to Dr. Puklin, but 
these represent only a small portion of women involved in 
the healing arts. "They were a conglomerate of different 
types and of different training,” she explained. "Those 
writing texts presumably had monastic or university edu¬ 
cations. Beyond that, there were women who took their 
place among those trained in the craft — just as the glass 
blowers or the weavers did — and learned to do their 
healing procedures through experience and apprenticeship.” 
In Italy in the fifteenth century, for example, women 
practiced surgery. It was a craft passed from fathers to 
their children. If he had no son, the father would teach his 
daughter rather than a nephew or the son of a neighbor. 
They obeyed very rigid codes of entry into practice. Other 
women practiced midwifery or were herbalists — and 
there were some empiric physicians as well. 
Maternal care and delivery historically were tasks 
performed by healing women. The women who attended 
to these strictly female conditions had recognized profi¬ 
ciency. Called midwives or sage-femmes, they included 
women of wealth and social standing as well as women 
whose livelihood depended on their practice. They 
assisted at the birth of emperor and commoner alike and 
often were honored and lavishly awarded for their 
services. 
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One such woman was Justine Dittriehin Siegmundin 
(1650- 1705), whose influence persisted well into the 18th 
century. Recognizing her obstetric skill, Frederick III 
appointed her court midwife to Brandenburg, and later in 
1701, court midwife in Prussia. In 1690, she published Die 
Chur-Brandenburgische Hoff-Wehe-Mutter, an authorita¬ 
tive text in the form of a dialogue. 
Some midwives, especially those in Italy during the 
16th and 17th centuries, studied at universities and pub¬ 
lished on gynecological matters. Isabella Contese, for 
example, flourished as a student and midwife during the 
Italian Renaissance. She wrote on female disorders and on 
cosmetics, a relatively obscure area of healing arts dating 
to antiquity, which was widely practiced by women of her 
era. Most midwives, however, learned their trade at the 
bedside and rendered prenatal counseling, delivery, and 
infant care without recording for history their experiences. 
The importance of the woman healer was predicated not 
only on certain knowledge they possessed, but also 
because of their proximity to the sick. Women were the 
heads of the estates or manors, and therefore were respon¬ 
sible for taking care not only of their families, but also the 
serfs and their families. It was a logical extension of their 
nurturing role. 
In his tales of the Knights of the Round Table, the 15th 
century author. Sir Thomas Malory describes such 
women. Morgan Le Fay, Queen Isolde and Maiden 
Lynette are but a few of the women who "serched his 
wounds, and stynted his blood. ” In the exhibit, “La Beale 
Isoud, who was a noble surgeon” illustrates women in the 
duties of both leech and surgeon throughout Arthurian 
legends. 
Most healing then was done with herbs. Since women 
tended the gardens it was natural that they also mixed the 
herbs. "What we are learning through intensive studies of 
herbal medicine today is that a number of these medicines 
were exceptionally specific and could not have been 
derived by happenstance,” Dr. Puklin stated. “They were 
applied by women of the past who, avoiding philosophical 
constraints of the time, used the same techniques of 
observation and reason and drawing conclusions that 
Hippocrates emphasized over and over again as the basis 
for all medical remedies.” 
“From this particular aspect of the exhibition we were 
trying to imply the sense of importance of the woman as 
healer in the societies from Biblical times until the 18th 
century,” she continued. “Then in the late 18th and early 
19th centuries, when medical knowledge rapidly increased 
simultaneously with the rise of “capitalism” in the middle 
classes, medicine became professionalized. In the past 
people in medicine had struggled to become professional 
without success. Therefore we see some of the polemics 
against women in medicine beginning then. For instance, 
in the late 18th century, male midwives challenged female 
mid wives, and began to encroach on women's long- 
recognized field,” she explained. “Put the midwifery 
movement today in this perspective and you can see the 
origins of some of the resistance to it. The diminution of 
women’s influence in obstetrical care really began to 
gather momentum in early 19th century.” 
Although “Images of Women in Medicine” is a small 
exhibition constrained by a lack of space and some 
materials, it is beautifully documented. One could wish for 
more illustrations in each of the three categories covered, 
but as it is, it evokes interest and curiosity about the 
subject. 
By Marjorie Noyes, based on an 
interview with Diane Puklin, Ph.D. 
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Office for Women in Medicine 
Today, many women are pursuing careers once considered 
for men only — law, religion, architecture, medicine — to 
name a few. For some, entry into these male-dominated 
bastions has been smooth, while other women have found 
that old prejudices die hard. 
About a third of the medical students at Yale are women, 
and there are increasing numbers of women postdoctoral 
fellows and faculty. More than a few have discovered that 
being involved in medicine in a traditionally male institu¬ 
tion can be rough going. 
In 1975, with support of Dean Robert Berliner and 
Deputy Dean Arthur Ebbert, Jr., on recommendation of 
the late Dr. Phyllis Bodel, the Office for Women in 
Medicine was founded. It has come a long way in seven 
years from the humble basement office with an indomi¬ 
table part-time student administrator, to its present com¬ 
fortably furnished quarters, with a staff of two dedicated, 
extremely busy women. Kay D. Codish, director, and Ann 
Baidack, assistant to the director, produce an extraordi¬ 
nary number of programs and workshops, in addition to 
publishing a newsletter and offering support services to 
women students and faculty. 
One of the few organizations of its kind in the country, 
the Office for Women in Medicine (OWM) is “committed 
to advancing the professional standing and personal lives 
of women in medicine and the medical sciences, helping 
them counter the prejudices and discrimination, sex-role 
stereotyping and compromise of personal life common to 
women in twentieth century medicine,” according to a 
brochure distributed by the Office. A part of the School of 
Medicine administration, the OWM is concerned with 
advocacy, program development, counseling, research 
and referral. The issues they are concerned with are 
specific to women in medicine throughout the country' — 
limitations in medical school admissions, discrimination 
in hiring and promotion policies, lack of visible role 
models, salary inequities, and limited access to the tradi¬ 
tionally “male” specialties. 
Combining an interest in medical science and a strong 
commitment to women’s rights with her background in the 
theater, Kay Codish orchestrates the many activities of 
OWM in much the way a theater director would a stage 
production. The approach is effective. 
A lively speaker series brings notable women in medi¬ 
cine to the School for discussions of relevant issues. Last 
year, for instance, the series included such topics as tenure 
at Yale; dual career marriages; alpha-fetoprotein screen¬ 
ing; pro-choice abortion tactics; reproductive health 
hazards for women; medical attitudes towards death and 
dying; minority women in today's medical system; nurse/ 
doctor relationships; and substance abuse among medical 
professionals. A number of lectures are offered on stress 
management, and budgeting and financial management 
for professional women. 
Last year, the OWM sponsored a day-long workshop 
“Women Meeting Women in Medicine,” offering an 
opportunity for women physicians of diverse backgrounds 
and disciplines to meet with women medical students. 
Co-sponsored by the Connecticut branch of the American 
Medical Women’s Association, the event was highly 
successful. A few months later, Ms. Codish and Ms. 
Baidack put a tremendous effort into the presentation of a 
two-day conference on “The Crisis of Battering: Profes¬ 
sional Response.” Co-sponsored by the Victimology 
Program of Yale-New Haven Hospital, it attracted a large 
audience of health care professionals, educators and 
service providers, including law enforcement officers. 
Social isolation is one of the most pervasive problems of 
women in medicine, according to Ms. Codish. This is 
especially true in the case of postdoctoral students, who 
often work odd hours in the laboratories and have little 
opportunity to meet other students. An overstuffed brown 
velvet couch, a caned rocking chair, lots of books and 
magazines on women’s concerns provide a friendly 
atmosphere in the office where women can meet and chat 
— or just relax from the rigors of study and work. Potluck 
suppers, especially the annual one held at the home of 
Dean and Mrs. Berliner, are another popular means of 
bringing together women faculty and students. 
One of the more important aspects of OWM is providing 
access to various support groups for women faculty and 
students, spouses of interns and medical students, and 
single mothers. It also offers an opportunity for discussing 
personal and academic problems on an individual basis, 
and can, on request, provide an annotated list of local 
therapists and counselors. 
As a part of the University’s equal opportunity/ 
affirmative action program, the OWM collects statistics on 
women and minority faculty members, housestaff and 
postdoctoral trainees. This mechanism for complying with 
affirmative action guidelines, monitoring accountability 
and achieving goals is being developed into a computer¬ 
ized system to store and evaluate on an ongoing basis 
information regarding salary, rank and promotions. At the 
same time, a log of sexist comments and incidents is 
maintained by the office to record incidents of sexist 
behavior and harrassment at the School of Medicine. The 
OWM encourages women to report such incidents, to 
discuss their complaints and to use grievance procedures to 
file complaints when treated unfairly or treated in an 
offensive manner. 
Although some of these activities are necessarily 
defensive, OWM is concerned not only with fostering and 
promoting activities, policies and strategies favorable to 
women in medicine, but also with demonstrating the 
enormous contribution women make and have always 
made to the medical and scientific professions. To this end 
it is planning to document the varied involvement of 
women affiliated with Yale medicine and science from 
1916, when women were first admitted to the School of 
Medicine, to the present. There has yet to be a woman 
chairman of a department or a woman dean, but Yale's 
women medical graduates and faculty have made many 
very significant contributions to the profession. 
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The First Yale Women Medical Graduates 
There were three women and thirty-two men in the Class 
of 1920 — the first class after the Yale Corporation voted 
in 1916 to accept women students in the School of Medi¬ 
cine. They were Louise Whitman Famam, who had 
received a Ph.D. degree in physiological chemistry from 
Yale; Helen May Scoville, a graduate of Wellesley 
College; and Lillian Lydia Nye, who had received B.A. 
and M.A. degrees from the University of Minnesota. 
Lillian Nye dropped out of the class to finish her medical 
studies at Johns Hopkins University, but Helen Scoville 
received her M.D. degree, cum laude, as did Louise 
Famam, who was also awarded the Campbell Gold Medal, 
given the student with the highest rank in exams upon 
graduation. 
Dr. Scoville, one of the first women other than secre¬ 
taries, librarians and nurses, to be hired by the School of 
Medicine, became an instructor in pathology and bacteri¬ 
ology. In 1936, she left Yale to attend at the House of 
Mercy Hospital in Pittsfield, Massachusetts. 
After graduating from Yale, Dr. Famam studied 
obstetrics at Johns Hopkins, following which she spent six 
months as an intern in pediatrics at Bellevue Hospital in 
New York. Then she was on her way to Changsha, China, 
where she was one of the first doctors in the Yale-in-China 
Association’s Yali Medical School. As a doctor in China 
she was called on to do much more than her specialty of 
pediatrics — and during the revolution she spent more time 
treating war injuries than treating pediatric patients. In the 
summer of 1930, when Mao's army stormed Changsha, 
the hospital personnel fled. Dr. Famam was the last to 
leave and the first to return. “I hated to go off and leave 
a man with a bullet in his chest liable to have pneumonia, 
with no doctor on board. So I stayed.” she wrote. 
Dr. Famam was married to Hugh Brian Wilson, an 
English businessman in 1931, and in 1933 moved to 
England, where she continued to practice medicine. 
During World War II, she replaced home medical service 
doctors who were called into war service, for which she 
received commendation from the British government. 
Yale Enters A Cooperative Research 
Agreement with Bristol-Myers for 
Development of Anticancer Drugs 
Bristol-Myers Company and Yale 
University have entered into a $3 million 
cooperative research agreement to 
facilitate the production and availability 
of new anticancer drugs. 
The agreement brings the investiga¬ 
tive talents of Yale medical scientists, 
who are recognized leaders in cancer 
chemotherapy research, together with 
the research and developmental 
resources of Bristol-Myers Company, a 
major producer and distributor world¬ 
wide of anticancer agents. Through on¬ 
going technical and scientific interac¬ 
tion, they will seek to employ the 
unique resources and skills of university- 
and industry-based approaches to 
development and production of new 
effective and safe drugs for the diagnosis 
and treatment of neoplastic diseases. 
President A. Bartlett Giamatti of Yale 
stated that he was extremely pleased 
with this major step forward in cooper¬ 
ative research. “The agreement with 
Bristol-Myers is testament to the 
opportunity for the University and 
industry to collaborate in areas of 
mutual research interest under condi¬ 
tions which don’t infringe our underly¬ 
ing principles of openness and free 
dissemination of ideas,” he said. “It is 
particularly rewarding to combine the 
skills of Yale's scientists with those of 
their industrial colleagues and to apply 
these in true cooperative fashion to the 
solution of major health problems such 
as cancer. The results of such collabo¬ 
ration serve the interests of the Univer¬ 
sity, industry and of the public.” 
Richard L. Gelb, Chairman of 
Bristol-Myers Company, said, “We 
are pleased to join in this collaboration 
with Yale. We believe this program can 
make an important contribution in the 
development of significant advances in 
cancer therapy.” 
Yale is one of very few research insti¬ 
tutions in the world where scientists 
involved in the development of a new 
anticancer drug work together from the 
first experiments at the laboratory 
bench through to treating patients in the 
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clinic. They have played a leading role 
in the development of several important 
drugs, and in addition, they have been 
conducting research to increase the 
effectiveness and reduce the toxic side 
effects of a number of drugs which have 
been used with some success, by revis¬ 
ing the scheduling of their administra¬ 
tion, and by utilizing them in 
combination. 
Bristol-Myers Company will provide 
support in the amount of $600,000 a 
year for five years to the Yale School of 
Medicine for research in oncology. The 
Company has the option to license 
cancer chemotherapy drugs discovered 
by participating faculty during the 
agreement period. 
Unlike cardiovascular, antimicrobial, 
and anti-inflammatory drugs, where 
investment to produce them can be 
readily recovered a few years after they 
enter the market, the probability of 
producing a major anticancer drug 
capable of returning the exceedingly 
large investment required to produce, 
test, and market it, is very low. For this 
reason, according to Dr. Alan C. 
Sartorelli, chairman of the Department 
of Pharmacology and head of the Sec¬ 
tion of Developmental Therapeutics of 
the Comprehensive Cancer Center at 
Yale, many drugs of possible use in the 
treatment of cancer discovered in 
university laboratories do not become 
patented and developed, and remain 
merely laboratory curiosities. 
“Although universities with support 
from government and private sources 
have the intellectual capability and 
resources to identify the new drugs with 
the potential for treating cancer, the 
resources of industry are required to 
conduct toxicology tests for safety 
essential for their production and 
distribution throughout the world. This 
collaborative venture could result in the 
movement of more agents with unique 
mechanisms of action to clinical trial 
and eventually, to public use,’’ he said. 
“It is with these goals in mind that Yale 
University and Bristol-Myers Company 
enter this collaborative scientific 
program.” 
Dr. Stolwijk, a Noted Environmental 
Physiologist Appointed Chairman of 
Epidemiology and Public Health 
Dr. Jan A.J. Stolwijk, a leading author¬ 
ity on the effects of the environment on 
human health, has been appointed 
Susan Dwight Bliss Professor and 
chairman of the Department of Epi¬ 
demiology and Public Health. A pro¬ 
fessor of epidemiology (environmental 
health) and a faculty member of the 
Institution of Social and Policy Studies 
at Yale since 1975, Dr. Stolwijk is also 
a fellow and associate director of the 
John B. Pierce Foundation Laboratory 
in New Haven. 
Highly regarded as a teacher and 
lecturer. Dr. Stolwijk is known through¬ 
out the world for his research on the 
effects of climate on the human thermo¬ 
regulatory system, as well as for his 
studies on health problems related to air 
pollution. During the 1950’s and 60’s 
he was involved in the development 
and evaluation of life support systems 
for the NASA space program. 
His current research interests include 
the public perception of technological 
risk, as well as the development of a 
scientific basis for victim compensa¬ 
tion. He is a member of the World 
Health Organization Committee on the 
Health Implications Related to Indoor 
Air Quality, and of the Committee on 
Indoor Air Pollutants, National Re¬ 
search Council of the National Acad¬ 
emy of Sciences. 
The Department of Epidemiology 
and Public Health is unique in that it is 
also an accredited school of public 
health, one of only twenty in the United 
States. With almost 200 full- and part- 
time faculty and 250 enrolled degree 
candidates, it is based both in the 
School of Medicine and the Graduate 
School. Many of its over 1200 alumni 
have achieved wide recognition as 
health administrators, researchers, and 
policy makers in private and govern¬ 
ment health agencies. As chairman. 
Dr. Stolwijk succeeds Dr. Robert W. 
McCollum, who resigned last Decem¬ 
ber to become dean of the Dartmouth 
Medical School. 
Bom in Amsterdam, Netherlands, 
Dr.Stolwijk attended Wageningen Uni¬ 
versity, Holland, where he received a 
B.S. degree in 1948, an M.S. degree in 
engineering with honors in 1951, and a 
Ph.D. degree in 1955. Following grad¬ 
uation, he was appointed Senior Sci- 
Dr. Stolwijk 
entific Officer at Large with the Dutch 
government. He came to the United 
States in 1955 as Maria Moors Cabot 
Research Fellow at Harvard Univer¬ 
sity, and in 1957, was appointed to the 
research staff of the John B. Pierce 
Foundation Laboratory, which is affil¬ 
iated with Yale University. 
Dr. Stolwijk joined the Yale School 
of Medicine faculty in 1962 as an 
instructor in physiology, and was pro¬ 
moted to assistant professor in 1964. In 
1968, he was appointed assistant pro¬ 
fessor of epidemiology (environmental 
physiology), and the following year he 
became an associate professor with a 
joint appointment in the Institution for 
Social and Policy Studies. He was 
promoted to professor in 1975. 
In addition to serving on the execu¬ 
tive board of the International Biome- 
teorological Society. Dr. Stolwijk is a 
member of a number of professional 
societies including the American Phys¬ 
iological Society, Biophysical Society, 
Aerospace Medical Society, American 
Public Health Association and the 
Society for Occupational and Environ¬ 
mental Health. 
A New Chairman Appointed for the 
Department of Molecular Biophysics 
and Biochemistry 
Dr. Dieter G. Soli, a leading scientist 
in the field of transfer ribonucleic acid, 
has been appointed chairman of the 
Department of Molecular Biophysics 
and Biochemistry. Dr. Soil has been 
professor in the department since 1976. 
Born in Stuttgart, Germany, Dr. 
Soil received a Diplom Chemiker in 
1960 and a Ph.D. degree in chemistry, 
summa cum laude in 1962, both from 
Thechnische Hochschule in Stuttgart. 
He came to the United States in 1962 as 
a postdoctoral fellow at the University 
of Wisconsin's Institute for Enzyme 
Research, and from 1965 to 1967, he 
was assistant professor there. He was 
appointed associate professor of 
molecular biophysics and biochemistry 
at Yale University in 1967. He was 
Visiting Professor of the Japan Society 
for the Promotion of Science in 1972, 
the same year he was awarded a 
Guggenheim Fellowship. 
The author of numerous scientific 
papers, abstracts and reviews. Dr. 
Soli has been executive editor of 
Nucleic Acids Research since 1974, 
and serves on the editorial boards of the 
Journal of Bacteriology and the 
Journal of Biological Chemistry as 
well. He was co-chairman of the 
Gordon Research Conference on 
Nucleic Acids in 1973; of the Banff 
Conference on the Genetics and Bio¬ 
chemistry of Suppression in 1975; and 
the Cold Spring Harbor Meeting on 
Transfer RNA, 1978. He is a member 
of the American Society of Biological 
Chemists, American Chemical 
Society, and the American Society for 
Microbiology. 
Dr. Evans Appointed John Rodman 
Paul Professor of Epidemiology 
Dr. Alfred S. Evans, a distinguished 
scientist in the field of preventive med¬ 
icine, has been named John Rodman 
Paul Professor of Epidemiology. Dr. 
Evans has been professor of epidemi¬ 
ology and director of the Section of 
International Epidemiology and the 
WHO Serum Reference Bank at Yale 
since 1966. 
The professorship honors a world- 
renowned member of the Yale faculty 
from 1928 to 1961, who developed the 
science of clinical epidemiology, and 
whose research was instrumental in 
determining the causes of rheumatic 
fever, infectious hepatitis and infec¬ 
tious mononucleosis. Dr. Paul, who 
died in 1971, is especially noted for his 
studies on poliomyelitis, which were 
significant contributions to the under¬ 
standing of the disease, and ultimately, to 
the successful immunization programs. 
Dr. Evans is a well-known authority 
on infectious diseases and especially on 
infectious hepatitis, mononucleosis 
and diseases of the lower respiratory 
tract. A graduate of the University of 
Michigan, he received his M.D. degree 
from the University of Buffalo, and his 
M.P.H. degree from the University of 
Michigan School of Public Health. 
Following military service as a medical 
officer with the U.S. Army in Japan, 
Dr. Evans joined the School of Med¬ 
icine faculty in 1946 as instructor and 
then assistant professor in the Section 
of Preventive Medicine. 
From 1950 to 1952, he was recalled 
to active duty with the Army and served 
as chief of the Hepatitis Research 
Laboratory, 98th General Hospital, in 
Munich, Germany. In 1952, he was 
appointed associate professor of pre¬ 
ventive medicine and microbiology at 
the University of Wisconsin School of 
Medicine. He served as professor and 
chairman of the Department of Preven¬ 
tive Medicine there and as director 
of the Wisconsin State Laboratory of 
Hygiene from 1959 to 1966, when he 
returned to the Yale School of Med¬ 
icine. Dr. Evans is the author of numer¬ 
ous publications, including Viral Infec¬ 
tions of Humans, published by Plenum 
Press, for which he received the 
American Medical Writers Award for 
the best book written for physicians in 
1977. He was awarded the Thomas 
Parran Lectureship and Medal by the 
University of Pittsburgh in 1978. A 
Dr. Evans 
fellow and member of the Board of 
Directors of the American College of 
Epidemiology, he is a member of a 
number of other professional societies 
as well, including the American Asso¬ 
ciation of the History of Medicine; 
American Epidemiological Society; 
American Medical Writers Associa¬ 
tion; and the American Society for 
Tropical Medicine. Dr. Evans has 
served as a Consultant in Epidemiology 
to the Surgeon General, U.S. Army, 
and was president of the Society of 
Medical Consultants to the Armed 




Dr. Kantor Named Paul B. Beeson 
Professor of Medicine 
Dr. Fred S. Kantor has been appointed 
Paul B.Beeson Professor of Medicine. 
A professor of medicine since 1973, he 
is well known for his research on the 
immune responses in man. 
The Paul B. Beeson Professorship 
honors a former member of the Yale 
medical faculty who served as chair¬ 
man of the Department of Internal 
Medicine from 1952 to 1965. This out¬ 
standing medical scientist and distin¬ 
guished teacher is now retired and 
living in Seattle. As a Helen Hay 
Whitney Fellow at Yale, Dr. Kantor 
studied under Dr. Beeson in 1960-61. 
A graduate of Union College, Dr. 
Kantor received his M.D. degree from 
New York University School of Med¬ 
icine in 1956. The following year he 
was an intern at Barnes Hospital in St. 
Louis, Missouri, and from 1957 to 
1959, he was research associate at the 
National Institute of Allergy and Infec¬ 
tious Disease, National Institutes of 
Health. 
Dr. Kantor came to the Yale-New 
Haven Medical Center in 1959 as 
assistant resident in medicine, and in 
1962 he was appointed to the faculty as 
instructor in medicine. He was pro¬ 
moted to assistant professor the follow¬ 
ing year, and to associate professor in 
1967. 
In addition to his appointments at 
Yale, Dr. Kantor has been honorary 
research associate in the Department of 
Zoology (Tumor Immunology) at Uni¬ 
versity College in London (1975-76), 
and a visiting professor of medicine at 
Pahlavi University, Shiraz, Iran, and at 
Hebrew University, Hadassah Medical 
Center, Jerusalem. He is a member of 
the American Association of Immunol¬ 
ogists, American Board of Internal 
Medicine, American Academy of 
Allergy, American Society for Clinical 
Investigation, and the Council on the 
American Heart Association. 
C.-E. A. Winslow Professor of 
Public Health Named 
Dr. James F. Jekel, an expert in health 
programs evaluation, has been 
appointed C.-E. A. Winslow Professor 
of Public Health. He has been a pro¬ 
fessor in the Department of Epidemi¬ 
ology and Public Health since 1980. 
The professorship was established in 
1958 in memory of Charles-Edward 
Amory Winslow, one of the nation’s 
most prominent public health teachers 
and leaders. Dr. Winslow organized 
the Yale Department of Public Health 
and from 1914 until 1945 served as its 
first chairman. Many of the Depart¬ 
ment’s current programs reflect C.-E. 
A. Winslow's interests, some of which 
are only now emerging as nationwide 
public health issues. 
Dr. Jekel is an authority on programs 
for pregnant adolescents. In 1975, he 
was awarded the first annual research 
award of the National Alliance Con¬ 
cerned with School Age Parents. 
Dr. Jekel came to Yale in 1967 from 
the Center for Disease Control, where 
he had been a commissioned member 
of the U.S. Public Health Service since 
1962. A graduate of Weslyan Univer¬ 
sity, Middletown, Connecticut, where 
he was elected to Phi Beta Kappa 
Honor Society, he received his M.D. 
degree from Washington University 
School of Medicine in St. Louis, and an 
M.P.H. degree from Yale University. 
Dr. Jekel was an intern and an assistant 
resident at Hartford Hospital. 
He is a member of the study section 
on social sciences and population of the 
National Institutes of Health, and of the 
maternal and child health section 
council of the American Public Health 
Association. In addition he is a fellow 
of the American College of Preventive 
Medicine and of the American Scien¬ 
tific Affiliation, as well as a member of 
the Association of Teachers of Mater¬ 
nal and Child Health, of which he was 
president from 1978 to 1980. 
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Challenging Questions Addressed in 
Symposium on Ethical Issues in 
Health Care 
In celebration of the dedication of its 
new patient care facility, the Yale- 
New Haven Hospital presented a 
symposium on “Ethical Issues in 
Health Care.” Four distinguished 
speakers and a panel probed some of 
the most sensitive issues currently fac¬ 
ing the medical profession. 
The speakers were: Paul B. Beeson, 
M.D., former chairman of the Depart¬ 
ment of Internal Medicine at Yale, now 
professor of medicine emeritus. Uni¬ 
versity of Washington; Lawrence G. 
Crowley, M.D., vice-president for 
medical affairs, Stanford University 
Medical Center; Albert R. Jonsen, 
Ph D., professor of ethics in medicine. 
Institute for Health Policy Studies, 
University of California at San 
Francisco; and Joseph B. Warshaw, 
M.D., former professor of pediatrics 
and obstetrics and gynecology at the 
School of Medicine and director of the 
Newborn Special Care Unit, Yale-New 
Haven Hospital. 
Setting the tone of the symposium, 
Dr. Jonsen cited three of the most 
challenging health care issues: medical 
research using human subjects, limited 
access to lifesaving technologies, and 
the appropriate use of life support. New 
medical technologies raise highly tech¬ 
nical and legal questions, yet beyond 
the jargon and legal arguing lie some of 
the oldest questions of society — what 
are the basic rights of the individual; 
who shall receive preferred treatment; 
and when does life lose its value? 
“The message of bioethics consists 
not in making definitions about resus¬ 
citation or informed consent, not in 
issuing regulations about research,” he 
stated. “It announces that the forms of 
care provided to preserve and restore 
human health must reflect the deepest 
moral beliefs of our culture.” 
Following Dr. Jonsen, Dr. Beeson 
stressed that health care must be appro¬ 
priate for those being cared for, and 
illustrated how right — and how wrong 
- extraordinary measures can be in 
prolonging the lives of the elderly. 
He told of an elderly patient who had 
suffered multiple serious injuries in an 
automobile accident. Wheelchair- 
bound and in great pain for months, the 
man passed through so many medical 
crises that his survival was termed a 
“miracle.” On the way to see his 
patient in the hospital. Dr. Beeson had 
to drive by a very poor school with few 
recreational facilities. “I must admit I 
sometimes thought that the tremendous 
sum spent on that man's care could 
have been better spent on the school,” 
he said. However, the man lived for 
some years, enjoying life, pleased to be 
with his family, and glad to have 
received care. 
On the other hand. Dr. Beeson spoke 
of a friend, who was suffering with 
cirrhosis and who did not have such 
good fortune. No longer able to respond 
to medication, he underwent emergency 
surgery. “For the next five days until 
he died, he hung on in the intensive care 
unit. Because of all his tubes and lines, 
he couldn't speak to his wife or touch 
her. But he winked at her." Dr. Beeson 
told the audience. “I kept going in and 
out of there and I thought to myself — 
what have we done to give this man 
such a horrible way to die?” 
Dr. Beeson then turned to the diffi¬ 
cult decisions created by the very high 
cost of caring for the elderly, citing 
passive mercy killing methods such as 
cutting back on antibiotics, withhold¬ 
ing fluids, and issuing orders not to 
resuscitate the patient. “We must never 
lose sight of the risk that these practices 
can put us on a slippery slope leading to 
inhumane practices,” he cautioned. 
Dr. Crowley told the audience while 
the percentage of industry-supported 
research in universities has generally 
declined over the last 30 years, the new 
field of genetic engineering has aroused 
mutual interest between industry and 
campuses as never before. The reasons: 
genetic engineering possesses great 
profit potential; most of the scientists 
with expertise in the field are in the 
universities, while industry has most of 
the money. 
“The problem is that industry and 
universities work in different ways 
towards different ends. Universities 
seek to create and freely spread new 
knowledge for human betterment. By 
contrast, industrial concerns control 
and withhold knowledge so that their 
products command a commercial 
edge,” he explained. Yet there is much 
to be gained by cooperative research, 
according to Dr. Crowley. “The key is 
for universities to keep their basic 
values foremost so as to protect their 
essential value to society.” 
Towards that goal, he suggested full 
public disclosure, in advance of all 
university/industry agreements; “no 
strings attached” industrial investment 
in university research; new patent and 
licensing agreements to reward the ini¬ 
tiative of faculty members; and gen¬ 
erous faculty leaves of absence so that 
professors can explore industrial jobs 
without creating conflicts of interest. 
Twenty years ago, as neonatology 
began to emerge as a sophisticated 
medical discipline, Yale-New Haven 
Hospital established the first newborn 
special care unit in the nation. Since 
then, enormous progress has been 
made in caring for infants at risk. For 
example, when the Yale Newborn 
Special Care Unit began less than half 
of infants weighing two- to three-and-a 
half pounds survived. Those who did 
often suffered severe, permanent dam¬ 
age from the inexact therapy of the day. 
Today, more than 90 percent of these 
infants survive, most in remarkably 
good health. 
“Judging from these advances, we 
have had great success,” said Dr. 
Warshaw, who has been director of the 
Unit for the last seven years. “How¬ 
ever, we now face major questions as 
we search for an appropriate balance 
between technology, humanity and 
expectation.” 
Beyond question, the staff of the 
Newborn Special Care Unit can do 
remarkable things on behalf of the 
almost 1,200 sick infants seen there 
each year and their families. What to 
do, however, and whether to do it are 
often difficult issues for families and 
Unit staff to decide. 
Recent negative publicity and result¬ 
ant investigations have focused public 
debate and legislative pressure on 
physicians. The cruel irony of the sit¬ 
uation is that care givers have been 
criticized both for over-using and 
hesitating to use life-supporting tech¬ 
nology. “There are no simple rules,” 
Dr. Warshaw said. “Each case is dif¬ 
ferent. What is a good decision for one 
family may be inappropriate for 
another. We must listen to families as 
well as to our own most informed med¬ 
ical judgements. 
“Those of us who work in newborn 
medicine are experts in understanding 
medical processes,” he continued. 
“We are experts in applying the very 
technologies which have created many 
of the ethical questions in newborn 
medicine. Hopefully, we are sensitive, 
compassionate, and will never lose our 
capacity to empathize with those who 
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suffer. However, in areas of social 
judgement and ethical concern, we are 
no better or no worse than any indi¬ 
vidual in our population. We have no 
purchase on the truth. We are conduits 
for the ethical wisdom and current 
values of our society. ’ ’ 
Hospital Dedicates its New Patient 
Care Facility 
It poured rain on every important occa¬ 
sion here this spring, and the dedication 
ceremony on June 13 for Yale-New 
Haven Hospital’s new patient care 
facility was no exception. When it 
became obvious that the relentless 
downpour was not about to let up, the 
gala affair planned for the Harkness 
lawn was hurriedly moved indoors by a 
troop of dedicated staff members. The 
U.S. Coast Guard Band, stranded with 
bus problems, was replaced at the last 
minute by the gallant Pressenda String 
Quartet; balloons meant to Boat aloft 
under blue skies were secured to the 
auditorium bannisters, and most 
impressive of all, the 700-pound 
cornerstone was hauled from the tent to 
the auditorium stage — all in time. 
In his welcoming address to the large 
audience, C. Newton Schenck, chairman 
of the Board of Trustees of the Hospital, 
praised his predecessor, Richard H. 
Bowerman. “This extraordinary man 
orchestrated for the Board the develop¬ 
ment of the new building, in its plan¬ 
ning, financing, and the crucial certifi¬ 
cate of need.” 
The $73 million project, the result of 
years of planning and three years of 
construction, replaces outdated facili¬ 
ties of the New Haven Unit with inte¬ 
grated patient care facilities. The new 
seven-story building which includes an 
emergency room twice the size of the 
one in the New Haven Unit, consoli¬ 
dates the departments of radiology and 
pediatrics, the operating rooms, admit¬ 
ting and discharge offices, and two 
cafeterias. 
“In planning and financing the 
building, we have had the opportunity 
to bring together all segments of the 
community to create something for the 
benefit of all,” said Mr. Bowerman, 
who observed that the Hospital had 
always been “nourished by two 
streams: University and Community 
physicians.” 
Following remarks by C. Thomas 
Smith, president of the Hospital, and 
Paul H. Johnson, chairman of the 
Hospital Campaign, United States 
Senator from Connecticut Christopher 
J. Dodd, delivered the dedication 
address. “This building is a good 
example of what Americans can do 
when the public and private sectors join 
hands in a common cause,” he said. 
“It’s clearly a tribute to the community 
and I’m proud to represent such 
people.” 
The dedication ceremony was the 
culmination of a weekend of activities 
planned in celebration of the new 
building, including a symposium on 
ethical issues in medicine. On June 12, 
nearly 500 employees, staff and friends 
dined and danced to big band music at 
the Dedication Dance, sponsored by 
the Community Associates of 
Yale-New Haven Hospital. 
CONGRATULATIONS! 
The Class of 1982 
Medical Students 
For the first time in many years, rain 
fell on commencement day this May 
24. Even though gloomy skies persisted 
throughout the day, the scene around 
Sterling Hall of Medicine was one of 
pride and joy, as balloons Boated aloft 
and cameras clicked everywhere. 
Families and friends of the eighty- 
eight recipients of the M.D. degree 
gathered in the Harkness Auditorium 
where they were welcomed by Dr. 
Howard Levitin, dean of students. 
Following the presentation of degrees 
by Dean Berliner, Dr. Leon E. 
Rosenberg, C.N.H. Long Professor of 
Human Genetics, delivered the 
commencement address, appearing on 
page 1 of this issue. 
Five students received the joint 
M.D./Ph.D. degree; Jeffrey M. 
Gimble; Kenneth M. Huttner; Ethan A. 
Lemer; David B. Menkes, and Lewis 
P. Rubin. Evangeline R.H. Franklin 
received a joint M.D./M.P.H. degree. 
Following the ceremony, a reception 
was held in Edward S. Harkness Lounge 
for the new graduates and their guests. 
Epidemiology and Public Health 
Students 
With their building and grounds still in 
disarray from construction, the Depart¬ 
ment of Epidemiology and Public 
Health moved its graduation cere¬ 
monies across town to the Yale Reper¬ 
tory Theater. Eighty candidates received 
M.P.H. degrees, and seven were 
awarded Ph.D. degrees. Denise 
Heinemann received a Doctor of Public 
Health degree. Their diplomas were 
presented by Dr. Robert C. Wallis, pro¬ 
fessor of epidemiology (entomology), 
following which Dr. Arthur J. Viseltear, 
associate professor of the history of 
medicine and public health presented 
the annual E. Richard Weinerman 
Fellowship to second year students 
Cecilia Zapata and Gerald Tracy. The 
Richard H. Schlesinger Fellowship 
was awarded to Rory Cohen, and Terry 
O’Connor received the Kay Howe 
Scholarship. The commencement 
address was delivered by Dr. Colin 
White, Ira Vaughan Hiscock Professor 
of Public Health and acting chairman of 
the Department. 
Physicians Associate Students 
On the 16th of August, 18 students 
were graduated from the Physicians 
Associate Program. The speaker for 
this 11th commencement was Dr. 
Alfred N. Sadler, Jr., the Program’s 
first director. Following his address, 
Linford Stillson, a member of the 
graduating class and president of the 
Jack Cole Society, presented the 
Didactic Instructor Award to Parker 
Bailey, who has served as coordinator 
and instructor in the animal surgery 
course in the program since 1972; and 
the Clinical Instruction Award to Dr. 
Kathleen H. Lyons, who accepted the 
award in behalf of Waterbury Hospital, 
whose Department of Emergency 
Medicine has been a training site for the 
P.A. students since 1973. The Jack W. 
Cole Society Award was presented to 
Elaine E. Grant, executive director of 
the Program. Following the conferring 
of certificates by Dean Robert Berliner, 
Dr. Howard Levitin, dean of students 
and medical director of the Physicians 
Associate Program closed the 
ceremony. 
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Yale Medical Faculty Give Virology 
Workshop in China 
At the invitation of the Ministry of 
Health of the People's Republic of 
China, Dr. Gueh-Djen Hsiung, profes¬ 
sor of laboratory medicine, organized 
and directed an advanced course in 
virology in Wuhan, People's Republic 
of China. The two-week course was 
held in October at Hubei Medical Col¬ 
lege, which was co-sponsor of the 
course with Hunan Medical College 
(formerly Yale-in-China Medical 
School), Yale-China Association and 
the Yale School of Medicine. 
Two-Hundred English-speaking 
Chinese scientists, selected by the 
sponsors in China, participated in the 
training workshop of lectures and 
laboratory exercises prepared by Dr. 
Hsiung and co-director of the course. 
Dr. William C. Summers, professor of 
therapeutic radiology, molecular bio¬ 
physics and biochemistry and human 
genetics. Altogether, nine scientists 
from institutions in the U.S. (including 
four from Yale) and Canada took part in 
the program, which resulted from a 
visit to China in 1980 by the Medical 
Committee of the Yale-China Associa¬ 
tion. 
During the visit, faculty of the 
School of Medicine observed medical 
practice and biomedical research of 
several of China's leading medical 
centers. At the conclusion, they and 
scientists from the host institutions 
agreed to sponsor a training workshop 
in medical and experimental virology 
to provide Chinese scientists with prac¬ 
tical experience and the most recent 
information on virological research. 
Since virology has emerged as an 
important clinical and research disci¬ 
pline only in the last twenty years, 
during the cultural revolution in China, 
scientists there have not had access to 
recent developments in the field. The 
intensive training workshop organized 
by Drs. Hsiung and Summers will pro¬ 
vide new information and techniques in 
virology to a nucleus of teachers and 
research scientists, who in turn, will 
provide expertise and leadership within 
the medical institutions of China. 
In addition to Dr. Hsiung and Dr. 
Summers, Yale participants in the 
course included Dr. Frank J. Bia, 
assistant professor of internal medicine 
and laboratory medicine, and Wilma P. 
Summers, senior research associate in 
therapeutic radiology. 
Promotions to Professor 
The following members of the medical 
faculty were promoted to the rank of 
professor effective July 1982: Philip 
W. Askenase, M.D., professor of 
medicine; Paul G. Barash. M.D., 
professor of anesthesiology; Paul D. 
Doolan, M.D., clinical professor of 
medicine; Maurice J. Mahoney, M.D., 
professor of human genetics, pediat¬ 
rics, and obstetrics and gynecology; 
Paul L. McCarthy. M.D., professor of 
pediatrics; Bruce M. McDonald, clin¬ 
ical professor of pediatrics; Sreedhar 
Nair, M.D., clinical professor of medi¬ 
cine; James J. Nordlund, M.D.. pro¬ 
fessor of dermatology; Donald M. 
Quinlan. Ph.D., professor of psychol¬ 
ogy in psychiatry; Clarence T. Sasaki. 
M.D.. professor of surgery (otolaryn¬ 
gology); Norman J. Siegel, M.D.. 
professor of pediatrics; Howard W. 
Smith, M.D., D.M.D., clinical pro¬ 
fessor of surgery (otolaryngology); 
Yung H. Son, M.D., professor of 
therapeutic radiology; Kay Tanaka, 
M.D., professor of human genetics; 
David C. Ward. Ph.D., professor of 
human genetics; Fred S. Wright. 
M.D., professor of medicine and 
physiology; Barry F. Zaret. M.D.. 
professor of medicine. 
In addition to the above promotions, 
Mary G.M. Cumen. M.D., Dr. P.H.. 
was appointed clinical professor of 
epidemiology and pediatrics as of July 
1982. Dr. Cumen has been a member 
of the faculty of the Columbia Univer¬ 
sity School of Public Health since 
1973; at Yale she will serve as director 
of the Connecticut Cancer Epidem¬ 
iology Unit and will be medical director 
of the Connecticut Tumor Registry, a 
unit of the State Health Department. 
Joshua Schor Receives 1982 
Marguerite Rush Lerner Award 
In 1981 Dr. Aaron Femer and family 
established the Marguerite Rush Femer 
Award to be awarded each year to a 
medical student who demonstrates 
outstanding skill in writing and/or 
performance in a non-scientific vein. 
Fast year the award went to Peter Blier. 
Feonard Saltz, and Henry Weiner for 
their delightful skit in the Second Year 
Show called Dr. Seuss. This year 
Joshua Schor, class of 1984, was 
awarded the prize for his poem titled 
“The Proof of Rain.'' 
Digestive Diseases Division 
Established 
After 27 years as chief of the Gastro¬ 
enterology Section of the Department 
of Internal Medicine, Dr. Howard M. 
Spiro has chosen to set aside his 
administrative duties and is taking a 
well-deserved sabbatical leave. The 
Gastroenterology Section and the Liver 
Study Unit have now been combined 
into a single Digestive Diseases Divi¬ 
sion with Dr. James L. Boyer as chief. 
Given the distinguished history of both 
components of the Division. Dr. Boyer 
plans to have them maintain independ¬ 
ent academic identities. Combining the 
sections, however, will permit a more 
efficient use of resources and facilities 
as well as a greater ease of developing 
new programs. 
Faculty Notes 
Dr. I. George Miller, whose research 
on Epstein Barr virus has attracted 
international recognition, received the 
1982 Squibb Award of the Infectious 
Disease Society. The award, given 
annually to an investigator 45 years old 
or younger who has made outstanding 
contributions to the field, was pre¬ 
sented to Dr. Miller by Dr. Dorothy 
Horstmann. John Rodman Paul Pro¬ 
fessor Emeritus of Epidemiology and 
Pediatrics. Dr. Miller was the first to 
successfully transfect cultured cells 
with complete EBV-DNA. Most 
recently he has been able to transfect 
mouse cells with cloned fragments of 
the EBV-genome, an approach which 
has paved the way to mapping several 
genome functions and opens up the 
possibility for defining the molecular 
mechanism of viral transformation and 
oncogenesis. Dr. Miller is John F. 
Enders Professor of Pediatric Infec¬ 
tious Disease and Epidemiology. 
The College of Physicians and Sur¬ 
geons of Columbia University pre¬ 
sented the 1982 W. Alden Spencer 
Award to Dr. Patricia Goldman- 
Rakic. professor of neuroscience. The 
award, given annually for outstanding 
contributions to neuroscience, cites her 
contributions to the understanding of 
the morphological, biochemical and 
functional organization of the primate 
association cortex — that part of the 
brain essential for memory and cogni¬ 
tion. Working with nonhuman pri¬ 
mates, Dr. Goldman-Rakic has 
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pioneered in analyzing the develop¬ 
ment of the prefrontal cortex. 
At its annual meeting in April, the 
American Physiological Society pre¬ 
sented Dean Robert W. Berliner the 
Ray G. Daggs Award. The honor is 
presented annually in recognition of 
distinguished service to the Society and 
to the science of physiology. 
Dr. Leon E. Rosenberg, C.N.H. 
Long Professor and Chairman of the 
Department of Human Genetics has 
been elected to the Institute of Medi¬ 
cine. The recipient of numerous honors 
for his contributions to research in 
human genetics. Dr. Rosenberg is also 
recognized as a distinguished clinician 
and teacher. Election to the Institute of 
Medicine is both an honor and a work¬ 
ing assignment. On appointment, 
members make a commitment to 
devote a significant amount of time to 
serve on committees involved in a 
broad range of health policy issues. 
The 80th Christian A. Herter Lecture 
was delivered by Dr. Charles 
Radding in May at New York Univer¬ 
sity School of Medicine. Dr. Radding, 
professor of human genetics and 
molecular biophysics and biochem¬ 
istry, spoke on “The Recombinase 
Activity of E.coli recA Protein: 
Synapsis and Strand Transfer.” 
The Federation of American Societies 
for Experimental Biology and The 
Burroughs Wellcome Fund awarded 
Dr. Gerhard H. Giebisch a Wellcome 
Visiting Professorship for the academic 
year 1982/83. The visiting professor¬ 
ships are offered annually to stimulate 
interest in the basic sciences and to 
recognize eminent scientists in physiol¬ 
ogy, biological chemistry, pharmacol¬ 
ogy, pathology, nutrition and immu¬ 
nology. Dr. Giebisch, who is Sterling 
Professor of Physiology, will deliver a 
Burroughs Wellcome lecture as well as 
participate in seminars and classroom 
discussions with faculty and students at 
the University of Alabama. 
Nine members of the School of Med¬ 
icine faculty and research staff will 
share a $175,000 award from the 
Swebilius Trust Fund to support 
research on the causes, therapy and 
prevention of cancer. They are Drs. 
Christopher C. Benz, assistant pro¬ 
fessor of medicine; Robert Gillies, 
research associate in molecular bio¬ 
physics and biochemistry; Edward 
Hawrot, assistant professor of 
pharmacology; Ann Korner, research 
associate in dermatology; R. Michael 
Liskay, assistant professor of 
therapeutic radiology; Mark Marsh, 
research associate in cell biology; Ira 
S. Mellman, assistant professor of cell 
biology; Judith White, research 
associate in cell biology, and Stephen 
Zuckerman, research associate in 
human genetics. 
Dr. Joan A. Steitz was elected a fellow 
of the American Academy of Arts and 
Sciences at the Academy’s 202nd 
meeting held in Cambridge, 
Massachusetts in May. Dr. Steitz who 
is professor of molecular biophysics 
and biochemistry, has received 
numerous awards and honors for her 
research on RNA processing. 
Dr. James F. Lecknian is one of two 
scientists to receive fellowships estab¬ 
lished by The John Merck Fund to 
encourage research related to certain 
problems of children and to advance the 
careers of promising young profes¬ 
sionals in the field of child psychiatry. 
Dr. Leckman is assistant professor of 
psychiatry and pediatrics. Child Study 
Center, and associate director of the 
Children’s Clinical Research Center. 
His research is directed toward deter¬ 
mining the biological and environ¬ 
mental factors involved in the trans¬ 
mission and expression of major 
developmental and psychiatric dis¬ 
orders in children and adults, as well as 
the behavioral and developmental 
correlates of brain metabolism. 
Dr. Myron Genel has been awarded a 
Robert Wood Johnson Health Policy 
Fellowship for a year of study and 
congressional work assignment in 
Washington, D.C. during 1982-83. 
The fellowships were established in 
1974 by the Institute of Medicine with a 
grant from the Robert Wood Johnson 
Foundation. The program, conducted 
in cooperation with the American 
Political Science Association, is 
designed to provide a better under¬ 
standing of major issues in health 
policy, and a knowledge of how federal 
health programs are established. The 
recipients, who are chosen on a 
competitive basis, are outstanding mid¬ 
career professionals working in 
academic health settings. Dr. Genel, 
who is professor of pediatrics and 
program director of the Children's 
Clinical Research Center, is the third 
member of the medical school faculty 
to be selected; in 1974, Dr. Arthur 
Viseltear, associate professor of the 
history of medicine and public health 
was one of the inaugural Robert Wood 
Johnson Health Policy Fellows; and in 
1976 Samuel Korper, former assistant 
dean for regional activities was selected 
as a fellow. 
At the annual meeting held in Montreal, 
Quebec in November, Susan Addiss 
was elected president of the American 
Public Health Association. A lecturer 
in the Department of Epidemiology and 
Public Health, Ms. Addiss chief of the 
Connecticut Bureau of Health Planning 
and Resource Allocation, and is 
responsible for conducting the state’s 
health planning activities, including 
implementing the state health plan. 
It was a busy fall for Dr. William F. 
Collins, Jr., who in September was 
Norman M. Dott Memorial Lecturer at 
the University of Edinburgh, Scotland, 
where Dr. Dott was the first professor 
of neurosurgery. In October, Dr. 
Collins, who is Harvey and Kate 
Cushing Professor of Surgery, was the 
honored guest of the Japan Neuro¬ 
logical Society at their 41st annual 
meeting in Tokyo, following which he 
was visiting professor at the Hokkaido 
University School of Medicine in 
Sapporo, and at the Tohoku Medical 
School in Sendai, Japan. 
At the annual meeting of the New 
England Surgical Society in October, 
Dr. William W.L. Glenn was elected 
president of the Society. Dr. Glenn, 
who is Charles W. Ohse Professor of 
Surgery, is well-known for his contri¬ 
butions to cardiothoracic surgery. 
In September, Dr. Marvin Sears, 
professor and chairman of the Depart¬ 
ment of Ophthalmology and Visual 
Science, joined the ranks of Yale 
School of Medicine faculty visitors to 
China. He spent several weeks lectur¬ 
ing at the Peking Medical Association, 
Shanghai Medical Association, the 
Peking Capital Hospital of the Chinese 
Academy of Medical Sciences, and the 
Nanking Hospital. His lectures covered 
new findings from automated peri¬ 
metry, medical therapy, and techniques 
of surgical and laser treatment in 
glaucoma, and the pitfalls of medical 
and surgical treatment. 
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I)r. Joseph Bertino, professor of 
medicine and pharmacology, has been 
named the first editor of the Journal of 
Clinical Oncology, the official publica¬ 
tion of the American Society of Clinical 
Oncology. Dr. John Marsh, professor 
of medicine, is an associate editor of 
the Journal. 
The American Medical Writers Asso¬ 
ciation awarded an honorable mention 
in the “Physicians Category" of the 
1982 AMWA Medical Book Awards 
competition to Endocrinology and 
Metabolism. The book was co¬ 
authored by Dr. Philip Felig, professor 
of medicine, and Dr. Arthur 
Broadus, associate professor of med¬ 
icine, with Dr. John Baxter and Dr. 
Lawrence Frohman. 
The 1982 Seymour L. Lustman Prize 
for research during the psychiatry 
residency was presented to Dr. Alan 
Breier. At the award presentation. Dr. 
Breier delivered a lecture entitled 
“Self-Control in Psychotic Disorders." 
Books by Faculty 
“The Biochemical Basis of Neuro¬ 
pharmacology," 4th edition. By Jack 
R. Cooper, professor of pharmacology, 
F. E. Bloom, and R.H. Roth, professor 
of pharmacology and psychiatry. 
Oxford University Press (Oxford, 
England) 1982. 
“Diagnostic Virology,” 3rd edition. 
G. D. Hsiung, professor of laboratory 
medicine, in collaboration with 
Caroline K.Y. Fong, senior research 
associate in laboratory medicine. Yale 
University Press (New Haven) 1982. 
“Cancer Therapy.” By John C. 
Marsh, professor of medicine, and 
David S. Fischer, clinical professor of 
medicine. G.K. Hall (Boston) 1982. 
“Letters to a Young Doctor." By 
Richard Selzer, assistant clinical 
professor of surgery. Simon and 
Schuster (New York) 1982. 
“Total Child Care — a Contemporary, 
Prepared Approach to Parenthood from 
Birth to Age Five.” By Lorisa 
DeLorenzo and Robert J. DeLorenzo, 
associate professor of neurology. 
Doubleday and Company (Garden 
City, N.Y.) 1982. 
Ira Stovin Goldenberg, M.D. 
Di. Ira S. Goldenberg, professor of 
surgery, died suddenly on July 31, 
1982 at the age of 57. 
Dr. Goldenberg was born in Bridge¬ 
port, Connecticut. He graduated from 
the University of Michigan in 1947 and 
received his M.D. degree from Boston 
University in 1951, where he was a 
member of AOA Medical Honor 
Society. 
Dr. Goldenberg served his internship 
and residency at Yale-New Haven Hos¬ 
pital and was a research fellow in the 
Department of Surgery during 1952— 
53. He was appointed a member of the 
Yale faculty in 1957 and became pro¬ 
fessor of surgery in 1968. He was an 
attending surgeon at Yale-New Haven 
Hospital and a surgical consultant at the 
West Haven Veterans Hospital and 
other Connecticut hospitals. 
A veteran of World War II. he was a 
member of numerous professional 
societies and organizations, including 
the American College of Surgeons and 
the American Association of Univer¬ 
sity Surgeons. 
Dr. Goldenberg was a leader in the 
field of breast surgery with a national 
reputation in treatment of breast 
cancer. He was a consultant to the 
National Cancer Institute, serving on 
the Breast Cancer Task Force. He was 
one of the pioneering supporters of the 
Hospice movement in this country, 
helping to found Connecticut Hospice 
and serving on its board of directors. 
A resident of Orange, his widespread 
interests included long term service to 
that town as an influential member of 
its Library Board and as its Police 
Department surgeon. Dr. Goldenberg 
was a noted antique collector and 
authority, and had attained the pres¬ 
idency of the Connecticut Antique 
Dealers Association for 1981-82. 
Ira Goldenberg was a unique physi¬ 
cian and human being. His early 
interest in breast cancer came at a time 
when medical science had little to offer 
in the way of cure or palliation for 
unfortunate victims of advanced dis¬ 
ease. His compassion, empathy, and 
skill enabled him to bring comfort to 
thousands of women and endeared him 
to them and their families. More than a 
consultant, he was always available 
when his patients needed him most. His 
sudden, tragic death has left a void that 
cannot be easily filled. S.S.M. 
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John Black Goetsch, M.D. 
John Black Goetsch, assistant clinical 
professor of surgery (urology), was 
born in Oak Park, Illinois, on April 30, 
1914. He died after a happy day of 
salmon fishing on the Matapedia River 
in New Brunswick, Canada, on August 
8, 1982. 
After attending public schools in 
Oak Park, he earned his B. A. and M.D. 
degrees at the University of Rochester. 
He served as a house officer on the 
surgical and urological services at the 
Strong Memorial Hospital in Rochester 
and took a year of training in surgical 
pathology at the same institution. After 
World War II service in the 40th Army 
General Hospital in the European the¬ 
ater, he took his urological residency 
under Dr. Clyde Deming at the Yale- 
New Haven Hospital. On completion 
of that residency, he devoted two years 
to research at the Yale School of 
Medicine under the auspices of the Jane 
Coffin Childs Fund and was awarded 
membership in Sigma Xi. He was certi¬ 
fied by the American Board of Urology 
in 1948. 
Dr. Goetsch entered the private 
practice of urology in New Haven in 
1949 and was continuously actively 
engaged in it until the time of his death. 
His interest in research and pathology 
never dwindled and resulted in the 
publication of a number of papers both 
in basic science and clinical expe¬ 
rience. He gave generously of his time 
to the teaching of medical students and 
house officers and was a faithful attend¬ 
ant at the Yale Urological tumor clinic 
for many years. His patients became his 
friends and were as devoted to him as 
he was to them. 
Those of us who linger briefly 
behind will never forget his kind, 
gentle nature and his warm, friendly 
smile. We are all diminished by this 
loss. R.R.B. 
Elmer V. Newton 
Elmer V. Newton, who had worked at 
the School of Medicine for 26 years and 
was well known to the students during 
this period, died on June 5, 1982. 
After having worked for many years 
for the New Haven Railroad, Mr. 
Newton was employed by Yale in 1956 
as an assistant in research in the Depart- 
ment of Anatomy. Generations of 
students will remember him in the 
anatomical laboratories. In 1971 he 
became a technical specialist for the 
Office of Student Affairs and as such 
continued to be a well known figure and 
friend to the medical students. 
He is survived by his wife, Winifred 
Goodrich Newton, and a brother, 
Kenneth, both of Branford, Con¬ 
necticut. 
Errata 
Your editor was very much embar¬ 
rassed by the number of errors which 
appeared in our last issue, spring/ 
summer 1982. As one keen alumnus 
wrote: “Most times I accept what I read 
in Yale Medicine as gospel truth. But 
this time I think you guys goofed, as 
noted on the enclosed pages. ’ ’ 
It may have been gremlins at work; 
however, the editor has to accept the 
blame. Our apologies to those who 
were misrepresented or misquoted and 
to our readers. 
Corrections are noted below. 
In the article on “Medical Illustration 
. . .”, the caption for the drawing on 
page 9 should have read: Illustration by 
Patrick Lynch of a horizontal section of 
a head looking up on the palate, molar 
teeth, and the base of the skull. It was 
drawn as a reference. 
On page 17, two errors appear in the 
item in the first column concerning the 
visiting professorship honoring Dr. 
Alfred Gilman. The textbook “Phar¬ 
macological Basis of Therapeutics” is 
now in its 6th edition, not the 8th 
edition. The first sentence of the fourth 
paragraph should read: Before coming 
to Yale, Dr. Gilman had been professor 
and chairman of the Department of 
Pharmacology at Albert Einstein Col¬ 
lege of Medicine since 1956. Our 
apologies to Dr. Gilman. 
A major omission marred the column 
entitled, “Why a Gift to Endowment?” 
by Drs. Gallagher and Kushlan in the 
Alumni News section on page 21. Their 
entire fourth paragraph and part of the 
final sentence in the third paragraph 
were left out in our production. There¬ 
fore, the column is being reprinted in its 
entirety on this page. 
Why a Gift to “Endowment”? 
“. . . Kissing your hand may make you 
feel very good but a diamond . . . lasts 
forever.” So, too, does a gift to the 
Yale Medical School Alumni Fund 
Endowment. “Endowment” to many 
of us spells permanence, “a gift in 
perpetuity”, “a gift that keeps on giv¬ 
ing” — those are what a gift to 
“Endowment” is all about. 
It is the permanence of a gift to 
Endowment that appeals to so many of 
those whose circumstances permit 
them to consider making a substantial 
gift. Unlike the Parisian’s kiss, it is not 
tor the moment. Year after year after 
year the income it generates will help to 
maintain the School’s quality. 
The “giving” also has permanence. 
Like “The Brook” of Alfred Lord 
Tennyson, it will “go on forever”. The 
total amount of a donor’s gift to 
Endowment is credited in his or her 
name and class in the year it is received 
and its income will be similarly credited 
each year thereafter. It is impossible to 
know how much this way of recogniz¬ 
ing a donor’s gift to Endowment may 
influence the donor’s decision to make 
a contribution. But is it not true that 
there is more than a little of “. . . this 
pleasing hope, this fond desire, this 
longing after immortality” deep in 
many of us? 
To consider permanence a major 
reason for a decision to make a gift to 
Endowment would seem to be a 
justifiable conjecture, but there are 
usually — probably always — other 
telling reasons. For example, the fact 
that the allocation of the income from 
the gift will be reconsidered annually 
appeals to many donors. Each year the 
Dean and his advisors assign the 
income from the Alumni Fund 
Endowment to that area they believe 
deserves the highest priority. In recent 
years, because of the rapid, extensive 
rise in tuition (it will be $8,750 next 
year!) it has gone into scholarship aid. 
Other donors like the variety of ways 
a major gift can be made to Endowment. 
For one, a Life Income gift best fits his 
or her circumstances; for another a 
Deferred Annuity gift, a Bequest, a 
Capital gift or a gift of a Life Insurance 
policy whose protection is no longer 
required will be appealing and 
appropriate. 
The fact that the gift’s capital is 
managed so as to compensate for 
attrition by inflation must impress 
every prospective donor; no one likes 
the thought that a gift’s real value will 
gradually (these days rapidly) diminish. 
To counteract this the Fund adds a 
fraction of each year’s income to the 
capital amount of the original gift. 
These brief speculations of why 
alumnae and alumni choose to make 
gifts to Endowment suggest another 
fundamental question: why does a 
graduate desire to make a substantial 
gift? Like many basic ones — there is 
no single, definitive answer. 
You, no doubt, have thought of more 
than one reason. There are many: 
“divers dive for diverse reasons” — 
and so do people who give. Some of the 
reasons are homely, familiar; others, 
equally valid, may be obscure. It’s a 
wise donor who knows his own motives. 
Warm feelings, fostered by happy 
memories of his or her own School 
experiences, or of one or more teacher’s 
encouragement, inspiration or friendli¬ 
ness, must be high on everyone’s list of 
reasons. An uncomplicated, simple 
feeling of obligation to repay the 
School for at least the difference 
between the tuition paid and the amount 
his or her education cost the School is 
another. Or a mix of empathy with 
succeeding generations of students and 
the memory of one’s own struggle may 
serve to breed a desire to make these 
younger people’s journey as beneficial 
as — and less grueling than — the 
donor’s. 
Then there are the complex, more 
intimate reasons: the need further to 
feed a still hungry ego, or to bolster a 
still less than solid identity. Not all the 
processes of adolescence reach their 
destinations before the thirties! 
And, often intertwined with one or 
more of those, is a reason that might 
better have been mentioned first; the 
fact that many donors previously had 
learned that giving is a rewarding 
experience, that it is “. . . more blessed 
to give than to receive”, and frequently 
more satisfying. 
Ros Gallagher, Chairman 
Sam Kushlan, Co-Chairman 
Yale Medical School 




The Alumni in Medicine Column 
Notes from the President 
Nicholas P.R. Spinelli, M.D. 
A strange and unprecedented monsoon 
drenched the festivities at the Yale 
Medical Alumni Day this past June 5th. 
Fourteen inches of rain, a record, fell 
on reunion Saturday. This did not 
discourage a banner number of attend¬ 
ees from assembling to register in the 
Cedar Street rotunda that morning. 
With the muffled hum of the downpour 
as background, the dripping forms of 
the drenched arrivals, umbrellas use¬ 
less, entered the loud and animated 
murmur of a happy, warm crowd. A 
tum-away audience heard an upbeat 
address by our dynamic University 
President Giamatti on Saturday 
morning. 
The adverse performance of the 
elements seemed to kindle a particular 
and undeniable enthusiasm for all 
components of the day's program 
(dampened attractions of the Yale golf 
course or the trip to the British Museum 
undoubtedly contributed.) The unani¬ 
mous consensus was that this had been one 
of the finest reunions within memory. 
Everyone seemed to get to know and 
converse with the spirited and spir¬ 
itually youthful members of the 50th 
reunion class at the several common 
social events. It was especially pleasing 
to see this group communicating the 
fascinating history and details of their 
distinguished medical careers of a half 
century with a group of young Yale 
medical students. Many among the 
50th reunion group enjoyed this dia¬ 
logue, (i.e. Farr. Clarke, Lam, 
Wegman, Humphreys et al). Less vis¬ 
ible because they were cloistered in 
their own special 25th reunion year 
program was the group led by Jack 
Levin and Gil Hogan, '57. They felt 
that every quarter century reunion class 
should do a similar type of program. 
The 10th year class, '72, under the 
energetic direction of Harry Malech 
assembled an enthusiastic group of 
returners. These “college kids of the 
late sixties" displayed no visible scars 
of their supposedly stressful academic 
times. 
The voices of the alumni body this 
past June could be heard with a seeming 
common enthusiasm: “more pro¬ 
grammed. structured reunions . . .” 
Levin, '57; “more attention to senior 
class reunion entertainment . . . ” 
Ogilvie '34/Pickett '44; “how can we 
get to know Yale medical alumni in the 
real world?" Gwin '84/Fish '85; “are 
there ways the many Yale Med/EPH 
grads in Washington. D. C. area could 
be gotten together?’’ Muriel Wolf '59. 
In these times when a process of 
societal alienation is described by the 
sociologists, perhaps we are returning 
to the traditional doorways of commu¬ 
nication which school reunions pro¬ 
vide. Reunion year 1982 was. in an 
interesting and declarative sense, a 
communication, reconnection, com¬ 
munion event if the feedback can be 
interpreted. Perhaps it wasn't the rain 
alone that nurtured the roots of the 
group's return to its past. Achieving the 
social intimacy among generations 
which we realized during this past 
reunion is always subconsciously a 
sought after goal. The challenge in 
future programming will be to structure 
events attractive enough to lure us to 
participate, in the absence of rain. In 
any event, the purpose of this reminis¬ 
cence is to convey the consequent stir¬ 
rings at alumni headquarters this 
summer and to report: 
Len Kemler, '42, volunteered to be 
chairman of the Program Committee 
again, for 1983, and assembled a core 
group this summer to begin planning. 
Jack Ogilvie and Larry Pickett co-chair 
a committee to plan a special program 
of entertainment and activities for the 
50th reunion group in 1983. 
Plans are underway for publication 
of a Yale Medical Alumni Directory. In 
responding to requests for information 
for this endeavor, we hope you all will 
participate enthusiastically in an effort 
which may provide you with useful 
information. Whether there are alumni 
who would be interested in a preceptor 
role for the rare Yale student interested 
in a tutorial experience, in the New 
Haven or Connecticut area or in distant 
hometown cities (“an orthopod in 
Chicago? ... a cardiologist in 
Denver?’’), is a question which a direc¬ 
tory would help answer. With such a 
resource the possibilities for those so 
inclined to achieve regional linkages 
within the Yale context are clear. 
The alumni/ae organization — a 
many-headed organism — can demon¬ 
strate dynamism, like any organism. 
We hope that this year's energy endures 
and flourishes and that next year’s 
reunion will bring even more pleasure 
to returning alumni/ae than did this 
year’s. It was in every way a model 
experience worth repetition. 
Alumni Weekend 
Soaked but Successful 
From the middle of May through the 
first two weeks of June, New Haven 
experienced an uninterrupted series of 
rainy weekends; however, the worst by 
far, was the torrential downpour on 
Saturday of the Medical Alumni 
Weekend. Heavy rains which began in 
the early morning hours continued 
throughout the day. By mid-afternoon, 
streets in West Haven. Hamden, and 
other neighboring towns were flooded, 
and many major highways were 
impassable. It was one of the worst 
rainstorms to visit the area in many 
years. 
In spite of the weather, the Medical 
Alumni Weekend was very successful, 
and the attendance set a new record. 
Although the official registration was 
336. it is estimated that about 400 
attended the events on Friday and 
Saturday. In addition, some of the five- 
year reunion class members who were 
unable to attend the events at the School 
were present at the class dinners on 
Saturday evening. 
An innovation this year was the 
Dean's reception on Friday afternoon. 
Held in the Beaumont Room, it 
provided a pleasant setting for friends 
and former classmates to meet, and the 
presence of several faculty and some 
medical students enabled returning 
alumni to hear about current events at 
the School. It was apparent that many 
of the alumni present at the reception 
were especially pleased to have an 
opportunity to chat with some of the 
medical students. 
The alumni were honored to hear 
President Giamatti speak on “Yale 
Today.’’ His talk given in the Histor¬ 
ical Library on Saturday morning drew 
an extremely large crowd; it was stand¬ 
ing room only, and several people were 
barely able to squeeze into the back of 
the room. The seminars which fol¬ 
lowed on Saturday also attracted con¬ 
siderable interest. 
As always, the buffet luncheon at 
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Edward S. Harkness Hall was a pieasant 
occasion and attracted a large turnout. 
Many who were present at the Medical 
Alumni Weekend commented: "It was 
the best yet!” 
Association of Yale Alumni in 
Medicine 
Annual Business Meeting on 
June 5, 1982 
The meeting held in Mary S. Harkness 
Auditorium was chaired by Dr. Nicholas 
Spinelli, president. Returning alumni 
were welcomed by Dean Berliner, and 
special greetings were extended to the 
reunion classes. Members of the class 
of 1932 celebrating their 50th reunion 
were introduced by Dr. Spinelli. He 
also introduced those present who had 
graduated prior to 1932: Helen Langner 
(’22), Myron Sailick (’24), Max Alpert 
(’28), Russell Scobie (’29), James Hart 
(’30), and Paul Lavietes (’30). 
On recommendation of the Nomi¬ 
nating Committee, the following were 
elected to serve on the Association’s 
Executive Committee, each for a term 
of two years: Gilbert Hogan (’57), R. 
Leonard Kemler (’43), Richard Norton 
('60 HS), O’Dell Owens (’76), 
Rebecca Solomon (’39). 
Alumni elected to serve as represent¬ 
atives to the Association of Yale 
Alumni (AYA) were: A. Frederick 
North (’56), Daniel Passeri (’75), 
Muriel Wolf (’59). 
Following the elections. Dr. Spinelli 
congratulated those newly elected and 
expressed appreciation to the two out¬ 
going members of the Executive 
Committee, Sarah Auchincloss (’76) 
and William Waskowitz (’57), both 
having loyally served for two-year 
terms. He also expressed appreciation 
to those who had completed terms as 
medical and public health representa¬ 
tives to the AYA, Victor Crown (MPH 
’69) and Harris Pastides (Ph.D. ’80). 
The next item of business was the 
report of the chairman of the Medical 
School Alumni Fund, Dr. Lowell 
Goodman. He noted that the total raised 
by the 1981 -82 campaign was expected 
to exceed $225,000 and would establish 
a new record in annual giving. The 
important influence of Dr. Leona 
Baumgartner's challenge gift of match¬ 
ing funds was noted. Following Dr. 
Goodman’s report, the following 
motion from the audience was voted 
unanimously: "In recognition of her 
extreme generosity, the Association of 
Yale Alumni in Medicine, at their 
Annual Meeting, express, record and 
communicate their sincere appreciation 
to Leona Baumgartner." 
Mrs. Kathleen Howe reported on the 
Public Health Alumni Fund, which also 
established a new record in the total 
amount of annual gifts. Mrs. Howe said 
that this year all Public Health Alumni 
contributions will be used to establish 
the Robert W. McCollum Fund for 
Student Aid, to honor the former 
chairman of Epidemiology and Public 
Health. 
There being no other business. Dr. 
Spinelli adjourned the meeting after 
announcing that the dates of the 1983 
Alumni Weekend would be June 3 and 4. 
REUNIONS 
1932 — Fiftieth 
By 
Clement Clarke and Myron Wegman 
The 50th reunion of Yale Med '32 was 
marred by what is said to have been the 
worst rainstorm in the history of New 
Haven, with resulting serious floods. 
Cushing, coming up from New York 
was almost three hours getting from 
Bridgeport to New Haven and to the 
Graduates Club. Wehger, coming 
from Bridgeport had to go by a very 
roundabout route taking an hour longer 
than usual. Clarke, who had organized 
the dinner, never made it all because his 
car got into the water on the way in. He 
and his wife had to be rescued and spent 
most of the night in Peppino’s Clam 
Bar before being taken home about five 
in the morning by a high-rise Coast 
Guard truck equipped with inflatable 
lifeboat and outboard just in case. After 
the dinner Wegman took the watery 
Whalley Avenue route to Southbury, 
swamped his rental car, waded to the 
rescue car of a female police officer and 
spent the night in the National Guard 
Armory on Goffe Street. 
The warmth of the meeting and the 
fellowship among the eight persons, 
four wives and one son who did get to 
the dinner, made up to some extent for 
the difficulties. Those who attended 
were: Bob and Robin Cushing, Frank 
and Shirley Carroll, Joe and Monica 
Donnelly, Lee Farr, Storer 
Humphries, Connie Lam, Dutch 
Wehger and his son, Roland, and 
Myron Wegman. 
1937 — Forty-fifth 
By Wilbur Johnston 
The class of 1937 did not have a formal 
reunion this year. Two letters were sent 
out by Wilbur Johnston to have a get- 
together, but there was no positive 
response from our members. 
Several messages and phone calls 
were received. Dennie Pratt called 
from Mt. Pleasant, South Carolina to 
report all was well. Also heard from 
were Al Spicer from Weekapaug, 
Rhode Island; Crosby Greene, from 
Baltimore, Maryland; Morgan 
Sargent, Quincy, Massachusetts; and 
Lucille Wiepert of Avon, Connecticut. 
All expressed a desire to wait for the 
tiltieth and hoped tor fewer weddings 
and other competitive reunions. 
Of course the ten inches of rain on 
Saturday, June 5th, established a record 
and was not helpful for those alumni 
attending the several arranged functions. 
1942 Med. 
No report received. 
1947 — Thirty-fifth 
By Philip Phi I bin 
Fifteen members of the class of 1947, 
about one-fourth, made it to the 35th 
for a most pleasant reunion. 
Despite record rains, there was little 
that dampened the pleasure of seeing 
familiar faces after so many years and 
hearing brief sketches of their activities. 
There were many laughs, some poign¬ 
ant memories, all enjoyable. There was 
correspondence from Barnes and 
Bowers which added to the evening. 
Blansfleld, Cannon, Chase, 
Colwell, Collins, Breg, Epstein, 
Friedlander, Kerin, Mache, 
Maniatis, McClelland, Newton, 
Tamm, and myself made it to our 
reunion headquarters at the New Haven 
Medical Society Building despite the 
downpour, where we had drinks and a 
delightful dinner. This was the climax 
to a very busy and educational day at 
the school and was arranged with due 
appreciation by Drs. Maniatis and 
Newton. 
The only disappointment was that of 
noting the absence of many of the class, 
all just a few hours from New Haven, 
particularly after seeing the large 
number traveling many miles to make 
it. 
Let’s do it better in 1987, our 40th. 
George Barnes, Jr., in honor of his 
special contributions to the medical 
profession, selected for fellowship in 
the American College of Radiology, 
received his award at its annual meeting 
in September. Dr. Barnes resides in 
Gig Harbor, Washington and is affili¬ 
ated with St. Joseph and Tacoma 
General Hospitals in Tacoma. 
1952 — Thirtieth 
By Harvey Young 
Sterling Characters Have Great 30th! 
With another issue of the class news¬ 
letter and photographs of reunions past, 
six members of the class of ’52 and 
their guests enjoyed a fine evening of 
reminiscing and dinner at the Graduate 
Club on June 5th. 
Mo Bogdonoff provided a most 
entertaining and truly enjoyable review 
of thirty years and a peek into the 
future. Ray Duff, although unable to 
attend, was present in that he arranged 
the evening’s location and the excellent 
meal. 
Those attending the reunion were: 
Mo Bogdonoff, Bob and Maggie 
Gerety, Art and Katie Hustead, Bill 
Klatchko, Don and Judy Schultz, 
Hilda and Harvey Young. 
Several were unable to attend 
because of conflicts with graduations of 
their offspring, and Jose Patino wrote 
that he was traveling and unable to put 
New Haven on his itinerary. 
1957 — Twenty-Fifth 
By Jack Levin 
Undaunted by the seven inches of rain 
which fell on New Haven on the 
Saturday of Reunion Weekend, 34 
members of our class (most of them 
accompanied by their wives) celebrated 
our 25th Reunion. Amazingly, the 
same number of our class (43%) 
attended the 20th Reunion. Those who 
travelled the farthest were Al 
Chun-Hoon (from Honolulu), Jack 
Levin (from San Francisco), and Dave 
Martin (from Wabasha, Minnesota). 
Following the program presented by 
the School of Medicine on Saturday 
morning and lunch, 1957 Medicine 
held a Non-Scientific Mini-Symposium. 
The speakers and topics were: Cliff 
Reifler (Going to College and Letting 
Go: Problems of Transition); Stan 
Kilty (From Private Practice to 
Organized Health Service Delivery); 
Howie Minners (Man in Space); and 
Tom Danaher (Experiences in 
Afghanistan). Then it was through the 
storm and down flooded roads to the 
shore and the Pine Orchard home of the 
family of Gil and Carol Hogan (This 
was not the first time that Carol’s 
mother, Mrs. Donovan, had offered the 
hospitality of her home to members of 
our class). The unending rain did not 
prevent us from enjoying cocktails, 
dinner, and much good conversation. 
Fortunately, the weather did not deter 
members of the Connecticut contingent 
from arriving as the evening progressed. 
Some of our Connecticut classmates 
stopped the dinner party from turning 
into a pajama party by guiding car 
caravans out of Pine Orchard onto 
relatively clear roads. 
Members of the class who attended 
the reunion were: Vince and Doria 
Andriole, Cal and Phyllis Bigler, 
Jack and Barbara Blechner, Harry 
and Joann Briggs, Jack and Ann 
Carey, AI and Myrna Chun-Hoon, 
Lou and Matty Cooper, Tom and 
Nancy Danaher, Joe Demis, Jim and 
Colleen Dorr, Ed Eyerman, Hal and 
Jo Fallon, Bob Fishbein, Ron and 
Estelle Fishbein, Tony and Mary 
Fons, Elizabeth and Ben Forsyth, 
Joyce and Bill Gryboski, Gil and 
Carol Hogan, Stan and Carol Kilty, 
Bill and Priscilla Kissick, Willard and 
Bea Krehl, Ed and Naomi Levin, Jack 
Levin, David Martin, Howie and 
Gretchen Minners, Hugh Moffet, 
Herb and Ann Newman, Joe and 
Nancy Pagano, Ray Phillips, Cliff 
and Barbara Reifler, Don and Amy 
Stahl, Arthur and Sheila Taub, and 
Bill and Barbara Waskowitz. Joe 
Amenta was suitably represented by 
his wife, Madilon. 
The reunion was organized by Jack 
Levin, Gil and Carol Hogan, Ron 
Fishbein, Howie Minners, and Bill 
Waskowitz. Particular thanks go to Gil 
and Carol for hosting the class dinner 
and to Howie for the enormous effort 
required for the preparation of the 
superb collection of biographic infor¬ 
mation. Bob Fishbein enjoyed himself 
sufficiently to be inspired to compose 
“The Anatomy of Alumni Day.” 
Finally and importantly, due in large 
part to the efforts of our recent Class 
Agent, Bill Waskowitz, 78% of our 
class have contributed over $9,000 to 
the Medical School Alumni Fund during 
our 25th reunion year. This is the 
highest level of participation and the 
greatest amount of money donated in 
the history of our class. I think we 
should attempt to achieve 100% partici¬ 
pation on the occasion of our 30th 
reunion. 
Editor’s note: 
The following by Robert Fishbein is 
being included at his special request. In 
a recent letter he noted that this “is not 
a poem, but a rambling essay" and 
explained its origin as follows: “The 
idea was conceived as we all sat in the 
Anatomy Lecture Room after class¬ 
mates Howie Minners, Cliff Reifler, 
Stan Kilty, and Tom Danaher had 
presented interesting experiences in 
their quartered century since we were 
ordained medical ministers. Gil Hogan 
proceeded to explain . . . with chalk 
drawn map . . . directions to the 
evening dinner at Mrs. Donovan's 
house . . and his rapid delivery (as 
everybody was taking notes) took me 
back — in a flash — to the labyrinth of 
anatomical quick sand when it was only 
the reassurance of Drs. Forbes, Crelin, 
and Gardner that I would survive in that 
jungle of knowledge . . . .” 
n 
The Anatomy of Alumni Day 
“A Prosector's Prose . . . ForThe Archives Of Posterity" 
It Was The Day Of Assault As We All 
Aluminumized To Recall And Recollect 
From The Point Of Our M . Deed . . A 
Quarter Of A Century Ago .... 
With Casted Characters And Characteristics 
We Gathered . . . Having Been Scattered Hither 
And Yonder . . . The Magnet Of Tradition 
Brought From As West As Hawaii, As South 
As Carolina, As North As Vermont, And 
Ironed The Filings In Between. Haven We 
Came. So Did The Rain . . . . 
Gil, Not To Be Confused With The Breathing 
Apparatus Of Fish, Helped Us Snorkel To The 
Donovan. . . Under Trestles And Over Puddles . . . 
Hydrofoil Style. We Were Hogan's Heroes, 
Sandwiched Between The Rain Drops. 
The Lord Had Taken An Overdose Of Diuretics. 
Clouds Were Emptying Their Bladders. Was 
This A Eulogy To Urology? Did The 
Almighty Need A New Plumber? Heaven Only 
Knows .... 
The Road Map From Cedar Street Took Me 
Back To The Labyrinth Of The Brachial Plexus . . . 
With All Its Turns And Twists . . . As Gil Said 
“Cervical One Across The Oak Street Connector 
From Behind C2 Getting On To The Ulnar 
Branch Going Distal To The Dorsum Of The 
Quinnipiac Bridge . . . Take The Left Fork 
In The Artery Under The Railroad Trestle 
Down Frontage Supine . . . This Is Sort Of Like 
An Elbow Joint. Past This Antecubital Fossa 
Follow The Flexor Muscles Along The Brachial 
Vein. . . This Route Is Won! Now Over The 
Branford Hill And Under The Carpal Tunnel . . . 
The Right Fork Is Meta To The Carpal And 
146 Degrees In Flexion To The Position Of 
Function. Get A Good Grip On The Steering 
Wheel And Keep Making Right Turns On 
Those Radial Tires Till You See An Arm . . . Or . . . Ry 
Of Pines In An Orchard. At The Intersection 
Of The Recurrent Branch Of The Radial Nerve 
And The Thenar Eminence Is Lake Place. This 
Arbitrary Tributary Runs Into The Sesamoid 
Known As Bony Island View Avenue. 
The Reunion Is At The Third Digit Of 
The Palm. That Is The Donovan." 
“Good Turtle-ing,” Said Gil Taking A Deep Breath 
Before Submerging. 
We Broke Ranks, Embarked, Drived, Derived, 
And Arrived. We Had Swum Under The 
Flood. 
This Was A Breeze, Compared To National Boards. 
From The Reign 
Of Aqua Haven 
On 
YALE ALUMNI DAY 
1962 — Twentieth 
By Michael Alderman 
The class of 1962, at graduation some 
75 strong, met in 20th reunion this past 
June. Consistent with the high spirit, 
the sense of camaraderie and the strong 
commitment to the Yale Medical 
School that has always characterized 
this group, attendance was high. 
Indeed, at the climactic weekend event 
— dinner at Mory’s on Saturday night 
— a record 21 class members were on 
hand. They came from literally all over 
the country, with Paul Ackerman 
from Southern California taking the 
distance traveled award. Bill Miller 
from Savannah, Georgia was not too 
far behind. Mickey Alderman, Ollie 
Dann, Dick Collins, Arnie Eisenfeld, 
Bruce Elfenbein, Joe Ferrone, John 
German, John Godley, John 
Hageman, Frank Hartman, Gary 
Jacobson, Dave Knoop, Carter 
Marshall, Malcolm Martin, Stan 
Matyszewski, Dave McConnell, Dick 
Pschirrer, Dave Seil, and Jim 
Spencer completed the group. The 
actual number of celebrants was 
swelled to 34 by the presence of 12 
spouses and one McConnell son. Word 
was also received from Walt Karney 
from the Walter Reed Medical Center 
in Bethesda where he is Chief of 
Nephrology. 
Following an extended cocktail 
hour, and satisfying dinner, some 
semi-serious time was devoted to 
recounting recent past and present 
activities, as well as conjectures upon 
the future and observations about 
medicine and life in general. Many 
seem to have followed a sometimes 
unexpected, but nevertheless interesting 
and exciting path so far. Perhaps not 
unexpectedly, the practitioners (a 
majority) view those in full time situa¬ 
tions with some envy — and vice 
versa. There was little apparent desire, 
however, on the part of either group to 
switch. Before venturing out onto New 
Haven streets, awash after torrential 
rains, all agreed it had been a memorable 
evening, thanks to arrangements by the 
Pschirrers, that should be repeated — if 
possible before the 25th and with even a 
larger turnout. 
Manuel Lipson, executive director of 
Massachusetts Rehabilitation Hospital 
in Boston and assistant clinical profes¬ 
sor of medicine at Harvard, has been 
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appointed an institutional member of 
the Interhospital Coordinating 
Committee on Rehabilitation at Harvard 
Medical School. The Committee, 
charged with formulating institutional 
arrangements for support of programs, 
development of resources, and plan¬ 
ning the governance of a Harvard 
Medical School system initiative in 
rehabilitation medicine, will also work 
to assemble the Division of Rehabilita¬ 
tion Medicine as an academic adminis¬ 
trative unit of the Faculty of Medicine. 
1967 — Fifteenth 
By Robert Kirkw ood 
Our fifteenth reunion began with a 
relaxed evening of cocktails and dinner 
at the country “estate” of Martin and 
Karen Wand in Avon, Connecticut. 
While little Wands ran around keeping 
us well served, Mary Williams Clark 
showed slides of the old Yale days, 
including our senior play, “Iatrogenic.” 
We could recognize most people as we 
relived Larry Henry playing the 
“hyper-tern”; Korobkin acting as the 
appropriately suave and tactful surgeon 
explaining cancer to Rigney, the 
emaciated patient; Hart, pipe in 
mouth, playing Dr. Freedman; and the 
Barber Shop quartet of Strohl, 
Crumley, Rosser and Kirkwood. We 
found most of us have not changed 
much in appearance through the 
fifteen-year turbulent passage and the 
decade of the seventies, although in 
many cases our lives surely have. 
The weekend of June 4th brought 
record rainfall to southern New 
England, and many of our classmates 
were unable to attend the celebration. 
The outdoor party at #1 South Street 
was cancelled. The dormitory looked 
much the same, although locks and TV 
surveillance cameras spoke of new 
times. The Medical Center was burst¬ 
ing with construction of tall and 
imposing laboratories, and the 
neogothic Catholic church had given 
way to the change. A large parking lot 
now covers the still unfinished 
connector. Yale is still vital and 
growing. 
Many of us did make it through the 
fender-deep water to Guilford and the 
Sachem House for dinner. We heard 
about each other’s lives, and talked and 
laughed about the Friday night parties 
we used to have with Manuel, followed 
by the next morning brain cuttings that 
cleared the sinuses. We remembered 
Liebow's honed lectures with slides 
deftly, and sometimes not so deftly, 
handled by the terrified pathology 
resident. We remembered the aura 
around the farewell talk of Paul 
Beeson, and felt proud to be from Yale. 
It felt good to be filled with the warmth 
of our renewed friendships. We missed 
those who could not be with us, and we 
paused in silence to remember our 
deceased colleagues, Barry 
MacAnally, Mike Lindsley, Alan 
Circle and Larry Henry. 
Our classmates who attended were 
Mary Williams Clark, Jim 
Dowaliby, John Drews, Dick Hart, 
Peter Herbert, Bob Kirkwood, Mel 
Korobkin, Tony Lovell, Laura 
Manuelidis, John Pastore, Brian 
Rigney, Joe Sabbatino, Helen Smits, 
Martin Wand, Bob Young, and Pete 
Zeman. 
Space in this journal is limited, and I 
will send a more lengthy newsletter 
soon that shares news that I received 
this year. 
1972— Tenth 
By Harry Malech 
The Yale University School of Medi¬ 
cine class of 1972 celebrated its 10- 
year reunion with a dinner at The Chart 
House restaurant on Saturday, June 5, 
1982. The Chart House is on the water¬ 
front and the deluge of rain on the 
windows and over the water added to 
the effect of being on a boat in the 
harbor. Though it wasn't apparent until 
the next day, this rainstorm resulted in 
some of the worst flooding in Connect¬ 
icut in several decades. I assume that all 
the dinner attendees got home ok. 
The group was large enough that we 
were able to discuss the current activi¬ 
ties of all members of our class except 
for a very few individuals. Several 
people brought their children, and most 
came with spouses which I think added 
greatly to the feeling that this was a 
comfortable gathering of old friends. 
Members of our class who attended 
were: Bruce Haak, John Foster, 
Peter Panzarino, Thomas Horn, 
John Fulkerson, Felix Freshwater, 
Robert DeBlasi, Jesse Jupiter, Philip 
Lebowitz, Philip Rothfeld, Michael 
Charney, Daniel Begel, Gary Strauss, 
Paul Lucky, and Harry Malech. 
1977 —Fifth 
No report received. 
IN MEMORIAM 
Walter C. Tilden 
May 7, 1982 
M.D. ’12 
William Y. Sayad 
March 16, 1982 
M.D. ’21 
Hyman W. Weinstein 
April 14, 1982 
M.D. ’23 
Edward M. Gould 
July 16, 1982 
M.D. ’24 
Jacques D. Soifer 
September 2, 1982 
M.D. '24 
William H. Hahn 
June 3, 1982 
M.D. ’26 
Edith N. Stainsby 
March, 1979 
M.D. ’26 
William H. Veale 
July 17, 1982 
ex med '26 
Mary B. Harris Michal 
February 28, 1979 
M.D. ’28 
Harry C. Oard 
March 12, 1982 
M.D. ’28 
Benjamin Castleman 
June 29, 1982 
M.D. ’31 
DeWitt Dominick 
May 20, 1982 
M.D. ’34 
Daniel M. Killoran 
May 30, 1980 
M.D. ’34 
Marguerite Booth 
March 28. 1979 
M.D. ’35 
Paul H. Twaddle 
February 14, 1982 
M.D. ’35 
Maurice A. de Hame, 
M.D. 
August 24, 1982 
ex med '35 
Hannibal Hamlin 
June 28, 1982 
M.D. ’36 
Chester H. Tidings 
October 12, 1981 
ex ph ’39 
Jackson H. Stuckey 
September 16, 1982 
M.D. '42 




B. Allen Richardson 
December 30, 1981 
M.D. ’43 
Lillian Welch M.P.H. ’66 
February 13, 1982 
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1981-1982 Medical School Alumni Fund Campaign 
Message from the Medical School 
Alumni Fund Chairman 
I am delighted to report that the 1981-82 Medical School 
Alumni Fund surpassed its previous record-breaking year by 
39%, with a grand total of $296,729! 
Leona Baumgartner '32 PhD., '34 M.D. provided the School 
and the Department of Epidemiology and Public Health with a 
$75,000 challenge award for new and increased gifts which 
enabled the Fund to raise additional money for student financial 
aid. This welcomed incentive from one of our own graduates 
could very well be the start of an important precedent. 
I want to thank all the alumni, former House Staff, parents 
and friends who responded so thoughtfully to our campaign; 
sincere thanks also to the volunteers who continue to provide the 
momentum that keeps our Fund growing at such a superb rate; 
and a very special acknowledgment to those volunteers who 
assisted the reunion Class Agents. This special effort contributed 
significantly to our excellent giving record during the past year. 
My first year as Chairman has been particularly interesting 
and very gratifying. I want to share with you several paragraphs 
written by one of our Class Agents that best describes my own 
feelings about Yale and fund raising: 
“The job of a fund raiser is at times rewarding; at other 
times almost fun, but most of the time extremely 
frustrating. 1 am impressed with the apathy toward the 
Medical School and its efforts to provide a quality of 
education to those who need funds. The Yale Medical 
School Alumni Fund really should be one of the top 
priorities on the list of my classmates. I learned many, 
many years ago when I graduated from high school, 
when in the commencement address, it was noted that 
‘With privilege goes responsibility.' I am afraid that 
there are too many of us, who forget this — like it or 
not. It is a privilege to be a physician; it is not a right. 
For all of the complaining and moaning that we physi¬ 
cians do at times, I think that the bottom line is that 
most of us are happy in our work, doing what we want 
to do, are respected in our profession and financially 
rewarded more than is adequate. 
I personally feel that giving financial help to the 
Medical School Alumni Fund is a small way of 
showing that we care, are grateful.’’ 
I appreciate your past support to look forward to another 
successful year. 
Lowell I. Goodman ’51 
Chairman 
A Message from the Dean 
This past year the Medical School Alumni Fund established a 
remarkable new record with contributions totalling $296,729. 
This surpasses the previous year — also a record breaker — by 
39%. Such manifestation of loyalty and support is extremely 
encouraging. 
As in previous years, your Medical School Alumni Fund 
contributions will be used to provide additional student loans. 
Money for student financial aid continues to be one of the 
School’s greatest needs. This need was recognized by Leona 
Baumgartner in establishing her $75,000 challenge grant to 
match new and increased gifts. We are especially grateful to her 
for providing this incentive. 
In addition to thanking those who have contributed to the 
Fund, I want to congratulate Lowell Goodman and all of those 
who worked with him to achieve these impressive results. Your 
continued support is greatly appreciated. 
Robert W. Berliner 
Message to Public Health Graduates 
The incentive of the Leona Baumgartner Challenge Fund; the 
honoring of retiring Chairman Robert W. McCollum by 
committing the proceeds of the 1981 -82 drive to a fund bearing 
his name and the efforts and generosity of many people, all 
combined to make this a banner year for Epidemiology and 
Public Health. A new record was established when 139% of the 
goal was achieved and a total of $48,799 raised to be used for 
student revolving loans. 
This level of giving reflects an awareness of and sensitivity to 
the tremendous financial demands on the student of today and 
presents the alumni/ae with the further challenge of maintaining it. 
Colin White 
Kathleen Howe 
Samuel B. Webb, Jr. 
Fund Officers 1981-82 
Medical School Alumni Fund 
Lowell I. Goodman '51, Chairman 
Malvin F. White '39, Vice Chairman 
William K. McClelland '47, Vice Chairman 
John L. Cieply '71, Vice Chairman 
J. Roswell Gallagher '30, Bequest & Endowment Co-Chairman 
Samuel D. Kushlan '35, Bequest & Endowment Co-Chairman 
Epidemiology and Public Health Alumni Fund 
Kathleen H. Howe '56, Co-Chairman 
Samuel B. Webb, Jr. '63, Co-Chairman 
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Medical School Alumni Fund Class Participation 
1980-81 1980-81 1981-82 1981-82 
Year Agent Total % Part. Total % Part. 
1908-21 $ 288 $ 7,758 
1922 Edward T. Wakeman 275 45% 285 56% 
1923 William Cohen 5,625 60% 760 71% 
1924 Myron A. Sallick 2,943 75% 2,195 63% 
1925 Alice A. S. Whittier 975 68% 945 73% 
1926 Maxwell Bogin 1,523 42% 521 58% 
1927 Henry Irwin Fineberg 1,161 42% 1,104 53% 
1928 Max Alpert 2,441 62% 2,297 68% 
1929 Paul F. McAlenney 2,022 84% 1,828 79% 
1930 J Edward Flynn 10,738 69% 5,343 58% 
1931 Michael D'Amico 2,075 54% 1,687 68% 
1932 Storer P Humphreys 1,024 55% 
Henry Brill *4,384 64% 
1933 Frederick Wies 4,198 55% 
Franklin M Foote 2,133 57% 
1934 DeWitt Dominick 2,211 64% 2,333 72% 
1935 James Q Haralambie 1.620 54% 2,977 52% 
1936 Hannibal Hamlin 3.319 43% 
George A. Hahn 2,671 44% 
1937 David Dolowitz 1,767 49% *1.622 50% 
1938 Nelson Ordway 1,986 60% 1,095 52% 
1939 Robert Ernst 1,855 38% 
Rebecca Z. Solomon 1.795 53% 
1940 James F. Ferguson 5,355 64% 2,555 64% 
1941 Charles B Cheney 1,785 61% 2,260 100% 
1942 Walter J. Burdette 11,679 53% *16,672 55% 
1943A Jonathan Lanman 2,030 54% 2,070 54% 
B S Brownlee Brinkley 1,242 43% 2,027 52% 
1944 Nicholas P R Spinel11 4,188 55% 4,615 65% 
1945 Richard W Breck 3,260 69% 3,359 64% 
1946 Julian A. Sachs *8,830 66% 6,542 49% 
1947 William Roy Breg 3,165 54% *6,142 68% 
1948 Paul Koehler 3,480 60% 3,905 62% 
1949 Daniel Elliott 2,945 48% 5.516 56% 
1950 David Frucht 1,661 32% 2,813 56% 
1951 Lowell I. Goodman *4,520 100% 5,275 52% 
1952 Harvey L. Young 3,102 38% *4.873 49% 
1953 Vincent Lynn Gott 3,445 49% 3,908 47% 
1954 John K Rose 2,616 45% 5,267 68% 
1955 Robert A Kramer 3,740 62% 4.443 52% 
1956 John H. Gardner III *14,930 63% 4,070 33% 
1957 William J Waskowitz 5,300 64% *9,291 79% 
1958 Charles A. Hall. Jr 3,890 43% 5,370 59% 
1959 Asa Barnes, Jr. 5,600 57% 6.665 62% 
1960 Thomas P. Kugelman 4,235 49% 3.495 40% 
1961 Jon D. Dorman *3.681 50% 2,580 35% 
1962 A. Richard Pschirrer 4,296 51% *11,849 65% 
1963 Craig H Llewellyn 3,085 37% 4,990 52% 
1964 William J Houghton 5,556 58% 4,390 60% 
1965 David A Hill 4.569 49% 4,425 49% 
1966 Mary Alice Houghton *3,642 54% 2,923 52% 
1967 James Dowaliby 3.960 59% *9,170 70% 
1968 Frank E Lucente 4,145 54% 2,760 46% 
1969 Lee Merrill Jampol 4,736 63% 6.888 67% 
1970 James R Missett 1.771 39% 2,001 36% 
1971 John L. Cieply *5.771 59% 4,046 47% 
1972 Paul A Lucky 1,619 46% *3,709 54% 
1973 David Bailey 1,189 34% 2,273 44% 
1974 Peter J Buchin 505 22% 710 26% 
1975 Daniel Passeri 605 20% 701 24% 
1976 Robert F. Taylor *987 21% 872 27% 
1977 David Kreis 555 22% *1,575 30% 
1978 Duke Cameron 521 14% 1,467 23% 
1979 Barbara Peters 165 6% 640 20% 
1980A Eduardo Alfonso 100 12% 225 15% 
B Mark Bernhardt 235 19% 317 18% 
1981 Anthony Urbano 365 15% 
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Medical Alumni $194,905 45% $224,432 48% 
Former House Staff 6,498 18% 6,863 21% 
Parents and Friends 5,439 9,858 
Miscellaneous 6,422 13,393 
Baumgartner Match — 42,183 
Medical School Alumni Fund Total $213,264 38% $296,729 42% 
^Reunion 
Public Health Alumni Fund Class Participation 
1980-81 1980-81 1981-82 1981-82 
Year(s) Agent Total % Part. Total % Part. 
1923-1941 Kathleen Howe $ 1,960 43% $ 4,258 56% 
1942 Eric W. Mood 320 43% 430 50% 
1943 Eric W Mood 310 21% 450 50% 
1944 Eric W, Mood 130 44% 345 44% 
1945-1949 Kathleen Howe 995 26% 4,035 40% 
1950 Elizabeth D. Robinton 290 42% 905 61% 
1951 Leonard F. Menczer 255 23% 455 35% 
1952 Yolande F. Lyon 515 42% 700 39% 
1953 Milton H. Sisselman 535 38% 615 40% 
1954 Ruth M. Taber 160 18% 110 24% 
1955 Frances R Ogasawara 230 36% 305 33% 
1956 Henry M. Parrish 735 32% 710 21% 
1957 Edward R. DeLouise 212 25% 602 43% 
1958 Thomas T Flynn 445 21% 300 14% 
1959 Dorothy M Wilson 415 31% 915 39% 
1960 Hannah Clark Russell 220 29% 400 33% 
1961 Gordon R. Beem 488 30% 665 59% 
1962 A. Kay Keiser 35 14% 105 31% 
1963 David Dolins 430 33% 550 43% 
1964 Estelle Siker 520 38% 1,310 54% 
1965 Michael E. Kove 305 30% 430 38% 
1966 Allen Cohen 245 23% 470 34% 
1967 James M. Malloy 770 33% 790 26% 
1968 Arnold R Saslow 560 28% 1,300 32% 
1969 Samuel P Korper 495 17% 940 26% 
1970 Susan W Balter 410 10% 1,125 31% 
1971 William P. Ferretti 1,622 34% 
John Bihldorff 1,360 49% 
1972 Daphne DeJ Gemmill 405 28% 715 36% 
1973 Judith G Beatrice 770 27% 600 19% 
1974(A) Rose Salisbury Beer 270 31% 
Elizabeth Helming 290 32% 
1974(B) Roberta Lawrence 455 35% 
Abigail L Smith 315 39% 
1975 Linda K. Broker 556 26% 1,321 41% 
1976 Elaine P. Anderson 380 25% 1,297 43% 
1977 Carroll Schilling Neisloss 575 24% 1,223 33% 
1978 Richard C. Poole 655 26% 1,073 33% 
1979 Ralph Tartaglione, Jr 575 26% 1.315 39% 
1980 Christina P. Quinn 543 27% 880 34% 
1981(A) Diane E. Goren 435 31% 
1981(B) Jill Goldwater 105 15% 
Alumni $18,790 28% $34,149 37% 
EPH Associates — 1,945 
Miscellaneous — 2,039 
Baumgartner Match — 10,667 
Public Health Alumni Fund Total $18,790 28% $48,800 37% 
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JOSEPH T EAGAN 
1922 
BENEDICT R HARRIS 
CHESTER HURWITZ 
HELEN PLANGNER 
REGINALD T LOMBARD 
MAURICE F O’CONNELL 




JOSEPH A JOHNSTON 
JACOB MELLION 
1924 
JOHN J BATCHELOR 
DAVID M RASKIND 
MYRONASALLICK 
JACQUES D SOIFER 
HAROLD T VOGEL 
1925 
DORENCE S COWLES 
EDWARD A CRAMTON 
WALDO F DESMOND 
HENRY W FERRIS 
MATTHEW GRISWOLD 
DAVIS H PARDOLL 
SAMUEL REBACK 
WELLES A STANDISH 
ALICEAS WHITTIER 
GONSALVO C WILLIAMS JR 
HOWARD A WOOD 
1926 






ALEXANDER E ROSENBERG 




HENRY IRWIN FINEBERG 
JOHN FREIHEIT* 
MEYER FRIEDENSON 
HERMAN H GOLDSTEIN 
ALBERTJABLONSKY 
NATHAN LEVY 
WILLIAM C MEREDITH 
MOSES ROTHBERG 
M DAWSON TYSON 




BERTHOLD R COMEAU 
SHELDON A JACOBSON 
EDWARD PJ KEARNEY 
RALPH E KNUTTI 
FERDINAND G KOJIS 
R HAROLD LOCKHART 
EDWARD LUDWIG* 
HARRY COARD 
NATHAN E ROSS 





JAMES RAE ARNEIEL JR 
FRANK H D’ANDREA 
CHARLES J EPSTEIN 




JOHN A HANGEN 
HAROLD J HARRIS 
GEORGE P JACKSON 
VERNON W LIPPARD 
PAUL F MC ALENNEY 
TONY LIEBMAN RAKIETEN 










FREDERICK FITZHERBERT BOYCE 
CHARLES BRECK* 
ROBERT D M CUNNINGHAM 
VINCENT A DOROSZKA 
KNOX H FINLEY 
J EDWARD FLYNN 
J ROSWELL GALLAGHER 
LEONARD GREENBURG 
JAMES C HART 
EDMUND L KITZMEYER 
PAUL H LAVIETES 
MOSES D LISC'HNER 
JAMES LYNCH* 
JOHN C MENDILLO 
PAUL WATSON 
AMY H WILSON 
CHARLES L WOOD 
1931 
DANA L BLANCHARD 
HENRY H BRIGGS JR 
BENJAMIN CASTLEMAN 
MICHAEL D'AMICO 
RICHARD L FRANK 
HELEN R GILMORE 




A PHILIP L.AFRANCE 
RHODA M MICKEY 
NELSON NEWMARK 
SHELDON PAYNE 
MORRIS L RAKIETEN 
ABRAHAM J SCHECHTF.R 
JAMES ASTRINGHAM 
1932 
LOUIS K ALPERT 
REGINALD V BERRY 
HENRY BRILL 
FRANK CARROLL 
CLEMENT C CLARKE 
HESTER B CURTIS 
JOSEPH P DONNELLY 
LEWIS F FOSTER 
CONRAD R LAM 
MARIO LPALMIERI 
ARTHUR J PRESENT 
ELIZABETH M RAMSEY 
BENJAMIN N TAGER 
RUDOLPH E VANDEVEER 
MYRON E WEGMAN 
CARL HENDRICKS WIES 
FRANK B WISNER 
EDMUND A ZYBULEWSKI 
1933 
MYRON ADAMS* 
LEE E FARR 
FRANKLIN M FOOTE 
JACK GREENBERG 
DANIEL F HARVEY 
GEORGE K HIRST 
ROBERT W HUNTINGTON JR 
JOHN G MARTIN 
JOSEPH MIGNONE 
RAYMOND E MILLER 
ASHLEY POND III 
LESTER Q STEWART 
SIDNEY STRINGER* 
FREDERICK A WIES 
FRANCIS M WOODS 
1934 
FREDERICK BECK 
JAMES F BLADES 
JOSEPH BUDNITZ 
DEWITT DOMINICK* 
DERICK A JANUARY 
KNOWLES B LAWRENCE 
THEODORE P MERRICK 
HERBERTC MILLER 
EDWARD T O'DONNELL 
JOHN B OGILVIE 
LUCIEN M PASCUCCI 
HARRY SHERMAN 
WILLIAM R WILLARD 
GEORGE ZALKAN* 
1935 
GEORGE A CARDEN JR 
SAWNIER GASTON 
H HOFFMAN GROSKLOSS 
JAMES QUINTIN HARALAMBIE 
W HOWARD HORNER 
SAMUEL DKUSHLAN 




JACK C SLEATH 
WALTER A L THOMPSON 
SAMUEL ZELMAN 
1936 
GEORGE HENDERSON BROWN 
LESTER WBURKET 
ALBERT W DIDDLE 
FRANKLIN F FERGUSON 
MARGARET C LGIEDEA 
GEORGE D GROSS 
GEORGE A HAHN 
LOUISE G HUTCHINS 
E ROBBINS KIMBALL 
PHILIP M LECOMPTE 
FREDERICK A POST 
MARGARET SOMMERS 
ROBERT H STEVENS 
MORRIS TAGER 
EDGAR W WARREN 
1937 
EDMUND R BLOWER 
DAVID A DOLOWITZ 
D CROSBY GREENE 
WILBUR D JOHNSTON 
ALFRED E KING 
DUNHAM KIRKHAM 
JAMES PMORRIEE 
CHARLES W NEUHARDT 
WINSTON J ROWE 
MORGAN SARGENT 
EDWARD J SHAW 
ALBERT D SPICER 
JOHN M THOMAS 
JEAN WELLS 
LUCILLE R WIEPERT 
LORANDE M WOODRUFF 
1938 
ROY N BARNETT 
HENRY LCARIDEO 
ROBERTA CRUTCHER 
JOHN A DILLON 
S CHARLES KASDON 
BENJAMIN E LYONS 
EDWARD NICHOLS 
NELSON K ORDWAY 
EDWARD W PINKHAM JR 
JAMES RADCLIFFE JR 
GEORGE E ROBERGE 
LESTER J WALLMAN 
J RICHARD ZAHN 
1939 
NORMAN LC'RESSY 
WILLIAM H DRUCKEMILLER 
JOHN P FERGUSON JR 
S JEROME GREENFIELD 
NATHANIEL KENIGSBERG 
MARGARET A LENNOX 
WARD J MC FARLAND 




REBECCA Z SOLOMON 
STUART S STEVENSON 
JOHN D TOBIN 
ARTHUR S TUCKER 
DARRELL G VOORHEES 
DOUGLASS W WALKER 
JOHN H WENTWORTH 
MALVINF WHITE 
1940 
THEODORE E ALLEN 
IOSEPH V BALDWIN 
RONALD S BECKETT 
JACKS BLAISDELL 
PHILIPS BREZINA 
CRAWFORD J CAMPBELL 
DAVID CROCKER 
THADDEUS S DANOWSKI 
WYNANT DEAN 
ROBERTM DUNLAP 
JAMES F FERGUSON JR 
EUGENE J FITZPATRICK JR 
JOHN C HALEY 
H STUART IRONS JR 
DONALD G JOHNSON 
PAUL D MAC LEAN 
EDWARD MARTIN 
WILLIAM R OAKES 
LEE S SANNELLA 
W NORMAN SEARS 
JOSEPH ESOKAL 
J CHAMPNEYSTAYLOR 
PATRICIA E WANNING 
JOHN B WELLS 
HELEN H WOODS 
1941 
LOUIS CACQUA 
ROBERT H ALWAY 
ROBERT H ARESON 
PAUL H BARBOUR JR 
WRANDAL BELL 
KNUTE E BERGER 
28 
* Deceased * Deceased 
MARVIN BLUM 
HUGH H BUTLER 
WILLIAM A CAREY 
JOSEPH P CARSON JR 
CHARLES W CASHMAN JR 
CHARLES BCHENEY 
HERBERT W DIEFENDORF 
ROBERT F DINE 
PETER A DUNCAN 
JOHN E FENTON 
LLOYD D FLINT 
JOHN FRANKLIN 
ROBERT L GILBERT 
FREDERICK PGLIKE 
STANLEY T GRZEBIEN 
THOMAS S HARVEY 
EDWARD R HARVEY JR 
WILLIAM EDMUND KENNEY 
SIDNEY L LASELL 
WILLIAM LEE 
BJORN LIH 
F EUGENE MARTIN 
JOHN R MC DERMOTT 
WILLYS M MONROE 
G HENRY MUNDT 
MALCOLM CMURFITT 
JEAN E NEIGHBOR 
EDWARD B O'CONNELL 
ROBERT WOLLAYOS 
GIOACCHINOS PARRELLA 
DAVID V PECORA 
EDWIN D ROGERS 
LESLIE SIMMONDS 
JANET H VAN ORDEN 
IRVING WALTMAN 
1942 
WILLIAM E BLOOMER 
JAMES M BUNCE 
WALTER J BURDETTE 
ROBERT E CARROLL 





ALLAN V N GOODYER 
CHARLES R HARMS 
WILLIAM HARRISON JR 
LEO KELLERMAN 
JOHN R LINCOLN 
PATRICKS MULLINS 
CHARLES F SCHOLHAMER 
RICHMOND W SMITH JR 
JACKSON H STUCKEY 
EDGAR B TAFT 
MAURICE TULIN 
FRANCIS P VOSE 
IRVING NORMAN WOLFSON 
1943 
RICHARD N ABBOTT 
JOHN R ALMKLOV 
JAMES L BRADLEY 
ROBERT F BRADLEY JR 
S BROWNLEE BRINKLEY 
HENRY B BRUYN JR 
THOMAS L BUCKY 
JANEBCADBURY 
PHILIP B CHASE 
HUNTER H COMLY 
RONALD W COOKE 
LYCURGUS M DAVEY 
JEAN P DAVIS 
JOSEPH I EPSTEIN 
R M FASANELLA 
C THOMAS FLYNN JR 
GERARD FOUNTAIN 
ROBERT H FURMAN 
HENRY H JONES 
R LEONARD KEMLER 
JONATHAN T LANMAN 
HENRY E MARKLEY 
SAWYER EMEDBURY 
HOYT B MILES JR 
RUSSELL A MOR1SSETTE 
WALTER J J NERO 
DOROTHEA R PECK 
EDWARD FRABE 
IRA A RASHKOFF 
EARLJ RHOADES 
HENRY A RIEDEL 
BERNARD R ROWEN 
MARCUS ESANFORD 
DONALD WSELDIN 
EDWARD FIERSEY SOULE 
FRANCIS A SPELLMAN 
SOPHIE TRENT STEVENS 
OLIVER G STONINGTON 
ROBERT LEE TAYLOR 
FREDERICK A WALDRON 
C WESLEY WATSON 
JOHN J WEBER 
ROBERT H WYATT 
1944 
CARLE ANDREWS 
EDWARD J CONWAY 
JOHN C COOLIDGE 
FRANK W COUNTRYMAN 
LAWRENCE S CRISPELL 
CHARLES H CROTHERS 
LAWRENCE G CROWLEY 
DONAL L DUNPHY 
ROBERT W FRELICK 
CAROL GOLDENTHAL 
CHARLES A HALL 
HOWARD B HAMILTON 
ROBERT 1 HINKLEY 
W RAYMOND JAMES 
WARDS JENKINS 
EDITH M JURKA 
FREDERICK F KRAUSKOPF 
ELLEN P MAC KENZIE 
KATHARINE HAWLEY MARTIN 
JOSEPH MASSARO 
A REESE MATTESON 
LAWRENCE K PICKETT 
LAURENCE G ROTH 
HAYNES W SHEPPARD 
SARAH PSHERWOOD 
NICHOLAS PR SPINELLI 
PRISCILLA DIENES TAFT 
ANTHONY VARJABEDIAN 
CALVIN W WOODRUFF 
REUBEN ZUCKER 
1945 
GEORGE HOWARD ALLISON 
A JOHN ANLYAN 
ALBERT S ATWOOD 
FREDERIC M BLODGETT 
RICHARD W BRECK 
CARLETON J BROWN 
LOUISE H BURR 
ALICE SHEPARD CARY 
JAY B COHN 
THOMAS P COTTER 
EDWARD M DANIELS 
RICHARD R DYER 
ROBERTS EASTON 
SIDNEYS FEUERSTEIN 
ALICE DERSHIMER FRIEDMAN 
RAYMOND A GAGLIARDI 
PHILIPS GOOD 
GOVE HAMBIDGE JR 
HERBERTS HARNED JR 
PAUL W HOFFERT 
O ROGER HOLLAN 
HANS R HUESSY 
LELANDW JONES 
RAYMOND E LESSER 
MARK MC D LINDSEY 
CHARLES E MC LEAN 
LAWRENCE J MORIN 
GEORGE W NAUMBURG JR 
FITZHUGH C PANNILL 
RAYMOND E PARKS 
RICHARD M PETERS 
CHARLES E SHERWOOD 
KENNETH C STEELE 
LEROY S WOLFE 
1946 
AARON T BECK 
FRANKLIN C BEHRLE 
SANFURD G BLUESTEIN 
LINUS W CAVE 
THOMAS J COLEMAN 
THOMAS A DOE 
H LAMBERT FILER JR 
GREGORY E FLYNN 
MARTIN E GORDON 
CHARLESS JUDD JR 
HAROLD KING 
BENJAMIN F KITCHEN JR 
VINCENT J LONGO 
RICHARD H MANN 
THOMAS J MATHIEU 
HUGH J MC LANE 
JOHN H MORTON 
FRANCIS REILLY* 
DAVID H RIEGE 
JULIAN A SACHS 
DONALD PSHEDD 
RICHARD G SISSON 
COLBY S STEARNS 
ROBERT R WAGNER 
WILLIAM P WALSH 
WILLIAM J WEDEMEYER JR 
ELIHU SWING JR 
1947 
GEORGE R BARNES JR 
HENRY N BLANSFIELD 
ALBERT W BOSTROM JR 
JOHN E BOWERS 
WILLIAM ROY BREG JR 
RICHARD G BRITTON 
JOHN L. CANNON 
M RICHARD CARLIN 
BETTY PRICE CARLIN 
CHARLES R CAVANAGHJR 
ROBERT A CHASE 
AMOZICHERNOFF 
WILLIAM F COLLINS JR 
ROBERT PDARROW 
ARCHIE L DEAN JR 
JEAN H DOUGHERTY 
OWEN W DOYLE 
FRANKLIN HAROLD EPSTEIN 
RICHARD K FRIEDLANDER 
FRANK L GOLBRANSON 
FRANK H HORTON 
ROBERT J KERIN 
DON F KIMMERLING 
RICHARD P LEVY 
BROCK LYNCH 
VICTOR A MACHCINSKI 
CHARLES L MACHE JR 
WILLIAM K MC CLELLAND 
ROBERT F NEWTON 
MYRON KNOBIL 
LAWRENCE C PERRY 
PHILIP H PHILBIN 
EDGAR B PHILLIPS 2D 




PATRICIA B TUDBURY 
ELLIS J VAN SLYCK 
M HENRY WILLIAMS JR 
1948 
RUSSELL J BARRNETT 
EDITH M BECK 
ALLYNG BRIDGE 
LEE BUCKINGHAM BROWN 
ARTHUR L COLEMAN JR 
RUTH ECORTELL 
G ROBERT DOWNIE 
MARIE C DUNCAN 
BOY FRAME 
EMIL FREI 3D 
JULIAN FRIEDEN 
ALLAN GREEN 
B HEROLD GRIFFITH 
SYLVIA PRESTON GRIFFITHS 
BEATRIX A HAMBURG 
RICHARD M HANNAH 
W RAYNERJOHNSON 
PAUL B KOEHLER 
ROBERT ELEMPKE 
JOHN P MORRIS 
JOHN B MORRISON 
DAVID E MORTON 
GERALD RNOWLIS 
JESSIE E PARKINSON 
GEORGE P ROSTEL 
LEWIS P ROWLAND 
BENJAMIN F RUSH JR 
GABRIEL SAVIANO* 
JEROME H SHAPIRO 
ANNE GST GOAR 
WALLACEWTURNER 
PAUL WOODBURY WELD 
1949 




THOMAS L CHIFFELE 
MARY PUCCI COUCHMAN 
PHILLIP GCOUCHMAN 
PETER R CUNNINGHAM 
N JOELEHRENKRANZ 
DANIEL W ELLIOTT 
GUNNAROENG 
ALBERT A FISK 
PAULS GOLDSTEIN 
FREDERICK W GRAY 
JACKSON HARRIS 
ROBERT C HOWARD 
GORDON D JENSEN 
BENJAMIN A JOHNSON 
FRANK D LAW 
ORVAL I MC KAY 
TIMOTHY F NOLAN JR 
RICHARD D OTIS 
JULIAN I PICHEL 
EDMUND L PIPER 
CHARLES L RENNELL JR 
DANIEL RUDMAN 
CARL M RUSSELL 
WILLIAM II SEWELL 
RAYMOND D SUDARSKY 
1950 
RUSSELL N ANDERSON 
LYALD ASAY 
JOHN E BOROWY 
KENT ELLIS 
THOMAS J FERRARO JR 
DAVID A FRUCHT 
CARL A GAGLIARDI 
29 
ARCHIE J GOLDEN 
CHESTERFIELD G GUNN JR 
WALLACE M KEMP JR 
MARILYN M KRITCHMAN 
SIDNEY S LEE 
JANUS C LINDNER 
MARGARETS LYMAN 
HAROLD MARCH 
JOHN H MEYERS 
ORLANDO J MILLER 




KAREL BEDRICH ABSOLON 
GOFFREDO ACCETTA 
W ROBERT ADAMS 
FRANK R ALLEN 
THOMAS T AMATRUDA JR 
ELEANOR CLAY 
JOHN J EGAN 
DANIEL X FREEDMAN 
LAWRENCE R FREEDMAN 
SIDNEY S FURST 
LOWELL I GOODMAN 
JOHN T GROEL 
ROBERT N HAMBURGER 
WILLIAM KIEKHOFER 
ROBERT D KING 
JOCELYN S MALKIN 
FRANCIS L MERRITT 
PAULDMILLIKIN 
WALTER S MORGAN 
ALBERT R MOWLEM 
RICHARD S MUNFORD 
CHARLES A NUGENT JR 
JOSE FELIX PATINO 
ARTHUR A PAVA 
MAJIC S POTSAID 






FRANK R COUGHLIN JR 
PHILIP GARDNER DEANE 
RAYMOND S DUFF 
JAMES R DURHAM 
RICHARD D FLOYD 
ROBERT PGERETY 
WILLIAM JOSEPH JOHNSON 
THOMAS S KELLY 
WILLIAM W KLATCHKO 
WILLIAM R LETSCH 
JAMES KENT LUCE 
N KARLE MOTTET 
SIDNEY NATHAN PALY 
ROBERT G PETERSDORF 
LEON A PHILLIPS 
JOHN MACKLIN ROBERTS 
LEONARD RUSH 
MARY WHEATLAND SCHLEY 
DONALD H SCHULTZ 
ROBERT B SCHULTZ 
VIRGINIA LEE SWANSON 
JOHN H WAGNER JR 
JOHN L. WOLFF 




HAROLD D BORNSTE1N JR 
WILLIAM R CHAFFEE 
ALLEN CHETRICK 
REX BCONN 
LOUIS R M DEL GUERCIO 
JAMES P DUNN 
DONNELL DENCIL ETZWILER 
A DANIEL HAUSER 
GEORGE L HOFFMANN 
DAVID PURDY HOLMAN 
ALVIN JOSEPH KEROACK 
RICHARD ROBERT KNOWLES 3D 
H1LDEGARD MUELLER LESLIE 
JOHN DUTCH LORD 
ROBERT N MELNICK 
WARWICK POTTER JR 
PAUL G QUIE 
JOSERAMIREZ-RIVERA 
BARBARA F ROSENBERG 
IRWIN K ROSENBERG 
VIRGINIA CSAFT 
RICHARD ANDREW SINNOTT JR 
LYNN CORTLAND STOKER 
MATTHEW ANDREW TANDYSH 
WILLIAM JUNIOR VANDERVORT 
WILLIAM AUGUST WILSON JR 
JAMES FREDERIC YOUNG 
1954 
W DEAN ASHWORTH 
FRANK P BERG 
RICHARD J BOUCHARD 
GEORGE N BOWERS JR 
RALPH K CAMPBELL 
JOHN R COLE 
ALAN H COVEY 
ARTHUR C CROVATTO 
DONALD D DAVIS 
WALTER J FREEMAN 
JOHN AGARIEPY 
EDWARD J GERETY 
FRANK LGRUSKAY 
NICHOLAS A HALASZ 
ROBERT P HATCH 
WALKER R HEAP JR 
LELAND E HILBURG 
HERBERTS HURWITZ 
ROBERT F HUSTEAD 
ROBERTJTJOY 
RICHARD LAMB 
EVA HENRIKSEN MAC LEAN 
PAUL N NEUFELD 
LOWELL E OLSON 
WILLIAM J PAULE 
ANTHONY V PICCIRILLO 
RICHARD D PULLEN 
JACQUES M QUEN 
EDWIN R RANZENHOFER 
JOHN KEITH ROSE 
ELIHU M SCHIMMEL 
LEONARD M SILVERMAN 
ROBERT L STEIN 
JOHN W VOSSKUHLER 
1955 
JOHN B ATWATER 
JOHN C BAILAR 111 
GEORGE E BECKER JR 
E EDWARD BITTAR 
DOUGLAS G BOYDEN 
IRWIN M BRAVERMAN 
EDWARD NOEL BRENNAN 
PADRAIC BURNS 
NICHOLAS A COASSIN 
EDWARD COPPOLA* 
PASQUALE JAMES COSTA 
JOHN G DALEY 
FRED WENDELL DOYLE 
WILLIAM O EDWARD 
LEROY ENGEL. 
F ROBERT FEKETYJR 
MAHLON V R FREEMAN 
BARBARA W GIBSON 
RUDOLPHJGOERKE3D 
PAULGONICK 
DICRAN GOULIAN JR 
ION GRESSER 
JOHN H HODGE 
D FRANKLIN JOHNSON JR 
HARRY O KENDALL 
DAVID R KESSLER 
ROBERT A KRAMER 
WILLIAM E LATTANZI 
GILBERT MPLEIB 
JOSEPH S MCGUIRE JR 
ROBERT C NODINE 
SHERWIN B NULAND 
GLORIA CONQUE 
JOHN C PACE JR 
ROBERT H PETERS JR 
GREGORY PETERSON JR 
ROBERTA REICH 
PHILLIP W SMITH 
ALAN A STONE 
ALEXANDER ZUCKERBRAUN 
1956 
ALVIN D BENJAMIN 
LEVON Z BOYAJIAN 
THOMAS M BROWN 
ROSALIE A BURNS 
JOSEPH CCERNY 
JAMES CCOLLIAS 
DONALD J DALESSIO 
CHANDLER DAWSON 
GILBERT M EISNER 
GEORGE E GREEN 
ALAN RGURWITT 
JOHN HERD HART 
WILLIAM H HINDLE 
WILLIAM V LEWIT 
LEO LUTWAK 
PRESTON C MANNING 




BENJAMIN A SHAVER JR 
DANIEL RSILBERT 
DONALD R SPERLING 
1957 
DONALD AGOSTINELLI 
JOSEPH S AMENTA 
LOUIS V AVIOLI 
F CALVIN BIGLER 
JACK NORMAN BLECHNER 
RICHARD I BREUER 
HARRY C BRIGGS 
CARL A BRINKMAN 
JOHN P CAREY 
ALBERT K CHUN HOON 
LOUIS Z COOPER 
HAROLD DICK CROSS 
JOHN D'AGOSTINO JR 
THOMAS H DANAHER 
F JOSEPH DANNEMILLER 
D JOSEPH DEMIS 
JAMES R DORR 
EDWARD LOUIS EYERMAN JR 
SALVATORE FALBO 
HAROLDJFALLON JR 
ROBERT E FISHBEIN 
RONALD H FISHBEIN 
JAMES R FITZGERALD 
ANTHONY L FONS 3D 
ELIZABETH H FORSYTH 
EDWARD O FOX 
ROBERT H GLASS 
ANNE H GOOD 
JACK PETER GREEN 
GILBERT F HOGAN 
WARREN R JOHNSON 
RICHARD LEE KAHLER 
ROBERT LINCOLN KAISER 
STANLEY E KILTY 
WILLIAM LKISSICK 
WILLARD A KREHL 
EDGAR H LEVIN 
JACK LEVIN 
MARK D MARSHALL 
DAVID E MARTIN III 
HOWARD A MINNERS 
ROBERT K MODLIN 
HUGH LAMSON MOFFET 
GEORGE ALBERT NELSON JR 
HERBERT A NEWMAN 
THOMAS FRANCIS O'BRIEN JR 
JOSEPH S PAGANO 
RAYMOND E PHILLIPS 
CLIFFORD B REIFLER 
LATHROP E ROBERTS 
MELVILLE P ROBERTS JR 
JESSE G RUBIN 
ARNOLD A SCHOOLMAN 
STANLEY SIMBONIS 
KENNETH A SIMON 
CHARLES A SLANETZ JR 
GILBERT B SOLITARE 




WILLIAM J WASKOWITZ 
JAMES G ZIMMER 
1958 
GEORGE K AGHAJANIAN 
JOSEPH E ANGELO 
JOHN P ARNOT 
GERARD N BURROW 
BENJAMIN BURSTEN 
DAVID A CARLSON 
JOHN A CARLSTON 
ROBERT V DISERENS 
LAWRENCE DUBIN 
DONALD A DUNCAN 
JOELCEBERLIN 
MICHAEL E FISHMAN 
RAYMOND A GAITO 
JOHN C GALLAGHER 
MARCIA KRAFT GOIN 
WILLIAM M GOULD 
JAMES GREENWALD 
STANLEY HARRIS 
ERNEST L HARTMANN 
MICHAEL KASHGARIAN 
HASKINS K KASHIMA 
JAY WARD KISLAK 
THEODORE W LIEBERMAN 
MYRON LOTZ 
THOMAS JMAURO JR 
MICHAEL JMC CABE 
ANDREW JOSEPH MC GOWAN JR 
RICHARD CHARLES MILLER 
ROBERT S NEUWIRTH 
CAROL F PHILLIPS 
DAVID M PUGH 
WILLIAM B RADCLIFFE 
PAUL A RUDNICK 
WILLIAM W SCHLAEPFER 
THOMAS R SHEA 
BRUCE H SKLAREW 
EDWARD LLOYD SOCOLOW 
RAYMOND W TURNER 
MARGARET SMITH WENZEL 
1959 
SCOTT INGRAM ALLEN 
CAROL J AM1CK 
ROBERT MAMICK 
ASA BARNES JR 
30 
Deceased 
FRANCIS A BEER 
JACK F BOWERS 
WILLIAM C BUTTERFIELD 
EDWARD CALL JR 
SIDNEY M COHEN 
MARTIN COLODZIN 
LYALLSCRARY JR 
RONALD C DE CONTI 
WILLIAM L DONEGAN 
GERALD FENICHEL 
ROBERT L FISHER 
ROBERT JGONYEA 
GERALD B GORDON 
W KEITH HADLEY 
WILLIAM H HEYDORN 
C RICHARD HINCKLEY 
LEONARD INKER 
JOHN J JASAITIS 
EDVARDAS KAMINSKAS 
DAVID W KINGSBURY 
MYRON SS LEE 
KATHRYN HUXTABLE LEWIS 
JAMES A O’NEILL JR 
ROBERT H OSTBERG 
NICHOLAS M PASSARELLI 
CHARLES A PHILLIPS 
LINCOLN T POTTER 
JAMES D PROKOP 
JAMES R RALPH 
DAVID PARDEE REED 
JOSEPH DOUGLASS ROBINSON JR 
JOSEPH D SACCIO 
CONSTANTINE J SAKLES 
MARC D SCHWARTZ 
OWEN A SHTEIR 
DAVID B SKINNER 
SANFORD P SOLOMON 
JAMES J STAGNONE 
LISA A STEINER 
JOHN S STRAUSS 
LEO H VON EULER 
ROBERT B WHITNEY JR 
MURIEL D WOLF 
1960 
VICTOR ALTSHUL 
ALAN W AMES 
STUART PBOWNE 
DONALD P BUEBENDORF 
STANLEY M K CHUNG 
NEIL R COOPER 
CALDWELL B ESSELSTYN JR 
PAUL JAY FRIEDMAN 
EUGENE C GAENSLEN JR 
JAMES I GILMAN 
ROLAND H INGRAM JR 
WILLIAMS KADEN 
ERIC P KINDWALL 
SUSAN TKLEEMAN 
THOMAS P KUGELMAN 
EDWARD R LANG 
THOMAS L LINCOLN 
EUGENE G MC CARTHY JR 
DONALD L MILLER 
RICHARD G MORRILL 
ALLAN W NEWCOMB 
FRED PALACE 
NANCY ROLICK POWELL 
ALBERT MATTHEW ROSS 
JOHN J SCHROGIE 
FRED STARGARDTER 
ROBERT CWALLACH 
MAY YUNG-FUN WOO WANG 
RONALD A YANKEE 
1961 
KENNETH A ARNDT 
EARL L BAKER 
ALBERT A BECHTOLDT JR 
PAUL DAVID DEITER 
RALPH J DEPONTE 




EDWARD C GILBERT 
LOUIS D HUNT 
RICHARD L KEEFE 
ROBERT ISAAC LEVY 
JOSEPH RICHARD LUSBY 
JOHN A MCCORMACK 
RICHARD ALLEN MOORE 
NORMAN I MOSS 
ROLAND DPAEGLE 
ROY E RONKE JR 
STANLEY G SCHADE 
HUGH C THOMPSON III 
FRANKLIN H TOP JR 
WARREN DWIDMANN 
JOHN R WOODWARD 
1962 
DAVID L ADAMS 
MICHAEL H ALDERMAN 
CHARLES B ANDERSON 
FREDERIC P ANDERSON 
ANN BRACE BARNES 
SPENCER J BRODY 
DEAN E BURGETJR 
FREDERIC K CANTOR 
RAY ALLEN CARLSEN 
RICHARD N COLLINS 
OLIVER TOWNSEND DANN 
ARNOLD JOEL EISENFELD 
I BRUCE ELFENBEIN 
JOSEPH DFERRONE JR 
JOHN W FOREMAN 
LEROY A FORSTROM 
STEPHEN JOHN FRICKER 
ROGER P FRIEDENTHAL 
JOHN A GODLEY 
DAVID HGROTH 
RODERICK CHAFF 
JOHN T HARRINGTON 
FRANK R HARTMAN 
PATRICIA CHASSAKIS 
J DALE HOWE 
VICTOR W HURST III 
GARY JACOBSON 
GLENN L KELLY 
DAVID E KNOOP 
JOHN P LYNCH 
CARTER L MARSHALL 
ALLAN L MATTERN 
STANLEY E MATYSZEWSKI 
DAVID J MCCONNELL 
WILLIAM G MEFFERT 
GEORGE STUART MILLER 
WILLIAM A MILLER 
DAVID D NICHOLAS 
A RICHARD PSCHIRRER 
JOSEPH ROSS 
DAVID SEIL 
JAMES A E SPENCER 
NANCY ANN STALEY 
LARRY LEE STEWART 
H OLIVER STOUTLAND 
SETH THALER 
SHERWOOD WALDRON JR 
WILLIAM FARNSWORTH WEBER 
STEWART R WRIGHT 
1963 
ARTHUR HOWARD ACKERMAN 
BARBARA ROSENTHAL ALMOND 
RICHARD J ALMOND 
MIGUEL R ALONSO 
V RICHARD BACK 
CHARLESWCARL JR 
THEODOREJCHU 
GORDON S COHEN 
JOHN E CONTE JR 
DAVID F CROSS 
ANDREW EDIN 
JOHN PELIOPOULOS 
B ALLEN FLAXMAN 
WILLIAM T FRIEDEWALD 
DAVID H FULMER 
ALEXANDER R GAUDIO 
F JOHN GENNARI 
VINCENT F GEREMIA JR 
LEE D GOLDBERG 
PETER B GREGORY 
GEORGE H HOLSTEN III 
HAROLD P KAPLAN 
EDWARD C LARKIN 
WILLIAM B LEHMANN 
CRAIG H LLEWELLYN MC 
EDWARD G LUND JR 
ROBERT H MARGULIS 
HERBERT MELTZER 
ROBERT E MUELLER 
JAY M POMERANTZ 
GENER PROFANT 
JOSEPH BUDD STEVENS 
PETER V TISHLER 
LAWRENCE TREMONTI 
HELEN N WALSH 
PETER G WEINER 
ALFRED J WISE 
1964 
MILLARD JAMDUR 
BERTON W ASHMAN 
LELAND S BERGER 
PHILIP BLUME 
ANTHONY J BRAVO 
ROBERT M BRIGGS 
THOMAS A CARDELLA 
JOSEPH FJCURI 
MARY V DIGANGI 
ANTHONY FERRANTE 
NORMAN C FOST 
PETER A GROSS 
JOHN FB HANEY 
GENE I HIGASHI 
LAWRENCE HORWITZ 
WILLIAM J HOUGHTON 
WILLIAM E KNIGHT 
LEWIS LANDSBERG 
THOMAS L LENTZ 
JAMES S LEVINE 
PAUL R LIGHTFOOT JR 
RICHARD MURRAY LINBURG 
ROBERT W LYONS 
WILLIAM F MATCHETT 
THOMAS OMC CANN 
ROBERTL MITCHELL 
ALAN H MORRIS 
JAMES J MURPHY 
DONALD AO’KIEFFEJR 
HOWARD C POMEROY 
WILLIAM B PRATT 
STANLEY J ROSENBERG 
NORMAN SCHER 
ROBERT L SHELTON 
TADASHI SHIMADA 
A THOMAS SNOKE 
LYALL C STILP II 
SIGRID L TISHLER 
STEPHEN WALTMAN 
1965 
SUSAN A AOKI 
THOMAS TAOKI 
JOHN H M AUSTIN 
PAUL BALTER 
VICTOR J BURNER 
THOMAS B CALDWELL III 
DAVID G CAMPBELL 
MICHAEL J CUMMINGS 
DAVID S FEDSON 
ROBERT I FINKEL 
RICHARD I FRANKEL 
FRANKJGRADY 
GARY LAWRENCE GROSS 
ROBERT ANDRE GRYBOSKI 
JAMES KGUDE 
REID R HEFFNER JR 
DAVID A HILL 
EDGAR W HULL 
RONALD J KARPICK 
ROBERT H KOEHL 
RICHARD J KOZERA 
DAVID J KUPFER 
SANDRA CHOOK LEVINE 
MARK W LISCHNER 
ROBERT R MC MEEKIN JR 
WALTER W NOLL 
A LAWRENCE OSSIAS 
JOHN A PARRISH 
ROBERT L PICKENS 
ALAN N RACHLEFF 
WILLIAM A RENERT 
GENE A ROBINSON 
JOHN H SEASHORE 
MARGRETTA ANN REED SEASHORE 
CHARLES J SEMONSKY 
DAVID M SHAMES 
DAVID P SIMMONS 
HARLAN SPITZ 
E JAMES STANLEY 
BERT YUAN-SHU WONG 
1966 
BENJAMIN FBALME 
JOHN D BAXTER 
FRANK C BELL 
JAMES EDWARD BROWN 
EUGENE PATRICK CASSIDY 
DONALDJCOHEN 
THOBURN AARON DADISMAN JR 
JOSEPH A DONADIO 
ROBERT E DRAGON 
MARVIN A EISENGART 
JARED M EMERY 
ROBERT N FRANK 
PETER D GIBBONS 
JEFFREY B GLUCKMAN 
STANLEY I GREENSPAN 
J MCLEOD GRIFFISS 
ROBERT A GUNN 
JAYG HAYDEN 
MARY ALICE HOUGHTON 
RICHARD J HOWARD 
BRUCE W JACKSON 
NEAL KOSS 
STUART M KOTLER 
WILBUR LKUKES 
LYNNE L LEVITSKY 
HENRY B MANN 
HAROLD MELLIN 
ELI H NEWBERGER 
JAMES DSLAVIN JR 
MARK SNIDER 
GARY L TOWNSEND 
LEE VAN LENTEN 
JOAN T WAYLAND 
JOHN W WICKENDEN 
WILLIAM B YEAGLEY 
ARNES YOUNGBERG 
RICHARD B YULES 
1967 
DANIEL L ARONS 
ARTHUR L BEAUDET 
31 
RICHARD S BOCKMAN 
DANIEL J BOOSER 
GARYC BURGET 
MARY WILLIAMS CLARK 
CYNTHIA RAPP CURRY 
MARIAN C DAVIDSON 
JAMES LUCIUS DAVIS III 
JAMES J DINEEN 
TIMOTHY J DONDERO JR 
ALEXANDER FDORA 
JAMES M DOWALIBY II 
JOHN A DREWS 
DENNIS GRANT EGNATZ 
HERBERT W FELSENFELD 
MELVIN VICTOR GOLDBLAT 
RICHARD J HART 
RICHARD L HEPPNER 
PETER N HERBERT 
GEORGE P HERR 
DAVID L INGRAM 
J ROBERT KIRKWOOD 
MELVYN KOROBK1N 
ANTHONY P LOVELL 
HALBERT BAYLESS MILLER 
STEPHEN W MILLER 
WILLIAM J MITCHELL 
JOSEPH L MORRIS 
JENNIFER ROBINSON NIEBYL 
JOHNOPASTORE 
WILLIAM E PERKINS 
BRIAN F RIGNEY 




SIDNEY C SMITH JR 
HELEN LSMITS 
ROBERT S STEINBERG 
RICHARD B SWETT 
M DAVID TILSON III 
KAREN HTOKER 
GEORGETYLER 
ROBERT A VOGEL 
ROBERT A VOLLERO 
JOSEPH F WALTER 
MARTIN WAND 
ROBERTS K YOUNG 
PETER M ZEMAN 
196S 
JOSEPH F ANDREWS JR 
PHILIP L BARRY 
DANIEL I BECKER 
STUART J BRILL 
DONALD RCOUSTAN 
RUTLEDGE W CURRIE 
BARBARA MAYER EGBERT 
ALAN G F1NESILVER 
RICHARD A GETNICK 
MARK GILBERT GRAND 
LEONARD GRAUER 
JOHN R HILL 11 
HARRY S HOLCOMB III 
DANIEL EKEIM 
JEFFREY S LEE 
MARCELIPPMAN 




JAMES B MORRIS 
JOHN A OGDEN 
JACKSON B E PICKETT III 
CHARLES T POST JR 
RALPH JEROME RAUCH 
ALFRED QSCHEUER 
JACOB JSCHLESINGER 
BRUCE STUART SCHOENBERG 
ELIZABETH M SHORT 
HOWARD W SIEGEL 
GERALD L SPRINGER 
LEE H STROHL 
PER HENRIK WICKSTROM 
ROBERT J WINER 
1969 
BRIAN D ALTMAN 
CHARLES S ANGELL 
DAVID G ANSEL 
DAVID W BARRY 
ROBERT E BELLIVEAU 
JOSEPH P CLEARY 
N ROGER COOKE 
RICHARD J DALY 
CHARLES A DINARELLO 
DOUGLASS T DOMOTO 
DANIEL M EICHENBAUM 
RALPH J FALKENSTEIN 
GARYSFARNHAM 
STEVEN A FRANKEL 
WILLIAM H FRAZIER 
ANNAS GAIL 
DAVID A GEER 
STEVEN M HERZBERG 
THOMAS C HOWARD 
LEE M JAMPOL 
JOEL MARK KAUFMAN 
JOHN J KELLY JR 
ROZELLA S KNOX 
ROWENA KOROBKIN 
STEPHEN KRANT 
LYNN G LAGERQUIST JR 
MICHAEL R LIEBOWITZ 
C ELONG III 
PAUL A MARKEY 
ARNOLD F MAZUR 
ELLEN B MILSTONE 
THOMAS FMINEHAN 
BRUCE K NAGLE 
LIONEL M NELSON 
NANCY OLMSTED 
RICHARD PPOLLIS 
DEBORAH A PUTNAM 
N BURGESS RECORD JR 
JOSEPH D ROBINSON 
JOSEPH M ROCHFORD 
DENNIS J RUDZINSKI 
DAVID JSAHN 
LUTZ H SCHLICKE 
ADRIAN MSCHNALL 
DAVID J SCHULAK 
GERALD J SMALLBERG 
ROBERTJ WALAT 
STEVEN C WHITE 
1970 
ELISSA B ARONS 
HENRY C’HESSIN 
MICHAEL JCHUSID 
ANNE MCB CURTIS 
MICHAEL D DANZIG 
JAMES EDE LANOJR 
JONATHAN ECKER 
BRUCE A FABRIC 
THOMAS H GOUGE 
PAULC HESSLER 
JAY H HOOFNAGLE 
ROBERTLJANCO 
JONATHAN I) KATZ 
MARK A KORSTEN 
THOMAS L LEWIS 
ANNE W LUCKY 
JAY W MARKS 
JAMES R MISSETT 
WILLIAM K MUELLER 
ROBERTM ROSA 
JOEL F RUBINSTEIN 
DENNIS E SHIELD 
STUARTSSHORR 
PHILIP ESTEEVES 
RAY W TRIPP III 




JUDITH L BADER 
MARIAN H BLOCK 
WILLARD CATES JR 
FREDERICK L COHN 
DAVID COSSMAN 
EDWARD C COTTLE 
MICHAEL CYNAMON 
JOHNSEBERSOLE 




JEROLD ALAN HABER 
KENNETH L HARKAVY 
WILLIAM W HAY JR 
WILLIAM S HOFFMAN 
ARTHUR FJONES 
RICHARD E KAUFMAN 
BARBARA K KINDER 
WILLIAM L KRINSKY 
LAURENCE W LEVINGER 
SHERRY W H LOO 
SAMUELS MASTERS 
JOHN C MILLS 
PATRICK TMINIHAN 
STEVEN H MOFFIC 
RICHARD ALBERT MOGGIO 
MARTIN PARIS 
JOHN A PATTI 
STUART B PHILLIPS 
ANTHONY V PROTO JR 
IRVING G RAPHAEL 
LAURIE JANE ROSENTHAL 
DOUGLAS R SCHMIDT 
JAMES PSOUTHWICK 
JONATHAN W STEWART 
RICHARD D TRAVERS 
YVONNE EVAUCHER 
PAULA VIGNOLA 
ALBERT CARL WE1HL 
1972 
ROBERT D ARBEIT 
MICHAEL A CATALANO 
MICHAEL LCHARNEY 
ALANJCLARK 
PHILIP L COHEN 
ROBERT FDEBLASI 
FRANCES DEGRAAFF* 
NORMAN M DINERMAN 
WILLIAM H DRUCKEMILLER 
MARC S FELLER 
JOHN W FOSTER JR 
M FELIX FRESHWATER 
DOROTHY M GOHDES 
ANDREW H GREENHILL 
THOMASLHORN 
VERNON H HUMBERT JR 
ANTHONY H JACKSON 
DONALD L KENT 
DAVID LKNEAPLER 
PHILIP W LEBOWITZ 
THEODORE M LEVIN 
PAUL A LUCKY 
HARRY LMALECH 
JEFFREY S MENKES 
JEROME H MEYER 
JORGE A MOTTA 
DAVID B MOYER JR 
JOHN P O'GRADY 
THOMAS H OGDEN 
EDWARD JOLINGER 
PETER J PANZARINO JR 
JOHN N POSCH 
DAVID HROMOND 
PHILIP M ROTHFELD 
JOHNSSMOLOWE 
LAWRENCE PTEMKIN 
PHILIP J WEYMAN 
BROOKE S WOLF 
JOHN D WRIGHT JR 
MICHAEL W YOGMAN 
STEVEN M ZELDIS 
1973 
DAVID A ADLER 
DAVID NELSON BAILEY 
MICHAEL L BRAMLEY 
MARY ANN BRUNSTETTER—SHAFER 
MARVIN MCHASSIN 
CHRISTOPHER M DORAN 
JOSEPH W EICHENBAUM 
JANE H FERGUSON 
RICHARD J FINGEROTH 
GEORGE I FRANK 
LEE GOLDMAN 
GARY V GORDON 
NEAL HANDEL 
DAVID C JOHNSON 
ANDREW G KADAR 
SAULLANDE 
GEORGE LISTER JR 
MARK G F MC CORMICK 
JOHN F MC QUADE III 
JOHN F NEIL 
CLAES M NILSSON 
DAVID E PEACH 
DAVID PICKAR 
CHARLES F REYNOLDS III 
JAMES S ROBERTSON 
JERROLD F ROSENBAUM 
ROBERT A SIROTA 
MICHAEL ESOLIN 
JOHN R STRA TTON 
JAMES F SULLIVAN 
THOMAS F SWEENEY 
ROBERTJ URSANO 
CHRISTINE A WALSH 
MARC A WEINBERG 
RICHARDS K YOUNG 
1974 
IRVING M ASHER 
DOUGLAS A BERV 
NEIL BLUMBERG 
PETER J BUCHIN 
PAUL DAVID 
VINCENT A D1 MARIA 
IRLLEXTEIN 
REGINALD K FRANKLIN 
ALLAN B FRIEDLAND 
MICHAEL A GERBER 
EDWARD L MARUT 
RICHARD C PASTERNAK 
ANDREW LRIES 
DAVID ZRITVO 
DANIEL I ROSENTHAL 
HARRY SHAMOON 
CAROL CTEITZ 
JOHN JONES THOMPSON 
JASON S ZIELONKA 
1975 
RALPH E BINDER 
NEIL BLUMBERG 
YVONNE E LOMAX BURNETT 
BRENDAN CLIFFORD 
PAUL A JOHNSON 
CAROLLKANDALL 
RICHARD J LOEWENSTEIN 
32 Deceased 
EPIDEMIOLOGY AND PUBLIC HEALTH 
ROBERT FMALACOFF 
HYMAN JM1LSTEIN 
MARY JANE MINKIN 
ANDREW B NEWMAN 
EDWIN G OLSON 
DANIEL J PASSERI 
VIVIAN REZNIK 
PHILIP J RICH 
ROBERTS SANDLER 
STEVEN A SCHWARTZ 
BARBARAJSTOLL 
MARK F WHEELER 
HENRY SWILLNER 
DOUGLAS R ZUSMAN 
1976 
SARAH S AUCHINCLOSS 
ALAN B BLOCH 
SHARON L BONNEY 
RANDALL DCEBUL 
RICHARDS CHILDS JR 
JOHN D CLEMENS 
VINCENT C DICOLA 






NORMAN V KOHN 
WILLIAM K LEVY 
GEORGE W LUEDKE 
LARRY MARKOWITZ 
JON S MORROW 
PAUL R RAMIREZ 
JAMES L ROSENZWEIG 
BONITA F STANTON 
ROBERT FTAYLOR 
PETER M TING 
JOHN C WILES 
1977 
GEORGE BOLEN 
JOHN J BORONOW 
MARGERY BUCK BRENNER 
CHRISTOPHER S CLARK 
SYBIL EDUCHIN 
ANNE H FLITCRAFT 
JAMES A FOX 
JULIA B FRANK 
ROBERT W HAND 
EDWIN K HUANG 
BRUCE L INNIS 
KAREN G KELLY 
DAVID J KREIS JR 
MARGARET S MC KENNA 
ROBERTJ MITCHELL 
R ANDREW PACKARD 
ALAN S PENZINER 
LAWRENCE E SAMELSON 
STEVEN J SCHEINMAN 
RICKY M SCHNEIDER 
SIMEON A SCHWARTZ 
MARKS SMITH 
GAIL M SULLIVAN 
RONALDJ VENDER 
DIANA RWASSERMAN 
I DOUGLAS WHITE 
1978 
MICHAEL J ANDERSON 
PATRICIA BELL 
DUKE E CAMERON 
JESSE MCEDARBAUM 
HOWARD M CHASE 
MARY-MARGARET CHREN 
EMILY A FINE 
MARK LFINKLESTEIN 
EUGENEGLENN FONG 
STUART M FORMAN 
ARTHUR M GERSHKOFF 
LINDA J HALL 
ALEXANDRA N HELPER 
ROBERT HERSHFIELD 
KENDRICK E LEE 
SETH M POWSNER 
ROBERT M ROTHBART 
NEAL D RYAN 
DONALD C SIMONSON 
CAROLINE R TAYLOR 
MARCIA J WADE 
SHARON R WEINSTEIN 
1979 
NANCY BERLINER 
JOANN N BODURTHA 
DAVID A BRENNER 
STUART L BURSTEN 
MICHAEL M CHANG 
ORLANDO FERNANDEZ 
JOEL I FRANCK 
JOHN JAY GARGUS 
DAVID E GOLAN 
BRUCE HALPERIN 
EDWARD C HALPERIN 
ARTHUR C JOHNSON III 
DAVID E NESS 
JEAN ROSENTHAL 
GARY LSCHAER 
CYNTHIA ANNE SHERMAN 
THOMAS JOSEPH SMITH 
MARK JAY YEAGER 
1980 
DAVID EADELBERG 
SETH LEO ALPER 
DAVID ALLEN AUGUST 
PATRICIA CHURCH BROWN 
MICHAEL W CHAMPEAU 
CLAUDIA DINAN 
FORREST JOHN DOUD 
TODD J GARVIN 
DAVID M DKASS 
MARY C KORNEI 
CESAR R MOLINA 
STEVEN IRA ROSENFELD 
JEFFREY M SHAPIRO 
JEFFREY N SIEGEL 
LESLIE WSOJKA 
MARCIA R TAYLOR 
MARIA L WHITE-GREENWALD 
1981 
CYNTHIA B ATEN 
PATRICIA A BURKE 
LOUIS ESSANDOH 
JUDY E GARBER 
PHILIP D GOLDSTEIN 
LAURIE J GORDON 
NEIL D GROSS 
ANNETTE D GUIDO 
SCOTT A HUNDAHL 
AIZIZ O LAWOYIN 
BARTON N MILESTONE 
ROBERT M MILSTEIN 
DAVID A PALY 
BARBARA A ROACH 
ANTHONY M URBANO 

















EDWARD B BOSWORTH 
MIRIAM M CAMPBELL 
EVELYN H HALPIN 
STANLEY B LINDLEY 
ELIZABETH MURPHY 
EUNICE NICKERSON TYLER 
1934 
IVAL A MERCHANT 
IWAOM MORIYAMA 
AMY H WILSON 
1935 
FRANKLIN M FOOTE 
ALMEDA KING 
1936 
M ALLEN POND 
1937 
LIDIE V DYER 
HOWARD WEST 
WILLIAM R WILLARD 
1938 
WILLARD H BOYNTON 
RICHARD KC LEE 
KATHERINE HAWLEY MARTIN 
LUCY S MORGAN 
JEAN H NELBACH 
1939 
CARL I COHEN 
JAMES CHART 
FRANCES S MILLER 
1940 
GEORGE FELDMAN 
ELIZABETH H PITNEY 
MEYER J PLISHNER 
1941 
ELEANOR H KERBY 






CLAIRE B REINHARDT 
CHARLES D SPANGLER 
1943 
RICHARD F CLAPP 
CAROLYN S KOFFLER 
ERIC W MOOD 
HENRIETTA N PAINE 
MIRIAM H ROHDE 
ADELEPSCHLOSSER 
JANE L WHITE 
1944 
MASSIMO CALABRESI 
JEAN F HESTON 
LILY BERMAN MOSTYN 
JANE Y PARKER 
JOE B GRABER 
LOIS M JUND 
JOHN C POTKAY 
1946 
D PATRICIA NELSON 
1947 
CLARA E COUNCELL 
ANNE E FULTON 








MARY L ELLIS 
MARY MARGARET FITZGERALD 
SAMUELS HERMAN 
BARBARA L HOLMAN 
RICHARD E JOHNSON 





ERNEST M GRUENBERG 
DOROTHY Y HALL 
ELEANOR P KOSTANT 
HILDA H KROEGER 
CHRISTINE ROWRE 
WILLIAM B PARSONS 
1950 
WYNTHA T BOOTHE 
HENRY G BRICKMAN 
IDA M BUCHER 
HILDA B CARR 
AUSTIN J EVANS 
JEROME M CLASSMAN 
DOROTHY R GRANOFF 
EUGENE K HARRIS 
MARTHA P JAYNE 
EVERETTE D REESE 
FRANCES K REYNOLDS 
ELIZABETH D ROBINTON 
NATHAN M SIMON 
JOHN D THOMPSON 
1951 
HECTOR R ACUNA 
CLARISSA E BOYD 
CLARENCE WILLIAM BUSHNELL 





ELIZABETH ULRICH THROM 
VIRGINIA E TORRES 
JAMES M A WEISS 
1952 
CAHID H CORBACIOGLU 
HOWARD DUNPHY 
VIRGINIA M GOOD 
JOANNA ADELE HENRY 
MALCOLM C HOPE 
ERLEEN FRANCES JAMISON 
CHARLES HOLWAY LAWRANCE 
SIDNEYS LEE 
HELEN KARDYS LORIA 
YOLANDEFLYON 
ANNE BARLOW RAMSAY 
BRENA B WOLFF 
1953 
JEANETTE AVERILL 
HAROLD ROBERT BERNSHOCK 
ABRAHAM CUTCHER 
1945 
ROSLYN R BILFORD 
MARY B DALE 
NAOMI BARER GOLDEN 
33 
CECILIA FRANCES Dl CICCO 
GRAYDON DORSCH 
WILLIAM H HERMANN 
BARBARA J LEE 
LAURENCE K RAINSFORD 
MILTON H SISSELMAN 
CONSTANCE B THOMAS 
1954 
DONALD R COWAN 
CALVIN PHATCHER 
WILLIAM A MARKEY 
RUTH MTABER 
1955 





FRANCES R OGASAWARA 
GERALD ROSENBLATT 
1956 
DAVID D BOYD 
KATHLEEN H HOWE 
PAULC KAUFMAN 
HENRY M PARRISH 
1957 
LEE DE CADY JR 
WILLIAM A CLERMONT 
EDWARD R DELOUISE 




PAUL W STERNLOF 
SYLVIA RTALBOT 
PATRICIA A VISCOSI 
1958 
HELEN H DAVENPORT 
E FIELD HORINEJR 
J PHILIP KEEVE 
EDWARD H NOROIAN 
THOMAS P WEIL 
1959 
CESAR A ALEMAN 
O WADE AVANTJR 
CONSTANCE AZZI 
RITA DINGMAN 
BENNETT I ENOWITCH 
JOHN T FOSTER 
FOLLY HOFER 
WILLIAM L KISSICK 
MARVIN A LAVENHAR 
LEE J PODOLIN 
ELLWYNDSPIKER 
KENNETH J WILLIAMS 
DOROTHY M WILSON 
196(1 
KATHRYN L D'AMICO 
WOUTER EKKER 
ROSE AIANNOTTA 
KATHARINE ANNA KEPPEL 
LOWELL STERN LEVIN 
R JOHN C PEARSON 
HANNAH CLARK RUSSELL 
ELSE NIEBUHR SCHULZE 
1961 
NICHOLAS G ALEXIOU 
GORDON R BEEM 
MARY S BLACKBURN 
MARTIN DONABED1AN 
ALFRED E FLETCHER 
GEOFFREY M JEFFERY 
HELEN M O'CONNELL 
MARGARET R PARKER 
HERBERT RUBINSTEIN 
ANGELA M RUSSO 
WILLIAM R SLIVKA 
K BERRIDGESOHLER 
HAROLD W WICKS 
1962 
THOMAS A BLUMENTHAL 
A KAY KEISER 
CHARLES A MAC INTOSH 
THOMAS R MAYHUGH 
1963 
DOROTHY WEICHERT BROCKWA\ 
DAVID DOLINS 
C DU VE FLOREY 
FRANK M ISBELL 
EDWARD M KENNEY 
JEAN M MAYNARD 
GEORGE EDDY PARKER 
RONALD VOGLESONG 
SAMUEL B WEBB JR 
1964 
MARIAS BAISIER 
ELIZABETH C BELLIS 
BARTLEY H CALDER 
JAMES JCULHANE 
KATHERINE MARIA DETRE 
CARTER L MARSHALL 
NEALL MASLAN 
CAROLE S PROFANT 
ALBERT E ROBINSON 
THEODORE ROSENBERG 
ESTELLESIKER 
MONROE W SPERO 
CLAUDEWELL SIDNEY THOMAS 
1965 
ROBERT M EDWARDS 




ELLIOT A SEGAL 
VIOLA J SPINELLI 
ALICE JTUREK 
SARAH L TURNER 
DAVIDS WEINER 
1966 
BARBARA L BRODY 
ALLEN COHEN 
AMALIA PCRAGO 
DOROTHY NOYES EVANS 
DIANA B FISCHER 
JENNIFER L KELSEY 
ROBERT CLOWRIE JR 
BIRCH H MILLIKEN 
RAIF E NASSIF 
NANCYAPERSILY 
1967 
PETER T ELLIOT-WOTI ON 
RICHARD W GERRY 
STEVEN JONAS 
JOSEPH F KUKLA 
PATRICIA D MAIL 
JAMES M MALLOY 
MICHAEL C QUADLAND 
BRUCE JSTEINHARDT 
BETH M WHELAN 
IRMA WILLNER 
ROBERT L WOODWARD 
1968 
GLENDA DAVIS ANDERSON 
SONIA M COLON 
JOSEPH L DORSEY 
ROBERT R EVERETT 
CARL R FISCHER 
HAROLD C LOVELY 
JEAN C MAC CORISON 
RICHARD L PETRELLI 
ARNOLD R SASLOW 
DOREEN PSHARABATI 
SHEILA W WELLINGTON 






GERALD R HARPEL 
SYLVIA N HOLTZBERG 
SAMUEL PKORPER 
JUDITH B NICHIPOR 
LOREN K OLSON 
SAMUEL D ROWLEY 
MARVASEROTKIN 
GERT M K WALLACH 
ROBERT L YOUNG 
1970 
FREDERICK G ADAMS 
SUSAN W BALTER 
ROBERT T BEEMAN 
MICHAEL B BRACKEN 
HAMILTON B BROWN JR 
SHAN CRETIN 
FORREST G DRESSLER JR 
ROBERT SGUREASKO 
J KEVIN KINSELLA 
PETER ORRIS 
DAVID A PEARSON 
NANCY NORTON REITZ 
CHARLOETTE F SCHWARTZ 
STEPHEN SKORCZ 
CAROL B VON STEIN 
JOSEPH A ZACCAGNINO 
1971 
JOHN BIHLDORFF 
EVELYN J BROMET 
WILLIAM F CAREY JR 
WILLARD CATES JR 
THOMAS W CHAPMAN 
KATRINA H CLARK 
DALE A CULP 
HARVEY FERNBACH 
WILLIAM PFERRETTI 
ANNE-MARIE A FOLTZ 
BILLIES HAMBLIN 
SARA P HARTMAN 
WANDAJ HATMAKER 
MOHAMED ISMAIL JOHNSON 
WILLIAM PKOUGHAN 
BERNARD G KOVAL 
CATHERINE S LINDENBERG 
MARK J MAGENHEIM 
JOAN L MARTINEZ 
EUGENES MAYER 






WALTER O SPITZER 
VICTOR J TUCCI 
JUDITH WHITCOMB 
1972 
STEPHEN B BARUCH 
MICHAEL L BENJAMIN 
FRANCES L BUSHNELL 
C GENE CA YTEN 
CATHERINE A CONNOLLY 
PAULFINLAYSON 
DAPHNE DEJ GEMMILL 
DOROTHY N LEWIS 
STEVEN M LIPSIUS 
GERALD MILLER 
SERGIO RUSCHEL 
JO ANN K SILVERSTEIN 
RAYMOND LSPHAR JR 
LAURENCE A TANNER 
FREDERICK A VAGO 
JOYCE R WAKSMAN 
1973 
EVA DANIELSSON COHEN 
BERNICE E COLEMAN 
ROBERT OIOTT 
CHANG S LAO 
DENNIS P MAY 
GARY DEAN SAX 




CARL J ZACK 
1974 
I WILLARD ABRAHAMS 
ROSE SALISBURY BEER 
GREGORY BELOK 
THOMAS A BENOIT 
IAN B BERGER 
ELIZABETH M HELMING 
STANLEY E KILTY 
ALANS KRIMSLEY 
ARTHUR L LANCKTON 
ROBERTA LAWRENCE 
KAREN K LINDFORS 
EVELYN B MOSTOW 
NILS R RICHARDSON 
SHELLEY SSHANOK 
ABIGAIL L SMITH 
MYRNA M WEISSMAN 
BIENVENIDOG YANGCO 
1975 
CLAYTON A AJELLO 
CHRISTINE PANTAYA 
EDITH N BAUM 
RALPH E BINDER 
LINDA K BROKER 
ANN C CUNNINGHAM 
GEORGE R CURRY 
HILLARY DEMBY 
JACK A EIFERMAN 
MARY FRANCES FLYNN 
DONNA BROWN GROSSMAN 
ANNE H HALL 
KENNETH G HILL 
ELIZABETH T HUNTER 
SUSAN M KAETZ 
JAMES EKNOBEN 
KATHY S KOHN 
NANCY J KREIGER 
STUART L LEFKOWICH 
ANGELA R MC LEMORE 
LAURENCE F MC MAHON JR 
LOIS S MICHAELS 
EILEEN MO'GARA 
MARY W PALSHAW 
WILLIAM P QUINN 
DALE P SANDLER 
EDWARD V SARGENT 
NANCY E STROUP 
THOMAS J TRUDELL 
AUDREYS WEINER 
MARION LEE WU 
1976 
PETER B AARONSON 




CATHERINE M BOYLE 
KATHLEEN KEENAN BUCHOLZ 
CYNTHIA D BUTLER 
DARRYL EUGENE CROMPTON 
FRANCES L DE PEYSTER 
AGUEDA N DEANS 
PAUL H ETKIND 
34 
BERTON D FREEDMAN 
ANNETTE B GAROFALO 
PHILIP D GOLDSTEIN 
KAREN A GORDON 
DAVID M CUTE 
JANET HEINRICH 
FRANCES ANNE KANACH 
ROBERT A KNAUF 
JANINALEVY 
GINOANALLI 
RUTH FITCH QUAH 
JAMES B ROKOS 
ROBERT RISDON SCHWARZ 
MARY JO SHEPARD 
ROBERT SILTEN 
MARCIA A TESTA 
THOMAS S WINGARDNER JR 
1977 
RICHARD B BURFORD JR 
PATRICK FCARONE 
STEVEN R COHEN 
BRUCE D CUMMINGS 
MARSHA E DUNN 
MARY K EICHELMAN 
GERARD J FOLEY 
PAULA YANEY GAMBILL 
DEBRA J GROSSMAN 
ELLEN DJASLOW 
RHONA KANTOR KERSHNAR 
ROBERT WALTER MAKUCH 
EDWARD MORGAN 
SHARON A MULGREW 
CARROLL SCHILLING NEISLOSS 
JAMES M O'CONNOR 
KRISTIN K O’CONNOR 
VERONICA C OESTREICHER 
HARRIS PASTIDES 
LINDA MENDELSOHN POTTERN 
DOROTHY A RICE 
WILLIAM T RICHARDS 
DEBORAH ROSE 
ABBY ROTHSCHILD 
ANTHONY V SARDINAS 
BARBARA G SMITH 
THOMAS H ULFELDER 
LEON F VINCI 
MARIA W WILLARD 
1978 
DAVIDS ABERNETHY 
KATHLEEN M BERMAN 
WILLIAM HARVEY BLITZ 
ALAN B BLOCH 
ROBERTJ FENSTERHEIM 
ROBERT H FRAZIER 
ANN T FREEDMAN 
NANCY G HILDRETH 
STEPHEN W HILDRETH 
DAVID W HOUCK 
WILLIAM A HOWARD 
JEAN CRUM JONES 
MARGARET LONG KARIS 
ROSLYN I LISS 
MAURA ANN LOUGHLIN 
MARGUERITE NELLIGAN 
ELIZABETH L PANTELICK 
TRUDEE PARENTEAU 
PATRICIA LYNN PERRY 
ELLEN J REIFLER 
ELLEN D ROTHBERG 
GEORGE C ROUSH 
KAREN C SCHNEIDER 
MICHELLE D SCHOENBERGER 
ROBERT E SCHWARTZ 
ROBERTA JO SHAPIRO 
ROBERTA NANCY SILBERT 
ALAN J SINISCALCHI 
MARIE STOECKEL 
BERNADETTE S VISSAN1 




RHONDA S BESUNDER 
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MEDICAL CARE OF THE AGED 
Paul B. Beeson, M.D. 
Dr. Paul B. Beeson, a professor of medicine emeritus, University of Washing¬ 
ton, Seattle, is editor-in-chief of the Journal of the American Geriatrics Society. 
He was one of four distinguished speakers at a symposium on ' 'Ethical Issues in 
Health Care" which was a part of the Yale-New Haven Hospital dedication 
ceremonies in June 1982. Dr Beeson has given Yale Medicine permission to 
publish this unedited transcript of the talk which he gave on that occasion. We 
believe that his comments on this topic will be of interest to our readers. 
With regard to the topie of ethical issues in the care of the 
elderly. I'd better begin by pointing out the limitation of 
my perspective. I am not an ethicist or a philosopher. I’ll 
be talking mainly on the basis of personal experience with 
individual cases, in a setting of academic medicine, in a 
tertiary care type of hospital. The patients there, often 
elderly, are referred for short-term stays, for diagnostic 
procedures or therapy. We have very little opportunity to 
observe their lives and progress outside the hospital as in 
other types of institutions. 
The issues I am going to be talking about have become 
much more insistent and much more troubling in the last 
thirty years because of developments in science and tech¬ 
nology of medical care and, particularly, because of the 
development of life support systems such as dialysis or 
assisted respiration, cardiopulmonary resuscitation, and 
so on. One of the ways which ethical issues intrude on 
these considerations has already been referred to: the 
matter of cost to society, inasmuch as health care amounts 
to almost 10% of the gross national product. We are 
obliged, I think, to consider the impact of what we do 
because we all pay these bills, through our taxes, third- 
party insurance, and so on. One statistic that impressed me 
greatly was to hear Dr. Sanders, the former head of the 
Massachusetts General Hospital, say that in the decade 
between 1965 and 1975, they employed 1,000 additional 
people, much of it because of the creation of 10 intensive 
care units. Of course, this is one of the reasons why cost is 
becoming so important. The elderly are a special case in 
point, because, although only 11% of our population is 
beyond the age of 65 years, that segment uses up about 
30% of the nation’s health bill. So problems of cost in the 
care of the dependent elderly are growing, and the problem 
is going to get worse because of the demography. More 
and more people are living into the age of retirement, long 
past the age of child-rearing. Families are becoming 
smaller, so that the earning proportion of our population is 
shrinking. Certainly after the year 2000, when the effects 
of the post World War II baby boom begin to bring that large 
chunk of the population into the age of retirement, the care 
of the elderly is going to become an even more serious 
problem. Another factor in addition to the ones that I've 
mentioned is malpractice litigation. There is, of course, a 
great increase in the amount of this. 
Now, we have entered an area of public discussions 
about the matter of sustaining life in patients who have 
suffered apparently irreversible brain damage. Our medi¬ 
cal journals are carrying editorials and general articles 
discussing such things as the care of the elderly, the ethical 
and societal issues involved. Some new phrases are heard 
on the wards nowadays such as “quality of life” and 
“death with dignity”. These are tossed about in a some¬ 
what careless way, without too much definition. 
Let me get into this by citing examples of problems that 
have made a great impression on me as an internist practic¬ 
ing in tertiary care hospitals. The first type is one that I saw 
soon after I moved to Seattle. I was walking down the 
corridor with one of the residents and we came to an old 
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man in a wheelchair. He (the resident) said, “I’ve got to 
show you our star patient.” The story was that several 
months before, this man had been struck by an automobile 
and had suffered multiple fractures of his extremities and 
also of his ribs so that he had a flail chest. He was rushed to 
the hospital and in the emergency room it was obvious he 
could not survive without assisted respiration. This was 
begun and still had to be carried out for some hours each 
night when I saw him, months later. In the immediate 
post-injury period, he suffered a renal shutdown and had 
been on dialysis for a while. He also had acute respiratory 
syndrome with a '’white lung", which eventually was taken 
care of. He had pneumonia and had been brought through 
that. He had any number of transfusions. He developed 
disseminated intravascular coagulopathy, which eventually 
subsided with platelet transfusions and other kinds of care. 
They could not do much for the fractures in his extremities 
because of these pressing problems, so the fractures were 
more or less allowed to heal in whatever positions the 
bones were in. This had left him with a good deal of pain. 
Two months after the injury, he developed mesenteric 
infarction and had to have a bowl resection. This had been 
successful, but he was by then a very frail man. I listened 
to this story and thought a great deal about it. I could guess 
at the expense involved in taking that man through all those 
kinds of treatments. Certainly in a hospital where bills are 
rendered to the patient's insurance company, the bill 
would have been in the tens of thousands of dollars — 
perhaps more than an average citizen could hope to save 
over a lifetime. I remember, too, that in driving back and 
forth to the hospital, I used to pass a public school in a 
low-income area of Seattle. The schoolyard had no recrea¬ 
tional facilities. Paint was peeling from the school build¬ 
ing, and many windows had broken panes. I kept thinking: 
my goodness, what could be done for that school for the 
amount of money that was spent in keeping that old man 
alive, to suffer a great deal of pain? My own inclination 
was that it has been unfortunate that our modem life¬ 
saving technology had been available. But there is an 
important follow-up: I saw that man three or four years 
later, when he was admitted to the ward on which I was 
attending physician. He was better; he was enjoying life, 
and was glad that all of those things had been done for him 
At the other end of this spectrum of dilemmas is a more 
common kind of problem. A patient is transferred into the 
acute care hospital from a nursing home because he has 
fever. On examination it is quickly recognized that the 
fever is due to pneumonia. Bacteriologic studies are 
carried out, the appropriate antibiotic therapy is given, and 
the patient is supported in the intensive care unit for a few 
days. But then it is found that the patient is severely 
demented, and unresponsive, and no one has come to visit 
him. The resident in charge calls the nursing home and 
says, "Your patient's fever is gone, his pneumonia is 
clearing, but he seems to have become so demented that 
we can't communicate with him.” The reply, "Well, he’s 
been that way for months. We simply felt we had to 
transfer him to you for the treatment of whatever was 
causing his fever, but he has been abandoned by his 
family. He sits here apparently unaware of events taking 
place around him.” Then the question comes up whether 
we had performed a worthwhile service by prolonging that 
kind of life. I must qualify a bit here, because in the world 
outside of academic institutions that kind of surprise 
doesn't present itself as frequently, because there is likely 
to be a doctor who knows the background and is in much 
better position to exercise options about aggressive treat¬ 
ment than the resident who happens to be on duty in the 
emergency room when such a patient comes in, unaccom¬ 
panied by information about the background. 
The matter of expense is one of the most troubling things 
in modem medicine. Should we recognize a duty to society 
and to our national welfare when we commit the expendi¬ 
ture of vast sums of money to the care of individual 
patients? This is a distasteful thing to have intruding on 
one’s clinical thinking — whether one should even give 
thought to expense, or whether the entire effort should be 
guided by the sanctity of human life and saving of human 
life? Those people who champion the view that there 
should be no other thought except the duty to prolong life 
to the very last possible moment have an easy way of 
getting out of this dilemma. Dr. Eugene Stead of Duke,- a 
person I have known well for a long time and for whom I 
have the highest regard, has written an editorial in the 
Journal that I edit. The Journal of the American Geriatrics 
Society, April, 1982, entitled "Ethical Issues in the Care 
of the Elderly”. He quite courageously, I think, takes up 
the subject of the cost of prolonging life and gives very 
thoughtful consideration of it. Stead is known for an ability 
to see things clearly, without regard to the opinions of 
those around him. He speaks of the fact that our society 
does countenance some inequities; as examples, he points 
to conditions that prevail in many of our institutions for 
care of mentally retarded people, the conditions in our 
prisons, the conditions in many of our nursing homes, the 
conditions of life in some of our inner cities, and he 
emphasizes that society is aware of these. Then he 
addresses the question whether we are justified in spending 
a great deal of money on a patient who cannot be expected 
to live more than another three months, or whether that 
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amount of money ought to go into education of dis¬ 
advantaged children. He says, “I would lean toward the 
latter.” As editor of the journal, I am already beginning to 
get some “static” on that statement, likening it to the 
attitudes of the Nazi experimentalists. 
Let me say just a word or two about the elderly as a 
group and our attitudes toward them, whether they’re sick 
or well. I've already mentioned that they are increasing in 
numbers. More people are living into seventies and 
eighties than ever before. There is no question that our 
culture tends to have a feeling toward the changes of old 
age that can almost be described as abhorrence. The dis¬ 
tortions of the body and of the mind make us appear 
unattractive, and contrast with our enchantment about 
youthfulness, and the way we try to look and act youthful. 
All one needs to do to get an indication of this is to leaf 
through a magazine or to sit and watch advertising on 
television. One gets the impression that all of the people 
who use toothpaste or deodorant, or who take pleasure 
cruises, are good-looking young people. We don’t see very 
much about what some people would like to feel are the 
beauties of aging. Why do we feel this way? Some psy¬ 
chologists say it is because we realize subconsciously what 
lies ahead for all of us, that we see in those older people the 
changes we hate to envision for ourselves. For many 
years, I noted an example of this sort of emotion when I 
used to take morning report with the housestaff. They 
identified with the people in their own age group, and 
spoke of their illnesses as “tragic”, but could comment 
objectively about the same illnesses in people forty years 
older. Then there are the unpalatable bits of hospital lingo 
that we hear about the older patients — for example, the 
term “gomer”. And articles are being written about the 
“hateful patient”. “Gomers” and “hateful patients” 
always seem to be older people. This gives us some idea of 
the way young health professionals tend to think of the 
elderly. And from there we move easily into that much 
used phrase, “quality of life”. They are asking them¬ 
selves: what is the quality of this patient's life? Is it really 
life with quality? They’re certainly not using it in the sense 
of “the quality of mercy”. They are not talking about high 
quality of life. Discussion of the quality of life begins 
when considering a person who is really only marginally 
existing, in a condition that none of us would ever like to 
think of for ourselves. Sometimes the word “quality” 
seems to be confused with the word “quantity”. Do we 
want to preserve this patient’s life for a few more days or 
weeks or months? The difficulty is: can we decide what 
quality of life means to that person? It is particularly hard 
for young people to decide issues of that kind in the case of 
elderly patients. One of the young physicians in Seattle, 
who is much interested in ethical issues in medicine, said 
recently, “For me, one of the features that makes for 
quality of life is the ability to love, but for an elderly, 
partially demented women in a nursing home, it may be 
represented by the ability to go on crocheting”. This is 
worth keeping in mind when we’re thinking about whether 
a given patient has a possibility of life of quality. It was 
remarked two centuries ago that a person who begins to 
take it on himself to decide about the value of someone 
else’s life can become the most dangerous person in the 
state. 
Let’s turn to what is sometimes referred to as passive 
euthanasia. That is, for example, withholding antibiotics 
when the elderly, dependent patient who seems to have 
nothing to live for, develops pneumonia. Or, cutting down 
on the intake of fluids; or failing to apply modem therapy 
with as much zest and force as we would in a younger 
individual. This business of passive euthanasia leads right 
into a sort of slippery slope toward inhumane treatment, 
and we have got to be awfully careful about the considera¬ 
tion of withholding antibiotics for the patient with 
pneumonia, as in the second example that I presented 
when I began. 
One of the things that comes up in modem hospitals now 
is the question of deciding in advance whether an attempt 
will be made to resuscitate a patient who has just died. 
Most hospitals now have their own private code which will 
summon the emergency team. In the hospital I’ve been 
working in, the term simply was “no code”. Perhaps a 
more widely used expression is “do not resuscitate”. 
There ought to be very careful safeguards in any institution 
as to who has authority to write such an order, and what 
persons will have to concur in it. Certainly the chief 
resident and the attending physician ought to concur. And 
the mere fact that that order is in the record should not 
necessarily interfere with taking every measure to help that 
patient to survive some acute episode, if it appears that 
there is a possibility of helping the patient. Ideally, that 
kind of decision ought to be taken in consultation with the 
patient at a time when the patient is competent to make 
such a decision. If not, we have the more difficult problem 
of discussing it with the patient’s family. I have always 
found a lot of difficulty here because I have a feeling that 
making a family help me with that kind of decision may 
lead them subsequently to have a feeling of remorse 
because they didn’t say, “No. Go for it. Try to keep him 
(or her) going”. I don’t have firm answers for this. I do 
think that discussing it with the patient well in advance is 
something that should be done more often: that patients 
will appreciate, and that it can do some good. One system 
for handling it is with the so-called “living will”. This 
doesn’t have true legal standing, but nevertheless it has a 
considerable value for the doctor in charge. The living will 
is simply a letter the patient addresses to the doctor at a 
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time when the patient is fully able to think things out. It 
usually says something to this effect: “If I should become 
severely disabled and mentally incompetent, I would pre¬ 
fer that if after a given period of time — say, two weeks of 
care — it appears that I am not showing any improvement, 
I would prefer that extraordinary measures not be used to 
sustain life". This is designed to help the doctor make that 
kind of decision and also to help the family. I have written 
such a letter to the doctor in whose care I am at the present 
time. I have talked to him about it and he said, “Just what 
do you mean?” My reply: “In the simplest terms, I just 
don't want to die in an intensive care unit”. If you look 
around in an intensive care unit, great as it is, and 
marvelous as some of its achievements are, you don't see 
any patient there who is having a good time. The patients 
are usually supine with things attached to all four extremi¬ 
ties. If unable to breathe properly, they’re intubated so that 
they can't speak. They may be able to write. They never 
seem to be turned from side to side but are always on their 
backs. This doesn't make a very suitable way to die, 
particularly because of all the hustle and bustle of healthy 
young strangers going and coming, talking across the 
patient about ‘the numbers’ and things of this kind. If you 
watch, you rarely see one of them even place a hand on a 
patient or engage the patient’s eyes with their own eyes. 
It’s a discussion across and above the patient as if he were 
not even there. 
My worst experience of this kind was with a colleague in 
Oxford, a distinguished scientist whom I had known for 
some years. We had attended many faculty meetings and 
some social engagements together. At the time of his 
terminal illness, he had cirrhosis of the liver and had begun 
to bleed massively from esophageal varices. We did all the 
usual things, but he did not stop bleeding. Finally, in 
consultation with the surgeons, it was decided to try an 
emergency shunt. He was operated on — a long five hour 
procedure — during which he had been intubated, so that 
when he regained full consciousness he was unable to 
speak. I was in and out of that intensive care unit frequently 
during the succeeding five or six days until he died. He 
continued to bleed. His wife sat in a little alcove outside. 
She would come in to see him now and then. He couldn’t 
speak to her. He couldn't even reach out and touch her. 
But he would wink at her, and I’ll never forget the sight of 
that brave little gesture. I kept asking myself, “What have 
we done to give this man such an awful way to die?” 
Well, I’m near the end of this. In the last few years in a 
veteran’s hospital in Seattle, I have had the experience 
many times of having a ward team of residents and stu¬ 
dents come in to see me about a patient: about this same 
question of sustaining life. I think they came to me because 
they knew I was old enough to be able to identify with the 
patient, and that I had been through this many times 
before. I didn't very often say, “Cut off his fluids, or his 
assisted respiration”. I usually counseled that we try not to 
make a decision about further supportive care for a few 
more days, because there was a good possibility the issue 
would be decided for us. But I admit that a time or two. 
when a patient we had known for a long time, who 
appeared to have widespread malignant disease and he 
then developed pneumonia, 1 was willing to say, “I don't 
think you have to”. And they would be relieved at this 
kind of advice. Whether it’s “right” I am certainly not 
going to try to say. 
We heard a little about the Hippocratic Oath this 
morning. To me the code that has seemed a good deal more 
applicable to day-by-day medicine is the few phrases on 
the tombstone of Edward Trudeau, a great American 
physician of the turn of the century who founded the 
Saranac Lake Sanitarium. Trudeau used to paraphrase an 
old French saying, “The doctor can cure now and then, 
can help often, and comfort always”. It is that last phrase 
that appears to be the most helpful one in these dilemmas 
— “comfort always” — and “comfort” applies to the 
family as well as to the patient. 
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THE STUDY OF EVENT- RELATED BRAIN POTENTIALS 
By William R. Goff, Ph.D. and Truett Allison, Ph.D. 
Drs. Goff and Allison have been co-principal 
investigators of the Neurophysiology Laboratory 
for twenty-three years. Under their direction, 
with the support of Dr. Gilbert H. Glaser, chair¬ 
man of the Department of Neurology at Yale, and 
Dr. Jacob Levine, chief of Psychology Service, 
West Haven Veterans Administration Medical 
Center, the Laboratory has become one of the 
largest of its kind in the world, and has achieved 
international recognition for its many research 
and clinical contributions. 
The dramatic increase in the use of computers and com¬ 
puter techniques in medical research and application to 
health care comes as no surprise to scientists in the 
Neuropsychology Laboratory. For over twenty years, the 
Laboratory, which is affiliated with the School of Medi¬ 
cine's Department of Neurology and located at the West 
Haven Veterans Administration Medical Center, has been 
using computers to study how the nervous system pro¬ 
cesses sensory input. 
Computers are crucial to the non-invasive recording of 
the minute electrical potentials generated by the nervous 
system in the course of sensory processing. Computer 
processing of the electroencephalogram (EEG) permits the 
systematic study of these potentials by allowing them to be 
recorded from the scalp of humans. Based originally on 
animal research in which recording directly from the 
exposed brain was possible, it has long been known that 
brain cells continuously generate electrical potentials as a 
result of electrochemical (ionic) changes which are con¬ 
stantly ocurring within and between them. Although we 
now know that the pattern of these potentials changes 
depending on whether the subject is alert or drowsy, awake 
or asleep, sick or well, in general the pattern of activity 
bears no necessary relationship to external sensory events. 
Thus, it is frequently referred to as “spontaneous” 
activity. 
The discovery of a second type of electrical brain 
activity, which is similarly related to sensory input, is attri¬ 
buted to Richard Caton while he was working at the Royal 
Infirmary School of Medicine in Liverpool in 1875. While 
recording from the exposed brains of rabbits, Caton found 
electrical potentials related to sensory stimulation which 
were superimposed on the spontaneous potential oscilla¬ 
tions. He immediately realized the implications of these 
stimulus-related potentials for cerebral localization 
studies. 
Although reported to the International Medical Con¬ 
gress held in Washington, D.C. that year, Caton’s work 
received little attention. Systematic study of brain electri¬ 
cal activity directly in humans became possible about 65 
years later with the report by Hans Berger, who in 1929 
repeated and confirmed Caton’s work, and extended the 
work to man by showing that the use of electronic tech¬ 
nology for amplification and visualization of very small 
electrical signals made it possible to record the spon¬ 
taneous potentials from electrodes placed on the scalp. 
This discovery laid the foundation of modem clinical 
electroencephalography (EEG). 
The type of stimulus-related potentials observed by 
Caton, now called “evoked potentials” (EPs), are 
generally of lower voltage than the EEG and, therefore, 
were poorly resolved by standard EEG techniques. This 
adverse ”signal-to-noise” ratio initially limited human EP 
research to components large enough to be distinguished in 
EEG traces or recorded from the brain during neurosurgi¬ 
cal operations. Systematic investigation of EPs in man 
became more feasible with the demonstration in 1951 by 
G.D. Dawson, an Englishman working at National Hos¬ 
pital in London, that the technique of “signal averaging” 
could be used to extract evoked brain potentials from 
background EEG noise in human scalp recordings. 
In the late 1950's, Dr. Burton S. Rosner, then at the 
Yale School of Medicine and the founder of the Neuro¬ 
physiology Laboratory, became interested in recording 
EPs. A psychologist educated in psychophysics and 
physiological psychology. Dr. Rosner was interested in 
relating subjective sensory experience as measured 
psychophysically to underlying neurophysiological 
events. 
Since psychophysical determinations require human 
subjects who can follow instructions and report sensations, 
human EP recording offered the opportunity to study 
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of any type were a relatively recent development and their 
size and cost precluded the dedicated laboratory use 
required to apply signal averaging of the EEG to EP 
recording. Thus, no instrumentation for such an applica¬ 
tion was available. 
At about the time, Truett Allison came to Yale as a 
doctoral candidate in psychology. Since his undergraduate 
training was in electrical engineering. Dr. Rosner inter¬ 
ested him in helping to design and build an averaging 
device. In 1959, Dr. William Goff joined the laboratory, 
and participated in the later stages of development of what 
was basically an analog computer using a continuous-loop 
magnetic tape recorder as its “memory.” This two- 
channel averaging device was a pioneering application of 
electronic technology to the recording of EPs from the 
scalp of humans. 
The Laboratory 's averager was capable of recording a 
much longer period after stimulus delivery (averaging 
epoch) than Dawson's device, and the scientific staff was 
able to observe complex SEP activity lasting as long as 350 
to 400 milliseconds post-stimulus. In the 1960's, their 
research focused on describing the morphology and scalp 
distribution of SEPs, its parcellation into segments by the 
demonstration of their different neurophysiological 
properties, description of their characteristics under 
barbituate anesthesia, which permitted their comparison to 
a considerable body of comparable animal literature, and 
changes in EP characteristics in various stages of sleep. A 
complementary program of animal research was con¬ 
ducted, oriented primarily to discovering the neuro- 
anatomical origins of human SEPs. Research was also 
expanded into the examination of EPs in the visual, audi¬ 
tory, and olfactory modalities. 
The first EEG averaging device based on digital com¬ 
puter technology became commercially available in the 
early 1960's as well, resulting in a rapid expansion of EP 
research throughout the world. Many clinical applications 
were attempted, but were not particularly successful, 
probably because there was still too little known about the 
neuroanatomical substrates of EPs. 
The Neurophysiological Laboratory’s (NPL) shift to 
more directly clinical research began in 1970 with a study, 
conducted by Dr. Peter Williamson, a Yale neurologist. 
It was designed both to determine the effect of strokes 
affecting the sensorimotor area, and to explore hypotheses 
based on animal research about the nature of SEP projection 
pathways to the brain. Clinically, a positive relationship 
was found between the degree of sensory deficit resulting 
from the stroke and alterations in the SEP. The results also 
indicated that the sensory projection pathways found in 
lower animals, such as the cat, were different from those 
of man. This finding, together with the observation that 
lower animals have less complex EPs than humans, indi¬ 
cated that, in general, case development of animal models 
of human EPs would require the use of primates. 
Both basic and clinical research has expanded rapidly, 
and has led to numerous clinical diagnostic and prognostic 
applications. The basic advantage of EP analysis for clini¬ 
cal use derives from the fact that it is an objective, benign, 
non-invasive test of the integrity of the somatic, auditory, 
and visual sensory systems and associated brain function 
which does not require patient cooperation, or even that 
the patient be conscious. It therefore has its most valuable 
use in conditions where routine neurological examination 
is undependable or impossible. 
NPL and similar laboratories are currently engaged in 
the development of human EP recordings to assist in the 
evaluation of neurological disorders. Since some EPs can 
be recorded without active participation by the patient (for 
example, while the patient is asleep or comatose), they are 
valuable in assessing the neurological status of patients 
who cannot communicate with the physician. For 
example, in collaboration with Drs. Bennett Shaywitz 
associate professor of pediatrics and neurology and Peter 
Rothstein at Yale, Drs. W.R. and G.D. Goff have been 
using somatosensory EPs (evoked by stimulation of the 
median nerve at the wrist) to evaluate the neurological 
status of children with Reyes Syndrome, a serious, often 
fatal disease afflicting young children. Physicians at Yale- 
New Haven Hospital have had considerable success in 
reducing the mortality rate from Reyes Syndrome by using 
deep sedation, muscle relaxation, and artificial ventilation 
to reduce the abnormally high pressure on the brain and 
other effects of the disease. However, this treatment has 
the undesirable side effect of preventing the physician 
from communicating with the child and from carrying out 
neurological examinations. EP recordings from Reyes 
Syndrome patients have demonstrated that the degree of 
abnormality in EPs relative to those of normal children 
provides a useful index of brain function during the course 
of treatment, and may predict which children are likely to 
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have later neurological or behavioral impairment. The use 
of EPs to assess the degree of brain damage in other types 
of coma and following traumatic head injury is also being 
actively investigated. 
Another important clinical application of human EP 
recordings is to help detect and localize lesions and other 
neurological abnormalities located in or near the sensory 
pathways. It has become clear over the last ten years that 
such lesions can produce definite EP abnormalities even in 
patients who report no noticeable symptoms. The detec¬ 
tion of such clinically “silent” lesions is proving valuable 
in the early detection of demyelinating lesions of the type 
which later develop into multiple sclerosis, in the early 
detection of brain tumors, and in detection of lesions of 
several types of hereditary neurological disease in persons 
who have affected family members but who have not yet 
reported symptoms themselves. Some of these abnormali¬ 
ties may also be detectable by radiological techniques such 
as the CT scan, but some produce little or no structural 
abnormality (at least in the early stages of the disease) and 
may be missed in radiological studies. 
Dr. Allison currently employs a battery of EP tests to 
search for such clinically silent lesions and to help verify 
the location of lesions whose existence is suggested by 
clinical findings or radiological studies. VA patients are 
tested at NPL and patients in Yale-New Haven Hospital are 
tested in a similar laboratory established by NPL and the 
Department of Neurology, and directed by Dr. Ann Hume 
research associate in neurology. The EP test battery con¬ 
sists of stimulating each of the three major sensory 
systems - the visual, auditory, and somatosensory systems. 
The visual test uses a checkerboard pattern stimulus which 
is rapidly moved twice each second so that the positions of 
the light and dark checks appear to reverse. This stimulus 
produces a barrage of nerve impulses traveling from the 
retina through the optic nerve to the thalamus and visual 
cortex. Activation of visual cortex produces a characteris¬ 
tic EP component approximately 100 milliseconds follow¬ 
ing the checkerboard reversal. As human EPs go, this 
potential is relatively large (about five millionths of a volt) 
and quite stable in latency in neurologically normal sub¬ 
jects. Abnormally long visual EP latencies indicate the 
presence of a lesion somewhere along the visual pathway. 
This technique is currently one of the most sensitive means 
of detecting demyelinating lesions in the optic nerve, a 
common precursor of multiple sclerosis. During the acute 
phase of the disease, patients may experience blurring of 
vision or other visual symptoms, but these often disappear 
after several weeks. However, recent work suggests that 
the demyelination is still present and produces the char¬ 
acteristic EP abnormality. Thus, a useful feature of this 
test is that it allows verification of optic nerve lesions 
which may have occurred years earlier and either produced 
no visual symptoms at the time or produced symptoms 
which disappeared before the person became concerned 
enough to see a physician. 
The auditory and somatosensory systems are tested with 
EPs in a similar manner, using acoustic clicks and brief 
shocks to a peripheral nerve, respectively. The auditory 
and somatosensory EPs that have been most clinically 
useful are those known to be generated by particular 
structures along the afferent pathway in each modality. By 
determining which potentials are abolished or altered, it is 
possible to infer the location of abnormalities in the peri¬ 
pheral nerve, brainstem, or midbrain. The auditory and 
somatosensory EPs are both extremely small (less than a 
The photograph illustrates recording of electrical activity from the surface of the brain to locate the sensormotor 
cortex during surgical removal of a tumor. 
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millionth of a volt) and between 500 and 1000 stimulus 
repetitions are usually necessary to resolve them 
adequately. Fortunately, such EPs can be recorded at 
stimulation rates of 5 - 10 per second, so that the tests can 
be carried out in a few minutes. Auditory EPs have been 
useful in the early detection of acoustic neuromas, 
demyelinating lesions of the brainstem or midbrain, and 
other types of neurological disease that affect those brain 
regions. Somatosensory EPs have also been useful in 
detecting demyelinating lesions, as well as other spinal 
cord, brainstem, and midbrain abnormalities. 
The pathophysiological mechanisms underlying some 
of the EP abnormalities in neurological disorders are rela¬ 
tively well understood. For example, the abnormally late 
visual, auditory, and somatosensory EPs associated with 
multiple sclerosis result from demyelinization of nerve 
fibers which slow their conduction velocity. The patho¬ 
physiological mechanisms responsible for other common 
EP abnormalities, such as the abolition of certain auditory 
and somatosensory EPs, are not yet understood. 
EP recordings are also clinically useful in neurosurgery. 
When abnormal tissue must be removed from the brain, it 
is important to spare cruicial areas such as sensorimotor 
cortex and the areas devoted to speech. In collaboration 
with Drs. Peter D. Williamson and Dennis B. Spencer of 
the Departments of Neurology and Neurosurgery, an NPL 
group headed by Dr. Charles C. Wood has developed a 
new technique based on cortical surface EP recordings for 
use in localizing sensorimotor cortex during neurosurgery. 
The traditional localization procedure was developed by 
Penfield and colleagues at the Montreal Neurological 
Institute in the 1930s and 1940s. It involves stimulation of 
the cortical surface with minute electrical currents. 
Stimulation of sensorimotor cortex produces sensations or 
movements in parts of the body corresponding to the 
cortical area stimulated. Careful mapping of the sensory or 
motor responses to stimulation of a number of different 
cortical sites allows the location and extent of sensori¬ 
motor cortex to be estimated. A disadvantage of the proce¬ 
dure for patients is that the surgery must be performed 
under local anesthesia so that they can be awake, coopera¬ 
tive, and able to report sensations and movements elicited 
by the cortical stimulation. 
The NPL procedure involves stimulation of the median 
nerve at the wrist as in the somatosensory EP recordings 
from the scalp described above, and recording from an 
array of sterilized electrodes placed directly on the 
exposed cortex. The median nerve stimulus produces EPs 
which have a characteristic spatial distribution on the 
cortical surface. The location of sensorimotor cortex can 
be reliably inferred from the form of that spatial distribu¬ 
tion. The NPL procedure is at least as reliable as the 
traditional electrical stimulation procedure, it is faster, and 
it does not require the patient's cooperation; hence it can be 
used with general anesthesia. 
A major value of EPs used in neurological test (para¬ 
graphs) derives in part from their insensitivity to subjective 
states; if the sensory pathways are intact, these EPs will be 
present. However, the signal averaging technique has also 
been used to study other potentials which are elicited only 
when a stimulus has meaning or significance within 
information processing tasks which the subject is perform¬ 
ing. Since such potentials are not, strictly speaking, 
“evoked," they have been termed "event-related poten- 
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tials” (ERPs). For example, if subjects are required to 
categorize each of a series of tones into two groups (for 
example, high versus low frequency tones), ERPs time- 
locked to those tones will include a group of potentials not 
present to the same stimuli delivered without a task. The 
timing of those potentials is proportional to the time 
required for the categorization: if the task is to categorize 
high and low frequency tones, these potentials will occur 
about 350 milliseconds after the tone onset, whereas if the 
task is more difficult, for example to categorize words into 
groups based on their meaning, the potentials will occur 
some 200-300 milliseconds later. Such ERPs are thought 
to represent activity of brain systems involved in elemen¬ 
tary cognitive processes. 
Dr. Gregory McCarthy of NPL and Dr. Shlomo Bentin, 
a visiting scientist from Israel, have been conducting 
research concerned with potentials sensitive to psycholo¬ 
gical task manipulations. There are two goals of this 
research: to attempt to characterize the psychological 
processes associated with these potentials, and to deter¬ 
mine what brain systems and structures are responsible for 
their generation. In employing this approach, NPL scien¬ 
tists hope to gain a better understanding of the neurological 
basis of certain cognitive processes. 
The value and utility of these neurophysiological tech¬ 
niques depends upon two types of knowledge: the statisti¬ 
cal limits of normality for potentials recorded from normal 
human subjects, and the knowledge of the anatomical 
structures which generate scalp potentials. NPL is engaged 
in research on both problems. They recently completed 
normative studies of some of the EPs used in neurological 
testing and have for many years conducted studies on the 
anatomical sources of scalp potentials. The latter include 
recordings from the exposed cortical surface of the human 
brain during neurosurgery and from chronically implanted 
electrodes in epileptic patients (see the companion article), 
experiments in primates and other nonhuman species 
under conditions comparable to those of the human record¬ 
ings and, together with Dr. Terrance Darcey of NPL, the 
development of mathematical models of electrical sources 
in the brain. 
In summary, the work of NPL has helped to establish EP 
and ERP recordings as a noninvasive means of studying 
electrical activity of the human nervous system. Such 
recordings are valuable as neurological tests for assessing 
the functional integrity of the sensory afferent pathways 
and related brain structures, and as a means of investigat¬ 
ing the neural structures involved in human cognitive 
processes. Because EP and ERP recordings provide a 
measure of some aspects of brain function, they are com¬ 
plementary to the CT scan and other radiological tech¬ 
niques for assessing brain structure. Together, such tech¬ 
niques have in the last decade vastly improved our ability 
to “see” deep within the brain from the outside. 
9 
PROGRESS IN TREATING INTRACTABLE EPILEPSY 
The Yale epilepsy surgery program is among the 
foremost in the world. Its success is due in part to 
intensive ongoing research in pre-surgical evalua¬ 
tion conducted at the West Haven Veterans 
Administration Medical Center, as well as to the 
development of new surgical procedures at the 
Yale School of Medicine. It is also the result of 
close collaboration between neurologists and a 
surgeon. 
Tom Regan met with interviewers in his room in the Yale 
Epilepsy Center at the West Haven Veterans Administra¬ 
tion Medical Center early in April. A handsome and 
articulate man in his early thirties, he had come there that 
morning from Utica, New York for psychological and 
neurological tests, and his head was crowned with a dozen 
or so scalp electrodes. A year ago, Mr. Regan had under¬ 
gone brain surgery to remove the site of epileptic seizures 
that had affected him for several years. 
An estimated 2 million Americans are epileptic. As a 
result of centuries of myths and misunderstanding about 
the disorder, a major problem for many of them is not only 
their seizures, but the psychological, social and economic 
problems the disorder causes. 
Derived from the Greek word, epilepsia, meaning ‘"to 
seize," epilepsy does not refer to a simple syndrome of 
similar symptoms, but rather, to a number of very different 
types of seizures that vary widely in severity, appearance, 
cause and consequence. Advances in pharmacology have 
led to the synthesizing of large numbers of anticonvulsant 
agents and today, epilepsy can be partly or fully controlled 
in at least three-fourths of all patients. There is new hope as 
well for at least some of those patients for whom drug 
therapy has not been successful. 
In addition to developing new technology and drugs to 
control epileptic seizures, the Department of Neurology at 
Yale has designed a comprehensive treatment program 
which includes psycho-therapy and socio-economic guid¬ 
ance. The Epilepsy Center at the V. A. Medical Center is a 
major part of this program. Designated by the Veterans 
Administration as its Northeastern United States Center 
for Epilepsy, it is one of the most highly developed such 
facilities in the country. 
Dr. Richard H. Mattson, clinical profesor of neurology, 
is director of the Center, where twenty-four hour a day 
intensive closed circuit TV/EEG monitoring enables more 
accurate diagnosis of seizures, as well as related problems. 
Its epilepsy surgery program is among the foremost in the 
world. 
The success of the Yale Epilepsy Surgery Unit is due in 
part to intensive on-going research in pre-surgical evalua¬ 
tion, as well as to the development of new surgical proce¬ 
dures. It is also the result of collaboration among the 
three neurologists of the Unit, Dr. Mattson, Dr. Susan 
Spencer, assistant professor of neurology, and Dr. Peter 
Williamson, associate professor of neurology, who work 
closely with Dr. Dennis D. Spencer, associate professor of 
surgery (neurosurgery), who is known world-wide for his 
work in epilepsy surgery. 
Patients are referred to the Epilepsy Center for surgery 
from medical centers throughout the Northeast United 
States when medication has failed to control their seizures, 
and there is no evidence of other illness or disorders, such 
as brain tumors. Criteria for selection include the patient's 
age (between ten and fifty years); the possible surgical 
accessibility of the disease site; the patient’s interest in and 
willingness to comply with the extensive pre-surgical 
evaluation; and whether the seizures significantly interfere 
with the patient's life. 
"We would probably not operate on a patient who, in 
addition to his epilepsy, was profoundly retarded and it 
was clear that the operation would not greatly improve his 
ability to function”, explained Dr. Williamson. Similarly, 
the Unit is sometimes referred patients for epilepsy surgery 
whose seizures are a problem, but whose psychiatric diffi¬ 
culties are an even greater problem. They are not con¬ 
sidered good candidates. “We don’t perform surgery to 
alleviate psychiatric problems — we do it for epilepsy. In 
fact, we consider major psychiatric problems a contra¬ 
indication for surgery.” 
Ninety percent of all epileptic patients experience their 
first seizures before they are twenty years old. Tom Regan 
is one of the exceptions. An Army veteran and college 
graduate employed as a construction manager of a large 
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Depth electrode recording shows the onset of a seizure located deep within the right temporal lobe. Precise localization of such seizure sites, which is not 
possible with scalp electrodes, enables Dr Dennis Spencer to successfully remove diseased areas without causing significant compromise to brain function. 
firm, he was in his twenties when his seizures began. They 
were mild at first but, as they increased in frequency and 
severity, he became profoundly depressed and his behav¬ 
ior became increasingly aggressive. Finally, he had to 
resign his job, and could no longer drive his car. When it 
became evident that medications and other therapies 
would not control his seizures, and in fact his epilepsy was 
becoming increasingly more severe, his doctors in upstate 
New York referred him to the Epilepsy Center in West 
Haven. 
Candidates for epilepsy surgery go through a battery of 
tests before the decision is made whether or not to operate. 
Detailed neuropsychological evaluation includes measure¬ 
ment of verbal and performance I.Q., verbal and visual/ 
spatial memory, language and motor function, and sensory 
perception. In addition, CT scans and scalp electro¬ 
encephalograms are made of each patient. 
The first human electroencephalogram from the scalp 
was recorded in 1929 by Hans Berger, a German psychia¬ 
trist. His observations that epileptic seizures were 
accompanied by major electrical disturbances of the brain 
as recorded on the EEG’s, paved the way for subsequent 
advances in characterization of epileptic seizures. 
Since then, new audio visual and medical technology 
have contributed to the development of highly sophisti¬ 
cated specialized seizure monitoring systems. The Epi¬ 
lepsy Center, under the leadership of Dr. Mattson, Dr. 
Gilbert H. Glaser, chairman of the Department of Neuro¬ 
logy, Dr. Lewis L. Levy, clinical professor of Neurology 
and others at Yale pioneered many of these advances. The 
monitoring is done by a highly experienced and motivated 
staff of nurses, EEG technicians and other paramedical 
professionals. 
The display can be tape recorded for repeated examina¬ 
tion by the staff, which facilitates more precise characteri¬ 
zation of seizures during sleeping as well as waking hours. 
"This information is of great value, not only for the 
diagnosis of specific seizure types, but also for the locali¬ 
zation of the onset of the attack," explained Dr. Mattson. 
A patient is considered an appropriate candidate for 
continuing evaluation if his or her seizures are consistent 
and appear to be coming from a part of the brain where 
surgery would not greatly impair vision, speech, motor 
control or memory. 
Next, electrodes are implanted deep within the brain for 
a more accurate localization and description of the sei¬ 
zures. It is a procedure that involves some initial pain, 
since implantation is done with only local anesthesia, and 
requires considerable patience on the part of the patient, 
who must be restrained in bed for the duration of from 
seven to ten days. Although not widely used, the staff at 
the West Haven V.A. Medical Center considers depth 
electrode recording essential in certain types of epilepsy, 
where seizures are likely to be located deep within the 
brain on the inside of the temporal or frontal lobe — areas 
not readily sampled by scalp electrodes. 
Up to four electrodes are inserted on both sides of the 
brain. Each electrode has eighteen contacts on it giving a 
potential for 144 recording points within the brain. After 
they have been implanted, they are hooked up to a moni¬ 
toring program similar to the one used for scalp electrodes. 
The Surgery Unit has developed a sophisticated 64-channel 
computerized monitoring system, which is currently under 
construction. For the time being, a prototype model is used 
which automatically detects and records seizures on 
magnetic tape. Patients are closely monitored until a 
sufficient number of seizures — at least three — are 
recorded, for final decision making about the viability of 
surgery. 
Although depth electrodes have been used for epilepsy 
since the 1950’s, the technique developed by Dr. 
Williamson and his colleagues at the Center is unique, and 
information derived from it is yielding important new 
insights into seizures. "The other two major centers using 
depth electrodes insert them from the side of the brain; we 
put them in from closer to the mid-line, and one through 
the base of the occipital lobe, which penetrates deep into 
the posterior lobe,” explained Dr. Susan Spencer. The 
electrodes are longer than ones used by other institutions 
and therefore, sample a greater area. 
The use of the posterior electrode is perhaps the most 
critical. “It certainly gives us the most information about 
temporal lobe epilepsy," said Dr. Williamson. "We have 
learned that occipital lobe onset seizures can look exactly 
like temporal lobe seizures. We have also found that many 
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that lobe than was previously thought. As a result. Dr. 
Dennis Spencer has developed a new technique for remov¬ 
ing temporal lobe seizures which seems very promising.” 
The procedure designed by Dr. Spencer involves 
removing part of the hippocampus as well as areas farther 
back in the temporal lobe and allows a more complete 
removal of the diseased area than previous surgical pro¬ 
cedures, without significantly compromising vision, 
speech, memory and motor function. Through her exhaus¬ 
tive review of world literature and her experience at Yale, 
Dr. Susan Spencer and her colleagues can now predict 
that, when seizures are precisely located. Dr. Spencer’s 
procedure has a 90 percent chance of curing the epilepsy. 
Since the hippocampus is important to memory, a 
simple test involving anesthetizing the part of the brain to 
be operated on is made. While that side has no sensation, 
the patient is presented with various pictures, words and 
objects. When the medication wears off, he is asked if he 
can remember what he had been shown. ‘‘This tells us how 
competent the temporal lobe that will not be operated on is 
in terms of memory, and if it’s not, we will not proceed 
with the operation,” Dr. Susan Spencer said. 
Operations are performed at Yale-New Haven Hospital 
by Dr. Dennis Spencer. He operated on Tom Regan last 
April. The procedure involved removal of the left tip of the 
left temporal lobe — “way down under,” according to 
Mr. Regan. It took about six hours and there was some 
pain, he remembers. “But that was a minor investment for 
a major improvement,” he said with a smile. 
For the first six months following the operation, he had 
trouble with memory and speech, but that as well as his 
attitude improved. “I began to approach things in a con¬ 
structive rather than destructive way. Now when things go 
wrong, I can laugh at them. It’s a great feeling.” 
Patients return to the Yale Epilepsy Center for follow-up 
testing every three months the year following surgery, then 
every six months the next year, and annually thereafter. 
Although Mr. Regan is still on medication as a pre¬ 
cautionary measure, some patients have been taken off 
anticonvulsant therapy with no adverse affects. 
What about patients whose seizures come from multiple 
sites or from areas in the brain that cannot be removed 
without creating serious deficits? In some, this problem 
can be approached by a sectioning of the corpus callosum — 
a technique known as “split-brain,” in which the two 
halves of the brain are physically separated. The corpus 
callosum is a large band of connective neural tissues 
resembling a large, multi-cable telephone line, that allows 
the two halves of the brain to communicate, and thus 
coordinate both sides of the body. Previously done in the 
1940's, the procedure fell into disfavor and was discon- 1 
tinued until early in the 1970's when it was revived and 
improved by neurologists and surgeons at Dartmouth 
Medical School. The Yale team began doing the proce¬ 
dure, modified by Dr. Dennis Spencer, a few years later. 
They are the two leading institutions in the country doing 
this type of surgery. 
Only patients with extremely severe epilepsy are con¬ 
sidered — patients whose seizures spread so quickly that 
they black out, fall down and suffer many injuries as a 
result. Some are so severely impaired they must live in a 
padded environment. When the operation is successful, it 
establishes better control and reduces the severity of the 
seizures. A decrease in abnormal behavior is frequently a 
very important side benefit. 
Contrary to what has been written in the popular press, 
the split-brain operation is not devastating. According to 
Dr. Williamson, coordination of the two sides of the body is 
a problem at first, but usually improves or the patient 
learns how to deal with it. There are admittedly problems 
with memory, types of motivation and several intellectual 
processes that, in the long run, may make it difficult for the 
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patient. “On the other hand, we see incredible gains in 
other functions that overshadow these problems. The 
seizures are much less frequent and definitely less severe; 
the patients no longer fall down or black out with the risk of 
terrible injury. “ 
Three-fourths of the patients who have undergone split- 
brain operations during the past decade, either at Dart¬ 
mouth or at Yale, have had good to excellent results. If 
this, and the temporal lobe procedure designed by Dr. 
Spencer, have proven so successful, why not opt for 
surgery over drug therapy in ail epilepsy? 
“That is a good question. The reason is the risks, which 
are such that we can only recommend surgery for people 
who have no alternative, and for those who we know will 
benefit from surgery.” Dr. Susan Spencer replied. “We 
know that some patients — those who have never worked 
or socialized or done anything productive or functional — 
will never achieve functional capacity even if they are 
cured of their epilepsy. We play God a little bit sometimes 
in making these decisions. But when you consider the 
tremendous amount of time and energy involved on the 
part of the staff, not to mention the incredible involvement 
on the part of the patient and the family, it doesn’t seem 
fair to spend all of this to get rid of seizures, when the 
family will still have someone they have to take complete 
care of anyway,” she added. “On the other hand, we can 
take people who have been completely devastated by the 
illness and absolutely cure them. It doesn't always work 
out the way you hoped it would, but when it does, it is 
tremendously rewarding.” 
Since epilepsy made it impractical for him to continue 
construction management, Tom Regan has learned a new 
profession and is now a traffic planner in Oneida County. 
He is eagerly awaiting the green light to drive again, and 
plans to buy a motorcycle as well. “I feel elated just 
looking forward to all of the things I can do again. ” 
By Marjorie B. Noyes 
The highly experienced and motivated staff of nurses, EEG technicians, and other paramedical professionals allow the Epilepsy Surgery Unit to function at a 




DR. COHEN IS APPOINTED 
DIRECTOR OF THE CHILD 
STUDY CENTER 
The Yale Corporation has appointed 
Dr. Donald J. Cohen, professor of 
pediatrics, psychiatry and psychology, 
director of the Yale Child Study Center. 
Dr. Cohen is a well-known authority on 
mental illnesses in childhood. His 
appointment is effective July 1. 
In his new position. Dr. Cohen will 
succeed Dr. Albert J. Solnit, a distin¬ 
guished child psychiatrist and author on 
the mental health of children, who has 
been director of the Child Study Center 
since 1966. Dr. Solnit, Sterling Profes¬ 
sor of Pediatrics and Psychiatry, will 
continue his research, patient care and 
teaching responsibilities. 
Dr. Cohen is also associate director 
of the Children’s Clinical Research 
Center at Yale-New Haven Hospital, 
and co-director of the Yale Mental 
Health Research Center. He is inter¬ 
nationally recognized for his investiga¬ 
tions in the neurochemical dysfunction, 
as well as the cognitive and learning 
disabilities of children with disorders 
such as autism, childhood psychosis, 
aphasia and Tourette’s syndrome. 
Applying methods of developmental 
psycholinguistics, he and his colleagues 
at the Child Study Center have studied 
language patterns in autistic and 
aphasiac children. In collaborative 
studies with teachers and parents, often 
involving hours of observation at home 
and in schools, they have delineated the 
relations between cognitive difficulties 
and social competence in these children. 
“The detailed description of chil¬ 
dren’s underlying competence often 
provides a framework for designing 
educational interventions for autistic 
children.’’ he observed. “While 
formal testing may underestimate a 
child's true competence, many hours of 
careful observation can reveal 
remarkable underlying abilities which 
can be capitalized on in specially struc¬ 
tured educational settings.” 
Dr. Cohen, who was graduated 
summa cum laude from Brandeis 
University in 1961, was a Fulbright 
Scholar in philosophy and psychology 
at Trinity College, Cambridge Uni¬ 
versity, England for a year before he 
attended Yale School of Medicine. He 
received the Miriam Kathleen Dasey 
Award and his M.D. degree cum laude 
in 1966. 
During the following two years he 
was a research and teaching fellow in 
psychiatry at Harvard Medical School 
as well as assistant in medicine at Chil¬ 
dren's Hospital Medical Center, 
Boston. From 1970 to 1972, he was a 
clinical associate at the National Insti¬ 
tute of Mental Health, Adult Psychiatry 
Branch, as well as special assistant to 
the Director of the Office of Child 
Development, Department of Health 
Education and Welfare. 
Dr. Cohen 
Dr. Cohen came to Yale in 1972 as 
associate professor of pediatrics, psy¬ 
chiatry and psychology, and was 
appointed professor in 1979. He has 
received a Woodrow Wilson Fellow¬ 
ship in Psychiatry (1961); Falk Fellow¬ 
ship of the American Psychiatric 
Association (1970-71); Annual Public 
Service Award, National Society for 
Autistic Children (1972); Special 
Recognition, Hofheimer Prize Board, 
American Psychiatric Association 
(1977); and the Ittleson Award. Ameri¬ 
can Psychiatric Association (1981). He 
is a member of the Board of Trustees of 
Brandeis University. 
The author of numerous publications 
and articles on mental illness in child¬ 
hood, he serves on the editorial boards 
of the Journal of the American 
Academy of Child Psychiatry, and The 
Journal of Child Psychology and Psy¬ 
chiatry. A fellow of the American 
Academy of Child Psychiatry and of 
the American Pediatric Society, he is 
also a member of the Western New 
England Psychoanalytic Society, the 
American Psychoanalytic Society, and 
the International Psychoanalytic 
Society. 
14 
SECTION OF CELL BIOLOGY 
BECOMES A DEPARTMENT: 
DR. JAMIESON IS APPOINTED 
THE NEW CHAIRMAN 
The Yale Corporation has established 
the Section of Cell Biology, and has 
appointed Dr. James D. Jamieson 
chairman of the Department, effective 
July 1. 
Dr. Jamieson will succeed Dr. 
George Palade, who has been chairman 
since 1973, when the Section of Cell 
Biology was established in the School 
of Medicine with a grant from the 
Commonwealth Fund. Dr. Palade, who 
received the Nobel Prize for Physiol¬ 
ogy and Medicine in 1974, will assume 
his new appointment as Special 
Advisor to the Dean of the School of 
Medicine on July 1. 
Dr. Jamieson, well known for his 
research in the structural and functional 
correlates of membrane components in 
epithelial tissues, is an outstanding 
teacher as well. He came to Yale in 
1973 from The Rockefeller University, 
where he was an associate professor in 
the Laboratory of Cell Biology, of 
which Dr. Palade was the head. 
Bom in British Columbia, Canada, 
he attended the University of British 
Columbia in Vancouver, where he 
received his M.D. degree in 1960. He 
was awarded the Eric W. Hamber Gold 
Medal for the highest ranking member 
in the graduating class, as well as 
the Homer Gold Medal in Internal 
Medicine. 
In 1966, he received his Ph.D. 
degree from The Rockefeller Univer¬ 
sity and was a member of the faculty of 
the Laboratory of Cell Biology there 
until his appointment as associate pro¬ 
fessor of cell biology at the Yale School 
of Medicine in 1973. He was promoted 
to professor in 1975, and was also 
appointed professor in the Department 
of Biology, Yale University in 1979. 
Dr. Jamieson has been director of the 
Yale Medical Scientist Training Pro¬ 
gram since 1975. 
Dr. Jamieson 
A member of the American Society 
for Cell Biology, of which he was 
1982-83 president. Dr. Jamieson is 
also a member of the Harvey Society, 
the American Society of Biological 
Chemists, and the American Pancreatic 
Association. He is a member of the 
editorial boards of Membrane Bio¬ 
chemistry; Blood Vessels; and the 
Journal of Cell Biology. 
Dr. Barash 
NEW CHAIRMAN OF THE 
DEPARTMENT OF 
ANESTHESIOLOGY 
Dr. Paul G. Barash, professor of anes¬ 
thesiology, has been appointed chair¬ 
man of the Department of Anesthesiol¬ 
ogy. He succeeds Dr. Luke M. Kitahata, 
who will resume his research and teach¬ 
ing activities in the Department. 
Dr. Barash’s research interests are 
directed at cardiovascular and respira¬ 
tory physiology as well as critical care 
medicine. He has been director of the 
Surgical Intensive Care Unit at Yale- 
New Haven Hospital since 1974. 
A graduate of City College of New 
York, he received his M.D. degree in 
1967 from the University of Kentucky 
College of Medicine. Following intern¬ 
ship at Kings County Medical Center in 
Brooklyn, he was a resident in anes¬ 
thesiology at Yale-New Haven Hospital 
from 1970 until 1973, when he was 
appointed assistant professor. He was 
associate professor from 1978 to 1982, 
when he was promoted to professor and 
appointed acting chairman of the 
Department of Anesthesiology. 
Dr. Barash is a member of a number 
of professional societies including the 
International Anesthesia Research 
Society; American College of Chest 
Physicians; American College of Anes¬ 
thesiology; American Society of 
Anesthesiologists; Society of Critical 
Care Medicine, and the Society of 
Cardiovascular Anesthesiologists. 
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A NEW CHAPLAIN IS APPOINTED 
Dr. Alan C. Mermann, clinical profes¬ 
sor of pediatrics and a distinguished 
pediatrician in the New Haven area for 
twenty-five years, has been appointed 
chaplain of the School of Medicine. Dr. 
Mermann, who is an ordained Protes¬ 
tant minister, has been actively 
involved for many years in ethical 
issues both locally and nationally. 
The Office of the Chaplain was 
established at the School of Medicine in 
1967 to support the humanistic needs 
and interests of medical students. In 
addition to offering counseling to stu¬ 
dents, the chaplain also conducts 
courses on medical ethics. “I hope to 
bring certain values to the job,” Dr. 
Mermann said. ”1 will approach it as 
both a physician and a pastor from a 
spiritual and behavioral viewpoint.” 
A specialist in pediatric hematology 
and oncology. Dr. Mermann received 
his B.A. degree from Lehigh Univer¬ 
sity in 1943, and his M.D. degree from 
Johns Hopkins University School of 
Medicine in 1947. He was an intern 
both at Bellevue Hospital in New York 
City and at Johns Hopkins Hospital, 
and completed his residency at 
Memorial Hospital in New York. 
Follow ing military service in Japan as a 
lieutenant in the medical corps, U.S. 
Naval Reserve, he was a research 
fellow at Sloan-Kettering Institute and 
was ordained a minister in the Con¬ 
gregational Church. 
Dr. Mermann has been a partner in 
private pediatrics practice in Guilford 
since 1954. Active in civil rights and 
peace efforts throughout his career, he 
was a volunteer physician for the Medi¬ 
cal Committee for Human Rights. 
Based on his involvement and observa¬ 
tions of the health problems of school 
children and migrant workers in 
Alabama, Tennessee and Florida, he 
was one of a team of physicians who 
testified before the U.S. Senate on 
hunger and deprivation among poor 
children of the South. 
He was appointed to the Yale faculty 
in 1954 as a clinical instructor in 
pediatrics, and was appointed clinical 
professor of pediatrics in 1979, the year 
he received a Master of Divinity degree 
from the Yale Divinity School. 
Y-NNH APPOINTS DR. FENN 
CHIEF OF STAFF 
Dr. John E. Fenn has been appointed 
chief of staff at Yale-New Haven Hos¬ 
pital, effective March 1. He succeeds 
Dr. Lawrence K. Pickett, William H. 
Carmalt Professor of Surgery, who 
resigned as chief of staff, but will con¬ 
tinue as associate dean for clinical 
affairs at the School. 
In announcing the appointment, C. 
Thomas Smith, president of the Hos¬ 
pital said, “Dr. Fenn's breadth of 
experience and intimate knowledge of 
the institution, in conjunction with his 
commitment to the Hospital, his 
demonstrated skill and integrity, augur 
well for Yale-New Haven Hospital. I 
am very pleased with this 
appointment.” 
Bom in New Haven, Dr. Fenn is a 
graduate of Hopkins Grammar School, 
Dartmouth College and the Yale School 
of Medicine. He received post-graduate 
training in surgery at Yale-New Haven 
Hospital. 
Dr. Fenn's specialty is vascular 
surgery. He has been associate chief of 
surgery as well as medical director of 
the operating room at Yale-New Haven 
Hospital prior to his appointment. A 
Fellow of the American College of 
Surgeons, he is a member of the 
American Medical Association, the 
Connecticut Medical Society, Connect¬ 
icut Society of American Board Sur¬ 
geons, the New England Society for 







TWO FACULTY ELECTED TO NAS 
The National Academy of Sciences has 
announced the election of Dr. Joan A. 
Steitz and Dr. Sherman M. Weissman 
as two of its 60 new members in recog¬ 
nition of their distinguished and con¬ 
tinuing achievements in original 
research. Election to membership in the 
Academy is considered to be one of the 
highest honors that can be accorded an 
American scientist or engineer. 
Dr. Steitz is professor of molecular 
biophysics and biochemistry. Her 
research is directed toward understand¬ 
ing molecular mechanisms of gene 
expression in both bacterial and 
mammalian cells. The work is focused 
on RNA molecules, their structures and 
how they function in processes that 
result in information stored in genes 
being expressed in the form of proteins. 
Recently her investigations have 
involved the use of auto-antibodies from 
persons with systemic lupus erythe¬ 
matosus, a rheumatic disease where 
patients make antibodies against their 
own cellular constituents. 
Dr. Weissman’s research has been in 
the molecular genetics of SV40 (a 
virus), the human hemoglobin genes 
and the genes of the major histocom¬ 
patibility complex. The work has been 
concerned with the relation between 
gene structure and the regulation of 
expression of genes, both in normal and 
in diseased states. Dr. Weissman is 
professor of human genetics, medicine 
and molecular biophysics and 
biochemistry. 
NEW FACULTY 
Ali A. Khodadoust, M.D., was ap¬ 
pointed professor of ophthalmology, 
effective September 1982. Dr. 
Khodadoust received his M.D. degree 
from the Shiraz University School of 
Medicine in Iran in 1962. Following 
residency training in ophthalmology at 
the Johns Hopkins Hospital, he was a 
member of the faculty at the Wilmer 
Institute prior to returning to Iran. From 
1968 to 1980, when he returned to the 
Wilmer Institute, he was professor and 
chief of the Department of Ophthal¬ 
mology at the Shiraz University School 
of Medicine. He is internationally 
recognized for his clinical work and 
research on corneal transplantation. 
Ellen R. Gordon, Ph.D., has joined 
the Liver Study Unit as a senior 
research scientist in medicine as of 
December 1982. Dr. Gordon, a bio¬ 
chemist, is internationally known for 
her studies of bilirubin metabolism and 
the effects of ethanol on intermediary 
metabolism in the liver. From 1966 to 
1978 she was on the faculty at McGill 
University in the Department of 
Experimental Medicine and since 1978 
she has been research associate and 
professor of medicine at the Mount 
Sinai School of Medicine in New York 
City. She has also served since 1980 as 
scientific director of the Alcohol 
Research Center at the Veterans 
Administration Medical Center, Bronx, 
New York. 
Effective February 1983, M. Wayne 
Flye, M.D., Ph.D., joined the faculty 
as associate professor of surgery and 
will be responsible for developing a 
transplant program. He was previously 
on the faculties of Duke University and 
the University of Texas Medical 
Branch in Galveston. Also as of Febru¬ 
ary, John F. Tallman, Ph.D., was 
appointed as associate professor of 
psychiatry. He will direct a research 
program in the brain biochemistry of 
major mental illness. He has been at the 
National Institutes of Health since 1972 
and since 1975 in the Section of Bio¬ 
chemistry and Pharmacology, Biologi¬ 
cal Psychiatry Branch, National 
Institute of Mental Health, where he 
was chief prior to coming to Yale. 
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SEARCH FOR NEW DEAN 
Since Dean Berliner will be retiring in 
June 1984, President A. Bartlett 
Giamatti has recently appointed a 
Search Committee which the President 
himself will chair. The Committee is 
looking for a nationally recognized 
leader in medicine or biomedical 
science with proven ability as a scholar 
and administrator. It would welcome 
suggestions from alumni or others of 
any individuals who would be 
considered strong candidates for this 
position. 
Nominations and applications should 
be submitted prior to September 1, 
1983. Curriculum and bibliography 
should be sent to: 
Search Committee for 
Dean of the School of Medicine 
Yale University 
Woodbridge Hall 
105 Wall Street 
New Haven, Connecticut 06520 
YALE STUDENT ELECTED 
PRESIDENT OF AMSA _ 
Valerie Stone, a fourth year medical 
student, is the newly elected 34th 
National President of the American 
Medical Student Association (AMSA). 
She is the fourth woman ever to hold 
this position, and is AMSA's first black 
president. Prior to this position, Ms. 
Stone was the National Coordinator of 
Minority Affairs, and also a member of 
AMSA’s Board of Trustees in 1981 and 
1982. 
Ms. Stone will take a year’s leave of 
absence to fill the full-time position of 
president. She will return to Yale in the 
spring of 1984 to graduate. She plans to 
specialize in primary care with a major 
concentration in pediatric and ado¬ 
lescent medicine, and is committed to 
improving health care policy. 
NOTE: The article on The First Yale 
Women Medical Graduates on page 10 
of the Fall/Winter 1982 issue of Yale 
Medicine, was based on an article in the 
Yale Journal of Biology and Medicine 
(1980), written by Susan Baserga, a 




Two new members have been 
appointed by President Giamatti to the 
Committee on Medical Affairs of the 
University Council. The primary func¬ 
tion of this Council is to study the major 
educational programs and activities of 
the University and to offer recom¬ 
mendations for their improvement. 
This work is carried out by the Coun¬ 
cil’s various committees, each of which 
has as chairman, a Council member 
appointed by the President of the Uni¬ 
versity. Committee members are not 
necessarily Yale alumni — many come 
from outside the Yale alumni body, 
often from outside the academic world: 
but they are all individuals who have 
particular expertise in the committee’s 
area of responsibility. 
The Committee of Medical Affairs 
has as its responsibility the School of 
Medicine, including programs in 
Epidemiology and Public Health, and 
the School of Nursing. It is chaired by 
Dr. William L. Kissick. 
Other members of the committee are 
Mr. Jack R. Aron (B.A. ’28), president 
of the J. Aron Charitable Foundation; 
Dr. George A. Carden, Jr., (B.A. '31, 
M.D. ’35), clinical profesor of internal 
medicine at Columbia University 
College of Physicians and Surgeons; 
Dr. June Osborn, professor of medical 
microbiology and pediatrics and asso¬ 
ciate dean of biological sciences at the 
University of Wisconsin; and Dr. 
Rozella M. Schlotfeldt, professor of 
nursing and former dean of the School 
of Nursing, Case-Western Reserve 
University. 
New members are Dr. Herman N. 
Eisen, who is professor of immunology 
at the Massachusetts Institute of 
Technology, and Dr. Arnold S. 
Reiman, editor of The New England 
Journal of Medicine. 
The Committee held its most recent 
semi-annual meeting in New Haven on 
April 14 and 15. 
SCHOOL'S BUILDING PROJECTS 
EARN RECOGNITION 
Two recent School of Medicine building 
projects have received awards. The 
New Haven Preservation Trust pre¬ 
sented a Merit Award to the School for 
its sensitive rehabilitation and creative 
reuse of the historic Jane Ellen Hope 
Building. The oldest building on the 
School’s campus, the red brick and 
rough stone building was built in 1902 
as a clinic building. Renovations by 
architects Alexander Purves and Allan 
Dehar Associates for its use as a teach¬ 
ing facility were completed last fall. 
First prize for excellence in consult¬ 
ing engineering in the category of 
mechanical and electrical design was 
awarded the School by the New York 
Association of Consulting Engineers 
for fostering excellence in engineering 
of its new chilled water thermal storage 
system. The firm of Meyer, Strong and 
Jones, P C. were mechanical and elec¬ 
trical engineers for the facility which 
was built to increase the capacity of the 
Sterling Power Plant in order to provide 
air conditioning for the Yale-New 
Haven Medical Center. 
Augustus G. Kellogg, director of 
facilities planning for the School, was 
responsible for organization and plan¬ 
ning of both projects. 
THE YALE JOURNAL OF 
BIOLOGY AND MEDICINE TO 
PUBLISH THE PROCEEDINGS 
OF THE INTERNATIONAL 
ORGANIZATION FOR 
MYCOPLASMOLOGY 
The Yale Journal of Biology and Medi¬ 
cine w ill publish the Proceedings of the 
Fourth International Organization for 
Mycoplasmology, which took place in 
Tokyo, September 1-7, 1982. The 
Proceedings will include approximately 
60 papers from scientists in Europe, 
Asia, Africa, Australia and North and 
South America, concerned with the 
clinical, epidemiological, taxonomic, 
molecular biological, evolutionary and 
immunological characteristics of these 
microorganisms and the diseases they 
produce. In addition, about 100 
abstracts of posters and brief presenta¬ 
tions will be included 
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AS ESSELSTYN FELLOW, NEJM 
EDITOR VOICES CONCERN 
ABOUT DEVELOPING MEDICAL/ 
INDUSTRIAL COMPLEX 
“The issue is whether health care is 
going to become simply a commodity 
like automobiles or shoes or tomatoes, 
and whether we are going to treat it as a 
business and allow the market place to 
determine the distribution and the cost 
of health care," Dr. Arnold S. Reiman 
told a group of reporters at a press con¬ 
ference prior to delivering the 1983 
Caldwell B. Esselstyn Lecture on 
“Health Care as Commerce, Medicine 
as Business: What does Profes¬ 
sionalism Mean?” The well-known 
educator and editor of the New England 
Journal of Medicine was on campus 
from March 21 to 23 as the Sixth 
Caldwell B. Esselstyn Fellow of the 
Department of Epidemiology and 
Public Health. 
Throughout his visit, in informal 
meetings and seminars with faculty and 
students, and in his lecture, he expressed 
concern, first voiced in a controversial 
article published in the NEJM in 
October 1980, about the major trend 
toward the development of a medical- 
industrial complex in the United States. 
“The personal commitment of the 
doctor to his patient, one on one, and 
collectively, of physicians to the health 
and welfare of society, has been 
weakened or strained by the growing 
specialization and sophistication of the 
means of health care, ” he said. 
“Furthermore, the change in the 
financing of health care with the third 
party reimbursement system has vastly 
increased the amount of money being 
put into the system and the amount of 
money doctors can earn. These two 
changes, specialization and third party 
reimbursement system, have encour¬ 
aged a kind of commercialism — an 
entrepreneuralism in medicine we have 
never seen before. Companies have 
gone into the health care business 
because the third party reimbursement 
system guarantees them a profit and the 
more special services they provide, the 
more money they make,” he told the 
reporters. “It is an irresistible oppor¬ 
tunity for entrepreneurial capitalism.” 
In response to a question from a 
reporter whether he thinks things are 
better or worse than when he wrote the 
article. Dr. Reiman said flatly, “I think 
it’s worse. The involvement of the 
medical profession in the commer¬ 
cialism has increased considerably, and 
there is a third development — a 
change of attitude on the part of 
government. As the cost of health care 
has increased, and as the federal 
government has reduced its commit¬ 
ment to health care, it is encouraging a 
medical market place, by treating 
health care as a commodity as a way of 
controlling its cost.” 
In conclusion the NEJM editor told 
reporters, “We don't know what 
influence the profit imperative is hav¬ 
ing on the delivery of health care. 
Ideally, I would like to see the medical 
profession take more responsibility for 
this question. I would advocate that 
doctors separate themselves totally 
from any financial interest in the health 
care industry and accept the principle 
that they should only gain financially 
from their own personal services and 
from overseeing the services of 
others ... I advocate that the medical 
professionals regulate themselves. It is 
imperative that there be careful studies 
of the effect of for-profit health care on 
the rest of the health care system. ” 
The Caldwell B. Esselstyn Fellow¬ 
ship was established in 1978 to bring to 
the Yale community an opportunity for 
dialogue on social and ethical issues as 
they affect health and the quality of life. 
It is the gift of the Esselstyn Foundation 
to the Department of Epidemiology and 
Public Health in honor of the late Dr. 
Esselstyn, Yale Class of 1925, who was 
a distinguished physician and humani¬ 
tarian. Previous Fellows have included 
Dr. Lewis Thomas, Dr. Benjamin 
Spock, Dr. Edmund Pellegrino, Dr. 
Charles Scriver and the late Dr. Rene 
DuBois. 
A VIDEOTAPE SERIES ABOUT 
THE HUMAN VOCAL TRACT 
With a series of five videotapes. Dr. 
Edmund S. Crelin has developed a 
creative and comprehensive approach 
to tracing the evolution and describing 
the anatomy, function and develop¬ 
ment of the human vocal tract. Pub¬ 
lished as original research data by Dr. 
Crelin, who is professor and head of the 
Section of Anatomy, the series is also 
intended as teaching material for high 
school and college biology courses. In 
addition, it should be of interest to 
graduate students and professionals in 
diverse fields such as anatomy, 
embryology, anthropology, linguistics. 
speech therapy and singing. 
Although they are a part of a series, 
each of the five tapes is designed to 
present a separate subject: the adult 
vocal tract; structural development; 
functional development; structural 
evolution; and functional evolution. 
Narrated by the author, they include not 
only drawings and models but also as 
much live action as possible. 
To simplify descriptions of how they 
function Dr. Crelin made rubber copies 
of the vocal tracts. One, using a plastic 
larynx and air under pressure, is the 
first copy ever made that produces 
vowel sounds by the same process used 
in living adults. 
In the tape on structural evolution, 
replicas are shown of nearly all of the 
fossil skulls of human ancestors from 
5,000,000 to 30,000 years ago. Dr. 
Crelin demonstrates how he used skull 
base anatomy to reconstruct the vocal 
tracts of human ancestors and trace 
their lineage to present day humans. It 
is noted that the development of the 
human vocal tract between three and 
six years of age is a synopsis of what 
occurred during human evolution 
between 1,000,000 and 50,000 years 
ago. 
Through the use of reconstructed 
functional vocal tracts and fossil skull 
replicas, the tape on functional evolu¬ 
tion demonstrates that the evolution of 
the vocal tract is related to the develop¬ 
ment of the frontal lobe in the human 
brain. In this tape Dr. Crelin offers the 
hypothesis that speech sounds first 
became language, which in turn led to 
abstract thought. 
Further information about the tapes, 
which run approximately 30 minutes 
and cost $200.00 each, may be 
obtained from Videoplay Systems, 
Inc., Tolland Industrial Park, P.O. Box 
800, Rockville, CT 06066; phone: 
(203)875-5211. 
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FRY COLLECTION ON VIEW 
IN LIBRARY 
Works by Peter Breughel. Rembrandt 
van Rijn, and Charles Addams are 
among those featured in “A NEW 
LOOK FOR OLD MEDICAL 
PRINTS,” an exhibit currently on view 
at the Yale Medical Library. The 
exhibit, subtitled "Conservation, 
Microphotography, and Microcom¬ 
puters in the Clements C. Fry Collec¬ 
tion,” was organized to introduce and 
explain a new system, developed at the 
Library to facilitate and enhance the 
cataloging, preservation, and accessi¬ 
bility of special museum collections. 
Combining the technologies of micro¬ 
image photography with microcom¬ 
puters, the system is the first of its kind 
to be applied in a library or museum 
environment. Its development and 
application was made possible through 
a gift from Hoffman-La Roche, 
Incorporated. 
The Clements C. Fry Collection, 
bequeathed to the Medical Library in 
1955, is one of the great collections of 
art related to medicine. Its 2000 prints 
and drawings present artists’ views of 
the practice of medicine over four cen¬ 
turies. "For many years, the collection 
has not been easily accessible to schol¬ 
ars, and its preservation has been a 
serious concern,” said Susan Wheeler, 
director of the project and preparer of 
the exhibit. "Our purpose was to 
develop a practical, low-cost method 
for creating full access to the collec¬ 
tion, while at the same time, preserving 
it and maintaining its security. The 
project represents a successful collabo¬ 
ration among specialists in diverse 
areas, some of whom have never applied 
their expertise to museum or library 
problems.” 
To facilitate the cataloging and con¬ 
solidation of records in the Fry Collec¬ 
tion, Dr. David Stagg, Director of the 
Biomedical Computing Unit, developed 
and wrote a flexible database manage¬ 
ment system, which makes available 
for the low-cost microcomputer some 
of the features of sophisticated pro¬ 
gramming which have previously only 
been available for larger computer sys¬ 
tems. The program provides for 43 
categories of information to be recorded 
for each item in the collection, together 
with retrieval of a print or drawing by 
any category. 
A method of visual access to the 
collection was devised by William 
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Guth, Director of Communications 
Media in the School of Medicine. Color 
microimages of each item in the collec¬ 
tion now permit scholars to view 
rapidly all, or a portion of the collection 
without compromising the security or 
preservation of the fragile originals. 
Conservation was a major part of the 
two-year project. Time, exposure to 
sunlight and air pollution, and chemical 
interaction of various papers and 
mounts had caused a number of the 
prints to be on the verge of destruction. 
Jane Greenfield, Conservator of the 
University Library, supervised the 
preservation and restoration of several 
hundred of the prints, examples of 
which are on view. 
The exhibition is designed to demon¬ 
strate some of the problems of main¬ 
taining small collections, together with 
practical solutions to those problems. It 
also reintroduces an important resource 
to the community. "Historical research, 
using art as a source, is dependent upon 
collections such as the Fry Collection. 
From historical graphic representations, 
it is possible to learn about the customs 
and practice of the past,” Ms. Wheeler 
noted. 
FESTSCHRIFT HONORING 
DR. HORSTMANN PUBLISHED 
BY THE YALE JOURNAL 
Dr. Dorothy M. Horstmann, John 
Rodman Paul Professor Emeritus of 
Epidemiology and Pediatrics, was 
honored at a party in June 1982, given 
by her many friends and students; 
manuscripts of a group of papers writ¬ 
ten in her honor were presented to her 
on that occasion. These papers have 
now been published in a special 230 
page issue of The Yale Journal of 
Biology and Medicine (Volume 55, 
No. 3-4). The distinguished author¬ 
ship, which reflects the high regard in 
which Dr. Horstmann is held through¬ 
out the world, includes 35 papers con¬ 
cerned with virology, ranging in scope 
from epidemiology to molecular biol¬ 
ogy. Additional copies are available at 
$24.95. These can be ordered from The 
Yale Journal of Biology and Medicine, 
333 Cedar Street, New Haven, CT 
06510. 
FACULTY NEWS 
At its annual meeting on April 26, the 
Greater New Haven Chamber of Com¬ 
merce presented its Community 
Leadership Award for 1983 to Dr. 
James C. Comer, Maurice Falk Pro¬ 
fessor of Psychiatry, Child Study 
Center and associate dean of the School 
of Medicine. In announcing the award 
the Chamber stated, "Dr. Comer’s 
contributions to this area have been 
most significant. He has been directing 
a project for the Yale Child Study 
Center in cooperation with the New 
Haven Public School systems; he has 
been a consultant to other school 
systems in the area. The results of the 
project he has led have constituted a 
success story now being copied in 
many other cities.” 
Dr. XandraO. Break efield received 
a McKnight Neuroscience Develop¬ 
ment Award in support of her research 
on "The Biochemical Component of 
Memory: Locating the Gene Responsi¬ 
ble for Familial Alzheimer’s Disease.” 
The Foundation established the awards 
to advance research in neuroscience 
especially as it pertains to memory and 
to a better understanding of disorders 
affecting memory and its biological 
substrates. 
Dr. Joseph S. Fruton and Dr. Robert 
Jay Lifton are among 292 scholars, 
scientists and artists awarded John 
Simon Guggenheim Fellowships for 
1983. Dr. Fruton, who is the Eugene 
Higgins Professor Emeritus of Molecu¬ 
lar Biophysics and Biochemistry, will 
work on studies in the history of bio¬ 
chemical sciences; Dr. Lifton, the 
Foundations Fund for Research in 
Psychiatry Professor of Psychiatry, 
will continue research for a book on the 
Nazi holocaust and nuclear threat. 
The American Society for Microbiology 
presented the 1983 Becton-Dickinson 
and Company Award in Clinical 
Microbiology to Dr. Gueh-Djen Edith 
Hsiung for her outstanding contri¬ 
butions to the field of diagnostic 
virology. The award honors a distin¬ 
guished microbiologist whose research 
accomplishments have led to important 
clinical microbiology applications. Dr. 
Hsiung is professor of laboratory medi¬ 
cine and chief of the Virology Labora¬ 
tory at the Veterans Administration 
Medical Center, West Haven. 
Three School of Medicine scientists 
have received research grants from the 
American Cancer Society. They are: 
Dr. George Miller, the John F. Enders 
Professor of Pediatric Infectious Disease 
and Epidemiology, who received a 
grant in support of his research in the 
molecular mechanism of viral transfor¬ 
mation and oncogenesis; Dr. Ravinder 
Nath, associate professor of therapeutic 
radiology, who has been awarded a 
grant to compare the effectiveness of 
americium-241 gamma rays with 
radium-226 gamma rays in the treat¬ 
ment of gynecological cancers; and Dr. 
Richard Peschel, assistant professor 
of therapeutic radiology, whose grant 
will support his study of the underlying 
radiobiology which occurs in tumors 
treated with continuous low dose rate of 
irradiation. 
Dr. Mark Cullen has been selected as 
a Henry J. Kaiser Family Foundation 
Faculty Scholar in Internal Medicine. 
Dr. Cullen is director of the Yale 
Occupational Medicine Program and of 
the General Occupational Health Clinic, 
and co-director of the Occupational 
Lung Disease Clinic at Yale-New 
Haven Hospital. 
The Professional Division of the 
American Association of Publishers 
has awarded the 1982 prize for the most 
outstanding book in the behavioral 
sciences to Father and Child, edited 
by Dr. Alan Gurwitt, associate clini¬ 
cal professor of psychiatry. Child 
Study Center, Dr. Stanley Cath, and 
Dr. John Ross. The award was based on 
contribution to the field and design of 
the book, which was published by 
Little, Brown and Company. 
In Washington, D.C. on May 24, Dr. 
James L. Boyer and Dr. Harold O. 
Conn, participated in "Meet the 
Researchers Day,” sponsored by the 
American Liver Foundation to famil¬ 
iarize the general public with progress 
in research in the treatment of liver 
diseases. Dr. Boyer, professor of medi¬ 
cine, is director of the Liver Study Unit 
at the School of Medicine, and Dr. 
Conn, also a professor of medicine, is 
chief of the Liver Unit at the Veterans 
Administration Medical Center in West 
Haven. 
Dr. Peter Jatlow, professor of labora¬ 
tory medicine and psychiatry, has been 
elected president of the Academy of 
Clinical Laboratory Physicians and 
Scientists (ACLPS) for 1983-1984. 
ACPLS is primarily concerned with 
teaching and research in laboratory 
medicine. Dr. Jatlow has also been 
appointed to the Clinical Chemistry 
Test Committee of the American Board 
of Pathology. 
The Academy of Laboratory Physi¬ 
cians and Scientists awarded the Gerard 
T. Evans Prize to Dr. Joseph Bove, 
professor of laboratory medicine, for 
"his outstanding contributions to the 
science and clinical discipline of 
laboratory medicine, and with gratitude 
of the many academicians in laboratory 
science whose careers were initiated 
and enriched by his guidance.” Dr. 
Bove is internationally recognized as 
an expert on the scientific and clinical 
aspects of blood transfusion, and is co¬ 
author of one of the major textbooks on 
this topic. 
The School of Medicine has been 
selected as one of five institutions to 
participate in the third Mental Health 
Research Network on Risk and Protec¬ 
tive Factors in the Major Mental Dis¬ 
orders. The network which is sponsored 
by the John D. and Catherine T. 
MacArthur Foundation brings together 
internationally recognized investiga¬ 
tors from the fields of psychiatry, psy¬ 
chology, biology, genetics, epi¬ 
demiology and sociology to examine 
risk and protective factors in patients 
with schizophrenia, antisocial per¬ 
sonality disorders, and affective dis¬ 
orders such as depression and manic- 
depressive illness. Dr. Myrna M. 
Weissman, professor of psychiatry, 
and Dr. Donald J. Cohen, professor of 
pediatrics, psychiatry and psychology 
have been named to lead research pro¬ 
jects for the network at Yale. 
Raymond Yesner, professor of 
pathology, delivered the WHO Lecture 
at the 72nd annual meeting of the Inter¬ 
national Academy of Pathology on 
March 1. His topic was classification of 
lung tumors. He also addressed the 
Arthur Purdy Stout Society of Surgical 
Pathologists on small cell tumors of the 
lung. 
Dr. George Palade received an award 
from the Yale Science and Engineering 
Association. The award was presented 
to the distinguished professor and 
chairman of cell biology at the Associ¬ 
ation’s annual meeting on April 6. 
BOOKS BY FACULTY 
"Working with Disadvantaged Parents 
and Their Children.” By Sally 
Provence, professor of pediatrics, 
Child Study Center; and Audrey 
Naylor, assistant clinical professor of 
social work. Child Study Center. Yale 
University Press (New Haven) 1983. 
192 pp. 
"Indefensible Weapons: The Political 
and Psychological Case Against 
Nuclearism”. By Robert Jay Lifton, 
professor of psychiatry; and Richard 
Falk. Basic Books (New York) 1982. 
"Thoracic and Cardiovascular Sur¬ 
gery”, 4th edition. Edited by William 
W. Glenn, M.D., Charles W. Ohse 
Professor of Surgery. Appleton- 
Century-Crofts (Norwalk) 1983. 
"Examine Your Doctor, A Patient’s 
Guide to Avoiding Medical Mishaps”. 
By Siegfried J. Kra, M.D ., associate 
clinical professor of medicine. Ticknor 
and Fields (New Haven) 1982. 
Basic M-Mode Echocardiography”. 
By Siegfried J. Kra, M.D. Medical 
Examination Publishing Co. (New 
Hyde Park, New York) 1982. 
"Deductive Echocardiography: Case 
Studies”. By Siegfried J. Kra, M.D.; 
and Kenneth Schwartz, M.D., assist¬ 
ant clinical professor of medicine. 
Medical Examination Publishing Co. 
(New Hyde Park, New York) 1982. 
"Strabismus and Ocular Motility”. By 
Caleb Gonzalez, M.D., professor of 
ophthalmology. Williams and Wilkins 
(Baltimore) 1983. 
“Basic Neuroradiology”. By Mohammad 
Sarwar, M.D., associate professor of 
radiology; Behrooz Azar-kia, M.D.; 
and Solomon Batnitzky, M.D., Warren 
H. Green Inc. (St. Louis) 1982. 
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EDWARD H. STORER. M.D. 
Edward Hammond Storer, professor of 
surgery and associate dean, died on 
February 21st, while cutting firewood 
on his wood lot in Guilford. A subdural 
hemorrhage led to his sudden and 
untimely death. 
Ed was a gentle man in every sense 
of the word. Bom in Rockland, Maine, 
in 1921, he embodied all of the fine 
qualities that have long been associated 
with the descendants of his staunch 
New England forebears. 
Hardworking, honest and forthright 
in his dealings with associates and 
friends — compassionate with those in 
need, and a keen sense of duty to the 
many who relied on him in so many 
different ways. 
Ed was a man of very few words but 
penetrating thoughts — preferring to 
express his views and values by the way 
he conducted his personal life — a life 
lived with integrity, generosity and 
devotion to his family. 
He received his undergraduate 
education at the University of Chicago 
where he held an Honor Scholarship 
and remained there to complete his 
medical studies in 1945. 
Perhaps the one phase of Ed's pro¬ 
fessional life of which he was most 
proud were the years spent in the 
laboratory of the great Lester Dragstedt 
at the University of Chicago Clinics 
from 1943 to 1950. It was during this 
time that his strong interest in scientific 
research was awakened and played a 
significant role throughout the 
remainder of his life. 
There at Chicago, in collaboration 
with Dr. Dragstedt, the pioneering 
work on the role of the vagus nerve in 
gastric secretion was carried out and led 
to a totally new concept in the surgical 
management of peptic ulcer disease, 
which remains predominant today. 
These were "heady” times for this 
young academic surgeon, in more ways 
than one. For it was there that he wooed 
and wed Dorothy — his wife of thirty- 
eight years. 
On leaving Chicago in 1952, the 
Storers moved to Seattle and the Uni¬ 
versity of Washington, where they fell 
in love with the Great Northwest. Their 
stay in Washington, was cut short 
however, by an invitation from another 
distinguished surgeon. Dr. Harwell 
Wilson, to join the faculty of the Uni¬ 
versity of Tennessee in Memphis, as an 
assistant professor of surgery and direc¬ 
tor of the Surgical Research Labora¬ 
tories in 1955. 
His research productivity continued 
unabated while at Tennessee, publish¬ 
ing 19 scientific papers and a textbook 
of surgery during the following ten 
years. His many contributions earned 
him a full professorship in surgery and 
a joint appointment in the Department 
of Physiology and Biophysics. 
Yale was fortunate, in 1959, when 
Ed accepted our invitation to join the 
faculty as a professor of surgery and 
serve as chief of surgical services at the 
West Haven Veterans Administration 
Hospital, where he subsequently 
assumed the additional roles of chief of 
staff and associate dean. Even in the 
face of these adminstrative burdens, he 
continued to make fundamental contri¬ 
butions to our knowledge of gastro¬ 
intestinal physiology through his many 
publications. Since 1969, Ed was 
editor of the textbook. Principles of 
Surgery — probably the leading text¬ 
book of surgery in the world and cur¬ 
rently in its 4th printing. 
While Ed enjoyed his professional 
work immensely, he was a man of 
many and varied interests. His fine bass 
singing voice, which so few of us were 
privileged to hear, was put to good use 
from time to time in singing madrigals 
and was a reflection of his abiding love 
of good music. 
His skills with tools of all kinds and 
flair for woodworking enabled him, 
with Dorothy's careful supervision, to 
convert the old Post Office in Sachem's 
Head to a charming home where guests 
were treated to the Storer’s warm and 
gracious hospitality. 
High on his list of pleasures was a 
good round of golf on the Yale Course, 
where he achieved a respectable handi¬ 
cap and was known to occasionally 
pick up a tournament prize. 
One of his most remarkable achieve¬ 
ments, at least to his contemporaries, is 
one he shared with Dorothy when they 
both passed the qualifying tests in 
scuba diving, and as recently as four 
weeks ago he and Dorothy were explor¬ 
ing the mysteries of the Caribbean Sea 
at a depth of 150 feet off Bimini Island. 
There is much, much more that one 
could say about Ed, but he of all 
people, would want this to be brief. 
I must say we'll miss Ed and his 
bright bow ties so lovingly designed by 
Dorothy and we are all grateful for the 
way this fine man enriched our lives. 
J.W.C. 
SUSAN C. ALTSHUL, M S N. 
Susan Cleveland Altshul. assistant 
clinical professor of nursing and psy¬ 
chiatry. died April 1, 1983 after a long 
illness. Mrs. Altshul was bom May 9, 
1941 in Norwood, Massachusetts and 
attended elementary and high schools 
in the Boston area. She graduated from 
Skidmore College with a B.S. degree in 
nursing in 1963 and worked for two 
years as a nurse and an instructor of 
nursing as a Peace Corps Volunteer in 
Turkey. Upon her return from Turkey, 
Mrs. Altshul worked for the Visiting 
Nurse Association of Boston for two 
years. 
She came to Yale in 1967 and in 1969 
received a M.S.N. degree from the 
School of Nursing. From June 1969 
until her death Mrs. Altshul was a cli¬ 
nical specialist (in psychiatric nursing) 
on the staff of the Mental Hygiene Cli¬ 
nic at the West Haven Veterans 
Administration Medical Center. She 
established and directed the Continuing 
Care Division of the Clinic and 
assumed responsibility for the coordi¬ 
nation of the treatment provided 
patients with chronic, disabling psy¬ 
chiatric difficulties. To this work Mrs. 
Altshul brought energy, true caring, an 
inquiring mind, and an interest in 
teaching others how to do what is easily 
seen as unrewarding treatment. She 
participated actively in a variety of 
research projects and presented at a 
number of professional conferences. In 
addition to her contributions to the 
Mental Hygiene Clinic, she was a 
valued member of the Nursing Service 
at the Veterans Administration Medical 
Center, and was involved in consulta¬ 
tive and teaching activities throughout 
the Medical Center. 
Mrs. Altshul is survived by her hus¬ 
band, Victor Altshul, an associate 
clinical professor of psychiatry, and by 
two children, Jonathan and Katherine. 
Contributions in her memory may be 
made to the Susan C. Altshul Fund (by 
check payable to "Veterans Admini¬ 
stration Medical Center,” sent c/o Paul 
Errera, M.D., Chief, Psychiatry 
Service, VAMC, West Haven, Con¬ 
necticut 06516). G.S.G. 
The foregoing tribute was presented by 
Dr. Jack W. Cole at a Memorial Ser¬ 
vice for Dr. Storer in Dwight Chapel on 




NEW CHALLENGE GIFT FOR THE ALUMNI FUND 
In the spring of 1982, announcement was made of Dr. 
Leona Baumgartner’s challenge gift to encourage new and 
increased contributions to the Medical School Alumni 
Fund and the Public Health Alumni Fund for student loans. 
Dr. Baumgartner pledged $75,000 for the Student Revolv¬ 
ing Loan Fund, provided that a further $150,000 in new 
money was given by medical and public health alumni and 
friends of the School — a one-for-two match. The re¬ 
sponse was impressive, and as of December 1982 the 
$150,000 in new money had been raised to qualify for Dr. 
Baumgartner’s $75,000 gift. 
Dr. Baumgartner has now offered a new challenge gift 
of $50,000 for the Student Revolving Loan Fund provided 
that an additional $150,000 in new money is contributed. 
Thus every dollar that you give to the Medical School or 
Public Health Alumni Fund above what you gave the 
previous year will now be matched one-for-three. If you 
made no gift last year, your contribution this year will be 
matched one dollar for every three. 
If Dr. Baumgartner’s new challenge is met, the much 
needed funds for additional student loans will be signifi¬ 
cantly increased. We hope that all of our medical and 
public health graduates will respond to this magnificent 
appeal. 
THE ALUMNI IN 
MEDICINE COLUMN 
Notes from the President 
Nicholas P.R. Spinelli, M.D. 
Alumni Directories/Alumni Directions 
The process is in progress. At this writ¬ 
ing 4,210 questionnaires have been 
mailed to graduates of the Yale School 
of Medicine; 1,955 to graduates of 
Epidemiology and Public Health; 
1,446 to members of Grace-New 
Haven and Yale-New Haven Hospital 
house staff; 477 to post doctoral fel¬ 
lows; and 147 to the relative new¬ 
comers among Yale graduates in the 
medical disciplines, the physician asso¬ 
ciates. The primary message of this 
communication (like that accom¬ 
panying the questionnaire) is: Please 
complete and return it promptly, 
preferably on receipt. 
For those delinquent, one repeat 
mailing will be forthcoming. It is frus¬ 
trating to be presented a deficient direc¬ 
tory or an inaccurate one; yet a satisfac¬ 
tory conclusion is contingent on every¬ 
one's cooperation and performance. 
Enough said, almost. 
The occasion does provoke rumina¬ 
tion and questions: inquiry into the 
mission, the purpose of our alumni 
organization; questions of purposes to 
be served by our planned directory. 
Will it serve as a tool to guide us to new 
or possible future directions? Does it 
pose “possibilities” otherwise unseen ? 
The inquiry, of course, illuminates 
the fragile structural nature of the 
Association of Yale Alumni in Medi¬ 
cine. The heart of its purpose remains 
the quinquennial return to New Haven 
for reunion, that tribal and ritual tradi¬ 
tion whereby we nourish a need to 
replenish our energies at their remem¬ 
bered source. The Executive Commit¬ 
tee of our Association functions largely 
to provide contact and definition for our 
reunion weekends each year. It is a 
focus as well for the review and tallying 
of our fund raising activities. In recent 
years these have grown from token 
gestures to more passionate statements 
of affirmative support for increasingly 
needy students. This response has been 
a touching and impressive one, and 
revealing two of our organization’s 
spiritual structure. About half of our 
graduates include their school in these 
concerns; perhaps the other half 
address similar concerns of other insti¬ 
tutions. Those addressing Yale Medical 
and Public Health Alumni Funds have 
been increasingly generous. 
Our Directory shall, of course, be a 
geographic guidepost for professional 
reference and consultation. But in a 
time when we stand on the threshold of 
great change in health care delivery, the 
fragmentation of Yale-degree profes¬ 
sionals to be traced makes our reference 
source more diverse and challenging. 
Our graduates with M.D., Ph.D., and 
Public Health degrees will answer three 
different questionnaires. Our trip 
through the directory maze of the future 
may be more complex and multi- 
purposed than that of the past. In 
answering the question of who your 
Yale neighbors are, our Directory poses 
the challenge of regional organizational 
development. The provinces have been 
heard from, those interested in such 
endeavors are there. The potential for 
their flourishing must be allowed to 
materialize. Should these ventures take 
root, the strength and breadth of our 
organization will have broadened struc¬ 
turally to a meaningful degree in the 
decades ahead. Education in medicine, 
as in all fields, faces financial stress so 
clearly defined in the future. For the 
50% who have manifested their con¬ 
cern for the survival of quality private 
education (as was provided them), 
access to a regionally structured alumni 
group would render the School's cur¬ 
rent activities more immediate, 
available, and involving. With a 
broadening of alumni organizational 
structure in this manner, the opportu¬ 
nity for addressing these supportive 
acts, be they financial or intellectual, 
which are the essence of positive 
alumni involvement, would be greatly 
enhanced. It would also provide the 
faculty and School administration an 
opportunity for continuity of a rela¬ 
tionship equally meaningful to them. 
Possibilities for maintaining continuing 
education bonds exist. Political, eco¬ 
nomic, social spin-off come readily to 
mind. There are so many possibilities. 
May the Directory be a way for the 
Yale student in medicine to seek 
counsel and direction? To those alumni 
close to New Haven and fortunate 
enough to have the opportunity to meet 
continued on the next page 
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Notes from the President — continued 
the student of the 80's, one must rank 
this as a “possible direction.” Their 
responsiveness to even superficial 
attention is disarming and provocative. 
To know them, however briefly, is to 
know that they are the best and the 
brightest. Their “Yale espirit” in the 
past few years is outstanding in my 
remembered time. Class spirit is 
achieving renaissance and is so evi¬ 
dently psychologically sustaining. 
However superficial the opportunity 
for an alumnus to interact with today's 
student, one is quick to realize the 
universality in time of the student 
experience: the inevitable evolution of 
role-models among faculty; the vital 
cohort-bonding which produces such a 
necessary psychologic support system, 
never more important in these times of 
more intense student stress. Sharing 
with them the remembered student 
anxieties of whatever era in time is so 
immensely reassuring to them and of 
value. An interface between student 
and alumnus is difficult to achieve 
because of time constraints bilaterally, 
but it can be productive. To observe 
them is to remember ourselves, to 
recognize the beginnings of our own 
professional matrix. It is to this con¬ 
stant, renourishing environmental 
source which we return then, quin- 
quennially, in our Spring. 
So again we ask you to respond to the 
Directory mission; for our organiza¬ 
tion, present and future; for its 
directions; for its possibilities. 
CLASS NOTES 
1922 
In June 1982, on the occasion of her 
90th birthday, Helen Langner was 
guest of honor at the Milford (Connect¬ 
icut) Medical Society meeting held at 
the Milford Yacht Club. An active 
member of the Milford Hospital Medi 
cal Staff, Dr. Langner was recognized 
for her 60 years of practice in the field 
of psychiatry both in Milford and for 
many years in New York City. 
1923 
The 1982 Maxwell Bogin Lectures were 
held on October 20. The series of lec¬ 
tures held each fall, deals with current 
topics in pediatrics and is structured to 
appeal to a wide audience interested in 
child healthcare. They were established 
in 1978 by the Pediatrics Department of 
Bridgeport (Connecticut) Hospital and 
sponsored by the friends and former 
patients of Maxwell Bogin who was 
chief of Pediatrics at Bridgeport Hospi¬ 
tal from 1949 to 1966. He was co¬ 
founder of the Children’s Medical 
Group from which he has since retired 
and is former president of the Hezekiah 
Beardsley Pediatric Society and former 
state chairman of the Connecticut 
Chapter of the Academy of Pediatrics. 
1927 
News received last fall, but too late to 
appear in the fall/winter issue of Yale 
Medicine, was that Albert Jablonsky, 
having retired in June 1982 after more 
than a half-century of private practice 
in Jeannette, Pennsylvania, was 
honored in a very special way by the 
city which he had served for so many 
years. 
Dr. Jablonsky not only served the 
health needs of the people of Jeannette 
but was active in community affairs. 
Shortly after World War II, he was 
among a group of community leaders 
who foresaw a need for a community 
hospital in Jeannette. In 1947 he was 
elected to the first executive board that 
directed the organization of planning 
and fund-raising for the proposed hos¬ 
pital which was to be erected as a 
“living memorial” to veterans of all 
wars. Having had an engineering as 
well as a medical degree. Dr. Jablonsky 
drew up the original plans for the 99- 
bed hospital and later served as 
chairman of the building committee. 
When the new Jeannette District 
Memorial Hospital opened in 1959 
under the operation of the Sisters of 
Charity, Dr. Jablonsky was elected the 
first president of the medical staff. 
Although now retired from practice, he 
still holds staff positions at both West¬ 
moreland Hospital and Jeannette 
District Memorial Hospital. 
In an official mayor's proclamation 
which cited Dr. Jablonsky’s “unselfish 
dedication and humanism toward his 
fellow man” during his 54 years of 
medical practice, November 5, 1982 
was designated as “Dr. Jablonsky 
Day” and a testimonial dinner was 
attended by his many friends, former 
patients, co-workers, hospital associ¬ 
ates and civic leaders. In addition to 
numerous proclamations, resolutions, 
and plaques presented in tribute to Dr. 
Jablonsky and his work, he and Mrs. 
Jablonsky received a special gift of ap¬ 
preciation—a promise of a trip for two 
“anywhere they want to go, at any time 
they want to take it.” 
1929 
A note from Paul McAlenney reported 
that Frank D’Andrea had spent several 
months in Papua, New Guinea on a 
volunteer medical service program. He 
noted that Frank has retired from anes¬ 
thesiology in Stamford, Connecticut to 
his Strawberry Hill Farm in Shoreham, 
Vermont, but that each year he contrib¬ 
utes his services as an instructor and 
anesthesiologist at some remote area 
hospital. 
Russell Scobie of Newburgh, New 
York, who retired after 50 years of 
active practice of pediatrics on June 20, 
1982, has received a number of new 
honors during the past year. A procla¬ 
mation by the Mayor of the City of 
Newburgh on February 19, 1982 noted, 
in part; “The City of Newburgh is 
proud of Dr. Russel B. Scobie, who has 
not only distinguished himself as an 
outstanding pediatrician, but has posi¬ 
tively affected the health of our entire 
community and been an ambassador of 
good will for our region. Dr. Scobie's 
dedication and commitment have 
become hallmarks of quality and ser¬ 
vice and we are pleased that his alma 
mater has honored Dr. Scobie with the 
Yale Medal; that he has received the 
Joseph B. Goldberger Award in Clini¬ 
cal Nutrition from the American Medi¬ 
cal Association; that our regional New 
York State Public Health Association 
has recognized him with its Distin¬ 
guished Service Award . . . .” 
In October 1982, the American 
Academy of Pediatrics selected Dr. 
Scobie for a special recognition award 
“for his pioneering and sustained ef¬ 
forts in promoting community water 
fluoridation throughout the world.” 
Having been instrumental in initiating 
the first mass fluoridation system, the 
now famous Newburgh-Kingston 
Water Fluoridation Study in 1945, he 
subsequently gained an international 
reputation in connection with the use of 
fluoride to reduce dental cavities. The 
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award was made at a luncheon meeting 
attended by about 1000 people in New 
York City. 
Most recently Dr. Scobie received 
the 1983 Newburgh Jaycees Distin¬ 
guished Service Award at a dinner on 
March 5 attended by 200 friends and 
neighbors. The local newspaper quoted 
Russ Scobie as follows: “I think that if 
I had to write about myself. I'd title the 
book after the old T.V. series 'I Led 
Three Lives.' The three lives I would 
chronicle deal with my work in pediat¬ 
rics as a physician, my work for the 
Yale Alumni Association, and my pet 
project, educating others as to the 
importance of water fluoridation. ” 
1932 
Myron Wegman, dean emeritus of the 
School of Public Health at University 
of Michigan, gave a principal address 
on the occasion of The Pan American 
Health Organization’s 80th anniversary 
in Washington in December. 
1935 
Samuel Kushlan retired in June 1982 
as associate physician-in-chief, Yale- 
New Haven Hospital, a position which 
he held for 15 years. A most rewarding 
aspect of those years was his close 
contact with the resident staff who 
impressed him not only as very bright, 
but also compassionate, intelligent, 
and thoughtful. Although hesitant to 
admit it, Sam feels that there must be a 
great many other such fine young men 
and women all over the country and 
throughout most of the world, giving 
him much more hope about the future 
than the media would lead one to 
believe. 
Sam is continuing his association 
with Yale-New Haven Hospital as a 
consultant to the chief of staff, a posi¬ 
tion in which he hopes his accumulated 
experience of 51 years in and around 
Yale-New Haven Medical Center will 
be useful and productive. 
He will continue to hold his faculty 
appointment as clinical professor of 
medicine. Among his other activities, 
he continues as co-chairman of the Yale 
Medical School Bequest and Endow¬ 
ment Program and welcomes your 
input and support in this crucially 
important area. Sam is also a member 
of the Advisory Committee on Investor 
Responsibility, a committee of the Yale 
Corporation. 
1936 
George Hahn wrote: "After practicing 
and teaching for almost forty years in 
the Philadelphia area, I decided to 
migrate to the Eastern Shore of Mary¬ 
land.” He now resides in Royal Oak, 
Maryland and is serving as tumor con¬ 
sultant at the Peninsula General Hos¬ 
pital, a 450-bed institution with a newly 
dedicated radiation therapy unit, which 
includes an 18 million volt electron 
beam machine and a 6 million volt 
(photon) machine and a versatile simu¬ 
lator. He has also been appointed con¬ 
sultant in gynecology, oncology at the 
240-bed Memorial Hospital in Easton. 
Dr. Hahn has been a director of the 
Yugoslavia-United States Medical 
Association since its inception about 
six years ago, and at the time of his 
writing, was planning to go to Sarajevo, 
Yugoslavia to attend the Third Scien¬ 
tific Meeting of the Association where, 
in conjunction with a gynecologist 
from Yugoslavia he was to moderate a 
session on neonatology. 
Dr. Hahn also noted: “I am enjoying 
serving as class agent since it enables 
me to renew contacts with my medical 
school classmates. I have heard from 
AI Diddle on a number of occasions; he 
is in the process of retiring from his 
practice in Knoxville.” 
1938 
Roy Barnett was honored on the occa¬ 
sion of his retirement on June 30, 1982 
after thirty-five years of service as 
chairman of the Department of Pathol¬ 
ogy at Norwalk (Conn.) Hospital. Over 
the years, he has earned the affection 
and respect of all who know him. At a 
dinner in his honor, he was given 
recognition for his many accomplish¬ 
ments during his distinguished service 
to the hospital, and it was noted that 
under his energetic and untiring leader¬ 
ship, the department has grown to a 
team of more than ninety professionals 
in seven laboratories conducting a 
multiplicity of tests — half a million a 
year — to help identify and arrest 
disease. 
Among his many innovations are his 
intiation of Norwalk Hospital’s first 
educational scientific conferences for 
the medical staff; his inauguration of 
the hospital’s first residency program 
providing post graduate specialty train¬ 
ing for physicians; his establishment of 
a school of medical technology; and his 
introduction of computer processing to 
speed access to patients’ laboratory 
data. 
Dr. Barnett, a resident of Westport, 
has also retired from his position as 
clinical professor of pathology at Yale. 
1939 
Arthur Tucker writes that he has 
retired as professor of radiology at the 
University of Michigan and has moved 
to Colorado. He is still active, how¬ 
ever, in practice and teaching at the 
Fitzsimons Army Medical Center, 
where he is pediatric radiologist. He 
and his wife. Gale, live at 12339 E. 
LaSalle Place, Aurora, Colorado 
80014. 
1940 
It’s high time to sharpen progressively 
dulling wits and my pencil to see what 
can be accomplished by this attempt to 
put a newsworthy column together. My 
thanks to Jim Ferguson for making it 
possible. I did receive a letter from 
Crawford Campbell dated (I shudder) 
September 21, 1982, telling me of his 
current hormone therapy for a prostatic 
malignancy, diagnosed last spring. 
There has been a good response to 
therapy; Christmas card contact in 
mid-December was lacking in further 
information. Crawford had seen Jim 
Flett’s sister, Mary, sometime back; 
she was hoping to set up a scholarship 
in Jim’s name, but plans had not as yet 
been completed. A letter from Champ 
Taylor in August indicates his retire¬ 
ment as of July 1st last. He spent July 
and August at his retreat near Hot 
Springs, Virginia, enjoying the “easy 
life”. Two later letters from Champ 
state that he had open heart (by-pass) 
surgery in April 1981 and continues to 
do well. Another letter reported that 
Jack Haley’s second daughter had died 
from a rapidly fulminating unusual 
form of malignancy. I would like to 
express sincere sympathy to Jack and 
his family in the name of 1940ers. A 
word about Jim Ferguson who keeps 
me informed about some of you, but he 
too is in the dark about many of our 
class who have chosen to remain silent. 
He and Iz were about to depart for 
South America (he didn’t say where or 
why; maybe to jog in the Andes, or 
perhaps because it’s summer down 
there). He reports favorably on his 
brush with prostatic mitotic activity 
(his euphemism). Helen Haury 
Woods has written Jim from Texas with 
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news of her husband, Dick, and his 
problem with chronic hepatitis, 
requiring a shunt. Follow-up letters in 
November were encouraging. Helen 
writes so enthusiastically about "their 
island" and the plethora of birds, some 
unidentifiable. Sounds idyllic. Her four 
children are in the East — one at State 
University of N.Y., one at Mt. Sinai in 
the Pediatrics O.P.D., and one at 
University of Massachusetts. Her son is 
in Chicago working on a "fuel-cell 
project." A note from Jack Blaisdell 
states that he now has given up surgery 
and hospital work, confining his 
medical activities to "minor trauma, 
office orthopedics, consultations, and 
second opinions". He has eight grand¬ 
children "with no end in sight". Maury 
Ross has retired, but still lives in Saco, 
Maine. (I'm ashamed to say he lives 
very close to me, but I never get to Saco 
and hence haven't seen him since our 
40th.) He has become involved with 
community services, such as child 
abuse programs, mental health, and 
Physicians for Social Responsibility. 
He says he is doing well though being 
treated for chronic lymphatic leukemia. 
He and Ellen were planning to go to 
Florida for the months of February and 
March. Joe Sokal is still at Duke, and 
enjoying North Carolina and his current 
project, "an international cooperative 
study of chronic myeloid leuke¬ 
mia". This project has involved travel 
to Bologna, Barcelona, Lyon, etc. Joe 
reports that #1 son is at the C.D.C. in 
Atlanta; #2 son has one more year to go 
with the U.S.P.H.S., operating the 
only Indian medical clinic in Texas. 
Norm Sears sent a long letter to Jim 
from Napa, California; he says he feels 
"pretty young" most of the time, 
except for some hypertension and reti¬ 
nal problems. He and other family 
members had large salmon catches out 
on the Campbell River in British 
Columbia late last summer. Norm 
reports the "class baby," his first son. 
is now 46 and very successful. His 
second son, Jim, is at Univ. of Massa¬ 
chusetts in Marine Botany. His third 
son lives in Beverly, Mass., and has a 
fascinating life involving music — 
composing and manufacturing 
flutes. Norm and his wife, Ty, may 
soon be returning to the Palo Alto 
area.Wy Dean and Biddy took a trip to 
Italy in July, returning to familiar 
stomping grounds. Wy reports the 
sudden onset of a neurological problem 
of vascular origin involving the right 
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frontal lobe. Check-up at the Mayo 
Clinic produced a "clean bill of 
health". He was about to leave for 
Sanibel Island in Florida as of early 
January. Hank Humphrey is still 
actively practicing in Ithaca, and for the 
first time is talking about retiring "in a 
year or two". (I'll believe it when I see 
it!) Hank sent a fascinating review of a 
case he handled—a schizophrenic who 
performed a Caesarean section on her¬ 
self with a pen-knife. She sutured 
the incision, walked down town with 
the premature infant strapped to her 
back, and was then picked up by a 
police officer who took her to the local 
hospital. Needless to say she was sub¬ 
sequently transferred to a psychiatric 
institution. I hope this doesn't start a 
new trend in obstetrics! If allotted 
sufficient space I would send to all 
1940ers the article from the Hartford 
Hospital entitled "A Roast for Ronny" 
on the occasion of Ron Beckett's 
retirement from the Department of 
Pathology at Hartford. The "roast" 
was given by one of his former resi¬ 
dents. It is a glorious but side-splitting 
tribute to Ron. a delightful characteri¬ 
zation. I honestly doubt Ron has really 
retired; he is so engrossed in his nomen¬ 
clature project. Jim Ferguson had a 
communication from Lee Sannella 
regarding "his interest in clarifying 
energetic states active in people 
today". My background in mundane 
things like child-bearing precludes 
comprehension of many facets of Lee's 
activities. He is also one of the directors 
of the Aesop Institute in Sebastopol, 
California, concerned with research in 
energy. Such widely diversified 
endeavors boggle the mind, at least my 
mind. Your class secretary's life in 
Maine goes on in an uneventful, non¬ 
medical sort of way. Thus far the winter 
has seemed like autumn with unseason¬ 
ably warm days. It makes one feel like 
ordering seeds, roto-tilling the garden, 
and doing other such like things. But 
never fear—the white stuff will come 
and 1 can once again dust off the cross¬ 
country skis. I continue my volunteer 
efforts with the Red Cross Blood 
Services, Northeast Region, exercise 
my Anglophilic propensities, occasion¬ 
ally discussing George Ill's affliction 
with porphyria. Not a very exciting life 
by some standards, but I do not regret 
my decision to retire early. Once again 
I extend a sincere invitation to any 
1940ers who wander this way. 
Class Secretary’, Donald G. Johnson 
Box / IS Bar Mills. Maine 04004 
1941 
Gioacchino Parrella was elected pres¬ 
ident of the Connecticut State Medical 
Society for 1982-83. He is a former 
president of the New Haven County 
Medical Association and practices 
general surgery in Milford. 
1942 
William Fleeson. the first associate 
dean for student affairs in the school of 
Medicine at the University of Connect¬ 
icut Health Center, retired on October 
1st. Dr. Fleeson. who was appointed to 
the faculty at the University of Con¬ 
necticut in 1963, was one of the six 
original members who took part in the 
detailed planning of the medical and 
dental schools and the Health Center's 
programs and facilities. Dr. Fleeson 
established admissions procedures for 
the School of Medicine, and in 1968, 
the first medical students were admitted, 
graduating in 1972. In 1974 he resigned 
his position as associate dean to 
concentrate on teaching as a professor 
of psychiatry. 
1944 
At last writing, Robert Frelich had 
assumed the role of program director of 
the Division of Resources, Centers and 
Community Activities of the National 
Cancer Institute in Washington while 
taking a sabbatical from his active 
oncology practice in Wilmington, 
Delaware. He wrote that he now has his 
pilot's license and "would happily fly 
to tell any of you about his activities". 
He had also completed a year as pres¬ 
ident of the Wilmington Medical 
Society. 
"I'm being repotted, not retired” is 
the way Lawrence Pickett explained 
his decision to relinquish the position of 
chief of staff of Yale-New Haven Hos¬ 
pital. Although he resigned from this 
post as of February 28, he will continue 
to serve as a member of the School of 
Medicine faculty as the William H. 
Carmalt Professor of Surgery and as 
associate dean for clinical affairs. He is 
currently enjoying a six-month sabbat¬ 
ical leave of absence. 
On his retirement as chief of staff. 
Dr. Pickett was honored at a gala recep¬ 
tion given by the Medical Staff of the 
Hospital on February 25. On that occa¬ 
sion Dr. Steven Wolfson, president, 
announced that the Medical Staff had 
established the Lawrence K. Pickett 
Lectureship to be given annually at 
Yale-New Haven Hospital. 
1945 
In honor of his contributions to college 
and university health, Isao Hirata, Jr. 
received the Edward Hitchcock Award 
at the 60th meeting of the American 
College Health Association. An 
authority on sports medicine. Dr. 
Hirata had been a member of the faculty 
at Yale until 1972, when he joined the 
staff of the University of South Carolina 
as director of Student Health Services. 
1946 
Aaron Beck received the honorary 
degree. Doctor of Medical Science 
(D.M.S.), at Brown University's 214th 
Commencement last May. Dr. Beck, a 
psychiatrist, supports a psychiatric dis¬ 
cipline which he calls cognitive therapy 
— a theory which for many years was 
met with resistance of others in his 
field, but which is now being used by 
many mental health professionals. 
Cognitive therapy begins by treating 
what had been considered more a 
symptom than an underlying problem 
— a patient's unrealistically negative 
views of himself. As the patient grad¬ 
ually accomplishes a range of tasks 
which have been set up by the psychia¬ 
trist for him to do, he is made aware of 
his distorted, negative self-views. 
Dr. Beck, an alumnus of Brown 
having received his A.B. in 1942, now 
resides in Wynnewood, Pennsylvania. 
1949 
Richard Barach was elected to fellow¬ 
ship in the American College of Radio¬ 
logy at its annual meeting in Sep¬ 
tember. Dr. Barach resides in 
Princeton, New Jersey and is affiliated 
with the Medical Center at Princeton 
and the Carrier Foundation in Belle 
Mead, New Jersey. 
1950 
Norman Loux, in 1955, together with 
other physicians and citizens commit¬ 
ted to the development of psychiatric 
and mental health services for their 
immediate area, founded the Penn 
Foundation for Mental Health, Inc. in 
Sellersville, Pennsylvania. Dr. Foux is 
senior psychiatrist at the Foundation 
which received the Good Neighbor 
Award from the Pennridge Chamber of 
Commerce. In presenting the award, 
the Chamber of Commerce expressed 
its appreciation to the Foundation and 
noted that "the excellent service of 
Penn Foundation for Mental Health has 
enriched the mental health of the entire 
community.’’ 
1951 
Daniel Freedman, chairman of the 
Department of Psychiatry at University 
of Chicago, was awarded the honorary 
Doctor of Science degree by Indiana 
University in May 1982. Dr. Freedman 
is an internationally acclaimed leader in 
psychiatric medicine and research. In 
the 1950’s he was involved in the 
development of new areas in pyscho- 
pharmacology and in the 1960's he 
discovered the link between hallucino¬ 
gens and the metabolism and disposi¬ 
tion of serotonin in the brain. He has 
made important advances in the inte¬ 
gration of basic and clinical disciplines 
in psychiatry and has brought the 
resources of psychiatry and medicine to 
bear on the public health issues and 
problems of drug abuse. He has had 
significant influence in legislative and 
policy issues affecting the use and 
abuse of psychotropic drugs. 
Dr. Freedman served as the 110th 
president of the American Psychiatric 
Association during 1981-82. His 
presidential address, "Science in the 
Service of the Ill’’ was published in the 
September 1982 issue of the American 
Journal of Psychiatry. 
1952 
The American College of Surgeons has 
elected Jose Felix Patino of Bogota, 
Colombia an honorary fellow; the 
award was conferred in October. It is 
distinctly unusual, and may be unique, 
that a surgeon who is already a fellow 
of the College, has received in addition, 
an honorary fellowship. 
The citation stated in part: "The 
American College of Surgeons, more¬ 
over, is greatly in debt to Dr. Patino 
for his numerous services. His 
long-standing membership on the Inter¬ 
national Relations Committee, his deep 
concern over the selection of Interna¬ 
tional Guest Scholars, and his current 
role as ACS governor for Columbia are 
all evidence of his great interest in 
College affairs.” It further noted that 
"Dr. Patino is a tireless worker, a 
superb surgeon, a concerned husband 
and father, and truly a gentleman. He 
stands as a stellar example of the signif¬ 
icant role of physicians in improving 
international relations.” 
1956 
William Hindie wrote from Honolulu 
that he has been appointed chairman of 
the National Task Force on Studies on 
Techniques for Assessment of Clinical 
Competence. This task force of the 
American College of Obstetricians and 
Gynecologists is to evaluate ongoing 
quality assurance both of individual 
physicians and departments of Ob-Gyn 
in the hospital setting. Dr. Hindle also 
serves on the National Health Care 
Commission, Committee on Gynecol¬ 
ogic Practice of the American College 
of Obstetricians and Gynecologists. 
1957 
A letter from Howard Minners gave 
news about his recent activities and also 
those of classmate, Robert Kaiser, 
who has received two national awards 
for his work in disease prevention and 
public health. 
Dr. Kaiser, who is director of 
U.S.P.H.S. Centers for Disease Con¬ 
trol's Division of Parasitic Diseases, 
received the 1982 William Crawford 
Gorgas Medal which is presented 
annually by the Association of Military 
Surgeons for the United States for 
"distinguished work in preventive 
medicine” in honor of Major General 
Gorgas, whose work in preventive 
medicine made possible the construc¬ 
tion of the Panama Canal. 
An alumnus of the Fondon School of 
Hygiene and Tropical Medicine from 
which he received a diploma in Tropi¬ 
cal Medicine and Hygiene in 1963, Dr. 
Kaiser was awarded the 1982 Ademola 
Medal which is presented by the 
School’s Council to past and present 
students who have made the greatest 
contributions to the promotion of health 
in developing countries. The medal 
honors Dr. G. A. Ademola, a key figure 
in the development of health and 
welfare services in Nigeria. 
Since 1964, Dr. Kaiser has been 
extensively involved in the Global 
Malaria Eradication Program, and 
particularly with malaria control in 
Central America and with health 
research in Egypt, the Caribbean, Cen¬ 
tral America, and Mexico. 
About his own activities. Dr. 
Minners wrote that he had traveled in 
September to Manila where he was 
head of the United States delegation to 
the World Health Organization West¬ 
ern Pacific Regional Committee 
Meeting. Following the sessions in 
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Manila, he visited research organiza¬ 
tions in Rangoon and Colombo, con¬ 
cluding his travels around the world 
with a short stop in Geneva with the 
World Health Organization. 
1958 
Gerard Burrow visited Yale in April 
to deliver The Philip K. Bondy Lec¬ 
ture, which honors the former chairman 
of the Department of Internal Medi¬ 
cine. Dr. Burrow is the Sir John and 
Lady Eaton Professor and chairman of 
the Department of Medicine at the 
University of Toronto. He spoke on 
thyroid disease in pregnancy. 
1959 
Gerald Fenichel spoke to the Yale 
Neurological Study Unit on September 
28; his topic was "The Neurological 
Complications of Immunization." Dr. 
Fenichel is professor and chairman of 
the Department of Neurology at Van¬ 
derbilt University School of Medicine. 
Leonard Inker, who resides in 
Wellesley Hills, Massachusetts and is 
affiliated with Framingham Union 
Hospital in Framingham, Massachu¬ 
setts, was awarded a fellowship in the 
American College of Radiology at its 
annual meeting in September. 
1960 
Announcement was made last fall by 
the regional medical director of the 
Kaiser-Permanente Medical Care Pro¬ 
gram and president of Northwest Per- 
manente, P.C., Physicians and Sur¬ 
geons in Portland, Oregon, that Stuart 
Bowne had been appointed Kaiser 
Sunnyside medical director and vice 
president of operations. He is respon¬ 
sible for medical services of the Kaiser 
Sunnyside Medical Center and Kaiser- 
Permanente Medical Offices in south¬ 
east metropolitan Portland. 
Dr. Bowne, physician in charge at 
Kaiser Foundation Hospital at El 
Cajon, California since 1979, previ¬ 
ously held positions with the Southern 
California Permanente Medical Group 
at San Diego. In 1967, he was appointed 
as a general and vascular surgeon; in 
1968, he became chief of surgery and in 
1978, assistant to the associate medical 
director. 
Northwest Permanente, P.C. Physi¬ 
cians and Surgeons is a group of 264 
physicians affiliated with Kaiser- 
Permanente Medical Care Program 
providing health care services to 
approximately 250,000 prepaid group 
practice Health Plan members in 
Oregon’s Portland, Vancouver and 
Salem areas. 
1961 
John Fenn was appointed chief of staff 
of Yale-New Haven Hospital, effective 
March 1. A life-long resident of the 
New Haven area. Dr. Fenn has been 
involved in many community activities 
and within the Hospital has served as 
associate chief of surgery, medical 
director of the operating rooms, presi¬ 
dent of the medical staff and in many 
other assignments. 
Another book on family therapy has 
been published by John Pearce. 
Ethnicity and Family Therapy, 600 
pp., edited by Monica McGoldrick, 
John Pearce and Joseph Giordano from 
the Guilford Press (New York City), 
came out last fall. This book, which 
should be very useful as a textbook, 
describes ways of doing therapy with 
18 different USA ethnic groups. Dr. 
Pearce reports that he is now starting a 
new book on cross-cultural marriage. 
1963 
In July 1982 Craig Llewellyn became 
professor and chairman of the Depart¬ 
ment of Military Medicine and Com¬ 
mandant of Students at the Uniformed 
Services University of the Health 
Sciences in Bethesda, Maryland. 
During the previous year he was a 
student at the Industrial College of the 
Armed Forces where he wrote a prize¬ 
winning research study on strategic 
aeromedical evacuation. 
This past November Colonel 
Llewellyn was installed as president of 
the International Health Society at the 
American Public Health Association 
meeting in Montreal. 
1964 
Remo Fabbri participated as a lecturer 
and member of a faculty of 17 at the 
annual workshop, "Application of 
Hypnosis in Therapy," of The New 
England Society of Clinical Hypnosis 
in Boston in April. Dr. Fabbri, a fellow 
of The American Society of Clinical 
Hypnosis and chairman of that Soci¬ 
ety's education committee, is also a 
fellow of the Academy of Psychoso¬ 
matic Medicine. 
Dr. Fabbri, specializing in the use of 
hynotic techniques in the treatment of 
psychosomatic and sexual disorders, 
practices in New Haven and is an 
associate psychiatrist at Yale-New 
Haven Hospital. 
1965 
Victor Burner, who has practiced in 
La Canada, California for over ten 
years, is the author of a book entitled 
"The Noblest Form," released by the 
Great Western Publishing Co., Glen¬ 
dale in 1981. The narrative, which 
closely follows the Biblical account, 
tells the story of David and Jonathan. 
Its form is operatic libretto so it may 
one day achieve musical expression. 
Dr. Burner is also a devoted musi¬ 
cian. He is a member of the American 
Guild of Organists and a trustee of the 
Southern California Conservatory of 
Music. He has played in Italy with the 
Rome Festival Orchestra, and in France 
with Les Jeunesses Musicales Fran- 
caises, and on tours with the Los 
Angeles Doctors Symphony Orchestra. 
Ronald Karpick has been elected to 
fellowship in the American College of 
Physicians and was so honored at the 
College's annual session in San Fran¬ 
cisco in April. Dr. Karpick, who resides 
in Falls Church. Virginia, is on the staff 
of the Alexandria Hospital, Northern 
Virginia Doctors Hospital, Fairfax, 




At the 1982 American Psychiatric 
Association meeting in Montreal, it 
was announced that Stanley Green¬ 
span was selected to receive the 1982 
Edward A. Strecker Award for out¬ 
standing research contributions to child 
psychiatry. 
1968 
Grace Jordison Boxer is now associ¬ 
ate chief of staff for education at the 
Ann Arbor Veterans Administra¬ 
tion Medical Center. In this position 
Dr. Boxer has responsibility to coordi¬ 
nate training for most of the medical 
center’s 950 employees and establish 
affiliation agreements with colleges 
and universities that bring as many as 
1,000 trainees to the medical center 
annually in areas such as medicine, 
surgery, pharmacy and physical 
therapy. She also oversees support 
services such as medical photography 
and illustration, the medical center 
library, and the patient education 
program. 
Before assuming her new position 
last year. Dr. Boxer served for three 
years as chief of the Hematology 
Section of the Indianapolis VA Medical 
Center and was from 1977 to 1982 
assistant professor of medicine at the 
Indiana University School of 
Medicine. 
She and her husband, Lawrence 
Boxer (HS ’68), have a six-year old 
son, David. 
1969 
Charles Dinarello has been promoted 
to physician in the experimental medi¬ 
cine division of the New England 
Medical Center Department of Med¬ 
icine. He also is an associate professor 
Qf medicine at Tufts University School 
of Medicine. Dr. Dinarello came to 
NEMC and Tufts in 1977 from 
Bethesda, Maryland, where he was a 
senior investigator for the Laboratory 
of Clinical Investigation of the National 
Institute of Allergy and Infectious 
Diseases, National Institutes of Health. 
John Kelly wrote in March that after 
two years of internal medicine at Yale 
and after having been a consultant in 
neurology at the Mayo Clinic, he is 
now an associate professor of neurol¬ 
ogy at Tufts Medical School and Tufts 
New England Medical Center in 
Boston where he is director of the 
Electromyography Laboratory. 
1972 
Announcement was made recently that 
Philip Cohen has been elected to 
fellowship in the American College of 
Physicians and he was so honored at the 
annual session of the College in San 
Francisco in April Dr. Cohen, who 
specializes in rheumatology, has been a 
resident of Chapel Hill, North Carolina 
for three years and is on the faculty of 
the University of North Carolina 
School of Medicine. 
Roy Kaplan, a resident of Leucadia, 
California, is specializing in rheuma¬ 
tology and is on the staff of the Mercy, 
Sharp Memorial, and University Hos¬ 
pitals in San Diego and the Arthritis 
Foundation, San Diego Chapter. He 
has been elected to fellowship in the 
American College of Physicians and 
was among the group to be so honored 
at the College’s annual session in San 
Francisco in April. 
1973 
David Adler has been appointed 
assistant chief of the Division of Adult 
Psychiatry in the Department of Psy¬ 
chiatry at the New England Medical 
Center in Boston. Dr. Adler, following 
residency at the Massachusetts Mental 
Health Center, joined the staff of the 
New England Medical Center in 1976. 
Thomas Romano and James 
Sullivan have been elected to fellow¬ 
ship in the American College of Physi¬ 
cians. Dr. Romano, a specialist in rheu 
matology, is on the staff at Los Altos 
Hospital in Long Beach, California. 
Dr.Sullivan, who resides in Quaker 
Hill in Connecticut, is on the staff of the 
Lawrence and Memorial Hospitals in 
New London and is an assistant clinical 
professor of medicine at Yale. 
1975 
Sydney Spiesel is now engaged in the 
private practice of pediatrics and ado¬ 
lescent medicine at 19 Edwards Street 
in New Haven. He will continue to 
serve on the Yale faculty as assistant 
clinical professor of pediatrics. 
Stephen Vlay, director of the Uni¬ 
versity Hospital Coronary Care Unit at 
State University of New York at Stony 
Brook has been elected to fellowship in 
the American College of Cardiology. 
1976 
Q’dell Owens is now at the University 
of Cincinnati Medical Center where he 
is assistant professor of obstetrics and 
gynecology and director of the Division 
of Reproductive Endocrinology and 
Infertility. Prior to this appointment. 
Dr. Owens had been working in this 
field at Harvard. 
1978 
John Ogland is now instructor and 
chief resident in the Department of 
Psychiatry at the Connecticut Mental 
Health Center at Yale. 
HOUSE STAFF 
1946 
The Coalition of National Health 
Organizations has acknowledged John 
McGovern’s tireless efforts in the 
promotion of health and a better quality 
of life for the people of the United 
States by presenting him with its 
Distinguished Service Award which 
cites Dr. McGovern for his significant 
contributions to health education and 
medicine. In addition to currently 
holding eleven university faculty posi¬ 
tions, eight of which are in Texas, Dr. 
McGovern remains director of the 
clinic that bears his name and which he 
organized. He is the chairman of the 
boards of the Texas Allergy Research 
Foundation and the John P. McGovern 
Foundation. A member of numerous 
honorary and professional societies in 
medicine, science and health educat¬ 
ion, Dr. McGovern continues to be an 
active consultant to the Board of 
Regents of the National Library of 
Medicine to which he received a Presi¬ 
dential appointment and which he 
chaired in 1973-74. 
1968 
Lawrence Boxer is director of Pediat¬ 
ric Hematology-Oncology at Mott 
Children’s Hospital in Ann Arbor and 
professor of pediatrics at the University 
of Michigan School of Medicine. 
29 
1975 
Regarding Herman Kamenetz’ latest 
publication, “Dictionary of Rehabili¬ 
tation Medicine", the publisher's 
(Springer Publishing Company, New 
York) catalog states: “This superb 
resource book offers in a single volume 
a look into the multidisciplinary world 
of medical rehabilitation in its broadest 
aspect . . . . It is a uniquely valuable 
reference source for teachers and stu¬ 
dents in medicine, physical, occupa¬ 
tional, and other therapies, nursing, 
psychology, prosthetics, physical 
education, speech pathology and other 
fields close to rehabilitation 
medicine. “ 
Dr. Kamenetz is chief of rehabilita¬ 
tion medicine at the Veterans Admini¬ 





In December, on the occasion of the 
80th anniversary of The Pan American 
Health Organization, welcoming re¬ 
marks were presented by the Organiza¬ 
tion's director Hector Acuna. Dr. 
Acuna noted in a recent letter that he 
has held this position for two four-year 
terms and that following the end of his 
second term in January 1983, he would 
be serving for six months in an advisory 
capacity with the director-general of the 
World Health Organization, Dr. 
Halfdan Mahler. 
After June 1983, he will be with the 
Area II Office of the Pan American Sani¬ 
tary Bureau in Mexico City. 
1967 
A brief note from James Malloy states 
that he is now director of University of 
Illinois Hospital in Chicago. 
1972 
Raymond Sphar, M.D. assumed 
command in January, 1983, of the Naval 
Medical Research Institute (NMRI), 
Bethesda, Maryland. Now in 
its 41st year of conducting basic and 
applied biomedical research, the Insti¬ 
tute has programs in casualty care, 
environmental stress, hyperbaric medi¬ 
cine, and infectious diseases. In addi¬ 
tion to the main laboratory complex at 
Bethesda, NMRI operates a detach¬ 
ment for toxicology research at 
Dayton, Ohio, and a newly-established 
unit in Lima, Peru, for tropical diseases 
research. There are customarily several 
U.S. Navy officers from NMRI on 
detached assignment to the Yale 
Arbovirus Research Unit. 
1977 
A letter from John Zil states: “I have 
been promoted to associate professor of 
psychiatry and medicine at University 
of California, San Francisco effective 
July 1, 1982. I remain on as chief of 
psychiatry and neurology at the Vet¬ 
erans Administration Medical Center in 
Fresno (a UCSF teaching hospital), 
where I am continuing two research 
projects on sleep-deprivation and 
cholinergic-driven effects on REM 
parameters." 
IN MEMORIAM 
Joseph Weiner, M. D. ex mec 1 '20 
January 13, 1983 
Maurice F. O'Connell M . D. ’22 
January 1, 1983 
Joseph A. Johnston M D. '23 
December 25, 1982 
David Freeman M. D. '24 
December 25, 1982 
Thomas Cottiero M. D '26 
December 14, 1982 
Hyman Cohen M. D. '27 
August 10, 1982 
Marion H. Douglas M. P. H. '27 
April. 1982 
Er-Chang Ping M. D. '28 
October 24, 1982 
Alvin A. Schaye M. D. '28 
February 25, 1983 
Yale D. Koskoff M. D. '31 
March 9, 1983 
Roberta Crutcher M. D. '38 
January 31,1983 
Philip E. Nelbach M. P. H. '38 
January 31, 1983 
Robert G. Ernst M. D. ’39 
February 18, 1983 
Rev. Sydney S. Byrne ex med 1 '40 
(date unknown) 
Charles W. Cashman. Jr. M. D. '41 
(date unknown) 
William F. Hillier, Jr. M. D. '43 
May 25. 1982 
CarletonJ. Brown M. D. '45 
December 7, 1981 
Nelson F. Evans M. P. H. '49 
(date unknown) 
Eunice R. Pellow M. P. H. '53 
(date unknown) 
Allan W. Ames M. D. '60 
(date unknown) 
David Paul Dunn M. D. '60 
December 17, 1982 
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Class of 1983 
First-Year Postgraduate Appointments 
Arizona 
University of Arizona Affiliated Programs, 
Tucson 
Augusta Roth — Family Practice 
California 
Kaiser Foundation Hospital, Los Angeles 
Mathew Clark — Family Practice 
Kaiser Foundation Hospital, Oakland 
Julie Faisst — Medicine 
Letterman Army Medical Center, San Francisco 
Richard Morales — Surgery 
Los Angeles County — University of 
California Medical Center, Los Angeles 
Miguel Martinez — Surgery 
John Neal — Neurosurgery 
San Diego Naval Hospital, San Diego 
Maria Schmidt — Surgery 
Stanford University Hospital, Stanford 
Richard Cawthon — Psychiatry 
Scott Lambert — Medicine 
University of California Affiliated Hospitals, 
San Diego 
David Easter — Surgery 
Elizabeth Nolan — Surgery 
University of California (Davis) Medical Center, 
Sacramento 
Frederic Martin — Medicine 
University of California Hospitals, San Francisco 
Stephen Cook — Medicine 
Jessica Herzstein — Medicine 
David Norton — Pediatrics 
David Schwartz — Medicine 
Yuen So — Medicine 
University of California Los Angeles 
Hospital and Clinics, Los Angeles 
Patricia Warkus- Daaboul — Psychiatry 
Bruce Yager — Pediatrics 
University of California Los Angeles 
Neuropsychiatric Institute 
George Bartzokis — Psychiatry 
Canada 
Toronto Western Hospital, Toronto 
James Deutsch — Flexible 
Connecticut 
Griffin Hospital, Derby 
Laurie Margolies — Flexible 
Hartford Hospital 
Gabino Lomeli — Transitional 
Norwalk Hospital 
Gem Goodman — Medicine 
Yale-New Haven Medical Center 
Amos Bodner — Medicine 
Elena Citkowitz — Medicine 
Nancy Czarkowski — Pediatrics 
Sean Dowling — Medicine 
Dianne Edgar — Surgery 
James Grober — Medicine 
Robert Johnson — Obstetrics & Gynecology 
Marshal Mandelkem — Psychiatry 
Lois Morton — Psychiatry 
Nancy Terrell — Medicine 
Michael Tom — Surgery 
Eric Winer — Medicine 
Tina Young — Pediatrics 
Yale University Graduate School 
Richard Chaillet — Physiology 
Waterbury Hospital 
Joan von Arras — Medicine 
District of Columbia 
Children’s Hospital, Washington 
Stephen Pearson — Pediatrics 
Walter Reed Army Medical Center, 
Washington 
Charles Lim — Radiology 
Hawaii 
Queens Medical Center, Honolulu 
Victor Perez — Psychiatry 
Illinois 
University of Chicago Clinics 
Daniel Sosin — Medicine 
Maryland 
Johns Hopkins Hospital, Baltimore 
Pamela Zeitlin — Pediatrics 
University of Maryland Hospital, Baltimore 
Barbara Brandt— Family Practice 
Massachusetts 
Beth Israel Hospital, Boston 
Brian D'Angona — Surgery 
Tammy Harris — Obstetrics & Gynecology 
Susan O'Donnell — Medicine 
Boston City Hospital, Boston 
David August — Medicine 
Elaine Daniels — Medicine 
Adam Lemer — Medicine 
Cambridge Hospital, Cambridge 
Eliot Gelwan — Transitional 
Massachusetts General Hospital, Boston 
Donald Johns — Medicine 
Harlan Pinto — Medicine 
Susan Skea — Psychiatry 
McLean Hospital, Mt. Auburn 
Eric Nestler — Psychiatry 
New England Deaconess Hospital, Boston 
William Kadish — Medicine 
University Hospital, Boston 
Judith Melin — Medicine 
Minnesota 
Mayo Graduate School of Medicine, Rochester 
April Chang — Medicine 
University of Minnesota Hospitals, Minneapolis 
David Lindgren — Orthopedic Surgery 
Jon Younger — Medicine 
Missouri 
Barnes Hospital, St. Louis 
Jerry Tobler — Diagnostic Radiology 
New Jersey 
University of Medicine and Dentistry of 
New Jersey — Rutgers Medical School, 
New Brunswick 
Laura Schafer — Psychiatry 
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Class of 1983 
First-Year Postgraduate Appointments — continued 
New York 
Bronx Municipal Hospital Center 
Daniel Sabbeth — Psychiatry 
Lenox Hill Hospital, New York City 
Brian Arenare — Surgery 
Montefiore Hospital, New York City 
Anil DeSilva — Surgery 
Mount Sinai Hospital, New York City 
Alan Reznik — Surgery 
New York University Medical Center, 
New York City 
Edouard Martin — Medicine 
Michael Silverberg — Medicine 
Presbyterian Hospital, New York City 
George Daniel — Obstetrics & Gynecology 
Jose Guillem — Surgery 
Ana Lamas — Medicine 
St. Luke's Hospital, New York City 
Janis Cutler — Flexible 
St. Luke’s-Roosevelt Hospital Center, 
New York City 
Randle Ware — Medicine 
The New York Hospital, New York City 
David Helfgott — Medicine 
Robert Kenet — Medicine 
Moshe Rubin — Medicine 
Leonard Saltz — Medicine 
North Carolina 
North Carolina Memorial Hospital, Chapel Hill 
Philip Spiro — Surgery 
Ohio 
Case Western Reserve University Hospital, 
Cleveland 
Patricia Kellner— Family Practice 
Cincinnati General Hospital 
James Glower— Emergency Medicine 
Oregon 
Providence Hospital, Portland 
Mary Johnson — Medicine 
University Hospital, Portland 
Barbara Keene — Pediatrics 
David Lichter— Family Practice 
Pennsylvania 
Graduate Hospital. Philadelphia 
Alan Bloom — Medicine 
Hospital of the University of 
Pennsylvania, Philadelphia 
Mark Boytim — Orthopedic Surgery 
Thomas Brockmeyer — Orthopedic Surgery 
Michael Choti — Surgery 
James Lucarini — Surgery 
Temple University Hospitals, Philadelphia 
Robert Kotloff — Medicine 
Abby Van Voorhees — Medicine 
Henry Weiner — Medicine 
Vermont 
Medical Center Hospital of Vermont, Burlington 
Colin Lee — Medicine 
Washington 
University of Washington Affiliated Hospitals, 
Seattle 
Emily Altman — Medicine 
Nancy Kraemer— Pediatrics 
Dwight Stapleton — Medicine 
Wisconsin 
University of Wisconsin Hospital and 
Clinics, Madison 
Brent Tetri — Medicine 
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ATTENTION! 
ALUMNI/AE IN MEDICINE AND 
PUBLIC HEALTH 
The most useful and interesting Alumni 
Directory is the one which is the most 
complete and up-to-date. Have you 
done your part for the new Yale School 
of Medicine Alumni/ae Directory? If 
yes, thank you. If no, this is an urgent 
reminder to return your questionnaire 
TODAY! For additional information 
call (203) 785-4674 (Medicine) or 
(203) 785-4845 (Public Health). 
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excerpts from the 
1983 COMMENCEMENT ADDRESS 
By Robert H. Gifford, M.D. 
I would like to welcome all of the smiling parents, 
grandparents, relatives, and friends who have come to 
New Haven for this happy occasion. You have every 
right to be proud of these men and women graduates. 1 
can attest to that, for many have come to be my very 
close friends during the past four years and 1 am in awe 
of their collective and individual abilities. 
In a few short weeks, most of you will find yourselves 
as interns, scattered across the land. It will be a memora¬ 
ble year. I’m certain that many of you have looked at 
graduation as the light at the end of the tunnel.but I 
caution you to remember that the light at the end of the 
tunnel could well be a train coming the other way. 
Although that train could represent the rigors of in¬ 
ternship, it might also be symbolic of the public's grow¬ 
ing unhappiness with us as a medical profession. Despite 
remarkable advances in our ability to diagnose and treat 
human disease, something is wrong with our image. 
How can things be wrong, you ask, w hen our physicians 
are more able than ever?; when people are living longer 
than ever?; when our hospitals are bulging with sophisti¬ 
cated equipment?; and when physicians are plentiful and 
moving into every nook and cranny of the country? How 
can the public possibly be disgruntled with all of that? 
Although the answers to these questions are complex, 
there is no doubt that the traditional doctor/patient 
relationship has become tarnished. Today, 1 want to 
examine five possible reasons relating to some of the 
public’s unhappiness. These five factors are important to 
consider here because they need attention and you soon 
will be in positions to do something about them. 
The first important factor contributing to the public’s 
dissatisfaction with American medicine has been our 
failure to provide a strong primary care system. In the 
past twenty-five years, we have encouraged our brightest 
doctors to become subspecialists and they are now' trip¬ 
ping over one another, competing for access to the same 
pool of patients. Specialists now account for fifty to sixty 
percent of all physicians. Any system of health care that 
encourages patients to see several different specialists, 
just for health maintenance, is bound to be expensive 
and inefficient. Furthermore, it does not guarantee good 
care. It is certain to annoy patients who don’t know 
w hich specialist to call when they simply feel sick all over 
and can’t identify a specific organ that is malfunctioning. 
Patients followed by several doctors may not only re¬ 
ceive several bills, but conflicting messages about their 
diagnoses and therapy. 
There must be a primary physician in charge, and, in 
my opinion, it is appropriate for that person to be a 
Dr. G iff ore! is professor of medicine, and chief of Medical Services at 
the Veterans Administration Medical Center in West Haven. 
highly trained, well paid, generalist who has the skills to 
handle a great many of the medical problems now re¬ 
ferred to subspecialists. This primary physician must be 
able to practice in a stimulating group environment, and 
be willing to tackle any complaint. The practice must be 
organized in such a way as to provide opportunities to 
get away from it from time to time, for continuing 
education, for a meaningful private life. The primary 
physician should he the backbone of our medical care 
system. Since it requires the most comprehensive knowl¬ 
edge and sensitivity, this role should be reserved for our 
most exceptional doctors and w'e must find ways to lure 
some of them away from the attractions of subspecialty 
practice. It is important to accept the notion that this 
primary physician is not just for trivial illness as the 
public has come to perceive. I know that it is possible to 
find outstanding generalists who can deal competently 
with most medical conditions. My current chief resident 
is one, and if he could just be cloned, I believe that we 
could do away with half of the medical subspecialists 
in the country. I would trust him to care for almost any 
non-surgical illness that 1 could have. His knowledge 
and clinical abilities are remarkable. He might need a 
specialist from time to time as a consultant, but certainly 















problem has been for subspecialists also to serve as 
primary physicians, but the extent and effectiveness of 
this practice may have been overstated in the recent 
literature. 1 would prefer to see committed generalists 
who have been trained for just that kind of practice. 
The real solution to this problem of encouraging gen¬ 
eralists to enter practice will probably have to be eco¬ 
nomic. Unfortunately, invasive maneuvers done to pa¬ 
tients continue to be reimbursed at a much higher rate 
than the good old-fashioned use of the brain alone. It is 
time to restore some balance to the system. Complex 
medical intensive care management should at least be 
the monetary equivalent of a simple surgical procedure. 
When insurance carriers reduce their support of expen¬ 
sive (and possibly unnecessary) procedures, and increase 
their support of general medical care, our best doctors 
may be more inclined to consider general medicine, 
general pediatrics or general psychiatry. 
In addition, medical educators must restore prestige 
to the general practice of medicine. Academia continues 
to foster the glory of subspecialization because most of 
the faculty are subspecialists. We must find ways to 
reverse the trend and retain outstanding general physi¬ 
cians on medical faculties, as well as to encourage our 
most capable young clinicians to consider general medi¬ 
cine as a way of life. I am hopeful that some of you will 
follow that course. 
A second reason that the public is displeased with us is 
related to the rapid pace of modern medicine and, as a 
result, poor communication with doctors. Doctors, un¬ 
fortunately, seem to be too busy to spend much time 
with patients as medicine has become more complicated. 
The hospital, too, has become a bustling place. 
Being a patient, it turns out, is an intensely personal 
affair, charged with worry and prone to misunderstand¬ 
ings. Every physician as well as everyone who works in a 
hospital must never forget that. We tend to become so 
accustomed to the hospital environment and to illness, 
that it is easy to forget how significant every little thing 
becomes for a patient. There must be a quiet respect for 
the special needs of the sick and ample time reserved by 
us to sit and talk with our patients. 
A third significant factor troubling the public is the 
enormous cost of medical care. They cannot understand 
why the total annual cost has finally reached ten percent 
of our gross national product. Is there any limit to the 
continued rise? The public grumbles that physician’s fees 
are too high even though they represent only twenty 
percent of the total cost of medical care; that insurance 
premiums are outrageous; that the costs of medicine, 
laboratory tests and procedures are shamefully inflated; 
and that the cost of a day in the hospital, to say nothing 
of the intensive care unit, is beyond that which any 
ordinary person can afford. I urge you to look at the bills 
of some of your hospitalized patients. It was shocking to 
me to see the cost of tests which I had ordered in sort of a 
casual way. A single day at Yale-New Haven Hospital, 
not including the physician’s fee, diagnostic tests, or 
drugs, currently costs $285.00 for a private room. If you 
are unfortunate enough to be in the intensive care unit, it 
will cost you about $700 dollars a day, double that of 
only two years ago. 1 bought my first car for less than 
that. A chest x-ray costs $41; a simple blood count, $5.50 
and $8.00 more if you want a differential count. Electro¬ 
lytes cost $25, enough to pay for a sumptuous dinner. A 
Swan-Ganz catheter costs $91 but a staggering $721 
hospital charge for its insertion in the procedure room, 
on top of a $350 professional fee, for a total cost of over 
$1000 for this commonly used procedure. And so it goes. 
It is important to realize that the hospital is not out to 
gouge the public. It is a non-profit organization. It is 
simply trying to stay solvent; to pay for its buildings, its 
work force, its equipment, and all the other things that 
we order. It is an enormously expensive business and we 
are, in part, responsible for the generation of much of it. 
What, if anything, can we do to stem the tide? The 
public wants sophisticated comprehensive care and is 
apparently willing to pay a large amount of money for it, 
but the increases are rapidly reaching a point where 
limits will be necessary. You can help. You will have to 
help. 
Consider the very real possibility that everything that 
we do to patients may not be absolutely necessary for 
quality care. Could home care be strengthened? Does 
every inpatient need a fancy hospital? Could a hotel or 
motel attached to a hospital substitute fora hospital bed 
in some cases? Do we, as physicians, think carefully 
about the cost effectiveness of tests ordered; of proce¬ 
dures done; and of therapies given? Are we aware of the 
relative cost of drugs and that one drug may be much 
cheaper than another with just about the same spectrum 
of action? For the most part, physicians are not well 
acquainted with what many of these things cost. We 
haven’t been used to thinking in these terms, but it will be 
essential to do so in the days ahead. I believe that it 
would be possible for us to reduce the current costs of 
medical care ten or twenty percent without compromis¬ 
ing the scope or quality of that care, simply by education 
and reminders to physicians about the costs of what they 
are generating. 
In addition, physician’s fees must be more realistic and 
balanced. Insurance carriers must stop rewarding high 
cost procedures and provide more financial incentives to 
curtail tests and to encourage comprehensive primary 
care. We must, as a group, support the inevitable 
changes in the current reimbursement program. We 
should, at the very least, acquaint ourselves with the 
details of our reimbursement systems, including medi¬ 
care, medicaid, and the new system coming in October, 
known as DRG, or diagnosis related groups, whereby a 
set amount will be prospectively paid to the hospital for a 
certain condition regardless of the actual cost. It is a 
subject too important to leave for others. 
A fourth reason for the public’s complaint with us has 
been our failure to accept death as a natural part of 
living. We still look at death as a failure of medical 
science. Sometimes it is just that, but our zeal to support 
life at all cost has not always been well received. The 
majority of our intensive care beds are occupied by 
patients whose life expectancy is only a few months. 
Respirators and other sophisticated monitoring equip¬ 
ment which do save many lives, also allow us to prolong 
the life of many with a terminal illness. We are all uneasy 
about the problem because it has always been difficult 
for physicians to discuss the option of no treatment with 
patients. For terminally ill patients, the Hospice move¬ 
ment represents a way to face death in a positive rather 
than a negative way. Hospice is a remarkable concept 
and its powerful message warns us not to neglect the 
dying. On rounds, do not pass by the room of a dying 
patient without stopping. A brief visit, soft words, a 
tender touch, and reassurance about pain control will 
bring comfort and peace to one’s final hours. 
Lastly, the public is unhappy because they have un¬ 
realistic expectations about what medical science can do 
for them. The media is partly to blame with its emphasis 
on spectacular medical experiments covered widely in 
the press, such as heart and liver transplants. Is it any 
wonder that the public tends to look at their bodies like 
an automobile? Bring it in for new parts and when it 
doesn’t work, blame the mechanic. We have not done a 
good job in educating the public to the limitations of our 
therapies. They Hock to emergency rooms expecting 
quick cures for the common cold. Americans have been 
gradually abandoning personal responsibility for their 
own health and insidiously transferring that responsibil¬ 
ity to us. We must provide vigorous leadership in in¬ 
forming the public that preventive medicine is still the 
best treatment. Alterations in personal behavior could 
profoundly reduce a number of major disease processes. 
We must become politically active and lobby on behalf 
of those causes which play such an adverse role on the 
health of this nation and world. 
Cigarette smoking kills tens of thousands of patients 
each year. As physicians, we have been a weak and 
ineffectual force in combating tobacco lobbies to reduce 
this terrible health problem. The complications of alco¬ 
hol continue to fill our hospital wards. We cannot sit 
back passively and watch the slaughter. We must help 
society find better ways to control this awful problem. 
Environmental pollution threatens us all; and worse, the 
unbridled proliferation of nuclear weapons poses a 
health threat with which we simply cannot cope. We 
must also decry the fact that the projected increase in the 
defense budget is more than the entire NIH budget for 
medical research. 
Physicians must be heard on these issues. We have a 
responsibility to our collective patients to speak out, to 
educate, and to become a political action group on 
behalf of health. I am counting on you to carry the torch. 
4 
SURVIVING THE THIRD YEAR 
By Laird D. Madison 
At a recent symposium for new clinical clerks. Dr. Thom¬ 
as Duffy noted a most striking aspect of the third year is 
“the extraordinary advancement that people make be¬ 
tween June of one year and June of the following. It is 
very important at the present time,... when you feel you 
are being tossed into a frenzy and really don’t know 
which way to turn, to simply know where you are in 
relation to what it is that’s being asked of you.” 
Medical education and medical providers have been 
under increasing attack from the public because of per¬ 
ceived deficits in the training of physicians and in provid¬ 
ing medical care in a humane fashion. Criticism of medi¬ 
cal curriculum and medical practice have come from The 
New York Times, The New England Journal of Medi¬ 
cine, The American Medical Student Association, and 
The Association of American Medical Colleges, to name 
a few. As students undergoing the training in question, 
we felt that, perhaps better than the faculty, we could 
understand some of the processes and experiences in the 
training of physicians which lead to this widespread 
criticism. Certainly, the internship year is a formative 
one for the physician, but as important is the third year 
of medical school when students encounter patients, 
patients’ families, doctors, nurses, and their fellow stu¬ 
dents in the environment in which they will function for 
the rest of their careers. No amount of attention in the 
first and second years of medical school can prepare 
students for the issues encountered in the third year. 
They can only be addressed and understood in the envir¬ 
onment in which they are relevant. 
Many changes occur in the behavior and thought 
processes of physicians as they are trained. We are not 
so cynical as to think that all of these changes are bad, or 
so naive as to think that those that are bad are entirely 
preventable. We do believe, however, that encouraging 
students to become aware of their environment and their 
role in that environment, to be more aware of the conse¬ 
quences of their actions on patients and on their own 
lives, would increase the likelihood of training a more 
humane physician with less damaging consequences 
throughout their careers to their patients, society, and 
themselves. Many students begin their third year with 
“good” values, but they have a hard time maintaining 
their beliefs during the onslaught of learning clinical 
medicine. They feel helpless, and they fail. . . repeatedly 
at what they are learning. The consequences of these 
failures are often detrimental to the treatment of patients 
and to the personal well-being of the student. The diffi¬ 
culties, the failures, and the helplessness are probably 
Laird D. Madison, a M.D.j Pli.D. Student, was largely responsible 
for the organization of the 1983 Clinical Clerkship Orientation Sym¬ 
posium. This article is based, in part, on a report he gave to the 
Medical School Council. 
unavoidable aspects of learning, but speaking out about 
difficult problems helps students to recognize them as 
problems, to recognize the feelings of helplessness as 
such, and to begin to identify solutions. 
Two years ago a group of Yale medical students con¬ 
ceived the idea of developing an educational program 
for third year clinical clerks that would supplement the 
traditional clerkship schedule. The idea grew out of the 
belief that this formative period was often unnecessarily 
troubling to students because of a lack of orientation to 
their new environment, and that as a result they were 
often unaware of the consequences of their actions on 
others and themselves. Last year, Patty Kellner (’83) 
organized a one-day symposium entitled, “Surviving the 
Third Year: The Well-Being of the Patient and the Med¬ 
ical Student.” Largely because of the success of that 
symposium, we organized and recently held the first of 
two planned symposia for third year students. The sym¬ 
posium held during the second week of the clerkship 
period in July was intended to provide a practical orien¬ 
tation to the experiences the students were beginning. It 
was organized by fourth and fifth year students through 
the office of Dr. Alan Mermann, Chaplain of the School 
of Medicine. 
Speakers from throughout the medical center gave 
short talks on subjects of interest to the new clinical 
clerks. Dr. Robert Lang and Dr. Alan Kliger, associate 
professors of medicine noted that, “the academic back¬ 
ground we all get preparing us for medicine leaves a huge 
gap when you start your third year.” They described 
their seminar for third year students in the medicine 
clerkship, “Issues in Medicine,” which tries “to work 
with students so they can discover from their experience, 
what it takes to feel good, to do it well, and to fit in the 
right place . . . No one pays very close attention to what 
we are feeling when we are with patients.” The impor¬ 
tance of trying to understand these feelings during the 
third year was underscored by noting that the “patterns 
that you set for yourself this year are likely the patterns 
you are going to use for the rest of your life.” 
Angela Holder, medicolegal counsel for the School 
and Hospital discussed common legal questions raised 
by students. She assured students that her office was 
eager to hear from students early about potential legal 
problems but observed that “the majority of students 
who come to her with what they think is a problem did 
not understand the situation . . . Part of your education 
may be finding out that what appears to be to an outsider 
like a certain clear and compelling screw-up ... is not.” 
She reminded students that “patients do not waive their 
right of privacy because they are in a teaching hospital 
. . . but that there are very few patients who don’t want 
to become involved with medical students ... They think 
you are kind, considerate and spend much more time 
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with them than other people do.” 
Dr. James Nocks, associate clinical professor of psy¬ 
chiatry. spoke about dealing with the alcoholic patient 
and noted that “somewhere along the line in medical 
school, a fair amount of negative learning takes place 
about alcoholism.” Following his talk. Dr. Leonard 
Grauer, associate clinical professor of medicine, encour¬ 
aged medical students to engage with the private attend¬ 
ing early in the care of private patients. 
Dr. Duffy, professor of medicine, noted that the ad¬ 
mission of medical students to the ward for learning “is 
not something that has gone on for a very long period of 
time.” He advised the students, “you must become the 
master of your physical examination . . . The problem 
that exists is that you will run away from what is the 
excitement of the initial encounter to be looking at your 
scans, to be looking at whatever it is that takes you down 
the corrider from where the most information can be 
generated . . . the patient.” 
“I think that (as students) you bring to you what 
amounts to a certain burden in the whole process of the 
doctor-patient relationship. The burden is a certain laid- 
back, mellow quality where you may substitute friend¬ 
ship for w'hat is the absolute need for detached 
concern where you are concerned about another hu¬ 
man being, but not to the point where you are so anxious 
that you’re making the wrong decisions,” Dr. Duffy told 
the students. “And. friendship oftentimes gets in the way 
of the necessary detachment w'hich doesn't move all the 
way to aloofness. You have to learn how to-walk a very 
tight rope, in terms of the tension, where you can use 
your professional knowJedge to help another human 
being, but not be overwhelmed by the suffering that it 
allows and demands your access to.” 
He cautioned the students to be aw'are of their role and 
to respect the difference between their role and that of 
the interns and residents. The urge of the student to be in 
charge overlooks “the greatest luxury that you have as 
medical students—to have access to an intensity of med¬ 
ical problems without having to go home at night and 
worry whether or not you helped somebody or hastened 
somebody’s death.” 
A very important element of the day consisted of small 
discussion groups of third year students led by fourth 
year students. In these sessions they discussed the real 
“work” of clinical clerks: work-ups, write-ups, and oral 
presentations. They discussed strategies for succeeding 
in various clerkships, common problems, and ways of 
trying to avoid them. Most importantly, they provided 
reassurance to each other that not only would they 
“survive” the third year, but that they could expect to 
triumph in their new skills and responsibilities by the 
time the year was through. 
The participation of most of the third-year class, 
many interested fourth-year students, as well as a 
number of concerned faculty, demonstrate that there is a 
body of knowledge and skills in the clinical years that 
spans all clinical disciplines that can and should be ad¬ 
dressed independent of ward and clinical experience. 
The current curriculum of the third and fourth years of 
medical school does not address these broader issues 
affecting our delivery of medical care. Since this period is 
one in which students first begin to form their clinical 
“styles” and attitudes it is important to reconsider what is 
to be accomplished in the second half of medical school. 
In an ideal situation the clinical attendings would ad¬ 
dress these broader issues as they become relevant in 
their dealings with students, thereby lending the support 
and wisdom of their broad clinical experience to those 
just entering the profession. The reality of the situation, 
however, is that the attendings are busy with many other 
activities, and clinical clerks end up learning and pattern¬ 
ing their behavior after the interns, people only two years 
more advanced in their training themselves. The interns 
are not necessarily concerned with their influence as 
teachers, and many aren’t displaying the best attitudes 
and behaviors because of their own stressful situation. 
Our activities in organizing symposia for third year 
students is a modest beginning in an effort to enrich the 
experience of the clerkship period. It is hoped that with 
the support of the faculty this effort could be continued 
and enlarged in the future. 
Dr. Mermarm led members of the Class of 1983 in the taking of the 
Hippocratic Oath at Commencement. 
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SURVIVAL: IS THAT OUR REAL GOAL? 
By Alan C. Mermann, M.D. 
“In the final analysis, to succeed is to survive relatively 
unscathed.”1 This statement from a “survival manual” 
written recently for medical students beginning clinical 
training bothers me. 1 am quick to grant that there is a 
measure of humor and exaggerated self-pity in the use of 
the word “survival” in reference to the rigorous life of the 
medical student today. But we are enjoined to take 
language seriously. Even in such diverse genres as 
humor, essays, innuendo, faux pas and prayer, we do say 
what we mean. So, when the second year class bequeaths 
a Survival Kit to the entering class and the fourth year 
students are easily recruited for a seminar for third year 
students designed to help them survive “going on the 
wards”, I think we should pay attention. 
Medicine is evolving rapidly. The remarkable applica¬ 
tion of high technology to laboratory methods, surgical 
and investigative procedures and life-saving apparatus 
has so altered hospital practice as to make it awesome, if 
not incomprehensible, to older physicians. The expo¬ 
nential growth of scientific knowledge has made “keep¬ 
ing up” with medicine-in-general impossible for the of¬ 
fice practitioner, and has pressed the physician and 
surgeon in an academic setting further into specializa¬ 
tion to maintain leadership, pursue research, and ad¬ 
vance scholarship. 
These scientific and technologic advances have pro¬ 
duced some unexpected results. The rise in patient ex¬ 
pectations for cure of illness and repair of injury is 
paralleled by an impressive increase in malpractice suits. 
Our capacity to maintain biologic existence by mechani¬ 
cal means, to change species by genetic engineering, to 
alter behavior by drugs, and to study and treat the 
human fetus has created a new discipline- biomedical 
ethics—which attempts to clarify some of the dilemmas 
we have produced and assist in the search for answers to 
confounding questions never anticipated. 
The most serious questions of all for medicine are 
raised by the necessity to allocate scarce resources. The 
social costs of developing an artificial heart, of dialysis of 
end-stage renal disease in the elderly patient, of organ 
transplantation, and of exquisitely designed and exe¬ 
cuted experiments in immunology are real and painfully 
apparent. A stroll -or perhaps safer, a drive- through 
the neighborhoods of most university medical centers 
will demonstrate, in a graphic way, the needs of our 
people. The relationship of our wealthy universities to 
the desperate, the poor, and the illiterate persons who 
live, both literally and figuratively, in their shadows, 
needs immediate definition and explanation. 
Dr. Mermann, clinical professor of pediatrics and chaplain of the 
School of Medicine, has practiced pediatrics in the New Haven area 
for twenty-five years. 
It is against this background of an uneasy paradox 
incredible scientific progress and rampant social 
decay- that the concerns of the medical student for 
survival must be examined. There are mixed messages 
being transmitted to the students and to the consumers 
of health services. On the one hand the universities, no 
less than the high-tech corporations, are in a race to 
exploit new methods for uncovering Nature’s long-held 
secrets of DNA replication, leukocyte function or hor¬ 
mone production. Toward these ends, impressive fund¬ 
ing is committed. On the other hand, students come to 
medical school, for the most part, to learn to become 
physicians responsible for the medical and psychological 
care of their fellow human beings. The teaching of the 
skills of interaction with patients, colleagues, adminis¬ 
trators, public health officials and lawyers is left, pretty 
much, to observing busy house officers and attending 
physicians. The role of the doctor in issues of allocation, 
public policy toward the poor and the goals of research is 
rarely discussed. 
The product of these decisions in the education of the 
student is the explosion of information in basic science 
taught in the first two years of medical school. Many 
students are hard pressed by the avalanche of facts which 
they are expected to process without any clues as to what 
is important for them in preparation for the clinical 
years. Tittle help is forthcoming from those teachers who 
have devoted their professional lives to research in the 
“pure” sciences. The intense competitiveness which be¬ 
gan in the undergraduate years continues, even in medi¬ 
cal schools which downplay examinations and grading. 
Perhaps the absence of formal examinations and non¬ 
grading creates more anxiety and confusion than we 
might like to believe. 
The most perplexing issues revolve around the impact 
of the role of the doctor on the personal life of the 
student. The model for medical students— the physician- 
teacher in medical school and hospital, and the practi¬ 
tioner in the community—again sends mixed messages 
to the student. The place of the physician in our culture 
has been one of prestige, power and wealth. Despite 
many current criticisms of the profession and ambiva¬ 
lent feelings toward them, physicians still maintain posi¬ 
tions of respect and prominence in society. This elevated 
status seems often in conflict with professed altruism of 
the medical profession. The effects of this conflict have 
been carefully outlined and discussed recently in an arti¬ 
cle in The New England Journal of Medicine.2 The 
increased incidences of suicide, drug and alcohol abuse 
and marital problems among physicians are disconcert¬ 
ing signs of personal unhappiness and lack of fulfillment 
in a profession held in high esteem. Techniques for 
surviving medical school may not function well over an 
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extended period of time of stress. 
The implication of survival is that the present is a 
difficult or painful period to be gotten through in antici¬ 
pation of better times; that the immediate is neither 
desirable nor rewarding. One of the reasons the clinical 
years are something to be survived is that many students 
and house staff have yet to develop an inner life capable 
of incorporating those painful and difficult parts of 
training which demand so much of us physically, emo¬ 
tionally, and intellectually. Conflict with other profes¬ 
sionals on the health care team; confrontation with pain, 
suffering and death; fatigue; a growing understanding of 
the devastating effects of illness; and an awareness of the 
futility of much of medical, surgical, and psychiatric 
practice, all combine to place serious stresses on the 
young student and house officer. 
When we look to the goals for which we are willing to 
survive those student years, we face again the physician: 
wealthy, prestigious, powerful in community or 
university—and often desperate and unhappy. Success 
may be a mirage, an illusion which fades as we approach 
its realization. Success becomes failure because the goal 
is not worthy of our best endeavors: in fact, did not even 
engage our selves. 
It is that engagement of the self in the care of the 
patient which can convert a survivor into a committed, 
even joyful, physician. One wonders what witticism 
would be forthcoming from the Osiers and Cushings of 
Medicine if “survival” was touted as a mark of the 
successful doctor. Studies have demonstrated that phy¬ 
sicians spend less and less time visiting patients as they 
become sicker with terminal illnesses. The more difficult 
the patient, the more obscure or untreatable the disease, 
the less personal is the care provided by the doctor. It has 
been said that physicians visit dying patients less because 
“death is seen as failure - as the enemy.” 1 think that is a 
romantic excuse for an inability of physicians to face, 
accept, and deal with the fact of death. So many of us are 
bothered, not by the fact that the patient died because we 
could do no more, but rather because death is a part of 
life which few of us handle well. This is true of pain, 
loneliness, anxiety, and telling the truth to others. The 
difficulties lie with the physician, not with the patient. 
Denial and avoidance are strange but frequent ways of 
dealing with reality. 
It has been noted that terminally ill persons are fear¬ 
ful, not of death, but of abandonment as they die. At the 
very moments in our lives when we need companionship, 
compassion and close contact with those we know and 
trust when we are critically ill or dying many physi¬ 
cians absent themselves. 
1 think that inhumane aspects of medical care result 
from the lack of careful and deliberate instruction during 
medical training which builds the resources for coping 
with trials which lie ahead. We need to learn, not only to 
withstand the devastating crises in medical practice, but 
to incorporate those experiences into and ever- 
deepening and satisfying psychological life. One of the 
greatest gifts which life has for us is the opportunity to 
become intimately involved in the lives of others. When 
the physician is free enough to acknowledge limitations 
usually all too apparent to the patient, then the rich and 
powerful experience of accompanying other human be¬ 
ings on a journey can be undertaken. It is willingness to 
open our hearts and minds to the pain and suffering of 
others that deepens us and allows more and more insight 
into our own needs and feelings, strengthening us and 
empowering us to do even more. Walking the extra mile 
can be an exercise in self-fulfillment and enlightenment. 
Reaching out can provide a positive and a hopeful pos¬ 
ture for living. I have found the hoary dictum, “First, do 
no harm,” to be a depressing and negative foundation 
for life, both as a physician and as a person. 
Many of us with advanced degrees in the sciences and 
the humanities have a grade-school level understanding 
of values, meanings and relationships between persons. 
If we can teach the latest developments in nuclear mag¬ 
netic resonance, we can also teach ancient skills in seek¬ 
ing self-knowledge, recognition of the inter-relatedness 
of all life, and the transient values of treasures kept 
where “moth and rust doth corrupt.” 
Physicians devote considerable time and energy to 
persons who are frightened and exposed to mortal 
danger. The attitudes we display toward our patients— 
the way patients see us are accepted by students in the 
health professions as a template for their behavior. Shal¬ 
lowness of spirit, unexamined values, inability to iden¬ 
tify with the feelings of the patient, and an exaggerated 
idea of the importance of the doctor all these teach that 
only limited success is possible for those who survive the 
clinical years. 
If medical students now think of clinical training and 
education as a time calling for survival, it is an attitude 
we have taught them. Practitioners, professors and re¬ 
search scientists—all need to search the depths of their 
personal and professional lives, examine their belief sys¬ 
tems and show forth, in a courageous and compassion¬ 
ate fashion, what it means to care for other persons. 
It is a temptation to reduce problems to the least 
common denominator, and this is often spoken of as 
oversimplification of complex problems. But we do have 
it on good authority that simplicity and deliberate search 
for the essentials of living are necessary.3 Survival is not 
enough. If we are to avoid despair we must take the risks 
implied in involving our lives with those of our col¬ 
leagues, our students and our patients. To live, not 
having loved, is desperation. To die, not having lived, is 
the ultimate tragedy. 
Footnotes 
1. Gusky, M.D., Jeff, Medical Student Ward Survival Manual, 
Medical Students Publishers, Dallas, 1982, p. 9. 
see also. Survival Manual: A Guide to the Classical Years, AMSA. 
1983 
2. Jonsen, Ph.D., Albert R., “Sounding Board: Watching the Doc¬ 
tor,” NEJM, vol. 308, no. 25, June 23, 1983, p. 1531. 








The major construction and reno¬ 
vation projects at the Medical Cen¬ 
ter are, for the most part, com¬ 
pleted. For more than two years, 
great craters and mounds of earth, 
attended by gigantic machines re¬ 
sembling prehistoric monsters, 
created near havoc in the area. 
( Yale Medicine, Fall 1979) From 
all of this has arisen a new parking 
garage, six levels high and two 
blocks long; a new hospital build¬ 
ing to replace the aged and out¬ 
dated New Haven Unit; and en¬ 
larged and improved facilities for 
therapeutic radiology research and 
patient care. And, three bridges 
have been added to the street- 
scape two to facilitate interac¬ 
tion between basic scientists and 
physicians at the bedside; one to 
protect users of the garage from 
traffic and the weather. The vener¬ 
able Hope Building has been given 
a new lease on life ( Yale Medicine, 
Winter 1982), and projects are un¬ 
derway to renovate still others 
of its vintage. All in all, the views 
here and about have changed 
considerably. 
New signs of brightly colored plastic, 
lighted at night, guide visitors who come to 
the Medical Center. The green, red, gold 
and white seal of the School of Medicine, 
on afield of blue, stands in front of Ster¬ 
ling Hall of Medicine. In addition to signs 
in front of major buildings, there are direc¬ 
tional signs and comprehensive maps of 
the Medical Center on several strategic 
<^j street corners in the area. 
The lawn in front of Hark ness dormitory is 
a favorite spot for lunch on balmy spring 
and summer days. In the background—the 
new park in front of the recent addition to 
the Hunter Radiation Therapy Center, 
and the bridge connecting the New Haven 










A park has been created at the intersection 
of Cedar Street and Davenport Avenue. 
Across Davenport A venue, the new hospi¬ 
tal building is connected with the Memo¬ 
rial Unit. 
<1 
The 250-foot covered walkway between 
the parking garage and the main entrance 
to the hospital is intended to provide safety 
and security for the faculty, staff, students 
and visitors who park there. Open twenty- 
four hours a day, the garage with space for 
2400 cars, greatly alleviates dire parking 
conditions in the area. York Street passes 









Entrance to the new emergency room is on 
Davenport Avenue, almost at the corner 







A SECTION OF MOLECULAR 
NEUROBIOLOGY IS 
ESTABLISHED WITH 
DR. STEVENS AS CHAIRMAN 
President A. Bartlett Giamatti has an¬ 
nounced the formation of a new Sec¬ 
tion of Molecular Neurobiology, and 
the appointment of Dr. Charles F. 
Stevens as the chairman, both for a 
term of five years, effective July 1. “I 
am confident the future of neuro¬ 
science at Yale will be strengthened by 
the establishment of this new Section,” 
President Giamatti said. 
Dr. Stevens, professor of physiol¬ 
ogy at Yale since 1975, is well known 
for his research on the molecular basis 
for nervous system function, and in 
particular, for his studies on the role of 
proteins in transmission of informa¬ 
tion over nerves and from one nerve 
cell to another in the brain. “During 
the past five years, there has been a 
very rapid and striking development 
of the molecular approach to practi¬ 
cally all areas of medical science, in¬ 
cluding the study of the human brain,” 
he said. 
The new Section of Molecular Neu¬ 
robiology will bring together six 
scientists of various disciplines, whose 
primary appointments will be in the 
Section, and who will interact with 
scientists from other departments in 
the University to apply molecular ap¬ 
proaches to traditional problems in 
neurobiology. In addition, Dr. Stev¬ 
ens will assume responsibility for or¬ 
ganizing a graduate program in the 
neurosciences, as well as continue his 
teaching of medical students. 
Elected to the National Academy of 
Sciences in 1982, Dr. Stevens is a 
graduate of Harvard College, and re¬ 
ceived his M.D. degree from Yale in 
1960, and a Ph.D. degree from Rocke¬ 
feller University in 1964. Prior to his 
appointment at Yale in 1975, he had 
been professor of physiology and bio¬ 
physics at the University of Washing¬ 
ton School of Medicine in Seattle, 
where he had been a member of the 
faculty since 1963. 
During the academic year 1969-70, 
Dr. Stevens was guest lecturer at Lo- 
rentz Institute for Theoretical Physics, 
Leiden University, The Netherlands. 
In 1979, Columbia University College 
of Physicians and Surgeons presented 
him the W. Alden Spencer Award for 
outstanding contribution to neuro¬ 
science, and in 1981, he was the Grass 
Lecturer for the Society of Neuro¬ 
science. 
SCHOOL DESIGNATED A 
CENTER FOR MAJOR N1H 
STUDY OF NEW TREATMENT 
FOR HEART ATTACK 
The National Institutes of Health have 
awarded more than S1.5 million to 
Yale University to establish one of 
three core laboratories and a clinical 
unit for collaborative clinical trials of 
a new treatment by thrombolysis of 
acute heart attack. Dr. Barry Zaret, 
professor of medicine and diagnostic 
radiology, is director of the labora¬ 
tory, and Dr. Charles K. Francis, as¬ 
sociate professor of medicine, is prin¬ 
cipal investigator of the clinical unit of 
Yale’s portion of the study, which in¬ 
volves radioisotope aspects of throm¬ 
bolysis in myocardial infarction 
(TIMI). 
“The concept of thrombolysis has 
been an exciting major step in cardiol¬ 
ogy,” according to Dr. Zaret. “The 
NIH study seeks to evaluate its effec¬ 
tiveness in preventing morbidity and 
mortality of heart attacks.” 
Studies based on initial observa¬ 
tions in Germany have shown that not 
only are heart attacks caused by a 
blood clot formed in the area of one of 
the vessels supplying blood to the 
heart, but also that the clot can be 
dissolved by aggressive therapy in¬ 
volving infusion of an anticoagulant 
either through a catheter at the sight of 
the clot, or intravenously. If throm¬ 
bolysis is administered in the early 
stages, blood flow is returned to the 
affected area, the heart attack may be 
aborted, and significant heart muscle 
damage may be prevented. 
The NIH sponsored T1M1 study 
will address two major questions. Is 
thrombolysis as beneficial as prelimi¬ 
nary studies indicate? Which method 
of thrombolysis—by catheter or by 
infusion—is the safest and most 
efficient? 
Approximately 1200 heart attack 
patients will be studied during the 
three-year investigation by major 
medical centers in the United States. 
Data generated from patients seen in 
the 12 clinical centers designated by 
the NIH will be analyzed and pro¬ 
cessed in the core laboratories at Yale, 
Maryland Medical Research Institute, 
and the University of Washington. 
The Yale portion of the study will 
assess the efficacy of intravenous in¬ 
jection of anticoagulants as opposed 
to lysis through a catheter. They will 
measure the overall benefits of throm- 
bolysis using radioisotopic techniques 
perfected by Dr. Zaret and his col¬ 
leagues, to measure heart function. 
In addition to Drs. Zaret and Fran¬ 
cis, participants in the Yale portion of 
the study will include Dr. Lawrence S. 
Cohen, Ebenezer K. Hunt Professor 
of Medicine, Dr. William P. Batsford, 
associate professor of medicine, and 
Dr. Harvey J. Berger, associate pro¬ 
fessor of diagnostic radiology and 
medicine. 
MYSTERY OF LYME DISEASE 
A STEP CLOSER TO BEING 
SOLVED 
Scientists at the School of Medicine 
have isolated for the first time a newly 
recognized spirochete from the blood, 
skin or cerebrospinal fluid of patients 
with Lyme disease. “The recovery of 
this organism from patients provides 
important evidence that the I. clam- 
mini spirochete is the causative agent 
of Lyme disease,” according to Dr. 
Allen C. Steere, principal investigator 
of the research. 
Previously the spirochete had been 
isolated only from Ixodes dammini, 
the tick identified as the probable 
transmitter of the disease. The new 
finding has implications for better di¬ 
agnosis and treatment of the illness, 
and may help in the understanding of 
some other immune-mediated dis¬ 
eases such as rheumatoid arthritis. 
Lyme disease, first recognized in 
1975 by Yale medical scientists includ¬ 
ing Dr. Steere and Dr. Stephen E. Ma- 
lawista, professor of medicine and 
head of the Section of Rheumatology, 
has affected hundreds of people along 
the Atlantic coast and in some mid- 
and far-western states. It typically be¬ 
gins in summer with a unique skin 
lesion, erythema chronicum migrans 
(ECM), which sometimes expands to 
a diameter of five inches or more, and 
may be accompanied by flu-like symp¬ 
toms. Weeks to months later, some 
patients develop neurologic or heart 
symptoms, and still later, may develop 
intermittent attacks of arthritis, which 
may become chronic. 
The later stages of Lyme disease 
often mimic several serious immune- 
mediated disorders including juvenile 
rheumatoid arthritis, rheumatoid ar¬ 
thritis, rheumatic fever, the Guillain- 
Barre syndrome and multiple sclero¬ 
sis. The fact that the Yale scientists 
recovered the I-dammini spirochete 
not only from the skin and blood of 
patients, but also from the cerebrospi¬ 
nal fluid of those with neurologic 
symptoms ten weeks after the onset of 
the illness, suggests that the organism 
may first invade the skin or blood via 
the tick bite, and eventually migrate to 
the nervous system. The course of the 
organism thereafter is still unclear. 
Dr. Steere and his colleagues are 
continuing their research to determine 
whether the spirochete is present dur¬ 
ing the late, arthritis manifestations of 
the disease, and if so, where it is lo¬ 
cated and what role it plays. “The 
question of a persistent infectious 
agent being necessary for continued 
disease activity, as opposed to trigger¬ 
ing by such an agent, followed by au¬ 
to-immunity, is of central importance 
in a number of immune-mediated dis¬ 
eases,” they reported. The first clue 
that Lyme disease was caused by an 
infectious agent was the fact that sev¬ 
eral children with typical symptoms 
lived in the same neighborhood in 
Lyme, Connecticut. The rural setting 
of the area, plus identification of ECM 
as a distinguishing characteristic 
of the illness, suggested that it might 
be transmitted by an arthropod. Sub¬ 
sequent investigation by the Yale team 
provided strong evidence that a re¬ 
cently identified tick, Ixodes dammini, 
was the victor. 
In 1979, Dr. Steere and his col¬ 
leagues found that penicillin or tetra¬ 
cycline given early in the illness, 
shortens the duration of ECM and can 
sometimes prevent more serious 
symptoms. This suggested that the 
causative agent was a penicillin- 
sensitive bacterium such as a spiro¬ 
chete. In 1982, a previously unrecog¬ 
nized spirochete was isolated by 
scientists at the Rocky Mountain Lab¬ 
oratory in Hamilton, Montana, from 
an Ixodes dammini tick collected on 
Shelter Island, New York, where a 







































The University’s 282nd Commence¬ 
ment was held on the Old Campus, 
between rain showers, on May 23rd. 
In contrast to the previous few years, 
when anti-war and social protests 
were evident, this year’s commence¬ 
ment was marked by a note of gentle 
humor amidst the traditional pomp 
and circumstance. Forestry graduates 
decorated their mortar boards with 
leaves, and Divinity School graduates 
stuck pipecleaner halos on theirs, 
while a small cast from the Drama 
School wore Groucho Marx masks. 
School of Medicine graduates re¬ 
mained relatively staid, with only an 
occasional happy-faced balloon rising 
from their ranks as they marched to 
their places beneath the elms. 
In addition to 1,189 bachelor’s de¬ 
grees awarded to graduating seniors, 
Yale presented 1,824 graduate and 
professional degrees, including 99 
M.D. degrees, and 74 M.P.H. degrees. 
Professor Dame Sheila Sherlock, who 
had been a guest lecturer at the School 
of Medicine a few days before, was 
one of nine distinguished men and 
women of the arts and science to re¬ 
ceive an honorary degree. Chairman 
and professor of medicine at the Uni¬ 
versity of London, she is an interna¬ 
tionally reknowned scientist, clinician, 
author and editor. 
Following the ceremony on the Old 
Campus, medical graduates returned 
to the School where, under a blue and 
white striped tent in the courtyard of 
Harkness Hall, Dean of Students 
Howard Levitin welcomed them and 
their families and friends. Dr. James 
P. Comer, associate dean, awarded 
more than 20 prizes and honors to 
graduates who had excelled during 
their four years as students. 
The ninety-nine members of the 
Class of 1983 then filed to the podium 
to receive their diplomas and congrat¬ 
ulations from Dean Robert W. Ber¬ 
liner. Six were awarded the M.D./ 
Ph.D. degree: Richard M. Cawthon, 
John R. Chaillet, Robert O. Kenet, 
Marshal Mandelkern, Eric J. Nestler, 
and Pamela L.. Zeitlin. In addition, 
Jose Gaston Guillem received a joint 
M. D. / M. P. H. degree. 
Following the presentation of de¬ 
grees, the new doctors took the Hip¬ 
pocratic Oath, led by Dr. Alan C. 
Mermann, chaplain of the School. Dr. 
Robert H. Gifford, professor of medi¬ 
cine, delivered the commencement 
address, excerpts from which appear 
on the preceding pages. A gala buffet 
luncheon served on the terrace of 
Harkness Hall concluded an occasion 
both solemn and joyous. 
For the second year, the Depart¬ 
ment of Epidemiology and Public 
Health abandoned its traditional blue 
and white tent, and held commence¬ 
ment exercises in the more weather¬ 
proof Yale Repertory Theater. 
Chairman Jan A.J. Stolwijk wel¬ 
comed the graduates and their guests, 
and Dr. Kyle Grazier, assistant pro¬ 
fessor of public health, presented the 
diplomas. 
The commencement address was 
given by Dr. Colin White, Ira 
Vaughan Hiscock Professor of Public 
Health. Announcement of the E. 
Richard Weinernran Fellowships was 
made by Dr. Arthur J. Viseltear, asso¬ 
ciate professor of history of medicine 
and public health, and Dr. Diana B. 
Fischer, senior research associate and 
lecturer in public health, announced 
the Richard H. Schlesinger Fellow¬ 
ship and the Kathleen Hara Howe 
Scholarship. Dr. James F. Jekel pre¬ 
sented the award of certificate, preven¬ 
tive medicine residency program. 
In addition to the 74graduates who 
received M.P.H. degrees, four E.P.H. 
students received Ph.D. degrees, 
awarded at the Graduate School. 
They were: Susan E. Brown. Priscilla 
F. Canny, Gretchen S. Dieck, and 
Rebecca T. Zagraniski. 
Following the ceremony, the grad¬ 
uates and their guests were feted at a 
buffet luncheon party. 
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SECOND YEAR STUDENT 
AWARDED ALF STUDENT 
RESEARCH FELLOWSHIP 
Michael L. Grossbard, a second year 
student, has been awarded a Student 
Research Fellowship from the Ameri¬ 
can Liver Foundation. Mr. Grossbard 
is studying the biochemistry of blood 
following liver damage in the labora¬ 
tory of Dr. James L. Boyer, professor 
of medicine and director of the Liver 
Study Unit. 
A national voluntary organization, 
the American Liver Foundation pro¬ 
vides facts about liver disease, the 
fourth leading cause of death to age 
65. The Foundation is currently plan¬ 
ning a national campaign to increase 
public support for liver research. 
YALE STUDENT RECEIVES 
AOAAWARD 
Matthew R. Moore, Class of 1986, 
was one of five students to receive the 
first annual Alpha Omega Alpha Stu¬ 
dent Research Fellowship Awards. 
The Awards were established last year 
to make available up to five $1,000 
prizes annually in support of student 
research. The 1983 award winning re¬ 
search projects were considered the 
“most promising” of 33 proposals of 
impressive quality received, according 
to the AOA award committee. In ad¬ 
dition to Mr. Moore, recipients were 
from Case Western Reserve Univer¬ 
sity, the University of Pennsylvania, 
University of California, San Fran¬ 
cisco, and Mount Sinai School of 
Medicine. 
RECEPTION FOR CLASS 
OF 1983 
The Association of Yale Alumni in 
Medicine held a reception on April 22 
for members of the medical class of 
1983. It was well attended by students 
in the graduating class and by a 
number of local alumni. Dr. Nicholas 
Spinelli extended greetings on behalf 
of the Alumni Association. It is 
planned to make such a reception hon¬ 
oring the graduates an annual event. 
AW A R PS AND HONO RS 1983 
Each year, members of the faculty and 
house staff are honored by colleagues 
and students for their various contri¬ 
butions to the medical profession. The 
1983 awards reflect the continuing re¬ 
gard at the Yale-New Haven Medical 
Center for excellence in patient care as 
well as for teaching and research 
accomplishments. 
Ihe Betsy Winters House Staff 
Award is presented annually to the 
member of the house staff of Yale- 
New H aven Hospital who has made 
the most significant contribution to¬ 
ward the education of medical stu¬ 
dents. The selection is made by the 4th 
year class, who this year presented the 
award to Bernard Shen, Class of 1981, 
who is a second-year resident in 
medicine. 
Dr. John Mellors, assistant profes¬ 
sor of medicine, received the Benedict 
R. Harris Award. Established in 1967, 
the award is made annually to the at¬ 
tending physician who has contrib¬ 
uted the most to the teaching of the 
house staff. 
The Samuel D. Kushlan Awards 
were established in 1969 to recognize 
the intern and second-year resident 
who have contributed the most to pa¬ 
tient care during rotation through the 
Memoral Unit Medical Service. Selec¬ 
tion of recipients is made in consulta¬ 
tion with the clinical faculty and the 
nursing service. The 1983 awards were 
presented to Dr. Lynn Tanoue, Class 
of 1982, an intern in the Department 
of Medicine, and Dr. Stewart Greis- 
man. Class of 1981, a junior assistant 
resident in medicine. 
The Francis Gilman Blake Award is 
presented annually by the graduating 
medical school class to the outstand¬ 
ing teacher of medical sciences. Dr. 
Frank .1. Bia, assistant professor of 
medicine and laboratory medicine, 
was so honored this year. 
The Department of Psychiatry each 
year presents the Seymour L. Fust- 
man, M.D. Research Awards for re¬ 
search accomplishments during resi¬ 
dency. This year, a first place award 
was presented to Dr. Robert B. lnnis, 
and second place awards were pre¬ 
sented to Dr. Alan Breier and Dr. Jef¬ 
frey Satinover. 
FIVE ON FACULTY BECOME 
PROFESSOR EMERITUS 
Five professors in the School of Medi¬ 
cine retired from the faculty on July 1. 
Dr. Stephen Fleck, professor of 
psychiatry and public health, and for 
many years, psychiatrist-in-chief of 
the Yale Psychiatric Institute, is well 
known for his studies on schizophre¬ 
nia. A member of the faculty for thirty 
years. Dr. Fleck received his M.D. de¬ 
gree from Harvard University follow¬ 
ing studies at the University of Frank¬ 
furt and the University of Amsterdam. 
As a leader in the application of 
clinical psychology to pediatric re¬ 
search, Dr. Ethelyn H. Klatskin has 
been a pioneer in developing rooming- 
in and other models of care for moth¬ 
ers and newborn children. A professor 
of psychology in pediatrics at the 
Child Study Center, Dr. Klatskin re¬ 
ceived her B.A. degree from the Uni¬ 
versity of Mississippi and her Ph.D. 
degree from Yale University. She has 
been a member of the School of Medi¬ 
cine faculty for almost 37 years. 
Dr. Robert M. Lowman, professor 
of diagnostic radiology, is former di¬ 
rector of the Memorial Unit radiology 
service at Yale-New Haven Hospital. 
He is well known by students, house 
staff, and attendings as an enthusiastic 
teacher. A member of the faculty for 
31 years, he is a graduate of Harvard 
College, and the University of Mary¬ 
land School of Medicine. 
Chairman of the Section of Cell Bi¬ 
ology since it was established on 1973, 
Dr. George E. Palade was co-winner 
of the 1974 Nobel Prize for Physiology 
and Medicine for his discoveries on 
structural and functional organization 
of cells. Dr. Palade, who is Sterling 
Professor of Cell Biology, will con¬ 
tinue his association with the School 
as Special Advisor to the Dean and a 
senior research scientist in Cell 
Biology. 
The chairman of the Department of 
Microbiology from 1950 to 1961, Dr. 
Henry P. Treffers, professor of pa¬ 
thology, has been on the faculty for 38 
years. An authority on the chemical 
aspects of immunity and of microbial 
resistance to chemotherapeutic 
agents, he received his B.A. and his 


















MENTAL HEALTH, MENTAL 
ILLNESS, AND THE FAMILY 
The Department of Psychiatry spon¬ 
sored a conference in June on key as¬ 
pects of the family in health and illness 
to honor Dr. Stephen Fleck, professor 
of psychiatry and public health and 
deputy chairman of the department. 
Dr. Fleck’s pioneering research at Yale 
spans the areas of family studies and 
schizophrenia as well as treatment and 
preventive strategies. 
The program held on June 10 and 
I 1 was introduced with opening re¬ 
marks by President A. Bartlett Gia- 
matti and Deputy Dean Arthur Eb- 
bert, Jr., who spoke on behalf of Dean 
Berliner. The keynote address was 
given by Dr. Daniel X. Freedman, 
chairman of the Department of Psy¬ 
chiatry at the University of Chicago. 
Speakers on the scientific program in¬ 
cluded Dr. Theodore Lidz, Sterling 
Professor Emeritus of Psychiatry, 
who was responsible for bringing Dr. 
Fleck to Yale in 1953. 
A banquet for Dr. Fleck held on 
Saturday evening, June 1 I, at the Park 
Plaza Hotel was attended by those 
who had participated in the confer¬ 
ence and about three hundred guests. 
A number of Dr. Fleck’s colleagues 
and former students paid tribute to 
him in a series of after dinner talks. 
DR. SOLNIT FETED 
Dr. Albert J. Solnit, Sterling Profes¬ 
sor of Pediatrics and Psychiatry, was 
honored at a gala reception held in the 
University Commons Woolsey Hall 
on Sunday, May 15. Jhe occasion, 
which was attended by several 
hundred representing both town and 
gown, celebrated Dr. Solnit’s seven¬ 
teen years as director of the Yale Child 
Study Center and his appointment as 
Freud Memorial Professor at Univer¬ 
sity College, London for the the year 
1983-84. 
Having served as director of the 
Child Study Center since 1966, Dr. 
Solnit has relinquished this position to 
devote his full attention to research, 
patient care, and teaching. Following 
a sabbatical yearat University College 
London, he will return to Yale in 1984. 
DR. KLATSKIN IS HONORED 
Former fellows of the Liver Study 
Unit convened on June 2 and 3 for a 
scientific program honoring Dr. Ger¬ 
ald Klatskin on the fifth year of his 
retirement. The program of 16 scien¬ 
tific presentations, covering a broad 
range of topics related to liver function 
and disease, effectively demonstrated 
the significant contribution Dr. Klats¬ 
kin has made to the field of 
hepatology. 
Dr. Klatskin, who is David Paige 
Smith Professor Emeritus of Medi¬ 
cine, came to Yale in 1933 as an intern 
in medicine. He has since earned rec¬ 
ognition not only as a leader in liver 
research, but also as an outstanding 
teacher. In May, the American Gas¬ 
troenterological Association honored 
him with its highest award, the Julius 
Friedenwald Award, for his distin¬ 
guished contribution to the field of 
gastroenterology. It was presented to 
him by Dr. James L. Boyer, w ho suc¬ 
ceeded him as director of the Yale 
Liver Study Unit. 
J he Gerald Klatskin Yale Liver Li¬ 
brary is being established to provide 
permanent archives for Dr. Klatskin’s 
collection of over 50,000 color slides 
from 10,000 liver biopsy specimens. 
Alumni and friends are invited to con¬ 
tribute to the fund in care of Dr. 
Boyer, Yale Liver Study Unit, 333 





























FACULTY NOTES PROMOTIONS TO PROFESSOR 
The following members of the medical 
faculty were promoted to professor¬ 
ships effective July 1983: lan M. Ar- 
mitage, Ph.D., professor (adjunct) of 
research in molecular biophysics and 
biochemistry; Edward Dunn, M.D., 
clinical professor of surgery; John E. 
Fenn, M.D., clinical professor of 
surgery; Lawrence P. Fielding, 
M.B.B.S., clinical professor of 
surgery; Angela R. Holder, LL.M., 
clinical professor of pediatrics (law); 
Sidney Hurwitz, M.D., clinical pro¬ 
fessor of pediatrics; Charles A. Jane¬ 
way, Jr., M.D., professor of path¬ 
ology; Arthur T. Rosenfield, M.D., 
professor of diagnostic radiology; 
John H. Seashore, M.D., professor of 
surgery and pediatrics; Clifford L. 
Slayman, Ph.D., professor of physi¬ 
ology; Eiji Yanagisawa, M.D., clinical 
professor of surgery (otolaryngology); 
Robert K.-J. Yu, Ph.D. professor (ad¬ 
junct) of research in neurology. 
NEW CLINIC ASSISTS 
TRAVELERS TO THE TROPICS 
Connecticut area vacationers, schol¬ 
ars, businesspeople and other travelers 
abroad will be interested to learn that 
a Tropical Medicine and International 
Travelers Clinic has been established 
by the Department of Internal Medi¬ 
cine. Located in Yale-New Haven 
Hospital, the Clinic’s staff are special¬ 
ists in the prevention, diagnosis and 
treatment of tropical diseases and 
other medical problems encountered 
in foreign travel. 
“Each year, many business and va¬ 
cation travelers leave the United 
States without adequate medical in¬ 
formation or preparation for their trip 
abroad,” according to Dr. Michele 
Barry, who with Dr. Frank J. Bia, 
directs the Clinic. “Lack of proper 
vaccinations, failure to take precau¬ 
tions against malaria and other tropi¬ 
cal diseases, and a poor understanding 
of how infectious diseases are com¬ 
municated can often result in needless 
illness.” 
Dr. Barry and Dr. Bia, who are as¬ 
sistant professors of medicine, have 
had extensive experience in evaluating 
and treating medical problems of the 
tropics at the Hospital Albert 
Schweitzer in Haiti, and in Southeast 
Asia. Dr. Barry is director of the 
Southeast Asian Refugee Clinic at 
Yale-New Haven Hospital, whose ser¬ 
vice not only to refugees, but to travel¬ 
ers to that area as well, prompted the 
development of the Tropical Medicine 
and International Travelers Clinic. In 
addition, another member of the med¬ 
ical staff, Dr. David Melchinger, asso¬ 
ciate clinical professor of medicine, 
was involved in the smallpox irradica- 
tion program in West Africa. 
The Clinic offers a unique service to 
residents and businesses in Connecti¬ 
cut and surrounding areas, according 
to Dr. Bia. “Most medical training in 
this country does not include very ex¬ 
tensive study of tropical diseases, so 
few physicians and other medical pro¬ 
fessionals are able to offer the kind of 
service and experience that are avail¬ 
able in the Clinic.” 
In addition to familiarizing travel¬ 
ers with the international vaccination 
requirements for diseases such as 
cholera, yellow fever, and smallpox, 
and initiating or updating immuniza¬ 
tion for polio, tetanus, typhoid and 
cholera the Clinic provides an effective 
regimen for malaria prevention, par¬ 
ticularly for travelers to areas where 
drug resistant strains of the disease are 
likely to be encountered. They will 
screen patients for previous tuberculo¬ 
sis exposure, as well as for immunity 
to hepatitis, and will administer 
gamma globulin when required. Phy¬ 
sician referral when abroad is pro¬ 
vided, and individuals with medical 
problems will be advised if their cur¬ 
rent therapy needs specific revision for 
the trip. 
On return, travelers may be 
screened for recent exposure to tuber¬ 
culosis; tested for the presence of intes¬ 
tinal parasites or pathogenic bacteria; 
and given a course of therapy to pre¬ 
vent delayed attacks of malaria. The 
Clinic strongly recommends that trav¬ 
elers visit there, when possible, at least 
four to six weeks prior to departure. 
Mt. Holyoke College conferred an 
honorary Doctor of Science degree on 
one of its distinguished alumnae. Dr. 
Ruth Whittemore, clinical professor 
of pediatrics. The citation read in part, 
“Through your clinical proficiency 
and sensitive concern for children, to¬ 
gether with your intense dedication to 
medical education, you provide a role 
model that has influenced thousands 
of nurses and physicians to follow in 
your footsteps. Your career is proof 
positive that the successful practice of 
medicine is more art than science; few 
physicians can present such an envi¬ 
able record of achievement.” 
Dr. Paul G. Barash, chairman of the 
Department of Anesthesiology, was 
named president-elect of the Society 
of Cardiovascular Anesthesiologists. 
The Society is an international organ¬ 
ization of specialists in the field of 
anesthesia for cardiac, vascular and 
thoracic surgery. Dr. Barash had pre¬ 
viously served as chairman of the Re¬ 
search and Education Committee, and 
most recently, as chairman of the Pro¬ 
gram Committee. 
The American Psychiatric Associa¬ 
tion presented the 1983 Samuel G. 
Hibbs Award to Dr. John Strauss, 
professor of psychiatry, for his work 
on understanding of psychiatric dis¬ 
orders. The prize is awarded annually 
to honor contributions to clinical re¬ 
search in psychiatry. 
The American Association for the 
Advancement of Science elected Dr. 
Lawrence Marks, associate professor 
of epidemiology and psychology, a fel¬ 
low of the association. Dr. Marks, 
who is also a member of the scientific 
staff of the John B. Pierce Foundation 
Laboratory, is well known for his re¬ 
search in psychophysics. 
Dr. Eleanor Adair, another member 
of the Pierce scientific staff, was also 
elected a fellow of the AAAS. 
The 42nd Annual Chapin Medal of 
the Rhode Island Medical Society was 
presented to Dr. Alvan R. Feinstein, 
professor of medicine and epidemiol¬ 
ogy. At the presentation ceremony, 
continued on next page 
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held on June 7, Dr. Feinstein delivered 
a talk on “Clinical Epidemiology: An 
Additional Basic Science for Clinical 
Medicine.”The medal commemorates 
Charles V. Chapin, an internationally 
known public health authority. Pre¬ 
vious faculty to receive this honor 
were Drs. Francis G. Blake, Stanhope 
Bayne-Jones, and John Rodman 
Paul. Dr. Leona Baumgartner, Class 
of 1934, also received this medal. 
The Federation of American Societies 
for Experimental Biology and The 
Burroughs Wellcome Fund have 
awarded Dr. Flenry J. Binder, profes¬ 
sor of medicine, a 1983-84 Wellcome 
Visiting Professorship in the Basic 
Medical Sciences. Dr. Binder who is 
well known for his research in gas¬ 
troenterology, will spend several days 
teaching and participating in seminars 
with students and faculty at the Uni¬ 
versity of Nevada School of Medicine, 
and deliver a Wellcome Lecture in the 
Basic Medical Sciences. The awards 
were established to stimulate interest 
in the basic sciences and to recognize 
eminent scientists. 
RICHARD K. GERSHON, M.D. 
Dr. Richard Keve Gershon, professor 
of pathology and biology, died at 
home on July 11, 1983, after a long 
struggle with lung cancer. 
He was born in New York City on 
December 24. 1932. A cum laude 
graduate of Harvard College, he en¬ 
tered the Yale University School of 
Medicine in 1954. After interrupting 
medical school for a year of research 
training in Paris, he received his M.D. 
degree from Yale in 1959. He received 
his training in Pathology at Yale, and 
became acting chief of the Viral and 
Rickettsial Diseases Medical General 
Laboratory of the United States Army 
in Japan. He joined the faculty of the 
Yale Pathology Department in 1964. 
He became interested in immunology 
as part of his research on the factors 
regulating tumor growth, and in 1967 
he spent a year furthering this interest 
as a visiting professor at the Chester 
Beatty Research Institute in London. 
After his return to Yale he became 
chief of the Division of Immunology 
in 1976, and was appointed director of 
the Laboratory of Cellular Immunol¬ 
ogy of the Howard Hughes Medical 
Institute at Yale in 1977. He was 
elected a member of the National 
Academy of Sciences in 1980. 
His research in immunology led to 
the discovery of subsets of T- 
lymphocytes, and in particular to 
identification of the suppressor T- 
lymphocyte. These discoveries dem¬ 
onstrated that immunity is not merely 
the result of an induction of a response 
but rather a highly controlled se¬ 
quence of events. He identified an 
immunoregulatory circuit which con¬ 
sists of inducer cells, precursor/ampli¬ 
fier cells, and effector cells, which may 
either induce or suppress the immune 
response. In his own colorful way he 
described this sytem as “an immuno¬ 
logic orchestra” which could play a 
variety of symphonies known as im¬ 
mune responses. It was his discoveries 
that allow us to further explore the 
mechanisms of the immune response 
to foreign invaders; and, perhaps most 
important of all, the reaction of the 
body to atypical proliferation, or 
cancer. 
He was widely recognized for his 
achievements, and just this year he re¬ 
ceived the George Thorn Award for 
outstanding medical research, and the 
Gairdner Foundation International 
Award for outstanding discoveries in 
medical science. 
To his classmates and friends he will 
be remembered for more than his 
scientific achievements. A connoisseur 
of wine and food, an enthusiastic 
sports fan, a world traveller, and a 
friend with a memorable sense of 
humor, he shared his joy in life with all 
around him. Whether as scientist, 
teacher, classmate or friend, he left a 
legacy to all of us. 
Dr. Gershon is survived by his wife, 
the former Robyn Mione, a daughter, 
Alexandra, his parents, and a brother. 
Dr. Michael Gershon, chairman of the 
Department of Anatomy at Columbia 
University. M.K. 
KAJ HARINE C. ANGELL 
Katharine Cramer Angell, the widow 
of James Rowland Angell, president 
of the University from 1921 to 1937, 
died on July 22, 1983, at the age of 93. 
She was a long-time friend and sup¬ 
porter of the School of Medicine. 
Contributions in Mrs. Angell’s mem¬ 
ory may be made to the Katharine C. 
Angell Medical Student Loan Fund, 
which was established in her honor on 
the occasion of her ninetieth birthday. 
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Alumni weekend gets better each year. 
The varied and interesting programs 
offered a neat balance of intellectual 
stimulation, sociability, and nostalgia— 
has been attracting alumni back to the 
Sterling Hall of Medicine in increasing 
numbers, and, the more, the merrier. 
This year, several events which were 
planned to coincide, added further 
dimension to Alumni Weekend, which 
began unofficially on Thursday, June 
2, with a scientific program honoring 
Dr. Gerald Klatskin, the former direc¬ 
tor of the Liver Study Unit. The next 
day, the program assumed a festive 
air, with interesting feature events and 
superb side shows as well. 
The Yale Alumni in Ophthalmology 
held its annual day-long meeting with 
symposia on the “Treatment of Hy¬ 
phema” and “Diagnosis and Treat¬ 
ment of Congenital Leukokoria) Syn¬ 
dromes Including Pars Plicata Surgery”. 
Dr. Morton F. Goldberg, professor 
and chairman of the Department of 
Ophthalmology at the University of 
Illinois, was the guest speaker. 
That morning, a symposium mark¬ 
ing the 60th anniversary of the School 
of Nursing, “Toward Humane Two- 
Tier Health Care”, attracted a large 
audience. Uwe Reinhardt, professor 
of economics and public affairs, 
Woodrow Wilson School of Public 
Health and International Affairs at 
Princeton, interspersed his talk with 
hard facts and pithy humor. 
At the same time, the Association of 
Yale Alumni in Public Health 
(AYAPH) and the Yale University 
Hospital Administration Alumni As¬ 
sociation (YUHAA) held their annual 
workshops and jointly sponsored a 
symposium on “The Administration’s 
View of the Federal Government’s 
Role in Medical Care and Public 
Health”. Keynote speaker. Dr. Robert 
J. Rubin, assistant secretary for plan¬ 
ning and evaluation, U.S. Department 
of Health and Human Services, gave 
the Reagan Administration “A” for 
effort in improving the nation’s health 
care system. 
In the afternoon, in an AYAPH 
seminar, “The Federal Government’s 
Role in Public Health: Another 
View”, Susan Addiss took issue with 
Dr. Rubin’s assessment in a hard hit¬ 
ting criticism of the Administration’s 
social and health policies. Ms. Addiss, 
(’69 EPH), is chief of the Bureau of 
Health Planning and Resource Allo¬ 
cation, Connecticut Department of 
Health Services, and president-elect of 
the American Public Association. 
Following her talk. Dr. Jan Stol- 
wijk, chairman of the Department of 
Epidemiology and Public Health, de¬ 
scribed research he and his colleagues 
are conducting on the effects of indoor 
air pollution, and new methodology 
they are developing for assessing such 
information. Dr. Stolwijk has been a 
strong advocate of federal environ¬ 
mental regulations based on more and 
better scientific information. 
As expected, the YUHAAA’s an¬ 
nual workshop addressed “Prospec¬ 
tive Payment and Diagnostic Related 
Groups”, with a talk by John D. 
Thompson (’50), professor of public 
health and nursing administration, 
who was one of principal authors of 
the controversial plan. He also spoke 
the next day in an Alumni Day sem¬ 
inar on the same subject. 
The EPH alumni program attracted 
one of the largest alumni audiences 
ever. Over 100 attended the reception 
and dinner held on Friday night in the 
Presidents Room at Woolsey Hall. 
On Saturday morning, still more 
alumni arrived at the Rotunda for a 
day beginning with remarks by Presi¬ 
dent A. Bartlett Giamatti, followed by 
four extraordinarily interesting and 
timely seminars. Dr. Edward Adel- 
berg was moderator for “Introduction 
to Genetic Engineering”, which in¬ 
cluded talks by Dr. William Summers 
on “Genetic Engineering in Research 
on Gene Structure and Organization”, 
and Dr. Michael Kamarack on “Ge¬ 
netic Research on Gene Expression”. 
Dr. John Dwyer held an enthusias¬ 
tic audience overtime with his talk on 
“The Immunological Twilight Zone: 
Evidence for the Mind’s Ability to 
Manipulate Immune Defense Mecha¬ 
nisms”. The promises and problems of 
DRGs were again explored by Profes¬ 
sor Thompson, joined in this seminar 
by Dr. Joanne Finley, who was Com¬ 
missioner of Public Health of New 
Jersey when that state was the first to 
use the system. The fourth seminar 
was given by Dr. Leo Cooney and Dr. 
Andrea Schaffner, who discussed the 
increasingly important topic of “Phy¬ 
sicians and the Aging Society”. 
The remainder of the day was di¬ 
vided between business and enter¬ 
tainment, with the annual meeting of 
the Association of Yale Alumni in 
Medicine followed by the traditional 
sherry hour and buffet lunch, and at 
4:30, a Social Hour was held in the 
Hope Building. Reunion classes held 
their individual class dinners that 
evening. 
Throughout the weekend, many 
alumni were overheard praising Louis 
Kaplan, associate dean for commu¬ 
nity and governmental relations and 
alumni affairs, and Constance Tol¬ 
liver, his senior administrator, for 
their very competent and creative 





No Report Received 
1933 
Fiftieth 
Yale Medical School’s class of 1933 
was represented by four graduates at 
their 50th reunion June 3 and 4, but 
they agreed that what was lacking in 
numbers was made up in fun and en¬ 
thusiasm. Of the 38 who graduated in 
1933, only 21 are known to survive. 
The events of Friday, June 3 and 
Saturday, June 4, described elsewhere 
in this issue, provided us with some 
interesting choices. There were also 
social hours each afternoon. 
Saturday evening the Yale Medical 
Alumni Association hosted a great 
dinner at the Graduates Club for the 
class of 1933. Present from our class 
were thoracic surgeon Francis Woods 
of Jaffrey, New Hampshire (who came 
3 days early for an Alumni College 
seminar on computers), internist Ray 
Miller of Trenton, New Jersey, path¬ 
ologist Robert Huntington of Cam¬ 
bria, California and public healther 
Franklin Foote of Wethersfield, 
Connecticut—the latter three were ac¬ 
companied by their wives. Present 
were officers of the association, also 
acting dean Art Ebbert, associate dean 
Lou Kaplan, former dean Vernon 
Lippard (’29) who was an intern in 
pediatrics when we were in school, and 
Harry Zimmerman (’27) who taught 
us pathology. 
Messages came from some class¬ 
mates: Jack Wolfe of Naples, Florida 
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reported having enjoyed 13 years in 
India and China and having learned 
that pitching bales of hay over a fence 
can produce disc problems; Joe Mig- 
none of North Haven has arthritis 
which kept him home; Ashley Pond of 
Taos, New Mexico found that a cervi¬ 
cal laminectomy last year put a stop to 
skiing, at least for now; Dan Harvey is 
in a skilled nursing facility in Hanover, 
New Hampshire; Paul Saffo of Rol¬ 
ling Hills, California, has a daughter 
who is professor of biology at 
Swarthmore and a son who is an at¬ 
torney; Ed Seelve of Berkeley, Cali¬ 
fornia, who practiced surgery in 
Worcester, Massachusetts lost his wife 
in 1978 but has remarried the widow 
of his roommate at Amherst. 
The big news is that our class did 
nobly in supporting the Medical 
School Alumni Fund in our reunion 
year to provide student loan funds. 
We had the highest per cent of 
contributors—67%—of all medical 
school alumni, and the highest aver¬ 
age gift of$375. Congratulations to all 




The far-flung Class of 1938 DID have 
a reunion dinner, thanks to the efforts 
of Charlie Petrillo, who made the ar¬ 
rangements. It was held at the Race 
Brook Country Club. Medical School 
days were re-lived in the company of 
Charlie and Ann Petrillo (New 
Haven), Ben and Blanche Lyons 
(Westport), Joe and Virginia Rey¬ 
nolds (Havertown, Pennsylvania) and 
I.es and Elizabeth Wallman (Burling¬ 
ton, Vermont). Jack Dillon u'rote 
from California saying that he is in 
good health and doing “good busi¬ 
ness”. Joe Criscuolo sent his best re¬ 
gards to all his classmates. 
Summers in Mattapoisett, Massa¬ 
chusetts; winters in Seminole, Florida 
are enjoyed by Jim Radcliffe and his 
wife. Jim’s nephew-in-law took over 
Jim’s practice in 1981. Still licensed, 
Jim keeps himself available for volun¬ 
teer work and keeps up with CME. 
Between whiles he enjoys tennis de¬ 
spite a triple-bypass operation. The 
Roy Barnetts, visiting Japan as guests 
of a Japanese Society, were not able to 
attend the dinner. 
Your secretary, now in her sixth 
year of retirement from anesthesiol¬ 
ogy at the V.A., accompanied a class¬ 
mate from high school days to our 
55th reunion held in Toronto, having 
graduated from a University of 
Toronto-sponsored school for mis¬ 
sionary children in Japan. Between 
domestic crises she works with the 
State Probation Department, and as a 
guardian ad litem for the local court 
and surrogate auntie for a “Boys’ 
Home”. 
Located just across the Connecticut 
River from Dartmouth and around 
the corner from the Norwich Inn, my 
house is the fourth on the right; the 
latchstring is always out on football 
weekends. Agnes V. Bartlett 
1943 (March) 
Fortieth 
The fortieth reunion was, indeed, out¬ 
standing and most deserving of super¬ 
latives. The attendance was the best 
ever, with 20 classmates and 16 
spouses. We invited the three who had 
to drop behind when attacked by the 
“red raider” and two of them 
attended Priscilla Dienes Taft (with 
her husband, Edgar) and Donal 
Dunphy. It was the first reunion for 
approximately five people. As for do¬ 
nations to the Medical School Alumni 
Fund, our class ranked first of all 
classes this year both for total amount 
contributed and for percentage of 
class contributing, as of June 4. 
Those present w'ere: Ralph Alley 
(Jane), Bill Davey (Artemis), Chuck 
Dowling, Rocky Fasanella (Marion), 
Tom Flynn, Gerry Fountain (Polly), 
Stu Joslin (Dorothy), Een Kemler 
(Joan), Doug Lindsey, Henry Mark- 
ley (Mary). Dee Peck (Hugh Dwyer), 
Ed Rabe (Emily), Mark Sanford 
(Mildred), Ted Soule(Florence). Hilly 
Spitz (Norma). Sophie Trent Stevens, 
Bob Taylor (Chris), Fred Waldron 
(Polly), John Weber (Clare), Morris 
Wessel (Irmgard). 
Many of us attended the Dean’s Re¬ 
ception Friday, continuing Saturday 
morning with the lectures which viv¬ 
idly showed aspects of the changes in 
the bio-sciences in the past 40 years. In 
the afternoon several classmates 
toured the recently completed modern 
hospital and other buildings of the 
Yale-New' Haven Medical Center, 
which is such a spectacular contrast to 
the old New' Haven Hospital w'e ea¬ 
gerly wandered through 40 years ago. 
We concluded w ith dinner for 39 at the 
Graduates Club (where 40 years ago 
women could not enter through the 
front door and could dine in one side 
room only). 
Ralph Alley an outstanding and 
lively master of ceremonies, recalled 
many unusual and amusing incidents 
of our student days. He also reminded 
us, with some help from Dr. Fulton's 
diary, of the stress, worry, tragedy and 
tension of our last sixteen months at 
Yale due to our entrance into World 
War IF He recalled our dignified and 
impressive graduation in the Histori¬ 
cal Library the first of the war- 
accelerated classes. 
Bob Taylor regaled us with one of 
his dead-pan down-east Maine stories 
about a postman’s trials with a cas¬ 
trated dog. Deedee Joslin recalled her 
apprehension about an encounter of 
her boss, Dean Bayne-Jones with an 
unknown (to her) character named 
Winternitz. 
Don Dunphy claims the most as¬ 
tonishing recent achievement- he has 
a two-year-old-baby! He also wins 
first prize for having the youngest 
child in the class. Hilly Spitz has two 
sons who are physicians. 
Doug Lindsey travelled the farthest 
(from Arizona) to come to Reunion. 
Five of those present have retired 
completely, although still carrying on 
medically related administrative or 
consulting activities. Three are work¬ 
ing shorter or fewer days. The other 
thirteen are still hard at it full time. A 
more detailed account of the careers of 
the entire class will be mailed to each 
member of the class soon. 
Overall, it was a highly successful 
and enjoyable weekend. We hope to 
see many more of the class at the forty- 
fifth reunion. Dorothea R. Peck 
1943 (Dec.) 
Fortieth 
Our 40th class reunion went beauti¬ 
fully, although we missed those of you 
who couldn't make it. 
It began at the Dean’s Reception 
Friday afternoon when I found Bob 
Bradley and his w'ife Betty, who had 
come down from Boston, along with 
Hoyt Miles and his wife Fuana from 
Reno and Bob Furman and his wife 
Mary Frances from Indianapolis. The 
Dean’s Reception was delightful and 
went on long after the dinner hour. 
You might be interested in learning 
that the fortuitous circumstance which 
graduated two classes in 1943 (ours 
and the one ahead of us) causes both 
classes to have reunions the same year. 
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For this reason we get to see and renew 
acquaintances with a number of those 
from the class just ahead of us. A 
number of these people were at the 
Dean’s Reception and we saw them 
elsewhere during the weekend. 
The following morning we had the 
opportunity to attend one of several 
seminars, while some of those attend¬ 
ing the reunion went on a tour of the 
new Museum of British Art at the 
main Yale Campus. 
Saturday morning Ronnie Cook 
and his wife Fran from Hartford 
joined us, and John Almklov and his 
wife Dorothy arrived from Bakers- 
ville, California. A beautiful open-air 
tent luncheon was served on the 
greensward in front of the residential 
hall. At the sherry hour preceding the 
luncheon Fred Haddad from Ansonia 
joined our reunion group. 
Saturday evening we had a delight¬ 
ful reunion dinner at Tom Bucky's 
house in Weston, near Bridgeport. 
Tom and his most gracious wife Doris 
put on a beautiful meal for us. We 
were pleasantly surprised on arrival to 
find Ira Rashkoff and his wife Gladys 
awaiting us there, having driven up 
from White Plains. Joe Epstein had 
indicated that he would get over to the 
dinner from Middletown but was un¬ 
able to make it. Fred Haddad also was 
unable to get there although he had 
hoped to. 
1 am going to write you all a long 
detailed letter later this summer. The 
Alumni Office will send this out for us, 
so don’t throw a letter from the 
Alumni Office away unopened on the 
assumption that it is just another mass 
mailing! Jim Bradley (and Ann) 
1948 __ 
Thirty-fifth 
Some of the members of the Class of 
’48 began their reunion festivities by 
meeting at Gail and Rus Barrnetts 
home on Friday evening. It was a very 
informative get-to-gether because we 
inspected the brand new Barrnett kit¬ 
chen and learned that Rus has 
gourmet cooking skills and the neces¬ 
sary accessories. (Perhaps, this will be 
the site of our next class reunion 
dinner. Just joking, Rus.) 
Dinner at Mory’s on Saturday, 
June 4, 1983, was preceded by a mo¬ 
ment of silence in memory of departed 
classmates Bob Maurer, Bob Law- 
son, Gabe Saviano and Jim Leslie. 
Those attending dinner were: Edith 
Beck, Gail and Rus Barrnett, Cecilia 
and Art Coleman, Amy and Jerry 
Shapiro, Nan(Godley)and Walter St. 
Goar, Sylvia (Preston) Griffiths and 
Ray, Betty and Paul Goldstein, Nora 
and Ben Rush, Gerry and John Mor¬ 
rison and Lorraine (formerly. Dr. 
Gardner’s technician) and yours truly. 
There was no formal program, but 
each class member had an opportunity 
to talk about their own achievements 
or families. Rus Barrnett provided his 
usual update on activities at the medi¬ 
cal school and the current student 
body. 
A lot of class members sent their 
regrets about missing the 35th reunion 
dinner: Jeanne and Hal Griffith had to 
cancel out 3 days before the reunion! 
Marty and Bob Downie had pre¬ 
viously scheduled, and paid for, a trip 
down the Colorado River. Bernie 
Naab couldn't attend because he had 
just lost his partner. Bud Rowland was 
in Europe. Ruth Cortell sent news 
about herself and her family. Jerry 
Nowlis, Howie Simon, Paul Talalay, 
Jane Andrews Rivers, Al Blaustein, 
Betty (McCleary) Hamburg, Vic Drill, 
Ray Johnson, Dick Peterson, Al 
Bridge, Dick Hannah and Al Green 
expressed regrets in not being able to 
attend. Probably, I've missed others, 
too. 
In closing, the class of ’48 placed 
third in total monies collected for 
reunion year classes. Thirty-one 
classmates contributed $6,571, an av¬ 
erage of $212 per gift. This, too, placed 
us third again, behind the classes of 
1933 and 1943 (March). My sincere 
thanks are conveyed to Nan (Godley) 
St. Goar, Sylvia Preston Griffiths, Hal 
Griffith, and John Morrison who so 
kindly helped me with the “Phona- 
thon,” which made all this happen. 
Thanks, too, to all the faithful con¬ 
tributors to the Yale Medical School 
Alumni Fund, whose monies are used 




Our class reunion began on an auspi¬ 
cious note Friday afternoon with a 
Symposium presented by 1953 gradu¬ 
ates and co-sponsored by the Depart¬ 
ment of Surgery, Dr. Arthur E. Baue, 
chairman. The participants were: Lou 
DelGuercio, Don Etzwiler, Vince 
Gott, and Bill Whalen. 
As we did five years ago, Maureen 
and I hosted dinner at our North 
Haven home Friday evening. While 
we were only fourteen around the din¬ 
ing table in 1978, this time we totaled 
twenty-five! Attending were: Jeanne 
and Remi Cadoret from their Iowa 
farm; Paula and Lou DelGuercio 
from Westchester; Doe and Jim Dunn 
of New Jersey; Marion and Don Etz¬ 
wiler from Minneapolis; Betty and 
Tom Gentsch of Miami; Iveagh and 
Vince Gott from Baltimore; Bob 
Hamlisch and his new wife, Robin, 
from Ithaca; New Yorkers Carol and 
Fred Lane; Ora and Howie Smith of 
New Haven; Betty and Lynn Stoker 
from Albert Lea, Minnesota; Bill 
Whalen of Willimantic, without Nina, 
who had become ill; and Martha and 
Bill Wilson f rom Storrs, Connecticut. 
Conversation was animated as we rem¬ 
inisced and updated. 
On Saturday evening twenty-three 
of us gathered in the elegant Board of 
Governors Room of the Quinnipiack 
Club for a delicious dinner. Unable to 
remain from the Friday gathering 
were the Gotts, Lanes, Wilsons, and 
Bill Whalen. However, the following 
were able to join us: New Haveners 
Joan and Al Chetrick; Hyla and Bob 
Melnick from Larchmont; Harvey 
Peck of Mahwah, New Jersey; and, all 
the way from San Juan, Leila and Jose 
Ramirez-Rivera. Following dinner, 
each of us had an opportunity to share 
personal and professional activities. 
Although each graduate present 
tried to update those assembled on the 
whereabouts and whatabouts of the 
absent brethren, it would be great to 
hear from each of you. 
Look forward to seeing you at our 




The twenty-fifth reunion of the class 
of 1958 got off to an impressive start 
with our meeting in the Beaumont 
Room of the Sterling Hall of Medi¬ 
cine. Surrounded by the portraits of 
our elegant professional ancestors, 
Mike Kashgarian had put together a 
stimulating introductory program, 
which was entitled “The Maturation 
of the Class of 1958.” Emeritus Dean 
Tom Forbes recalled some of our finer 
moments, and then Paul Rudnick, Lee 
Phillips, and Gerry Burrow each 
spoke for a few minutes about their 
professional lives and how their expe- 
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riences at Yale had affected them. 
Deputy Dean Art Ebbert made a pre¬ 
sentation to Dick “The Gooch” Ger- 
shon's wife and family honoring 
Gooch's tremendous scientific contri¬ 
butions in the field of immunology. 
Because of Gooch's illness, he was un¬ 
able to attend, but we were all deeply 
touched with the warmth of the 
presentation. 
Friday evening, large numbers of 
the group enjoyed an outdoor concert 
by the New Haven Symphony, which 
fortunately was not rained out. The 
next morning, we were pleased to hear 
President Giamatti address the visit¬ 
ing alumni on the problems of the 
medical school and, particularly, in 
choosing a new dean since Dr. Ber¬ 
liner will be retiring this coming year. 
We then had the opportunity to listen 
to stimulating programs varying from 
the practical aspects of the DRG’s to 
molecular biology, and then a pleas¬ 
ant luncheon was held in the Harkness 
dining room. That evening, the crown¬ 
ing achievement of our resident reun¬ 
ion arranger, Mike Kashgarian, was 
presented. Whether or not the Quin- 
nipiack Club will ever allow members 
of the class of '58 through its doors 
again is purely speculative at this 
point. At any rate, Mike saw to it that 
the kitchens and the wine cellars pre¬ 
pared a feast which was truly elegant. 
After a few moments of pleasantries, 
the toasting began. Everyone rose and 
said a few well-chosen words about 
classmates and their experiences. 
M uch of it, of course, is unprintable. It 
was a superb evening, and it culmi¬ 
nated in more good fellowship at the 
top of the Park Plaza Hotel. All those 
who attended had a marvelous time, 
and I think are all looking forward to 
returning to New Haven in another 
few years to renew old friendships 
once again. 
The California contingent was im¬ 
pressive in its numbers and included 
Rudnick, McClanahan, and Tom 
Mauro. Gene Spector and John Arnot 
came from St. Eouis, Gerry Burrow 
from Toronto, Dave Pugh from Kan¬ 
sas City. George Aghajanian, Dave 
Carlson, Mike Kashgarian, Ray Gaito 
and John Creatura were the Connecti¬ 
cut representatives. Dave O'Keefe, Jay 
Kislak, Andy McGowan, Ed So- 
colow, Joe Cillo, Ted Lieberman all 
came from the New York/ New Jersey 
area. Bill Schlaepfer was our lone 
Pennsylvanian. John Carlston came 
from Virginia Beach, Virginia, and 
Pat McKegnev and Al and Lee Phil¬ 
lips traveled from Vermont. The irre¬ 
pressible Bob Donohue regaled us 
with stories of impossibly difficult cat¬ 
aracts, and we aptly dubbed him “The 
King of Holyoke.” Ray and Maria 
Turner came from Washington, D.C., 
as did Capt. Pete Flynn, and Jack and 
Pauli Wood from Rhode Island. The 
ever-smiling Jim Ralph and Dick 
Hinckley came from Amherst, Mas¬ 
sachusetts. Those dignified, proper 
Bostonians who attended included the 
Al Muggias, Ernie Hartman, and Leo 
McCallum. 
We owe many thanks to Mike 
Kashgarian for arranging everything 
and to the Yale School of Medicine for 
giving us all a good start and permit¬ 
ting us to have made such warm 
friendships, which began nearly 30 
years ago. Those of us present at the 
reunion certainly missed seeing the 
other classmates, and do hope that we 
will hear from them via the Alumni 
News and certainly at our next reun¬ 
ion in five years. 
Just as this report was going to 
press, we heard the sad news that Dick 
Gershon died at home on June 11, 
1983. Paul A. Rudnick and Michael 
Kashgarian 
P.S. For those of you who deny the 
allegations regarding the Quinnipiack 
Banquet, I (Paul) have pictures in liv¬ 
ing color to support my contentions, 




Twelve members of the Class of '63, 
ten of whom were accompanied by 
their spouses, met for our twentieth 
reunion dinner at the Graduates Club 
on Elm Street. Peter Gregory, who 
toils in academia in sunny California, 
won the prize for coming from the 
most distant location. Peter’s daugh¬ 
ter, when she enters Yale as a freshman 
in September, will join the Dalsimer, 
Edin, Gaudio, Kaplan and Meltzer 
families in making regular tuition 
payments to Yale. Of that group of 
proud parents, Jim and Adele Dalsi¬ 
mer sent regrets (Jim is now in private 
psychiatric practice in Boston, and 
Adele is assoc, prof, of English at Bos¬ 
ton College.) The Edins, Gaudios and 
Kaplans were all in attendance. Andy 
and Becky Edin were runners-up to 
Peter for the travel award (Winona, 
Minnesota). The Edins enjoyed the 
hospitality of Jon and Jean Fessel, in 
Guilford, during theirstay in Connect¬ 
icut. Jon refuses to accept the distinc¬ 
tion of “only grandfather” in the class 
(son Michael, 27, has two sons, Nick, 
age 5, and Tony, age 3), until we hear 
from Gary Van Galder. At the other 
end of the spectrum. Dudley Danoff, 
w ho was unable to attend, writes, “My 
two kids (by my first and only mar¬ 
riage) are 22 months and 3lA years 
respectfully . . .” Dudley also writes 
that he had spoken with John Conte, 
who lives in San Francisco, and who 
apparently is the proud father of a 
brand new baby girl, as of April 1983 
(child #1, wife#!, duly reported.) Herb 
Meltzer, who is now professor of psy¬ 
chiatry at the University of Chicago, 
and director of a research unit at the 
Illinois State Psychiatric Institute, was 
unable to join us. Our thanks to Judy 
Davis, who practices psychiatry in 
Chicago, and whose husband directs a 
similar unit, for passing on the gossip. 
Rounding out the group for dinner, 
were the Peter Tishlers (Peter is doing 
research in human genetics and run¬ 
ning a house staff training program 
in medicine at the Brockton, 
Mass. VA), the George Holstens 
(George is a pathologist in Springfield, 
Massachusetts), Jay Pomerantz, who 
is practicing psychiatry in Long- 
meadow, Massachusetts, with his 
wife, Farida; Craig and Gail Llewellyn 
(Colonel Llewellyn is professor and 
chairman. Department of Military 
Medicine, at the Uniformed Services 
University School of Medicine, in 
Bethesda) and the Bill Lehmanns. Bill 
is practicing ENT in Hartford. Also 
practicing in Hartford, in pulmonary 
disease. Bob Mueller reported that his 
daughter Sarah w ill be a freshman at 
Wellesley, while his wife Marnie, who 
is a vice-president at Connecticut 
Mutual Life Insurance supports him 
through his mid-life crisis. Completing 
the Massachusetts contingent were Al 
and Suzanne Wise, making the trip 
from Williamstown. 
Among those who were unable to 
come to New Haven, but sent new'sy 
letters which we all shared at dinner, 
were Ric and Barbara Almond, who 
confessed that their oldest son, David, 
just completed his freshman year at 
Harvard; Dorothy Otnow Lewis, w ho 
is professor of psychiatry at NYU; 
Dave Holden, who is directing a fam¬ 
ily practice residency program in Wich- 
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ita; Gordy Cohen, who has given up 
medicine, and is now the prosperous 
president of Jeneric Industries, Inc. in 
Wallingford, Connecticut; Chuck 
Wilson, who is a diagnostic radiologist 
in Costa Mesa, California; John Gen- 
nari, who is chief of nephrology at U. 
of Vermont; and Alan Shapiro, who 
after 6 years in Puerto Rico, now prac¬ 
tices urology in Los Angeles. 
Everyone who was able to attend, 
really enjoyed the evening. We look 
forward to a big attendance for our 
25th. Plan now for that first week of 
June 1988, to be with us in New Hav¬ 
en. Hal Kaplan 
1968 
Fifteenth 
The class of '68 held its fifteenth year 
reunion dinner at Mory’s. Joe and 
Carol Andrews came in from Nor¬ 
walk, Connecticut where Joe is prac¬ 
ticing internal medicine. Don Coustan 
stopped in from Providence, Rhode 
Island where he is practicing obstetrics 
and gynecology. Bill Flynn, a peri¬ 
pheral vascular surgeon, and his wife 
came down from Boston. Dick and 
Paula Getnick joined us from Water- 
bury, Connecticut where Dick practi¬ 
ces as an ophthalmologist. Kevin 
Hennessey and his wife came up from 
Kensington, Maryland where Kevin 
practices neurology. Jerry Springer, 
who practices emergency medicine in 
Waterford, Connecticut, also made it 
to the dinner as did Bruce Wenger. 
Peter Jokl, who is in New Haven prac¬ 
ticing orthopedics with a subspecialty 
interest in sports medicine, and who 
helped arrange the dinner, was unfor¬ 
tunately unable to attend. I also have 
stayed in New Haven to practice in¬ 
ternal medicine and cardiology and 
gerve as co-director of the Coronary 
Care Unit at Yale-New Haven Hospi¬ 
tal. We were all impressed with how 
little anyone had changed over the 
past fifteen years and all hope to be 
back for the 20th year reunion. We 
look forward to seeing many more of 




The tenth reunion was an occasion for 
a range of activities. A preliminary 
gathering of the local class of 1973 was 
sponsored by the Office of Alumni in 
April, as was a telethon to accessible 
members of the class from David Bag- 
gish, John Kirkwood, George Lister 
and Thomas Sweeney. Vintage 73 
mustered a capacity crowd of 30 for a 
first-night dinner at Mory's on June 
3rd. The grounds of the Association of 
Yale Alumni was our home base for an 
all-afternoon gathering on June 4th 
(these sites won out over the Old Lyme 
Yale outdoor facility, several local 
country clubs, and a variety of more 
formal campus settings, in the hopes 
that those in the class with children 
would feel free to bring them to the 
reunion). Dinner on June 3rd was a 
time for catching up on the past de¬ 
cade, a bit of which I may recapitulate 
for those unable to attend. 
Jim Neviackas and his wife arrived 
from the reaches of Illinois, where he 
is an active nephrologist, while An¬ 
drew Kadar returned from vacation in 
Greece en route to Los Angeles (where 
he is an anesthesiologist). Rick and 
Harriet Fingeroth took time from a 
busy orthopedic practice and several 
children in Springfield to attend the 
dinner, as did Rob and Karen Sirota, 
who arrived from Philadelphia where 
Rob is a nephrologist at the Albion 
Hospital. Sessions Cole arrived from 
Boston, a lone representative of that 
northern contingent. It was rumored 
that Randy Zusman is unable to find 
his way out of his new mansion in 
Newton, Massachusetts and that Joe 
Simeone, Jerry Rosenbaum and Dave 
Adler remain alive and well in the 
same city. Lee Goldman is doing well, 
recently having joined the administra¬ 
tion of the Department of Medicine at 
the Brigham. Bennett and Helene 
Blitzer have recently moved to Cin¬ 
cinnati, Ohio and Michael Bramley 
sends his regards from North Caro¬ 
lina, where his pediatric practice was 
too hectic to allow a jaunt North for 
our siesta. Word from Mary Ann 
Brunstetter-Shafer has fulfilled her 
fourth year class show role in her sub¬ 
specialty of adolescent VD. Joe Con¬ 
nors has entered medical oncology in 
Vancouver while Claes Nilsson (in 
San Francisco), Paul Abrams (at 
Frederick, Maryland), Bob Polack- 
wich (in Tampa, Florida) as well as 
your reunion secretary have all 
reached the same subspecialty by a 
variety of routes. John McQuade, III 
is doing well in cardiology in North 
Carolina. Chris (Kull) Walsh and her 
husband arrived from Little Neck, 
Long Island to bring us good cheer 
from the Big Apple; Marc Weinberg, 
Jerry Nagler and others from there 
were unable to make the festivities. 
The syndicate continues to gather for 
intermittent outings, vague details of 
which filter back to assure us that 
Dave Peach, Dave Coulter, James 
Robertson, Chris Reynolds and Joe 
Connors continue with their previous 
fraternity. We missed Midge Tripp, 
who has moved from Morgantown, 
West Virginia to Michigan and Danny 
Moros, who was detained in the city 
with his wife Anne, who has just ful¬ 
filled Danny’s ambitions in psychiatry 
and together had their first child, 
Elizabeth. 
On the afternoon of the 4th, follow¬ 
ing the lectures and formal activities of 
the reunion celebration, a stout bunch 
of holdovers from the preceding eve¬ 
ning were joined by Gary Gordon, his 
wife and children from Philadelphia, 
and a pleasant cookout was held in the 
courtyard of the AY A House, ar¬ 
ranged by George Lister. We all owe 




No Report Received 
CLASS NOTES 
1931 
At the 1983 meeting of The American 
Pediatric Society, the John Howland 
Award “for distinguished service in 
pediatrics” was given to Drs. Helen 
and Harold Harrison. In his presenta¬ 
tion speech. Dr. Laurence Finberg be¬ 
gan as follows: 
“Three special features characterize 
the thirty-second awarding of The 
Howland Medal. The first is unique in 
that the award is to a team of pediatric 
investigators; a married couple, Helen 
C., and Harold E. Harrison. Sec¬ 
ondly, more than in most years of 
honoring the distinguished men and 
women of pediatrics, this one clearly 
illuminates the strong generational 
ties and continuity in American pedi¬ 
atrics during the seventy-eight years 
since John Howland became a 
member of The American Pediatric 
Society. Finally, this year’s award rec¬ 
ognizes excellence across the whole 
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spectrum of pediatrics specified in 
our constitution; advancement of 
knowledge, education, clinical treat¬ 
ment and prevention of children’s dis¬ 
eases, and also humanitarian child 
advocacy.” 
He then traced the careers and ac¬ 
complishments of the Harrisons when 
they were at Yale and subsequently at 
the New York Hospital and then at 
Johns Hopkins and the Baltimore 
City Hospital. In conclusion, he ob¬ 
served: “They have carried the torch of 
American pediatrics from those fol¬ 
lowing the founding generation to our 
contemporary one. They have given us 
an impressive, even awesome, exam¬ 
ple and challenge.” This presentation 
speech will be published in its entirety 
in Pediatric Research at a later date. 
1960 
Alan Ames wrote recently in regard to 
theerroneous report of his death in the 
spring issue of Yale Medicine: “Dear 
Classmates: I am happy to inform you 
that the report of my death was pre¬ 
mature. My health remains excellent, 
and 1 am enjoying the practice of car¬ 
diology, and life in general, out here in 
Oregon.” 
1961 
Robert Levy has been appointed vice 
president for health sciences at Co¬ 
lumbia University, effective July 1. 
Dr. Levy will have primary responsi¬ 
bility for the health sciences at Co¬ 
lumbia as the senior university officer 
on the Washington Heights campus. 
He will oversee the activities on that 
campus and supervise the deans of the 
Schools of Medicine, Dental and Oral 
Surgery, Nursing and Public Health 
while providing overall direction and 
coordination to Columbia’s health 
sciences programs. 
Since 1981 Dr. Levy has held the 
positions of vice president for health 
sciences at Tufts University and pro¬ 
fessor of medicine and Dean of the 
School of Medicine. He was pre¬ 
viously associated with the National 
Heart, Lung and Blood Institute for 
18 years, and served as director from 
1975 to 1981. 
1967 
An Artificial Heart Training Program 
is being planned at Pensacola, Flori¬ 
da’s West Florida Hospital under a 
preliminary agreement signed in April 
by Hospital Corporation of America, 
of which West Florida Hospital is an 
affiliate, and Kolff Medical, Inc., man¬ 
ufacturer of the JARVIK-7 Artificial 
Heart. The agreement was to be sub¬ 
ject to the approval of the University 
of Utah where an intensive two-year 
training program is to be held with the 
goal of qualifying in the use of the 
JARVIK-7 Artificial Heart. 
David Conkleand two other cardio¬ 
vascular surgeons from Medical Cen¬ 
ter Clinic and West Florida Hospital 
will spend about two years studying 
and performing total artificial heart 
surgery research in Utah. The team 
will cooperate with the University of 
Utah and four to six other institutions 
in a multi-center series of experimen¬ 
tal human artificial heart trials, and it 
is projected that after approximately 
two years, it will be prepared to make 
application for approval to proceed 




A very successful twenty-fifth reunion 
of medical house staff (1957-58) was 
held at the School of Medicine on 
Saturday, May 21. A morning scien¬ 
tific program was followed by lunch¬ 
eon and a tour of the new Yale-New 
Haven Hospital building. In the eve¬ 
ning, a reception at the home of Dr. 
Howard Levitin, Dean of Students, 
was attended by Dean and Mrs. Rob¬ 
ert Berliner. The reunion dinner at 
Mory’s was the occasion for reminis¬ 
cences of house staff days and deeds 
under the leadership of the chief resi¬ 
dent. Robert Petersdorf. 
Those members of the medical 
house staff who attended the reunion 
included David Bernanke, Rubin 
Bressler, Alexander Deutsch, Fritz 
Fenster, Ben Forsyth, Jay Goodkind, 
Donald Harter, Marie-Louise John¬ 
son, Willard Krehl, Edgar Levin, 
Herbert Lubs, Jr., Richard Norton, 
Robert Petersdorf, Robert Rentz, 
Robert Shope. Most were accompa¬ 
nied by spouses. The reunion was 
planned by Drs. Forsyth and Harter 
with the cooperation of the Associa¬ 
tion of Yale Alumni in Medicine and 
the School’s Alumni Office. 
IN MEMORIAM 
Inglis F. Frost 
April 7, 1983 
M. D. T2 
Francis M. Dooley 
(date unknown) 
M. D. ’22 
Prof. Edward Tolstoi, M. 
May 22, 1983 
D. 
ex med '22 
C. Eugene Woodruff 
April 5, 1983 
M. D. ’26 
George H. Zinn 
June 1, 1983 
M. D. ’27 
Norman E. Gissler 
(date unknown) 
M. D. '28 
Arthur J. Gavigan 
(date unknown) 
M. D. ’31 
Crawford J. Campbell 
June 24, 1983 
M. D. ’40 
Marvin Blum 
April 16, 1983 
M. D. '41 
Ross Lionel Wilson 
(date unknown) 
M. D. ’43 
(Dec.) 
Lawrence J. Morin 
May 12, 1983 
M. D. '45 
Col. F. Joseph Dannemiller. MC 
April 30, 1983 M. D.'57 
Leslie Plonsky 
May 6, 1983 
M. D. ’79 
Lathrop E. Roberts 
July 3, 1983 
M. D. ’57 
Martin L. Stein 
June 5, 1983 
M. D. ’30 
Paul Watson 
May 29, 1983 
M. D. ’30 
Edward A. Cramton M. D. ’25 
July 13, 1983 
Erratum: In the Spring 1983 issue In 
Memoriam, Allan W. Ames, M. D. 
’60, was listed in error based upon a 
report from the Alumni Records Of¬ 
fice. We subsequently learned that the 
deceased Allan W. Ames was a 1918 
graduate of Yale College. 
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“HELLO, I’M CALLING FROM NEW HAVEN 
AND WE NEED YOUR HELP.” 
That’s what students at the Yale School of Medicine 
were saying this past spring as they spent several eve¬ 
nings calling medical alumni across the country to ask 
for their support of the 1982-83 Medical School Alumni 
Fund. 
That phonathon the first in Medical School Alumni 
Fund history—proved to be an enjoyable and worth¬ 
while experience for callers and alumni alike. It offered a 
unique opportunity for alumni and students to engage in 
enthusiastic conversation, sharing impressions and con¬ 
cerns, refreshing memories, learning about one another. 
It also offered more tangible results: 
*significant increases in pledge amounts for the 
Fund, which earned additional dollars from the 
Baumgartner Challenge 
*a substantial number of new contributors to the 
Fund 
*important new dollars for the Student Revolving 
Loan Fund, which is helping to ease the financial 
burden of so many Yale medical students 
Medical education at Yale can continue to maintain its 
excellence only with the support of those who have 
benefited from the School’s tradition of excellence. We 
need your continuing and generous support. 
YALE MEDICAL SCHOOL ALUMNI FUND 
P.O. Box 1890 
155 Whitney Avenue 
New Haven, Connecticut 06508 
PHOTOS ON THIS PAGE BY FRANCINE McCANCE 
Yale Medicine 
333 Cedar Street 
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HOW DO WAYS OF LIVING AFFECT HEALTH? 
By Lisa F. Berkman and Lester Breslow 
The purpose of this study is to explore the 
relationship between certain behaviors and 
social connections of individuals — ways 
of living and physical health status — and 
mortality. 
The idea that ways of living are related to health is not 
new. In the Western World, the Greeks and Romans 
recognized the importance of preventing illness through 
living sensibly. Hygeia, the Greek goddess of health, 
represented the view that “health is the natural order of 
things, and a positive attribute to which men are 
entitled if they govern their lives wisely.” Medicine’s 
most important function, according to this viewpoint, 
was to discover the natural laws by which human 
beings were ensured “a healthy mind in a healthy 
body.” The idea of host susceptibility to illness was 
part of classical medical thought, and the philosophy 
of maintaining health by living properly has roots not 
only in Western, but also in Chinese, Middle Eastern, 
and other ancient civilizations. 
The purpose of this study is to explore the relationship 
between certain behaviors and social connections of 
individuals — ways of living and physical health status 
and mortality. In our exploration of these relation¬ 
ships, we have been guided by two thoughts. The first is 
that in most industrialized countries new living circum¬ 
stances are responsible for an increasingly large proportion 
of the morbidity and mortality among middle-aged 
and older adults. These disease determinants reside primarily 
within the social environment and promote certain 
distinctive behaviors. They have always been related to 
health status in some way, but may previously have 
been obscured by other causative factors including 
exposure to virulent and infectious organisms. 
The second thought concerns the precise role these 
social and behavioral factors play in causing disease. 
This article has been excerpted, with permission from 
Health and Ways of Living by Lisa F. Berkman and 
Lester Breslow, published by Oxford University Press, 
October 1983. Dr. Berkman is associate professor of 
epidemiology and public health. 
Most epidemiologic investigations, and medical research 
in general, focus on the relationship between specific 
factors and specific diseases. It is becoming increasingly 
apparent, however, that some factors are associated 
with a wide range of diseases and may, in fact, 
influence susceptibility to disease in general. Social 
and behavioral factors appear to be particularly likely 
to influence health status in this way. Thus our 
investigation concentrates on sets of these factors that 
may be associated with many diseases. 
CONCEPTUAL FRAMEWORK 
The significance of this work comes from the idea that 
health and disease arise mainly from circumstances of 
living. Within rather well-defined biologic limits, the 
health, disease, and mortality pattern of any community 
generally reflects the conditions of life in that communi¬ 
ty. Rural communities with poor sanitation, located in 
areas heavily infested by parasites, mosquitoes, and 
other disease agents and vectors are afflicted with one 
pattern of health, disease and mortality. Urban commun¬ 
ities starting on the path of industrialization but 
affected by crowding, inadequate food, and poor 
sanitation have another pattern. Modern metropolitan 
communities with advanced industrialization and rea¬ 
sonably good sanitation, but low physical demand 
coupled with access to plenty of fatty foods, alcohol 
and cigarettes, have still a third kind of health, disease, 
and mortality pattern. 
Ways of living in the latter kind of community, just 
as in the others, underlie the typical health picture 
found there. Hence, ascertaining specific ways of living 
that are responsible for the health impairment and 
premature deaths that occur (or, on the contrary, ways 
of living that favor health and longevity) may lead to 
advances in health care. Knowledge that exposure to 
such disease agents as Anopheles mosquitoes and 
malaria, snails and schistosomes, drags down the 
health of a community, open the path to improvement 
in such communities. Rudimentary industrialization 
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with accompanying inadequate nutrition, exhaustion, 
and overcrowding have usually brought misery and 
premature death from tuberculosis and other diseases 
and injuries to many people.Knowledge of these 
relationships has led to social improvement and a 
healthier life. Correspondingly, knowledge of the 
precise features of living that harm health and preclude 
enjoyment of life’s potential in the modern commun¬ 
ities of the United States and similar countries should 
lead to further advances in health. 
This thought stimulated development of the Health 
Population Laboratory in Alameda County, California, 
a community typical of the United States in the late 
twentieth century. The first aim was to measure health 
in the sense of the World Health Organization defini¬ 
tion, “physical, mental, and social well-being.” The 
second was to examine ways of living in such a 
community that might contribute to or detract from 
the health of its people. 
One set of ways of living to be studied consisted of 
seven common habits, such as excessive use of alcohol 
and cigarette smoking. Early investigations based on 
the Alameda County data confirmed and extended 
what was already known about the relationship of 
obesity, cigarette smoking, excessive use of alcohol, 
and other habits to health and mortality. A summary 
health practices score, with one point for each of seven 
favorable health practices, correlated highly both with 
physical health status in 1965 and with longevity based 
on mortality during the next five years. For example, a 
man at age 45 who was observing six or seven of the 
health practices had a life expectancy of about 11 years 
more than that of a 45-vear old man with a health 
practices score of three or less. 
Another aspect of living namely, the nature and 
extent of a person’s social network — also attracted 
attention as a possibly significant factor in health and 
longevity. Earlier work by others had shown, for 
example, that being married was more favorable to 
health than being divorced, single or widowed. Moving 
from one community to another, and thereby breaking 
social ties, appeared adverse to health. Belonging to a 
church seemed favorable. The original design of the 
HPL had provided for study of these factors. Thus it 
became possible to examine the relationship of social 
networks to physical health and mortality. 
According to the HPL concept, health consisted of 
the three probably interrelated dimensions of well¬ 
being: physical, mental and social.Each of these three 
could be regarded as a spectrum, so that an individual 
could be located at certain points on all three spectra 
and these points would represent that person’s degree 
of health. Thus, for example, at age 25 a person would 
likely fall toward one (the healthy) end of the Physical 
Health Spectrum, and at age 85 toward the other. 
Death means reaching the latter end of the spectrum. If 
these concepts reflect reality, and if health practices 
and social networks influence both physical health and 
The HPL approach to health — that is, its 
measurement, what influences it, and, 
implicitly, how it may be improved 
departs from the prevailing scientific focus 
on understanding the biologic mechanisms 
of disease as the way to advance health. 
mortality, then health practices and social networks 
should also influence one’s progress over time on the 
Physical Health Spectrum. Persons selected at any one 
time would, as a whole, be expected to move during the 
ensuing decade toward the less healthy end. Would 
that average movement toward poorer health and 
ultimate death, however, be measurably retarded by 
favorable health practices and strong social networks? 
Would it be accelerated by poor health practices scores 
and weak social networks? The HPL provided an 
opportunity to examine the issue by making available 
a questionnaire measure of people’s physical health 
status in 1965, their mortality through 1974, and 
another measure of health status for the same people 
who survived to 1974 and completed a second ques¬ 
tionnaire. 
The HPL approach to health — that is, its measure¬ 
ment, what influences it, and, implicitly, how it may be 
improved departs from the prevailing scientific 
focus on understanding the biologic mechanisms of 
disease as the way to advance health. Discovering the 
precise mechanism by which cells become cancerous 
might well open the path toward some means of 
countering the development of cancer. The same 
rationale applies generally to other diseases that 
plague modern humanity. History demonstrates, how¬ 
ever, that interventions can be quite effectively planned 
without completely understanding the biological mech¬ 
anisms involved. For example, it now appears that the 
sanitary campaigns, social reforms, and nutrition 
programs of the nineteenth and early twentieth century 
had at least as much to do with overcoming tuberculo¬ 
sis, cholera, pellagra, and other infections and non- 
infectious diseases as did the discovery of the tubercle 
bacillus and other pathogenic microorganisms, impor¬ 
tant as these discoveries were. These interventions 
were frequently based on associations found between 
contaminated water or dietary factors and disease 
outcomes without the precise identification of the 
causal agents involved. 
One task for the health scientists, then, is to examine 
as people generally do, but more systematically and 
with scientific vigor precisely what ways of living 
preclude or enhance the possibility of maximum health 
and longevity. Health and ways of living are natural 
phenomena and as such they are subject to scientific 
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investigation. The crudeness of our definitions, con¬ 
cepts, and methods of measuring these phenomena 
only makes the task more challenging, not less impor¬ 
tant. Advancing knowledge in this direction will, it is 
hoped, help people who are seeking a healthful style of 
living in modern, urban, industrialized communities. 
Developing a knowledge base for guiding such action 
broadly would carry us beyond such significant but 
particular items as that cigarette smoking in the early 
1980’s accounts for more than 300,000 premature 
deaths in the United States each year, and that 
excessive consumption of alcohol adds greatly to that 
toll. 
The usefulness of data from the HPL studies, as in 
any scientific investigation, depends on the methods of 
data collection. Because of the nature of the investiga¬ 
tions intended, the laboratory staff devoted the first 
five years essentially to developing and testing such 
methods. That preparatory work enabled them to 
proceed with data collection that was economical, 
represented accurately the adult population of Alameda 
County, showed reliability and validity so far as these 
could be ascertained, and provided information making 
it possible to follow up the sample. All these points had 
to be assured to the highest possible, and certainly to a 
satisfactory degree, before starting on the main study 
in 1965. 
SUMMARY OF FINDINGS 
Of the 2229 men aged 30 to 69 years constituting a 1965 
sample of men that age in Alameda County, 9.5 
percent died during the period from 1965 to 1974. On 
the other hand, only 6.4 percent of the 2496 women 30 
to 69 years of age in the sample died in that same time 
period. That mortality picture is consistent with statis- 
Health Practices 
Analysis of the data revealed five common habits to be 
strongly, and each one independently, associated with 
mortality during the nine years of follow-up. These 
habits, called high-risk health practices, were smoking 
cigarettes, consuming excessive quantities of alcohol, 
being physically inactive, being obese or underweight, 
and sleeping fewer than seven or more than eight hours 
a night. 
Two additional habits, skipping breakfast and snack¬ 
ing rather than eating regular meals, had been shown 
in an earlier analysis to be associated with mortality. 
The earlier analysis covered five and a half years’experience 
in the entire adult population sample, including those 
under 30 and over 69 years of age. The analysis 
reported here indicates that, for persons aged 30 to 69 
years, not eating breakfast and snacking do not carry 
as heavy a mortality risk as the other five health 
practices. 
To construct a simple Health Practices Index for 
purposes of further analysis, each of the five favorable 
health practices (ie.,not smoking cigarettes, drinking 
alcohol moderately if at all, being physically active, 
maintaining moderate weight, and sleeping seven to 
eight hours per night) was given one point. These 
points added to a score of 0 - 5 for each person. Thus, 
people with a score of 0 - 2 can be considered as 
following high-risk health practices; 4 - 5, low-risk, and 
3, intermediate. 
Persons following the various individual high-risk 
health practices experienced death rate 25-115 percent 
higher than persons who followed the corresponding 
low-risk practices. Mortality, however, showed a strik- 
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ingly higher gradient with the Health Practices Index 
that summarized all five health practices for each 
person. Thus, the death rate among men 30 - 49 years 
of age with a health practices score of 0 - 2 was 840 
percent (8.4 times) as high as that among men the same 
age with a health practices score of 4.5 For men aged 
50 - 59 and 60 - 69, the relative risks were 2.4 and 1.7, 
respectively. As with practically all risk factor analyses 
among men, the association was stronger tor younger 
men. Among women, the corresponding relative risks 
in the three age groups (30 - 49, 50 - 59, and 60 - 69) 
were 2.9, 2.0, and 4.0 respectively. 
These data confirm the strong relationship between 
number of health practices followed and mortality 
found in earlier analyses of the HPL data. Interpreta¬ 
tion of that association, however, is by no means 
obvious. Persons who were seriously ill in 1965, and 
thus likely to die in the ensuing few years, may already 
have been unable to maintain normal weight, to 
exercise, or to sleep regularly seven to eight hours a 
night. A low health practices score, hence, might have 
reflected poor health and the likelihood of early death, 
rather than having preceded and possibly been 
causally related to — mortality. Do “poor health 
practices” result in fatal illness or vice versa? 
If profound and soon-to-be fatal illness in 1965 had 
been largely responsible for the low health practices 
scores in the sample, then the deaths associated with 
those scores should have occurred mainly among 
persons who were already disabled in 1965, persons so 
sick as to be unable to exercise, or maintain normal 
weight, and whose sleep was disturbed, and among 
those who died in the first years of the follow-up 
period. 
In fact, the data do not support that hypothesis. 
Among men, an even steeper mortality gradient pre¬ 
vailed among those with no health problems and those 
with symptoms only, than among persons who reported 
some chronic conditions and disability of varying 
degrees. Also, during the period from 1965 to 1974, less 
than one-seventh of the male deaths occurred among 
the five percent who had any disability and a Health 
Practices Index of 0 - 3 in 1965. Finally, only a small 
minority of the deaths in that group occurred during 
the first year and a half of the follow-up, when 
seriously ill people would have been likely to die. 
Though there was a slight concentration during the 
early years, the deaths were distributed fairly evenly 
over all nine years. Thus the striking association 
between health practices and mortality cannot be 
explained by pre-existing disease resulting in the “poor 
health practices.” 
Analysis of the data reveals, moreover, that the 
health practices score predicts mortality independently 
of socioeconomic status, race, and seven psychological 
factors examined. Finally, the Health Practices Index 
is related not only to total mortality, but strongly also 
to death rates from each of four major categories of 
disease: coronary heart disease, cerebrovascular and 
other circulatory disease, cancer, and all other diseases. 
Social Networks 
Several items in the questionnaire were used as a 
measure of the nature and extent of social connections 
in the form of marriage, contacts with close friends and 
relatives, church membership, and affiliation with 
non-church groups. The HPL mortality rates showed a 
gradient with each of the four components of the social 
network. For example, the age-adjusted mortality 
among unmarried men aged 30 to 69 years was 14.7 
compared with 8.4 among married men. The corre¬ 
sponding rates among women were 7.6 and 5.8. 
Mortality among men with few close friends and 
relatives was 12.5, but only 7.4 among men with many 
close friends and relatives; corresponding rates among 
women were 11.2 and 4.6. 
To investigate their cumulative relationship to mor¬ 
tality, the four types of social connections were used to 
construct a Social Network Index. The latter divided 
the study population into four groups: 1 (fewest 
connections), II, III, and IV (most connections). 
This Social Network Index showed a gradient with 
mortality: group I had the highest death rate and group 
IV the lowest. The mortality gradient with the Social 
Network Index was just about as striking as with the 
Health Practices Index. Men constituting the most 
isolated group had an age-adjusted mortality rate 2.3 
times higher than men with the strongest social 
connections; among women the difference was 2.8. 
Because a person’s social network is obviously 
related to that individual’s position in the social 
structure, we examined the social class, race, level of 
urbanization, geographic mobility, and occupational 
mobility as possibly confounding variables. All of 
these had been shown by other investigators to be 
associated both with social networks and with health. 
Analysis was therefore directed toward ascertaining 
the relationship between each of the sociostructural 
elements (social class and others) and between social 












Index predicted mortality independently of the other 
social factors. 
Many studies show an association between socio¬ 
economic status, and health data from the HPL 
confirm that association. The latter also reveal, how¬ 
ever, that throughout the socioeconomic spectrum 
men and women with few social contacts had higher 
mortality rates than those with many connections. 
This finding supports the conclusion that the Social 
Network Index predicts mortality independently of 
socioeconomic status. Analysis also indicated that the 
relationship between social isolation and mortality 
risk could not be attributed to race, geographic 
mobility, occupational mobility, or level of urbaniza¬ 
tion so far as these could be measured from the 
questionnaires. The social network gradient in mor¬ 
tality likewise persisted through the varying levels of 
preventive health care. 
It is often suggested that psychological states may 
either mediate the relationship between social networks 
and mortality or affect the people’s network directly. 
According to the first hypothesis, people without 
social ties become lonely, depressed, or otherwise 
psychologically disturbed and some such state induces 
disease. According to the second hypothesis, people 
who are psychologically disturbed find it difficult to 
maintain social ties. 
Thus, the findings indicate that the extent 
to which people maintain social connections 
is strongly associated with risk of mortality. 
The relationship holds independently of 
age, physical health status at baseline, 
position in social structure including 
socioeconomic status, level of preventive 
health care and the seven psychological 
factors that were examined. 
In order to explore these issues, the psychological 
characteristics ascertained in the 1965 survey were 
analyzed. Seven of these factors, including personal 
uncertainty, anomie, and life satisfaction were selected. 
Of them, the one termed life satisfaction proved to be 
most significant for predicting mortality, the relative 
risk being almost 2 for men and 3 for women. 
Nevertheless, the Social Network Index was associated 
with mortality independently of life satisfaction, as 
well as the other six psychological factors examined. 
Thus, the findings indicate that the extent to which 
people maintain social connections is strongly associ¬ 
ated with risk of mortality. The relationship holds 
independently of age, physical health status at baseline, 
position in social structure including socioec.onomic 
status, level of preventive health care and the seven 
psychological factors that were examined. 
The association between health practices, social 
networks, and mortality is clear. And it appears to be 
independent of possibly confounding factors such as 
age, sex, race, physical health status at baseline, 
preventive health care, and socioeconomic status when 
these factors are considered one at a time. The 
possibility that, cumulatively, these factors might 
account for the association was also examined, using 
multiple logistic analysis. The latter method confirmed 
the independence of the associations between mortality 
and the health practices and social networks. When 
considering all potential confounders (including both 
social networks and health practices) simultaneously 
in the logistic analysis, the approximate relative mor¬ 
tality risk for those with many high-risk health practices 
was 2.4 for men and 2.2 for women. For those with 
least social contacts, the risks were 2.2 and 2.4 for men 
and women, respectively. 
Both sets of factors were also found to be associated 
in the expected direction, with changes in health status 
occurring between 1965 and 1974. As anticipated, 
physical health status for the sample population as a 
whole declined over the nine-year period, consistent 
with aging of the population. The decline was signifi¬ 
cantly greater, however, among those who were follow¬ 
ing high-risk health practices, had weak social networks 
in 1965, or both; correspondingly, the decline was 
significantly less among persons with low-risk health 
practices and strong social networks. These associations 
are independent not only of each other, but also of 
socioeconomic status. 
In summary, the data substantiate early findings of 
the H PL that health is associated with certain common 
habits called health practices, and with social networks. 
The associations are strong and prevail not only with 
regard to health status as originally determined in the 
1965 survey, but also through nine years of mortality 
experience, and through decline of physical health 
status over the same time period. Persons with high- 
risk health practices and weak social networks die off 
more rapidly and their physical health deteriorates 
faster. The associations of these two sets of ways of 
living persist in all four major categories of causes of 
death, as well as in mortality as a whole. They are 
independent of — that is, cannot be “explained by” 
age, sex, socioeconomic status, baseline physical health, 
and other potentially confounding factors examined. 
These findings raise many issues that cannot be 
directly answered by further analyses of these data. 
Some of the questions have to do with social networks: 
How are social networks related to health status? What 
is it about social isolation that carries health conse¬ 
quences? What are the biologic mechanisms that lead 
from social disconnection to disease and death? Other 
similar questions concern the relationships between 
health habits and morbidity and mortality, though we 
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are closer to understanding how certain physical 
aspects of living, such as exposure to cigarette smoke, 
affect health. 
What can be clearly perceived is the historical 
relationship between ways of livingand the patterns of 
health, disease, and mortality. During the early stages 
of industrialization, the conditions of life among the 
increasing numbers of people who were being drawn 
into factory work obviously affected health and mortal¬ 
ity. Major determinants were the physical conditions 
of life such as grossly poor sanitation, polluted water, 
crowding, and impaired access to food. Later stages of 
industrialization have brought relative affluence to 
masses of people. This relative affluence has made rich 
food, cigarettes, and alcohol widely available and 
attractive; it has also reduced the physical demands of 
life. In addition, advanced industrial civilization, espe¬ 
cially in the United States, has profoundly changed 
family patterns and other social relationships. 
forms of noninfectious respiratory disease. About 
midway through the twentieth century when this 
changed pattern was recognized, it seemed to many 
that cancer and cardiovascular disease were occurring 
as a “naturaL’concomitant of aging. Now it is becoming 
evident that ways of living still determine the disease 
picture, that premature deaths in our type of society 
generally reflect, among other things, cigarette smoking, 
excessive consumption of alcohol, and other common 
habits termed health practices in this work; and by 
what are here termed weak social networks. A perspec¬ 
tive in which chronic diseases are not viewed as an 
inevitable part of the aging process invites efforts to 
extend both the life span and years of life free from 
disability. Such a view now seems justifiable; in fact, 
evidence is mounting that many of the physiological 
changes we commonly think of as part of the “natural 
aging process” are to a large degree environmentally 
determined. 
The significance of this work comes from 
the idea that health and disease arise 
mainly from circumstances of living. Within 
rather well-defined biologic limits, the 
health, disease, and mortality pattern of 
any community generally reflects the 
conditions of life within that community. 
It now appears that these alterations in ways of 
living may be fundamentally responsible for the con¬ 
trasting patterns of disease in the two periods. In the 
latter part of the nineteenth and early twentieth 
centuries, tuberculosis and other respiratory infections, 
as well as typhoid and other intestinal infections, 
dominated the scene. In the latter part of the twentieth 
century, their place has been taken by coronary and 
other cardiovascular diseases, lung cancer, and other 
DOUG NOYES 
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COMPUTERS IN MEDICINE 
Last year, over 1.4 million computers were sold 
worldwide; a million of them in the United States 
alone. Sales may more than quadruple this year, 
leaving little doubt that by the turn of the century, 
computers will be as common in American homes as 
television sets are today. In the meantime, they have 
become so commonplace in industry, business and 
education, that it is difficult to imagine the world 
before computers. 
Computer Unit is Installed at the School of Medicine 
A Biomedical Computing Unit has been installed on 
the third floor of the Sterling Hall of Medicine to meet 
some of the special needs of the Medical Center 
community. Its primary function is to provide scientific 
investigators with collaboration at a sufficiently high 
academic level to contribute to the design and imple¬ 
mentation of research projects using computers, accord¬ 
ing to Dr. David Stagg, the director. 
The three-room unit includes a 32-bit virtual memory 
machine which can support a wide variety of hardware 
and software options. It can be used via terminals 
located in a separate area within the unit, or via 
telephone. The terminal room also houses a graphics 
terminal with a hard copy option and a digital XY 
plotter. A small single-user computer is also available 
as is compatibility with other computer units. 
The Unit’s staff are trained in biomedical research as 
well as computer science. Their collaborations are 
primarily in the basic sciences, particularly neuro¬ 
science, and research involving image processing tech¬ 
niques. They are also becoming increasingly involved 
in clinical research and projects involving data manage¬ 
ment. 
This fall, the Office of Graduate and Continuing 
Education held a seminar for members of the Medical 
Center community to demonstrate the varied uses of 
computers currently being applied in basic science 
investigation and clinical research here. They include a 
video game for patient education in management of 
childhood asthma; expert consultation systems;image 
development and enhancement; and patient care 
information systems. Examples of computer application 
to clinical medicine, to basic medical research, and to 
diagnostic imaging follow. 
Expert Computers in Clinical Medicine 
Dr. Perry L. Miller, assistant professor of anesthe¬ 
siology, is developing “expert” computer systems in 
several areas of medicine, using Artificial Intelligence 
(AI) techniques to critique a physician’s plan. Artificial 
Intelligence is the science of designing complete compu¬ 
ter systems to behave, respond or perform tasks in 
ways which appear to exhibit intelligence. AI tech¬ 
niques have been applied to many problems including 
playing games such as chess, “understanding” written 
or spoken language, recognizing objects in a visual 
scene, and performing medical diagnosis. 
A recent direction in AI research has been the 
development of “expert systems” — problem solving 
computer systems which contain knowledge about a 
practical, real-world domain, such as medicine, com¬ 
puter system design, or geologic analysis. The system’s 
knowledge is usually gathered from one or more 
human experts with the goal of developing a system 
which can make expert-level judgements and recom¬ 
mendations. Over the past decade, a number of expert 
systems have been developed in medicine; most, how¬ 
ever, are still in the research stage. 
Previously developed expert systems in medicine 
have taken the approach of simulating a physician’s 
decision-making process. They gather information as a 
physician would, and then try to arrive at similar 
conclusions. When applied to medical management, 
such systems have the clinical effect of trying to tell a 
physician what to do. 
Dr. Miller’s systems are different. Instead of trying 
to tell a physician how to practice medicine, the system 
first asks how he or she proposes to manage the 
patient. It then critiques the proposed plan, discussing 
the risks and benefits of that plan as opposed to 
alternatives which might be reasonable or preferred. 
As a result, a critiquing system tells the physician, 
“This is what I think of your management plan”, 
whereas the traditional computer-advisor says,“This is 
how I think you should manage your patient.” 
There are several potential clinical advantages to the 
critiquing approach. It accommodates the inherent 
variation of medical practice. It leaves the primary 
responsibility for formulating patient management 
with the physicians, and allows the computer to play a 
secondary role, providing feedback to help evaluate 
and optimize their approach. It casts the computer in 
the role of an ally, rather than a potential competitor. 
Dr. Miller is applying the technique in several types 
of medical management, one of which is described 
here, along with excerpts from their output, illustrating 
the critiquing nature of their advice. 
HT-ATTENDING system for essential hypertension 
HT-ATTENDING is designed to critique the pharma¬ 
cologic management of essential hypertension, and is 
being developed in collaboration with Dr. Henry R. 
Black, director of the Hypertension Clinic and associate 
professor of medicine. In treating a hypertensive 
patient with gout, a physician has proposed initiating 
antihypertensive treatment with hydrochlorothiazide 
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50 mg bid, a commonly used initial program. 
The computer replied. In the United States, diuretics 
are recommended by most authorities as initial or step 
one therapy. Since the initiation of diuretic therapy 
may precipitate a gouty attack, you may wish to start 
prophylactic treatment when beginning a diuretic in a 
patient with gout. 
A thiazide diuretic or similar acting agent is the drug 
of choice for most patients. Hydrochlorothiazide is a 
commonly used thiazide diuretic. Chlorthalidone or 
metolazone are alternative agents worth considering 
since they are long-acting and can be given once a day. 
We usually start treatment with a lower dose than the 
dose you proposed. We now recommend treatment 
with hydrochlorothiazide 25 mg qd or bid. Recent 
work by Mater son* has shown that low doses or 
diuretics may be as effective as higher doses yet cause 
less hypokemia.The reference to Materson is 
available on-line. After the system’s critique, the 
physician may ask to see any such references and may 
also ask for additional information about the various 
issues discussed. 
In treating hypertension, a physician usually starts 
with one agent, and periodically either increases 
dosages or adds further agents until blood pressure is 
controlled. There is a bewildering, changing array of 
drugs available, each with risks and benefits. As a 
result, there is great latitude for practice variation. At 
the same time, it is extremely difficult for a practicing 
physician to keep current with all the various possible 
options. The critiquing approach gives physicians 
feedback as to how their approach fits in with current 
thinking in the field and the current spectrum of agents 
available. 
The application of microcomputers in research 
The use of computers in research laboratories is a 
phenomenon which has grown with the rise of the 
computer industry itself. Until the end of the I970’s, 
medium-sized computers dominated the laboratory 
environment, providing for the first time a computer 
system which was fast, had large storage capacity, and 
was, in comparison to its forerunners, relatively in¬ 
expensive. 
Over the last four years, this domination has been 
changing. Microcomputer systems are now finding 
their way into the laboratory. Initially reserved for 
word processingand simple mathematical applications, 
microcomputers, whose speed and functional capa¬ 
bilities have been increasing as rapidly as their price 
has been falling, are now serious contenders for the 
data aquisition, display and analysis tasks of many 
research laboratories. 
Microcomputers are being used in every area of 
laboratory experimentation, ranging from their in¬ 
clusion in complex equipment, where they are enhan¬ 
cing functionality and ease of use, to complete control 
of entire experiments. Ideally suited to handling both 
simple repetitive tasks as well as simplifying complex 
ones, they are helping to speed up the often long 
process of analysis and interpretation of experimental 
results. Their inherent flexibility allows them to be 
easily adapted to a wide variety of different situations 
within the laboratory. 
For instance. Dr. Brenda Ritchie’s laboratory in the 
John B. Pierce Foundation Taboratory is investigating 
problems of human neuromuscular fatigue and in 
quantifying relationships between physiological vari¬ 
ables such as force, EMG, and the electrical activity 
associated with single unit motoneurons. With Dr. 
Simon Smith, associate research scientist with the 
Biochemical Computing Unit, they have developed a 
computer system based on a popular microprocessor 
which has many of the features formerly seen in much 
larger systems, but for considerably reduced cost. 
This laboratory computer system actually contains 
four separate microprocessors, each performing a 
dedicated task. One acts as the “master” system, and 
the other three are used to speed up the processing 
required to handle special features. 
To compliment this hardware, several software 
packages have been developed. This integrated software 
allows for data acquisition from the experimental 
setup or from an FM tape recorder to the storage 
device; preliminary data review and analysis using the 
graphics display; and secondary data analysis — or 
comparisons between different experiments. 
This system is being used in the determination of the 
relationships between fatigue, motorneurone activity, 
and voluntary force generation in a variety of human 
muscles, and is shedding new light on the role of 
motoneuron activity in the generation of muscle force. 
The more recent and highly successful introduction 
of second generation microcomputer systems will help 
to further the development of less expensive, more 
powerful and highly functional laboratory computer 
systems. The role of the microcomputer in modern 
research can only continue to increase in the future. 
Computers in medical imaging 
Digital computers have wide application in medical 
imaging, according to Dr. John Gore, associate pro¬ 
fessor of diagnostic radiology and director of NMR 
imaging at Yale. An image is a recording of some signal 
from different parts of an object which contains 
features that convey information to an observer. The 
“signal” may, for example, be the x-ray intensity 
transmitted through the body, while the “features” 
could be the shadows cast by bones and organs in the 
body. Such images occur in several different guises in 
medicine, but one of the most important areas that 
directly affects patient care is diagnostic imaging, 
which includes conventional radiography, ultrasound, 
nuclear medicine, computed tomography, and now, 
nuclear magnetic resonance (NMR) imaging. Digital 
computers are used extensively to create, display, and 
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manipulate or process images, particularly in tomo¬ 
graphy and NMR imaging where usually the entire 
imaging system is centered around a computer. 
NMR imaging has developed in the last decade as a 
powerful addition to the range of methods available 
for creating images of the inside of the body. It uses the 
properties of some atomic nuclei, notably the hydrogen 
nucleus contained mainly in water and fat to absorb 
and re-emit energy in characteristic amounts when 
placed in a magnetic field. A radiofrequency transmitter 
is first used to disturb the nuclei in atoms, and a tuned 
coil connected to a sensitive radio receiver is used to 
detect the response of the body nuclei as they recover 
and emit a weak signal. Coils which produce magnetic 
field gradients are driven by powerful audio amplifiers 
to add further information about where the signals 
come from. An NMR scanner, therefore, comprises 
several complex electronic modules, but the heart and 
brain of the system is a computer, which manages and 
coordinates the various subunits, records and analyses 
the signal information, and displays the resultant 
image. 
For example, the computer communicates through 
a special interface to the radio frequency transmitter to 
define the complex electrical waveforms that are fed to 
the transmitter coil used to excite the nuclei. The 
precise shapes and magnitudes of these excitations are 
defined in software, and they are stored in computer 
memory as arrays of numbers. Similarly, when the 
appropriate NMR radio signal is induced in the 
receiver coil, it is converted to digital form and the 
numerical samples are stored in memory for processing. 
In NMR, the nature of the image information is 
strongly dependent on the shapes and timings of the 
various pulse sequences used to procure a signal, and 
these are controllable in a very flexible way by 
computer software. The computer therefore controls 
all aspects of data collection, and a crucial role is 
played by the interface between the digital and ana¬ 
logue worlds. 
Once data is acquired into memory, several numerical 
computations usually take place. For example, in 
NMR the signal may require filtering to remove 
unwanted interference, smoothing to remove sharp 
spikes, interpolation between samples and then Fourier 
transformation. The latter is a complex mathematical 
manipulation that can only practically be performed 
by computer, and which is often the reason for 
including an array processor that performs such 
calculations very rapidly in the computing system. 
In both CT and NMR, many different signals are 
accumulated and then recombined to form an image, 
and this image reconstruction is always performed by 
computer. The image produced exists in computer 
memory as a large two-(or three-) dimensional array of 
numbers (typically 256 X 256) that correspond to the 
measured image quantity from specific small volume 
elements (voxels) of the object. This quantity may be 
the x-ray absorption (in x-ray CT scanning), the 
hydrogen nucleus NMR properties, the activity of a 
radio nuclide, and so on. The array of numbers in 
memory is used to control the intensity of a video 
display so that the stored number value corresponds to 
the image brightness in one Dicture element (pixel). 
Many types of further image processing may occur 
after the image is obtained. For example, whole images 
may be added to improve the quality. One particularly 
important type of such arithmetic is subtraction. Two 
images taken at different times may be subtracted to 
reveal only those regions that have changed. If, in the 
interim, a contrast agent is introduced, the agent alone 
will be visualized in the difference image. Such sub¬ 
traction methods are now widely used for x-ray 
angiographic studies to observe blood vessels and 
flow. A wide variety of techniques have been developed 
to improve image quality, and these are readily 
implemented using fast computer processing. Smooth¬ 
ing may be performed to reduce the mottle of an image, 
and thereby improve the detection of low contrast 
objects, while edge enhancement may be implemented 
improve the ability to resolve fine details and increase 
sharpness. 
Computers may also be used to extract quantitative 
information from images, which cannot be done bv the 
human visual system alone. These may be simple 
statistical quantities, such as the mean and variance 
over a region of interest. Where the spatial pattern of 
pixel values conveys information about the nature of 
the object, texture analysis may be useful to discriminate 
tissues, e.g. for analyzing ultrasonic speckle patterns. 
Edge detection and boundary mapping may be auto¬ 
mated to allow accurate planimetry or volume estima¬ 
tions to be made such as in calculating heart chamber 
volumes. The computer-generated result may be less 
prone to illusion and artefact and more reproduceable 
than that produced by a human observer. 
There is currently much research in digital image 
processing, manipulation and algorithm development, 
and ideas and techniques may cross fertilize from one 
area of imaging, such as satellite reconnaissance, to 
another — such as in vivo medical diagnostic imaging. 
The medical community can expect to see a greatly 
increased involvement of digital computers in all types 
of medical imaging. 
Material for this article was provided bv Drs. Stagg, 
Miller, Smith and Gore. 
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A LOOK AT MEDICAL EDUCATION TODAY 
— a case for the “Yale System” 
The Association of American Medical Colleges 
(AAMC) is undertaking a Project on the General 
Professional Education of the Physician and College 
Preparation for Medicine. During the first six months 
of 1983, the Project Panel held four regional meetings 
at which representatives from medical schools, under¬ 
graduate colleges, and various professional organiza¬ 
tions were invited to report. The following statement 
was presented at the Northeastern Regional hearing in 
May by Dr. Fred S. Wright on behalf of the Yale 
School of Medicine. Dr. Wright, professor of medicine 
and physiology, is chairman of the School's Curriculum 
Committee. 
My aim will be to provide testimony in line with the 
goals of the AAMC Project: to tell about our approach 
to medical education, about our course of instruction, 
and about the philosophy on which it is based. 
Among curriculum types, the outline of courses at 
Yale would probably be viewed as traditional. The 
four-year program is divided into preclinical and 
clinical phases. The division is not absolute, but in 
general outline, the first three semesters are devoted to 
preclinical science courses and the third year is occupied 
by clinical clerkship rotations. Between these segments, 
an integrated program in the fourth semester provides 
an Introduction to Clinical Medicine. In this semester, 
students are offered, for the first time, formal instruc¬ 
tion in clinical assessment, diagnostic procedures, and 
pathophysiology. Thus, during much of the first two 
years, teaching is in a classroom situation. The formal 
work in nearly all of these courses is approached by a 
combination of lectures and small group discussions 
(or in a few cases, laboratory sessions) that meet 
regularly during the course. 
This general plan has guided course scheduling with 
only minor modifications for the past ten years. At the 
end of the 1960’s, Yale experimented with a “new 
curriculum” that introduced in the first semester, 
clinical concerns such as history taking and physical 
examination, and provided at the end of the first year, 
an apprentice-like experience with a preceptor, usually 
in community practice. Overall, this program was 
intended to integrate basic science and clinical medicine 
by presenting both throughout all of the four years. 
Within a few years, however, it became clear that this 
intention was not being realized. In particular it was 
evident to many that the effort to enrich the program 
of the last two years with further courses in the basic 
sciences was not succeeding. 
Having characterized Yale’s present curriculum as 
being nearly classical in its resemblance to the formula 
standardized early in this century, I must go on to say 
that the milieu in which this general structure exists 
very likely differs from that in many other schools. 
Despite periodic revisions of the schedule of courses, 
the general policy governing implementation of the 
schedule (referred to in New Haven as “the Yale 
System)” has somehow persisted with little change 
since it was adopted more than 50 years ago: 
1. Primary responsibility for setting priorities 
and for successfully completing their medical 
studies is vested with students. 
2. Advancement of individual students proceeds 
at a rate best for each student. 
3. A thesis is required of all students. 
4. Examinations are not required during or at 
the conclusion of individual courses. 
5. Proficiency in pre-clinical subjects is dem¬ 
onstrated by successfully passing a compre¬ 
hensive examination. Originally, this examina¬ 
tion was a one-week session of written and 
oral exercises offered twice a year; since the 
1940’s, the requirement has been met by 
passing the National Board Exam Part I. 
Naturally, this rather idealistic approach, which 
attempts to reduce competition in a competitive world, 
is not without problems. It is not best for all students; 
some would probably accomplish more in a more 
rigidly structured program. Since attendance at classes 
is not required, sometimes students and teachers do 
not meet and this is not helpful. Faculty morale suffers 
when students do not appear. In the present era, 
however, these difficulties are not dominant and the 
general level of participation and involvement on the 
part of both students and faculty is high. Teaching in 
this voluntary and non-punitive environment is a 
pleasure. The importance of this approach, and its 
benefits, struck me when I read David Roger’s descrip¬ 
tion, published in The Pharos last spring, of a visit with 
medical students. He described “an outpouring of 
frustration, disappointment, and real rage.” The stu¬ 
dents “felt they were being lectured to death.” They 
complained of insufficient time for study and of 
“dreary never-ending series of quizzes, tests, and other 
bracings.” 
We think that some of these difficulties have been 
avoided at our school because of the basic policy I 
referred to as the Yale system. In view of the apparent 
viability of this 50-year-old experiment, we hope the 
committee will recognize and affirm the advantages of 
having each school set its own standards and course of 
study. It would be a great service if the committee 
report restated the important difference between indiv¬ 
idual academic programs leading to a degree, and the 
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process of certification qualifying graduates to practice 
medicine. Certification ought to remain exclusively 
with licensing boards. They should set their own 
standards of competence for the practice of medicine 
in their jurisdictions. Schools should develop their 
own curricula and thus be able to innovate and to 
respond to their own particular strengths. As this 
committee reviews medical education throughout the 
country, we think it is important to preserve the 
possibility of individual innovations and approaches 
and to avoid setting particular guidelines that could 
well serve as ammunition for particular interest groups 
who might want one specific course or another to be 
taught in all schools. The curriculum should not be a 
political issue open to coercion by such interest groups. 
The features of medical education at Yale that I have 
described briefly, the traditional course structure, and 
the unusual (although now long-standing) approach to 
requirements, are really technical matters. What it is 
that we are trying to teach, and that this structure is 
supposed to enable students to learn, remains the focus 
of our continuing concern. We are engaged in a 
continuing struggle to provide general education for 
future physicians. One reason that this is a struggle is 
the increasing specialization of both medical practice 
and our own faculty. Both faculty and students tend to 
deal in subspecialty interests, at the cost of missing 
opportunities to involve themselves in a broad range of 
more generally useful information. We are attempting 
to develop and maintain a program that treats the 
medical school years as preparation for further post¬ 
graduate training, not as preparation sufficient for 
medical practice. We believe, therefore, that two 
elements are essential: a secure grounding in the 
sciences relevant to medical practice; and clinical 
activities that develop habits of mind and behavior 
that will outlast particular currently popular techniques 
of diagnosis and treatment. 
This does not mean that we demean or ignore the 
facet of this project concerned with “qualities, values 
and attitudes.“We must be equally concerned with the 
ability of doctors to respond to patients’ needs in a 
compassionate and understanding manner. The admis¬ 
sions committee must recruit students who possess, 
and the medical school program must foster continuing 
development of those qualities necessary in the wise 
and caring physician. But we think it is very important 
to recognize that concern for humane and compassion¬ 
ate medical care is not alternative to dedication to 
scientific knowledge or clinical acumen. We are very 
concerned that our program of instruction in basic 
science remain strong. After describing his worries 
about medical education, David Rogers went on to 
state the two major objectives of medical school: to 
inculcate personal habits of learning (to make the 
physician a continuing learner throughout his or her 
lifetime); and to lay down an appropriate scientific 
base, to understand facts, think deductively and gain 
experience in logical decision making. He seems to be 
saying that medical education in the basic sciences 
should not be viewed as a hurdle to get over, or as a 
burden to bear, or as a destructive dehumanizing 
ordeal, but rather that the information and the intellec¬ 
tual activity involved in dealing with it are a crucial 
element in forming habits of mind that will serve 
physicians in their future continuing education. 
1 was also struck in reading Paul Starr’s new book. 
The Social Transformation of American Medicine, by 
the pervasive references to the importance of science to 
the development of present day medicine. Starr argues 
that medicine’s link to modern science is one of the 
important factors underlying its very legitimacy. To 
choose one such statement from this book: 
“Modern medicine is one of those extraordinary works 
of reason: an elaborate system of specialized knowledge, 
technical procedures, and rules of behavior. By no 
means are these all purely rational: our conceptions of 
disease and responses to it unquestionably show the 
imprint of our particular culture, especially its individu¬ 
alist and activist therapeutic mentality. Yet, whatever 
its biases and probably because of them, modern 
science has succeeded in liberating humanity from 
much of the burden of disease. Few cultural relativists, 
suffering from a bad fever or a broken arm, would go 
so far to prove a point as to trade a modern physician 
for a traditional healer. They recognize, in behavior if 
not always in argument, that in medicine the dream of 
reason has partially come true.” 
There is a need for balance in the curriculum, for 
vigilance to be sure that courses dealing with science 
and courses concerned with patient care both provide 
effective general education. However, we do not 
believe that blame for whatever may be amiss today in 
medical education should be laid at the door of basic 
science. I think we all realize that effective medicine in 
the future will be based in part on the pre-clinical 
sciences we call “basic” and to a fearful extent on 
science that we do not yet know but must be prepared 
to understand and apply. At Yale we are looking for 
ways to get more general education, including science, 
into the curriculum. 
Medical education should equip the student with a 
scientific approach to medical problems, the skills 
necessary to obtain clinical information, and the 
ability to respond in a compassionate manner to the 
problems of patients. Medical education should empha¬ 
size problem solving that is independent of a large 
instantly recalled data base. Increasingly ,the ability to 
master all of the information necessary to practice 
medicine will become a more distant and unachievable 
goal and the use of information retrieval systems will 
become increasingly common. Therefore, it is important 
for the medical student and the future physician to be 
able to acquire necessary information from available 
sources, to learn to use this information to solve 
clinical problems, and to do this while retaining and 
developing the capacity to offer understanding and 
sympathy to fellow humans when they sorely need it. 
HERE AND ABOUT 
DR. BONDY APPOINTED 
CHIEF OF STAFF, V.A. MEDICAF 
CENTER IN WEST HAVEN 
The Veterans Administration has 
appointed Dr. Philip K. Bondy chief 
of staff at the Medical Center in West 
Haven. Dr. Bondy, who is professor 
of medicine, and is well knowm as an 
outstanding teacher and endocrin¬ 
ologist, has also been appointed asso¬ 
ciate dean for the V.A. Medical Center. 
A graduate of Columbia College 
and Harvard Medical School, Dr. Bondy 
first came to Yale in 1948 as Alexander 
Brow ne Coxe Fellow' in Physiological 
Chemistry. He became a member of 
the School of Medicine faculty in 
1952, when he was appointed 
assistant professor of medicine. In 
1965, he was named Ensign Professor 
of Medicine, and the following year, 
he was appointed C.N.H.Long Pro¬ 
fessor and chairman of the Depart¬ 
ment of Internal Medicine. He left 
Yale in 1972 to become Cancer Re¬ 
search Campaign Visiting Professor 
of Medicine at the Institute of Cancer 
Research, and consultant in medicine 
at the Ludwig Institute of Cancer 
Research in London; appointments 
he held until 1977, when he returned 
to Yale as professorof medicine, and 
as associate chief of staff for research 
at the V.A. Medical Center. 
Editor-in-chief of the Yale Journal 
of Biology and Medicine, Dr. Bondy 
is also editor of the Metabolism 
Section of the Year Book of Medicine 
and serves on the editorial boards of 
Cancer Topics and Merck Manual. 
Elected to Phi Beta Kappa, Sigma Xi 
and Alpha Omega Alpha honor socie¬ 
ties, he is a fellow of the American 
College .of Physicians, the American 
Association for the Advancement of 
Science, and the Royal College of 
Physicians, and a member of a number 
of professional societies including 
the American Society for Clinical 
Investigation, Association of Ameri¬ 
can Physicians, the American Feder¬ 
ation for Clinical Research, and the 
Association of Physicians of Great 
Britain and Ireland. 
CHAIRMAN APPOINTED FOR 
DEPARTMENT OF 
LABORATORY MEDICINE 
Dr. Peter I. Jatlow, an authority on 
the clinical toxicology and pharma¬ 
cology of psychotropic drugs, has 
been appointed chairman of the De¬ 
partment of Laboratory Medicine at 
Yale, and director of clinical labora¬ 
tories at Yale-New Haven Hospital. 
He succeeds Dr. David Seligson, 
professorof laboratory medicine, who 
has held these offices since 1972. 
Dr. Jatlow, who is professor of 
laboratory medicine and psychiatry, 
is well known for his extensive clinical 
studies of the effects of cocaine and 
antidepressant drugs as well as drugs 
used in the treatment of children with 
attention deficit disorders. He was 
the first to successfully measure the 
level of cocaine in the blood of individ¬ 
uals taking the drug by various routes. 
A graduate of Union College, Sche¬ 
nectady, he received his M.D. degree 
from the State University of New 
York, Downstate, and came to Yale 
in 1962 as an intern in pathology at 
Yale-New Haven Hospital. He was 
appointed to the School of Medicine 
faculty as an instructor in pathology 
in 1964, and was promoted to assistant 
professor four years later. In 1975, he 
was named director of clinical chem¬ 
istry in Yale-New Haven Hospital, 
and the following year, was appointed 
professor of laboratory medicine. He 
received a joint appointment as pro¬ 
fessor of psychiatry in 1978. 
Dr. Jatlow serves on the editorial 
boards of several professional journals 
including Chemical Chemistry, Jour¬ 
nal of Analytic Toxicology, Titera- 
peutic Drug Monitoring, and Clinica 
Chemic Acta. He is president of the 
Academy of Clinical Laboratory 
Physicians and Scientists and is a 
member of numerous other national 
advisory committees including the 
National Institute on Drug Abuse 
and the American Board of Pathology 






CELEBRATES 30th ANNIVERSARY 
The John B. Pierce Foundation Lab¬ 
oratory celebrated its 50th anniversary 
on November 4th, and paid tribute to 
Dr. A.Pharo Gagge, fellow emeritus. 
Dr. Gagge has been a member of the 
Laboratory’s scientific staff since it 
was founded in 1933 to conduct 
research and educational programs 
“for the increase of knowledge to the 
end that the general hygiene and 
comfort of human beings and their 
habitations may be advanced.” 
Dr. C.E.-A. Winslow was appointed 
the first director of the Laboratory 
while he was chairman of the Yale 
Department of Public Health, and he 
retained both offices until his retire¬ 
ment in 1945. Under his leadership, 
and that of subsequent directors, the Lab¬ 
oratory has gained worldwide recog¬ 
nition for its many significant contri¬ 
butions to the field of environmental 
physiology. In recent years of energy 
shortages and increasing pollution 
production, their work has assumed 
added importance as governments 
seek a balance between energy conser¬ 
vation and a healthful environment. 
The close relationship between the 
Pierce Laboratory and the Depart¬ 
ment of Epidemiology and Public 
Health has continued. A major por¬ 
tion of Yale’s program in environ¬ 
mental health is conducted in the 
Pierce Laboratory, and in 1968, quali¬ 
fied graduate students and postdoc¬ 
toral fellows were admitted as majors 
in environmental physiology in the 
Department of Epidemiology and 
Public Health. 
Dr. Gagge, who is also professor 
emeritus of epidemiology, is well 
known in the scientific world for his 
contributions to the field of thermo¬ 
physiology. In the 1930’s, he and his 
colleagues developed the use of parti- 
tional calorimetry, a widely applied 
method of measuring absorbed or 
evolved heat, which is less compli¬ 
cated than the use of a full calorimeter. 
In addition, his research led to the 
development of the ET*Scale, a bio¬ 
physical index combining the physical 
properties of the skin surface, to give 
a single temperature index of the 
environment. Based on a concept 
similar to the weather reporter’s fam¬ 
iliar THI (Temperature Humidity 
Index), ET* is a more scientific and 
accurate assessment of the effect of 
the environment on human comfort. 
More recently, Dr. Gagge designed a 
method for direct measurement of 
thermal insulation of all types of 
clothing as they are worn during 
heavy exercise as well as during rest. 
His research is of importance to 
scientific programs, including those 
of NASA, involved with the effects of 
the environment on human health. 
Dr. Jan A. Stolwijk, chairman of 
the Department of Epidemiology and 
Public Health and associate director 
of the Laboratory, was chairman of 
the anniversary program. Historical 
events of the institution recounted by 
Dr. Vernon Lippard, dean emeritus 
of the School of Medicine, and mem¬ 
bers of the Laboratory were followed 
by the reading of tributes to Dr. 
Gagge from colleagues and friends 
from around the world. 
CMHC RESEARCH CENTER 
NAMED IN HONOR 
OF SENATOR R1BICOFF 
On September 28, the research facili¬ 
ties of the Connecticut Mental Health 
Center were dedicated as the Abraham 
Ribicoff Research Facilities, in honor 
of the former Governor of Connecti¬ 
cut. President A.Bartlett Giamatti 
was joined by Governor William A. 
O’Neill and Dr. Herbert Pardes, direc¬ 
tor of the National Institute of Mental 
Health in a tribute to Senator Ribicoff 
and his long support of mental health 
programs as governor. Secretary of 
Health, Education and Welfare, and 
U.S. Senator. 
During his terms as governor. Sen¬ 
ator Ribicoff was a strong proponent 
of the Connecticut Mental Health 
Center, which was established in 1966 
as a cooperative endeavor of the 
State of Connecticut Department of 
Mental Health and Yale University. 
Research conducted at the Center is 
recognized internationally for its 
many contributions to basic and clini¬ 
cal studies of mental disorders. 
PHYSICIAN ASSOCIATES HOLD 
TWELFTH COMMENCEMENT 
On August 22, twenty-one students 
received Certificates Of Physician 
Associate in a ceremony in the Mary 
S.Harkness Auditorium. They were 
the twelfth class to graduate from the 
program established in the School of 
Medicine in 1973 under a grant from 
the National Institutes of Health. 
Elaine E. Grant, executive director 
of the Program, and Dr. Howard 
Levitin, dean of students and medical 
director of the Program, officiated 
during the commencement, which 
included an address by Dr. Lowell 
S. Levin, professsor of public health. 
Gary Spinner, a student, presented 
the Didactic Instructor Award to Dr. 
David Coleman, a postdoctoral fellow 
in the Department of Internal Medi¬ 
cine, for his exemplary efforts in the 
education and training of physician 
associates. 
Clinical Rotation Site Awards were 
presented to Danbury Hospital, Law¬ 
rence and Memorial Hospital, Nor¬ 
walk Hospital, Surgical Associates 
ot New Haven, Waterbury Hospital, 
Yale-New Haven Hospital, and the 
West Haven Veterans Administration 
Medical Center. Deputy Dean Arthur 
Ebbert,Jr.,and Debbie Waldes, assis¬ 
tant director of the Program, awarded 
the certificates, following which the 
graduates and their families and 
friends celebrated at a reception in 
their honor in the adjoining courtyard. 
The Yale Physician Associate Pro¬ 
gram is classified as Type A, offering 
extensive training in general medical 
theory and clinical practice. Graduates 
are capable of examining patients, 
taking a medical history, and assisting 
physicians in performing diagnostic 
and therapeutic procedures. They function 
under the supervision and responsi¬ 
bility of the physician, and under 
special circumstances, with defined 
rules, may perform without the immedi¬ 
ate surveillance of the physician. 
HOSPITAL DEDICATED 
TO FORMER DEAN 
The Bayne-Jones Army Community 
Hospital located at Fort Polk, Louisi¬ 
ana was dedicated on August 12,1983. 
The 169-bed hospital is named in 
honor of Brigadier General Stanhope 
Bayne-Jones, who joined the Yale 
faculty in 1932 as professor of bacteri¬ 
ology and who served as dean of the 
School of Medicine from 1935 to 
1940. He was also master of Trumbull 
College from 1932 to 1938. 
At the outbreak of World War II, 
Dr. Bayne-Jones resigned as dean in 
order to enter military service. He 
was called to active duty as a lieuten¬ 
ant colonel in 1942, and was soon 
promoted to the rank of colonel and 
in 1944, to brigadier general. When 
Dr. Bayne-Jones died in 1970 at the 
age of 82, he was buried with honors 
in Arlington National Cemetery. 
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THE ROYAL SOCIETY 
HONORS DR DOUGLAS 
Dr. Will iam W. Douglas, professor 
of pharmacology, has been elected a 
fellow of the Royal Society. In 
honoring him, the British scientific 
society cited Dr. Douglas’ research 
on the physiology and pharmacology 
of endocrine, exocrine and other 
secretory cells, which has led to the 
recognition of the involvement of 
calcium in stimulus-secretion cou¬ 
pling. Chartered by King Charles II 
in 1663 as the “Royal Society of 
London for Improving Natural 
Knowledge”, the society is one of the 
oldest and most prestigious scientific 
academies in the world. 
A native of Glasgow, Scotland, 
Dr. Douglas has been a member of 
the School of Medicine faculty since 
1968. Lollowing graduation from the 
University of Glasgow, he did post¬ 
graduate work in physiology at the 
University of Aberdeen before return¬ 
ing to the University of Glasgow, 
where he received his M.D. degree 
with honors in 1949. He served as a 
major in the Royal Army Medical 
Corps prior to appointment on the 
Medical Research Council at the 
National Institute for Medical Re¬ 
search in London. 
Dr. Douglas first came to the 
United States during a leave of 
absence in 1952, when he was ap¬ 
pointed an associate professor of 
pharmacology at the Albert Einstein 
College of Medicine. He was appoin¬ 
ted professor of pharmacology in 
1958. In addition to election to the 
Royal Society, Dr. Douglas has been 
honored with the John Gaddum 
Memorial Award from the British 
Pharmacological Society and the 
H.B. Van Dyke Memorial Award 
from Columbia University. 
DR.LEVY IS HONORED 
Colleagues and friends gathered at 
the West Haven Veterans Adminis¬ 
tration Medical Center on November 
4th for a symposium in honor of Dr. 
Lewis Levy, clinical professor of 
neurology. A member of the School 
of Medicine faculty since 1954, Dr. 
Levy was chief of Neurology Service 
at the V.A. Medical Center from 
1955 to 1976, and chief of the Cerebro¬ 
vascular Section from 1979 to 1983. 
He was director of the Stroke Acute 
Care Unit from 1971 to 1976. 
Guests were welcomed to the sym¬ 
posium by Dr. Richard H. Mattson, 
who succeeded Dr. Levy as chief of 
the Neurology Service, and Dr. Philip 
K.Bondy, chief of staff and associate 
dean, introduced the speakers. Dr. 
Gilbert H. Glaser, chairman of the 
Department of Neurology, moderated 
the morning session, while the after¬ 
noon session was led by Dr. Harold 
E. Booker, director of Neurology 
Service, V.A.Central Office. 
During the day-long event, the 
Veterans Administration awarded 
Dr.Levy a special commendation 
which read in part,“During the three 
decades of his leadership. Neurology 
grew from a single staff member to a 
61-bed independent service that is 
recognized as one of the outstanding 
units within the V.A.system . . .He 
initiated the development of a number 
of specialized units including the first 
Epilepsy Center and the Stroke Treat¬ 
ment Unit, that have served as proto¬ 
types for both the V.A. as well as for 
non-federal hospitals. 
“Dr. Levy was instrumental in start¬ 
ing the neurology residency training 
at the Center which has been inte¬ 
grated with the program at the Yale 
School of Medicine. Over the years 
more than 60 resident physicians 
have trained under his expert guidance 
.. .Concurrently, (he) has been exten¬ 
sively involved in both clinical and 
basic research, particularly in cerebral 
vascular disease. He has encouraged 
and fostered similar participation of 
his staff. Most importantly, his devo¬ 
tion to the human aspects of medical 
care has won him the respect and 
warm admiration of all who are 
fortunate enough to know him.” 
A HEALTH GUIDE FOR 
GLOBAL TRAVELERS 
A “Global Disease Guide” has been 
created and developed by Dr. Martin 
E. Gordon, associate clinical professor 
of medicine. This desk-top, record¬ 
sized informational disc permits in¬ 
stant finger-tip dialing of disease pre¬ 
valence in 170 countries. The many 
voluminous and often obscure data 
references have been culled and 
brought together as a physicians’ 
world scanner to aid in post-travel 
diagnosis as well as an immediate 
guide to pre-travel immunizations. 
Color codes direct the physician to 
prevalence rates of viruses, helminths, 
protozoa, bacteria, rickettsia and 
even venomous bites and stings. The 
diverse types of arboviruses, dengue, 
schistosoma and the resistant malarial 
strains are readily spotted, height¬ 
ening the physicians’ ability to rec¬ 
ognize diseases that are no longer 
tropical or exotic in this jet age. 
Dr. Gordon’s continuing interest 
in parasitology, the paucity of readily 
available references, and the need to 
increase physicians’awareness of dis¬ 
eases of the traveler led him to develop 
the Global Disease Guide as an aid in 
disease prevention and post-travel 
diagnosis. National distribution of 
the Guides to medical schools, hos¬ 
pitals and physicians has just been 
initiated. Inquiries can be directed to 
Dr. Gordon at 111 Sherman Avenue, 
New Haven, Connecticut 06511. 
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THE CASE OF 
THREE MISSING HAMSTERS 
Three infected hamsters reported 
missing from their cage in the animal 
containment facility on the ninth 
floor of the Laboratory of Epidemiol¬ 
ogy and Public Health became over¬ 
night celebrities — of a sort. “Infected 
Yale Hamsters Escape” was headline 
news for the wire services, major 
television and radio networks and 
newspapers across the nation, includ¬ 
ing the New York Times, which de¬ 
voted almost half a page to the story. 
The hamsters have not been found, 
and are presumed dead. Although 
their disappearance caused consider¬ 
able stir in the media and concern in 
the University, the three rodents and 
others like them in the LEPH-9 facility 
are of little threat to human health 
and the likelihood that they escaped 
from the facility is practically nil. The 
incident, however, called attention 
to several potential areas which are 
vulnerable to error. 
The hamsters were among several 
hundred research animals in a major 
study of Alzheimer’s disease being 
conducted by Dr. Elias Manuelidis, 
professor of neuropathology and neu¬ 
rology. They were infected with Creutz- 
feld-Jacob virus, a so-called “slow 
virus”, which is invariably fatal, and 
causes symptoms of senility similar 
to those of Alzheimer’s disease. Be¬ 
cause of its extremely low transmissi- 
bility in animals - only by injection 
into brain tissue — the C-J virus has 
been classified as Level 2 by the 
Center for Disease Control. Classifica¬ 
tion is according to risk level from 
Level 1, minimal risk, to Level 4, high 
risk. 
Dr. Manuelidis and his colleagues 
had been working with C-J infected 
rodents for more than a decade in 
their laboratory in Brady Memorial 
Laboratory, but to further assure 
safety and security, the animals were 
moved last year to the recently com¬ 
pleted Level 3 animal containment 
facility on the ninth floor of the 
Laboratory of Epidemiology and Pub¬ 
lic Health. Research procedures and 
equipment there were reviewed by 
leading experts from the National 
Institutes of Health and the Center 
for Disease Control, who found the 
facility met, and indeed, exceeded, all 
of the requirements for biological 
safety for this research. Safety pre¬ 
cautions are supervised and enforced 
by the Division of Animal Care and 
by the Department of Biological Safe¬ 
ty, University Health Services. 
An associate in research for the 
C-J virus study first discovered that 
the hamsters were missing on October 
third. She later reported that the lid 
appeared to have been pushed off 
their cage, which was quite warped 
due to repeated autoclaving (high 
pressure steaming for decontaminating 
infectious material). Health and safety 
officers, however, were unaware of 
the missing hamsters until a week 
later, when Robyn Gershon, acting 
director of the Department of Biolog¬ 
ical Safety, made a periodic, unan¬ 
nounced inspection. 
A series of meetings has since been 
held to ascertain facts of the escape, 
and to plan remedial actions. Two 
problems addressed are the need for 
the establishment of a more definitive 
line of responsibility for maintenance 
of the containment facility, and a 
more accurate method for keeping a 
census of the animals. The high cost 
of maintaining the LEPH-9 animal 
containment facility is another factor. 
Cages have to be replaced repeatedly 
due to damage from autoclaving. 
The Division of Animal Care recently 
invested $ 14,000 on new cages report¬ 
edly more durable than ones previ¬ 
ously used, and because of persistent 
problems, the autoclave itself will be 
replaced at an estimated cost of 
$125,000, according to Dr. Stephen 
Barthold, the acting director. 
Although most are confident that 
their health and safety is not endan¬ 
gered, faculty, staff and students in 
the Laboratory of Epidemiology and 
Public Health have expressed concern 
over the incident. In discussing it 
with them. Dr. Edward Adelberg, 
deputy provost for the biomedical 
sciences, told them that the delay in 
notifying University officials about 
the missing hamsters was certainly an 
error, but he assured them that precau¬ 
tions will be taken to ensure that no 
“accidents of this nature will occur in 
the future.” Dr. Jan Stolwijk, chair¬ 
man of the Department of Epidemiol¬ 
ogy and Public Health was firm in 
agreeing that the problems must be 
remedied. “It would be difficult to 
maintain a viable working atmosphere 
if this sort of thing keeps happening,” 
he said. — MBN 
W. H.O. WORKSHOP ON 
TRYPANOSOMES HELD HERE 
A workshop on African trypano¬ 
somes, sponsored by the World Health 
Organization, was held at the School 
of Medicine in November. Dr. Frank 
F. Richards, professor of medicine, 
was host to the three-day meeting of 
scientists from Africa, Europe and 
the United States. 
African trypanosomes are the para¬ 
sites responsible for trypanosomiasis 
(sleeping sickness) and N’gana, a 
disease affecting domestic livestock 
which has had severe implications for 
the economy of African nations. Accord¬ 
ing to Dr. Richards, who is well- 
known for his research in tropical 
medicine, the incidence of sleeping 
sickness in Uganda and Sudan has 
risen sharply in recent years following 
war and unrest in those countries. 
Drugs used for treatment of trypano¬ 
somiasis are effective in the early 
stages of the disease, but many of 
them have considerable toxicity and 
can be given only for short periods. 
In addition, they are of little use in 
regions where re-infection is an ever¬ 
present risk. 
For these reasons, efforts to find a 
vaccine for trypanosomes have been 
accelerated in recent years. So far, 
the trypanosomes have outwitted the 
biologists studying the disease, accord¬ 
ing to Dr. Richards. “The disease is 
remittent, giving rise to many succes¬ 
sive waves of fever and trypanosome 
parasitemia in the host. In each wave, 
the parasites are covered by a different 
protein overcoat - Variant Specific 
Glycoprotein (VSG). The host does 
make antibodies to one VSG and 
destroy the parasites. This destruction 
is, however, rapidly followed by the 
emergence of a second population of 
the parasites, carrying a different 
VSG,” he explained. 
The progeny of a single parasite 
has been shown to produce 100 or 
more different VSG surface proteins, 
and it seems likely that as many as 
1000 different genes coding for the 
proteins are present. 
In addition to Dr. Richards, partici¬ 
pants from Yale included Dr. Curtis 
Patton, associate professor of epi¬ 
demiology, Dr. Larry Ruben, post¬ 
doctoral fellow in epidemiology, and 
Dr. Thomas Lalor, postdoctoral fellow 
in medicine. 
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THE FIRST INTERNATIONAL 
SYMPOSIUM ON LYME DISEASE 
IS HELD AT YALE 
“The Lyme disease story begins with 
two mothers in Lyme, Connecticut,” 
Dr. Allen Steere said in introducing 
the First International Symposium 
on Lyme disease, held here on Novem¬ 
ber 16-18. The mothers, skeptical of 
the diagnosis of juvenile rheumatoid 
arthritis in their children and several 
others in their neighborhood in 1974, 
called Dr. Andrew Spielman at the 
Connecticut State Department of 
Health, who in turn conferred with 
the Yale Section of Rheumatology. 
Thus began an intensive investigation 
into the cause and treatment of a 
mysterious and serious new disease 
which ultimately would involve col¬ 
laboration with scores of scientific 
investigators in the United States and 
Europe. 
One of the mothers, Mrs. Polly 
Murray, and Dr. Spielman were 
among the more than 100 participants 
at the symposium, which was spon¬ 
sored by the Yale Journal of Biology 
and Medicine and the Section of 
Rheumatology. The Journal will pub¬ 
lish a limited edition of a book based 
on the symposium in mid-1984. 
The theme of the symposium was 
established in the first session with a 
PHOTOS BY SVI \ MAR ISON 
report of the clinical spectrum and 
treatment of Lyme disease by Dr. 
Steere, who is associate professor of 
medicine and principal investigator 
of the Lyme disease research at Yale. 
His report was followed by a history 
and comparison to Lyme disease of 
European erythema migrans disease 
disorders seen in Europe, by Dr. 
Klaus Weber, a dermatologist and 
allergist from Munich, West Ger- 
Germany. Dr. Stephen Malawista, 
professor of medicine and chief of the 
Section of Rheumatology, spoke on 
the implications of the Lyme disease 
study for research on other rheumatic 
diseases in a talk entitled “Lyme 
disease: a unique human model for 
an infectious etiology of rheumatic 
disease.” 
For the next two days, talks by 
leading investigators from throughout 
the United States, Germany and Scan¬ 
dinavia dealt with other related tick- 
borne disorders in Germany and Scan¬ 
dinavia; a description of Ixodes dam- 
mani, the tick vector of the disease; 
and an indepth study of the spirochete 
discovered last year to be the causative 
agent, and the host response to it. 
The final two sessions were devoted 
to epidemiologic studies of Lyme 
disease. Each talk was followed by 
lively discussion. 
Top left. Dr. Steere with Mrs. Polls Murray 
and Wilson Nolen. Mr. Nolen w as the major 
sponsor of the symposium. 
Left. Dr Willy Burgdorfer, Acting Chief. 
Epidemiology Branch of the National Institute 
of Allergy and Infectious Disease, center, first 
isolated the Lyme disease spirochete from Ixodes 
dammini ticks. 
Below, Dr. Klaus Weber with Dr. Gustav J. 
Dammin, professor emeritus. Harvard School 
of Public Health, for whom the lick. Ixodes 
dammini. is named. 
PROFILE 
THE CLASS OF 1987 
The 102 members of the Class of 1987 
arrived on Cedar Street early in Sep¬ 
tember looking slightly bewildered, 
but nevertheless ready to meet the 
challenges of the coming four years 
with the competence, humor and 
perseverance expected of students 
admitted to the Yale School of Medi¬ 
cine. The average age of the class is 
23; and their cumulative GPA scores 
average 3.63; twenty of the 68 men 
and 34 women represent minority 
populations. 
Almost a third of the students 
spent their undergraduate years in 
Ivy League colleges. Interestingly, 
more Harvard undergraduates applied 
(181) and were accepted (37), than 
Yale students (118 and 22), although 
11 from Yale and 10 from Harvard 
actually matriculated. Sixteen of the 
first year class have advanced degrees, 
including five Ph.D. degrees. 
Statistics aside, this class, as others 
before it, is impressive not only for 
the outstanding scholastic achieve 
ents of its members, but also for the 
wide diversity of academic back¬ 
grounds and extracurricular interests 
they represent. This is in keeping 
with an established trend in the School’s 
admissions policy, according to Dr. 
Thomas Lentz, assistant dean for 
admissions. 
Although the majority of students 
were science majors, there is variety 
even within their ranks, including 
those who concentrated in biology, 
engineering, chemistry, biochemistry, 
physics, or mathematics. Twenty-one 
members of the class majored in the 
humanities, while thirteen others stud¬ 
ied social sciences. Not without honor 
students, the class includes a Fulbright 
scholar, as well as those who received 
All-American Academic Awards and 
magna cum laude.summa cum laude, 
and Phi Beta Kappa honors. 
And there is talent — musicians 
who sing in choirs and glee clubs, and 
others who play the violin, cello, 
trumpet, guitar or flute in marching 
bands, symphony orchestras, and jazz 
and rock groups. Some are writers, 
including two published poets, a sci¬ 
ence writer and a medical editor; and 
members of the radio-television world, 
including a disc jockey, radio announ¬ 
cer, television producer and a director. 
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Every year in September, the Office of Student 
Affairs sponsors a picnic for first year students. 
A Iways a success, the picnic provides an oppor¬ 
tunity for new students, faculty and adminis¬ 
tration to meet informally. 
Some are dancers — modern, ballet 
and folk, while others have taken 
part in theatrical productions. 
Athletes in tne class have partici¬ 
pated in varsity track, swimming, 
soccer, tennis, crew and football 
including two students who are former 
stars of Yale teams in more victorious 
times. Others play baseball, squash 
and volleyball just for the fun of it. 
And there is one magician among the 
ranks, whose skills, in the final analy¬ 
sis, may be the envy of all from time 
to time during the next four years. 
LOME 
ACCREDITATION RENEWED 
The Yale University School of Medi¬ 
cine was visited for three days in 
March 1983 by a survey team repre¬ 
senting the Liaison Committee on 
Medical Education, which is jointly 
sponsored by the Association of 
American Medical Colleges and the 
American Medical Association 
Council on Medical Education. The 
purpose of the visit was to evaluate 
and accredit the program in medical 
education leading to the M.D.degree. 
As a result of this survey, the Liaison 
Committee on Medical Education 
voted to confer continuing full accredi¬ 
tation for ten years, the maximum 
length of time under the current 
rules. 
STUDENTS PRESENT LECTURE 
SERIES ON NUCLEAR ARMS 
The key to successful arms control 
talks lies in maintaining a continuity 
in the negotiations which thus far 
have been disrupted with each new 
presidential administration “trying 
to reinvent the wheel”, Paul Warnke 
told the large audience attending the 
final lecture in a series on the “Age of 
Nuclear Arms — a Medical Perspec¬ 
tive.” Warnke, the director of the 
U.S. Arms Control and Disarmament 
Agency during the Carter Administra¬ 
tion and chief negotiator for SALT 
talks in 1977 - 78, was received enthusi¬ 
astically by the audience which over¬ 
flowed Mary S. Harkness Auditorium. 
The series of twelve weekly lectures 
sponsored by the Office of the Dean 
and the Department of Internal Medi¬ 
cine, was organized by students to 
present future physicians with an 
understanding of the consequences 
of nuclear war, as well as the political 
and historical forces that underlie the 
current standoff. The course did not 
espouse any particular solution to 
the problem. 
“We believe this course embodies a 
progressive movement in Yale medical 
education — as future leaders of the 
medical profession, Yale medical stu¬ 
dents should be experts on issues that 
most threaten human health and well¬ 
being,” said Joshua Freedman, the 
second year student primarily respon¬ 
sible for organizing the series. 
“Further, because of their high stand¬ 
ing in the public image, physicians 
are empowered to help form a con¬ 
sensus on how best to prevent nuclear 
Armageddon.” 
Speakers included well-known lead¬ 
ers in the historical, technological, 
political and medical aspects of nuclear 
warfare. Gaddis Smith, Larned Pro¬ 
fessor of History, presented the first 
lecture, followed the next week by a 
highly informative two-hour talk on 
nuclear technology by Kosta Tsipis, 
co-director of the Program in Science 
and Technology at M.l.T. Dr. Jan 
Stolwijk, chairman of the Department 
of Epidemiology and Public Health; 
Dr. Robert Jay Litton, professor oi 
psychiatry; Dr. Richard Stahl, assis¬ 
tant professor of surgery, and Dr. 
Stuart Finch, a former member of 
the Yale faculty, who is now professor 
and chief of the Department of Medi¬ 
cine at Rutgers Medical School at 
Camden, were among the speakers. 
In addition to Mr. Warnke, the final 
lecture was to have included Eugene 
Rostow. The former director of the 
U.S. Arms Control Agency in the 
Reagan Administration was unable 
to participate due to illness. 
Students Joshua Freedman, Laura 
Kuckes and Jeremy Holtzman are to 
be commended for the superb organi¬ 
zation of this important lecture series 

















A crew from the School’s Physical Plant 
installed the gift oj Dr. Felix Marti-thane: in 
the Hope Building. 
GIFT OF DR. FELIX MARTI- 
IBANEZ IS DISPLAYED 
The impressive silk-screen of the title 
page of Andreas Vesalius’ De Humani 
Corporis Fabrica, recently installed 
in the Hope Building, is part of a gift 
of books and manuscripts from the 
estate of the late Dr. Felix Marti- 
Ibanez, founder and publisher of 
MD Magazine. Published in 1543, 
the Fabrica is one of the most impor¬ 
tant medical works of the Renaissance, 
blending perfectly anatomical skill, 
artistic design, and format. The tur¬ 
bulent scene represents a public ana¬ 
tomy conducted by Vesalius, who is 
surrounded by students, members of 
the church, representatives of nobility, 
and rectors of the University and 
City of Padua. Vesalius dissects and 
demonstrates from the body, dispens¬ 
ing with the demonstrators seen quar¬ 
reling among themselves under the 
table in the foreground. Other sym¬ 
bols and characters are depicted on 
the title page, which may be seen in 
its original edition in the Historical 
Library. 
DISTINGUISHED MEDICAL 
HISTORIAN IS SIXTH JOHN F. 
FULTON FELLOW 
Leonard G. Wilson, professor and 
head of the Department of History of 
Medicine at the University of Minne¬ 
sota, and former editor of The Journal 
of the History of Medicine and Allied 
Sciences, was named the John F. 
Fulton Fellow in the History of Medi¬ 
cine for 1983. During his visit to Yale 
in November, Dr. Wilson delivered a 
series of lectures and met with students 
and faculty for informal discussions. 
On November 4th, he delivered the 
Sixth Annual John F. Fulton Memo¬ 
rial Lecture entitled, “Internal Secre¬ 
tions in Disease; the Historical Rela¬ 
tions of Clinical Medicine and 
Scihysiology. ” The lecture, 
which was held in the Medical Histor¬ 
ical Library, was sponosored by the 
Beaumont Medical Club. 
The fellowship, named for the late 
Dr. Fulton, who was Sterling Pro¬ 
fessor of the History of Medicine and 
one of the founders of the Yale 
Medical Library, was endowed in 
1978 by Dr. Bern Dibner, director of 
the Burndy Library, Norwalk, Con¬ 
necticut. The Fellow is selected an¬ 
nually by a committee of the Beau¬ 
mont Medical Club. 
Illustration from the American Medicine Show 
25 Cents per Box. 
CUSHING ROTUNDA FEATURES 
THE “AMERICAN MEDICINE 
SHOW” 
“The American Medicine Show”, cur¬ 
rently on view in the Cushing Rotunda 
of the Yale Medical Library, provides 
a history of this unique American 
institution, from its European roots 
through its heyday, to current research, 
to document the phenomenon. 
The travelling patent medicine show 
pioneered the idea of sponsored enter¬ 
tainment in the United States and 
Canada by providing free concerts, 
vaudeville and Wild West shows as 
an inducement to buy Hamlin’s 
Wizard Oil, Kickapoo Indian Sagwa, 
and a host of other cure-alls. The 
shows declined in the 1930’s and 40’s, 
but not before spawning such famous 
entertainers as Red Skelton. 
Materials in the exhibition are lent 
from the collection of Wiliam H. 
Helfand, eminent collector and au¬ 
thority on the history of pharma¬ 
ceutical advertising and senior vice 
president of Merck Sharp and Dohme 
International. The exhibit was pre¬ 
pared by Mr. Helfand and Brooks 
McNamara, professor of performance 
studies at New York University and 
author of Step Right Up,a history of 
American Medicine Shows. The exhi¬ 
bition was designed by Donald Vlack, 
curator of the Museum of Performing 
Arts, Lincoln Center. Catalogues of 
the exhibit are available, tree of 
charge, in the Historical Library. 
The exhibit coincided with the 250th 
meeting of the Beaumont Medical 
Club, held on January 20, when Mr. 
Helfand and Professor McNamara 


































Members of the faculty have taken 
an active role in the growing field of 
organ transplantation. Dr. Gary Fried- 
laender, associate professor of surgery, 
was named interim president of the 
American Council on transplantation, 
a new national group formed by the 
U.S. Department of Health and 
Human Services to coordinate the 
efforts of private groups that now 
seek to match organ donors with 
recipients, as well as to educate the 
medical profession and the public 
about the need for more donors. In 
May, Dr. Friedlaender was elected 
president of the American Association 
of Tissue Banks. Both organizations 
are dedicated to the expansion and 
improvement of the present voluntary, 
non-profit system of procuring organs 
and tissues for transplantation. They 
strongly oppose their purchase or 
sale, citing the potential for jeopar¬ 
dizing recipient safety and creating 
an inequitable and inefficient distri¬ 
bution of transplants. 
As a Robert Wood Johnson Health 
Policy Fellow of the Institute of 
Medicine last year. Dr. Myron Genel 
was assigned to the Investigations 
and Oversight Subcommittee of the 
House of Representatives Committee 
on Science and Technology, and was 
largely responsible for organizing that 
committee’s Congressional hearings 
on organ transplantation. Subse¬ 
quently, he was extensively involved 
in the drafting of corrective legislation 
which culminated in the introduction 
of a National Organ Transplant Act. 
Dr. Genel, who is professor of pedia¬ 
trics, is director of the Children’s 
Clinical Research Center at Yale. 
In October, Yale-New Haven Hos¬ 
pital became the sixth hospital in the 
United States to perform liver trans¬ 
plants, when Dr. M. Wayne Flye and 
a team of physicians and nurses per¬ 
formed the surgery on a six-year old 
New Haven girl with life threatening 
liver disease. Dr. Flye, who is associate 
professor of surgery, and the support 
team Hew to Florida at 2:30 am to 
retrieve the liver from the body of a 
20-month old drowning victim, and 
completed the operation in New 
Haven by 11 am the same day. The liver 
began to function immediately and 
the little girl is making a satisfactory 
recovery. 
The National Kidney Foundation 
presented Dean Robert W. Berliner 
the 1983 David M. Hume Memorial 
Award. This award is the Founda¬ 
tion’s highest tribute to an individual 
in the field of nephrology. “Dr. 
Berliner has made a number of major 
contributions to the basic understand¬ 
ing of the kidney, including demon¬ 
stration of potassium secretion by 
the renal tubule, the fundamental 
concept that illustrates the way in 
which the kidney handles potassium. 
His accomplishments and dedication 
have established him as a spokesman 
for the scientific community at large 
regarding health issues,” said Dr. 
David Ogden, president of the Na¬ 
tional Kidney Foundation in presenting 
the award to Dean Berliner at the 
Foundation’s annual meeting on 
December 3rd. 
The Lawrence Berkeley Laboratory 
of the University of California, Berke¬ 
ley, invited Dr.Jan Stolwijk, chairman 
of the Department of Epidemiology 
and Public Health, to deliver the first 
Craig D. Hollowed Memorial Lecture 
on Indoor Air Pollution. Dr. Hollo- 
well, who was a senior scientist at the 
Laboratory, was internationally 
known for his research in indoor air 
quality, a field in which Dr. Stolwijk 
is also a leading authority. 
For its Bicentennial Meeting, the 
Society of the Cincinnati in the State 
of Virginia invited Dr. David Musto 
to participate in a symposium on 
historic peacemaking and peacekeep¬ 
ing in celebration of the bicentennial 
of the Treaty of Paris. At the meeting, 
which was co-sponsored by the Smith¬ 
sonian Institution and The American 
University, Dr. Musto spoke on “The 
Internalization of British Traits After 
the Peace.” Dr. Musto is professor in 
the Child Study Center (psychiatry) 
and the history of medicine. 
For his pioneering contributions to 
the understanding of erythrocyte mem¬ 
brane proteins, Dr. Vincent T.Mar- 
chesi was presented the 1983 Karl 
Landsteiner Memorial Award of the 
American Association of Blood 
Banks. In a ceremony held at their 
annual meeting in New York on 
November 1, the A ABB cited Dr. 
Marchesi’s studies which have 
“allowed new insights into the organi¬ 
zation of normal and abnormal mem¬ 
branes, and have provided a practical 
and powerful approach to assessing 
molecular abnormalities in certain 
inherited hemolytic diseases.” Dr. 
Marchesi is Anthony N. Brady Pro¬ 
fessor and chairman of the Depart¬ 
ment of Pathology, and professor of 
cell biology and biology. 
The Board of Directors of the Univer¬ 
sity of Puerto Rico has appointed 
Dr. Caleb Gonzalez visiting professor 
of ophthalmology; and in ceremonies 
held on November 18, he was honored 
as “Distinguished Alumnus” of the 
In ter-American University-Poly 
Alumni Association. In addition. Dr. 
Gonzalez, who is professor of ophthal¬ 
mology and visual science, was selec¬ 
ted as Special Guest at the annual 
convention of the Section of Opthal- 
mology of the Puerto Rico Medical 
Association. 
Dr. John McL.Morris was recently 
named the Verstandig Distinguished 
Visiting Professor of Tennessee Center 
for the Health Sciences. Dr. Morris, 
who is John Slade Ely Professor of 
Obstetrics and Gynecology, is well- 
known in the fields of women’s health, 
birth control and gynecological 
cancer. 
The Embryology section of Dr Frank 
Netter’s new book, “Nervous System, 
Part I Anatomy and Physiology”, 
was prepared in collaboration with 
Dr. Edmund S. Crelin, professor of 
anatomy. The volume is a part of The 
Ciba Collection of Medical Illus¬ 
trations. 
Three members of the Department of 
Surgery have been elected to offices 
in professional organizations. The 
Society of Neurological Surgeons 
(Senior Society) appointed Dr. 
William CoIlins,Harvey and Kate 
Cushing Professor of Surgery (neuro¬ 
surgery), president-elect. Dr. Irshad 
Chaudry, senior research scientist, 
was elected to the Executive Council 
of the Shock Society; and Dr. Wayne 
Southwick, professor of surgery (ortho¬ 
pedics), was recently appointed vice- 
president of the American Ortho¬ 
paedic Association. 
Dr. Charles M. Raddingand Dr. Uta 
Francke attended the International 
Congress of Genetics held in New 
Delhi, India in December. Dr. 
Radding, who is professor of human 
genetics and molecular biophysics 
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and biochemistry, spoke on “The 
recombination mechanism of rec A 
protein.” Dr. Francke’s talk was on 
gene mapping on human and mouse 
chromosomes. She is associate pro¬ 
fessor of human genetics and 
pediatrics. 
Dr. Sidney Blatt, professor of psychol¬ 
ogy and psychiatry, was elected a 
Distinguished Practitioner of the 
National Academies of Practice. Dr. 
Blatt was cited for his contributions 
to the study of depression and 
schizophrenia. 
NEW BOOKS BY FACULTY 
“Osteochondral Allocrafts: Biology, 
Banking, and Clinical Applications.” 
By Gary E.Frieddlaender,M.D.,<mo- 
ciate professsor of surgery (ortho¬ 
pedic); Henry .(.Mankind, M.D.,and 
Kenneth W.Sell, M.D. Little, Brown 
and Company (Boston) 1983. 403 pp. 
illus. 
“Laboratory Medicine in Clinical 
Practice.” Edited by Harvey N. Man- 
dell, M.D..associate clinical professor 
of medicine; and Margaret Johnson 
Bia, M.D. .associate professor of medi¬ 
cine. John Wright - PSG Inc. (Little¬ 
ton, MA)1983. 432 pp, illus. 
“The Origins of Anesthesia” by Dr. 
Sherwin B.Nuland,associate clinical 
professor of surgery, has been pub¬ 
lished for the members of The Classics 
of Medicine Library, Division of 
Gryphon Editions, Ltd., Birmingham, 
Alabama. Dr. Nuland has prepared 
an introduction to this volume, com¬ 
mentary which precedes the presenta¬ 
tion of each historical paper, and an 
extensive bibliography. The excerpts 
and illustrations contained in this 
volume were furnished to the publisher 
courtesy of the Yale Medical Library. 
ALUMNI NEWS 
1927 
On October 16, Harry Zimmerman 
was a guest of honor at a dinner 
which initiated the celebration of 
Montefiore's Centennial Year to com¬ 
memorate the hospital’s founding in 
1884. Dr. Zimmerman, who is a 
member of Montefiore Medical Cen¬ 
ter Staff and Alumni Association 
executive committee and principal 
scientific advisor to the Centennial 
Committee is a consultant in path¬ 
ology at Montefiore and professor of 
pathology emeritus at the Albert Ein¬ 
stein College of Medicine. 
1932 
Conrad Lam and his wife, Marian, 
were honored recently at a farewell 
reception on the occasion of Dr. 
Lam's retirement after 50 years of 
service at Henry Ford Hospital in 
Detroit, Michigan. Among the letters 
of recognition which were presented 
to Dr. Lam at the reception were 
those from President and Mrs. Ronald 
Reagan, Michigan’s Governor James 
Blanchard, U.S. Congressman Carl 
Levin, Senator Don Riegle, Mayor 
Coleman Young, Henry Ford II, and 
Stan Nelson, Hospital executive vice- 
president. 
The reception was attended by 
colleagues from the Division of 
Cardiac and Thoracic Surgery, other 
physicians and HFHers, according 
to an account published in the Henry 
Ford Hospital Weekly Newsletter. In 
addressing his remarks to Dr. Lam, 
Dr. Donald Magilligan. Jr..head of 
Cardiac and Thoracic Surgery said, 
“Dr. Lam, you will be remembered 
by your accomplishments at HFH — 
8,500 operations and 207 articles 
in addition to being one of 10 world 
pioneers in cardiac and thoracic sur¬ 
gery ... T his gathering is a very small 
way to say 'thank you' for what 
you’ve contributed to HFH. You 
make us all feel very proud.” 
He also announced a special tribute 
to Dr. Lam that will continue year 
after year. The Annual Conrad R. 
Lam Lectureship of Cardio Thoracic 
Surgery, a new yearly lecture series, 
is to be sponsored by the Division of 
Cardiac and Thoracic Surgery and is 
scheduled to begin in 1984. The inau¬ 
gural speaker will be Dr. Denton 
Cooley of the Texas Heart Institute. 
In expressing his appreciation. Dr. 
Lam said .“This has been great. I owe 
much to everybody here. 1 only wish 
that all of you could have been with 
me in medical school at Yale Univer¬ 
sity in 1931. Right before 1 came to 
HFH, I was told 'Conrad, you're 
wasting your time taking the exams 
to work at H FL - you’ll never make 
it.' That was a long time ago. Now', 
maybe I rate a place on the wall”, he 
said, pointing to the portraits of 
noted Henry Ford Hospital physicians 
which hang on the walls of the Staff 
Dining Room. 
1933 
The first of the Annual Robert W. 
Huntington, Jr. Lecture Series was 
presented by Dr. George Lundberg, 
editor of the JAMA, at Kern Medical 
Center in California on November 4 
and 5. The lecture series was named 
in honor of Robert W. Huntington 
who, for twenty-five years in the 
Kern County Service pursued his 
interests in coccidioidomysis, neo¬ 
plasms and forensic pathology. 
1949 
In July it was announced that the 
616-bed patient care towers and cen¬ 
tral core of the North Division of 
Duke University Hospital have been 
named the Anlyan Tower in honor of 
William Anlyan, chancellor for health 
affairs and senior administrative offi¬ 
cial Duke University Medical Center 
since 1964. In his announcement, 
Duke University President Terry San¬ 
ford noted that “naming the tower 
for Dr. Anlyan honors a man who is 
a national leader in medicine and in 
medical administration. He has kept 
Duke on the cutting edge of medical 
research and practice. He inspired 
the extraordinary Duke North Hospi¬ 
tal and led the University through the 
challenge of its construction. He is 
the principal figure in Duke Hospital’s 
greatest expansion, which this build¬ 
ing represents.” 
1951 
Daniel Freedman is now Judson 
Braun Professor of Psychiatry and 
Pharmacology and director of the 
Division of Adult Psychiatry and 
vice chairman. Department of Psy¬ 
chiatry at the University of Califor¬ 
nia at Los Angeles. 
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1952 
Harvey Young wrote recently of his 
two new responsibilities: “1 have 
started my first of three years as a 
member of the Board of Trustees of 
the Pacific School of Religion in 
Berkeley, California. It is the oldest 
seminary in the West, having been 
founded in 1866. 1 have attended the 
first meeting of the Board and am 
sure 1 shall enjoy the challenge and 
the responsibilities of membership. 1 
have also started back into organized 
medicine. 1 was elected as vice speaker 
of the House of Delegates of the 
Washington State Medical Associa¬ 
tion in September. 1 am committed 
to four years, the last three as speaker 
of the House of Delegates. So 1 am 
not suffering from an excess of free 
time.” 
1955 
William Edward of Albuquerque, 
New Mexico, has been elected to the 
Board of Governors of the Associa¬ 
tion of Yale Alumni for a three-year 
term 
1956 
In a recent message, Hawaii’s Gover¬ 
nor George Ariyoshi extended “on 
behalf of the people of Hawaii, our 
deepest appreciation to Dr. William 
H. Kindle f or his dedicated service 
and leadership as a member and 
chairman of the Commission on Pop¬ 
ulation and the Hawaiian Future.” 
Dr. Hindle was a member of the 
Temporary Commission on Popula¬ 
tion Stabilization in 1971 whose work 
led to the establishment in 1973 of the 
Commission on Population and the 
Hawaiian Future; in 1974, he began 
serving as a member on that commis¬ 
sion and in 1975 was appointed by 
Governor Ariyoshi to the chairman¬ 
ship, a position he has held for the 
past eight years. 
The citation further states: “Dr. 
Hindle’s eminently sound guidance 
of the commission’s work has helped 
to increase community understanding 
of, and concern for, the serious im¬ 
pacts of population pressures and the 
vital need for population planning 
and growth management to protect 
the limited resources and fragile envi¬ 
ronment of our island state.” 
With the fulfillment of its mandate 
and on its own request, legislation 
was passed terminating the commis¬ 
sion as of July 1,1983; its functions of 
population planningand management 
will be absorbed by the Department 
of Planningand Economic Develop¬ 
ment. 
A note received from Dr. Hindle in 
October stated that he has been elected 
president-elect of the Hawaii Medical 
Association and that he has served 
for six years as treasurer of the 
H.M.A. 
1959 
Ronald DeConti wrote recently that 
he became professor of medicine at 
Albany Medical College and chief of 
oncology at the Albany Veterans 
Administration Medical Center Hos¬ 
pital as of September 1. Dr. DeConti 
left Yale in 1974 to become director 
of oncology at Springfield (Massa¬ 
chusetts) Medical Center, now known 
as Bay State Medical Center, and 
from 1980 served there as acting chief 
of the combined Hematology/Oncol¬ 
ogy Section until he left for his new 
position in Albany. 
1962 
David Gelfand was named a fellow 
of the American College of Radiology 
in recognition of his outstanding per¬ 
formance in medicine. He was so 
honored at the annual meeting of the 
College in Denver in September. He 
is affiliated with North Carolina 
Baptist Hospital in Winston-Salem. 
1964 
Diane Shrier has been awarded the 
Exceptional Merit Award for 1982-83 
by the University of Medicine and 
Dentistry of New Jersey. This award, 
which recognizes those members of 
the faculty who achieve a level of 
productivity and excellence which 
substantially exceeds accepted stan¬ 
dards, was also awarded to Dr. Shrier 
for 1980-81. Dr. Shrier is clinical 
associate professor of psychiatry and 
pediatrics and director of child and 
adolescent psychiatry at New Jersey 
Medical School (Newark) of the Uni¬ 
versity of Medicine and Dentistry of 
New Jersey. 
1965 
Robert Cohn wrote in August that 
since 1978, he has been associate 
director of the Clinical Laboratories 
at the Children’s Hospital of Phila¬ 
delphia and is a member of the 
Division of Metabolism of the Depart¬ 
ment of Pediatrics. 
His second book,“Metabolic Dis¬ 
ease: A Guide to Early Recognition”, 
co-authored with Karl Roth of the 
Medical College of Virginia was pub¬ 
lished by Saunders in May, 1983. A 
previous book, “Principles of Meta¬ 
bolic Control in Mammalian Sys¬ 
tems”, co-edited by R.Herman, R. 
Cohn and P. McNamara, was pub¬ 
lished by Plenum in 1980. 
He also wrote that since graduating 
in 1965, he has taken great pride in 
the continued progress at Yale Medical 
School and especially looks forward 
to interacting with graduates who 
come to Children's from Yale to 
continue their training. 
Mohandas Kini has been elected presi¬ 
dent of the Massachusetts Society of 
Eye Physicians and Surgeons and 
chairman of the Section on Ophthal¬ 
mology of the Massachusetts Medical 
Society. Dr. Kini, who resides in 
Wakefield with his wife, Joanne and 
theirfourchildren, practices ophthal¬ 
mology in Boston. He is director of 
Retina Services and a consulting sur¬ 
geon in ophthalmology at University 
Hospital, which is a teaching affiliate 
of the Boston University School of 
Medicine. 
David Kupfer, professor of psychiatry 
at the U niversity of Pittsburgh School 
of Medicine since 1975 and director 
of the Mental Health Clinical Re¬ 
search Center for Affective Disorders 
at Western Psychiatric Institute and 
Clinic since 1977, has been appointed 
chairman of the Department of Psy¬ 
chiatry at the University of Pittsburgh 
School of Medicine. Dr. Kupfer has 
received a number of honors during 
his career including the 1975 A.E. 
Bennett Research Award in Clinical 
Science, the 1977 Anna Monika Foun¬ 
dation Award for Research in De¬ 
pression, and the 1979 Daniel H.Efron 
Award. He is on the editorial boards 
of several publications and has written 
more than 150 articles on affective 
states, sleep, and psychopharmacology. 
1966 
Reynold Spector has been elected to 
membership in the Association of 
American Physicians. He is professor 
of medicine and pharmacology at the 
University of Iowa College of Med¬ 
icine where he serves as director of 
the Divisions of General Medicine 
and Clinical Pharmacology. During 
the current academic year. Dr. Spector 
is a visiting professor of biochemistry 
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at Stanford University. 
Richard Yules is the author of a new 
book, “The Pilot’s Complete Medical 
Guide”, an authoritative and up-to- 
date guide which discusses medical 
problems that affect Hying capability, 
physical and mental fitness, common 
sensory misperceptions and physical 
reactions to altitude and flight pheno¬ 
mena. 
Dr. Yules is a colonel and senior 
flight surgeon in the Air National 
Guard, USAF, and a senior FAA 
medical examiner and crash investi¬ 
gator. In 1976, he was named U.S. 
Flight Surgeon of the Year. He has 
written, in addition to four medical 
books, more than forty articles on 
aerospace medicine. Dr. Yules prac¬ 
tices otolaryngology and facial plastic 
surgery in Worcester, Massachusetts. 
1967 
Stephen Schimpff has been appointed 
director of the University of Maryland 
Cancer Center at the University of 
Maryland School of Medicine and 
Hospital in Baltimore. 
1968 
Ralph Greco, chief of the Section of 
General Surgery and the Division of 
Surgical Oncology at Rutgers Medical 
School, has been promoted to pro¬ 
fessor of surgery. He is also chief of 
General Surgery and Surgical Onco¬ 
logy at Middlesex General-University 
Hospital in New Brunswick. Dr. Greco 
completed his residency at Yale in 
1973. After two years of military 
service, he joined the Rutgers faculty 
as an assistant professor in 1975, and 
in 1979 was promoted to associate 
professor. 
Dr. Greco has published widely in 
the area of surgical immunology. He 
is doing research on the biochemical 
bonding of antibiotics to surgically 
implantable devices and is also a 
participating principal investigator 
in the National Surgical Adjuvant 
Project for Breast and Bowel Cancer. 
On September 1st, Elizabeth Short 
joined the staff of the Association of 
American Medical Colleges as director 
of the Division of Biomedical Re¬ 
search and Faculty Development and 
deputy director of the Department of 
Academic Affairs.She will be respon¬ 
sible for monitoring biomedical re¬ 
search policy issues and working with 
the AAMC’s Council of Academic 
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Societies member societies to advance 
biomedical research and faculty 
development. 
Gordon Sasaki, who is assistant pro¬ 
fessor of surgery (Division of Plastic 
Surgery) at University of Southern 
California School of Medicine was 
awarded The Robert H. Ivy Award 
of the American Society of Plastic 
and Reconstructive Surgeons at their 
November meeting in Dallas. 
The Award, made annually for the 
outstanding scientific presentation of 
the year, is for his presentation at the 
Society’s 1982 meeting in Honolulu, 
Hawaii. His paper, “Pathogenesis 
and Treatment of Infant Skin Straw¬ 
berry Hemangiomas: Clinical and in 
vitro Studies of Hormonal Effects”, 
is to be published in the March 1984 
issue of Plastic anti Reconstructive 
Surgical Journal. 
1969 
David Upton wrote recently that he 
has written a new book, “Mental 
Health Care and National Health 
Insurance - A Philosophy of and an 
Approach to Mental Health Care for 
the Future” and that he is currently 
engaged in writing a textbook on 
psychotherapy and a book on the 
psychological aspects of hospital care. 
Dr. Upton, who resides in Alexandria, 
Virginia, formerly served as consultant 
to the United States Senate Veterans 
Affairs Committee; was consultant 
to the Los Angeles County Commun¬ 
ity Mental Health Center Systems; 
and has held the position of chief of 
psychiatry at the United States Army 
Mental Health Clinic at Fort Belvoir, 
Virginia. 
1970 
A novel by Robert Litman entitled 
“Wynnefield and Limer” has recently 
been published by the Ivy League 
Press, Inc. Of Arlington, Virginia. 
This story about a young doctor and 
his fight to overcome great adversity 
should have wide appeal. The author, 
a family physician in Ogdensburg, 
New York, is a member of the medical 
staff of the A. Barton Hepburn 
Hospital and is currently president of 
the Northern New York Chapter of 
the American Heart Association. 
1971 
On October 5, Ralph Kirmser received 
the 1983 Magida Award presented by 
the Richard and Hilda Rosenthal 
Foundation of Stamford, Connecti¬ 
cut. Dr. Kirmser, an internist in 
Norwalk, was cited for demonstrated, 
notable capability in patient treatment 
and care. The Magida Award was 
established in 1979 by the Rosenthal 
Foundation to honor the late Dr. 
Melville Magida of Stamford and his 
qualities as a concerned and outstand¬ 
ing physician. 
Dr. and Mrs. Kirmser and their 
three children reside in Wilton. 
HOUSE STAFF 
1946 
John McGovern was recently honored 
by the American School Health Associ¬ 
ation by being awarded the William 
A.Howe Award, the Association’s 
highest tribute, at its annual conven¬ 
tion in Louisville, Kentucky. Dr. 
McGovern was cited for his enduring 
advocacy of, and meritorious contri¬ 
butions to, the health of the nation’s 
children and youth. 
1948 
David Hamburg is president-elect of 
the American Association for the 
Advancement of Science (AAAS) 
and is scheduled to assume office as 
president at the annual meeting in 
May 1984. Dr. Hamburg served as 
president of the Institute of Medicine 
of the National Academy of Sciences 
for a five-year term beginning in 
1975. In 1980, he moved to Harvard, 
where he founded a new Division of 
Health Policy Research and Educa¬ 
tion. He assumed his present position 
as president of the Carnegie Corpora¬ 
tion in January 1983. Since moving 
to the Carnegie Corporation, he has 
given considerable attention to the 
problems of conflict between groups 
and nuclear war. 
1957 
Herman Kamenetz, chief of Rehabili¬ 
tation Medicine at the Veterans Ad¬ 
ministration Medical Center in Wash¬ 
ington, D.C., wrote at the end of July 
that he would be retiring “in a few 
days and it is a particular joy for me 
that Nessan McCann (HS 66), will 
take over my position at this Medical 
Center.” 
Have we heard from you recently? 1961 
Chase Peterson took office as presi¬ 
dent of the University of Utah on 
August 1, 1983. He was formerly vice 
president for health sciences and be¬ 
came nationally known last winter as 
spokesman for the University of Utah 
medical team when Barney Clark 
struggled to live with an artificial 
heart. 
1962 
Samuel Heilman is now physician- 
in-chief at the Memorial Sloan-Ket- 
tering Cancer Center in New York 
City. 
1966 
“Your Aching Back: A Doctor’s Guide 
to Relief” by Augustus A.White III, 
has been published by Bantam Books 
of New York City. Dr. White is professor 
of orthopedic surgery at the Harvard 
Medical School and chief orthopedic 
surgeon at the Beth Israel Hospital in 
Boston. In this well illustrated paper¬ 
back volume written for backache 
sufferers. Dr. White provides a great 
deal of valuable information and also 
gives answers to questions frequently 
asked by his patients. As he notes in 
the introduction, “I'm writing this 
book to tell those of you with back 
problems what scientific and clinical 
research has substantiated to be true 
about backache.” It is a book which 
should be helpful to physicians and 
patients alike. 
Nessan McCann has been named the 
new chief of Rehabilitation Medicine 
at the Washington, D.C. Veterans 
Administration Medical Center, ac¬ 
cording to a letter received from 
Herman Kamenetz (HS 57), his pre¬ 
decessor. 
1970 
Robert Resnik has been named chair¬ 
man of the Department of Reproduc¬ 
tive Medicine at University of Califor¬ 
nia at San Diego. 
1979 
Robert Shoen has joined Dr. James 
Kenney and Dr. Charles DiSabatino, 
Jr. in the private practice of internal 




Gregory Belok and his wife, Diane, 
are the proud parents of a son Arie 
Chaim Belok, born on June 25, 1983. 
Dr. Belok wrote in July, but his news 
was received too late to appear in the 
summer issue of Yale Medicine. 
IN MEMORIAM 
Robert F. Zimmerman, M.D 
June 30, 1983 
ex med’31 
Donald R. Mills 
August 2, 1983 
M D.’34 
Frederic E. Houghton 
November 23, 1979 
ex med’37 
Hugh H. Butler 
July 4, 1983 
M.D.’41 
Edwin I). Murphy 
September 20, 1983 
M.D.’43 
(March) 
Richard K Gershon 
July II, 1983 
M.D.’59 
Stuart J. Brill M.D.’68 
August 15,1983 
1976 
Leon Speroff, professor and chairman 
of the Department of Obstetrics and 
Gynecology at Oregon Health Sci¬ 
ences University School of Medicine, 
has been appointed professor and 
chairman. Department of Repro¬ 
ductive Biology, Case Western Re¬ 
serve University School of Medicine 
Have you received a special honor or 
award? Have you been elected to office 
in a professional society? Have you 
travelled in a foreign country and/or 
participated in an international semi¬ 
nar? Are you working in a particularly 
interesting, unusual area? 
If you have news about yourself or 
about your classmates, please send 
items to the Editor, Yale Medicine, 333 
Cedar Street, New Haven, Connecticut 
06510. The Alumni News section wel¬ 
comes news from medical alumni, pub¬ 
lic health alumni and former house 
staff. 
1984 ALUMNI WEEKEND 
JUNE 7, 8 and 9 
PLAN NOW TO ATTEND! 
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1982 -1983 ALUMNI FUND REPORT 
FUND OFFICERS 1982-83 
MEDICAL SCHOOL ALUMNI FUND 
Lowell 1. Goodman '51, Chairman 
Malvin F. White '39, Vice Chairman 
William K. McClelland '47, Vice Chairman 
John L. Cieply 71, Vice Chairman 
J. Roswell Gallagher '30, 
Bequest $ Endowment Co-Chairman 
Samuel D. Kushlan '35 
Bequest & Endowment Co-Chairman 
Samuel D. Kushlan '35 
Chairman, Former House Staff 
EPIDEMIOLOGY AND PUBLIC HEALTH ALUMNI FUND 
Kathleen H. Howe '56, Co-Chairman 
Samuel B. Webb, Jr. '63, Co-Chairman 
A Message from the Dean 
Once again the Medical School Alumni Fund has set a 
phenomenal new record with contributions totalling 
$449,065. Chairman Lowell Goodman and the many 
volunteers who have worked with him deserve 
congratulations and our sincere appreciation for this 
remarkable achievement. 
This past year our loyal alumna, Leona Baumgartner, 
established a second challenge gift for new and increased 
contributions; this undoubtedly provided incentive for the 
growth in annual giving. The Fund also received two large 
gifts to the Endowment. In addition to these three major 
gifts, I was greatly encouraged to learn that 28 of our 
graduates made contributions of $1000 or more. Medical 
alumni participation this year was 50 percent. 1 want to 
thank each of you who contributed to the 1982-83 
campaign and urge you to continue your support during 
the years ahead. 
As I have noted previously, money for student financial 
aid continues to be a high priority of this School. As in 
previous years, your Medical School Alumni Fund 
contributions will be added to the Student Revolving 
Loan Fund and thus enable us to provide additional 
loans. 
I he students and faculty of the School of Medicine join 
me in thanking you for your interest and support. 
Robert W. Berliner 
Message from the Medical School Alumni Fund 
Chairman 
The Medical School Alumni Fund again broke all 
previous records and I thank each and every one of you 
who helped to make the 1982-83 such an outstanding 
success. Final receipts were $449,065 an increase of 51% 
over the amount received in 1981-82. This total includes 
dollars earned from the Baumgartner Challenge awards, 
earned income and two large gifts to the endowment 
program. J he number of contributions from alumni, 
former house staff, parents and friends rose to 1,889; 
alumni participation increased to 50%. 
In January after the Medical School Alumni Fund and 
the Public Health Alumni Fund earned the entire $75,000 
Baumgartner Challenge, Leona Baumgartner '32 Ph.D., 
'34 M.D., generously provided an additional challenge of 
$50,000 for new and increased gifts for the School's 
student loan program. 
The challenge awards, and the interest and efforts of the 
vice chairmen, the class agents, reunion phonathon 
volunteers, and student telephoners all provided the 
momentum that made our campaign so successful. 
I appreciate everyone’s support and I am confident our 
program will continue its upward swung. 
Lowell 1 Goodman '51 
Message to Public Health Graduates and Friends 
Money raised by the Public Health Alumni Fund is used 
for the Department’s student financial aid program. Each 
year the support received from EPH alumni and friends is 
an indication not only of their loyalty, but also shows 
their awareness of the financial crisis facing today’s Public 
Health students. 
We want to thank everyone who helped us to achieve 
our goal with a grand total of $36,572. A very special 
acknowledgment goes to Dr. Leona Baumgartner w ho 
provided us with two generous challenge awards. These 
incentives continue to have a great impact on the level of 
giving and the number of contributors. We look forward 
to another, even more, successful year. 
Jan A. S. Stolwijk 
Kathleen H. Howe 
Samuel B. Webb, Jr. 
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1922 Edward T. Wakeman 286 56 561 56 
1923 William Cohen 760 71 634 57 
1924 Myron A. Sallick 2,195 63 2,400 
( 118,000) 
63 
1925 Alice A. S. Whittier 945 73 805 67 
1926 Maxwell Bogin 522 58 671 50 
1927 Henry Irwin Fineberg 1,105 53 1,229 47 
1928 Max Alpert 2,297 68 2,795 79 
1929 Paul F. McAlenney 1,829 79 1,572 71 
1930 J. Edward Flynn 5,343 58 3,800 65 
1931 Michael D’Amico 1,687 68 1,373 44 
1932 Henry Brill 4,384* 64 1,045 43 
1933 Franklin M. Foote 2,133 57 5,399* 76 
1934 Dewitt Dominick 2,333 72 
John B. Ogilvie - — 2,703 50 
1935 James Q. Haralambie 2,978 52 2,276 52 
1936 George A. Hahn 2,672 44 3,275 35 
1937 David Dolowitz 1,623* 50 1.590 53 
1938 Nelson Ordway 1,095 52 2,630* 60 
1939 Rebecca Z. Solomon 1,795 53 3,020 53 
1940 James F. Ferguson 2,555 64 4,369 69 
1941 Charles B. Cheney 2,260 100 3,331 59 
1942 Walter J. Burdette 16,672* 55 1,789 55 
1943 A Jonathan Lanman 2,070 54 10,107* 64 
1943B S. Brownlee Brinkley 2,028 52 4,419* 57 
1944 Nicholas P. R. Spinelli 4,615 65 7,086 67 
1945 Richard W. Breck 3,360 64 3,590 58 
1946 Julian A. Sachs 6,542 49 _ _ 
1946A Charles S. Judd, Jr. — — 4,702 59 
1946B Thomas J. Whelan, Jr. — — 2,388 73 
1947 William Roy Breg 6,143* 68 4,320 61 
1948 Paul Koehler 3,905 62 8,141* 66 
1949 Daniel Elliott 5,516 56 4,169 58 
1950 David Frucht 2,814 56 3,688 62 
1951 Lowell I. Goodman 5,276 52 5,515 50 
1952 Harvey L, Young 4,873* 49 3,845 43 
1953 Vincent Lynn Gott 3,908 47 4,950* 59 
1954 John K. Rose 5,267 68 6,172 80 
1955 Robert A. Kramer 4,443 52 5,748 53 
1956 John H. Gardner III 4,070 33 4,925 53 
25 
MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION 








1957 William J. Waskowitz 9,291* 79 _ _ 
I957A Ronald H. Fishbein — — 3,320 63 
I957B Howard Minners — — 3,160 67 
1958 Charles A. Hall, Jr. 5,370 59 _ 
I958A Charles A. Hall, Jr. — — 4,525* 71 
I958B Paul A. Rudnick — — 6,025* 71 
1959 Asa Barnes, Jr. 6,665 62 _ _ 
I959A Asa Barnes, Jr. — — 3,210 58 
I959B Muriel D. Wolf — — 3,825 66 
I960 Thomas P. Kugelman 3,495 40 _ _ 
I960A Roland H. Ingram — 4,555 48 
I960B Thomas P. Kugelman - — 3,995 53 
1961 Jon D. Dorman 2,580 35 _ _ 
1961A Earl L. Baker — — 2,815 72 
1961B John R.Woodward — — 1,830 39 
1962 A. Richard Pschirrer $11.849* 65 _ _ 
I962A A. Richard Pschirrer — — 3,600 63 
I962B Frank R. Hartman — — 1,190 31 
1963 Craig H. Llewellyn 4,990 52 5,770* 49 
1964 William J. Houghton 4,390 60 _ _ 
1964A William J. Houghton — — 2,440 55 
I964B William B. Pratt — — 3,350 74 
1965 David A. Hill 4,425 49 5,710 54 
1966 Mary Alice Houghton 2,923 52 _ — 
1966A Mary Alice Houghton — — 2,270 79 
I966B Henry B. Mann — — 1,410 46 
1967 James Dowaliby 9,170* 70 _ _ 
1967 A James Dowaliby — — 1,940 67 
I967B John A. Drews — — 3,025 60 
I968A Frank E. Lucente 2,760 46 3,130* 67 
I968B Donald Lyman 3,233* 
( 20,000) 
66 
1969 Lee Merrill Jampol 6,888 67 7,436 61 
1970 James R. Missett 2,001 36 2,795 42 
1971 John L. Cieply 4,046 47 — 
1971A John L. Cieply — — 3,117 59 
1971 B Barbara K. Kinder — — 3,145 57 
1972 Paul A. Lucky 3,709* 54 3,208 53 
1973 David N. Bailey 2,273 44 — — 
1973 A David N. Bailey — — 2,029* 54 
I973B Lynne M. Liptay — — 1,680* 53 
1974 Peter J Buchin 710 26 2,155 32 
1975 Daniel Passeri 701 24 — — 
I975A Daniel Passeri — 488 28 
I975B Mary Jane Minkin — — 445 22 
1976 Robert F. Taylor 873 27 1.325 26 
1977 David Kreis 1.575* 30 — — 
1977A David Kreis 620 22 
I977B Ronald J. Vender — — 731 36 
1978 Duke Cameron 1.467 23 — — 
I978A Duke Cameron — — 775* 31 
I978B Kendrick E. Lee 
•Reunion 
— 140* 10 
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YEAR (S) AGENT 1981-1982 1981-82 1982-83 1982-83 
TOTAL % PART. TOTAL % PART. 
1979 Barbara Peters 640 20 — — 
1979 A Michael R. Hausman — — 275 21 
I979B Laurie Smaldon — — 495 17 
1980 A Eduardo Alfonso 225 15 453 23 
1980B Mark Bernhardt 317 18 395 18 
1981 Anthony Urbano 365 15 665 13 
1982A Muriel Cyrus _ _ 10 4 
1982B Jed B. Gorlin — — 50 15 
1982C Lynn T. Tanoue — — 45 7 
Alumni 224,432 48 377,120 50 
Former House Staff 6,863 21 8,053 18 
Parents and Friends 9,858 13,589 
Interest and Miscellaneous Gifts 13,393 10,492 
Baumgartner Match 42,183 39,811 
$296,729 42% $449,065 42% 
PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION 
1923-41 Kathleen Howe $4,258 56 $2,844 53 
1942 Eric W. Mood 430 50 550 50 
1943 Eric W. Mood 450 50 390 36 
1944 Eric W. Mood 345 44 295 33 
1945 — 180 38 120 31 
1946 — 25 1 1 35 22 
1947 250 39 290 39 
1948 3,085 44 
Elizabeth D. Robinton 720 33 
1949 495 26 
Elizabeth L) Robinton 490 33 
1950 Eric W. Mood 905 61 723 52 
1951 Leonard F. Menczer 455 35 635 48 
1952 Yolande F. Lyon 700 39 730 39 
1953 Milton H. Sisselman 615 40 735 40 
1954 Ruth M. Taber 1 10 24 120 29 
1955 Frances R. Ogasawara 305 33 390 43 
1956 710 21 
David D. Boyd 352 32 
1957 Edward R DeLouise 602 43 422 52 
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1958 Thomas T. Flynn 300 14 825 21 
1959 Dorothy M. Wilson 915 39 535 33 
1960 Hannah Clark Russell 400 33 565 33 
1961 Gordon R. Beem 665 59 410 45 
1962 A. Kay Keiser 105 31 70 23 
1963 David Dolins 550 43 650 38 
1964 Estelle Siker 1.310 54 1,025 50 
1965 Michael E. Kove 
H. Patterson Harris 
430 38 
540 31 
1966 Allen Cohen 470 34 200 10 
1967 James M. Malloy 790 26 1,260 28 
1968 Arnold Saslow 1,300 32 1,420 46 
1969 Samuel P. Korper 940 26 820 28 
1970 Susan W. Balter 1,125 31 1,330 27 
1971 John Bihldorff 1,360 49 1,500 42 
1972 Daphne DeJ Gemmill 715 36 650 27 
1973 Judith G. Beatrice 600 19 965 22 
1974 Elizabeth Helming 290 32 345 36 
1974B Abigail L. Smith 315 39 395 48 
1975 Linda K. Broker 1,321 41 1,666 39 
1976 Elaine P. Anderson 1,297 43 890 36 
1977 Carroll Shilling 1,223 33 960 30 
1978 Richard C. Poole 1.074 33 1,400 35 
1979 Ralph Tartaglione, Jr. 1,315 39 1,315 40 
1980 Christina P. Quinn 880 34 665 25 
1981A Diane E. Goren 435 31 390 17 
B Jill Goldwater 105 15 255 27 
I982A Michelle Visconti _ _ 121 12 
B Amy B. Wilson — — 199 23 
Alumni $34,149 37% $31,532 33% 
Interest and Miscellaneous Gifts 3,984 1,262 
Baumgartner Match 10,667 3,778 
Public Health Alumni Fund Total $48,800 37% $36,572 33% 
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Yale School of Medicine 
1982-1983 Contributors 
1903 
Robert L. Rowley* 
1906 
Charles R. Mitchell* 
1908 
Michael A. Parlato* 
1912 
Walter C. Tilden* 
1913 
Ralph E. Taylor* 
1919 




Ella W. Calhoun 
1922 
Benedict R Harris 
Chester E. Hurwitz* 
Helen P. Langner 
Reginald T. Lombard 
Maurice F. O'Connell 





Julius A. Olean 
Hyman W.Weinstein* 
1924 
John J. Batchelor 
D.Anthony D’Esopo 
David M. Raskind 
Myron A. Sallick 
Harold T. Vogel 
1925 
Dorence S. Cowles 
Waldo F. Desmond 
Henry W. Ferris 
William E. Hall 
Stanton K. Livingston 
Samuel Reback 
Welles A. Standish 
Alice A.S. Whittier 
Gonsalvo C. Williams,Jr. 









Alexander E. Rosenberg 
1927 
Milton B. Berman 
Wallace R. Bostwick* 
Henry 1. Fineberg 
John M. Freiheit* 
Meyer Friedenson 
Herman H. Goldstein 
Albert Jablonsky 
Nathan Levy 
William C. Meredith 
Moses Rothberg 
Alfred F. Seibert 
1928 
Max Alpert 
Clement F. Batelli 
John Burke 
Berthold R. Comeau 
Sheldon A. Jacobson 
Raymond A. Johnson 
Edward P.J. Kearney 
Ralph E. Knutti 
Ferdinand G. Kojis 
R.Harold Lockhart 
Edward W. Ludwig* 
Nathan E. Ross 
Robert I Rubinstein 
John M. Russell* 
Lewis A. Scheuer 
George C. Wilson 
1929 
James R Arneilljr. 
Frank H. D'Andrea 
Charles J. Epstein 
Robert A. Frisch 
Olive Gates 
George S. Goldman 
Alexander O Hoff* 
John A. Hangen 
Harold J Harris 
George P. Jackson 
Vernon W. Lippard 
Paul F. McAlenney 
Tony L. Rakieten 
William F. Roth,Jr 
Russell B. Scobie 
Robert Tennant 
Newell R. Washburn* 






Frederick F. Boyce 
Charles A. Breck* 
Frank H.Couch 
Robert D. M. Cunningham 
Vincent A. Doroszka 
Knox H. Finley 
J Edward Flynn 
J. Roswell Gallagher 
James C. Hart 
Edmund L. Kitzmeyer 
Paul H. Lavietes 
Jack Lehner 
Moses D. Lischner 
James M. Lynch* 
John C. Mendillo 
Amy H. Wilson 
Charles L. Wood 
1931 
Henry H. Briggs, Jr. 
Benjamin Castleman* 
Michael D’Amico 
Helen R. Gilmore 
Paul A. Harper 
Harold E. Harrison 
Morris F. Heller* 
Thomas C. Jaleski 
A. Philip La France 
Rhoda M. Mickey 
Nelson Newmark 
Sheldon Payne 
Abraham J. Schechter 
1932 
Louis K. Alpert 
Henry Brill 
Frank Carroll 
Clement C. Clarke 
Joseph P. Donnelly 
Lewis F. Foster 
Storer P. Humphreys 
Conrad R Lam 
Arthur J. Present 
Elizabeth M. Ramsey 
Benjamin N. Tager 
Myron E. Wegman 
1933 
Myron J. Adams* 
Fred W Buse 
Warren P. Cordes 
Lee E. Farr 
Franklin M. Foote 
Jack Greenberg 
Daniel F. Harvey 
George K. Hirst 
Robert W. Huntington, Jr. 
John G. Martin 
Joseph Mignone 
Raymond E. Miller 
Ashley Pond 111 
Paul L. Saffo 
Lester Q. Stewart 
Sidney Stringer* 
John J. Wolfe 
Francis M. Woods 
1934 
Leona Baumgartner 
James F. Blades 
Knowles B. Lawrence 
Theodore P. Merrick 
Herbert C. Miller 
Edward T. O’Donnell 
John B. Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
William R Willard 
George Zalkan* 
1935 
George A. Carden, Jr. 
Edward F. Falsey 
Sawnie R. Gaston 
H. Hoffman Groskloss 
James Q. Haralambie 
Samuel D. Kushlan 
Norman E, Peatfield 
Norman P. Rindge 
Clark P. Searle 
Jack C. Sleath 
Walter A. L. Thompson 
Samuel Zelman 
1936 
George H. Brown 
Lester W. Burket 
Franklin F. Ferguson 
Margaret C. L. Gildea 
George D. Gross 
George A. Hahn 
Louise G. Hutchins 
Philip M. Lecompte 
Donald F. Marshall 
Frederick A. Post 
Morris Tager 
Edgar W. Warren 
1937 
Edmund R. Blower 
David A. Dolowitz 
D. Crosby Greene 
Joseph B. Hollinshead 
Benjamin F. Hoopes 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrell 
Charles W. Neuhardt 
T. Dennie Pratt 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
Lucille R Wiepert 
Lorande M. Woodruff 
1938 
Roy N. Barnett 
Agnes V. Bartlett 
Henry L. Carideo 
John A. Dillon 
S. Charles Kasdon 
Benjamin E. Lyons 
John J. McGillicuddy 
Edward Nichols 
Nelson K. Ordway 
Charles Petrillo 
Edward W. Pinkham, Jr 
James Radcliffe, Jr. 
George E. Roberge 
Lester J. Wallman 
J. Richard Zahn 
1939 
Norman L. Cressy 
William H. Druckemiller 
Robert G. Ernst* 
John l1. Ferguson, Jr. 
Joseph B. Forman 
S. Jerome Greenfield 
Paul E. Huston 
Nathaniel Kenigsberg 
James P. Murphy 
Russell Nahigian 
Douglas S. Riggs 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
Stuart S. Stevenson 
John D. Tobin 
Arthur S. Tucker 
Darrell G. Voorhees 
John H Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
Thaddeus S. Danowski 
Wynant Dean 
Richard E. Dormont 
Robert M Dunlap 
James F. Ferguson, Jr. 
Eugene J. Fitzpatick, Jr. 
Henry D. Humphrey 
H. Stuart Irons, Jr. 
Donald G. Johnson 
Ira D. LeFevre, Jr. 
Paul D. MacLean 
Edward Martin 
William R. Oakes 
Maurice Ross 
Lee S. Sannella 
W. Norman Sears 
Joseph E. Sokal 
J. Champneys Taylor 
Patricia E. Wanning 
John B. Wells 
Helen H Woods 
1941 
Robert H. Alway 
Robert H Areson 
W. Randal Bell 
Knute E. Berger 
William A. Carey 
Joseph P. Carson, Jr. 
Charles B. Cheney 
Herbert W Diefendorf 
Robert F. Dine 
I loyd I). Flint 
John Franklin 
Robert L. Gilbert 
Sidney L. Lasell 
Bjorn Lih 
F. Eugene Martine 
Willys M. Monroe 
Malcolm C. Murfitt 
Edward B O'Connell 
Robert W Ollayos 
Gioacchino S. Parrella 
Edwin D. Rogers 
Leslie Simmonds 
Janet H Van Orden 
1942 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 
Donald S. Childs, Jr 
Vincent J. Collins 





Allan V. Goodyer 
Charles R. Harms 
William Harrison, Jr. 
Leo Kellerman 
John R. Lincoln 
Patrick S. Mullins 
Dean Nichols* 
Samuel Ritvo 
Richmond W. Smith, Jr. 
Edgar B Taft 
Maurice Tulin 
Irving N. Wolfson 
1943 (March) 
Ralph D. Alley 
John R. Brobeck 
Lycurgus M, Davey 
C. Thomas Flynn, Jr. 
Gerard Fountain 
Stuart L. Joslin 
R. Leonard Kemler 
Jonathan T. Lanman 
Douglas L.indsey 
Henry E. Markley 
Walter J. J. Nero 
Dorothea R. Peck 
Edward F. Rabe 
Earl J. Rhoades 
Henry A. Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Edward H Soule 
Hilliard Spitz 
Sophie T. Stevens 
Oliver G. Stonington 
Robert L. Taylor 
Robert G. Turner 
Frederick A. Waldron 
John J. Weber 
Robert II Wyatt 
1943 (December) 
Richard N. Abbott 
John R. Almklov 
David G. Borden 
James L. Bradley 
Robert F. Bradley, Jr. 
S. Brownlee Brinkley 
Henry B. Bruyn, Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H Comly 
Norman I Condit 
Deceased 29 
Jean P. Davis 
Joseph I Epstein 
Robert H Eurnian 
Victor C. Hackney 
Frank R Hurlbutt. Jr. 
Henry H Jones 
Joseph F. Kell 
Hoyt B. Miles. Jr. 
Ira A Rashkoff 
Donald W. Seldin 
Francis A. Spellman 
C. Wesley Watson 
1944 
Carl E. Andrews 
Edward J. Conway 
John C. Coolidge 
Frank W, Countryman 
Charles H Crothers 
Law rence G. Crowley 
John H Doherty 
Donal 1 Dunphy 
Carol Goldenthal 
Charles A. Hall 
Howard B. Hamilton 
W. Raymond James 
Edith M. Jurka 
Frederick F. Krauskopl 
Ronald E. Losee 
Ellen P. Mackenzie 
Elias J. Marsh 
Katharine H. Martin 
Nora H Mason 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy 
Lawrence K. Pickett 
Laurence G. Roth 
Haynes W. Sheppard 
Sarah P Sherwood 
Nicholas P. R. Spinelli 
Priscilla I) Taft 
Anthony Varjabedian 
Cabin W. Woodruff 
Reuben Zucker 
1945 
George H. Allison 
A. John Anlyan 
Albert S. Atwood 
Frederic M. Blodgett 
Richard W Brcck 
Louise H. Burr 
Alice S. Cary 
Sanford I Cockerell 
Jay B. Cohn 
Thomas P Cotter 
Edward M. Daniels 
Richard R Dyer 
Robert S. Easton 
Sidney S. Feuerstein 
Alice I). Friedman 
Raymond A. Gagliardi 
Philip S. Good 
Herbert S Harned. Jr. 
Paul W Hoflert 
O. Roger Hollan 
Hans R. Huessy 
William I Jenney 
Raymond E. Lesser 
Mark M. Lindsey 
Charles E McLean 
George W Naumburg. Jr 
Richard M Peters 
Charles I Sherwood 
Joseph R. Stanton 
Kenneth C. Steele 
1946 
Margaret J. Albrink 
William G. Banfield. Jr. 
Aaron T. Beck 
Franklin C. Behrle 
Sanfurd G. Bluestein 
Linus W. Cave 
James F. Cooney 
Robert R. Cooper. Jr. 
Thomas A. Doe 
Gregory F. Flynn 
Martin E. Gordon 
Charles S Judd. Jr. 
Harold King 
Benjamin F Kitchen. Jr 
James A. Kleeman 
Vincent J. Longo 
Richard II. Mann 
Thomas J. Mathieu 
Hugh J. McLane 
Joe D. Morris 
John H Morton 
John F. Neville. Jr. 
I aura W. Neville 
Francis Reilly 
David H Riege 
Phillips E. Roth 
Julian A. Sachs 
Donald P Shedd 
Richard G. Sisson 
Colby S. Stearns 
R Bruce Thayer 
Robert R W'agner 
William J. Wedemeyer, Jr. 
J homas J. Whelan. Jr. 
Hugh R. Williams 
F.lihu S. W'ing. Jr. 
1947 
George R Barnes, Jr. 
Henry N Blansfield 
Albert W. Bostrom. Jr. 
John E. Bowers 
William R Breg. Jr. 
John L. Cannon 
M. Richard Carlin 
Betty Carlin 
Charles R. Cavanagh. Jr. 
Robert A. Chase 
Amo? I. Chernoff 
William F. Collins,Jr. 
Robert P Darrow 
Archie L. Dean, Jr. 
Jean 11 Dougherty 
Owen W. Doyle 
Franklin H. Epstein 
Edward D. Foord 
Frank H Horton 
Robert J. Kerin 
Don F. Kimmerling 
Richard P. Levy 
Brock Lynch 
Victor A. Macheinski 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry 
Edgar B Phillips 11 




Patricia B. ludbury 
Ellis .1. Van Slyck 
M. Henrv Williams. Jr. 
1948 
Russell J Barrnett 
Edith M. Beck 
Allyn G Bridge 
Arthur L. Coleman. Jr. 
Ruth E. Cortell 
G Robert Downie 
Victor A. Drill 
Marie C. Duncan 
Boy Frame 
Emil Frei 111 
Julian Frieden 
Allan Green 
B Harold Griffith 
Sylvia P Griffiths 
Beatrix A. Hamburg 
Richard Hannah 
Ross R Harcus 
Paul B Koehler 
Robert E Lempke 
John P Morris 
John B Morrison 
David E. Morton 
Cierald R. Nowlis 
James M. Post, Jr. 
George P. Rostel 
Lew is P. Row land 
Benjamin F. Rush. Jr. 
Gabriel A. Saviano* 
Jerome H. Shapiro 
Jessie P Spear 
Anne G. St. Goar 
Paul Talalay 
Wallace W. Turner 
Paul W. Weld 
1949 
William G. Anlyan 
Alfred E. Bacon. Jr 
Henry W. Baird, 111 
William D. Bevis 
Jonathan S Bishop 
Thomas L. Chiffele 
Mary P. Couchman 
Phillip G. Couchman 
Peter R Cunningham 
N. Joel Ehrenkranz 
Daniel W. Elliot 
Gunnar O. Eng 
Albert A. Fisk 
Paul S. Goldstein 
Eleanora C. Gordon 
Frederic W'. Gray 
Jackson Harris 
Robert C. Howard 
Benjamin A. Johnson 
Frank D. l aw 
Orval 1. McKay 
Richard D. Otis 
Julian I Pichel 
Edmund L. Piper 
Charles 1 Rennell. Jr. 
Murray Z. Rosenberg 
Daniel Rudman 
Carl M. Russell 
William IL Sewell 
Raymond D Sudarsky 
1950 
Russell N. Anderson 
l yaI D. Asay 
John E Borowy 
William II Bucher 
Alvin Davis 
Claude W. Delia 
Kent Ellis 
Thomas J. Ferraro. Jr. 
Daniel Fine 
David A. Frucht 
Archie J. Golden 
Chesterfield G. Gunn. Jr. 
Wallace M. Kemp. Jr. 
Marilyn M. Kritchman 
Sidney S. Lee 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry 1 McClelland 
John H Meyers 
Orlando J. Miller 
Robert T. Sceery 
Cy nia B. Shimm 
Jane B Shumway 
Martin Smith* 
1951 
Karel B Absolon 
W. Robert Adams 
Thomas T. Amatruda. Jr. 
Muriel H Bagshaw 
Eleanor C. Bigley 
Allan A. Brandt 
John J. Egan 
Daniel X. Freedman 
Sidney S. Furst 
Ralph M. Gofstein 
Lowell I Goodman 
John T. Groel 
Robert N. Hamburger 
Carrold K. Iverson 
Paul D. Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Charles A. Nugent. Jr. 
Jose F. Patino 
Arthur A. Pava 
Majic S. Potsaid 
William F. Stephenson 
Harold M. Sterling 
John S. Sullivan 
William Tay lor* 
Andrew S. Wong 
1952 
John W. Arnold 
Frank A. Carone 
Frank R. Coughlin. Jr 
Philip G. Deane 
Raymond S. Duff 
James R. Durham 
William J. Johnson 
James K. Luce 
N. Karle Mottet 
Robert F. Owen 
Robert G Petersdorf 
Leon A. Phillips 
John M. Roberts 
Elizabeth M. Rush 
Leonard Rush 
Mary W. Schley 
Donald 11 Schultz 
Robert B. Schultz 
Virginia L. Swanson 
John H Wagner. Jr. 
Doris 1 Wethers 
John L. Wolff 




Harold D. Bornstein 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
Louis R. DelGuercio 
James P Dunn 
Donnell D. Etzwiler 
Thomas O. Gentsch 
Vincent L. Gott 
Robert E. Hamlisch 
A. Daniel Hauser 
George L. Hoffman 
David P. Holman 
Peter B Hukill 
Alvin J. Keroack 
Robert F. Kiley, Jr. 
Richard R. Knowles III 
Hildegard M Leslie 
Preston L. Leslie 
Robert N Melnick 
Harvey M. Peck 
Warwick Potter. Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
Barbara F. Rosenberg 
lrw in K Rosenberg 
Virginia C. Saft 
Richard A. Sinnott. Jr. 
Ora K. Smith 
Ly nn C. Stoker 
Matthew A. Tandysh 
William J. Vandervort 
William A. Whalen. Jr. 
William A. W'ilson 
1954 
W. Dean Ashworth 
Frank P Berg 
George W. Bostwick 
Richard J. Bouchard 
George N. Bowers. Jr. 
Ralph K. Campbell 
John R Cole 
William D. Cone 
Alan H. Covey 
Arthur C. Crovatto 
Donald D. Davis 
Frederick J. Fiederlein 
Walter J. Freeman 
Orlando F. Gabriele 
John A. Gariepy 
Edward J. Gerety 
Frank L. Gruskay 
Nicholas A. Halasz 
Robert P. Hatch 
Walker R Heap. Jr. 
Eva H Henriksen 
Samuel J. Hunter 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J. T. Joy 
Donald S. Kornfeld 
Lowell A. Kristensen 
Richard Lamb 
Harry C. Miller. Jr. 
Paul V Neufeld 
James J. Nora 
Lowell E. Olson 
William S. Palmer 
William J. Paule 
Anthony V Piccirillo 
Richard D. Pullen 
Jacques M. Quen 
Edwin R Ranzenhofer 
Earl D. Rees 
David M. Robinson 
John K. Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
John W. Vosskuhler 
30 Deceased 
1955 
John B. Atwater 
John C' Bailar 111 
George E Becker. Jr 
E. Edward Bittar 
Douglas G. Boyden 
Irwin M. Braverman 
Edward N. Brennan 
Padraic Burns 
Leo R Cardillo 
Nicholas A. Coassin 
Edward D. Coppola* 
Milton Corn 
Pasquale J. Costa 
Fred W. Doyle 
William O. Edward 
Leroy Engel 
F. Robert Fekety, Jr. 
Mahlon V. R Freeman 
Barbara W. Gibson 
Rudolph J. Goerke III 
Paul Gonick 
Dicran Goulian, Jr. 
Ion Gresser 
John H. Hodge 
D. Franklin Johnson, Jr. 
Harry O. Kendall 
David R. Kessler 
Gilbert M. P. Leib 
James l.um 
Joseph S. McGuire. Jr. 
Robert C. Nod me 
Sherwin B. Nuland 
Gloria C. Onque 
John C. Pace, Jr. 
Robert II Peters, .1 r 
Gregory Peterson, Jr 
Robert A Reich 
E. Brantley Scott, Jr. 
Phillip W. Smith 
Alan A. Stone 
Alexander Zuckerbraun 
1956 
Alan E. Aplel 
Peter Bios, Jr. 
Levon Z. Boyajian 
Thcmas M. Brown 
Rosalie A. Burns 
Joseph C. Cerny 
Chandler Dawson 
S. Evans Downing 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John FI. Gardner 111 
Sumner Gochberg 
George E. Green 
Armen C. Haig 
.loan M. Hardenbergh 
John II Hart 
Robert L. Hill 
William H. Hindle 
Marie-Louise T. Johnson 
Jerome O. Klein 
William V. Lewit 
Leo Lutwak 
Jacob Mainzer, Jr. 
Preston C. Manning 
Dwight F. Miller 
Norman F. Moon 
Donald .1. NalebufT 
David A. Page 
George W. Paulson 
Stewart E. Pursel 
Robert L. Scheig 
James Scheuer 
Edward C. Senay 
Benjamin A. Shaver, Jr. 
Donald W Sherrick 
Daniel R. Silbert 
1957 
Donald Agostinelli 
Jack N, Blechner 
Harry C. Briggs 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold D. Cross 
Brian Crowley 
John D’Agostino, Jr 
Thomas H Danaher 
James R Dorr 
Edward L. Eyerman, Jr. 
Salvatore Falbo 
Harold J. Fallon, Jr. 
Robert E. Fishbein 
Ronald II Fishbein 
James R. Fitzgerald 
Anthony I . Fons, 111 
Elizabeth H Forsyth 
Gary A. Fry 
Robert H Glass 
Anne H. Good 
Jack P. Green 
Joyce D. Gryboski 
Malcolm Hill 
Gilbert F. Flogan 
Warren R Johnson 
William L. Kissick 
Edgar H I .evin 
Jack Levin 
Bennett F. Markel 
Mark I). Marshall 
David E. Martin 111 
Howard A. Minners 
Robert K Modlm 
Hugh L. Moffet 
George A. Nelson, Jr. 
Herbert A. New'tnan 
Thomas F. O’Brien, Jr. 
Jopseph S. Pagano 
Raymond E. Phillips 
Clifford B. Reifler 
Arnold A. Schoolman 
Kenneth A. Simon 
Gilbert B. Solitare 
Robert W Southworth 
Donald C. Stahl 
Arthur Taub 
Romeo Vidone 
William J. Waskowitz 
Robert E. Youngen 
James G. Zimmer 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P. Arnot 
Peter A. Benson 
Gerard N. Burrow 
Benjamin Bursten 
David A. Carlson 
John A. Carlston 
John A. Creatura 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Raymond A. Gaito 
John C. Gallagher 
Marcia K. Goin 
William M. Gould 
James Greenwald 
Charles A. Hall, Jr 
Stanley Harris 
Michael Kashgarian 
Haskins K. Kashima 
Jay W. Kislak 
Theodore W. Lieberman 
Myron Lotz 
Jack W. Love 
Thomas J. Mauro, Jr. 
Michael J. McCabe 
Leo T. McCallum 
Andrew J. McGowan, Jr. 
F Patrick McKegney, Jr. 
John A. Merritt, Jr. 
Albert Muggia 
Robert S. Neuwirth 
Carol F. Phillips 
David M. Pugh 
William E. Radcliffe 
Paul A. Rudnick 
William W. Schlaepfer 
Bruce H. Sklarew 
Richard E. Sledden 
Edward L. Socolow 
Arlene Sweedler 
Raymond W. Turner 
Margaret S. Wenzel 
John P. Wood 
Pauline B. Wood 
1959 
Scott I Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes, Jr. 
Francis A. Beer 
Jack F. Bowers 
William C. Butterfield 
Edward Call, Jr. 
Sidney M. Cohen 
Ronald C. DeConti 
William I Donegan 
Gerald Fenichel 
Robert L. Fisher 
Robert J. Gonyea 
Gerald B. Gordon 
W. Keith Hadley 
William II. Heydorn 
C. Richard Hinckley 
Leonard Inker 
John J. Jasaitis 
Edvardas Kaminskas 
David W. Kingsbury 
Myron S. S. Lee 
Kathryn H. Lewis 
Daniel L. Macken 
Raymond Mark 
John C. Marsh 
D. Kent Morest 
James A. O’Neil. Jr. 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
Lincoln T. Potter 
James D. Prokop 
James R. Ralph 
David P Reed 
Joseph D. Robinson, Jr. 
Joseph D. Saccio 
Constantine J. Sakles 
Marvin 1 Schulman 
Marc D. Schwartz 
David B Skinner 
Sanford P. Solomon 
James J. Stagnone 
Lisa A. Steiner 
Leo H Von Euler 
Muriel D. Wolf 
1960 
Victor Altshul 
Alan W. Ames 
Donald P Buebendorf 
Stanley M. K. Chung 
Jon E. Courtney 
Louis A. D’Avanzo 
Caldwell B. Esselstyn, Jr 
Warren H. Fisher 
Paul J. Friedman 
Alvin E. Friedman-Kien 
Eugene C. Gaenslen, Jr. 
Gary E. Gathman 
James I. Gilman 
Roland H. Ingram, Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Frank .1 Kleeman 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R Lang 
Thomas 1 Lincoln 
Edward Longo 
Eugene G. McCarthy, Jr. 
Donald L. Miller 
Richard G. Morrill 
Allan W. Newcomb 
Buford L. Nichols, Jr. 
J. Thomas Okin 
Fred Palace 
Jerrold M. Post 
Charles H. Robinson, Jr. 
Fred Stargardter 
Robert C Wallach 
May Y. Wang 
Ronald A. Yankee 
1961 
Kenneth A. Arndt 
Earl L. Baker 
Frank II. Baker 
Albert A. Bechtoldt, Jr. 
Robert S Briggs 
David W. Brook 
Orson R. Dee 
Paul D. Deiter 
Ralph J. Deponte 
Ronald A. Dierwechter 
Jon D. Dorman 
T. Wayne Downey 
Philip Felig 
John E. Fenn 
Norbert Fleisig 
James M. Giffin 
Edward C. Gilbert 
Robert S. Gillcash 
David D. Griffith 
Louis D. Hunt 
Richard L. Keefe 
Robert I Levy 
Joseph R. Lusby 
David B Matloff 
Anoush Miridjanian 
Richard A. Moore 
Norman I. Moss 
John C. Parker 
Roy E. Ronke, Jr. 
Thomas H. Sakoda 
Stanley G. Schade 
Robert N. Taub 
Hugh C. Thompson 111 
Franklin IF Top, Jr. 
David E. Weaver 
Warren D. Widmann 
John R Woodward 
1962 
Jon M. Aase 
Paul H. Ackerman 
Michael H. Alderman 
Charles B Anderson 
Frederic P. Anderson 
Ann B Barnes 
Spencer J. Brody 
Dean E. Burget, Jr. 
Fredric K. Cantor 
Richard N. Collins 
Arnold J. Eisenfeld 
Joseph D. Ferrone, Jr 
John W. Foreman 
Leroy A. Forstrom 
Stephen J. Fricker 
John N. German 
Roderick C. Half 
John T. Harrington 
Patricia C. Hassakis 
Walter W Karney 
Glenn L. Kelly 
Bernard Kosto 
John P. Lynch 
Malcolm A. Martin 
Stanley E. Matyszewski 
William G. Meffert 
Malcolm S. Mitchell 
David D. Nicholas 
A. Richard Pschirrer 
Joseph Ross 
James A. E. Spencer 
Nancy A. Staley 
II Oliver Stoutland 
Seth I haler 
Sherwood Waldron, Jr. 
Stewart R. Wright 
1963 
Arthur H. Ackerman 
Miguel R. Alonso 
V. Richard Back 
Gordon S. Cohen 
John E. Conte, Jr. 
David F. Cross 
Andrew Edin 
John P. Eliopoulos 
B. Allen Flaxman 
David II Fram 
William T. Friedewald 
David H. Fulmer 
Alexander R. Gaudio 
F, John Gennari 
Lee D. Goldberg 
Peter B. Gregory 
George H HOlsten 111 
Constantine D. Kyropoulos 
William B. Lehmann 
Craig H. Llewellyn 
Edward G. Lund, Jr. 
Robert H. Margulis 
Herbert Meltzer 
Robert E. Mueller 
Jay M. Pomerantz 
Gene R. Profant 
Joseph B. Stevens 
Lee B. Talner 
Peter V. Tishler 
Lawrence Tremonti 
Helen N. Walsh 
Peter G. Weiner 
Seth M. Weingarten 
Alfred J. Wise 
* Deceased 31 
1964 
William A. Alonso 
Millard J. Amdur 
Sidney M. Baker 
Leland S. Berger 
Philip Blume 
Anthony J. Bravo 
Thomas A. Cardella 
Joseph F. J. Curi 
Alfonso Esguerra 
Remo Fabbri, Jr. 
Anthony Ferrante 
Norman C. Fost 
Peter A. Gross 
John F B. Haney 
Gene 1 Higashi 
William J. Houghton 
William E. Knight 
I ewis Landsberg 
Richard V. Lee 
Thomas L. Lent/ 
James S. Levine 
Paul R Lightfoot, Jr. 
Richard M. Linburg 
Robert W. Lyons 
Andrew E. MacMahon 
William F. Matchett 
Thomas O. McCann 
Robert L. Mitchell 
Alan H. Morris 
James J. Murphy 
Donald A. O’Kieffe. Jr 
William B. Pratt 
Stanley J. Rosenberg 
Jonathan J Russ 
Richard P Saik 
Robert L. Shelton 
Diane K Shrier 
A. T homas Snoke 
I yall C. Snip II 




Susan A. Aoki 
ITomas T. Aoki 
John H M. Austin 
Paul Balter 
Victor J Burner 
David G. Campbell 
Dewey A. Christmas, Jr. 
Robert M. Cohn 
Michael J. Cummings 
David S. Fedson 
Robert I. Finkel 
T rank J. Grady 
Gary L. Gross 
Robert A Gryboski 
James K. Gude 
Reid R Heffner, Jr. 
David A. Hill 
Carl E. Hunt 
Ronald J Karpick 
Mohandas M. Kim 
Robert II Kochi 
Richard J. Ko/.era 
David J. Kupfer 
Sandra C. Levine 
Mark W. I.isehner 
Philip I). Manfredi 
Walter W. Noll 
A. Lawrence Ossias 
John A. Parrish 
Robert I . Pickens 
Robert II Prall 
Alan V Rachleff 
William A. Renert 
Gene A. Robinson 
John H. Seashore 
Margretta A. Seashore 
Charles J. Semonsky 
David M. Shames 
David P. Simmons 
Harlan Spit/ 
E. James Stanley 
Alan W. Stone 
Bert Y. Wong 
1966 
Benjamin F. Balme 
John D. Baxter 
Patricia Ba/emore 
Robert P. Ba/emore 
Frank C Boll 
Philip Bernstein 
James E. Brown 
Eugene P Cassidy 
Donald J. Cohen 
Joseph A. Donadio 
Robert E. Dragon 
Marvin A. Eisengart 
Jared M. Emery 
Peter M. Fitzer 
Robert N. Frank 
Peter D. Gibbons 
Jeffrey B. Gluckman 
Stanley I. Greenspan 
J McLeod Griffiss 
Robert A. Gunn 
Stuart T. Hauser 
Jay G. Hayden 
Mary Alice Houghton 
Richard J Howard 
Bruce W. Jackson 
Gordon R Kelly 
Neal Koss 
Stuart M Kotler 
David C. Law 
Lynne L. Levitsky 
Henry B. Mann 
Harold Mellin 
Eli IT Newberger 
Neil J Peterson 
William D. Peterson 
Joel Singer 
James D. Slavin, Jr. 
Parker J. Staples 
Gary L. Townsend 
Lee Van Lenten 
Joan T. Wayland 
John W. Wickenden 
William B Yeagley 
Arne S. Youngberg 
1967 
Daniel L. Arons 
Edward W. Bartlett 
Arthur L. Beaudet 
Arthur W. Boddie 
Daniel J. Booser 
Gary C Burget 
William T. Cave 
David M. Conkle 
Cynthia R. Curry 
Marian C. Davidson 
James L. Davis 111 
James J. Dineen 
Timothy J. Dondero, Jr. 
James M. Dowaliby II 
John A. Drews 
Peter R. Egbert 
Melvin V. Goldblat 
Richard J. Hart 
Richard L. Heppner 
George P Herr 
J. Robert Kirkwood 
Melvyn Korobkin 
Anthony P. Lovell 
Laura K Manuelidis 
Halbert B Miller 
Stephen W. Miller 
William J. Mitchell 
Joseph L. Morris 
Jennifer R. Niebyl 
John O. Pastore 
William E. Perkins 
Robert I Roy 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith, Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
M David Tilson 111 
Karen H. Toker 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Redford B Williams, Jr 
Robert S. K. Young 
1968 
Julius H. Anderson 
Joseph F. Andrews, Jr. 
Philip L. Barry 
Daniel I Becker 
Stuart J. Brill 
Donald R Coustan 
John Demarchi 
Edward M. Druy 
Barbara M. Egbert 
Lamar Ekbladh 
Alan G. Finesilver 
William F. Flynn 
Richard A. Getnick 
Mark G. Grand 
Leonard Grauer 
Ralph S. Greco 
Kevin N. Hennessey 
John R Hill II 
Harry S. Holcomb III 
Peter Jokl 
Peter A. Kirkpatrick 
Jeffrey S. Lee 
Ellen M. Lippman 
Marc E. Lippman 
Peter A. Livingston 
Frank E. Lucente 
Donald O. Lyman 
Rodrigo Martinez 
John A. McCutchan 
Maria S. McCutchan 
David P. Millett 
Richard P. Mills 
Richard M Morehead, Jr. 
James B. Morris 
John A Ogden 
James W. Ogilvie 
Margot Onek 
Jackson B Pickett 111 
Charles T. Post, Jr. 
Ralph J. Rauch 
Gordon H. Sasaki 
Bruce S. Schoenberg 
Elizabeth M. Short 
Howard W. Siegel 
David A. Soskis 
Gerald L. Springer 
T ee H Strohl 
Per H Wickstrom 
Creed W. Wood 
1969 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E Belliveau 
William F. Bynum 
N. Roger Cooke 
Leo M. Cooney, Jr. 
Richard J. Daly 
Charles A. Dinarello 
Ralph J. Falkenstein 
Steven A. Frankel 
William H. Frazier 
Anna S. Gail 
Royal J. Gay 
David A. Geer 
Robert O. Gordon 
Steven M. Her/berg 
Thomas C. Howard 
Lee M. Jampol 
Joel M Kaufman 
Paul IT Kelker 
John J. Kelly, Jr. 
Rowena Korobkin 
Stephen Krant 
Lynn G. Lagerquist, Jr. 
Michael R Liebowitz 
C. E. Long 111 
Robert L. Marier 
Arnold F. Ma/ur 
Lloyd F. Mercer 
Ellen B Milstone 
Thomas F. Minehan 
Lionel M. Nelson 
Timothy A. Pedley 
Deborah A. Putnam 
N. Burgess Record, Jr 
Joseph D. Robinson 
Joseph M Rochford 
Dennis J Rud/inski 
David J. Sahn 
Adrian M, Schnall 
David J Schulak 
Gerald J. Smallberg 
Robert J. Walat 
Stephen R. Webb 
Steven C. White 
1970 
Elissa B. Arons 
Michael J Chusid 
Thomas E. Ciesielski 
C. Norman Coleman 
Michael D. Danzig 
James E. DeLano. Jr. 
David K. Dueker 
Jonathan Ecker 
Richard L. Edelson 
Robert A. Epstein 
Bruce A. Fabric 
Thomas H. Gouge 
Paul C. Hessler 
Jay H. Hoofnagle 
Jonathan D. Katz 
Gerard T. Kennealey 
Kenneth A. Khoury 
Ely A. Kirschner 
Mark A. Korsten 
Thomas L. Lewis 
Anne W. Lucky 
Leonard M. Milstone 
John J O’Brien 
Robert M. Rosa 
Joel F. Rubinstein 
Dennis E. Shield 
Stuart S. Shorr 
Brian Weiss 
C. Bruce Wenger 
Joellen Werne 
Daniel Wuensch 
Karl O. Wustrack 
1971 
Judith L. Bader 
Gregory W. Bartha 
Willard Cates, Jr. 
John L. Cieply 
Frederick L. Cohn 
David Cossman 
Edward C. Cottle 
Michael Cynamon 
John S. Ebersole 




Michael C. Gallant 
Jared J. Gardner 
Richard Gloor 
Michael J. Hart 
William W. Hay, Jr. 
W. Robin Howe 
N. Timothy Jette 
Arthur F. Jones 
Richard E. Kaufman 
Barbara K. Kinder 
Ralph J. Kirmser 
William L. Krinsky 
Laurence W. Levinger 
David H. Lippman 
Samuel S. Masters 
John C. Mills 
Patrick T. Minihan 
Richard A. Moggio 
Richard R. Neufeld 
Robert Park 
John A. Patti 
Barry B. Perlman 
Michael C. Piercey 
Anthony V. Proto, Jr. 
Irving G. Raphael 
David M Rinzler 
Laurie J. Rosenthal 
Douglas R. Schmidt 
James P Southwick 
Jonathan W. Stewart 
Daniel R. Synkowski 
Richard D. Travers 
Yvonne E. Vaucher 
Paul A. Vignola 
Albert C. Weihl 
Jerold C. Woodhead 
Daniel G. Wright 
1972 
Robert D. Arbeit 
Michael A. Catalano 
Leonard H. Cohen 
Philip L. Cohen 
32 
Gloria Cummings* 
Robert F. Deblasi 
William H. Druckemiller, Jr. 
William F. Duke 
John W. Foster, Jr. 
M. Felix Freshwater 
Dorothy M. Gohdes 
Andrew II Greenhill 
Thomas L. Horn 
Vernon H. Humbert, Jr. 
Anthony H Jackson 
Jessie B. Jupiter 
Roy A. Kaplan 
Donald L. Kent 
John W. Klay 
David L. Kneapler 
Philip W. Lebowitz 
Theodore M. Levin 
Paul A. Lucky 
Harry L. Malech 
Jeffrey S. Menkes 
Stewart A. Metz 
Jerome H. Meyer 
Jorge A. Motta 
David B Moyer, Jr. 
T homas H. Ogden 
Edward J. Olinger 
John N. Posch 
Philip M. Rothfeld 
John S. Smolowe 
Frederick D. Stockwell 
Gary M. Strauss 
Lawrence P Temkin 
Philip J. Weyman 
Brooke S. Wolf 
John D. Wright, Jr. 
Michael W. Yogman 
Steven M Zeldis 
1973 
David A. Adler 
David A Baggish 
David N. Bailey 
Mary Ann Brunstetter-Shafer 
James N. Campbell 
Marvin M. C'hassin 
Joseph M Connors 
Christopher M. Doran 
Joseph W. Eichenbaum 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert E. Galloway 
Lee Goldman 
Gary V. Gordon 
Gary T. Grimes 
Howard S. Honig 
Wanda D. Huff 
David C. Johnson 
Andrew G. Kadar 
Michael S. Kramer 
Lynne M. Liptay 
George Lister, Jr. 
Mark G. F. McCormick 
John A. McDowell 
John F. McQuade Ill 
Jerry Nagler 
John F. Neil 
Claes M. Nilsson 
Victor L. Pappoe 
David E. Peach 
David Pickar 
Robert H. Posteraro 
Charles F. Reynolds III 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
John P. Sherck 
George D. Shoup 
Robert A. Sirota 
John R. Stratton 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Marc A. Weinberg 
Richard S. K. Young 
1974 
Irving M. Asher 
Douglas A Berv 
Bruce D. Blumberg 
Neil Blumberg 
Peter J. Buchin 
Bert D. Collier, Jr 
Vincent A. DiMaria 
Michael K Eshelman 
Irl L. Extein 
Reginald K Franklin 
Allan B Friedland 
Michael A. Gerber 
David Grant 
Ancil A. Jones 
Leon F Kraft 
Edward L. Marut 
Marjorie A. S. Oda 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Daniel I Rosenthal 
Carol C. Teitz 
John J. Thompson 
Jason S. Zielonka 
1975 
J. Edwin Atwood 
Ralph E. Binder 
Neil Blumberg 
Yvonne E. Burnett 
Brendan Clifford 
Kevin Kane 
Martin B Leon 
Richard J. Loewenstein 
Hyman J. Milstein 
Mary J. Minkin 
Andrew B. Newman 
Edwin G. Olson 
Daniel J. Passeri 
Vivian Reznik 
Philip J. Rich 
Fred P. Rosenfelt 
Richard L Roth 
Robert S. Sandler 
Jane Snyder 
Barbara .1. Stoll 
Henry S. Willner 
Douglas R. Zusman 
1976 
Sarah S. Auchincloss 
Sharon L. Bonney 
Randall D. Cebul 
John D. Clemens 
Geoffrey Etherington 
Leonard Firestone 
Rose H. Goldman 
Glenn A. Gorlitsky 
Randall S Hawkins 
Avi J. Hettena 
Norman V. Kohn 
William K. Levy 
George W. Luedke 
Larry Markowitz 
Paul R. Ramirez 
Mark C. Ruchman 
John T. Sladky 
Bonita F. Stanton 
F. Peter Swanson, Jr. 
Robert F Taylor 
Frank B. Watkins 
John C Wiles 
Carol M. Ziminski 
1977 
John J. Boronow 
Margery B. Brenner 
Richard D. Bucholz 
Christopher S. Clark 
Sybil E. Duchin 
James A. Fox 
Julia B. Frank 
Robert W Hand 
Edwin K Huang 
Bruce L. Innis 
Karen G. Kelly 
Howard K. Koh 
David J. Kreis, Jr. 
Rex L. Mahnensmith 
Margaret S. McKenna 
Robert J. Mitchell 
Alan S. Penziner 
Lawrence E. Samelson 
Ricky M. Schneider 
Simeon A. Schwartz 
Gail M. Sullivan 
Ronald J. Vender 
Steven L. Warsof 
Diana R. Wasserman 
J. Donald White 
Daniel Wohlgelernter 
1978 
Thomas T. Amatruda 
Michael J. Anderson 
Richard J. Baron 
Duke E. Cameron 
David F. Cawthon 
Jesse M. Cedarbaum 
James N. Dreyfus 
Eugene G. Fong 
Stuart M Forman 
Linda J. Hall 
Robert Hershfiled 
J. Edward Jackson 111 
Robert L. Kraft 
Seth M Powsner 
Neal D. Ryan 
Donald C. Simonson 
Harry Staszewski 
Stanley .1. I illinghast 
Jonathan D. Weinberg 
Sharon R. Weinstein 
David L. Wessel 
1979 
Nancy Berliner 
Richard D. Bey 
Guthrie S. Birkhead III 
Michael M. Chang 
Orlando Fernandez 
John J. Gargus 
Bruce Halperin 
Edward C. Halperin 
Jeffrey L. Kaine 
Timoth W. Mckeithan 
David E. Ness 
Westley Reeves 
Gary L. Schaer 
Jill A. Silverman 
Thomas .1 Smith 
John T. Woo 
Jeffrey Work 
1980 
David E. Adelberg 
Seth l.. Alper 
Frederick R Aronson 
David A. August 
Jay M Baraban 
Mark S. Bernhardt 
Paticia C. Brown 
Stuart l.. Bursten 
Michael W. Champeau 
Forrest J. Doud 
T odd J. Garvin 
Gary 1 Greenwald 
Christopher G. Henes 
Jonathan L. Jacobs 
Theodore W. Marcy 
Suzanne M. Matsui 
Cesar R. Molina 
Steven I. Rosenfeld 
Albert L. Siu 
Hillel D. Skoff 
Marcia R. Taylor 
1981 
Cynthia B. Aten 
Patricia A. Burke 
Colleen Bursten 
Christine M. Duranceau 
Louis Essandoh 
Ramona Q. Fung 
Robert S. Goldman 
Laurie .1. Gordon 
Scott A. Hundahl 
Barton N. Milestone 
Robert M. Milstein 
Barbara A. Roach 
Anthony M. llrbano 




Jed B. Gorlin 
Michael E. Katz 
Carrie A. Redlich 
Albert L. Ungricht 
Stephanie Wolf-Rosenblum 
Epidemiology and Public Health 
1982-83 Contributors 
1923 
Isidore S. Falk 
Leonard Greenburg 
1927 
Alice S. Baldwin 
1928 
Mamie F. Hulsman 
1929 
Gertrude S. Boyle 
1930 
Ruth E. Grout 




Edward B. Bosworth 
Miriam M. Campbell 
Evelyn H. Halpin 
Stanley B. Lindley 
Elizabeth Murphy 
1934 
Ival A. Merchant 
Iwao M. Moriyama 
Amy H. Wilson 
1935 






Lidie V. Dyer 
Howard West 
William R. Willard 
1938 
Willard H. Boynton 
Richard K. Lee 
Katharine H. Martin 
Andrew S. Wong 
1939 
Carl I. Cohen 
James C. Hart 
Frances S. Miller 
1940 
Elizabeth H. Pitney 
Meyer J. Plishner 
1941 
Roslyn L. MacNish 
Alexander Witkow 
1942 
Henry F. Canby 
Leonard Parente 




Richard F. Clapp 
Carolyn S. Koffler 
Eric W. Mood 
Laurence T. Rogers 
Miriam H. Rohde 
1944 
Massimo Calabresi 
Jean F. Heston 
1945 
Jane Y. Parker 
Roslyn R Bilford 
Mary B. Dale 
Naomi B. Golden 
Joe B. Graber 
Lois M. Jund 
1946 
Edith M. Blakeley 
D P. Nelson 
1947 
Sidney S. Chipman 
Clara E. Councell 
Anne E. Fulton 
Lillian L. Konick 
Raymond W. Leonard 
Edna Miller 
Jean M. Pinder 
Cecil G. Sheps 
Samuel Zibit 
1948 
Mary L. Ellis 
Mary M. Fitzgerald 
Samuel S. Herman 
Barbara L. Holman 
Richard E. Johnson 
Dorothea S. Labelle 
1949 
Eleanor C. Connolly 
Lena M. Di Cicco 
Edgar L. Geibel 
Eleanor P. Kostant 
Hilda H. Kroeger 
Christine R. Owre 
William B. Parsons 
Elizabeth D. Robinton 
Mary C. Springer 
1950 
Henry G. Brickman 
Hilda B Carr 
Helen P. Cleary 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R Granoff 
Eugene K. Harris 
Martha P. Jayne 
Everette D. Reese 
Frances K. Reynolds 
Nathan M. Simon 
John D. Thompson 
1951 
Hector R. Acuna 
Clarissa E. Boyd 
Norton Ci. Chaucer 
Joanne E. Finley 
Florencia M. Herrera 
Homer P. Hopkins 
George Kraus 
Leonard F. Menczer 
Emi T. Ogi 
Jessie P. Spear 
Angelica Z. Syseskey 
Elizabeth U. Throm 
Virginia E. Torres 





Malcolm C. Hope 
Charles H. Lawrance 
Sidney S. Lee 
Helen K. Loria 
Yolande F. Lyon 
Richard B. Ogrean 
Ralph T. Palmer 
Jeanne E. Paty 
Anne B. Ramsay 
Brena B. Wolff 
1953 
Jeanette Averill 
Harold R. Bernshock 
Abraham Cutcher 
Graydon Dorsch 
William H. Hermann 
Barbara J. Lee 
Laurence K. Rainsford 
Milton H. Sisselman 
Constance B. Thomas 
Donald N. Zehl 
1954 
Donald R Cowan 
Alvin Hamburg 
Calvin P. Hatcher 
William A. Markey 
Ruth M. Taber 
1955 
Lester M. Bornstein 
Amy L. Cawley 
Evelyn S. Farnsworth 
Israel Gitlitz 
Morris London 
Mary M. Mogan 
Frances R Ogasawara 
Gerald Rosenblatt 
Daniel E. Ross 
1956 
David D. Boyd 
Kathleen H. Howe 
Paul C. Kaufman 
Julia R. Nole 
Mary K. Ochiai 
Henry M. Parrish 
1957 
Janet Beach 
Lee D. Cady 
William A. Clermont 
Edward R. DeLouise 
Sheldon S. King 
Edna M. Klutas 
William R. Metzger 
Jerome R. Sapolsky 
Shirley T. Steidel 
Paul W. Sternlof 
Sylvia R. Talbot 
Patricia A. Viscosi 
1958 
Josephine Blanchett 
Helen H Davenport 
Thomas T. Flynn 
Philip B Hallen 
Edward H Noroian 
Thomas P Weil 
1959 
Cesar A. Aleman 
Bennett I. Enowitch 
John T. Foster 
Folly Hofer 
William L. Kissick 
Marvin A. Lavenhar 
Lee J. Podolin 
John S. Pullman 
Hugo Saenz Noguerol 
Ellwyn D. Spiker 
Kenneth J. Williams 
1960 
Bruce A. Barron 
Gyla E. Brooks 
Kathryn L. D’Amico 
Wouter Ekker 
Rose A. lannotta 
Katharine A. Keppel 
Lowell S. Levin 
Hannah C. Russell 
1961 
Gordon R Beem 
Mary S. Blackburn 
Martin Donabedian 
Alfred E. Fletcher 
Yoh O. Lee 
Helen M. O’Connell 
Margaret R. Parker 
Angela M. Russo 
William R. Slivka 
K.B Sohler 
1962 
Richard B. Blakney 
James E. Bowes 
Thomas R. Mayhugh 
1963 
Dorothy W. Brockway 
Raul R. Cuadrado 
David Dolins 
C.D. Florey 
Edward M. Kenney 
Jean M. Maynard 
David R. Sheehan 
Samuel B Webb,Jr. 
1964 
Maria S. Baisier 
Elizabeth C. Beilis 
Katherine M. Detre 
Linda F. George 
Virginia L. Hamel 
Martin Hirsch 
Carter L. Marshall 
Carole S. Profant 
Theodore Rosenberg 
Estelle Siker 
Monroe W. Spero 
Claudewell S. Thomas 
1965 
Robert M. Edwards 
H P Harris 
James F. Jekel 
Michael E. Kove 
Peter J. Levin 
Elliot A. Segal 
Viola J. Spinelli 
Alice J. Turek 
1966 
Allen Cohen 
Jennifer L. Kelsey 
Birch H Milliken 
1967 
Caroline F. Cheng 
Richard W. Gerry 
Ann Gomez 
Steven Jonas 
Joseph F. Kukla 
Patricia D. Mail 
James M. Malloy 
Brigitte Prusoff 
Bruce J. Steinhardt 
Beth M. Whelan 
Irma Willner 
Robert L. Woodward 
1968 
Philip D. Cobb 
Soma M. Colon 
Joseph L. Dorsey 
Robert R Everett 
L.C. Fernow 
Carl R. Fischer 
Katherine S. Fraser 
Francis J. Greaney 
Susan F. Klein 
Jean C. MacCorison 
John M. Patton 
Richard L. Petrelli 
Arnold R. Saslow 
Doreen P. Sharabati 
Elizabeth S. Small 
Martha F. Steel 
Sheila W, Wellington 
Elizabeth C. Wright 
Barbara L. Yetka 
1969 
Susan S. Addiss 
Victor Crown 
Gerald R Harpel 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
Samuel P. Korper 
Robert Merritt 
Judith B Nichipor 
Marva Serotkin 
Wanda Vierthaler 
Gary K. Weygant 
Robert L. Young 
1970 
Susan W. Balter 
Arthur A. Berarducci 
Michael B. Bracken 
Shan Cretin 
Walter M. Gawlak 




David A. Pearson 
Nancy N. Reitz 
Charlotte F. Schwartz 
Stephen Skorcz 




Evelyn J. Bromet 
Willard Cates 
Katrina Clark 
Dale A. Culp 
John A. Daeley 
Harvey Fernbach 
William P. Ferretti 
Anne-Marie A. Foltz 
Sara P. Hartman 
Wanda J. Hatmaker 
Mohamed 1. Johnson 
William 1’. Koughan 
Bernard G. Koval 
Catherine S. Lindenberg 
Mark J. Magenheim 
Eugene S. Mayer 
Joseph S. McManus 
Lloyd F. Novick 
David A. Osgood 
Carol L. Paul 
Jane Silver 
Walter O. Spitzer 
David L. Stockton 
1972 
Stephen B. Baruch 
Paul G Bushnell 
Catherine A. Connolly 
Paul Finlayson 
Daphne D. Gemmill 
Dorothy N. Lewis 
Sergio Ruschel 
Jo Ann K. Silverstein 
Laurence A. Tanner 
Frederick A. Vago 
Joyce R Waksman 
Carol H Yee 
1973 
Emily M. Barclay 
Judith G. Beatrice 
Eva D. Cohen 
Bernice E. Coleman 
Ellen B. Doft 
Chang S. Lao 
Dennis P. May 
Marjorie E. Nelson 
Gary D. Sax 
Janet B. Schoenberg 
Thomas J. Stranova 
Irene Trowell-Harris 
Bonnie C. Yankaskas 
1974 
Gregory Belok 
Thomas A. Benoit 
Ian B. Berger 
Roger H Bernier 
Roger D. Brittain 
Olga M. Brown 
Beth G. Crocker 
J B. Eagle 
Elizabeth M. Helming 
Roberta Lawrence 
Karen K. Lindfors 
Edward A. Martinez 
Richard H. Matheny 
Heather M. Ogilvy 
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Nils R. Richardson 
Carol T. Schreiber 
Shelley S. Shanok 
Abigail L. Smith 
J.L.. Tanenbaum 
Myrna M. Weissman 
1975 
Clayton A. Ajello 
Christine P. Antaya 
Edith N. Baum 
Ralph E.Binder 
Gerald Bisbee 
Linda K. Broker 
Ann C. Cunningham 
George R. Curry 
Hillary Demby 
Linda K. Demlo 
Jack A. Eiferman 
Gerard R.Goulet 
William J. Grego 
Anne H. Hall 
Philip D. Kennedy 
James E. Knoben 
Kathy S. Kohn 
Nancy J. Kreiger 
Stuart L. Lefkowich 
Angela R. McLemore 
Laurence F. McMahon 
Dennis W. Mesenhimer 
Lois S. Michaels 
Mary W. Palshaw 
William P. Quinn 
Dale P. Sandler 
Edward V. Sargent 
Nancy E. Stroup 
Franziska U. Ulrich 
Audrey S. Weiner 
Marion L. Wu 
1976 
Elaine P. Anderson 
William F. Appicelli 
Cheryl F. Austein 
Catherine M. Boyle 
Kathleen K. Bucholz 
Frances L. DePeyster 
Joanna M. Erikson 
Paul H. Etkind 
Berton D. Freedman 
Annette B. Garofalo 
Gail 1. Genvert 
Linda J. Goodhart 
Karen A. Gordon 
Frances A. Kanach 
Robert T. Kauer 
Robert A. Knauf 
Robert C. Marquardt 
Lawrence V. Meagher 
Ruth F. Quah 
Mary Jo Shepard 
Robert Silten 
Marcia A. Testa 
Gladys A. Williams 
Thomas S. Wingardner 
1977 
Richard B. Burford 
Patrick E. Carone 
Steven R. Cohen 
Gerard J. Foley 
Ellen D. Jaslow 
Susan J. Kennedy 
Rhona K. Kershnar 
Teri J. Klein 
Wendy K. Lefkowich 
I heodore V. Marsters 
Maria W. Marvin 
Martin A. Mass 
Kristin K. O’Connor 
Jean B. Oster 
Harris Pastides 
Linda M. Pottern 
Dorothy A Rice 
Deborah Rose 
Abby Rothschild 
Anthony V. Sardinas 
Carroll Schilling 
Barbara G. Smith 
Gail M. Sullivan 
Rose M. Truax 
Thomas H. Ulfelder 
Leon F. Vinci 
1978 
David S. Abernethy 
Vijaya V. Bapat 
Kathleen M. Berman 
William H. Blitz 
Maura Carley 
Robert J. Fensterheim 
Robert H. Frazier 
Ann T. Freedman 
Janice F. Gold 
Olympia Hadjimichael 
Stephen W. Hildreth 
David W. Houck 
William A. Howard 
Jean C. Jones 
Margaret I,. Karis 
Roslyn 1. Liss 
John Mauro 
Christopher M. Maylahn 
Marguerite Nelligan 
Elizabeth L. Pantelick 
Ellen J. Reifler 
George C. Roush 
Karen C. Schneider 
Robert E. Schwartz 
Roberta J. Shapiro 
Gloria Shappy-Meickle 
Roberta N. Silbert 
Alan J. Siniscalchi 
Marie Stoeckel 
Sydney S. Tang 
Bernadette S. Vissam 
Lucy E. Weiger 
Karen S. Wolchuck 
1979 
Bruce S. Anderson 
Virginia P. Bainbridge 
Marianne Berwick 
Marna P. Borgstrom 
Russell J. Bramlage 
Maria A. Buatti 
Christopher M. Cannon 
Elizabeth S. Carter 
Ralph J. Coburn 
Susan DeRenzo 




Judith B. Gancher 
Lucinda H. Gerson 
Bruce H. Heckman 
Shelley Heifer 
Karen G. Hellenbrand 
Catherine Hobbins-Norton 
Karen Kmetzo 
Paul A. Kowalski 
Renee S. Leary 
Bennett M. Locke 
Mary E. Lorenzi 
Elisabeth L. Luttgens 
Osvaldo Marrero 
Laura G. Meisler 
Patricia J. Moore-Pastides 
Anna M. Reager 
Betty J. Reid 
Marcia C. Richardson 
Lisa K. Rosenfeld 
William E. Schweizer 
Audrey P. Silvey 
Ralph Tartaglione 
Ilene B. Wachs 
Louise Wise 
1980 
Phillip R. Aaron 
Gary J. Aboff 
Frederick R. Aronson 
Curtis S. Breslin 
Deborah J. Carr 
Sheila Conneen 
Diane L. Denis 
Phyllis F. Dower 
Beth M. Finkelstein 
Susan G. Gold 
Ellen B. Greif 
Samuel S. Hamilton 
Lester W. Holcomb, Jr. 
Virginia S. Humphrey 
Helen E. Kelly 
Yee-Lean Lee 
Robert V. Levine 
Paul A. Locke 
Anne M. McNally 
Ann L. Prestipino 
Christina P. Quinn 
Jeri A. Rose 
Jane T. Siegal 
Alice S. Stark 
Benita J. Sticca-O’Colman 
Richard G. Stracqualursi 
Philip A. Witman 
1981 
Jean Adnopoz 
Rollin C. Chew 
Ann M. Dunbar 
Kristen H. Forrest 
Richard T. Forsley 
Robert Fox 
Barbara A. Gaugler 
Marie F. Gavula 
Louis M. Gonzalez 
Susan A. Hart 
Blackford Middleton 
Marlee D. Mooney 
Charles W. Nelson 
Mary E. Papke 
Elizabeth N. Shapiro 
Karin Swanson 
Joan H. Urquhart 
John A. Yopp 
1982 
Lynn A. Baden 
Janet M. Bedney 
Nancy P. Hopkins 
Charles A. Klivans 
Linda F. McCaig 
Jill A. Okrent 
Susan G. Poland 
Dale A. Rublee 
Lisa E. Stone 
Scott D. Stratton 
Michele T. Visconti 
Sandra M. Warren 
Daniel Wartenberg 
Alvin C. White 
Amy B. Wilson 
Epidemiology and 
Public Health Associates 
1982-1983 Contributors 
Thomas H.G. Aitken 
Edward M. Cohart 
Daniel H. Freeman,Jr. 
Adolf Pharo Gagge 
Horace M. Mazzone 
John W. Meigs 
John A. Nelson 
Cohn White 
House Staff 
Mary C. Bibro 
Steven A. Brody 




Douglas P. Hobson 
Eric A. Hyson 
Wayne Julian 
Steven Karp 
Jill P. Karpel 
Joel C. Labow 
Sheri J. Lagin 
Peter G. Levinson 
John D. Lewis 
Steven Macht 
Frank Masino 
Richard J. Maunder 
Seymour C. Nash 
Ruth E. Oda 
Raymond L. Osborne 
Robert L. Paltzik 
Pradip M. Pathare 
William A. Pettinger 
Donald C. Rankin 




Stephen A. Ross 
William T. Rowe 
Mark Rubenstein 
Anton Schittek 
Louis N. Scotti 
S. William Seidman 
Leonard M. Selsky 
Richard A. Selzer 
Vernon H. Sharp 
Stephen R. Schell 
Frederic N. Silverman 
Paul I. Silverstein 
Earl J. Simburg 
Richard I. Staiman 
Sally K. Stansfield 
John G. Steciw 
Sturla Stefansson 
Elsa L. Stone 
Fred L. Strieker 
Craig Summers 
Herbert Tabor 
Imad F. Tabry 
Theodore Tyberg 
Daniel W. Vanheeckeren 
Romulo L. Villar 
E. Maurice Wakeman 
Thomas A. Warthin 
Alan Weinberg 
Ssu I. Weng 
Herbert A. Wenner 
Robert R. White 
Elizabeth Wiesner 
Robert J. Williamson 
Suna Woods 
Eiji Yanagisawa 
Robert C. Young 
Marvin P. Zimmerman 
Richard W. Zimmerman 
Lawrence H Zingesser 
Louis Zinterhofer 
35 
Parents and Friends 
Sidney H. Abrams 
Kurt I. Altmann 
Dorrance 1. Anderson 
Robert August 
Stanley August 
John & Marie Babich 
Edwin Beall 
Suzanne Berman 
Ormonde L. Brown 
Minnie R. Cartwright 
Abe Cazen 
Richard Childs 
Sidney J. Cohen 
Willibald H. Conzen 
Daniel W. DeRenzi 
Kenneth T. Doran 
William C. Drennan 
William G. Dyess 
Max Finkelman 
Jose M. Garcia-Madrid 
Roger W. Gilbert 
Herbert I. Goldman 
Harold Grant 
Kenneth H. Gutner 
Murray Halperin 
Earl Hellerstein 
Frederick W. Heilman 
Robert E Herzstein 
Carl Hirshfield 
Gloria F. Holmes 
J. S. Holt 
Harold Katz 
Kenneth P. Kinney 
Theodore H. Klein 
Boris Kliot 
Harry D. Krause 
Sanford M. Leff 
Joseph Litchman 




Herbert A. Nestler 
Victor M. Newman 
William G. O’Donnell 
Richard D. Otis 
William E. Palmer 
Samuel Perlman 
Levi V. Perry 
Leonard Portney 
Howard 1. Ratain 
R. Donald Reich 
Irving Rosenberg 
Joel G. Roth 
Klaus G. Rucker 
Jack Saltz 
Harold & Frances Sampson 
Joseph Schlesinger 
Arthur A. Shachner 
Norman N. Sharpe 
Jerry Sherman 




Mark L.. Sternlicht 




Irene G. Werne 
Tony Y. Wong 
Rosalyn Yarmush 
Sheldon M. Young 
Herman H. Zusman 
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DR. ROSENBERG — DEAN DESIGNATE 
Dr. Leon E. Rosenberg, one of the nation’s leading 
geneticists and a distinguished teacher and clinician, 
has been appointed the next dean of the School of 
Medicine. On July 1, he will succeed Dr. Robert W. 
Berliner, who has been dean since 1973. Dean Berliner 
plans to take a sabbatical year before retiring as 
professor emeritus of physiology and medicine. 
Dr. Rosenberg, who is C.N.H.Long Professor of 
Human Genetics, Medicine and Pediatrics, helped 
organize the Department of Human Genetics and has 
been the chairman since it was established in 1972. 
Under his direction, the department has pursued a 
vigorous and comprehensive program, ranging from 
basic research into the molecular structure and function 
of the gene to caring for and counseling patients with 
genetic problems at Yale-New Haven Hospital. 
In announcing Dr. Rosenberg’s appointment. Presi¬ 
dent A. Bartlett Giamatti said, “The University and its 
School of Medicine are immensely fortunate that Dr. 
Rosenberg has accepted this important position. He is 
a distinguished physician-scientist and 1 know he will 
provide the school with superb leadership in the 
coming years. I wish to affirm again the University’s 
commitment to the life and work of the school, and to 
say how fortunate we all are to have in our next dean 
what we have had in Dean Berliner, an outstanding 
leader for the School and citizen of the University.” 
“Dr. Rosenberg is a highly respected member of the 
medical center community who has brought great skill 
and effective leadership as chairman of the Department 
Human Genetics,’’said C. Thomas Smith, president of 
Yale-New Haven Hospital. “I applaud President 
Giamatti’s choice and look forward to working with 
Dr. Rosenberg as we both seek to serve the joint 
interests of the hospital and the School of Medicine.” 
Born in Madison, Wisconsin, Dr. Rosenberg received 
his B.A. and M.D. degrees, both summa cum laude 
from the University of Wisconsin. Following internship 
and residency at the Columbia-Presbyterian Medical 
Center, he was a clinical associate and senior investi¬ 
gator with the National Cancer Institute’s Metabolism 
Service from 1959 to 1962, when he first came to Yale 
as a senior assistant resident in medicine. He returned 
to the National Cancer Institute before he was appointed 
assistant professor of medicine at Yale in 1965. He was 
named professor of human genetics, medicine and 
pediatrics in 1972, and was appointed to the C.N.H. 
Long professorship in 1980. 
Dr. Rosenberg has emphasized that he will remain 
committed to the clinical program of the School as well 
as to its teaching and research activities. “I look 
forward to the challenge that this appointment 
presents,” he said. “The excellence of this place is a 
tribute to a fine faculty which has been recruited by 
successive Yale presidents and deans, to the high 
standard of the students we are able to enroll, and to 
the effective partnership between Yale’s medical school 
and Yale-New Haven Hospital. This is a unique school 
which proudly demonstrates that succesful cooperation 
can exist among the teaching, research and clinical 
sides of medicine.” 
2 
Dr. Rosenberg is a fellow of the American Academy 
of Arts and Sciences, the American Association for the 
Advancement of Science, and past-president of the 
American Society of Human Genetics. He received a 
Guggenheim Foundation Fellowship in 1972, and the 
following year, the Borden Award from the American 
Academy of Pediatrics for outstanding achievement in 
research relating to infant nutrition and development 
of children. In 1982, the University of Wisconsin 
School of Medicine presented him with its Distin¬ 
guished Alumni Citation, and that same year, he was 
elected to the Institute of Medicine of the National 
Academy of Science. Dr. Rosenberg is a member of 
numerous professional societies including the Associa¬ 
tion of American Physicians, the American Pediatric 
Society, the American Society of Biological Chemists, 
and the American Society of Human Genetics. 
In 1980, when he was elected president of The 
American Society of Human Genetics, Dr. Rosenberg 
told his colleagues, “When your experiments don’t 
work, or your grant deadline is approaching, or your 
patients appear ungrateful, don’t unburden yourself to 
your undergraduates, your graduate students or your 
postdoctoral fellows. Lock yourself in the closet, jog, 
complain to your spouse, have a beer, but don’t 
frighten the kids. They might just take you seriously. If 
you must tell it like it is, please be sure to give equal 
time to the privileges and pleasures of academic life, to 
the dazzling sense of well-being that follows scientific 
discovery, and to the excitement that each of us knows 




by C. Thomas Smith 
The following article was excerpted front a talk by Mr. 
Smith, entitled “The Health Needs of the Disenfran¬ 
chised: The Impact on Connecticut Hospitals’’, 
presented at the Fifth Annual Leadership Program for 
Trustees, Physicians, Nurses, and Administrators in 
September 1983. The program was sponsored by The 
University of Connecticut, The Capital Area Health 
Consortium, and The Connecticut Hospital 
Association. 
Hospitals and the poor are not new acquaintances. 
Students of hospital history know that the first hospitals 
were primarily places for the poor to die. People of 
means did not go to hospitals, since there was little that 
could be done for patients except to provide basic 
sustenance and comfort. The charitable origins of 
hospitals reflected the concern, especially of religious 
groups, to provide a shelter for the disadvantaged of 
our society. The development of medical knowledge 
and technology which changed hospitals to places of 
healing also changed their clientele to all members of a 
community. 
Since most hospitals began for charitable purposes, 
they maintained that format as they changed from 
social agency to technical institute to complex corpor¬ 
ation. Throughout this evolution, non-profit hospitals 
have continued to provide services to people with little 
or no resources. Unfortunately, the pressure on financial 
performance may have caused some institutions to 
forget these charitable origins and to focus on doing 
well financially versus doing good for the community. 
Although too often not understood, it is necessary to 
be financially strong in order to be able to provide free 
services. While charity care is free to the recipient, it 
obviously costs something to provide it. That cost 
must be supported by resources; good will is insufficient. 
Forgetting our charitable origins, however, ignores 
one of our reasons for being and invites treatment as 
any other commercial enterprise. Preservation ot our 
non-profit status requires attention to the reason it was 
conferred. 
Non-profit hospitals have always attempted, to 
varying degrees, to make services available to the 
disadvantaged. Prior to the passage of Medicare and 
Medicaid, government payment for “charity” or 
“welfare” patients was often a token amount that was a 
Mr. Smith is president of Yale-New Haven Hospital 
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fraction of the costs. Hospitals made up the difference. 
However, since the development of cost-based payment, 
there has been a myth that hospitals were paid by 
certain buyers of care, especially governments, on a 
full cost basis. The public, and even some hospital 
staff, believe that all costs are paid by third-parties. 
Unfortunately, such is not the case. Even after the 
implementation of Medicare and Medicaid, hospitals 
have continued to be paid on a cost-minus basis for 
government-sponsored patients, although payment 
levels have been significantly better than prior to these 
programs. Certain expenses, such as free care, bad 
debts, fund-raising costs and a provision for capital 
requirements (except for for-profits), were all excluded 
from the so-called cost-reimbursement equation. 
We have allowed, indeed required, the non-profit 
hospitals of our nation to function as quasi-tax 
authorities with income redistribution functions. Govern¬ 
ment underfunding has forced hospitals to levy a tax 
on non-government patients to make up for the short¬ 
fall on patients paid for by governments. Hospitals 
with large numbers of low-income, government-spon¬ 
sored patients are especially vulnerable to such 
underpayment. 
The extent to which a hospital serves such patients 
determines the degree of increase in charges to other 
patients to cover this short fall. This cost-shifting 
























historical relic in the near future. 
If the achievements of the health sector were applied 
to another area, it would be judged a raging success. 
Goals were achieved regarding increased access, 
comprehensiveness of care, diffusion of technology, 
expansion of knowledge, increased capacity, high 
utilization, recession-proof employment and constantly 
increasing sales. Since 40 percent of resources for this 
sector come from governments, who have other prior¬ 
ities, such success interferes with other obligations. 
Therefore, instead of being applauded for our achieve¬ 
ments, we are being scrutinized for our excesses. 
We seem to have passed through an era of societal 
concern that everyone have access to all health services. 
While we fell short of that goal, we came close. A 
Robert Wood Johnson Foundation report showed 
that the number of visits to physicians per person per 
year changed between 1964 and 1978 in favor of the 
poor. Specifically, in 1964 the poor averaged 24 
percent less visits than the non-poor, whereas in 1978 
the poor averaged 19 percent more visits. In terms of 
expense, the same study showed average Medicaid cost 
equal to the population average, suggesting equivalent 
utilization of services by the poor. 
Limited government resources have called attention 
to the need to place limits on growing government 
obligations. Perhaps no other area of social service 
support has had the somewhat open-ended funding as 
has health. As governments have attempted to augment 
or provide support for other essential services, i.e., 
housing, food, general assistance, even education, they 
have been far more restrictive in goals and practice 
than in health. Some of us believe that health deserves 
such special treatment due to its essentiality for 
sustaining life and enhancing its quality. However, 
other essential needs have never been supported at the 
same qualitative level as have health services. Unfortu¬ 
nately, for both the recipients and the providers, main¬ 
stream health care seems destined for the lowest 
common denominator which is applied to other essential 
social services. 
Sadly, poverty breeds health problems. While attend¬ 
ing to disabling disease or injury is a priority across all 
segments of society, maintenance of health does not 
merit priority attention from people who are unem¬ 
ployed, hungry and worried about the next rental 
payment. In addition, given the high proportion of 
secondary school drop-outs in this category, little 
opportunity has been available to instill the importance 
of prophylactic care and the impact of life style choices 
on health status. Consequently, problems develop that 
might be avoidable and medical services are often 
sought late in the disease process. 
The over-used slogan, “Health Care is a Right”, has 
perhaps deluded us into believing that such an assertion 
made it true. While much legislation has been passed to 
improve access to services, there has not been statutory 
and funding support to undergird the slogan. Absent 
any legal right, therefore, we must continue to depend 
upon a sense of moral obligation to support the 
assertion. 
“Rights” imply that someone or some agency (usually 
government) has responsibility to assure that they are 
fulfilled. Without an assured government commitment 
to guarantee delivery of needed services, health 
providers are left to try, as they have historically, to 
play a quasi-governmental role without funding to 
support it or taxing authority to finance it. This places 
providers in the position of deciding how to allocate 
their scarce resources between individual needs which 
may be compelling, e.g., liver transplants, versus 
attempting to do the greatest good for the greatest 
number of people. Such profound decisions are never 
easy, and they are impossible in the face of individual 
need. No one is comfortable in deciding to withhold 
available care for financial reasons. Broad public 
policy guidelines should be developed through the 
political process in consultation with providers, rather 
than leaving such judgements to ad hoc, emotional 
circumstances. 
While health services are essential to all segments of 
society, medical treatment of diseases which grow out 
of poverty conditions is analogous to treating symp¬ 
toms, not underlying causes. Episodic conditions may 
be ameliorated, but they are just as likely to reappear. 
Acute health services barely touch the fundamental 
problems which produce some of the disconcerting 
health statistics. 
In the recent important book, “The Social Transfor¬ 
mation of American Medicine”, author Paul Starr 
commented on the doubt that developed in the late 
1970’s regarding the ability of the health system to 
solve all health problems. Several pertinent quotes 
portray the cynicism which developed in concert with 
concern about rising costs: 
“Instead of merely questioning whether hospitalization and 
surgery were excessive, critics began to ask whether medical care 
made any difference in the overall health of society.” 
“It had long been known that medical care, especially when 
compared with the environment or social behavior, has relatively 
modest effects on mortality rates... It suddenly struck intellectuals 
and policy makers of diverse persuasions that this was the answer 
to those who constantly wished to expand access to health care.” 
“If the first revelation of the seventies had been that a 'health care 
crisis’ existed, the second revelation was that health care hardly 
affects health . . . the generalization of doubt undermined the 
generalization of rights. Distributive justice is a morally compelling 
concern, after all, only when what there is to distribute, or 
redistribute, is truly valuable. If it is irrelevant or harmful to 
human welfare, the poor would be better off without it.” 
Such skepticism has forced health providers to 
carefully evaluate the efficacy of treatment programs. 
Closer scrutiny is being applied to new technology to 
be sure that it will make a difference for patients, either 
therapeutically, economically, or in terms of comfort 
or human dignity. Too often, new medical technology 
is additive, rather than substituting for existing modal- 
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ities. Changed financial incentives will have a marked 
impact on past practices of each hospital having all 
alternative services, to having only those which are 
most therapeutically beneficial and cost effective. 
Despite a healthy doubt about health services solving 
problems which are best addressed by other social 
interventions, there remains a significant demand for 
necessary services by the poor. Even though medical 
interventions may be episodic of broader underlying 
social problems, the episode must still be managed. 
Medical care will still have to be provided and 
hospitals will be the major providers. What alternatives 
are available to hospital leadership to cope with the 
probable continued inadequate funding for care for 
the permanent and temporarily poor, as well as other 
financial pressures on our institutions? One simplistic 
solution, articulated by a former Secretary of the 
Department of Health and Human Services, is that 
hospitals are so obese that the loss of fat is not only 
achievable by hard-nosed management, but it will also 
result in a healthier hospital with little untoward 
impact on patients. Presumably, this would solve our 
financial problems and assure the poor of needed care. 
To be sure, honest appraisal requires acknowledgement 
that such steps can be achieved in some hospitals. 
Similarly, many governmental programs can be 
managed more effectively, as can many businesses. No 
sector of our society (including HHS) has a corner on 
management wisdom and skills, nor is any perfect. We 
can all utilize resources more effectively. 
Rather than be defensive, we should be sure we 
understand and convey to our communities the conse¬ 
quences of financially-oriented decision-making to 
health services. Certainly, steps should be taken to 
eliminate inefficient practices. If that means merger 
between institutional programs which will assure the 
community access to effective services, it should be 
done, regardless of bruised institutional egos. However, 
if program closure means patients will not have access 
to needed services, the community must decide what 
price it is willing to pay to have them available. 
Some communities have decided that the most 
attractive solution is to turn their hospital (sometimes 
a government-owned facility, sometimes owned by a 
non-profit entity, even religious institutions) over to a 
national for-profit hospital chain. No doubt, such 
steps are attractive in the short-run, because of the 
financial relief provided. In addition, the management 
responsibilities are assumed by an organization that 
may be better able to handle them. However, the long¬ 
term impact of such a step on the less fortunate of the 
community may be disastrous. A recent series in the St. 
Petersburg, Florida, newspaper. The St. Petersburg 
Times, described the impact of for-profit institutions 
on those without the ability to fully pay for their care. 
Denials of service and shifting of patients to non-profit 
hospitals is common in this environment. 
Other newspapers and magazines have recently had 
numerous articles on changes occurring in the health 
care industry. Several have featured the increasing role 
of large corporations which control health services. 
This reasonably recent phenomenon was noted in Paul 
Starr’s book, as he expressed his views of one impact 
from this trend: 
“A corporate sector in health care is also likely to aggravate 
inequalities in access to health care. Profit-making enterprises are 
not interested in treating those who cannot pay. The voluntary 
hospital may not treat the person the same as the rich, but they do 
treat them and often treat them well. A system in which corporate 
enterprises play a large part is likely to be more segmented and 
more stratified. With cutbacks in public financing coming at the 
same time, the two-class system in medical care is likely to become 
only more conspicuous.” 
Perhaps in our perceived role as guardians of the 
community’s health, fulfilling a quasi-governmental 
function, we have assumed that we are best able to 
make decisions as to how the community expends its 
health care dollars. We have been allowed to function 
relatively freely in the past, but concern about costs is 
changing the locus for decision-making away from 
providers. Buyers of care will now' be calling the shots. 
Our burden will be to assure that the consequences of 
decisions are fully understood, including any untoward 
impact on a segment of patients. This will require that 
we understand what difference health service makes 
and that we function as advocates for those least able 
to speak up for their needs. 
Our institutional missions proclaim our commitment 
to everyone’s needs, but the price may become too 
high. Our past income redistribution practices seem 
short-lived. Furthermore, with the demise of cost- 
based payment, we w ill no longer be paid for what we 
do. Now we must learn to do that for which we get 
paid. The distinction between these patterns is signifi¬ 
cant and far-reaching. If those who buy our services 
are willing to pay only for the services provided and 
nothing else including subsidizing care of the poor 
then we will either comply w ith such strictures or go 
out of business. Perhaps some hospitals or programs 
should close. However, the poor are likely to be most 
affected by such terminations, as the non-poor can 
seek service elsew here. Therefore, our only option is to 
devise ways to reduce costs to levels wdiich buyers are 
willing to pay. 
In the short-run, we may see several actions by 
hospitals: 
1. Product-line evaluations will, inevitably, 
result in the termination of programs 
which are not financially viable. The poor 
are especially vulnerable to such changes. 
2. Some patient shifting may occur as providers 
seek to minimize their free care and bad 
debts. The absence of public hospitals in 
Connecticut may limit patient transfers 
between hospitals, but it will not mitigate 
the existing pattern of ambulatory care. 
While hospitals and non-hospital providers 
6 
may compete for remunerative ambulatory 
services, there is little competition with 
hospitals to serve those with few or no 
resources. Means need to be developed to 
share this community responsibility, or 
certain institutions will eventually collapse 
from this unevenly distributed burden. 
Physicians, particularly, should consider 
the long-term consequences of this pattern 
and their responsibilities to share some of 
the load. 
3. Health services to the poor will be scaled 
down to essential services. Basic care will 
be provided, absent amenities which may 
be considered desirable, but not critical. 
4. More careful financial screening will occur 
to assure that those receiving subsidized 
services are those who most need them. 
Those eligible for governmental support 
will be required to show evidence of 
approval for it prior to receiving service. 
5. Emergency care will continue to be provided 
by hospitals, but the closure of high-cost, 
low usage services will result in shifting of 
patients requiring specialized care which 
will be available at fewer institutions. 
Non-emergent care will be limited or 
deferred. 
The longer view is always cloudier. However, a 
number of forces already in motion suggest probable 
nationwide trends that will ultimately affect all 
hospitals: 
1. Prudent buyer efforts by government and 
business will force institutions to pare 
costs to levels purchasers are willing to 
pay. Hospitals will seek government- 
financed patients, even at reduced payment 
levels, to the extent that marginal costs 
are covered. 
2. Multi-institutional development will enable 
vertically integrated providers to contract 
directly (perhaps via capitation) with buy¬ 
ers for a full range of services. Incentives 
will be developed to contain buyer expense 
and to place risk on providers, as well as 
patients. 
3. Contracted services will be limited to those 
deemed essential or with a demonstrable 
payoff. This will include support for so- 
called wellness or prevention programs. 
4. Hospitals will aggregate resources among 
themselves and with other providers to 
gain advantage of scale, to spread risk, to 
share expertise and to enhance competitive 
positions. 
Despite our dreams, we never eliminated two-tier 
care. In fact, there are several tiers and, in health as in 
other areas, personal resources determine which tier 
we are on. Perhaps limited resources make the “equal 
access, equal care” goal unattainable. Even if we 
cannot achieve equal care, just as we have not achieved 
equality in education, nutrition, housing or in other 
important areas, we must not relent on equal access. 
Hospitals have long been the guardian of the disadvan¬ 
taged in our communities, never doubting people’s 
right to be served. What is at issue is to what extent, 
and how, the financial burden will be handled. 
My preferred definition of management is trusteeship 
for other people’s interests. This suggests that those 
who are responsible for our institutions trustees, 
management, medical and nursing leadership must 
have a clear understanding of who such “other people” 
are, as well as what their “interests”are. The history of 
Connecticut’s hospitals suggest that they do have such 
understanding: they exist to serve their community 
with responsive and responsible health services. This 
constituency has included all of the community, both 
the poor and the non-poor. However, in an environment 
of increasingly scarce resources, decisions will have to 
be made which may negatively affect the poor in the 
short-term. The ultimate strategy has to be to prevent 
institutional financial failure, in which case no one 
benefits. Such survival strategy will undoubtedly create 
hardships for those with perhaps the greatest need and 
the least resources, financial and political, to press 
their cause. In the give and take of an individual’s 
needs versus those of a community, the democratic 
process is prone to decide on the greatest good for the 
greatest number. One person’s loss may be several 
other’s gain. While that may make good political and 
financial sense, we must vigilantly defend the presence 
of compassion and respect for human dignity as a 
necessary counterbalance to data-derived decisions. 
Our survival requires tough-minded management of 
the resources entrusted to us. Our missions, history, 
and, indeed, our conscience demand that all decisions 
take into account their human impact on those we seek 
to serve. 
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GERALD KLATSKIN, M.D. 
By James L. Boyer, M.D. 
In May 1983, Dr. Gerald Klatskin, David Paige Smith 
Professor Emeritus of Medicine, received the Julius 
Friedenwald Medal, the highest honor of The American 
Gastroenterological Association. On this occasion. Dr. 
James L. Bover delivered the following tribute to Dr. 
Klatskin. It is reprinted here with permission of the Elsevier 
Publishing Company. Inc.,from Gastroenterology; 85: 
1235-8. copyright 1983 by The American Gastroenterology 
Association. Dr. Boyer, professor of medicine, succeeded 
Dr. Klatskin as director of the Yale Liver Study Unit. 
Today, the American Gastroenterological Association 
presents its highest honor to a legendary figure in 
American medicine, a man who has made an indelible 
impression on generations of students and physicians 
by his single-minded dedication and devotion to the 
study of the liver and his compulsive, yet articulate, 
analysis of hepatic pathology and clinical liver disease. 
In the few minutes that we have this morning, I will 
attempt to capture something of the essence of Gerald 
Klatskin, and to trace a few historical events that have 
influenced and highlighted the career of this distin¬ 
guished clinician-scholar. 
Let me begin with my own impressions as I entered 
his office for the first time in the fall of 1965, seeking a 
fellowship appointment, my anxiety having been height¬ 
ened by repeated stories of his imposing intellect and 
personality. But hardly had I explained the purpose of 
my visit when he spied, tucked under my arm, a box of 
liver biopsy slides I had brought from Calcutta, where 
1 was in the Public Health Service. He immediately 
examined them under the microscope in great detail 
without so much as a word, then launched into a full 
discussion of the subject, including background litera¬ 
ture, as if he had just prepared a most comprehensive 
review. From this extraordinary encounter, which I 
later learned was his daily routine, began a long 
association as his student, colleague, and most impor¬ 
tantly, as with many of you here today, his devoted and 
admiring friend. What are the characteristics of this 
man we honor today? 
Dr. Gerald Klatskin, known affectionately as “G.K.” 
or the “Klat,” or simply “Gerry,” is unmistakable 
whether one encounters him in the hospital corridors, 
in the hotel lobby at an annual meeting, or, as is most 
likely, in his office, as the photograph so characteristi¬ 
cally depicts. The broad forehead, the bushy eyebrows, 
the gruffness of his voice, these outward physical 
manifestations of a “Great Bear,”as he has been called, 
belie the personality beneath. He is, in fact, a kindly. 
unpretentious man, whose entire career has been 
focused, with nearly absolute determination, on the 
pursuit of medicine and his specialty. Gifted with 
extraordinary intelligence and qualities of complete 
honesty and integrity, his scholarship encompasses the 
entire range of clinical liver disease, including disorders 
as diverse as sarcoidosis, porphyria, chronic hepatitis, 
alcoholic liver injury, hepatic adenomas, and bifur¬ 
cation tumors (the latter bearing his name). He is a 
pioneer in the development of liver biopsy techniques 
and their histologic interpretation, a supreme performer 
of the clinical consultation, the ultimate visiting pro¬ 
fessor and biopsy consultant, and mentor to many 
leaders in medicine today. 
How did all this begin? 1 must confess that despite 
my long association with Gerry, I decided to hold a 
series of interviews with him in preparation for this 
occasion. Quite frankly, 1 did not want to miss the 
opportunity to hear the story right from the beginning. 
It will come as no surprise to those of you who know 
him well that I spent many hours at this activity — all 
delightful nor will you be surprised to hear me say 
that he has not forgotten a single name, nor anecdote, 
nor episode. Indeed, the only fact that he cannot recall 
is why he decided to study medicine in the first place! 
Let me highlight just a few of these events. 
Dr. Klatskin was born in 1910 in New York of 
parents of Russian origin. He graduated from high 
school at the young age of 16, already interested in 
medicine, and completed college at Cornell in only 
three years, graduating Phi Beta Kappa in 1929 at the 
onset of the Depression. During his freshman year at 
college, he wandered into the embryology and histology 
labs and discovered to his surprise and delight that 
tissues could be imbedded, stained, and examined 
under the microscope. He was enthralled by the 
process, and visited so often that the chairman of the 
department offered him a part-time job. Here began 
his fascination with histology. He worried about 
entrance into medical school, but was easily admitted 
to Cornell Medical School in New York, where he 
graduated first in his class in 1933. 
One spring weekend, a medical student friend drove 
him to New Haven. Elm trees spanned Cedar Street in 
those days, and the friendliness of a small town and the 
relaxed atmosphere of the students and housestaff all 
appealed to this young man from Brooklyn. He 
applied for an internship in medicine and was accepted. 
Eugene DuBois, Chief of Medicine at Cornell, preferred 
that he apply to Johns Hopkins, telling Gerry that Yale 
was “just a little village hospitaL’and “you can do a lot 
better.” But Gerry was already enamored with Yale, 
and in July of 1933, he began the first of two lifelong 
obsessions; July 1983 marked the 50th anniversary of 
this extraordinary association. His second obsession 
was, of course, with the liver. Like many hepatologists 
of his era, Gerry’s World War II army experience was 
central to this development. Posted in Calcutta, India, 
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because of his curiosity to learn more about rare and 
exotic diseases, he became interested in hepatitis and 
amoebic abscess. Later, when transferred to Schick 
Army Hospital in Iowa, he met Cecil Watson, who had 
a profound influence on him. Watson emphasized a 
careful, systematic approach to the study of the liver, 
and introduced Gerry to the concept of a battery of 
liver function tests called hepatograms. This approach 
was entirely new and it appealed to Gerry, for back at 
Yale only serum lipids and proteins were thought to be 
useful. In 1946, he returned to New Haven intent on 
establishing a proper liver laboratory. With the 
support of his Chairman, Francis Blake, but with the 
outspoken opposition of his Laboratory Chief, John 
Peters (then, Mr. Metabolism), Gerry set about to 
gather equipment, having been expelled from Peters’ 
laboratory. Soon consults and requests for tests came 
pouring in, and even Peters, who didn’t speak to Gerry 
for two years, became impressed. 
Gerry performed the first liver biopsy at Yale in 
1947. The Pathology Department laughed at the 
miserable size of the specimen and deemed this approach 
a failure. After a few false attempts and inadequate 
preparations. Hazel Hubbel, the Chairman’s technician, 
took over the project. She introduced Gerry to Carnoy’s 
fixative and the Massontrichrome stain. Later, Hazel 
joined the Liver Unit, and no tribute to Gerry would be 
complete without recognizing this unusual and dedi¬ 
cated woman. A “born scientist,” she was his equal for 
perfection. Because she abhorred automatic equipment, 
she handled the processing, including knife-sharpening 
by hand, for many years. Visitors to the Liver Unit 
from around the world came to pay her homage and to 
praise her work, but she never admitted to being 
pleased. Countless fellows became her staunch ad¬ 
mirers. With Hazel’s handiwork, Gerry combined his 
own keen interest in photography with the evolving art 
of liver biopsy preparation. The result, over a 35-year 
period, has been the accumulation of more than 50,000 
Kodachromes from nearly 10,000 liver biopsy speci¬ 
mens. The Kodachromes, which are all correlated with 
detailed clinical data from each case, represent the 
largest personal collection of clinical pathologic cor¬ 
relations of liver disease in the world. A permanent 
library in Dr. Klatskin’s honor is currently being 
established for this collection. 
This “pathologist’s pathologist” also earned the 
accolade of “the clinician’s clinician.” Early in his 
career he was given the title of DRD, “Doctor of Rare 
Diseases,” by Dr. Peters for the depth of his knowledge 
of esoteric as well as the more common clinical entities. 
His compulsive attention to detail is legendary. What 
one of his fellows does not recall Gerry uncovering a 
critical fact in a patient’s history or physical examina¬ 
tion that had been missed by countless examiners 
before him, arriving at an entirely different and 
inevitably correct diagnosis, and then recounting from 
memory an encyclopedic background literature on the 
subject? An undiagnosed patient or a difficult manage¬ 
ment problem was presented and usually resolved by 
the “Klat” at his weekly consulting rounds. Gerry 
taught by example and demonstrated time and again 
the rewards of careful, critical attention to detail by the 
bedside. 
Undoubtedly, the greatest beneficiaries of Gerry’s 
skills were the 47 postdoctoral fellows who came to 
train with him during the years between 1951 and 1978, 
and over the years, their accomplishments have been 
his pride and joy. He is fond of pointing out the values 
of an unstructured, broadly based training program. 
As the first recipient of a training grant in liver disease 
in 1959, he maintained this grant for 17 years. Despite 
the unstructured nature of his program, which often 
cast fellows adrift in the laboratory to sink or swim, 34 
are employed in academic medicine, 19 are currently 
full professors, seven have become chairmen of depart¬ 
ments, and one is a dean. Most are members of the 
American Gastroenterology Association and the 
American Association for the Study of Liver Disease. 
Three have been AG A councillors, and four are former 
presidents of the AASLD. 
Throughout his career, Gerry has been relatively 
unaffected by the national and international recognition 
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that has come to him. He refused offers to move from 
New Haven, and successfully avoided additional 
administrative positions. Although he served as Acting 
Chairman of the Department of Medicine at Yale on 
four different occasions, he never wished to accept this 
responsibility permanently, preferring instead to pursue 
the interests that he loved the best. 
Nationally he has served on several important 
committees, including the Gastrointestinal Nutrition 
and Liver Disease Training Committees of the National 
Institutes of Health between 1959 and 1964, and the 
Surgeon General’s U.S. Army Medical Research and 
Development Command from 1965 to 1975. He is a 
member of the American College of Physicians, the 
American Association of Physicians, the American 
Association for the Study of Liver Disease, and the 
Interurban Clinical Club, serving as president of the 
latter two organizations in 1958 and 1966, respectively. 
Many honors have come his way, including (at Yale) 
the David Paige Smith Professorship, the Francis 
Blake Award for Outstanding Student Teaching (he 
was the first recipient), and the Mastership and 
Distinguished Teacher Award from the American 
College of Physicians in 1974 and 1979. 
He has a daughter, Jane, who is a lawyer in 
Copenhagen, and three grandchildren, all Danes; a 
daughter, Ann, a graduate student in computer sciences; 
and a son, Robert, an electrical engineer in Los 
Angeles at the Howard Hughes Aircraft Space Program. 
His wife, Lynn, who is here today, has recently retired 
from her own distinguished 37-year career at the Yale 
Child Study Center, where she was Professor of 
Psychology. 
Gerry’s many scientific and scholarly accomplish¬ 
ments are well known and include the first demonstra¬ 
tion that viral hepatitis and the Australian antigen 
were associated with chronic hepatitis (1); the identifi¬ 
cation of birefringence of protoporphyrins in liver 
biopsy specimens (2); the beneficial effects of alcohol 
withdrawal on the natural history of alcoholic liver 
disease (3); the prognostic significance of acute liver 
cell injury in hepatitis (4,5); definitive evidence for an 
association between halothane and hepatitis (6); the 
clinical significance of granuloma in liver biopsies (50 
percent of the world’s published literature on this 
subject come from his own material) (7,8); recognition 
that cholangiocarcinoma presents as a bile duct bifur¬ 
cation tumor (so-called Klatskin’s tumor) (9); recogni¬ 
tion of the common association of fever with Laennec’s 
cirrhosis (10); recognition that alcoholic hyperlipemia 
precedes and may precipitate episodes of pancreatitis; 
the design of an effective liver biopsy needle (the 
Klatskin needle, although he never received royalties); 
and many other clinical and scientific observations 
that he and his fellows pursued. 
It has been said that the essence of a great man is the 
lasting impressions of his students. Dr. L. Frederick 
Fenster, Clinical Professor at the University of Wash¬ 
ington, summarized his impressions four years ago on 
the occasion of a festschrift where his fellows honored 
Gerry, and I quote some of these: 
“The Klat is warm, unassuming, and totally unpre¬ 
tentious. Affable, garrulous, and good-humored, his 
story-swapping (more accurately described as story¬ 
telling) abilities are almost legendary. He combines 
complete intellectual honesty and scientific skepticism 
with a voracious curiosity and almost unbelievable 
thoroughness. Who else, when titillated by anew 
problem or question, would write or call every known 
source of pertinent information, read every relevant 
paper in whatever language, review every pathology 
specimen (and take photos of each), and end up by 
being one of the world’s experts on the subject, simply 
because his curiosity would allow no other course of 
action? In the (50) years he has been at Yale, Gerry 
Klatskin has become an institution within an institution, 
an internationally famous physician. But at Yale, he 
has remained comfortable, intrinsic, and truly at 
home. At Yale he is, like jaundice itself, a natural 
phenomenon requiring no apology. He is unchangingly 
an essential structural and functional element of the 
institution. 
“Gerry Klatskin has been a tremendous positive 
influence on all of us. Just as he has always taken 
satisfaction in our accomplishments, we have been 
proud to have studied under his direction. He has been, 
in this academic world of verbiage, a unique example 
of how to educate by example. He is the best in his 
field, still unspoiled and unchanged by his international 
stature.”( 11) * 
In conclusion, let me add my own personal reflections, 
which I know to be shared by many others. For myself, 
he has provided, above all else, an unparalleled model 
of excellence. No matter what activity he is involved in, 
he has demonstrated time and time again the rewards 
of meticulous attention to detail and the importance of 
pursuing scientific truth for its own sake and for the joy 
that comes from new discoveries, whether these be 
made from a careful history or physical examination, 
or by analyzing specimens under a microscope, or 
basic work at the laboratory bench knowledge and 
truth for their own sake and for no other. It is perhaps 
for this reason, most of all, that the American Gastro¬ 
enterological Association honors Dr. Gerald Klatskin 
today, on the 50th anniversary of his distinguished 
medical career. Gerry, will you please come forward to 
accept the Julius Friedenwald Medal? 
* References on request from Yale Medicine 
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. . . IN PROGRESS 
at the Yale School of Medicine 
Spring, 1984 
With this issue, the editors introduce a new section to 
acquaint our readers with a few of the very many research, 
teaching, and clinical projects throughout the School. These 
brief reviews of some of the work in progress in medicine 
and public health are intended to illustrate the excellence 
and broad scope of programs which have given the School 
its reputation as one of the leading medical institutions in 
the country. 
One of the frustrations in medicine is the long wait, often up 
to two weeks, for results of diagnostic tests for certain 
illnesses. This is especially discouraging in very ill patients, 
when rapid treatment can make a significant difference in 
the outcome. Dr. David Ward, professor of human genetics 
and molecular biophysics and biochemistry, has developed 
a modified nucleotide technology to provide more rapid and 
accurate diagnosis of viral, bacterial and fungal infections, 
as well as for the detection of certain genetic disorders. 
The invention involves modified nucleotides or “tagging” 
molecules, called biotins, which mimic the natural nucleotides 
of DNA or RNA. They are incorporated enzymatically into 
portions of genetic material taken from blood, urine or 
tissue samples from the patient and then detected by 
interaction with proteins that bind specifically to such 
modified nucleotides. If that material is matched with other 
genetic material known to be associated with a specific 
disease, a diagnosis can be made. Alternately, the “known” 
DNA could be tagged with biotin and a match could be 
attempted with a patient’s sample. 
For practical application of this technique. Dr. Ward and 
his colleagues are developing small cards lined with spots of 
DNA from a number of specific viral, bacterial or fungal 
strains. A specimen of biotin-tagged blood, urine or tissue 
from a patient will be applied to the cards. If the specimen 
hybridizes to one of the spots, the spot will change color, 
indicating the presence of the disease strain, and diagnosis 
can then be made within hours, or at the most a day. 
In addition to significantly reducing the amount of time 
necessary for accurate diagnosis, it is anticipated that this 
new methodology will replace procedures currently in use in 
biomedical research that rely heavily on the use of radioactive 
material. Although it can be applied to DNA methods for 
the isolation of genes, the new technique is not based on 
recombinant DNA technology, and cannot be characterized 
as genetic engineering, according to Dr. Ward. 
Research which may open an entirely new approach to 
treatment of multiple sclerosis is in progress in the laboratory 
of Dr. J. Murdoch Ritchie, Eugene Higgins Professor of 
Pharmacology. He has recently been awarded a grant by the 
National Multiple Sclerosis Society to study the biophysical 
basis of nervous dysfunction in demyelinating disease. 
Dr. Ritchie has developed techniques for measuring ion 
channels in the surface membrane of nerve fibers. Each ion 
channel is specialized to permit the passage of only one type 
of ion, either sodium or potassium. As a message moves 
along a nerve fiber to a muscle, it is activated by a movement 
of sodium, which enters the nerve fiber through a sodium 
channel, and by a movement of potassium as it goes out 
through a potassium channel. These channels open and 
close at strategic moments. In order to prepare nerve fiber 
for the next message, another structure in the fiber mem¬ 
brane, the sodium-potassium pump, carries the sodium out 
and the potassium in, between messages. This three-way 
cycle appears to operate for every message transmitted in the 
nervous system. 
In multiple sclerosis, patches of inflammation form in the 
brain and spinal cord, eventually causing the protective 
myelin sheath surrounding nerve fibers to break down, thus 
interrupting nerve transmission. In previous work. Dr. 
Ritchie demonstrated that when the myelin is damaged or 
lost, the number of potassium channels increases, spreading 
into other parts of the nerve fiber surface membrane. His 
current research involves new methods to ascertain the exact 
changes in the numbers of these channels when myelination 
begins in the course of nervous system development; when 
demyelination occurs under various experimental conditions; 
and when myelin regenerates, as it sometimes does. He will 
then relate these changes to changes in the function of the 
nerve fibers. 
According to the National Multiple Sclerosis Society, this 
research may provide the key to one approach to multiple 
sclerosis therapy — that of generating conduction of nerve 
impulses in the permanent absence of myelin. 
A team of Yale specialists are performing cochlear implant 
surgery followed by extensive rehabilitative therapy to 
enable profoundly deaf persons to hear. The collaborative 
program of the Section of Otolaryngology at Yale and the 
Rehabilitation Medicine at the V. A. Medical Center in West 
Haven is funded by a grant from the Veterans Administration. 
Candidates for cochlear implantation are persons who 
have become deaf in both ears after they have learned 
language, and for whom the use of a conventional hearing 
aid is of little or no benefit. Cochlear implantation followed 
by extensive audiologic and speech therapy enables them to 
distinguish male and female voices, certain environmental 
sounds such as sirens and bells, and some simple words. 
Although it does not enable them to understand speech, 
there is evidence that the device improves the patients’ 
ability to read lips, and enables them to monitor their own 
voices. According to persons w ho have received implantation 
therapy, among the most positive aspects are an increased 
sense of security and independence. 
The cochlear implant system is comprised of a microphone, 
signal or voice processor and transmitter, external and 
internal coils, and active and ground electrodes. The 
microphone, placed at ear level, picks up sound and carries 
it to the signal processor which is worn on the body. The 
sound is processed and transmitted to an external coil which 
is held in place behind the ear by magnetic attraction to an 
internal coil which is implanted under it in the mastoid 
cavity. The signal is magnetically induced across the coils 
and carried down the electrodes from the internal coil into 
the inner ear. The procedure to implant the internal coil in 
the inner ear is similar to other techniques of ear surgery 
which present relatively little risk. 
Approximately 18 million people in the United States 
have some degree of hearing loss; and nearly one out of 
every 100 has severe to profound deafness. In 1969, the 
estimated cost to the nation for the education, care and 
compensation for the deaf was $100 million. This amount 
may have doubled since then. 
There are two types of deafness: conductive or middle ear 
deafness, and sensorineural or nerve deafness. During the 
past 30 years, the development of microsurgical techniques 
has enabled otologic surgeons to treat all forms of conductive 
deafness. However, the majority of hearing impaired Ameri¬ 
cans have nerve or sensory deafness, and until recently there 
has been no treatment for this type of hearing loss. 
The cochlear implant procedure and therapy is carried 
out at the V. A. Medical Center. The team includes Dr.Jaclyn 
B.R. Spitzer, assistant clinical professor of surgery (oto¬ 
laryngology); Dr. Frederick Richardson, associate professor 
of medicine, neurology and pediatrics, and chief of Rehabili¬ 
tation Medicine Services at the V.A. Medical Center; Dr. 
Linda J. Gardiner, assistant professor of surgery (otolaryn¬ 
gology); Dr. J. Cameron Kirchner, assistant professor of 
surgery (otolaryngology), and Dr. Clarence T. Sasaki, 
professor of surgery (otolaryngology), and chief of the 
Section of Otolaryngology. The cochlear implant device was 
developed by the House Ear Institute in collaboration with 
the 3-M Company. 
The U.S. Public Health Service has termed Acquired 
Immune Deficiency Syndrome (AIDS) a “public health 
problem that merits the highest level of concern” and has 
made it a top priority. East year, recognizing a need for 
specialized attention for patients with AIDS, a group of 
health professionals at the Yale-New Haven Medical Center 
representing physicians, nurses, social workers, religious 
ministries, infection control and public health administrators, 
began meeting as a multidisciplinary team to coordinate the 
care provided to these patients. 
An outpatient clinic was opened in early June to evaluate 
the vast numbers of “worried-but-well” persons with early 
signs and symptoms of A IDS, and persons with well-defined 
cases of AIDS. In the past six months, the clinic has had 
approximately 170 patient visits, most of whom have signs 
and symptoms of the disease. The clinic also provides 
follow-up care for patients who have been hospitalized. In 
September, the Hospital employed Jeannee M. Parker, 
R.N., M.P.H.,as an AIDS program coordinator to serve as 
liaison to all hospital departments caring for AIDS patients, 
and to be a consultant to community organizations with 
concerns about the illness. 
Despite the number of patients affected by AIDS there 
are tew clues to indicate the etiology of this complex illness, 
or what treatment modalities may be the most successful. As 
a result, investigators are pursuing a number of approaches. 
Dr. John Dwyer, associate professor of medicine and 
pediatrics and chief ot the Section of Clinical Immunology 
has implanted thymic tissue, removed from infants under¬ 
going open heart surgery, into the muscle tissue of the 
forearm of AIDS patients. It is hoped that this new tissue 
will stimulate the production of T-lymphocytes in these 
immunodeficient patients. Although the procedure is new to 
patients with AIDS, it has been successful in patients with 
other immunodeficiency syndromes. 
Using a variety of laboratory techniques. Dr. George 
Miller, John F. Enders Professor of Pediatric Infectious 
Disease, is conducting research to identify and characterize 
viral agents associated with AIDS and Kaposi’s sarcoma, 
which occurs in its highly malignant form in 30 to 40 percent 
of AIDS patients. With his colleagues. Dr. Warren Andiman 
and Dr. James Robinson, he will conduct thorough diag¬ 
nostic virology studies on AIDS patients, especially children, 
in an attempt to isolate viruses from hematopoietic elements 
and other affected tissues. Further, they will attempt to 
establish cell lines from tissues of AIDS patients and to 
examine them for cell of origin, presence of viruses, viral 
nucleic acids, or viral-specific antigens; also to transmit 
AIDS agents in vitro to primary and continuous hemato¬ 
poietic cell lines of man and subhuman primates.They will 
also attempt to determine whether cytomegalovirus alone, 
or in combination with other viruses isolated from AIDS 
patients, will transform morpologically human endothelial 
cells or monocyte cultures in vitro. 
In another study. Dr. Peter Tattersall, research scientist in 
the Department of Human Genetics, will develop a mouse 
model to study parvoviruses as a possible cause of AIDS. It 
has been suggested that the severe T-lymphocyte depletion 
which underlies Acquired Immune Deficiency Syndrome 
may be the result of infection with a human T-cell-tropic 
parvovirus, acting in synergy with a state of lympho- 
proliferative stress. To test this hypothesis, a mouse analog 
of AIDS will be sought, using infection with MVM(i) in 
conjunction with T-cell activators such as mitogens, viruses 
or allogenic cells, to produce a profound T-cell depletion. 
The research team working with Dr. Tattersall will also test 
the implications and predictions derived from this model 
system for human AIDS. 
The recent development of endoscopic, non-surgical tech¬ 
niques such as extracorporeal shock wave lithotripsy, 
percutaneous ultrasonic nephrolithotripsy, and transurethral 
ureterorenoscopy, have greatly improved treatment of renal 
and ureteral stones. For the past two years. Dr. Bernard 
Lytton, professor of surgery (urology) and chief of the 
Section of Urology, and his colleagues have been treating 
patients with tw o of these relatively new techniques, percu¬ 
taneous nephrolithotripsy and transurethral ureteroreno¬ 
scopy, with promising results. 
Percutaneous nephrolithotripsy is performed in collabora¬ 
tion with Dr. Morton Glickman, professor of diagnostic 
radiology, who first cannulates the renal collecting system 
with a long fine needle under radiographic control, using 
fluoroscopy. A guidewire is inserted through the needle into 
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the renal pelvis and over this, a small catheter is placed into 
the renal pelvis. The following day, this tract is dilated up to 
about 10 millimeters in diameter and a small cannula is 
inserted into the renal pelvis. A specially designed nephro- 
scope and other instruments can then be passed easily into 
the kidney so that calculi can be visualized and removed. 
Small stones are removed with grasping forceps or a basket, 
while larger calculi are disintegrated with a special ultra- 
sonically powered probe which incorporates a suction 
device to remove the fragments. Harder stones may require 
electrohydraulic disintegration. Staghorn calculi occupying 
the entire collecting system have also been successfully 
removed. 
In the second technique, the ureteroscope is passed 
through the urethra and then directly into the ureter to 
visualize stones. Small stones are extracted with instruments 
under direct vision; larger stones have been disintegrated by 
an electrohydraulic shock wave generated by an electrical 
discharge at the tip of a special small electrode passed 
through the instrument. These procedures are generally 
performed under spinal or epidural anesthesia. 
To date, 80 of the 100 patients with renal or ureteral 
stones at Yale have been successfully treated with one or the 
other of these techniques. In addition to the success rate, the 
pain and discomfort of stone removal is significantly 
decreased as there is no incision, and hospital stay and 
convalescence time are markedly reduced. It is probable that 
approximately 70 to 80 percent of all kidney and ureteral 
stones requiring removal will be treated by these non- 
surgical techniques. 
A new surgical approach to the treatment of malignant 
ventricular arrhythmias was introduced at Yale last summer 
by Dr. Alexander Geha, professor of surgery and chief of the 
Section of Cardiothoracic Surgery, and his colleagues. It 
has already benefitted a number of patients suffering from 
recurrent sustained and medical refractory ischemic ventri¬ 
cular tachyarrhythmias. 
Each year, approximately one million Americans die of 
cardiovascular disease. About two-thirds of these deaths are 
due to cardiac disease, and half of this group die suddenly. 
Presumably, a major portion of the victims of “sudden 
death” have suffered abrupt ventricular tachyarrhythmias. 
With increasing sophistication in emergency medical care 
and the rise in the use of cardiopulmonary resuscitation 
programs, the lives of many more heart patients are being 
saved. 
Ventricular tachyarrhythmias are the result of either 
enhanced automaticity or re-entrant arrhythmia or both. 
Automatic arrhythmias are common following cardiac 
surgical operations and in the early period after myocardial 
infarction. They arise from cells in the specialized conduction 
system in the ventricle in response to factors such as hypoxia 
and ischemia, electrolyte imbalance, increased catecho¬ 
lamines and drugs. Automatic arrhythmias characteristically 
resolve when the enhancing stimulus is removed. Re-entrant 
ventricular tachycardia is most frequently associated with 
chronic ischemic heart disease and is encountered in those 
patients with previous infarction who present with syncope 
or “sudden death”since it may lead to ventricular fibrillation. 
It is referred to as malignant arrhythmia and can be induced 
in the electrophysiological laboratory by programmed 
ventricular stimulation. Surgery has proven feasible only for 
re-entrant ventricular tachycardia. 
In patients with re-entrant ventricular tachyarrhythmias, 
programmed ventricular electrical stimulation provides a 
tool for diagnosis and evaluation of treatment. The induci- 
bility of a ventricular arrhythmia by programmed stimulation 
is considered as evidence supporting re-entry as a mechanism 
for the arrhythmia. This is determined in the electrophysio¬ 
logical laboratory which, at Yale, is directed by Dr. William 
Batsford, associate professor of medicine. Based on electro- 
physiologic studies, the patient is started on the anti- 
arrhythmic agent which seems to be most effective; if pacing 
is indicated, an appropriate pacemaker is implanted. 
In 10 to 30 percent of patients with malignant ventricular 
arrhythmias, however, an antiarrhythmic regimen and/or 
pacing prove ineffective. These patients become candidates 
for surgical therapy, prior to which they undergo more 
detailed electrophysiologic evaluation including endocardial 
mapping of both ventricles during induced ventricular 
tachycardia to locate the site of origin of the arrhythmia. 
This is done by catheter mapping of various sites in both 
ventricles to find the earliest site of electical activation 
during ventricular tachycardia or to locate a site of contin¬ 
uous electrical activity close to the area of old infarction. 
The origin of the refractory tachycardia in the majority of 
the patients is in the left ventricle. This preoperative 
mapping provides an indication of the approximate location 
of the short-circuit responsible for the re-entrant mechanism. 
The surgical approach in these selected patients was 
developed three years ago at the University of Pennsylvania 
and Duke University and was brought to Yale by Dr. Geha. 
The operation requires cooperation of the electrophysiologic 
and surgical teams in the operating room to achieve accurate 
direct epicardial and endocardial mapping during induced 
ventricular tachycardia in the open chest. By slipping a ring 
electrode on the index finger, the surgeon makes an 
electrical map of the outside of the heart as it beats, looking 
for the area of short circuit. With the use of the heart-lung 
machine, the heart is then opened through the scar of the old 
myocardial infarct and a detailed map of the inside of the 
heart is made, far more detailed than Dr. Batsford and his 
associates are able to make with an electrode catheter 
preoperatively. 
The area identified by surgical mapping as responsible for 
the short circuit is often located on the inside of the left 
ventricle, adjacent to the grossly scarred heart muscle, and 
often appears normal to the naked eye. Once identified, it is 
removed, and other mechanical defects in the heart wall, 
such as an aneurysm, and/or valvular dysfunction are 
corrected. When necessary, a coronary bypass operation is 
also performed to improve the blood flow to the heart 
muscle itself. 
The results of the elctrophysiologically directed endo¬ 
cardial excision in the patients treated at Yale have been 
very gratifying. No patients have had spontaneous sustained 
ventricular arrhythmias after the operation. The Yale 
surgical team had previously studied and reported their 
experience w ith patients hav ing refractory ventricular arrhyth¬ 
mias and previous documented infarction, who were treated 
by coronary bypass grafting and/or aneurysmectomy, as 
well as correction of other mechanical defects when present. 
In that group of patients, 19 of 26 long-term survivors 
continued to have spontaneous recurrent ectopy after the 
operation; the introduction of mapping-guided endocardial 
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excision marks the only change in the surgical procedures 
and has accounted for the aboliton of spontaneous recurrent 
ventricular tachycardia in the recent group of patients. 
Again, the operation is an intricate one and depends upon 
close cooperation between the surgical and electrophysio- 
logical teams. The electrophysiologists record the map 
obtained by the surgeons and interpret it on the spot, in 
order to localize and remove the small mark in the heart wall 
which is causing the runaway beats. 
Within the last several years, critical but previously unrecog¬ 
nized metabolic functions of the pulmonary circulation have 
been described. Dr. C.N. Gillis, professor of anesthesiology 
and pharmacology, and his colleagues are studying the 
physiological and pathophysiological roles of these processes. 
The metabolic functions referred to are the uptake and 
catabolism of vasoactive hormones and drugs by the 
pulmonary microvasculature. In particular, we have studied 
the fate of circulating vasoconstrictor hormones, including 
catecholamines, 5-hydroxytryptamine and prostaglandins. 
During their passage through the pulmonary microvascu¬ 
lature, many of these substances are removed to such an 
extent that very little survives to reach the systemic circula¬ 
tion. Thus, it seems one function of the lung is to prevent 
these potent vasoconstrictor hormones, which may be 
released on the venous side of the circulation, from reaching 
the systemic arteriolar bed, where they may have deleterious 
effects. 
Much of this metabolic activity is now known to occur in 
endothelial cells of the pulmonary microvessels. Since these 
cells are also know n to be injured early in disease processes 
leading to acute respiratory failure, a current interest of Dr. 
Gillis ’ laboratory is the measurement of these processes in 
the intact animal, or in the patients, to determine whether 
such processes are altered in advance of clinically detectable 
Acute Respiratory Distress Syndrome (ARDS). 
They have established that in experimental lung injury, 
caused by high inspired oxygen tensions, endotoxin admini¬ 
stration or embolization, there is a diminished metabolic 
capacity of pulmonary endothelial cells; furthermore, this is 
evident at a time when no discernible morphologic change, 
indicating injury, can be seen. At the clinical level, they have 
also established that there is a significant decrease in the 
ability of the pulmonary circulation to take up and metabolize 
prostaglandins in patients suffering from acute respiratory 
failure. 
From this and related work, it may be possible to develop 
methods for the early detection of the endothelial injury. If 
successful, the latter effort may yield a method to predict 
impending ARDS at a time when treatment of this very 
serious and life-threatening situation may be initiated earlier 
and therefore, be more effective. 
Research in the laboratories of Dr. Joan Steitz, professor of 
molecular biophysics and biochemistry, and Dr. John 
Hardin, associate professor of medicine (rheumatology) is 
aimed at understanding the cause of systemic lupus erythe¬ 
matosus (SLE). A highly complex inflammatory disease 
that strikes mainly young women, SLE often causes a skin 
rash and arthritis, but may affect any organ. 
Despite its clinical variability, the occurrence of anti¬ 
nuclear antibodies (ANA) has been recognized as a nearly 
universal feature in virtually all affected patients. Although 
there are many different types of ANA, they can each be 
identified from the particular structures (antigens) to which 
they bind. In recent years it has become increasingly 
important to understand which types of ANA are present in 
individual patients. Some of these antibodies, such as the 
one known as anti-Sm, have extremely good correlations 
with the diagnosis of SLE. Others, such as anti-native DNA, 
have special roles in causing tissue injury. Since ANAs are 
such a characteristic feature of SLE, it is reasonable to 
believe that whatever mechanism leads to their production 
has a great deal to do with the cause of lupus. 
The work at Yale concentrates on understanding the 
structural and biochemical features of the molecules that 
become the targets for ANA. Their studies have demonstrated 
that some of these antigens are located on the polypeptide 
components of ribonucleoprotein particles that have roles in 
gene expression. Others are located on segments of histones, 
that are exposed within the structure of chromatin. Presently, 
the investigators are looking for common denominators 
among all of the many different components of the cell 
nucleus that could explain why a relatively select group of 
these structures begin to act as autoimmunogens in patients 
with lupus. If these factors can be identified, they hope to 
understand the cause of lupus. For similar reasons they are 
also interested in understanding how the ANA found in SLE 
compare with those found in patients with other rheumatic 
diseases such as rheumatoid arthritis, drug induced lupus, 
scleroderma, or inflammatory muscle diseases. Presently 
each of these latter diseases appears to have its own 
characteristic set of ANA. 
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THE SCIENCE OF CLINICAL EPIDEMIOLOGY 
A new kind of medical scientist has been emerging over 
the past decade, and they are already making their 
mark on the quality of medical care service in this 
country. At the mid-century, it had become evident 
that health care delivery was becoming increasingly 
complex and physicians were needed who were skilled 
not only as clinicians but also had the analytical 
capabilities to examine a broad range of health care 
problems. In 1973, to meet this challenge, the Robert 
Wood .Johnson Foundation established its Clinical 
Scholars program. 
Based on programs started in several medical schools 
during the late 1960’s, it offers twenty young physicians 
each year the opportunity for two years of graduate- 
level study and research in non-biological disciplines 
such as clinical epidemiology, law, economics or 
behavioral sciences, which influence medicine and 
health affairs. The Foundation currently funds six 
such programs in medical institutions throughout the 
United States. Some graduates of the program have 
become involved in developing and managing a variety 
of health care institutions and delivery systems; others 
are contributing to the formulation, conduct and 
evaluation of public policy issues in the health field. 
Yale was one of the first schools to receive a grant to 
establish a Robert Wood Johnson Clinical Scholars 
Program, and it soon became recognized as one of the 
leaders. As stated in the recruitment brochure, its 
purpose is to “develop a new breed of investigative 
scholarly clinicians concerned with challenges in the 
strategies, delivery systems, and policies associated 
with patient care.” 
The four scholars enrolled each year come from a 
variety of backgrounds and are either Board eligible or 
Board certified physicians. Although they are encour¬ 
aged to maintain their clinical and patient-care interests, 
it is expected that during the two-year program, their 
primary interest will be the educational and research 
activities of the program. 
Dr. Alvan Feinstein, professor of medicine and 
epidemiology, has been the program’s director since 
the beginning. Regarded by colleagues and scholars 
alike as a superb, provocative and demanding teacher, 
he organized and formulated its basic philosophy, and 
does a large share of its teaching. 
The original goals for the Yale program included 
plans for recruiting talented scholars; assembling 
capable faculty; developing an effective core curriculum 
in the methodology of research; providing suitable 
attention to medically related issues of social science; 
and supplying supervision, stimulation and assistance 
to the scholars during the research portion of the 
program. The basic mechanisms for accomplishing 
these goals were set in place when the program began 
in 1974, and most of them have been maintained with 
relatively few substantial changes, according to Dr. 
Feinstein. 
The curriculum for the program includes a core 
course in quantitative clinical epidemiology for the 
first year scholars, and seminars in health policy and 
delivery conducted by invited lecturers as well as by the 
faculty, for both first and second year scholars. These 
seminars cover a wide range of subjects such as health 
manpower legislation, various facets of medical ethics, 
malpractice, and the economics of medicine. Scholars 
are also encouraged to take selected elective courses 
offered in the Department of Epidemiology and Public 
Health, the Child Study Center, the Institution for 
Social and Policy Studies and the Law School. The 
second year is devoted almost entirely to the design 
and completion of an original independent research 
project, using skills developed in the program. 
Clearly the clinical epidemiology course is the 
keystone of the Yale Clinical Scholars Program. 
Developed by Dr. Feinstein specifically for the scholars 
to provide them with the skills necessary for managerial 
decisions of patient care and other activities in the 
delivery of health care and in health policy, it has since 
served as a model for programs in other medical 
schools, and a Clinical Epidemiology Section was 
established at the annual joint meeting of the American 
Federation for Clinical Research, American Society 
for Clinical Investigation and the Association of 
American Physicians. 
The principle of clinical epidemiology is the applica¬ 
tion of basic science and epidemiologic research tech¬ 
niques, and when appropriate, economic and sociologic 
data skills, to areas that are of primary concern to 
clinicians. The course consists of four main components: 
data processing, computer orientation, research design, 
and biostatistics. It has proven to be a highly effective 
way to provide clinical scholars with critical exposure 
to the general methods of epidemiology, biostatistics 
and computers, while at the same time, developing new 
methods of evaluating and advancing specific aspects 
of the conventional methods that are pertinent to their 
clinical concerns. 
“To my knowledge, the Yale program is the one that 
focuses most clearly on the original purposes of the 
Robert Wood Johnson Foundation, which is to train 
academicians and investigators in the techniques of 
clinical research,” said Dr. James F. Jekel, C.E.-A. 
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Dr. Feinstein 
Winslow Professor of Public Health, who has been on 
the Clinical Scholars Program faculty since 1975. 
“There had been no clear track for people who wanted 
to do clinical research. For the most part, they 
stumbled into it either by working in a research 
laboratory, or by taking part in an epidemiologic study 
in a school of public health, and then making the 
transition to clinically oriented techniques.” 
Traditionally, it had been thought that clinical data 
couldn’t be used for science unless they were quantita¬ 
tive. “One of Dr. Feinstein’s most significant contribu¬ 
tions to medical science has been to insist that clinical 
phenomena and clinical data are scientifically very 
important, and he has demonstrated this in a number 
of studies, such as those he conducted on the prognosis 
of cancer patients and patients with a history of 
rheumatic fever,” according to Dr. Jekel. 
Dr. John Leventhal, associate professor of pediatrics 
and the Child Study Center, recently received a grant 
from the Robert Wood Johnson Foundation to study 
the effects of home glucose monitoring on diabetic 
children and their families. A graduate of Tufts School 
of Medicine, he trained in pediatrics at Yale for three 
years before entering the Clinical Scholars Program in 
1976 to further his interest in doing research in 
childhood behavioral problems, child abuse and chronic 
childhood illness. He has received several grants for 
research projects in these areas since completing the 
program. The disciplines and skills he acquired as a 
scholar have enabled him to design more effective 
protocols for these studies, he said, especially in areas 
such as choosing patient populations and formulating 
research strategies. 
But the program isn’t only tailored to those interested 
in clinical research. Dr. Lolita M. McDavid is a second 
year scholar interested in health policy and planning 
administration. “It was made very clear to me when I 
was interviewed for admission that the strength of this 
program is in clinical epidemiology,” she said, “but 1 
decided that the kind of skills 1 would learn here would 
serve me in better stead than would programs in other 
schools that were strong in health policy.” 
The w ife of a bank vice-president and mother of a 
three-year-old daughter, she describes herself as a 
“bent arrow” who received a B.A. degree in political 
science and history, an M.A. degree in public admini¬ 
stration, and who worked as an administrator for 
several years before entering Case Western Reserve 
University School of Medicine in 1975. She was a 
resident pediatrician at The Cleveland Clinic Founda¬ 
tion when she applied to the Robert Wood Johnson 
Clinical Scholars Program. 
“This program gives you a very solid background in 
making your point,” she explained. “For instance, 
most people in health policy and planning have 
backgrounds in sociology, or psychology, or public 
health. They often have difficulty in firming up their 
plans because they don't have the tools. You get those 
tools in this program.” 
Although the scholars come from a variety of 
backgrounds and have interests as diverse as religion 
and ethics, and health policy and planning, most have 
had experience in the real world of medicine. Returning 
to an academic environment has rewards and a few 
frustrations. 
“It’s a radical change from residency, where one 
tends to work 100 hours a week and is entirely 
immersed in patient care,”admitted Dr. Dale Matthews, 
a first-year scholar whose interests are rooted in 
medical ethics and physician-patient relationships. A 
cum laucle graduate of Princeton University where he 
majored in romance languages, he received his M.D. 
degree from Duke University and did his internship 
and residency in medicine at the University of Connect¬ 
icut Health Center. “The balance here is completely 
different. I see patients one or two half-days a week, 
and do some teaching of nursing and medical students, 
but its quite a change from my previous medical 
experiences. In many ways, the first year is like going 
back to college, in that course are structured, there are 
assignments, and then there is time for reading and 
reflection.” 
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Dr. Leventhal mentioned it, and others have con¬ 
firmed that designing and completing the research 
project is perhaps the most difficult part of the two 
years. “It’s a curious paradox. The program is very 
structured during the first year, yet at the same time, 
we are expected to develop a research project primarily 
on our own.” Dr. Matthews explained. “I have found 
that among our own group, each of us is his own worst 
enemy pushing himself harder than our instructors 
are pushing us. To decide what we want to investigate, 
and then do it without anyone telling us we have to do 
it, or how we must do it, or whento do it, is an 
important step in our careers that is unlike anything in 
medical school or residency training.” 
Through the ten years of the Yale Clinical Scholars 
Program a camaraderie has been established not only 
between scholars in the same year, but between all 
graduates of the program. Underlying this is a sense of 
gratitude for the opportunities the course offers, as 
well as a sense of respect for the faculty and their 
values. Often mentioned are Dr. Ralph Horwitz, co¬ 
director of the program, who was one of its first 
graduates, and is now head of the Section of General 
Medicine, Dr. Jekel, the assistant director, and Dr. 
George Silver and Carolyn Wells, who have been with 
the program since it began. Dr. Feinstein, though, merits 
their special admiration. 
“I compare this program to the Harvard Business 
School,” said Dr. McDavid. “They recruit people who 
are good, and then give them skills that others in their 
field don’t have. They also give them the imprint of 
being Harvard Business School graduates, and for the 
most part, they excel,” she explained. “In the same 
way, the Yale Clinical Scholars leave here with the 
skills and the tools, as well as with a built-in support 
system of having Yale and the Robert Wood Johnson 
Foundation behind them.” 
Dr. Jekel, center, leads a discussion in quantitative 
clinical epidemiology. Dr. Matthews is seated at the far right. Because 
classes are small, there is opportunity for indepth discussion of topics 
introduced in this first-year Clinical Scholars course. 
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HERE AND ABOUT 
NEW DIRECTOR APPOINTED 
FOR CANCER CENTER 
Dr. Alan C. Sartorelli, chairman of 
the Department of Pharmacology, 
and a leading cancer investigator, has 
been appointed director of the Yale 
Comprehensive Cancer Center. Dr. 
Sartorelli, who is head of the Develop¬ 
mental Therapeutics Program of the 
Center, has been its deputy director 
since 1982. He succeeds Dr. Jack W. 
Cole, Ensign Professor of Surgery, 
who has been director since 1978. 
“We are looking forward to continu¬ 
ing our work in areas of cancer 
research and patient care as well as 
serving the needs of the people of 
Connecticut,’’said Dr. Sartorelli. “The 
Yale Comprehensive Cancer Center 
is one of 20 Comprehensive Cancer 
Centers in the country, as designated 
by the National Cancer Institute. 
One of Yale's unique strengths is the 
Department of Pharmacology, which 
develops new drugs or drug combina¬ 
tions to be used in treating cancer. 
These new therapies are rapidly moved 
into clinical practice through sections 
such as Medical Oncology, where 
patients are being treated with some 
of the most advanced drugs,” he 
explained. “Another important pro¬ 
gram of the Cancer Center is the 
Department of Therapeutic Radio¬ 
logy, headed by Dr. James J. Fischer, 
which combines basic research in 
radiobiology and radiologic physics 
with radiotherapy in one of the best 
and most advanced treatment pro¬ 
grams in the nation. The Center also 
serves as the focal point for cancer 
information and education through¬ 
out the State by interacting with 
community organizations, such as 
the American Cancer Society, hospi¬ 
tals, physicians, nurses, social workers, 
dieticians, and the general public.” 
Dr. Sartorelli, who received his 
Ph.D. in biochemical oncology from 
the University of Wisconsin, has been 
a member of the Department of 
Pharmacology at Yale since 1961; he 
was promoted to professor in 1967, 
and named chairman of the Depart¬ 
ment in 1977. The author of over 400 
publications, he isexecutive editor of 
Pharmacology and Therapeutics and 
Dr. Sartorelli 
regional editor for the American 
continent of Biochemical Pharma¬ 
cology. He has been a director of the 
American Association for Cancer 
Research, a member of the Board of 
Scientific Counselors of the Division 
of Cancer Treatment of the National 
Cancer Institute, and a member of 
the Council for Analysis and Pro¬ 
jection of the American Cancer 
Society. 
In addition to Dr. Sartorelli’s 
appointment, Marion E. Morra, 
communications manager, has been 
named to the new position of assistant 
director of the Cancer Center. Dr. 
Joseph R. Bertino, chief of the Section 
of Medical Oncology, and Dr. 
Sherman M. Weissman, professor of 
human genetics, medicine and molecu¬ 
lar biophysics and biochemistry, and 
head of the Molecular Virology Pro¬ 
gram at the Center, will continue in 
their present positions as the Center’s 
associate director for clinical science 
and associate director for basic 
science, respectively. 
Dr. Manuelidis 
TWO ON FACULTY RECEIVE 
AWARDS FOR RESEARCH IN 
THE NEUROSCIENCES 
Dr. Pasko Rakic and Dr. Elias 
Manuelidis are among the first re¬ 
search scientists to receive the Javits 
Neuroscience Investigator Awards of 
the National Institute of Neurological 
and Communicative Disorders and 
Stroke (NINCDS). The award, 
passsed by a 1984 Act of Congress to 
honor Senator Jacob K. Javits of 
New York, recognizes NINCDS grant¬ 
ees who have achieved a distinguished 
record of contributions in the field of 
neurological and communicative 
sciences, and who can be expected to 
be highly productive over the next 
seven years. 
Dr. Rakic, who is the Dorys 
McConnell Duberg Professor of 
Neuroscience and chairman of the 
Section of Neuroanatomy, received a 
grant of $1,500,000 for seven years 
for research on the neurogenetic pro¬ 
cesses in the fetal brain. A leading 
scientist in brain research, he is best 
known for his investigation of neuro¬ 
nal maturation, as well as for research 
on the development of the visual 
system and cerebellum in primates. 
His work has important implications 
for investigation of the interaction of 
genetic and environmental factors 
governing human behavior and intelli¬ 
gence, as well as for understanding 
neurological diseases. A native of 
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Dr. Rakic 
Yugoslavia, he came to Yale in 1978 
from the Harvard Medical School, 
where he had been on the faculty 
since 1972. 
N1NCDS awarded Dr. Manuelidis, 
professor of neuropathology and 
neurology, almost $ 1,200,000 for seven 
years to continue his well-known 
research on Alzheimer’s disease. Inter¬ 
nationally recognized for his studies 
of dementias. Dr. Manuelidis and his 
colleagues are among a small group 
of scientists working on the hypothesis 
that Alzheimer’s disease is caused by 
a slow-virus of the type recovered 
from brain tissues of victims of the 
fatal but rare form of dementia, 
Creutzfeldt-Jakob disease. Their work 
involves comparison of the mecha¬ 
nisms and progress of Creutzfeldt- 
Jakob disease in laboratory animals 
with changes seen in patients with 
Alzheimer’s disease and other forms 
of senile dementias, in an attempt to 
understand the course, and eventually, 
the cause of the disorders. A native of 
Greece, Dr. Manuelidis was director 
of the Pathological Anatomical Labo¬ 
ratory of the German Research Insti¬ 
tute of Psychiatry, Section of Brain 
Pathology at the Kaiser Wilhelm 
Institute before coming to the United 
States and to Yale in 1951. 
DR. BARRON TO BE HONORED 
A symposium in obstetrical physi¬ 
ology will honor Dr. Donald H. 
Barron, professor emeritus of physi¬ 
ology. Sponsored by the University 
of Florida College of Medicine De¬ 
partments of Obstetrics and Gyne¬ 
cology and Continuing Medical Edu¬ 
cation, it will be held on April 1 I to 
13 in Kissimmee, Florida. 
Dr. Barron was one of the first to 
recognize that an understanding of 
the principles of physiology as they 
apply to the process of human repro¬ 
duction is the foundation of the clinical 
practice of obstetrics. He devoted his 
professional career to the study of the 
basic aspects of reproductive physi¬ 
ology, and his scientific contributions 
to the field are widely recognized. 
Through his teaching and his research, 
he has been responsible for many of 
the important basic contributions to 
the field during the past 25 years. 
Dr. Barron started his career at 
Yale as a teaching fellow from 1929 
to 1932. He returned in 1939 as a 
Sterling Fellow and in 1943, he was 
appointed associate professor of 
physiology. He was a professor of 
physiology from 1947 until his retire¬ 




The Daniel S. Kapp Educational 
Fund for Therapeutic Radiology has 
been established by a gift from Mr. 
and Mrs. Gordon B. Tweedy of Brew¬ 
ster, New York. Mr. Tweedy is a 
member of the Class of 1929 at Yale 
College and received his law degree 
from the Yale Law School in 1932. 
The Fund which honors Dr. Daniel 
S. Kapp, associate professor of thera¬ 
peutic radiology, will establish a per¬ 
manent endowment, the income from 
which will be used to bring distin¬ 
guished scientists and clinicians to 
Yale as visiting lecturers in the field 
of therapeutic radiology. It is antici¬ 
pated that there will be several visiting 
lectureships each year. 
“We are extremely grateful to Mr. 
and Mrs. Tweedy for establishing 
The Daniel S. Kapp Educational 
Fund at Yale,’’said Dr. James Fischer, 
professor and chairman of the Depart¬ 
ment of Therapeutic Radiology. “One 
of the major needs of our department 
has been a source of funds to bring 
outstanding individuals to Yale to 
lecture in the field of therapeutic 
radiology. The need has been met by 
this generous gift which honors our 
colleague, Dr. Kapp. 
The Yale Department of Thera¬ 
peutic Radiology has established a 
reputation worldwide for leadership 
in research, patient care and teaching. 
One of the first departments in the 
United States to be designated in 
1960 by the National Cancer Institute 
as a radiation therapy-radiobiology 
research center, it has continued to 
make major contributions to improved 
treatment methods used in radiation 
therapy centers throughout the coun¬ 
try, including the Hunter Radiation 
Therapy Center at Yale, which is one 
of the largest and most up-to-date in 
the U.S. 
Dr. Kapp received his B.S. and 
M.S. degrees in physics from Poly¬ 
technic Institute in New York, and 
his Ph.D. and M.D. degres from 
Stanford University. He was a resident 
in therapeutic radiology at the Stan¬ 
ford University Medical Center from 
1973 to 1976, when he was appointed 
assistant professor of therapeutic 
radiology at Yale. In 1980, he was 
appointed chief of Gynecologic Radi¬ 
ation Therapy, and in 1982, he was 
promoted to associate professor. Dr. 
Kapp returned to Stanford University 
School of Medicine in January as 
associate professor in the Division of 
Radiation Therapy. 
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NEW HAVEN COUNTY MEDICAL 
ASSOCIATION CELEBRATES 
ITS BICENTENNIAL 
By David Musto, M.D. 
The New Haven County Medical 
Association came into being just 
months after the Definitive Treaty of 
Peace was signed with Great Britain 
in September 1783. Called together 
at the historic coffee house on the 
east side of the Green in New Haven 
(where the post office now stands), 
the Association was formally oganized 
on January 5, 1784 and chose as its 
first president. Dr. Eeverett Hubbard, 
a man destined in 1792 to become the 
first president of the Connecticut 
State Medical Society. 
Dr. Hubbard spoke to the Associa¬ 
tion on February 2, 1784 in a brief 
statement which encompassed much 
of medical philosophy and the practice 
of medicine. He pointed out that 
although we are all the same as 
regards the parts of our bodies, we 
differ greatly in temperament, and 
this difference in personality must be 
taken into account by the physician. 
This sensitivity to the patient’s needs 
is the theme which was emphasized at 
the bicentennial convocation on 
March 22. Dr. Hubbard concluded 
his observations by expressing the 
hope: “May the blessings of heaven 
ever attend this society, that peace, 
brotherly love and knowledge in the 
art of healing may flourish so as to 
exceed any of the renowned societies 
of the same denomination in Europe.” 
Whether the New Haven County 
Medical Association has exceeded all 
the renowned societies of medicine in 
Europe may be open to dispute, but 
that later members of the society did 
indeed distinguish themselves in the 
development of medicine, there is no 
disagreement. One of the members. 
Dr. Jonathan Knight (1789-1864) was 
a leader in the formation of the 
American Medical Association in the 
middle of the last century, and Dr. 
Worthington Hooker (1806-1867) is 
now recognized as a major pioneer in 
the field of medical ethics with his 
sensitive analyses of the mutual rights 
of patient and physician. Dr. Hooker 
was also a prolific author of children’s 
textbooks on science and nature, and 
one of New Haven's elementary 
schools is named after him. 
Furthermore, members of the 
County Society were among the 
founders in 1810 of The Medical 
Institution of Yale College, and exer¬ 
cised authority over the School jointly 
with Yale College until 1884.The 
distinguished history of the County 
Association is preserved in records 
which exist without a break back to 
the first meeting in 1784. An extensive 
exhibit on its history, displaying many 
of the Association’s and Yale’s 
treasures in the history of medicine is 
on view in the Yale Medical Library 
until June. 
Dean Robert Berliner held a reception on February 2 in honor of the New 
Haven County Medical Association's centennial celebration. Dr. Theodore 
/.anker, right, is president of the Association. 
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PROGRAM FOR HUMANITIES 
IN MEDICINE 
The School of Medicine recently 
received a grant from the Connecticut 
Council for the Humanities in support 
of a new program for humanities in 
medicine. Directed by Dr. Howard 
M. Spiro, professor of medicine, the 
program is presenting a series of 
twelve semi-monthly lectures through¬ 
out the spring and fall to bring to¬ 
gether scholars in the humanities and 
members of the medical profession in 
discussions about the influence of the 
arts and letters on medicine and 
health. 
Speakers include Dr. Robert Coles, 
professor of psychiatry and medical 
humanities at Harvard University; 
Arnold Rampersad, professor of 
English at Rutgers University; Arthur 
Caplan, associate for the humanities 
at the Hastings Center; and Dr. Martin 
Carey, associate professor of medi¬ 
cine, physiology and biophysics at 
Harvard University. They will discuss 
topics as diverse as the physician as a 
writer; the effects of health and well¬ 
being on art and visa versa; ethical 
issues in organ transplantation, and 
creativity and illness. 
The purpose of the series, according 
to Dr. Spiro, is to encourage medical 
students and professionals to expand 
their definitions of health and disease 
through a better understanding of 
the cultural and intellectual influences 
on health and well-being, as well as to 
stimulate scholars in the humanities 
to take a greater interest in health 
related issues. The lectures are open 
to the public without charge. 
FACULTY NOTES 
Dr. Luke Kitahata received a fellow¬ 
ship from the German Academic 
Exchange Service for collaborative 
research with Professor Manfred 
Zimmerman of the University of 
Heidelberg. They have conducted a 
study of the effects of microinjection 
of morphine sulfate in the brainstem 
on dorsal horn neurons of the lumbar 
spinal cord, and clarified some of the 
important mechanisms of morphine 
analgesia. Dr. Kitahata, professor of 
anesthesiology, was chairman of the 
Department from 1973 to 1982. 
The American College of Physicians 
has awarded the Willard O. Thompson 
Memorial Traveling Fellowship to 
Dr. Caroline Riely, associate professor 
of medicine and pediatrics, for re¬ 
search on liver disease in children. 
She will spend six months at l’Hopital 
d’Enfants in Bicetre, France studying 
biliary artresia, a liver disease attri¬ 
buted to arrested fetal development, 
which has an unusually High incidence 
in the Bicetre area. 
The Japan Society for the Promotion 
of Science has awarded a research 
fellowship to Dr. Ethan Nadel, asso¬ 
ciate professor of epidemiology (envi¬ 
ronmental health) and physiology. 
As a fellow. Dr. Nadel will spend a 
month in Japan for discussion and 
observation, as well as to deliver 
lectures and participate in seminars. 
Dr. Nadel, who is an associate fellow 
of the John B. Pierce Foundation 
Laboratory, is known for his studies 
on factors contributing to the regula¬ 
tion of the circulatory system in 
humans under stressful conditions 
such as heat or exercise. 
Dr. John Hobbins, professor of ob¬ 
stetrics and gynecology, has been 
elected vice-president of the American 
Institute of Ultrasound in Medicine. 
The chief of the Section of Peri¬ 
natology at Yale-New Haven Hospi¬ 
tal, he has played an important role 
in the devlopment of ultrasound as a 
tool for perinatal diagnosis and for 
the monitoring of fetal growth and 
development. Dr. Frederick Kremkau, 
associate professor of diagnostic 
radiology has been elected to the 
board of the American Institute of 
Ultrasound in Medicine. 
Dr. Alan Gurwitt has been appointed 
to the editorial b,oard of the Inter¬ 
national Journal of Psychoanalytic 
Psychotherapy. Co-editor of “Father 
and Child: Developmental and Clinical 
Perspectives”(Little,Brown), he is an 
associate clinical professor of psychi¬ 
atry (Child Study Center. 
The National Academy of Practice in 
Social Work has elected Audrey 
Naylor, a Distinguished Practitioner. 
An assistant clinical professor in the 
Child Study Center, Ms. Naylor is 
the author of two books and numerous 
articles on social work. One of nine 
academies representing various as¬ 
pects of health care, the National 
Academy of Practice in Social Work 
was founded recently by leaders in 
that field. 
At the 93rd meeting of the Horace 
Wells Society, honoring the discovery 
of anesthesia in the United States, 
Dr. Paul Barash was presented the 
Award of Merit for outstanding con¬ 
tributions to the field. Dr. Howard 
Smith, ‘53, clinical professor of sur¬ 
gery and president of the society, 
presented the award, following 
opening remarks by the chairman of 
the board of trustees. Dr. Wilbur 
Johnston, ‘37. Dr. Barash, who is 
professor and chairman of the Depart¬ 
ment of Anesthesiology, delivered a 
talk on “Cocaine in America: 1984.” 
Dr. Leonard Kaplow has been elected 
president of The Histochemical 
Society and will assume office in 
April. He is professor of pathology 
and laboratory medicine, and chief 
of Laboratory Service at the Veterans 
Administration Medical Center in 
West Haven. 
Dr. Paul H. Duray, instructor in 
pathology, presented a talk on “Pa¬ 
thology of Synovitis in Lyme Disease” 
at the meeting of the International 
Academy of Pathology, held in San 
Francisco in February. 
NEW BOOKS BY FACULTY 
“Hypothesis and Evidence in Psycho¬ 
analysis.” Marshall Edelson, M.D., 
Ph.D., professor of psychiatry. Uni¬ 
versity of Chicago Press (Chicago) 
1984.179 pp. 
“Perinatal Epidemiology.” Michael 
B. Bracken, associate professor ad¬ 
junct of research in epidemiology 
and obstetrics and gynecology. Oxford 
University Press (Oxford) 1984. 500 
pp, illus. 
Surgery of the Skull Base.” Clarence 
T. Sasaki, M .D., professor of surgery ; 
(otolaryngology); Brian F. McCabe, 
M.D.; and John A. Kirchner, M.D., 
professor of surgery (otolaryngology). 
J.B. Lippincott Company (Phila¬ 
delphia) 1983. 
“Divorce and Your Child.” Sonja 
Goldstein, LL.B., Lecturer, Child 
Study Center, and Albert J. Solnit, 
M.D., Sterling Professor in the Child 
Study Center, Pediatrics and Psychi¬ 
atry. Yale University Press (New 
Haven)1983. 160 pp. 
“Comprehensive Surgical Atlases in 
Otolaryngology and Head and Neck 
Surgery.” K.J. Lee, M.D., editor-in- 
chief, assistant clinical professor of 
surgery (otolaryngology). Gruneand 
Stratton (New York) 1983. 5 volumes, 
including: “The Atlas of Head and 
Neck Surgery.”Bruce W. Jafek, M.D., 
and Clarence T. Sasaki, pro¬ 
fessor of surgery (otolaryngology); 
“The Atlas of Cleft Lip and Cleft 
Palate Surgery.” Howard W. Smith, 
M.D., D.M.D., clinical professor of 
surgery; and “The Surgical Atlas of 
Otology and Neuro-otology.” Eiji 
Yanagasawa, M.D., clinical professor 
of otolaryngology. 
The fourth edition of “Principles of 
Surgery”, published by McGraw-Hill 
Book Company (New York) is dedi¬ 
cated to Dr. Edward H. Storer, one 
of the associate editors, “Whose con¬ 
tributions to surgical physiology and 
education constitute a lasting legacy. 
Whose efforts related to ‘Principles 
of Surgery’ contributed significantly 
and eased the editorial process 
throughout the production of four 
editions.” Dr. Storer, professor of 
surgery and associate dean, died in 
February 1983. 
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ALFRED GILMAN, Ph D. 
Dr. Alfred Gilman, an internationally 
recognized medical scientist, author 
and authority in the field of pharma¬ 
cology, died suddenly at his home in 
New Haven on Friday, January 13, 
1984. 
He was born in Bridgeport, Con¬ 
necticut on February 8,1908 and in 
his 75th year was actively engaged in 
writing and in lecturing at Yale and 
in numerous advisory capacities. After 
graduating from Yale College in 1928 
and being awarded a Ph. D. degree in 
biochemistry from Yale University in 
1931, he served as a research fellow 
and, from 1935, as assistant professor 
of pharmacology and toxicology at 
Yale until he left for Army service in 
1943. He served as chief of the Pharma¬ 
cology Section of the Medical Division 
with the rank of major. 
In 1946, he was appointed to an 
associate professorship in pharma¬ 
cology in the Columbia University 
College of Physicians and Surgeons 
in New York City, and became a full 
professor there in 1948. He held this 
position until 1956, when he accepted 
the chairmanship of the Department 
of Pharmacology at the newly estab¬ 
lished Albert Einstein College of 
Medicine in New York City. There he 
also served as associate dean for 
graduate studies. On his retirement 
from this position in 1973, Dr. Gilman 
and his wife returned to New Haven, 
where as a professor emeritus from 
Albert Einstein College of Medicine, 
he volunteered his services to teach in 
the Yale School of Medicine. 
With the title of lecturer in pharma¬ 
cology, he taught with singular effec¬ 
tiveness until his death. Indeed, on 
the very day he died he was to have 
delivered the concluding lecture in 
the pharmacology course, a lecture 
devoted to an overview of drug 
therapy, past-present-and future, 
which he was uniquely qualified to 
deliver and which had become some¬ 
thing of an annual event — awaited 
eagerly by students and faculty alike. 
All recognized his great stature in the 
field and his ability to captivate his 
audience by wisdom, force of argu¬ 
ment, and obvious dedication to the 
discipline of modern pharmacology 
which he had done so much to develop. 
His ability to fire the enthusiasm of 
the medical students and young 
doctors for the rational use of thera¬ 
peutic drugs was remarkable. But 
this was only one facet of his many 
contributions to medicine. 
Dr. Gilman's most influential con¬ 
tribution to medical science was his 
authorship in collaboration with Dr. 
Louis S. Goodman, of a landmark 
textbook, first published in 1941, 
that was to revolutionize the teaching 
of pharmacology and the perspective 
of generations of physicians. This 
text. The Pharmacological Basis of 
Therapeutics, was at once recognized 
as an astonishing tour de force. It not 
only presented a treasury of pharmaco¬ 
logical facts, but it organized these 
within a novel framework where they 
were interwoven, in a unique manner, 
with current biochemical and physio¬ 
logical knowledge and with patho¬ 
physiological and clinical concerns 
so that the whole provided a refresh¬ 
ingly rational basis for drug therapy. 
One reviewer, in 1941, surely echoed 
the general view when he wrote that 
the text was “the kind of work that 
might have been the fruit of the 
collaboration of a team of authors, 
and it is difficult to think how two 
men did it.” From today’s perspective, 
with this now classic textbook soon 
to enter preparation for the seventh 
edition and long since “multi- 
authored” the accomplishment is 
even more remarkable and the great 
impact of the work on the field of 
pharmacology and on clinical medi¬ 
cine is universally acknowledged. 
In addition. Dr. Gilman contributed 
importantly in several fields of bio¬ 
logical experiment. His early studies 
illuminated the osmotic relation be¬ 
tween blood and body fluids and led 
him, eventually, to a series of out¬ 
standing works on renal pharmacol¬ 
ogy. In the interim, in the I940’s, he 
published extensively and authori¬ 
tatively on the newly developed organo¬ 
phosphorous anticholinesterases, and 
with his colleague, Louis Goodman, 
was responsible for the clinical intro¬ 
duction, in 1946, of the first effective 
cancer chemotherapeutic agent, nitro¬ 
gen mustard. 
He also served at the national level 
as a valued consultant and advisorto 
various governmental agencies and 
committees, as well as to industry 
and many private foundations. Thus 
he played a key role in governmental 
review of drug efficacy, serving 
notably on the Drug Research Board 
of the National Academy of Sciences, 
of the National Research Council, 
from 1963 to 1972, latterly as 
chairman. 
Dr. Gilman received many honors 
as a result of his remarkable profes¬ 
sional achievements and contribu¬ 
tions. He was elected to the presidency 
of the Society for Pharmacology and 
Experimental Therapeutics (1960) and 
to membership in both the American 
Academy of Arts and Sciences and 
the National Academy of Sciences, 
and he was awarded the degree of 
D.Sc. from Dartmouth in 1979. 
Alfred Gilman’s great stature and 
authority in the field of pharamcologv 
never eroded his modest character 
nor the gentleness, patience and under¬ 
standing with which he advised and 
encouraged the many who sought his 
help. A revered teacher, colleague 
and friend has been lost, but the 
splendid influences of the man on so 
many aspects of medicine will persist. 
Dr. Gilman is survived by his wife, 
the former Mabel J. Schmidt of 
Bridgeport, whom he married in 1934, 
by two children. Dr. Alfred G. Gilman, 
chairman of the Department of Pharma- 
cology. University of Texas Health 
Science Center at Dallas, and Joanna 
Gilman Feins of Hingham. Massa¬ 




The Alumni in Medicine Column 
Notes from the President 
Nicholas PR. Spinelli, M.D. 
It’s cool and comfortable in Howard 
Levitin’s office on this suffocatingly 
hot August day. The Office of Student 
Affairs, 1983, is quiet and free of the 
usual noise and bustle during this 
holiday period. I glimpse Dean Betsy 
Winters at her desk,her door always 
open, as I cross the foyer into Dr. 
Levitin’s office. 
I try to recall the administrative 
wing of 1943 when I was a student. 
Was it “suffocatingly hot” in those 
days before air-conditioning? My 
memory fails at recollection; it rejects 
the recall of discomfort and distress, 
a guileful trick of senescence. 1 have 
passed the door which belonged to 
Miss Dasey who, unappointed, was 
the student-advocate-confidante of 
my day. Was she indeed unappointed, 
serendipitous in this role? 1 do not 
know. She was the Registrar in an 
immensely simpler administrative 
structure, in an immensely simpler 
time. Her eyes twinkled. It felt good 
to talk with her. Dean Winter’s role 
is, indeed, more structured and de¬ 
fined. But like Miss Dasey, her per¬ 
formance has become a legend among 
medical students of her time. “She 
can do anything. Bring her the most 
incredible idea or problem. She comes 
up with a solution.” “She’s the most 
compassionate, sensitive person you 
could know. She listens.” 
Dr. Levitin’s office is unpretentious 
and functional, as pragmatic as the 
dozens of daily dialogues with students 
must be. The pictures of the student 
body are prominent on his office 
wall. It reveals this man’s concern for 
each student for whom the Yale 
School of Medicine bears educational 
responsibility. Howard is the common 
pathway through which flows informa¬ 
tion concerning the needs, the prob¬ 
lems, the progress of every medical 
student at Yale. The story of him and 
his team, of the multifaceted mission 
of the Office of Student Affairs was 
reported in Yale Medicine in the 
winter of 1980. 
Hiscommentsare punctuated with 
the names of his colleagues as we 
speak of the students of this and the 
last decade, each touched by the 
unique stresses of their time: Betsy 
Winters, Jim Comer, Pam Nyiri, Lil 
Dalton, Tom Lentz, and Alan Mer- 
mann. Each of them interfaces with 
the entire student body, and as filters 
they offer assistance to the academi¬ 
cally or otherwise troubled student. 
The appropriate team member is 
available to Dean Levitin should a 
problem require consultation. Curricu¬ 
lum, clerkships, the thesis, electives, 
student evaluations, residency, and 
financial aid all grist for the mill of 
communication, the final denominator 
which brings a student to the Office 
of Student Affairs, the department 
that Dr. Levitin heads. 
He is thoughtful and ruminative as 
he reviews his experience since the 
late 60’s when he assumed the role 
from Dr. Thomas Forbes, himself 
beloved of students of the decade 
before, the communicator of the fifties. 
“Perhaps the most challenging 
and rewarding part of my job is 
helping students ad just to the intellec¬ 
tual challenge of the “Yale System” 
and the psychological stresses of 
medicine. Anxiety, the companion of 
medical students from time immemo¬ 
rial, is a constant presence. For today’s 
students, medicine is more complex 
than it was in the past. The knowledge 
explosion, the changing image of the 
physician, major financial problems 
and many new and different career 
opportunities are ever present. They 
come to school with the highest ideals 
and slowly realize that they will have 
to make adjustments. All students 
tend to go through this matamorpho- 
sis, but the additional change from 
layman to physician is an additional 
burden for our students.” 
Howard Levitin came to Yale as a 
fellow in metabolism in 1956 (one of 
the salt/water boys of the post-Peters 
era). I remember him coming to give 
CME lectures on “salt and water”at 
my community hospital 20 miles away, 
our Yale faculty consultant. His 
student affairs role emerged a decade 
later and has grown to its present 
status. “I was from New York but 
went to Southwestern Medical School 
in Dallas,” he recalls. “It was tradi¬ 
tional, not as emotionally binding as 
Yale. We had a Miriam Dasey .... a 
Betsy Winters .... her name was Ann 
Rucker.” One readily perceives New 
Haven, not Dallas, dominates the 
commitment of this man today. What 
1 hear as I talk to him is a description 
of student development in this modern 
time of vastly increased knowledge 
and technology, a more stressful 
reality than we older alumni knew. 
“We ask that they be mature in their 
crises, but they are as scared as we 
were,” notes Dr. Levitin. “What did 
we do, how did we cope in our less 
stressful time?” 1 ask myself. And my 
answer seems valid; that during World 
War II the forced communality of life 
of the 40's (Company C, Yale Unit, 
Howard Avenue) forced us to be our 
own support system. We turned the 
absurd pressure of that time, the war, 
into a form of catharsis, sharing, 
interpersonal challenging which 
helped disperse anxiety. Our emo¬ 
tional needs and conflicts were dealt 
with in an ad hoc fashion, with no 
structured system. Today’s support 
system must be thoughtfully struc¬ 
tured to meet this essential need. It is 
one of many megabudget medical 
school items. 
My nagging notion that somehow 
as alumni, we might be of help to the 
students with this same process of 
emotional support, through commun¬ 
ication as alumni, continues to fail to 
materialize. Neither students nor 
alumni, in the end, have the time 
which can be structured socially to 
achieve this end. Yet I am continually 
amazed by how extraordinarily grati¬ 
fied those students would be to share 
the fact that there is a universality 
about student anxiety, no matter 
what the time setting, that the pain of 
today’s suffering to acquire personal 
achievement dissipates with the heal¬ 
ing touch of time. 
“Those of you who have been 
there, who are there, can describe the 
directions which we are still not able 
to see. Direction is what we need.” 
He is an eager, earnest, third year 
student who is interested in plastic 
surgery. 1 can easily arrange an appoint¬ 
ment with an experienced, practiced 
plastic surgeon I know. As alumni, 
we can be of help in many such ways. 
We must continue to pursue the 




Our appreciation to Paul Saffo (’33) 
for sending us news about Howard 
Wood who resides in Torrance, Cali¬ 
fornia. Dr. Wood left private practice 
12 years ago, but retired just last 
September when he resigned his posi¬ 
tion as physician for the Torrance 
Unified School District. He became 
90 in January, and in addition to a 
birthday celebration by the students 
of the Howard A. Wood Elementary 
School, he was honored by the Tor¬ 
rance Kiwanis Club for four decades 
of community service. As noted in an 
article in the local newspaper, “Daily 
Breeze”, he is probably best remem¬ 
bered as the motivating force behind 
the creation of an independent city 
school district for Torrance almost 
40 years ago.” 
1932 
“Health Care in China”, an AMSA 
study tour of the People’s Republic 
of China, June 19 - July 7, will be led 
by Myron Wegman. The American 
Medical Student Association is spon¬ 
soring this as a part of its medical 
education program. Dr. Wegman, 
dean-emeritus of the University of 
Michigan School of Public Health, is 
president of the American Association 
for World Health. His connections 
with China began in 1972, when he 
chaired a Conference on Public Health 
in the People’s Republic of China, 
co-sponsored with the Center for 
Chinese studies and the Josiah Macy 
Foundation, and was co-editor of the 
book that resulted from the confer¬ 
ence. As a member of the National 
Academy of Sciences-sponsored 
Committee on Scholarly Exchange 
with the People’s Republic of China, 
he was a member of the first medical 
delegation to the People’s Republic 
of China, in 1973. Dr. Wegman was 
appointed to the Committee on Ad- 
vaned Study of China in 1978 and 
visited China again with the CASC 
subcommittee in 1979 to arrange 
long-term placement for the first 
group of Americans to do advanced 
study and research in China since the 
establishment of the People’s 
Republic. 
1933 
Robert Huntington spoke at the 
Fourth International Conference on 
Coccidioidomycosis held in San Diego 
in March. His address entitled “A 
Modern View of Coccidioidomycosis 
From a Personal Historic Perspective” 
was one of the highlights of the 
scientific program. The conference 
was organized under the auspices of 
the American College of Chest 
Physicians. 
1938 
Announcement was received in Febru¬ 
ary that Charles Petrillo has moved 
from New Haven to new offices in 
Guilford, Connecticut for the practice 
of ear, nose and throat diseases. 
1953 
William Whalen is president of the 
newly organized Connecticut Peer 
Review Organization (CPRO). Unlike 
most physician review programs, 
CPRO includes representatives of 
both the providers (physicians and 
facilities) and the payors (business, 
industry and insurance carriers). Dr. 
Whalen is also president-elect of the 
Connecticut State Medical Society 
and is currently chief of the medical 
staff at Windham Community Memo¬ 
rial Hospital in Windham, where he 
practices surgery. 
1954 
In October Robert Joy gave the 
eighth annual Joseph Garland Memo¬ 
rial Lecture of the Boston Medical 
Library. Dr. Joy, professorand chair¬ 
man of medical history at the Uni¬ 
formed Services University of the 
Health Sciences, spoke on “Health 
Reform in Nelson’s Royal Navy.” 
The lecture honors the memory of 
Dr. Joseph Garland, who was editor 
of The New England Journal of 
Medicine from 1947 to 1967. 
1958 
Michael Kashgarian is currently 
serving as president of the Yale-New 
Haven Hospital Medical staff. 
1960 
Festus Adebonojo, professor of pedia¬ 
trics at Cornell University Medical 
College, has been named professor 
and chairman of the Department of 
Pediatrics at Meharry Medical College 
School of Medicine in Nashville, 
Tennessee. 
1968 
John Ogden, who has been on the 
faculty at Yale since 1972, has been 
appointed professor of orthopedic 
surgery at the University of South 
Florida College of Medicine in 
Tampa. 
1969 
Lee Jampol, professor of ophthalmol¬ 
ogy at University of Illinois College 
of Medicine, has been named profes¬ 
sor and chairman of the Department 
of Ophthalmology at Northwestern 
University Medical School in Chicago. 
1971 
H. Steven Moffic and his wife, Rusti, 
were among 23 American academi- 
ians awarded fellowships by the Amer¬ 
ican Jewish Committee to attend the 
annual Academician’s Seminar in 
Israel in December. Dr. Moffic’s re¬ 
search interest is ethnic identity, and 
on his return, he wrote two short 
pieces for the seminar’s journal on 
“Singing for the Scholars: the Yiskor 
Service at Yad Vashem”, and “From 
the Ivory Tower to the Dead Sea: the 
Genesis of a Seminar”. Dr. Moffic is 
associate professor of psychiatry at 
Baylor College of Medicine. 
1974 
In a note received in November Isaac 
Hoch and Jane Snyder Hoch said 
that they “will be moving to Israel 
this December to participate in the 
development of family medicine in 
Israel and will be affilliated with the 
Department of Primary Care at Ben- 
Gurion University of the Negev.” 
They also wrote that they have been 
in private practice in Northampton, 
Massachusetts since 1978, have three 




Harvey Berger has been named direc¬ 
tor of the Nuclear Medicine Division 
and Magnetic Resonance Research 
at Emory University School of Medi¬ 
cine in Atlanta, Georgia. 
1978 
The American Academy of Pediatrics 
announced last fall that Elizabeth 
Hodgson has been elected to fellow¬ 
ship in the Society. Dr. Hodgson is 
on the staff at Athens General Hospi¬ 
tal and at St. Mary’s Hospital in 
Athens, Georgia. The Academy, an 
association of physicians certified in 
the care of infants, children and 
young adults, has 25,000 members in 
the United States, Canada and Uatin 
America. 
1980 
Holiday greetings from Steven and 
Lisa Rosenfeld (PH‘79) included the 
additional news that they became the 
proud parents of a baby boy, M ichael, 




Viola Spinelli, formerly vice president 
for operations at Bridgeport (Conn.) 
Hospital, has been named senior vice 
president, with responsibility for over¬ 
seeing and supervising all the institu¬ 
tion’s major operations. Miss Spinelli 
held the position of associate adminis¬ 
trator of the Tufts New England 
Medical Center in Boston before 
joining Bridgeport Hospital in 1977. 
1969 
Susan Addiss became president of 
the American Public Health Associa¬ 
tion in November of 1983. As a 
member of the APHA, Ms. Addiss 
has served as Action Board chair¬ 
person, as a Governing Councilor, as 
a member of nominating and awards 
committees, and has testified before 
the U.S. Congress on important 
health-related matters. 
She is chief of the Connecticut 
Department of Health Services 
Bureau of Health Planningand Re¬ 
source Allocation; her responsibilities 
include conducting Connecticut’s 
health planning activities and imple¬ 
menting the state health plan. Ms. 
Addiss also holds teaching appoint¬ 
ments in Epidemiology and Public 
Health at Yale, and in Community 
Medicine and Health Care at the 
University of Connecticut Medical 
Center. 
INFORMATION 
REGARDING CHANGES IN 
CLASS AFFILIATION 
Medical graduates and Public Health 
graduates are assigned to a Class 
based on the year in which the degree 
is earned, or would have been earned 
in those cases where the work is not 
completed. Under special circum¬ 
stances, and by written request, alumni 
may affiliate with another Class for 
reunion and fund-raising purposes. 
Such affiliations will be made only 
when an alumnus has interrupted or 
extended the program of study and 
graduates in a year other than the 
year of graduation expected at the 
beginning of studies. 
Requests by alumni/ae for changes 
in Class affiliation may be submitted 
to: Alumni Records Office, P.O. Box 
1950 Yale Station, New H aven, 
Connecticut 06520. 
In Memo riant 
J. Craig Potter, M.D. ex med ‘21 
August 22,1983 
A.Glenn Evans M.P.H.‘34, M.D.‘39 
(Date unknown) 
Dan Tucker H.S.‘39 
September I 1, 1983 
Milton Rose M.D.‘35, D.P.H.‘41 
August 10,1983 
W. Norman Sears 
February 14,1984 
M.D.‘40 
Robert F. Dine 
July 1, 1983 
M.D.’41 
Richard E. Bodkin 
November 11, 1983 
ex med ‘41 
Ann Brace Barnes 
January 10, 1984 
M.D.‘62 
John T. Adams 
April, 1980 
ex med ‘83 
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JAPANESE THEATER ON MEDICAL ALUMNI WEEKEND 
An exciting program has been planned 
for the Medical Alumni Weekend to 
be held this year on June 7, 8, and 9. 
In addition to the outstanding aca¬ 
demic seminars and traditional, and 
always popular social events, this 
year’s program will include a presenta¬ 
tion by Dr. Howard Hamilton, Class 
of 1944, of Japanese Noh Theater. 
The oldest continually extant thea¬ 
ter in the world, Japanese Noh was 
perfected in its present form about 
500 years ago. It is a symbolic, non- 
realistic, poetic monodrama with 
origins in ancient Japanese and 
Chinese dance and religious ceremony. 
Noh is performed by elegantly cos¬ 
tumed actors, often masked, on a 
unique stage devoid of realistic scenery 
or properties. The highlight of the 
drama is a stylized dance section of 
minimum movement and spare 
gestures. The poetic imagery of Noh 
ranks with the best of Japanese liter¬ 
ature. Strictly maintained performing 
traditions are passed down through 
succeeding generations by hereditary 
Noh Schools. 
In the mid-18th century, five Noh 
Schools were officially recognized by 
the Tokugawa regime. The Kita 
School was established around 1618. 
Dr. Hamilton began studying Noh 
on his arrival in Japan in 1956, under 
the tutelage of Izumo Tsunekazu, a 
certified Master of the Kita School in 
Hiroshima. He has also received in¬ 
struction from several masters of the 
Kita School in Tokyo, as well as 
instruction in musical aspects of Noh 
from the former head of the Morita 
Noh Flute School. 
Playing leading roles. Dr. Hamilton 
has performed in 30 full-length Noh 
dramas in Hiroshima and Tokyo, as 
well as in the annual three-day Noh 
Festival at the Shrine on Miyajima 
Island. He is the only non-Japanese 
actor to appear in Noh Drama on the 
450-year old stage of the Shrine. In 
addition, he appears in six to eight 
Kita recitals annually, and has 
appeared in several television perfor¬ 
mances in Japan. In this country, he 
has given a series of lectures and 
demonstrations in art galleries and 
on college campuses. 
Dr. Hamilton's performance on 
Alumni Weekend will be presented 
by the Class of 1944 at 4 p.m. on 
Saturday, June 9, in Fitkin Amphi¬ 
theater. All alumni and their guests 
are invited to attend, but advance 
registration is required. 
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HIGHLIGHTS OF MEDICAL ALUMNI WEEKEND 











Medical School Student Affairs Office Open House 
Class of 1944 Reunion Seminar 
Yale Alumni in Surgery Seminar 
Edward Storer Memorial Lecture 
Yale Alumni in Ophthalmology 1984 Annual Meeting 
Yale School of Nursing Annual Alumnae/i College 
School of Nursing Alumnae/i Seminars 
AYAPH and YUHAAA Annual Workshops** 
AYAPH and YUHAAA Joint Session 
Alumni Reception to Honor Dean and Mrs. Robert W. Berliner 
**Association of Yale Alumni/ae in Public Health (AYAPH) 
Yale University Hospital Administration Alumni Association (YUHAAA) 









Remarks by A. Bartlett Giamatti, president of Yale University 
Yale Alumni in Otolaryngology Reunion 
Alumni Seminars 
Annual Meeting of the Association of Yale Alumni in Medicine 
Sherry and Buffet Luncheon 
Seminar “Health Care Marketing” 
Japanese NOH Drama Theater Performance and Lecture* 
Reception Honoring Dean Donna Diers, School of Nursing 
* Advanced registration required 
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ALUMNI WEEKEND 
JUNE 7, 8, 9 
ALWAYS GREAT, 
WILL BE EVEN GREATER! 
DON’T MISS IT. . . 
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Smiling in the rain that drenched commence¬ 
ment are Dean Berliner (left) and Banner 
Bearer Robert Havlik. 
Umbrellas, not balloons, stole the 
scene this year, as graduates and 
their families and friends gathered 
in the relentless downpour for 
traditional graduation ceremonies 
on the Old Campus. Later, in the 
Mary S. Harkness Auditorium, 
108 damp but jubilant medical 
students received diplomas from 
Dr. Robert W. Berliner, 
officiating at his last 
commencement as Dean of the 
School. Among the graduates 
there were 100 M.D. candidates; 
five M. D. / Ph. D. candidates; one 
M. D. / M. P. H. candidate; one 
M. D. / J. D. candidate and one 
M.D./J.D./M.P.H. candidate. 
Dr. George Palade, Sterling 
Professor Emeritus of Cel! 
Biology and Special Advisor to 
the Dean, delivered the 
commencement address, which 
follows. 
Dr. Jan Stolwijk, Susan Dwight 
Bliss Professor and chairman of 
the Department of Epidemiology 
and Public Health officiated at 
the E. P. H. ceremonies, held once 
again under their traditional blue 
and white striped tent. Eighty-two 
men and women received M. P. H. 
degrees; 11 Ph. D. degrees were 
awarded, and one Doctor of 
Public Health. Dr. Colin White, 
who retired in June as Ira 
Vaughan Hiscock Professor of 
Public Health, delivered the EPH 
commencement address. 
By George Palade, M.D. Forty-five months ago, 1 had the pleasure of being the first member 
of the faculty of this medical school to give you a formal lecture in 
the first course of your curriculum. It was an introductory lecture to 
Cell Biology. And now, 1 am, at your request, the last faculty 
member to address you the day you are leaving your medical school to begin 
stepwise progression through the second half of your training, through 
internship, residency and laboratory work towards your final positions 
within the medical community of this country. 
Of course, this day is not the end of your efforts to learn whatever is needed 
for your demanding profession. But it marks the end of a significant phase, 
the one in which a foundation was laid (in reasonably logical fashion) to 
allow you to understand the reasons behind specific disease cases that you’ll 
have to diagnose and manage, as well as the knowledge of the day will make 
it possible. More importantly, it is also the foundation over which new layers 
of knowledge should be added through the years of your career, as work in 
biomedical sciences will continue to progress. 
Since advances in this field have proceeded at a spectacular rate over the 
last few years, the foundation was intended to be broad and solid, relevant 
not only for the medicine of today, but also - if possible — for that of a 
number of years to come. While that foundation was under construction, 
you may have had questions about the relevance of some of its building 
blocks. But you may have second thoughts about this issue a few years from 
now. In any case, you should realize that your alma mater might suffer severe 
mental pains if, in the future, your patients may know more than you do 
about some basic aspect of their condition, because they read about it that 
day in the New York Times, or even their local newspaper, - because your 
foundation was not broad enough, or because you didn't have a chance to 
read about that specific issue in The New England Journal of Medicine. 
Remember that the publication lag in the New York Times is much shorter 
than in any properly edited medical or scientific journal. So, relevance in the 
past, the present and especially the future should be considered on a safely 
broad basis. 
But now, leaving this question aside, let’s consider first your past 
experience and then your future: 
you handled bravely the mountains of information of the first year and a 
half of your curriculum. Even if predigested and neatly packaged, those 
mountains generated rushing torrents of letters and words that could have 
flooded your minds, and scrambled them forever, but they didn’t; 
you survived the acid test of the fourth semester of the curriculum, when 
weaker souls would have collapsed under the weight of the triple demands of 
the Pathophysiology course, the first round of board examinations, and 
especially the second year show; 
you went successfully through your clerkships; 
you made smoothly that critical transition from well-worn casuals to ties 
nice ties — and jackets impeccable jackets - (or their feminine 
equivalents); 
you looked carefully at your image as reflected in the eyes of your patients, 
your residents and your faculty, and adjusted the source of the image in the 
right direction, whenever adjustment was needed. 
And now, 45 months later, and, I would say, 40,000 read pages later, you are 
ready to face the world as medical doctors. However you look at it, and 
notwithstanding any touch of slight irony, it has been a great performance. 
You are fully entitled to be proud of it. You deserve the unreserved 
congratulations of your faculty, your younger and older colleagues, and 
1 
especially of your families. 
But what about the future? 
re you entering your 
profession under the fog of 
stagnation, or the clouds of 
doubt and uncertainty? Or are you 
becoming medical doctors at a time 
when promise of progress and, w ith 
it, promise of great professional 
rewards, are to be found right 
around the corner, past your entry 
into the field? 
The answer to this question is 
undoubtedly the brightest part of 
the entire picture. You should con¬ 
sider yourselves unusually fortunate. 
In fact, you should congratulate 
yourselves for the excellent timing 
of your graduation. 
If the primary objective and the 
major source of satisfaction of a 
physician, practicing at whatever 
level fate places her or him, is to 
cure or prevent diseases, especially 
incapacitating, painful, destructive 
diseases, you are entering the ranks 
of your profession when there is 
finally hope that we’ll be able to 
control at least some of these dis¬ 
eases in your life-time, perhaps 
even during the first ten to twenty 
years of your professional activities. 
Over the last century, especially 
over the last fifty years, your pre¬ 
decessors were able to solve the 
awesome problem of infectious dis¬ 
eases with such success that Homo 
sapiens moved all the way from the 
position of an endangered species, 
endangered by the major epidemics 
of the past, to that of a species that 
has overpopulation problems, and 
thereby damages in part the environ¬ 
ment and threatens most of the rest 
of the biosphere. The problem of 
infectious diseases is, generally 
speaking, solved, although some 
remaining pockets are still awaiting 
practical solutions. 
Today, however, we are finally 
closer than ever before to a 
precise understanding of neo¬ 
plastic diseases in molecular terms. 
And this is a major achievement. 
We are finally seeing the morbidity 
and mortality curves for cardiovas¬ 
cular diseases coming down at an 
unexpectedly rapid rate, primarily 
because of improved management; 
we can detect many inherited metabolic 
diseases in time to avoid many 
unnecessary familial tragedies; and 
given time and a better organization 
of our society, we could eliminate 
at least part of these inborn metabolic 
diseases. 
Moreover, our rapidly advancing 
understanding of the organization 
and control of expression of eukary¬ 
otic genes, including our own, and 
the biotechnology developed during 
these advances, makes possible the 
development of new, highly refined 
diagnostic and prognostic tools that 
will greatly improve the manage¬ 
ment of many diseases and the 
prevention of many genetic disor¬ 
ders. Similar tools may also help us 
in controlling whatever problems 
we still have with infectious diseases. 
Biotechnology may even make 
possible gene therapy, that dream 
of the over-optimistic and most 
venturesome among us. But you 
should realize that cell therapy may 
also become a valid alternative, 
provided that in the meantime, we 
learn more about the complex and 
remarkably resourceful system that 
governs our immune reactions. 
So, with all these facts and 
promises in mind, I believe 
that you should raise a toast 
today to the timing of your gradua¬ 
tion two glasses of good cham¬ 
pagne are definitely warranted. But 
before having the third glass, how¬ 
ever, you should pause and consider 
that, in fact, not all the dragons and 
nightmares of human pathology 
are on the verge of being tamed, 
conjured or dissipated. Between 
what we know' and w hat we would 
like to know in medicine there is 
still a gap. In some cases, that gap is 
as big, wide and dark as the Grand 
Canyon early in the morning when 
most of its depth is shrouded in 
darkness. In that black abyss we 
can place schizophrenia and the 
degenerative diseases of central ner¬ 
vous systems of all ages, especially 
the old. 
At this junction, I would like to 
turn for a few minutes autobio¬ 
graphical because 1 need a part of 
my story to make a point. As you 
probably know, my formal training 
was in medicine, but as you probably 
do not realize, I went through the 
equivalent of a complete internship 
and residency program before going 
back to the laboratory. 
At the beginning, I liked the 
heroics of medical care in major 
emergency cases, and the challenge 
of great responsibility put on my 
rather young shoulders. I had no 
problems duringa year in infectious 
diseases, primarily because I realized 
that there w as hope of improvement. 
I did reasonably well through two 
years of internal medicine, but to¬ 
wards the end, I started having 
doubts about the future. And I 
didn't like at all a year in neurology 
because I saw too much despair 
and too little hope. 
So. I went back to internal medi¬ 
cine, in which I functioned for a 
year or so as an assistant professor, 
and during that period I became 
progressively uncomfortable about 
the gap between what I knew and 
w hat I had to know to live up to the 
expectations of my patients. They 
expected me to speak with the 
authority of an oracle, but not 
withstanding my efforts and my 
many books, my authority rested 
on a very modest bank of significant 
information. So, in the late 1930's, 
when sulfonamides had already 
emerged as the new miracle drugs, 
but before antibiotics entered the 
scene, I left internal medicine and 
moved back to a laboratory. 
No mouse, rat, guinea pig or 
rabbit w as going to ask me, “Doctor, 
are you sure of your diagnosis?” 
-or “Is this treatment of yours 
the best there is for my condition?” 
And no mouse or guinea pig was 
going to embarrass me more serious¬ 
ly by telling me, "Doctor. I am so 
happy to be in your hands, because 
you know so much about my 
condition.” 
It was not really giving up medi¬ 
cine, it was going back to the 
scientific foundation of medicine 
and trying to do something about 
that disturbing gap. By a series of 
unusually happy circumstances (for 
which I was not directly responsible), 
I was able to contribute reasonably 
well to the new field of cellular 
2 
biology, which soon turned cellular 
and molecular biology, and rapidly 
became the common ground or the 
starting line for many other fields 
of biomedical interest. You may 
know that neurobiology in our 
school is now cellular and molecular, 
that many other institutions 
have cellular and molecular immuno¬ 
logy, and that pathology and even 
medicine are becoming cellular and 
molecular. There is even a Journal 
of Molecular Cardiology on the 
market! 
However, were 1 a member of 
your graduating class, my 
decision would not be so 
easy. I would consider very seriously 
medical practice, academic medicine, 
and especially clinical research 
because: 
we know today so much more 
than 40 or 45 years ago; 
at present, our knowledge in bio¬ 
medical sciences is so much deeper 
and coherent than it was in the late 
1930's; 
our diagnostic and therapeutic 
arsenal is so much more powerful 
and extensive - it covers, in fact, a 
very large sector, if not the whole 
front, of clinical sciences; 
and especially because basic re¬ 
search, directly relevant to human 
diseases, can be carried out success¬ 
fully on cells taken directly from 
human patients afflicted by hemato¬ 
logic, immunologic, and neoplastic 
disorders. This kind of work may 
soon become possible in other fields 
of clinical interest. 
We can come back now to the 
excellent timing of your graduation 
and examine more critically some 
relevant issues. 
The timing is so much better 
than that of many of your prede¬ 
cessors, because they brought the 
biomedical sciences up to the level 
from which you are starting. They 
provided you with a high and firm 
base line, which is the way it is 
because under it are buried the 
shoulders of Hippocrates, Galen, 
Maimonides, Pasteur, Erlich, Osier 
and those of legions of more recent 
doctors and surgeons, even the 
shoulders of most of the members 
of your faculty. 
You are the benficiaries of a long 
ascending road that brought us all 
the way from prehistoric witchcraft 
to the medical sciences of today. As 
any other beneficiaries, you should 
consider yourself in duty bound to 
sink, in time, your shoulders under 
the same baseline to raise it even 
higher and make it even firmer for 
the classes of the late 1990’s or the 
early 2,000’s. 
But, before sinking your shoulders 
under the feet of future generations, 
make sure that they are as hard as 
possible. No innocent youngster 
should sink while stepping on soft 
or mushy shoulders. Remember 
that we have narrowed the gap 
between what we know and what 
we should know, but we have not 
succeeded in closing it yet. Re¬ 
member that there is still a wide gap 
in cardiovascular diseases, and a 
dark, huge chasm in many mental 
diseases. It may take many shoulders 
to fill that abyss, but there is no 
other way. 1 hope some of you will 
work on these gaps and, if you do, I 
wish you the best of luck. 
Dr. Palade Now, disregarding for the 
moment those gaps and those 
chasms, did I paint too opti¬ 
mistic a picture of the immediate 
future of your profession? 
I really don’t think 1 did. 
Yet, 1 have to in ject a few correc¬ 
tions because I feel they are needed. 
There are admittedly a few clouds 
on the horizon that deserve to be 
considered. 
THE FIRST CLOUD: We find 
ourselves, at present, in a situation 
in which our inventiveness moves faster 
than the increase of our material 
resources. This is obvious in the 
case of the so-called half-way tech¬ 
nologies. Renal failure requires sus¬ 
tained dialysis. Obstructive coronary 
arteriosclerosis is bypassed by vascu¬ 
lar autografts, and organ transplan¬ 
tation is the object of considerable 
and general attention. 
Yet most, if not all, of these 
procedures are palliatives, not cures. 
And none of them is inexpensive 
enough to be applicable or afford¬ 
able in all cases, even if the society 
as a whole pays the expenses we are 
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moving toward different ways of 
management for the rich and the 
poor and the move is clearly undesir¬ 
able. The problem is how to direct 
our attention away from mechanistic 
inventiveness toward basic research 
aimed at preventing such afflictions 
as kidney failure or arteriosclerosis 
in general. This becomes, of course, 
one more reason to concentrate on 
those gaps already mentioned. 
THE SECOND CLOUD: We 
hear more and more often that 
patients are unhappy, although they 
receive in most cases good or excel¬ 
lent treatment, and although they 
live today longer than at any time 
in history. 
Patients like to be treated as 
persons, to be the object of the 
visible attention of their physicians. 
They believe their doctors concen¬ 
trate too much - sometimes exclu¬ 
sively on the charts, numbers 
and molecules of the sick, rather 
than on their patients’ emotional 
whole. Not even the most intractably 
molecular biologist likes to be 
treated like a collection of molecules 
out of order when she or he is sick. 
And the same applies clearly for the 
most scientifically minded physi¬ 
cians when they become patients. 
edicine is often referred 
to as an art. And indeed, 
it shares with the real arts 
two major properties. Medicine can 
generate rewarding, even engross¬ 
ing, results by skillfully handling 
ordinary, often uncertain, poorly 
defined elements, just like the arts. 
And, in the past at least, like all the 
arts, medicine kept man in the 
center field of its attention. But 
now, medicine seems to be pushing 
man as a whole, out of the limelight; 
it appears bent on replacing him/ her 
by derivatives which are scientifi¬ 
cally valid, but are perceived as 
cold, inaccessible abstractions by 
the sick, ordinary mortal. This de¬ 
humanizing trend is general and 
afflicts most severely the plastic 
arts. 
The roots of this second fall from 
grace — this time on earth — can 
be traced to a misinterpretation of 
science. 
Slowly, over the years, we became 
aware that perhaps (and let me 
emphasize this perhaps, because I 
would not like to hurt the feelings 
of any believers among you) perhaps 
we are not the daughters and sons 
of Deity, or, in any case, the object 
of Its special attention. We are, it 
seems, the last primate species pro¬ 
duced by evolution, big clever 
monkeys, but monkeys nonetheless. 
Artists usually follow the major 
trends in the thinking of their times, 
but doctors should have their own, 
more lasting set of values. The 
theological record indicates quite 
clearly that as a species Homo 
sapiens is a specialist in recurrent 
failure. His record as the Son of 
God, which means the immediate 
product of absolute perfection, has 
always been questionable, often 
miserable. 
But his prehistorical and historical 
record as a later times primate has 
been, and still is, unique and splen¬ 
did, unsurpassed and probably 
unsurpassable. For this reason alone 
he deserves to remain in the center 
of our field of attention artistic, 
medical, scientific and otherw ise. 
Besides, this creature definitely 
needs constant attention. Moreover, 
through history, this kind of treat¬ 
ment has been the most powerful 
instrument in the betterment of the 
species. 
So, as medicine becomes more 
and more of a science, it must 
retain this element of its art-like 
past. We have to find the means 
that will allow the physician to 
communicate with the patient as a 
person, dealing with another person 
badly in need of attention. Under 
this level of intense, unmitigated 
personal attention, the sick mole¬ 
cules of the patient must, ofcourse, 
be treated with other appropriate 
molecules prescribed by the physi¬ 
cian, but the patient as a person 
cannot be left out of the limelight. 
THE THIRD CLOUD: The medi¬ 
cal profession is acquiring a question- 
able reputation: it is becoming, on 
the average, an affluent profession 
and often likes the overt expression 
of its affluence obtained, natur¬ 
ally, from professional fees. 
In the Christian calendar, there 
are only two doctor-saints — Cosme 
and Damien. And they are there 
because they were taking care of 
their patients without requesting 
any fees. 1 am not suggesting any¬ 
thing as radical as that. But, after 
paying those huge debts (incurred 
while in medical school), could you 
think twice before buying a Mer¬ 
cedes Benz, a Jaguar or even a 
Cadillac, instead of, say, a Ford 
Escort or a Nissan Stanza? In our 
times, such means of ego gratifica¬ 
tion work only during the lifetime 
of the owner of the ego. Sometime 
ago they were admittedly supposed 
to work forever. But even if we 
would go back to those times, and 
even if we would be buried in our 
Mercedes Benzes, the archeologists 
of the next millennium may say, 
“What a clumsy, rudimentary ma¬ 
chine we found in the tomb of that 
great doctor!” The long ships in 
which Viking queens and kings 
were buried a millennium before, 
or the chariots in which Sythian 
chieftains were put to rest even 
more millennia before, have at least 
the advantage of being highly 
esthetic objects. 
And now we come to the end. 
You are leaving, taking w ith 
you the emotional equivalent 
of a few fibers from the heart ol 
your alma mater, and, from your 
faculty, the emotional equivalents 
of such precious objects as sodium 
channels, signal recognition parti¬ 
cles, snRNP, scRNP, TATA boxes 
or the latest membrane receptor. 
Each one of you is a special 
person among all men and women. 
Each one of you is a precious 
daughter or son of your alma mater. 
Each one of you deserves a bright 
future. 
Farewell, and out there remember 
to treat your patients as persons 
remember the gaps and the chasms 
still to be filled. and harden your 
shoulders for the sake of the future. 
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The brain — three pounds of tissue — more than 10 billion neurons — is 
ceaselessly active whether we are awake or asleep. Neurons, no one of which 
is exactly like another, are so intricate that each is connected to thousands of 
others by complex chemical processes and electrical circuitry. To function, 
these circuits depend on myriad channels — protein molecules that act as 
tiny valves to control the flow of electric current. 
The task of studying and understanding such an enormously sophisticated 
organ is so staggering that it has long defied detailed analysis. But this basic 
machinery of human behavior is finally yielding its secrets. 
New techniques and instrumentation developed in the past decade provide 
researchers with tools hardly even imagined when today’s freshly minted 
neurologists entered medical school 
At Yale, these tools are being applied by teams of researchers employing 
the collaborative efforts of experts in neurophysiology, neurochemistry, 
neuroanatomy, immunology and molecular biology. Contemporary neuro¬ 
science evolved into a multidisciplinary approach because the pursuit of 
these separate disciplines proved constraining to research. 
All neuroscientists share the same general question: How does the brain 
work? But this one major question can be approached at many different 
levels. 
Four researchers at Yale are looking for the answer in strikingly different 
ways. They are PatriciaGoldman-Rakic, professor of neuroscience; Pasko 
Rakic, chairman of neuroanatomy and Dorys McConell Duberg Professor of 
Neuroscience; Charles Stevens, chairman and professor of molecular neuro¬ 
biology, and George Aghajanian, professor of psychiatry and pharmacology. 
The questions they ask and the techniques and methods adopted in pursuit of 
their answers may seem esoteric at first glance, but come together to have 
important therapeutic implications. 
HOW DOES THE BRAIN WORK? 
HOW DOES IT DEVELOP? 
HOW DO THESE QUESTIONS 
RELATE TO BRAIN DISORDERS? 
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PATRICIA GOLDMAN-RAKIC 
by Nissa Simon 
Nissa Simon, an award-winning freelance 
medical writer, is the author of "Don't 
Worry You 're Normal: a Teenager’s Guide 
to Medical Self-Help", published by Thomas 
Y. Crowell. 
“People have been interested in the subject I'm studying the cortex - for 
centuries. Scientists have been asking questions, but the answers have been 
unsatisfactory,” said Dr. Goldman-Rakic. “Progress was slow because we 
didn’t have good methods. But in the last decade, methods developed rapidly 
and as the methods get better, the questions get better and the answers get 
better. There’s been an enormous revolution in techniques: computers, 
sophisticated biochemical assays, sophisticated methods for analyzing 
connections in the brain.” 
In very early stages of brain science, scientists thought the brain was one 
intermeshed network without breaks — that one cell and its process couldn’t 
be separated from another. In fact, the brain is made up of discrete units 
connected to one another. “This is the neuron doctrine, which is now 100 
years old,” said Dr. Goldman-Rakic. “What is new is that now you can see 
each unit and actually trace the connections. 
“The brain is the most complex structure in the universe,” she continued. 
“Every cell in the brain - and there are so many you can’t even imagine the 
staggering number is connected to other cells by a most complex wiring 
system. Billions of individual elements communicate with each other in a 
complicated manner, but one that can be unravelled. 
“When you use a microscope and biochemical methods and physiological 
techniques, you can dissect the brain into these elements. And these elements 
are the subject of our study. 
“One step in unravelling it is finding out how the individual neurons are 
assembled and what kind of circuitry they form. This can be done now. It 
sounds a bit like science fiction, but it can be done in a way that was 
impossible even ten years ago.” 
Dr. Goldman-Rakic is interested in the cerebral cortex, the region of the 
brain that controls thought and language, where information from our 
senses is analyzed, and where our body’s responses are determined. “You 
almost have to be a metascientist to be interested in the cortex because you 
can't understand it without know ing its connection to other structures in the 
brain and other organs in the body, such as the circulatory system, endocrine 
glands and even the viscera. So you end up learning about these other 
structures, too.” she said. 
One of Dr. Goldman-Rakic’s interests is studying the development of 
connections in the cortex. 
“We want to know' what happens to the brain from its earliest stages to old 
age,” she explained. “In both monkeys and humans, most of the brain’s 
developmental events take place before birth.” Dr. Goldman-Rakic studies 
the development of cortical connections in monkeys by injecting radioactive 
tracers into fetuses and then returning them to the womb where their 
development continues uninterrupted until delivery. 
Her studies showed that cortical connections are surprisingly well- 
developed at birth.“I was surprised to see that. However, the connections 
aren’t fully developed because they continue to add outgrowths in the form 
of dendrites and axons. First a cell comes to be located in a specific place; 
then it sends out extensions to make contact with other cells in other places. 
And that process continues after birth. “But the basic blueprint is there. We 
can liken it to having a narrow footpath from A to B. Then, as the path is 
more travelled, it gets wider. Finally it becomes a road,” Dr. Goldman-Rakic 
continued. 
Neuroscientists now believe that this process of maturing contacts is the 
neurological basis for learning and the development of skills. When a child 
speaks for the first time or w alks for the first time, some of these connections 
have matured. “You’re born with all the neurons you’ll ever have,” said Dr. 
Goldman-Rakic. “Those cells then do a lot of growing up and getting 
educated. That’s what experience does; experience trains those cells.” 
According to Dr. Goldman-Rakic, the critical event in the brain’s development 


















All scientists know that the 
process of discovery, the 
Eureka! factor, is built from 
days and years and decades 
of painstaking research, 
assembled bit by bit, equation 
by equation. But even the 
daily and weekly routine has 
its own appeal and 
excitement. 
What’s the most exciting 
part of your work? 
Nissa Simon 
and another. The development of these fine contacts allows communication 
between neurons to take place. 
“At a synapse, the neurotransmitter of one cell is released and stimulates 
the receptors on the next cell, and that will fire the cell. We believe that 
development involves the fine tuning of the system as these synaptic 
connections are formed. We look for correlations between when synapses 
are formed in a structure in the brain and the maturation of a function that 
depends on that structure,” Dr. Goldman-Rakic stated. 
The brain is highly differentiated. There are brain centers concerned with 
hunger, for example, and those are of great interest to researchers concerned 
with obesity, weight control and all disorders that affect feeding. Then there 
are centers that are important for fine control of motor skills, like the 
cerebellum. There are centers for the mediation of vision, hearing and 
speech. 
These centers develop in parallel. In language and speaking, for instance, a 
child must use both audition and vision to associate sounds with an object. 
‘Book’ must have both a sound and an image. “That involves at least two 
types of information,” continued Dr. Goldman-Rakic, “and those must be 
synthesized at the level of the cortex where the two systems are integrated. 
The cerebral cortex exerts the highest level of control of all of these 
functions. And that’s the area I’m interested in and trying to understand. 
“Most of my work and my life in research will be spent gathering more 
neurobiological information about the systems that mediate these functions. 
I believe they will be explicable in neural terms. Just as we can now explain 
the patellar reflex, just as we can now approach an explanation of sensory 
processes, we will be able to explain higher cortical processes physiologically, 
because they’re organized the same way. One function doesn’t have a 
separate set of rules. The relationship between structure and function is the 
same. For example, we discovered that cortical cells are arranged in 
modules. These modules, presumably information-processing units, are not 
unlike modules of the visual cortex that organize visual information. If we 
can understand how they’re organized, we can begin to study them. And 
their function will emerge,” Dr. Goldman-Rakic said. 
“Neuroscientists have been reluctant to think integratively about how to 
apply knowledge of the elements of neuroscience to how we might think of 
human behavior,” she continued. “If you understand the brain’s wiring and 
you understand the biochemical constituents, then you can also think about 
a rational means of drug therapy to apply when cells are lost through injury 
or through disease. We hope that eventually this will enable us to treat 
diseases that involve the loss of cortical cells. Many of the neurological 
diseases that are coming to our attention, like Alzheimer’s, senile dementia, 
and even Huntington’s chorea and Parkinson’s disease, all have symptoms of 
dementia — and the cortex is probably involved.” 
The most exciting part of 
my research is gaining 
insight into a complex 
problem that Eve been 
working on for a long time. 
You begin to think you ’ll 
never really understand it, 
then one day you get an 
additional bit of information 
that attaches to some other 
information that you have 
—and suddenly a new view 
opens up. 
This is an intensely private 
experience. You can share it 
with other people afterwards. 
When you take them through 
that process vicariously, they 
may or may not realize how 
your knowledge developed. 
You, however, know how you 
started with nothing and 
came to something. Then 
when you have a new insight 
you realize how pitiful your 
previous understanding was. 
It’s exciting to see that your 
understanding which was at 
first primitive, can be 
enriched and realize how your 





“There are three questions worth asking in neuroscience today,” said Dr. 
Rakic. “How does the brain work? How does it develop? How do both of 
these questions relate to various brain diseases.? 
“My research is concerned with finding answers to the second question: 
How does the brain develop? 
“The questions we’re asking have been around a long time,” he said, “but 
answers are possible now because of the explosion in new methodology. 
These new methods actually make it possible to trace the migration of 
neurons as the brain develops during gestation. 
“Using DNA labeling, we determined the sequence of genesis of various 
cell classes in selected brain centers. We showed that all neurons in primates 
are generated only during limited periods,” Dr. Rakic explained. “Unlike 
cells in other organs in our body, most brain cells are generated before birth. 
A few' are added during the neonatal period but not a single neuron can be 
added during adult life. Basically, we’re stuck with what we’re born with. 
“In fact, we postulate that new neurons could interfere w ith the retention 
of previous experiences. Therefore, we think that a final set of neurons, a 
stable population of neurons, is essential for the primate brain to retain 
previous experience encoded in a synaptic pattern,” continued Dr. Rakic. 
“We found that cells in primates, including humans, migrate long 
distances after they’re generated in utero,”he said. “While still in utero, they 
move from place of their last division to their final destination. That’s a 
delicate process that must be precise in terms of time and space. In monkeys 
this occurs about mid-gestation. But the brain is not formed, because during 
that period they must migrate to their final position. Then the process of 
formation of connections continues through the second half of pregnancy, 
after birth and during infancy. These migrating cells will later function as 
local circuit neurons in the neocortex.” When the cells arrive, their 
morphological, cytological, biochemical and physiological maturation 
continues; they still must develop connections and appropriate neuro¬ 
transmitters. 
In order to mediate behavior, cells must connect with each other in some 
way. “Our main problem is to define the rules that govern the formation of 
these synaptic connections in the brain,” said Dr. Rakic. “To what extent are 
they determined genetically? To what extent can they be modified by 
environmental factors such as training and experience?” 
In the past, these connections were thought to be ‘hard-wired’, a phrase 
borrowed from computer science to describe structures that are genetically 
determined. “Now we know that the final synaptic pattern at least in 
higher organisms, including primates — is highly variable and depends on 
many factors, including sensory experience,” said Dr. Rakic. Genetic 
information encoded in the DNA of individual neurons does play an 
essential role, but the innate blueprint can be modified by non-genetic 
factors. This interaction allows an immense structural variability in synaptic 
organization that may be the biological basis of our individuality and the 
single most significant reason for the evolutionary success of the primate 
brain. 
“We had long suspected that the environment plays a role in the formation 
of neuronal connections. But it was actually demonstrated less than ten years 
ago,” continued Dr. Rakic. 
“The way connections are made in the brain can be likened to sculpting a 
figure from a piece of stone,” he explained. Most neurons are overproduced 
during fetal life. Optic nerves, for instance, contain about three times as 
many fibers during mid-gestation as we will have as adults. 1 his was initially 
discovered in the monkey and later found true of humans as well. Similarly, 
primates have 150 million fibers connecting the two halves of the brain at 
birth. During infancy, this number is reduced to the adult level of fewer than 
50 million. 
“There is an excess of material and the only way to refine it is by 
eliminating what is not needed,” said Dr. Rakic. He calls this process 
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‘selective elimination’. “The brain is not formed by every neuron being 
programmed precisely to make contact with another neuron. Rather, there is 
an excess of neurons and their axons make the best connections by trial and 
error. Those connections that are functional and serve the individual best are 
reinforced and survive. Those that don’t serve a purpose will disappear. It’s 
rather like Darwin’s theory of survival of the fittest: in this case, survival of 
the best connections in the brain.” 
Dr. Rakic believes that early training can play a sigmticant role. “When 
you recognize that your child has three times as many axons as you have on 
the corpus callosum connecting the two halves of the brain, you realize that 
during those infantile years the environment determines which of these 
axons will survive and which will not. The environment includes education 
and training as well as the chemical environment, which includes drugs and 
nutrition,” he said. 
The implications of this research are great, because once we understand 
the development of the normal brain, we can also understand abnormal 
development — which occurs more frequently than suspected. “There are 
many subtle abnormalities that can’t be detected by routine pathological 
examination. In our technological world, we are just beginning to assess the 
problems associated with external chemical and environmental influences 
on the brain,” commented Dr. Rakic, “problems that our predecessors did 
not have.” 
Dr. Rakic recently received a telephone call from a member of the United 
Nations commission assessing physical consequences of the atomic blasts at 
Hiroshima and Nagasaki, almost 40 years ago. They were examining 
individuals who were fetuses when their mothers were exposed to the blast, 
yet were born and survived. He told Dr. Rakic that most of the survivors who 
suffered from mental problems were between ten and 17 weeks of gestational 
age at the time of the blast, and the commission wondered why. 
“1 said that coincides well with the time that the major wave of neuronal 
migration to the neocortex occurs. This wave contains the neurons that later 
form the local circuits that are responsible for higher cortical function,” said 
Dr. Rakic. “Therefore, 1 could predict that they have problems of higher 
cortical function rather than sensory-motor problems. And that’s exactly 
what happened to this group of survivors. Some cannot work, many of them 
don’t have jobs, some of them are institutionalized. They don't have any 
problems with social adjustment.” 
Dr. Rakic suggested that perhaps their local circuit neurons didn’t 
complete their migration to the cortex because of the radiation. They may 
have been stopped below the cortex. The United Nations scientists answered 
that they thought radiation could kill cells, but they didn't know whether it 
could stop cell migration once it was initiated. 
“We have experimental data showing that this precise neuronal migration 
depends on the interaction between postmitotic cells and special path¬ 
finding elongated fibers that exist transiently in the brain,” said Dr. Rakic. 
“This interaction, which depends on molecules in the cell membrane 
surfaces, is highly sensitive to temperature, chemistry and irradiation. So I 
predicted that even far from the epicenter of the blast, radiation might also 
affect neuronal migration.” 
Six months later Dr. Rakic received another telephone call. A Japanese 
neuropathologist found the protocol of one patient who was a fetus at the 
time of the blast and died 12 years later. After her death, pathological 
examination showed clearly that a lot of neurons were dispersed below the 
cortex. Because the neurons didn’t reach their normal position, they couldn’t 
make appropriate contacts and therefore couldn’t function properly. 
Thus, although Dr. Rakic’s laboratory is devoted to experimental work 
with animals, the work has direct implications for neurology and psychiatry. 
“1 have always been fascinated with how the human brain develops and 
how it works,” he said. “There’s not necessarily a direct line from the simplest 
creatures to human beings. Our work is designed to provide a bridge between 
the two.” 
It's difficult to say just which 
part of my work excites me 
most. That’s like asking 
which of your children you 
like most. It s not a fair 
question. 
W hen / came to this 
country, l was a resident in 
neurosurgery. I thought that 
the most exciting thing to do 
was to perform surgery on 
the brain — say to remove a 
tumor. But I soon realized 
that studying how the brain 
is put together may advance 
the field more than 
removing tumors. Science is 
like art or music: you have 
an opportunity to create and 
discover something new for 
yourself— and for others. 
The fact that you have the 
privilege of looking at the 
organ which governs all 
human activity, the fact that 
you try to understand this 
organ by using your own 




T. CHARLES ERIKSON 
There are different levels of 
excitement. Science as a 
social endeavor is exciting. 
To work with young people 
and have them learning and 
contributing; all the human 
interactions of the people 
who work together on these 
projects — I find all that 
exciting. 
The human brain contains more than ten billion neurons give or take ten 
million. “That’s about the same number as there are stars in our galaxy,” said 
Dr. Charles Stevens. Each of these neurons communicates with thousands of 
others by a method of such daunting complexity that a single three-pound 
human brain has more "computing components’ than all the world’s 
computers taken together. 
It’s easy to think of the brain as an electrical system, especially in this age 
of computers. That invites us to think of neurons, the elements of the brain, 
as like computer components. And in some ways, the comparison is apt. 
Until recently, it was thought that neurons received signals through the 
dendrites, fibrous branches sprouting from the cell body, integrated them 
and emitted outgoing signals through the axon, the stem of the neuron. The 
reality, however, turns out to be more complex. Axon transport is no longer 
thought to be one-way. There is also reverse flow where substances needed 
by the cell are brought back along the axon. And dendrites, thought in the 
past to only receive signals, may also leak substances in the other direction. 
The signalling system between neurons is both electrical and chemical. 
The signal generated by a neuron is an electrical impulse, but the signal is 
transmitted along the axon and across the synapses chemically. These signal- 
transmitting chemicals, neurotransmitters, carry the message from one 
neuron to another. 
Specific molecules on the membrane of the neuron are responsible for 
nerve impulses and for synaptic transmission. "'These protein molecules that 
are embedded in the cell membrane are called "integral membrane proteins’. 
They are the key to understanding neuron function and therefore, brain 
function,” explained Dr. Stevens. 
A special class of these proteins, called channels, are the molecules 
responsible for the electrical activity of the brain. “All cells have pumps to 
keep calcium and sodium ions on the outside and potassium ions on the 
inside,” continued Dr. Stevens, “and they also have channels that spend the 
energy stored by the pumps by opening and closing to let ions pass through 
the membrane. The flow of ions causes voltage changes that give rise to nerve 
impulses and electrical activity. 
“When one of these channels opens, sodium ions, for instance, will move 
from the outside of the cell to the inside. An electrical current results from 
this movement, and the amount of that current is minute,’’said Dr. Stevens. 
“Amps are a measure of how much current flows through a light bulb. 
Milliamps flow through transistors. Picoamps flow through these pores. A 
picoamp is a thousandth of a milliamp, so it’s a millionth of an amp. Usually 
a pore stays open for a thousandth of a second and then it closes. We measure 
the picoamps that flow through during that instant.” 
There are hundreds or thousands of different kinds of channels, but they 
all belong to two major categories. One category is responsible for nerve 
impulses and the other category is responsible for synaptic transmission. The 
first category opens and closes in response to voltage differences, and is 
called "voltage-gated’. The second type opens when a particular molecule, a 
neurotransmitter, binds to a receptor on the channel protein. I hese 
chemically-gated channels are called "ligand-gated’. 
According to Dr. Stevens, the fact that specific molecular properties are at 
the core of brain function has been known for a long time. But the exact 
molecular operation is now becoming available because of new techniques. 
“The methods we use now to study individual channel molecules didn't 
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exist a decade ago,” Dr. Stevens said. 
At the turn of the century, many people believed that molecules were 
mathematical fictions, not real entities. “And now we study them one at a 
time,” said Dr. Stevens. “We take pictures of individual molecules through 
electron microscopes so that things no one had even seen when 1 was in 
college we not only see, but we study.” 
Even as recently as ten years ago, no one had ever recorded the current that 
flowed through a single channel. In fact, the notion of the structure of a 
channel was vague. Inferences about how channels behaved were made 
indirectly by very complicated mathematical techniques. 
“Not only did people not quite believe that channels existed, they didn't 
know how many there were and how to tell them apart. But now that we can 
record from a single channel, we can recognize them because each one 
behaves differently,” stated Dr. Stevens. “So the kinds of things that were 
inconceivable less than a decade ago are now our bread and butter.” 
The immediate goal of the work is to make a physical theory for the nerve 
impulse. “We should be able to predict the outcome of any experiment on 
nerves that you could pose from the equations we devise. These equations 
shouldn’t be arbitrary, but should express the essential physical mechanisms 
that underlie nerve impulses. That’s been a goal of neurobiology for a long 
time,” he explained. 
Although researchers can take photographs of an individual neuron, they 
still cannot count the exact number of channels on a cell. “In the 
photographs, they don’t come with a label that says, ‘1 am a channel’, so we 
have to know that the channel exists by some other method before we can 
take the picture,” said Dr. Stevens. “The new molecular and cloning 
techniques and the methods of recording the electrical How through a single 
channel now allow us to count the number of molecules for the first time. 
“The precise implications aren’t clear yet because we’ve been studying 
individual molecules for such a short time, but we have a fair idea of what to 
expect. One area researchers are investigating is learning, seeking the 
methods of information storage,” Dr. Stevens continued. “Learning also 
involves channels. At one level, learning is thought to depend upon a 
particular connection — say between cell A and cell B. By virtue of 
experience and the arrangement of nerve impulses, cell A becomes either 
more or less potent in relation to cell B. That happens because the properties 
of some of the channels are modified. This is called neuromodulation.” 
Dr. Stevens made the comparison to what happens when a technician 
wants to change the characteristics of an electronic circuit in a computer. “If 
you want the computer to go faster, for example, you unplug one set of chips 
and plug in another,” he said. “The nervous system has the interesting ability 
to change its own behavior. It’s as though it were using the same chips instead 
of changing chips, but modifying their characteristics so that they behave 
differently. People in our group are studying how this happens — how 
neurotransmitters modify the behavior of channels.” 
Presumably, all diseases of the nervous system that are not associated with 
trauma or viruses are going to be ultimately related to these molecular 
mechanisms. “The fate of the basic scientist is to work out all the mechanisms 
as far as you can go,” concluded Dr. Stevens. “Once you’ve done that, you 
know what to do for diseases. But you can’t know which diseases are related 
to which mechanisms until you know what the mechanisms are. I'm at the 
level of working out the basic mechanisms.” 
To set a problem for 
yourself and get a solution is 
exciting. It's like climbing 
mountains, I suppose, 
because you tell yourself 
you 'cl be happy if you could 
do this one thing — and 
then you achieve it. 
Science is an esthetic 
discipline. Whenever you 
finally understand 
something, there’s a great 
simplicity implied by your 
understanding. You can 
suddenly see many things 
explained by one simple 
idea. 
It’s also exciting to realize 
that you 're doing something 
that people have dreamed 
about, something that was 
inconceivable before. To 
make a contribution is an 
exciting thing. That s true of 
all science. 
All of these things are true 
of any part of science, of 
course, and this is no 
different from any other 
kind of science — but it’s 
more intensified in 
neuroscience today because 
the field is moving so rapidly 
and everything is so new. It's 
as if you’ve come into a new 
world where nothing is like 






T CHARLES ERIKSON 
“Because psychoactive drugs are chemical substances, they act on chemical 
systems in the brain,” said Dr. George Aghajanian, professor of psychiatry 
and psychopharmacology. “In the mammalian brain, 99 percent of all 
communication between neurons is chemically mediated. One neuron 
secretes a chemical substance that will cross a synapse and affect the firing of 
the next neuron. There are dozens of these chemical transmitter systems in 
the brain.” 
According to Dr. Aghajanian, most of the drugs that affect behavior 
antipsychotic drugs, antidepressant drugs, antianxiety drugs and antimanic 
drugs — affect some specific aspect of the process of chemical 
neurotransmission. 
“An antipsychotic drug, for example, blocks the transmission of dopamine 
at the synapse. Antianxiety drugs affect the transmission of impulses carried 
by another neurotransmitter, gamma-amino-butyric acid (GABA).” 
As a working hypothesis, investigators assume that specific brain 
chemicals affect specific patterns of neuronal behavior. They concentrate on 
one neurotransmitter and try to relate the effects of a drug to that substance. 
Because the drug might have certain behavioral effects, an association is 
established between that particular neurotransmitter and a behavioral or 
psychiatric state. 
“That’s oversimplified, of course, because for one thing, we know that all 
of these neurochemical systems are connected to each other. There’s a 
growing recognition that we have to understand how these different systems 
interact,” said Dr. Aghajanian. “The research moves back and forth, 
between trying to isolate effects and trying to understand interactions. We 
first focus on one substance and one synapse. We try to understand the 
process of transmission mediated by that substance and how drugs affect 
that process. Then we must step back and see how that fits into the general 
process.” 
The group within which Dr. Aghajanian works is interdisciplinary. He 
himself does cellular electrophysiology as well as electromicroscopy to look 
at the functional and morphological aspects of transmission on single 
neurons or synapses. Others in the group take a neurochemical approach 
and look at the chemical nature of receptors on nerve cells. 
“Much of our work has to do with characterizing precisely the nature of 
each receptor. We can look at this electrophysiologically by seeing how the 
application of a chemical transmitter will act at one of these receptors. We 
can look at it biochemically. And we can look at it behaviorally,” explained 
Dr. Aghajanian. “We have people in the group who study the behavioral 
consequences of stimulating certain kinds of receptors. One of the real 
advances in neurophsychopharmacologv in recent years has been to define 
more precisely the subtypes of receptors through which the chemical 
transmitters act.” 
This opens the way to developing drugs that are more selective for the 
specific receptor subtypes in order to minimize untoward side effects. More 
precise definitions of the receptor subtypes should make it possible to 
promote the therapeutic action of a drug and reduce unpleasant side effects. 
At one time, receptors were only conceptual constructs. It was assumed 
that when a cell responded in a particular way to a specific substance, a 
chemical substance on its surface acted as a recognition site to detect the 
presence of the chemical messenger. When this happened, a cascade of 
biochemical and electrophysiological events would result, leading to the 
final response of that cell to the transmission of the chemical message. 
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Recently developed biochemical methods allow identification and isolation 
of those receptor substances, which are embedded in the cell membrane. 
Only a few receptors have been fully characterized so far, and researchers are 
trying to isolate virtually every known receptor to determine its primary 
structure, that is, its sequence of amino acids. 
Most cells have receptors fora large number of chemical transmitters, but 
not all cells have the same complement of receptors. A specific type of 
neuron can also be characterized by its receptivity to the known types of 
chemical transmitters. This is done electrophysiologically, by recording the 
activity of a single neuron. 
“You can place a micropipette into an individual neuron,” said Dr. 
Aghajanian. “Then you inject a detectable dye into the neuron, and later 
analyze the brain histochemically for the presence of a specific neurochemical. 
You can show the chemical is in a given cell because the dye causes it to 
fluoresce. Then one knows with absolute certainty that a given cell belongs to 
a certain neurochemical type.” 
In some cases, this research has obvious therapeutic implications. One 
dramatic example from recent research led to a treatment for opiate 
withdrawal. The treatment is the result of research on the locus caeruleus, 
which is the primary source of norepinephrine enervation in the brain. When 
these neurons are activated excessively in primates, an anxiety-like state 
results. 
“In the laboratory here, we’ve shown that these cells become activated 
during opiate withdrawal,” said Dr. Aghajanian. “T his led to a connection 
being made between the symptoms of opiate withdrawal and the activation 
of these neurons. 
“Normally, the release of norepinephrine from these neurons maintains a 
state of alertness or attention. When they become overactivated, this might 
become anxiety. We know that these cells are heavily laden with receptors 
for opiates, including morphine,” he continued. “However, repeated adminis¬ 
tration makes these cells tolerant to morphine, which has an inhibitory effect 
and suppresses their firing activity. If you then remove the morphine, the 
cells become overactive, which causes withdrawal symptoms. 
“Basic laboratory researchers and clinical researchers subsequently 
collaborated to develop a treatment for opiate withdrawal that suppresses 
the activity of neurons by affecting a different receptor. Clonidine, an 
anti-hypertensive drug, suppresses many of the unpleasant symptoms of 
opiate withdrawal by suppressing a non-opiate receptor, the alpha-2- 
adrenalceptor. Because the continued administration of opiates doesn’t 
affect that receptor, the cell is amenable to the inhibitory effect of clonidine. 
We normalize the cell’s activity by, so to speak, making an end run around 
the opiate receptor. 
“Although the receptors for opiates and the alpha-2-adrenaceptors are 
distinct, we’ve shown that their final action is mediated through common 
mechanisms, which is why one can substitute for the other. Both receptors 
act through suppressing the cyclic AMP system, which ultimately regulates 
the opening and closing of the potassium channel. 
“In a way, we start where the basic laboratories like those of Drs. 
Goldman-Rakic, Rakic, and Stevens leave off. We try to integrate the 
various basic approaches into an overall picture of how drugs affect the 
brain’s functioning and particular systems in the brain. By this kind of 
approach, we expect to relate basic research to clinical research,” concluded 
Dr. Aghajanian. 
What I find most exciting is 
that we can get down to an 
elementary level of analysis, 
we can look at ion channels 
and molecular receptors. 
This is the sort of thing that 
could only be done in simple 
systems in the past because 
the mammalian brain 
seemed to be too complex to 
attempt that kind of 
analysis. 
Now we can do that kind 
of fundamental analysis in 
the mammalian brain. And 
it’s through this work that 
we will be able to recognize 
the real advances. Then, at 
the same time we re doing 
fundamental research, we 
can work at the clinical 
level. That’s what I find 
exciting. 
Neuroscience is advancing 
rapidly, but the cooperation 
of neuroscience and 
psychiatry is coming more 
slowly. Yale is one of the 
few places where basic 
research in neuroscience 
takes place side by side with 




perfecting organ transplantation 
— and beyond 
by Polly Carter 
Polly Carter is a freelance science wi 
Dr. M. Wayne Flye’s goal is to transform Yale-New Haven Hospital into a 
multi-organ transplant center. In the process, he is also helping to transform 
his branch of medicine. 
This protean organ transplant surgeon manages to juggle two separate 
spheres of research together with his clinical work and his hectic schedule of 
operations. “It is important for a clinician and even more important for a 
surgeon, to bridge the gap continually between what’s happening in the 
laboratory and what’s happening clinically,” Dr. Flye believes. “As a 
physician, I can appreciate some of the problems and applications of current 
research better because I see the day-to-day laboratory results. At the same 
time, some of my clinical problems arouse questions that wouldn’t occur to 
or be appreciated by someone working only in the laboratory.” This 
balanced perspective enables Dr. Flye to carry out both immunosuppressive 
research, which is directly applicable to daily practice, and regenerative 
research, which is ambitiously aimed at the future. 
After four years with the University of Texas Medical Branch in 
Galveston, Dr. Flye joined the Yale faculty in February 1983 as associate 
professor of surgery and the director of organ transplantation and immunol¬ 
ogy. He is also a consultant for the National Cancer Institute. 
Although a pioneer in his field. Dr. Flye is unusually experienced. He had, 
in fact already performed over 300 porcine liver transplant operations before 
performing the operation in October last year on a six-year old girl, and 
earning Yale-New Haven the rank of sixth center in the United States to 
perform a liver transplant. 
To date. Dr. Flye has performed eleven liver transplants at Yale-New 
Haven, and has three patients waiting. “It’s just a matter of getting the 
necessary organs,”he said. He has lost count by now of how many pigs have 
passed successfully under his scalpel. 
“Dr. Flye is a supersurgeon,” declared his research associate, George 
Rodgers. “He’s capable of doing things other surgeons wouldn’t attempt, 
because his research and his technique go hand in hand.” An assistant in 
research in surgery, Mr. Rodgers has been workingwith Dr. Flyesince 1979, 
taking care of the myriad details of their immunosuppressive research 
investigating the potential of the new wonder drug cyclosporine (CyA). 
Scientists discovered cyclosporine almost by accident in 1970, while they 
were looking for a new antibiotic. At first, few researchers appreciated the 
drug’s specific immunosuppressive qualities; then in 1977, Professor Caine 
of Cambridge University demonstrated CyA’s ability to prolong organ graft 
survival in laboratory animals. That news, according to Mr. Rodgers, “really 
woke up the transplantation world.” 
Cyclosporine forces the immune system to accept a transplanted organ 
instead of perceiving the grafted tissue as a foreign antigen or “enemy” 
substance, and mistakenly defending the body by fighting and rejecting the 
transplant. 
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Although there are hundreds of subsets of lymphocytes, or white blood 
cells, that can be directed against one antigen or another, there are two main 
categories: B cells and T cells. While B cells make antibodies, T cells regulate 
B cells and the immune response. 
When the body is stimulated by an antigen, the T cells divide so that a 
clone of cells expands. CyA suppresses the immune system hy preventing this 
rapid multiplication of T cells, but, unlike other immunosuppressive drugs, 
CyA operates without actually killing cells; it simply blocks the T cells from 
dividing. 
“With cyclosporine we can inhibit one particular clone of cells to an 
organ,” explained Dr. Flye. No one yet knows exactly how CyA works on 
the molecular level, but investigators soon hope to find out. 
Still another important feature of Dr. Flye’s work is his special pig farm 
presided over by Mr. Rodgers. Since most farm pigs are so inbred for meat 
qualities, they often accept organ grafts without treatment. Mr. Rodgers 
specially breeds genetically defined miniature pigs in order to examine the 
response to grafts across genetic barriers and modification of rejection. 
The two most important criteria in choosing a donor liver to transplant are 
compatibility of blood type and compatibility of size. Normally, if the host 
pig A is given pig B’s liver, it rejects the liver immediately, perceiving it as 
antigenic. However, when Dr. Flye puts B’s liver into A and proceeds to give 
A a short course of cyclosporine (for as brief a time as 25 days) to protect the 
liver, he circumvents the rejection process and pig A accepts the graft. 
When a kidney of the same B genetic makeup is grafted, the host pig A 
rejects this additional organ, although the liver remains healthy. A second 
attempt at “B” kidney transplantation provokes a hyperacute rejection while 
the original B liver in pig A continues to be well tolerated. This indicates that 
the kidney has a different antigenic structure from that of the liver. In 
general, livers aren’t as antigenic as kidneys. 
“Whenever you have tissue transplanting you have to worry about tissue 
typing, and make sure the tissue matches,” Mr. Rodgers said. He is in charge 
of maintaining the genetic integrity of the herd, at present about 15 breeders 
and their offspring. Two more pig patients, placidly awaiting the outcome of 
Dr. Flye’s latest liver-and-kidney grafts, live in the medical school animal 
care facility. 
The FDA did not approve general release of CyA until December 1983, 
which meant Dr. Flye had to obtain special permission to use the drug to 
ensure graft acceptance when he performed his first three liver transplant 
operations. 
Dr. Flye’s first clinical transplant operation was on a six-year old girl, who 
had been given only a few weeks to live. After alerting the New England 
Organ Bank to search intensively for a donor organ of compatible size and 
blood type, a 20-month old drowning victim was reported in Florida. Dr. 
Flye and his support team flew there at 2:30 am to retrieve the liver. Since 
“ Ultimately, we would like 
to reach the stage where a 
failed organ would not need 
to be replaced at all, but 
could be supported while it 
regenerated its capabilities. ” 
DR FLYE 
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How can a rat’s liver 
completely regenerate within 
three to four clays when 70 
percent of it is removed? 
And why, once the organ 
has reattained normal size, 
does the regenerative process 
then stop? Why does the 
liver not keep on growing 
uncontrolledly as a tumor 
would? If harnessed, this 
process might be 
transferable to human 
beings. 
George Rodgers, an assistant in research in 
surgery, works with Dr. Five in research 
that may ultimately lead to human organ 
regeneration. 
livers are so delicate that they cannot be stored outside of the body for more 
than six to eight hours, the child was called away from her brother’s birthday 
party later that same morning, and the transplant was completed by 11 am. 
Protected by CyA, the liver began to function at once. 
The liver’s complexity has earned it a reputation as perhaps the most 
difficult organ to transplant. It should not take, proportionately, anything 
like the same amount of time and effort for Dr. Flye and his colleagues to 
master transplantation of the heart, lung, or pancreas. 
Approaching his goal of treatment of liver disease from another direction. 
Dr. Flye is also conducting research to try to define the molecular stimulus of 
regenerative growth, and to characterize whatever protein or other factor is 
modulating the regenerative behavior which is almost unique to the liver. 
In an aside. Dr. Flye provided backround: “If you take an amphibian — a 
salamander or a starfish and cut its leg off, it will regenerate the whole leg. 
As you go higher up the phylogenetic scale, you lose that ability. There have 
been studies with rats, though, in which the forearm was removed and an 
electrical stimulus applied, with some regeneration resulting. 
“This electrical stimulation may release a chemical that promotes 
regeneration,” explained Dr. Flye.“ For some reason as we’ve evolved most 
of our organs have lost that regenerative ability, except for the liver, and to a 
lesser extent the kidney.” 
How can a rat’s liver completely regenerate within three to four days when 
70 percent of it is removed? And why, once the organ has reattained normal 
size, does the regenerative process then stop? Why does the liver not keep on 
growing uncontrolledly, as a tumor would? If harnessed, this process might 
be transferable to human beings. 
To study the precise mechanism of regeneration it is necessary to isolate 
the responsible molecules. This is obtained by first performing a rat 
hepatectomy; making an emulsion out of the organ; and extracting from the 
supernatant the molecule that stimulates other cells to grow in culture. 
Knowing already that “there’s something in there,” Dr. Flye and his staff 
pass the preparation through a series of biochemical purifications to try to 
characterize this “something”. 
Presumably the same molecules are instrumental in repairing and 
regenerating the injured liver in a patient. “If we could properly characterize 
this process, we’d be a step closer to providing help for a patient’s liver to 
regenerate to support a transplanted liver during rejection,” speculated Dr. 
Flye. “It must be a fairly basic mechanism of control for the liver that 
regenerates since other major organs like the heart do not have this capacity. 
“Ultimately, we would like to reach the stage where a failed organ would 
not need to be replaced at all, but could be supported while it regenerated its 
capabilities.” 
At present, there are still very few multiple organ transplant centers in the 
United States. The various interests represented at Yale-New Haven Medical 
Center are directed by Dr. Ali Khodadoust for ophthalmology; Dr. Gary 
Friedlaender for orthopedics; Dr. Charles Cuono for skin grafts; and Dr. 
Flye, Dr. Alexander Geha, and colleagues in general and cardiothoracic 
surgery for kidney, liver, heart, lung and pancreas. 
Dr. Flye is now working out the details of pancreas transplants in his 
laboratory. Further studies will examine lung transplants. “The lung is tricky 
because it has so many enzymes that begin to digest it as soon as you try to 
preserve it,” he observed. “Improvements in organ preservation are of 
concern to all areas of transplantation; however each organ has its special 
requirements.” 
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... IN PROGRESS 
... a brief report on some of the 
many research projects ongoing in 
the School of Medicine. 
In the early 1970’s, Dr. Luke Kitahata, 
professor of anesthesiology, was among 
the first to discover that opioid anal¬ 
gesics are effective in blocking pain 
signals to the spinal cord. It was the 
first indication that a drug such as 
morphine acts on sites other than the 
brain to alleviate pain. This initial 
work by Dr. Kitahata has led to an 
expanding field of research in the phar¬ 
macology of pain transmission in the 
spinal cord, and possible ways of selec¬ 
tively targeting specific drugs that would 
be more effective in alleviating pain. 
Administering opioid analgesia to 
the spine has several advantages for 
surgical patients as well as for non- 
surgical patients with acute and chronic 
pain syndrome. Requiring a minimum 
of drugs for a very powerful effect, it 
acts on only those parts of the body 
involved pain. Unlike conventional 
spinal anesthesia with local anesthetics, 
the patient does not lose touch sensation 
or motor function. 
As with any new technique, however, 
there are complications. One infrequent 
but serious problem is respiratory de¬ 
pression following injection of opioid 
drugs. Dr. Kitahata and his colleagues 
are studying the basic mechanisms of 
this condition in order to increase the 
therapeutic value of this newly devel¬ 
oped method of pain control. 
In related research. Dr. John G. 
Collins, assistant professor of anes¬ 
thesiology and pharmacology, has de¬ 
monstrated that injection of epinephrine 
near the spinal cord is effective in 
blocking neurons that signal pain. This 
action provides an alternative explana¬ 
tion for epinephrine enhancement of a 
spinal block. 
Of more significance. Dr. Collins has 
demonstrated that when applied to the 
spinal cord in combination with an 
opioid, epinephrine requires only very 
low doses to block pain signaling 
neurons. In fact, the dosage is so low 
that neither drug used independently in 
that amount would be effective. 
These findings have led to an ongoing 
study of the interaction of known pain 
inhibiting neurotransmitters in the 
spinal cord. The ultimate goal is to 
develop a multidrug combination that, 
when applied near the spinal cord, will 
block pain signals without producing 
undesired side effects. 
The neurophysiological basis for pain 
accompanying disease or injury is fre¬ 
quently obscure. Although it is possible 
for pain to originate solely within the 
central nervous system, the usual cause 
is the activation of certain sensory 
peripheral nerve fibers in muscle, joint, 
bone or visceral organs. The sensory 
receptors at the ends of these fibers 
specialize in responding to noxious 
stimulation. 
Dr. Robert LaMotte, associate pro¬ 
fessor of anesthesiology and neuroanat¬ 
omy, has developed an experimental 
neurophysiological model of clinical 
pain in which pain produced in humans 
by localized heating of the skin to 
precisely controlled temperatures is 
measured by quantitative sensory test¬ 
ing. The responses of heat sensitive 
“pain receptors” are recorded electro- 
physiologically in anesthetized monkeys 
as well as in awake humans. The recep¬ 
tor responses are then correlated with 
the sensory measurements of pain in 
humans. 
In other experiments. Dr. LaMotte 
and his colleagues have altered the 
local chemical environment of these 
heat-sensitive pain receptors, either by 
mild burn to the skin or by local 
injection of a minute amount of inflam¬ 
matory chemical substance. This radi¬ 
cally increased pain sensitivity: normally 
non-painful stimuli such as gently warm¬ 
ing or rubbing of the skin, became 
painful; and normally painful stimuli 
became much more so. In neurophysio¬ 
logical experiments in Dr. LaMotte’s 
laboratory this clinical state, known as 
hyperalgesia, was shown to result from 
the local sensitization of the heat-sensi¬ 
tive pain receptors — particularly those 
with non-myelinated nerve fibers. 
These experimental models of pain 
and hyperalgesia will be useful in deter¬ 
mining how changes in the local chemi¬ 
cal environment of pain receptors can 
alter their sensitivity. Such alterations 
could be responsible for clinical condi¬ 
tions such as causalgia — a chronic 
burning pain, sensation and hypersensi¬ 
tivity to innocuous stimulation, such as 
the rubbing of clothing against the 
skin. The model will also be useful in 
the development of drugs to block 
functions in pain receptors without 
affecting other types of sensory 
receptors. 
ICANCERI 
The National Cancer Institute recently 
awarded a grant of $421,000 for support 
for three years of research being con¬ 
ducted by Dr. Sara Rockwell on the 
use of perfluorochemical emulsions as 
adjuncts to radiotherapy. The target 
for this research is improved treatment 
of those solid tumors which are resis¬ 
tant even to the best of current treat¬ 
ment. 
Because of their oxygen transport 
properties, perfluorochemicals have 
been studied at a number of institutions 
for use in perfusing organs for transplant 
and for use after trauma or during 
surgery when blood transfusions are 
impossible, or are refused on religious 
grounds. Dr. Rockwell, professor 
(adjunct) of research in therapeutic 
radiology, is investigating the effects 
on solid tumors of one such perfluoro¬ 
chemical, Fluosol-DA 20%, to deter¬ 
mine whether this agent may be useful 
as an adjunct to radiotherapy. 
“Laboratory studies on animals with 
solid tumors, and studies of cancer 
patients treated with radiotherapy and 
combined modalities suggest that the 
resistance of some tumors to treatment 
may be the result of oxygen deficient 
(hypoxic) regions in the tumors,” Dr. 
Rockwell explained. “Solid tumors of¬ 
ten have abnormal, inadequate and 
poorly functional vascular beds, which 
render many tumor cells chronically or 
transiently hypoxic. Because oxygen 
sensitizes cells to the effects of x-rays, 
these radiation-resistant hypoxic cells 
may survive treatment with radiother¬ 
apy and allow tumors to recur. 
Fluosol is composed of a balanced 
salt solution with properties similar to 
plasma, containing a very fine stabilized 
emulsion of droplets of liquid perfluoro¬ 
chemicals (PFCs). These PFCs have 
the unusual property of being able to 
dissolve very large amounts of oxygen 
up to 40 percent of their weight. 
When Fluosol is infused intravenously, 
the PFC droplets will circulate in the 
blood and carry oxygen and because 
they are much smaller than red blood 
cells, they may reach and deliver oxygen 
to areas inaccessible to red cells, such 
as the hypoxic regions of tumors. 
In preliminary studies. Dr. Rockwell 
and her colleagues have found that 
infusing laboratory animals that have 
breast cancer or sarcomas, with Fluosol 
and having them breathe oxygen before 
and during radiotherapy increases the 
number of tumor cells killed by radia¬ 
tion, but does not increase the toxicity 
of the radiation to the blood-forming 
cells of bone marrow. Further studies 
will examine the effect of Fluosol treat¬ 
ment on other tumors and other normal 
tissues, to evaluate whether this agent 
in combination with radiotherapy has 
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Dr. Charles Stevens was appointed 
professor and chairman of the Section of 
Neurobiology when it was established a 
year ago for teaching and conducting 
research on the molecular basis of brain 
function, structure and development. 
Since then, he has brought together a 
faculty of outstanding young scientists 
with interests in molecular biology and 
neurobiology. 
Two have recently been recognized with 
important awards. Dr. Richard W. 
Aldrich, above, assistant professor, has 
been named a 1984 Searle Scholar with a 
grant for three years in support of his 
studies of the properties of voltage-gated 
sodium channels. This research is aimed 
at increasing the understanding of the 
basic mechanisms of brain function. 
Dr. Michael Lerner, below, also an 
assistant professor, has been awarded a 
Me Knight Foundation Scholars Award 
for three years. He is investigating the 
genetic basis of olfactory receptor cells — 
research that has significant implications 
for understanding the mechanisms of 
memory and for treating conditions of the 
central nervous system such as spinal cord 




the potential for effective treatment of 
solid tumors in humans. 
Another project, in collaboration 
with Dr. Alan Sartorelli, acting chair¬ 
man of the Department of Pharma¬ 
cology and director of the Comprehen¬ 
sive Cancer Center, has examined the 
effects of drugs w hich might selectively 
kill hypoxic cells because of their 
unusual physiologic characteristics or 
environment. These drugs — bioreduc- 
tive alkylating agents — are not active 
in their original forms, but are enzy¬ 
matically activated within cells, to give 
reactive drugs. Some bioreductive alkyl¬ 
ating agents are activated more readily 
in hypoxic cells than in aerobic cells, 
and therefore, selectively kill hypoxic 
cells. Members of Dr. Rockwell’s labora¬ 
tory, as well as of other laboratories in 
the Department of Therapeutic Radi¬ 
ology, have been working with Dr. 
Sartorelli and his colleagues to assess 
whether the combination of these drugs 
and radiotherapy would be especially 
effective in the treatment of solid 
tumors. 
In another study. Dr. Ravinder Nath, 
associate professor of therapeutic radio¬ 
logy, in collaboration with Dr. Richard 
Peschel, assistant professor. Dr. Robert 
.1. Schulz, professor, and Laurence 
Gray, a radiation physicist, is developing 
the use of Americium-241 radioactive 
resources for treatment of uterine cancer 
in anticipation of achieving two impor¬ 
tant benefits: the ability to protect 
critical normal organs; and the substan¬ 
tial reduction of radiation exposure to 
medical personnel. 
Radium was first used in the treat¬ 
ment of cancer of the uterine cervix in 
1903. Today, therapy typically combines 
the use of intracavitary radium or cesium 
radioactive sources and external beam 
therapy. Intracavitary radiation a 
form of brachytherapv - is performed 
by placing radioactive sources at very 
short distances from the tumor in a 
body cavity to deliver a highly localized, 
lethal dose to the tumor while sparing 
the sensitive normal tissues nearby. 
Because the lower energy gamma 
rays of americium can be effectively 
shielded w ith thin layers of lead or gold 
placed on the outside of the applicator. 
Dr. Nath and his colleagues are develop¬ 
ing Americium-241 sources for brachy- 
therapy. A thickness of 0.4 mm of lead 
can reduce the intensity of americium 
gamma rays by half, in contrast to 12 
mm of lead required to shield radium 
gamma rays.In addition, it should be 
possible to custom modify the applicator 
for each patient’s anatomy and tumor 
distribution, according to Dr. Nath. 
Further, Dr. Nath has predicted that, 
with americium, it would be possible to 
place effective shielding material within 
body cavities. For example, a patient’s 
bladder could be filled with hypaque 
and the rectum with barium sulfate to 
shield the distal portions of these organs, 
while still treating the more proximal 
areas where tumor infiltration might 
occur. 
In addition to therapeutic considera¬ 
tion, the exposure to radiation of medi¬ 
cal personnel is another consideration 
in the use of brachytherapy techniques. 
Nurses w ho care for patients undergoing 
conventional brachytherapy receive 
a higher rate of exposure to radiation 
than most members of a hospital staff, 
because the high energy of gamma rays 
of radium and cesium make it imprac¬ 
tical to reduce exposure by shielding. 
Devices developed to remove the radio¬ 
active sources from a patient during 
routine nursing care have not been 
entirely satisfactory because they com¬ 
promise the positioning of radioactive 
sources and are uncomfortable and 
inconvenient to the patient. 
The use of americium would be 
strikingly different, according to Dr. 
Nath, because a lead shield of only 1.4 
mm thick would reduce radiation levels 
by a factor of 1000. Effective shielding 
of operating room personnel could 
easily be achieved, and exposure to 
medical personnel and visitors w'ould 
be negligible. 
Most anticancer drugs do not cross 
the blood-brain barrier, and are there¬ 
fore ineffective as brain tumor therapy. 
In research to find a more effective 
treatment of brain tumors and other 
cancers of the central nervous system. 
Dr. William N. Hait, assistant professor 
of medicine, is studying the interaction 
of drugs with calmodulin, a calcium¬ 
binding protein which plays an impor¬ 
tant role in cell proliferation and cell 
differentiation. 
He will isolate calmodulin from nor¬ 
mal brain tissue and compare its char¬ 
acteristics with calmodulin isolated from 
brain tumors. “We have been able to 
demonstrate that drugs which inhibit 
the activity of calmodulin will inhibit 
the growth of brain tumor cells grown 
in culture," he said. “Our goal in this 
project is to find more potent inhibitors, 
and ones that may potentially be selec¬ 
tive for the calmodulin of the tumor 
cells. Since many of the inhibitors 
previously identified are known to ac¬ 
cumulate in the brain, it should be 
possible to achieve higher concentra¬ 
tions of the drugs in tumors grow n in 
animal tissue,” he explained. This re- 
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search is supported by a grant from the 
American Cancer Society. 
A major concern in anticancer drug 
therapy is the damage these drugs 
cause to surrounding normal tissue. In 
an effort to learn more about the 
interactions of normal cells and cancer 
cells during chemotherapy, Dr. Evan- 
gelo Canellakis, professor of pharma¬ 
cology, has developed a method tor 
growing cancer cells in co-culture with 
normal cells. Because the method is 
extremely sensitive, he is able to follow 
the outgrowth of five to ten tumor cells 
seeded on a bed of normal cells. The 
tumor cells then form new individual 
colonies. At this point. Dr. Canellakis 
is able to estimate the growth of indi¬ 
vidual cancer cells that grow in contact 
with normal cells. 
Using this method, he will study the 
response of cancer cells to drug toxicity, 
to determine whether, as it is thought, 
normal cells protect cancer cells from 
the killing action of the drug. Prelim¬ 
inary studies have indicated that the 
effect of an anti-cancer drug on cancer 
cells is influenced by the length of time 
the cancer cells have been in contact 
with the normal cells, on the growth 
rate of the normal cells and on com¬ 
munication between cancer cells. 
HYPERTENSION 
The School of Medicine received $2.1 
million from the National Institutes of 
Health to participate with 16 other 
institutions in a collaborative clinical 
trial to determine whether long-term 
administration of antihypertensive 
therapy to elderly persons with isolated 
systolic hypertension (ISH) reduces the 
incidence of stroke and other complica¬ 
tions of high blood pressure. Dr. Henry 
R. Black, associate professor of internal 
medicine, is principal investigator of 
the program at Yale. 
More than three million Americans 
have ISH. In fact, the condition is more 
prevalent than diastolic hypertension 
in the age group over 70, and affects as 
much as twenty percent of that popula¬ 
tion. Previous studies have indicated 
that these persons face a two-to-three 
fold increased risk of stroke, as well as 
other cardiovascular diseases and death. 
Whether or not ISH should be treated 
is an important health issue, not yet 
resolved because of a lack of sufficient 
scientific evidence. “This study will 
provide the necessary facts about this 
important problem,” said Dr. Black. 
“If the study shows that treatment 
reduces strokes and other complica¬ 
tions, we will be able to prevent serious 
disabling disease with inexpensive and 
easily applied techniques.” 
In addition to assessing the effects of 
long-term antihypertensive therapy on 
stroke, the objectives of the study in¬ 
clude assessing the effects of this therapy 
on cardiovascular mortality and mortal¬ 
ity from all other causes, as well as the 
prevention of dementia and depression. 
The clinical centers will also study 
possible adverse effects of chronic use 
of antihypertensive drug treatment in 
the elderly. 
The Systolic Hypertension in the 
Elderly Program (S H EP) will last approxi¬ 
mately six years. Each of the 17 partici¬ 
pating institutions will serve as a Clinical 
Center fortheSHEP program and will 
identify and enroll 300 relatively healthy 
individuals over sixty years old who 
have ISH. Half of this group will 
receive standard antihypertensive ther¬ 
apy for from four to six years; the 
others will receive a placebo. All of the 
participants will be seen at regular 
intervals by the medical personnel of 
the SHEP clinical centers. 
Dr. Charles Francis, associate pro¬ 
fessor of medicine, and Jan Davey, 
M.S.N., clinical studies researcher in 
medicine, will work with Dr. Black in 
the Yale SHEP program. Yale-New 
Haven Hospital, Park City Hospital in 
Bridgeport, and the Meriden-Walling- 
ford Hospital will participate in patient 
evaluation and follow-up. 
PEDIATRICS 
The School has received a grant of 
$800,000 from the Robert Wood John¬ 
son Foundation to participate in the 
Foundation’s Infant Health and Devel¬ 
opment Program to test the effectiveness 
of combining early childhood develop¬ 
ment services with pediatric care in 
reducing the incidence of health and 
developmental problems in low birth- 
weight infants. There are indications 
that programs designed to provide pedia¬ 
tric social and educational support to 
low birthweight infants and their fami¬ 
lies promote enhancement of develop¬ 
ment in these infants in preschool years, 
but as yet there has been no definitive 
study on a national level. 
In the program, 135 low birthweight 
infants will be enrolled and randomly 
assigned to one of two treatment levels. 
Infants will receive full continuing pedia¬ 
tric and developmental services to assess 
their progress after discharge from the 
hospital, according to Dr. David T. 
Scott, assistant professor of pediatrics, 
director of the Yale study. Infants in 
one of the groups will receive additional 
services, including parental education 
and day-care provided by the Quinni- 
piac College Day Care Facility. 
Pediatric and developmental assess¬ 
ment services will take place in the 
Department of Pediatrics, co-directed 
by Dr. Scott and Dr. Laura R. Ment, 
associate professor of pediatrics and 
neurology, in collaboration with Dr. 
Richard A. Ehrenkranz, associate pro¬ 
fessor of pediatrics. 
Most traditional pediatric programs 
prepare residents to deal with acute 
illness and well child care, but fail to 
provide comprehensive educational ex¬ 
periences in three critical areas: develop¬ 
mental and psychosocial problems, 
chronic illness, and adolescent medicine. 
Dr. Paul McCarthy, professor of pedia¬ 
trics, is director of the Integrated Con¬ 
tinuity Group Program in the Depart¬ 
ment of Pediatrics, which has been 
developed to improve residents’training 
in these areas.The program is supported 
by a grant of $618,000 from the Health 
and Human Resources Division of the 
Public Health Service. 
Twelve residents will participate in 
the Integrated Continuity Group (ICG) 
throughout the three years of training. 
T hey will see on a regular basis a panel 
of continuity patients including well 
children as well as children with develop¬ 
mental and psychosocial problems, 
chronically ill children, and adolescents. 
Faculty with special interest and exper¬ 
tise in the three critical areas, will teach 
and supervise the program. A nurse 
practitioner, social worker and child 
psychiatrist will be an integral part of 
the supervisory team. 
It is anticipated that on completion 
of the program, residents will be com¬ 
petent to (1) identify and evaluate 
psychosocial and behavioral problems 
of children in their practice;(2) provide 
appropriate counseling for psychosocial 
and behavioral problems and make 
appropriate referrals to mental health 
clinicians; (3) collaborate with other 
health and educational professionals in 
the care of chronically ill children; (4) 
understand the impact of chronic disease 
on families; (5) recognize and manage 
psychosocial problems of adolescents. 
If evaluation of the program clearly 
demonstrates its effectiveness, the ICS 
program will become a model for teach¬ 
ing general pediatrics at Yale. It could 
also serve as a model for other teaching 
programs in pediatrics throughout the 
country. 
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“ . . . it, as a whole, has competed 
so successfully for NIH research 
and training funds as to rank 
among the top three medical 
schools nationally in each of the 
last five years. ” 




NEUROSCIENCES BY FOUR 
YALE SCIENTISTS 
In its 1984 fiscal appropriations, 
the Congress of the United States 
asked that special awards be made 
for outstanding research in the neuro¬ 
sciences in honor of Jacob K. Javits, 
the former senator from New' York. 
Since then, four Yale scientists have 
received Javits Neuroscience Investi¬ 
gator Awards designated by the 
National Institute of Neurological 
and Communicative Disorders and 
Stroke (N1NCDS) for investigators 
who have a distinguished record of 
substantial contribution in a field 
of neurological or communicative 
science, and who can be expected 
to be highly productive over the 
next seven years. 
In February, Dr. Elias Manueli- 
dis, professor of neuropathology 
and neurology, received $1.2 million 
for his research on Alzheimer’s 
disease, and Dr. Pasko Rakic, Dorys 
McConnell Duberg Professor and 
chairman of the Section ol Neuro¬ 
anatomy, received $1.5 million for 
research on the neurogenic processes 
in the fetal brain.( Yale Medicine, 
Spring 1984). 
More recently, NINCDS awarded 
$1.2 million to Dr. Robert K. Yu 
for basic research to understand 
degenerative diseases of the central 
nervous system, and $1 million to 
Dr. Robert H. EaMotte for his 
studies on the mechanisms ol pain. 
The awards are for a period of 
seven years. 
Dr. Yu, professor (adjunct) of 
research in neurology, is regarded 
as an outstanding scientist in the 
fields of neurochemistrv and devel¬ 
opmental neurobiology. In on-going 
basic research to better understand 
the processes of motorneural degen¬ 
eration seen in amyotropic lateral 
sclerosis (AES), multiple sclerosis 
(MS) and other disorders of the 
central nervous system, he is study- 
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mg normal and abnormal glycosphin- 
golipids, sugar containing sub¬ 
stances which are located in cells of 
nerve fibers. In particular, he is 
investigating the properties of glyco- 
sphingolipids called gangliosides, 
to better understand the relation¬ 
ships of ganglioside metabolism 
and the physiological dysfunction 
associated with a variety of neuro¬ 
logical diseases. 
“There is evidence that ganglio¬ 
sides play an important role in the 
degenerative process of the central 
nervous system seen in these dis¬ 
eases,” Dr. Yu said. “Through our 
research, we hope to be able to 
develop methods to interfere with 
this process.” 
Dr. EaMotte’s research is directed 
at determining the neurophysical 
origins of cutaneous pain, itch and 
hyperalgesia. Specifically, the stud¬ 
ies will attempt to determine the 
chemical origin of hyperalgesia. 
“The results of these studies will 
be useful in identifying those central 
neurons at the level of the thalamus, 
that process sensory information 
about pain, itch and hyperalgesia,” 
he explained. This information, in 
turn may lead to the development 
of specific pharmacological agents 
that act peripherally to block the 
pain-causing chemical or to act 
centrally to block sensory processing 
in neurons that transmit pain. 
Dr. EaMotte is an associate pro¬ 
fessor of anesthesiology and neuro¬ 
anatomy. 
YALE SCIENTISTS 
RECOGNIZED FOR AN 
IMPORTANT 
BREAKTHROUGH IN 
RESEARCH ON LUPUS 
A team of Yale medical scientists 
has been awarded the first Lee 
Howley Sr. Prize for outstanding 
research which represents a major 
advance in the understanding of 
rheumatic diseases. The Arthritis 
Foundation presented the prize to 
Drs. Joan A. Steitz, John A.Hardin 
and Michael Lernerforthe identifi¬ 
cation of prominent autoantigens 
in systemic lupus erythematosus. 
Yale is considered one ol the 
leading institutions in the world for 
systemic lupus erythematosus (SLE) 
research. Scientists have come here 
from Japan and Europe to learn 
new techniques developed by Drs. 
Steitz, Hardin and Lerner for clinical 
and basic science research in SEE 
and other rheumatic diseases. 
Dr. Steitz, professor of molecular 
biophysics and biochemistry, is in¬ 
ternationally recognized for her re¬ 
search in deciphering molecular 
mechanisms of gene expression in 
bacterial cells. Dr. Hardin, who has 
made significant contributions to 
the understanding of the patho¬ 
physiology of SLE with his earlier 
studies of immune regulation, is 
associate professor of medicine in 
the Section of Rheumatology. Al¬ 
though Dr. Lerner’s career began 
only a few years ago, he has received 
several important awards for his 
research. A 1981 graduate of the 
School of Medicine, he was ap¬ 
pointed assistant professor of mole¬ 
cular neurobiology last fall. 
By providing a clear concept of 
the nucleoprotein autoantigens that 
seem to trigger diseases such as 
SLE, this team has made a major 
contribution to both basic molecular 
biology and to clinical medicine. In 
addition, their studies have demon¬ 
strated the usefulness of human 
antibodies as tools for basic 
research. 
The work began in 1979, when, 
as a student working with Dr. Steitz, 
Dr. Lerner began to dissect the 
structure and function of small 
RNA-protein complexes that are 
found in all cells, but which pre¬ 
viously had been poorly understood. 
Using the autoantibodies which are 
found in practically all patients 
with SLE as a tool, he was able to 
define three distinct classes of small 
nuclear and cytoplasmic ribonucleo- 
proteins. 
Using this approach, Drs. Steitz, 
Lerner, and Hardin have character¬ 
ized the structures within cells that 
trigger autoimmune responses to 
give rise to antinuclear antibodies, 
the characteristic immune system 
abnormality in SLE. At the same 
time, they have developed a group 
of defined patient sera and mono¬ 
clonal antibodies for clinical and 
basic science research. 
In recognition of his 
achievements as a scholar, in 
honor of that commitment to 
the highest standards of 
quality, and for his many 
contributions in many wavs 
to science, to Yale and to this 
country, I am privileged to 
announce the creation of the 
Robert W. Berliner 
Professorship of Internal 
Medicine in the Yale School 
of Medicine. 
President A. Bartlett Giamatti 
The occasion was a reception honoring Dean and Mrs. Berliner on 
June 23rd in the courtyard of the Beinecke Rare Book and Manuscript 
Library. Almost 600 guests gathered to join President Giamatti in 
raising a “glass to Lea and Bob Berliner in affectionate thanks for all they 
have done to enrich our lives and in the highest and delighted anticipation of 
the many, many years to come and all the ways they will sustain us.” 
Earlier in his remarks, the President cited Dr. Berliner’s accomplishments 
during the eleven years of his deanship. “Under Bob Berliner’s leadership, 
the School has become one of the top two or three institutions in America in 
terms of hosting research supported by peer reviewed grants. He has 
overseen the creation of outstanding teaching facilities in the Hope Building, 
the renewal of in-patient teaching facilities at the Yale-New Haven Hospital, 
the development of the Faculty Practice Plan, and the establishment of the 
first major fund-raising campaign in the history of the School.” 
Dean and Mrs. Berliner 
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HERE & ABOUT 
A NEW CHAIRMAN 
IS APPOINTED FOR 
HUMAN GENETICS 
Dr. Carolyn W. Slayman, a leading 
research scientist and educator, has 
been named chairman of the Depart¬ 
ment of Human Genetics. She suc¬ 
ceeds Dr. Leon E. Rosenberg, who 
assumed the office of dean of the 
School on July 1. 
In announcing the appointment. 
President A. Bartlett Giamatti said, 
“I am enormously grateful to Pro¬ 
fessor Slayman for taking on this 
important responsibility, and I am 
confident that under her leadership 
the department will continue to 
flourish.” 
Dr. Slayman, who is professor of 
human genetics and physiology, 
has been a member of the Depart¬ 
ment of Human Genetics since it 
was established in 1972. Herspecial 
research interest is in the proteins 
that transport nutrients across cell 
membranes, and in the genes that 
code for those proteins. In addition, 
she is recognized as an outstanding 
teacher, as exemplified by her ap¬ 
pointment as the first director of 
graduate studies for the Department 
of Human Genetics, a post she has 
held almost continuously since 1972. 
In 1981, she was appointed chairman 
of the Genetic Basis of Disease 
Review Committee of the National 
Institutes of Health. This committee 
reviews applications for predoctoral 
and postdoctoral training grants in 
genetics. 
Dr. Slayman graduated from 
Swarthmore College in 1958 with 
highest honors in biology and chem¬ 
istry. She received her Ph.D. degree 
in biochemical genetics from Rocke¬ 
feller University in 1963, and spent 
the following year as a National 
Science Foundation Postdoctoral 
Fellow at Cambridge University. 
Her first academic appointment 
was as an instructor in biology at 
Western Reserve University, Cleve¬ 
land. She came to Yale in 1967 as 
an assistant professor of microbiol¬ 
ogy and physiology. In 1972, she 
was appointed associate professor 
of human genetics and physiology, 
and in 1979, she was promoted to 
professor. 
A Research Career Development 
Awardee of the NIH from 1968 to 
1973, Dr. Slayman served on the 
NSF Advisory Panel on Genetic 
Biology from 1974 to 1977, and was 
associate editor and a member of 
the editorial board of Genetics from 
1977 to 1982. She is a member of 
the Board of Overseers of Bowdoin 
College, Brunswick, Maine, and of 
the Board of Trustees of Foote 
School in New Haven. 
NEW CHAIRMAN 
APPOINTED FOR 
DEPARTMENT OF MB&B 
Dr. William H. Konigsberg has 
been appointed chairman of the 
Department of Molecular Biophys¬ 
ics and Biochemistry, effective July 
1. He succeeds Dr. Dieter G. Soil. 
Dr. Konigsberg’s research inter¬ 
ests include protein chemistry, the 
molecular biology of DNA replica¬ 
tion in bacteriaphage, and initiation 
of blood clotting. He joined the 
Yale faculty in 1964 as an associate 
professor of biochemistry, and was 
promoted to professor in 1976. 
A graduate of Rensselaer Poly¬ 
technic Institutes, he received a 
Ph.D. degree in organic chemistry 
from Columbia University. The fol¬ 
lowing year, he was a National 
Science Foundation Fellow at The 
Rockefeller Institute, where he sub¬ 
sequently became a research associ¬ 
ate, and in 1959, assistant professor. 
A DIRECTOR IS 
APPOINTED FOR THE 
MEDICAL LIBRARY 
Bella Z. Berson, acting medical 
librarian since January, has been 
appointed director of the Yale Med¬ 
ical Library, effective August 1. 
She will also retain her title of 
associate librarian of the University 
Library, a post she has held since 
1982. 
Mrs. Berson has been associated 
with the Yale University Library 
since 1969. A graduate of New 
York University, where she was 
elected to Phi Beta Kappa, she 
received her masters degree in 
library science from the University 




OF THE SECTION OF 
ORTHOPAEDIC SURGERY 
Dr. Gary E. Friedlaender has been 
appointed chief of the Section of 
Orthopaedic Surgery. Dr. Fried¬ 
laender, who is associate professor 
of surgery, is well known for his 
research in orthopaedic transplanta¬ 
tion. He is interim president of the 
American Council on Transplanta¬ 
tion, a group formed by the U.S. 
Department of Health and Human 
Services, and president of the Ameri¬ 
can Association of Tissue Banks. 
Dr. Friedlaender’s major roles 
will be to facilitate the review of 
current structure and function of 
orthopaedics in the Yale-New Haven 
Medical Center and to make recom¬ 
mendations concerning long range 
goals for the orthopaedics program 
at Yale, according to the announce¬ 
ment of his appointment by C. 
Thomas Smith, president of the 
Hospital and Dean Leon E. Rosen¬ 
berg. “The term of this appointment 
will be short, reflecting a mutual 
desire to complete expeditiously an 
orderly review process while sustain¬ 




CHAIRMEN OF THREE 
DEPARTMENTS 
Dr. Samuel O. Thier, chairman of 
the Department of Internal Medi¬ 
cine, has been appointed chairman 
of the search committee for a chair¬ 
man of the Department of Psychia¬ 
try to succeed Dr. Morton Reiser, 
who has held that post since 1969. 
Members of the committee include 
Dr. David Clement, clinical pro¬ 
fessor of pediatrics; Dr. William 
Collins, Jr.,Harvey and Kate Cush¬ 
ing Professor of Neurological Sur¬ 
gery; Mr. Vincent Conti, vice-presi¬ 
dent, Y-NHH; Dr. John Fenn, clini¬ 
cal professor of surgery; Dr. Sidney 
Klaus, professor of dermatology; 
Judith B. Krauss, associate dean. 
School of Nursing; Dr. James W. 
Prichard, professor of neurology; 
Dr. Sally Provence, professor of 
pediatrics. Child Study Center; Dr. 
Pasko Rakic, chairman. Section of 
Neuroanatomy; and William 
Kessen, Eugene Higgins Professor 
of Psychology and Pediatrics. 
Dr. Aaron Lerner has announced 
his intention to retire as chairman 
of the Department of Dermatology. 
Dr. Lerner, who was appointed head 
of the Section of Dermatology in 
1958, has been chairman since it 
became a department in 1971. A 
search committee for his successor 
is being chaired by Dr. Richard 
Greenspan, chairman of the Depart¬ 
ment of Diagnostic Radiology. Mem¬ 
bers of that committee include Vin¬ 
cent Conti, vice-president of 
Y-NHH; Dr. Paul Errera, professsor 
of psychiatry; Dr. Marilyn Far- 
quhar, professor of cell biology; 
Dr. Paul McCarthy, professor of 
pediatrics; Dr. Stephen Malawista, 
professor of medicine; Dr. John 
Moench, associate clinical professor 
of neurology; Dr. Jon Morrow 
assistant professor of pathology; 
Dr. Frederick Naftolin, chairman 
of the Department of Obstetrics 
and Gynecology; Dr. Richard Stahl, 
assistant professor of surgery; and 
Dr. Joseph Weissberg, associate 
professor of therapeutic radiology. 
A third search committee has 
been appointed for a chairman of 
the Department of Surgery to suc¬ 
ceed Dr. Arthur E. Baue. Chaired 
by Dr. Paul Barash, chairman of 
the Department of Anesthesiology, 
the committee includes Dr. Joseph 
Bove, professor of laboratory medi¬ 
cine; Dr. James Boyer, professor of 
medicine; Dr. Joyce Gryboski, pro¬ 
fessor of pediatrics; Dr. Robert 
Handschumacher, professor of phar¬ 
macology; Dr. John Hobbins, pro¬ 
fessor of obstetrics and gynecology; 
Dr. Vincent Marchesi, chairman of 
the Department of Pathology; Dr. 
Richard Mattson, professor of 
neurology; Dr. Frederick Sachs, 
associate clinical professor of medi¬ 
cine; Dr. Marvin Sears, chairman 
of the Department of Ophthalmol¬ 
ogy and Visual Science; and Joseph 
Zaccagnino, executive vice presi¬ 
dent, Y-NHH. 
FOURTH YEAR STUDENT 
AWARDED FELLOWSHIP 
Reginald Sanders, a member of the 
class of 1985, has been named the 
1984 recipient of a Commonwealth 
Fund Fellowship with an award of 
$5000 for the fellowship stipend 
and research support. This program, 
sponsored by The Commonwealth 
Fund and National Medical Fellow¬ 
ships, Inc., is specifically designed 
to encourage academically gifted 
minority medical students to prepare 
for careers in academic medicine 
and biomedical research. 
Mr. Sanders will be working 
with Dr. Ali Khodadoust, professor 
of ophthalmology, on the role of 
hypoxia in neovascularization using 
the cornea as a model. 
“We all have to remember to tell 
our students, when they get 
discouraged by another tong week 
in the lab when nothing's worked, 
that the thrill when something 
does work is worth it all. ” 
Carolyn Slayman quoted ini ogue 
FIRST YJB&M RESEARCH 
PAPER AWARD 
The Yale Journal of Biology and 
Medicine presented its first Yale 
Journal Student Research Paper 
Award to Bruce K. Jacobson of the 
class of 1986. He was presented 
with a check for $1000 for the best 
paper based on research carried out 
at the School of Medicine by a 
candidate for an M.D. or Ph.D. 
degree and submitted to The 
Journal. 
Mr. Jacobson’s paper, “Immuno¬ 
suppression Following Escision of 
Burn Eschar and Synergeneic Graft¬ 
ing in Major Thermal Trauma”, 
was based on research carried out 
in the Department of Surgery in 
collaboration with Dr. Christopher 
C. Baker. The paper will be pub¬ 
lished in a forthcoming issue of The 
Journal. A similar contest will be 
conducted annually. 
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. . it contains one Nobel 
laureate, George Palade, and no 
fewer than 17 members of the 
National Academy of Sciences, 11 
members of the A merican 
A cademy of A rts and Sciences, 
and 9 members of the National 
Institute of Medicine...” 




TWO ON FACULTY ELECTED 
TO N A S 
Dr. Marilyn G. Farquhar and Dr. 
Gerhard H. Giebisch are among 
five Yale professors to be elected to 
the National Academy of Sciences 
at its 121 st annual meeting in Wash¬ 
ington, D.C. on May 1. Election to 
the NAS, one of the highest honors 
for an American scientist, is in 
recognition of distinguished achieve¬ 
ment in original research. 
Dr. Farquhar, professor of cell 
biology, is recognized for her out¬ 
standing research on secretion and 
membrane recycling in anterior pitu¬ 
itary and other cells. Prior to her 
appointment to the Yale medical 
faculty in 1973, she was professor 
of pathology at the University of 
California, San Francisco until 1971, 
when she was appointed professor 
at Rockefeller University. Dr. Far¬ 
quhar received a B.A. degree in 
zoology and M.A.and Ph.D. degrees 
in experimental pathology from 
the University of California at 
Berkeley. 
An authority on renal function. 
Dr. Giebisch, who is Sterling Pro¬ 
fessor of Physiology, has received 
numerous honors and awards for 
his research. Born in Vienna, Aus¬ 
tria, he received his M.D. degree in 
1951 from the University of Vienna 
Medical School. Prior to his ap¬ 
pointment in 1968 as professor and 
chairman of the Department of 
Physiology at Yale, Dr. Giebisch 
had been professor of physiology at 
Cornell University Medical School. 
AND TWO TO THE 
AMERICAN ACADEMY OF 
ARTS AND SCIENCES 
Dr. Joseph F. Hoffman and Dr. 
Charles F. Stevens were among six 
Yale professors and 73 leading 
scholars, scientists, public figures 
and artists recently honored by 
election to the American Academy 
of Arts and Sciences. Dr. Hoffman 
is Eugene Higgins Professor of 
Physiology, and Dr. Stevens is chair¬ 
man and professor of molecular 
neurobiology. Both are members 
of the National Academy of Sciences 
as well. 
FACULTY NOTES 
Dr. Samuel O. Thier has been 
elected chairman of the American 
Board of Internal Medicine for the 
year 1984-85. Dr. Thier is Sterling 
Professor of Medicine and chairman 
of the Department of Internal Medi¬ 
cine. I he ABIM is the certifying 
body for physicians who specialize 
in internal medicine and in nine of 
its subspecialties. 
The University of Rochester award¬ 
ed an honorary Doctor of Science 
degree to Dr. Joan A. Steitz, profes¬ 
sor of molecular biophysics and 
biochemistry. One of three bio¬ 
medical scientists to receive the 
honorduringthe University’s School- 
of Medicine and Dentistry com¬ 
mencement, she was cited for her 
“record of continuously outstanding 
research” that has provided “new 
insights into the translation of 
genetic information into proteins 
and ultimately into cellular 
function.” 
Dr. Richard H. Greenspan, profes- 
sorand chairman of the Department 
of Diagnostic Radiology, received 
the Gold Medal of the Association 
of University Radiologists for his 
basic research in pulmonary embo¬ 
lism and the application of a variety 
of imaging techniques. The Gold 
Medal is the highest honor of the 
AUR, presented to individuals 
whose contributions to the field of 
radiology, academics and the AU R 
merit special recognition. 
The Class of 1983 at the University 
of Arizona College of Medicine 
invited Dr. Harold O. Conn to be 
keynote speaker at their convocation 
in May. Convocation is a special 
program for the College of Medicine 
graduates, held prior to the gradua¬ 
tion ceremony for the entire univer¬ 
sity. Dr. Conn is professor of medi¬ 
cine and chief of the Hepatic Disease 
Unit at the Veterans Adminstration 
Medical Center in West Haven. 
The American College of Physicians 
recognized Dr. Philip K. Bondy 
with an ACP Mastership for his 
outstanding contributions to medi¬ 
cine. Dr. Bondy, professor of medi- 
24 
cine and associate dean at the Veterans 
Administration Medical Center, West 
Haven, was honored for his contribu¬ 
tions to internal medicine as an educa¬ 
tor, author, administrator and ex¬ 
pert investigator. The editor of The 
Yale Journal of Biology and Medi¬ 
cine, he is known for his studies on 
internal secretory glands and for 
research in cancer. Dr. Bondy is 
one of about 150 of the 60,000 
members of ACP to be honored 
with the rank of ACP master. 
The American Orthopaedic Associa¬ 
tion has elected Dr. Wayne O. 
Southwick, professor of surgery 
(orthopedic) its vice president. Dr. 
Southwick is well known as a teacher 
of medical students and residents 
and as a research scientist. His 
studies on surgery of the cervical 
spine and the slipped capital femoral 
epiphysis are recognized throughout 
the world. 
The American Heart Association, 
South Central Connecticut Chapter 
honored Dr. Ruth Whittemore as 
its Woman of the Year at the 
annual meeting in May. Dr. Whitte¬ 
more, who is clinical professor of 
pediatrics, was cited for her outstand¬ 
ing contributions to the American 
Heart Association in the field of 
pediatric cardiology. 
For their research paper entitled 
“Air Quality in Buildings During 
Smoking and Nonsmoking Occu¬ 
pancy”, Drs. Brian P. Leaderer and 
William S. Cain received the Crosby 
Field Award of the American So¬ 
ciety of Heating, Refrigerating and 
Air Conditioning Engineers. Dr. 
Leaderer is associate professor of 
epidemiology and public health and 
Dr. Cain is associate professor of 
epidemiology and psychology. Both 
are associate fellows of the John B. 
Pierce Foundation Laboratory as 
well. I heir work was reported in 
the Spring 1982 issue of Yale 
Medicine. 
Dr. Robert Shulman, professor of 
molecular biophysics and biochem¬ 
istry and chemistry was presented 
the Gold Medal Award of the 
Society of Magnetic Resonance for 
his creative research in the applica¬ 
tion of nuclear magnetic resonance 
spectroscopy to biomedical and clin¬ 
ical research. He was corecipient of 
the award with Dr. George Radda 
of Oxford University, during the 
annual meeting of the Society of 
Magnetic Resonance in New York 
on August 14. 
Dr. Kyle Grazier.assistant professor 
of epidemiology and public health, 
is one of five Fellows selected for 
the first class of the Robert Wood 
Johnson’s Program for Faculty 
Fellowships in Health Care Finance. 
The purpose of the program is to 
develop outstanding university 
faculty with the skills needed to 
teach and conduct research in the 
rapidly changing field of health 
care finance, such as DRG’s. PPO’s, 
ratesettingand others. Fellowships 
begin at The Johns Hopkins Medical 
Institutions with an intensive three- 
month study of the latest innova- 
ions in health care finance. During 
the following nine months. Fellows 
will have a structured field and 
research experience in a public or 
private health care financing organ¬ 
ization. 
The 20th Annual Meeting of the 
New England Public Health Associ¬ 
ation held this past spring was 
dedicated to Dr. Ira V. Hiscoek, 
Anna M R.Lauder Professor Emer¬ 
itus of Public Health. 
JOSEPH M1GNONE, M.D. 
Dr. Joseph Mignone, assistant clini¬ 
cal professor of medicine, died on 
July 5 in Yale-New Haven Hospital. 
He was 75 years of age and had 
practiced medicine in New Haven 
for 45 years prior to his retirement 
in 1981. 
Born in New Haven in 1909, he 
attended Yale where he received his 
bachelor’s degree in 1930 and his 
M.D. degree in 1933. Following 
house staff trainingat Duke Univer¬ 
sity Hospital and the New Haven 
Hospital, he entered practice in 
1936. During World War II, he 
served as a medical officer in the 
U.S. Navy and saw active duty in 
the South Pacific and Philippines. 
Dr. Mignone was first appointed 
to the Yale School of Medicine 
faculty in 1941 as a clinical assistant 
in medicine. On his return from 
military service in 1946, he became 
a clinical instructor, and in 1956 he 
was promoted to assistant clinical 
professor of medicine. He was a 
member of the attending staffs at 
the Yale-New Haven Hospital and 
at the Hospital of St. Raphael, 
where he was chief of medicine 
from 1943 to 1977 and served as 
president of the staff from 1967 to 
1968 and director of ambulatory 
services from 1971 to 1976. He was 
president of the New Haven Heart 
Association from 1952 to 1954. 
He is survived by his wife, Louise, 




Dr. Mary Elizabeth McGarry, assis¬ 
tant clinical professor in the Child 
Study Center and pediatrics, died 
in the Yale-New Haven Hospital 
on July 5 at the age of 63. She was a 
native of New Haven and a graduate 
of Albertus Magnus College and 
the Tufts University School of Medi¬ 
cine. She did her internship at 
Children’s Hospital in Boston. 
Dr. McGarry held appointments 
in the Yale Department of Pediatrics 
from 1957 to 1961. She was then 
appointed as an instructor in the 
Child Study Center and subse¬ 
quently as a research associate. 
Since 1969 she has been as assistant 
clinical professor. 
In addition to her pediatric activi¬ 
ties, she was a member of the New 
Haven Symphony Associates and 
the New Haven Council of Catholic 
Women. She was the widow of Dr. 
John C. McLaughlin and is survived 









The following is President 
Gianwtti's address to the alumni 
on Saturday, June 9th. 
Universities do not only promote change; they also maintain continuity. To 
maintain the interplay between continuity and change provides the challenge 
in this unique environment. Although we generally regard the faculty as the 
stable component of the university enterprise, it too is remarkable for 
change. Every year numerous members of the faculty are recruited, and 
numerous others leave - some for other universities or careers, others by 
dint of retirement. But this changing faculty scene involves much more than 
the names or ranks of people on the roster. The research questions this 
faculty ask, and the means they employ to answer the questions they raise 
about the mysteries of health and disease are continually being modified. 
Tikew'ise, the body of information w'hich the faculty must transmit to 
students is anything but static. This is particularly true today as the dramatic 
advances in cellular and molecular biology, in genetics, in immunobiology, 
and in neurobiology affect not only the basic fountains of biomedical 
thought, but also the means bv which disease is detected, treated and 
prevented. 
But this year the Yale School of Medicine changes in a way (fortunately 
for me as President) which occurs quite infrequently. As you all know, 1984 
marks the end of Bob Berliner’s term as Dean of the School of Medicine and 
the beginning of Dean-Designate Tee Rosenberg’s elevation (in my view at 
least) to this most important post. As these two good friends accomplish this 
transition upon which we all depend, it is fitting for me to mention some 
things about them. 
Bob Berliner came back to Yale as Dean in 1973 after an illustrious 
scientific and administrative career at the National Institutes of Health. His 
1 1 years as steward at Yale’s School of Medicine have been outstanding ones. 
Let me remind you of Bob Berliner’s notable accomplishments as Dean: 
He has recruited more than half of all the men and the first woman serving 
(or soon to serve) as chairs of the School’s 22 departments and sections.; 
He has helped secure the funds for the Nathan Smith Bridge building 
which joins the old New Haven Hospital unit w ith Sterling Hall, and which 
houses key components of the Department of Human Genetics and the 
Comprehensive Cancer Center; 
He has resisted the temptation to demolish this old. proud and beautiful 
Hope Building, choosing instead to turn it into a much needed (and now 
much enjoyed) teaching center; 
He has helped bring major private support to the School through such 
programs as the Howard Hughes Medical Institute in Immunology and the 
Bristol-Myers affiliation with Pharmacology; 
He has sustained and strengthened a strong working relationship with 
Yale-New Haven Hospital a bond critical to the success of the entire 
venture; 
He has managed the School’s finances such that student tuition here now 
ranks 45th in the country, while at the same time mounting the already 
mentioned new programs. 
For these accomplishments and much, much more, the University, the 
School, and indeed the country owe Bob a great but unpayable debt. 
But what of the man to whom the University now entrusts the leadership 
of this strong, complex school? Having chaired the committee responsible 
for selecting Lee Rosenberg, and having had the good sense to recruit him 
successfully, I am pleased to describe him to those of you unfamiliar with this 
man. He is theC.N.H. Long Professor; he built one of the finest departments 
of human genetics from the ground up; he is nationally recognized as a 
national spokesman on matters of medical science and has the trust and 
admiration of colleagues throughout our School and the country. 
And, so. in a few weeks, and in the unobtrusive way institutions of learning 
change their helmsmen (or perhaps more appropriately, their orchestra 
conductors), the venerable Yale School of Medicine w ill have a new Dean. I 
know he does not need to be reminded of the strength of the place or its 
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problems, but 1 believe it is right 
that 1 take the remaining moments 
to reflect with you to whom, 
after all, this School also belongs in 
trust - in the state of the place. 
Very often (perhaps too often), 
university Presidents are pictured 
as waking up in nightly cold sweats 
thinking about the insoluble prob¬ 
lems of their massive, cacophonus 
Medical Schools. I cannot tell you 
that the Yale School of Medicine 
never provokes such restlessness 
for me, but 1 must remind you of 
the other side of that coin —- the 
enormous strength of the place 
which derives first and foremost, 
from the remarkably intelligent, 
devoted, and entrepreneurial faculty 
by whatever objective criteria one 
can employ: 
it contains one Nobel laureate, 
George Palade, and no fewer than 
17 members of the National Aca¬ 
demy of Sciences, 1 1 members of 
the American Academy of Arts and 
Sciences, and 9 members of the 
National Institute of Medicine; 
it, as a whole, has competed so 
successfully for N1H research and 
training funds as to rank among the 
top three medical schools nationally 
in each of the past five years; 
it has responded to the challenge 
of providing exemplary clinical care 
by adding new programs in trans¬ 
plant surgery, in fetal medicine, in 
clinical epidemiology, and in geron¬ 
tology; 
it has added new courses to the 
medical curriculum in immunology, 
genetics, and neurosciences and has 
continually strived to modify the 
curriculum so as to reflect the ever 
changing nature of medical thought 
and practice; 
and it has reached out to house 
officers, postdoctoral fellows, com¬ 
munity physicians, foundations, 
governments and businesses to share 
its experience and educate practi¬ 
tioners, scientists, and legislators 
alike. 
But it has done all this with 
insufficient resources. That problem, 
members of the alumni, you and 1 
must help solve. Two years ago, I 
appointed a special development 
advisory committee for the School 
of Medicine chaired by George 
Palade and including among its 
members Bob Berliner, Lee Rosen¬ 
berg, Sam Thier, Arthur Baue, Jan 
Stolwijk, Alan Sartorelli, and Art 
Ebbert. A year ago, I reported to 
you that this committee recom¬ 
mended that the University mount 
a major fund raising campaign for 
the School of Medicine — the first 
such campaign in the School’s his¬ 
tory. 1 endorsed that recommenda¬ 
tion and 1 expect my recommenda¬ 
tion for the campaign to be approved 
by the Corporation next week. 
1 am most pleased, one year later 
to have the opportunity to bring 
you up-to-date on this issue, which, 
1 think is central to the future of the 
medical school. First, the campaign 
target has been set at $125 million 
and the campaign duration projected 
at five years. Second, we have re¬ 
cruited a dean, Lee Rosenberg, 
who has an appetite for this en¬ 
deavor, and a director of develop¬ 
ment, Sue Dorn, who is recognized 
as among the most outstanding 
institutional development officers 
in the country. Third, we have 
commissioned a New York firm to 
prepare and deliver the case state¬ 
ment for the campaign by September 
1, 1984. Fourth, the goals of the 
campaign have been honed. The 
principal needs include: some $40 
million in endowment funds to but¬ 
tress the School’s foundations; funds 
totalling $30 - $40 million to erect a 
Magnetic Resonance Center, a 
Faculty Practice Plan building, and 
a new 50,000 square foot research 
building aimed at blending funda¬ 
mental and applied research interests 
toward the molecular basis of medi¬ 
cine; several millions of dollars 
toward student financial aid ex¬ 
pected to take the form of scholar¬ 
ships, fellowships, and low interest 
loans; and the remainder to accom¬ 
plish such tasks as library renova¬ 
tion, new faculty seed funds, and 
senior faculty equipment replace- 
“This is an effort for all 
of us. And / expect the 
campaign to succeed. . . ” 
President Giamatti 
ment funds. I expect this campaign 
to be launched officially during the 
next academic year. 1 expect to 
work diligently towards its goals 
and ask each of you —in your own 
ways — to do the same. This is an 
effort for all of us by all of us. And, 
1 expect the campaign to succeed. 
Yale University has many jewels 
in its crown. The School of Medicine 
is one of these. Like any jewel, its 
apparent brilliance depends on the 
nature of the light and its state of 
care. These parameters change but 
the intrinsic worth of the jewel does 
not. Thank you, for coming back to 
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Dr. Arthur Griswold, left, and Dr. Helen 
iMngner of the Class of 22. 
ASSOCIATION OF YALE ALUMNI 
annual business meeting 
The meeting held in the Jane Ellen 
Hope Building was chaired by Dr. 
Nicholas Spinelli, president. After 
recognition of distinguished senior 
alumni in the audience, special recog¬ 
nition awards were presented to 
those members present of the 50th 
year class of 1934. 
Dr. Robert Berliner was intro¬ 
duced and expressed his sincere 
appreciation to the alumni for their 
support during his eleven years as 
dean. Later in the meeting. Dean 
Berliner gave a brief historical 
account of the Hope Building and 
announced the dedication of the 
restored amphitheater to the alumni. 
He said, “Henceforth, this room 
will be known as the John B. Ogilvie 
Alumni Amphitheater, named alter 
a distinguished alumnus, who is a 
member of the great class of 1934. 
It gives me great pleasure to an¬ 
nounce this at this final meeting 
with you in my role as dean of this 
great school.” 
Dr. Spinelli then surprised the 
dean. On behalf of the Association 
of Alumni in Medicine, he presented 
Dr. and Mrs. Berliner with lifetime 
membership and the privilege ol 
distinguished senior alumni were recognized . . . 
Dr. Myron Sallick, left and Dr. David 
Raskind, both members of the Class of 
1924, which celebrated its 60th reunion. 
IN MEDICINE 
participating in all future activities. 
In presenting this warm, sincere 
expression of appreciation. Dr. Spi¬ 
nelli noted, “Our gratitude for your 
service to our school, its students, 
and its alumni cannot be adequately 
conveyed.” 
Distinguished Alumni Awards 
in the form of Yale chairs with 
suitably inscribed plaques were then 
presented by Dr. Spinelli to Dr. 
Leona Baumgartner and Dr. Ogil¬ 
vie. They in turn each made a brief 
but moving statement of appreci¬ 
ation to the School of Medicine 
noting, in each case, what a Yale 
medical education had done to 
further their careers. 
At the conclusion of the business 
meeting. Dr. Lowell Goodman gave 
a report on the Medical School 
Alumni Fund 1983-84 annual giving 
Dr. Harry Zimmerman 27, center, with 
Mrs. Zimmerman and a friend. 
campaign,and Mrs. Kathleen Howe 
presented an optimistic report for 
the Public Health Alumni Fund. 
Elections were an earlier part of 
the business meeting. On recom¬ 
mendation of the Nominating Com¬ 
mittee chaired by Dr. Thomas 
Kugelman, the following were 
elected to serve on the Association’s 
Executive Committee, each for a 
term of two years: Gilbert Hogan 
(’57), John Pastore (’67), Rebecca 
Solomon (’39), Ora K. Smith (’53), 
and Lynn T. Tanoue(’82). In addi¬ 
tion, Alexander Gaudio (’63), was 
elected as a representative to the 
Association of Yale Alumni (AYA) 
Assembly. 
Following the elections. Dr. Spi¬ 
nelli congratulated the newly elected 
and expressed appreciation to those 
going off the Executive Committee, 
Leonard Kemler (’43), Richard 
Norton (’60 HS), and O’Dell Owens 
(’76), and to Carol Goldenthal (’44) 
who had served as a representative 
to the AYA. He also noted that he 
hoped these dedicated alumni would 
participate in Association activities 
in the future. 
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. . . as were members of the great Class of 1934 
To Leona Baumgartner, M.D., Ph.D. 
. . For many years, you have contributed 
much needed support for student financial 
aid. Most recently, you have added to your 
many and regular generosities by estab¬ 
lishing a challenge fund, which has resulted 
in the Medical School Alumni Fund reaching 
record heights in annual giving. This will 
provide additional revolving loan funds for 
grateful students. 
"Now celebrating your fiftieth reunion 
with your Medical School Class, the Associa¬ 
tion of Yale Alumni in Medicine with great 
pride expresses its appreciation for the 
reflected glory in which we bask, and for 
your many generosities." 
Citations and Yale Chairs were bestowed 
on Dr. Leona Baumgartner and Dr. John 
B. Ogilvie, by the Dean and Faculty and 
The Association of Yale Alumni in Medicine. 
Cordial greetings were sent to the members 
of The Class of 1934 by the Dean and 
Faculty of the Yale School of Medicine: 
“ You left Yale in the turmoil of the great 
Depression. As you completed your training, 
the country became embroiled in war. Your 
country and the world have survived these 
and lesser crises and conflicts. In the fifty 
years since your graduation, these vagaries 
of life have not deterred you from your 
great contributions as clinicians, scholars, 
academicians, scientists and public servants. 
“ Like you, your University and its School 
of Medicine have weathered the storms, 
and have continued to gather on its Faculty 
outstanding individuals in research, educa¬ 
tion, and clinical medicine. 
“ Yours was the privilege to learn from 
and follow in the footsteps of the great 
leaders on the Faculty a half-century ago. 
“ Today, new leaders are gathered together 
to constitute the Faculty of the University 
and the School of Medicine. They note with 
great pride the honor and esteem your 
illustrious lives have brought to Yale. Though 
your ranks have thinned from 33 to 22, your 
light shines bright at this half century mark. 
“ We salute you. " 
To John B. Ogilvie, M.D. 
“... your continued and regular support of 
annual giving has been a model for many to 
follow. The students who have profited by 
your generous support of the Student Loan 
Fund are many, and their gratitude is 
unmeasured. Most recently, you became 
aware of funds needed to complete restora¬ 
tion of the Hope Building, specifically the 
old amphitheatre so etched into the memory 
of medical students of the long past. Your 
generosity was responsible for the comple¬ 
tion of that project, now a teaching center 
of beauty and utility, as well as nostalgia. 
"By these deeds, you have demonstrated 
a loyalty unmatched and without bounds. 
The fruits of your wisdom and the fruits of 
your fiscal generosity have helped in main¬ 
taining exemplary programs appropriate 





The ranks of the class of 1929 are 
depleted but those who turned up for 
the 55th reunion seemed to be remark¬ 
ably fit. Those in attendance were 
Frank D'Andrea, George Goldman 
Vernon I.ippard, Russ Scobie and Bob 
Tennant. 
Although the temperature hovered 
around 90 degrees, the meetings were 
comfortable in the recently renovated 
and air-conditioned Hope Building. 
(Remember when that was the New 
Haven Dispensary?) Features of the 
meetings were an interesting address by 
President Giamatti and seminars on 
topics such as the immunological 
mechanisms in desensitization and re¬ 
combinant DNA, which were never 
heard of when we were students. 
We assembled for dinner at the Gradu¬ 
ates Club where the unplanned entertain¬ 
ment turned out to be the portraits of 
the entering class taken in September 
1925. Of the 55 in the group, 38 gradu¬ 
ated on schedule in 1929. Seventeen of 
that number survive. We were saddened 





On June 8 and 9, the class of 1934 
(Yale’s best class!) reunioned in New 
Haven. Those attending were Leona 
and Alex Baumgartner, Joseph and 
Rose Budnitz, Herbert and Polly Mil¬ 
ler, John and Donna Ogilvie, Harry 
and Ida Sherman, Wedgewood and 
Ann Webber and Knowles Lawrence. 
An elaborate, interesting program 
was prepared by the Medical School 
and Alumni Association. 
Three seminars of general interest 
were presented; a Yale Alumni-in 
Surgery seminar was presented by the 
class of 1959, and the class ol 1944 
contributed significantly to the program 
under the guidance of Nicholas Spinelli 
The business meeting was featured 
by the awarding of the new' Alumni in 
Medicine Distinguished Service Awards 
to Leona Baumgartner and John Ogil¬ 
vie. Dr. Berliner announced that the 
restored amphitheater in the Hope Build¬ 
ing would be called the John B. Ogilvie 
Alumni Amphitheater. Proper acknow¬ 
ledgement was made to Leona Baum¬ 
gartner for her generous matching fund 
gift to the Alumni Fund, which has 
stimulated contributions to record 
levels. 
A gourmet luncheon of lobster and 
roast beef on Saturday w as followed by 
a performance and lecture on Japanese 
Noh drama theater by Howard Hamil¬ 
ton (’44). 
In the course of the weekend a 
reception was held for Dr. and Mrs. 
Berliner. The new dean. Dr. Leon 
Rosenberg, was introduced. All de¬ 
cided that the Medical School has 
been, and will remain, under excellent 
guidance. 
Alter dinner at the Graduates Club, 
the Class of 1934 dispersed and will 
reunion again in 1989. 
It is impossible to thank all the 
individuals who made this reunion as 
successful as it was. But great apprecia¬ 
tion exists for the thought, effort and 





The distinguished class of 1939 enjoyed 
their 45th reunion on June 8 and 9. The 
members present were Harold and 
Estelle Coopersmith, Joseph and Livia 
Forman, Jerome and Phoebe Green¬ 
field, Nathaniel and Esther Kenigsberg, 
Ernest and Dene Sarason, Darrell and 
Catherine Voorhees, Stuart Stevenson, 
and J. Wheeler MacDonald, the Arthur 
Tuckers, and Paul Huston. 
The peak day of activity, Saturday, 
had all of us enjoying varied, truly 
exciting seminars in the morning, fol¬ 
lowed by the school reunion meeting 
with delightful speakers. We then re¬ 
paired to a sherry hour followed by a 
bountiful repast. Thereafter, some 
toured the new, impressive facilities at 
the Medical School, while others toured 
the Yale Center for British Art. Stu 
Stevenson, however, had to return to 
New York at this point. 
Following a brief respite, we gathered 
at the Woodbridge Country Club for 
cocktails and candlelight dinner, w here 
we were free to swap tall tales and short 
fabrications. We all recalled anecdotes 
of many individual members of the 
class who did not attend, and read 
letters from Norm Cressy, John Fergu¬ 
son, Pete Murphy, and Doug Walker, 
regretting their absences. 
The assembled group, in turn, regret¬ 
ted not having more of our members 
present. But we plan an even larger 
turnout, in what seems like a short time 
these years, for our next togetherness. 
Joseph B. Forman 
1944 
40th 
Twenty-three members of the class of 
1944 attended our 40th reunion in New 
Haven last June 8th and 9th, and we 
felt it was the best ever of many memor¬ 
able reunions. There was a feeling of a 
comfortable family group even more 
than ever before. Five years ago Reese 
Matteson attended for the first time 
and enjoyed it so much that he regretted 
all the previous reunions he had missed. 
This year Jerry Kaye and Reuben 
Zucker had the same reaction. An 
additional factor that made this reunion 
even more our own is that Nick Spinelli 
is the President of the Association of 
Yale Alumni in Medicine. He was 
chairingjust about everything, and in a 
very masterly w ay, especially noticeable 
when unforseen circumstances arose. 
Nick had done a very sensitive job in 
preparing the reunions for the whole 
school, but particularly ours. As at our 
last reunion, we were the only class 
with a Reunion Seminar on Friday, 
open to and attended by many others 
besides our class members. We also 
have a star performer in How ie Hamil¬ 
ton. who gave a Noh demonstration 
and lecture w ith slides in the Harkness 
Auditorium Saturday afternoon, open 
to everyone. Our class’ reunion gift to 
the School of Medicine amounted to 
S20,000, also a record. It seems that our 
class is, and is recognized as, outstand¬ 
ing in every w'ay. Who would have 
foreseen this, seeing a bunch of young 
Army recruits back in 1943! 
Most of us were domiciled together 
at Silliman College, which for me was 
full of atmosphere, and very like the 
College at Oxford w here 1 spent a week 
last summer. Many arrived on Thursday 
evening, and on Friday morning we got 
together, about 15 of us, to hear what 
we all were doing. Bob Frelick. who is 
now at the National Cancer Institute, 
and the inimitable Ronnie Losee, gave 
presentations with slides. The others 
who were there reported extemporane¬ 
ously. That afternoon in our Seminar, 
Larrys Crow ley and Pickett, both deans 
at medical schools (Stanford and Yale) 
spoke about problems of medicine in 
the U.S., now and in the future, with 
Larry Pickett specifically explaining 
the Yale picture. Then Russ Monroe 
spoke about “Genius and Madness”, a 
subject he has been researching and 
w riting about, and then 1 (Edith) spoke 
about the use of mental imagery in the 
treatment of physical and mental illness. 
A reception was held on the top floor 
of the new Hope Building in honor of 
30 
Dean Berliner, who is retiring this July. 
Even in a job which requires one to 
refuse a lot of requests. Dean Berliner 
has endeared himself to all who have 
had the privilege of working with him. 
Nick had invited the whole class to be 
his guests at Leon’s for dinner Friday 
evening, but there was a strike of their 
employees. So instead, we went to a 
restaurant on the shore for an extensive 
seafood dinner. 
Saturday morning there was a choice 
of three seminars. I attended the one 
where Howie Hamilton and Stu Finch 
described their work in Hiroshima 
researching the long-term effects of the 
atom bomb. That afternoon, Howie 
got dressed up in a georgeous costume 
made of silk so heavy it can stand by 
itself, and illustrated the various cate¬ 
gories of the Noh drama. The masks 
used to depict the characters are real 
works of art, and one thought there 
was a real Japanese actor behind them. 
Howie had the typical growling sound 
of some of the Japanese language, the 
unique, slightly bent forward stance, 
and the leg work down perfectly. 
Our class dinner was at the Gradu¬ 
ates Club, and it was a very warm, 
congenial affair. We had an extemporan¬ 
eous performance by Corky which had 
us all in uproarious laughter for half an 
hour. Nick was asked to fill in informa¬ 
tion about those who were not present, 
but had written. He stood in front of 
the big fireplace with a lot of papers in 
his hands, but one side of the room said 
they could not hear. So, Corky got up 
and interpreted for that side. A profes¬ 
sional comedian could not have done 
nearly as well. As the evening wore on, 
someone asked me “What are we going 
to do tomorrow?” We dispersed on 
Sunday, but if you all wish, I will plan 
to have a Sunday program at my house 
in five years. 
Those who attended the reunion, 
almost all accompanied by spice, were 
Conway, Coolidge, Corcoran, Country¬ 
man, Crowley, Doherty, Frelick, Gold- 
enthal, Hamilton, James, Jurka, Kaye, 
Losee, MacKenzie, Martin, Matteson, 
Monroe, Pickett, Roth, Spinelli, Taft, 
Zucker. Special guests were Donald 




The class of ’49 reunion activites were 
mainly dinner at the Graduates Club. 
Present were Bill Anlyan with his 
aunt; Harry Baird with wife Nora; 
Peter Cunningham with wife Jan; 
Gunnar Eng with wife Connie; Paul 
Goldstein with wife Betty; Nora Gordon 
with husband Harry; Dan Halvorsen 
with wife Maxine; Dick Otis with wife 
Mary, and Martha Vaughan with hus¬ 
band Jack. 
Majority present have children and 
grandchildren in various configurations. 
A lew have retired; most still working. 
All locally or nationally famous. Pro¬ 
posal to have a class convocation to 
report on our unique contribution to 
American medicine is in review, and 
you may hear more from this. 
Peter Cunningham 
William Anlyan, chancellor for health 
affairs at Duke, has been named to the 
Council of the University-Government- 
Industry Research Roundtable, a 13- 
member committee newly created by 
the National Academy of Sciences for 
the purpose of looking after science’s 
interests in Washington. Funds for the 
Roundtable have been provided by the 
Alfred B. Sloan Foundation and The 
Andrew W. Mellon Foundation. Frank 
Press, president of the Academy, has 
said that the Roundtable “offers an 
opportunity to address questions bear¬ 
ing on the health of American science 
in a manner not previously available.” 
DeWitt Baldwin is now president of 
Earlham College, a four-year Quaker 
liberal arts institution in Richmond, 
Indiana. Previous to his appointment 
in the spring of 1983. he had served as 
professor of psychiatry and behavioral 
science and assistant dean for rural and 
community health at the University of 
Nevada School of Medicine, as well as 
director of the Center for Geriatric 
Education and Research. He added 
that he is also serving as chairman of 
the Behavioral Sciences Test Committee 
tor the Part I Examination of the 
National Board of Medical Examiners 
and serves on that Board. 
1954 
30th 
After several days of attending Alumni 
Weekend seminars and receptions, com¬ 
paring present day New Haven with the 
New Haven of 30 years ago, attending 
the Japanese Noh drama performance, 
etc., nine members of the class of 1954 
met for dinner on Saturday evening, 
June 9, at the Graduates Club. 
T hose attending were Alan and Sylvia 
Covey, Jack and Elaine Gariepy, Frank 
and Bette Gruskay, Low'd! and Barbara 
Olson, Anthony and Jeanne Piccirillo, 
Robert and Anita Stein, and Herb 
Hurwitz.who escorted a lovely daughter, 
Diana. 
We enjoyed an excellent dinner, had 
an opportunity to visit, read letters 
from Edward Gerety, Jacques Quen, 
and John Rose, and 1 am certain 
everyone made a firm resolution to 
return for our 50th in 2004. 
Lowell E. Olson 
1959 
25th 
1 he story of the silver anniversary of 
the Yale Med Class of ’59 really began 
in a dimly lit room at the rear of Mory’s 
Tavern around the first of the year. 
There a small group met for supper and 
wine (selected from Mory’s “private” 
stock) to organize and implement a 
plan for the greatest reunion that a 
class known for its superlatives ever 
had. Nick Passarelli, Kris Keggi, Herb 
Kaufman, Joe Saccio, John Marsh, 
and Marc Schwartz planned (and drank) 
well. Then, in the ensuing months, they 
took a lot of time to make arrangements 
and personally phone every member of 
the class to urge them to come back to 
New Haven. The response was tremen¬ 
dous! We recorded the best attendance 
ever for a 25th reunion class: 50 of our 
members gathered from the four corners 
of the U nited States to enjoy a wonderful 
two days of fun and fellowship; Mai 
and Audrey Ing from Hawaii, Lyall 
and Phyllis Crary from Washington, 
Rae Larsen and Line Potter from Flor¬ 
ida and a cast of thousands from the 
northeast. 
The official functions began Friday. 
That afternoon all the talent for a 
seminar entitled “Yale Alumni in Sur¬ 
gery” was supplied by the Class of ’59. 
In turn, the attendees were enthralled 
by moderator Passarelli, Keggi on 
“Non-Cemented Ceramic Hip Replace¬ 
ment' ”, O'Neill on “Surgical Manage¬ 
ment of Hypertension in Children with 
Vascular Abnormalities”, Butterfield 
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on “Caricatures of the 18th Century 
Anatomists and Surgeons” and Hey- 
dorn on “Beta-Endorphins. Naloxane 
and Shock”. This was followed by the 
Edward El. Storer Lecture given by 
Dave Skinner entitled 'The Pathophysi¬ 
ology of GastroEsophageal Reflux”. 
Thereafter the meeting ad journed to an 
alumni reception honoring retiring Dean 
and Mrs. Robert Berliner. 
About 6 pm we boarded a bus in 
front of 333 Cedar and departed for the 
Villa Keggi near Middlebury. Conversa¬ 
tions which had begun on the bus 
continued as we strolled the broad 
green lawn surrounding Julie and Kris’ 
country home. Libations and hors 
d’oeuvres, especially the unique Maui 
potato chips supplied for the occasion 
bv ex-officio member of the Class of'59 
(King) George LeBouvier, enhanced 
the convivial assemblage. Lobsters and 
clams steamed in seaweed, sweet corn 
and onions, new potatoes, chicken and 
fish followed by watermelon, made a 
repast perfect for the evening in its 
informality. Afterwards, we gathered 
on the back porch to view slides made 
around Grace-New Haven Hospital 25 
years before. Many were the comments 
about subsequent changes in girth and 
thatch. 
Saturday morning, most of us arose 
early for seminars, meetings or tours of 
the new Yale-New Haven Hospital or 
the new Yale Center for British Art. 
Prior to noon we posed for reunion 
pictures in front of Sterling Hall of 
Medicine and then meandered to Hark- 
ness for sherry and lunch. Remember, 
we were the first class to inhabit it all 
four years. 
During the afternoon some toured, 
some attended the Japanese Noh drama 
theater performance, and a few mad 
dogs braved the scorching 100 degree 
heat for the class tennis tournament. 
There were no winners, only survivors. 
The New Haven Lawn Club hosted 
us for what deserves to be remembered 
as one of the most unique dinner 
dances ever. It was a formal party in a 
sauna, there being no air conditioning 
and the monster east coast heat wave at 
its worst. Before our eyes the dignity of 
the pillars of American medicine crum¬ 
bled as coats were shed, then ties, and 
in the case of DeConti, even pants. As 
the remaining garments became soggy, 
fluid and electrolyte balance suffered 
and the ladies experienced problems 
restretching their pantyhose. Susie 
Fisher did her thing in the club pool 
and others thought seriously about 
joining her. 
Dinner began with shrimp cocktails. 
progressed through prime rib and as¬ 
paragus and finished with Bananas 
Foster while Pat Dorn’s band, without 
an amplified guitar in sight, serenaded 
us with favorites from the the '50’s. 
After supper, while the band took a 
break, we gathered around the dance 
floor. Nick began with a moment of 
silence as we remembered our deceased 
classmates: Dick Gershon, Bill Edwards, 
Rog Atwood, Bob Davis, Phil Griffin, 
Arl Pond and Tony Warner. Then 
Marc Schwartz settled himself at the 
piano to lead a singalong of old favorites 
from the Senior Show of the Class of 
’59, "Day-O, Spend All Nite on OB 
Ward” and “That's All There Is, We 
Hope You've Had a Ball or Even Two”. 
Between numbers various members of 
the original cast recreated their roles 
using a musty, yellow, old script sup¬ 
plied by Marc. Perhaps the most hilar¬ 
ious routine of the evening was per¬ 
formed by Pogo, Nick and Kauf as they 
slid their glasses up and down their 
noses simultaneously while attempting 
to read the faded print. John Marsh, 
Bob Fisher, and Bob Amick harmonized 
their V A number again as we all realized 
that time doesn’t change some things 
such as our appreciation of the 
special experience we had at Yale. 
The attendees were: Bob and Carol 
Amick, Ace and Jean Barnes, Frank 
and Gwen Beer, Jack and Edie Bowers, 
Bill and Ellie Butterfield, Sid and Phyl¬ 
lis Cohen, Lyall and Phyllis C’rary, Ed 
and Franny Clayton, Marty Colodzin, 
Ron and Louise DeConti, Bob and 
Suzie Fisher, Paul Friedman, Bob and 
Lorraine Gonyea, Gerry and Lois Gor¬ 
don, V era Glocklin, Rod and Nancy 
Hartmann, Bill and Joan Heydorn, 
Fen and Judy Inker, Mai and Audrey 
Ing, Bill and Ann Jablonski, John and 
Mary Ann Jasaitis, Ed Kaminskas, 
Herb and Nancy Kaufmann, Kris and 
Julie Keggi, Daveand Ginny Kingsbury, 
Rae Larsen, Ray and Sally Mark, Dan 
and Maritze Macken, John and Carol 
Marsh, Brian and Judy McGrath, Kent 
and Rosemary Morest, Pete and Joy 
Molloy, Ron and Pat Morris, Jim and 
Sue O'Neill, Bob and Freda Ostberg, 
Nick and Mary Lou Passarelli, Fine 
Potter, Jim and Bunny Prokop, Jack 
and Lou Poglinco, Dave and Joan 
Reed, Joe and Carol Robinson, Joe 
Saccio, Marc and Anne Schwartz, Dick 
and Clare Senfield, Dave and Ellie 
Skinner, Sandy and Naomi Solomon, 
Jim Stagnone, I.isa Steiner, and Mimi 
and Dick Wolf. 
Asa Barnes 
Malcolm Ing wrote from Honolulu in 
March that this year has been very busy 
for him in that he has been recently 
appointed chief of ophthalmology at 
the John A. Burns School of Medicine, 
University of Hawaii, and also elected 
president of the Hawaii Ophthalmo- 




Despite the torrid New Haven climate, 
the ever-present overtures for contribu¬ 
tions, and the war-zone atmosphere 
around Leon’s Restaurant, the class of 
1964 20th reunion w'as an unqualified 
success. 
Alumni “traveling the farthest” 
awards went to Al Morris (Salt Lake 
City), Tony Alonso (Tampa), and Skip 
Stilp (Neenah, Wisconsin). 
The “best preserved” (without the 
use of artificial substances) accolade 
went to Dick Hockman, who on several 
occasions during the evening was mis¬ 
taken for a busboy. 
Class scribe, Joe “Nautilus” Curi, 
w on the physical fitness prize for weigh¬ 
ing less than in his original application 
photograph. 
The “where is your kid in college?” 
medals were swamped by Diane Shrier 
(daughter at Yale), Tony Bravo (son at 
Harvard), and Bob Briggs (daughter at 
Princeton). 
The Bacchanalian feasting was only 
interrupted by the academic “turks” 
who insisted on checking periodic blood 
alcohol (Few Landsberg), cholesterol 
(Virgil Brown), and colony count (Bob 
Lyons), levels. 
Later. John Hanev and Mary Di- 
Gangi led a soul searching, nostalgic 
group therapy session. Fortunately, 
Fee Berger misplaced his interesting 
collection of class radiographs of the 
early 1960’s. 
At the close of the festivities, Sid 
Baker supposedly returned to the Gesell 
Institute to redefine the effect of a Yale 
Medical education on early childhood 
behavior patterns. 




The class of 1969 gathered at Mory’s 
for their 15th reunion and we were 
amazed at how little any of us had 
really changed and how much we all 
felt for each other. For those of us 
present it was a time of reminiscing, 
rhapsodizing, and renewing and in retro¬ 
spect, perhaps the closest Yale ever 
made us come to the three R’s. But we 
did learn to cut the meat, so here goes. 
Charles Angell and Sandy and their 
children, Leah and Jordan, live in 
Baltimore where Chuck practices cardio¬ 
logy and internal medicine. Seth Char- 
ney came in from San Francisco where 
he practices psychiatry and has become 
a real estate maven. Leo Cooney and 
Kathleen live in New Haven with their 
boys, Timothy and Joshua. Leo does 
rheumatology and geriatrics as well as 
is father manager of the Yale Youth 
Hockey team. Lee Jampol with Carol 
lives in Chicago with their children, 
Melissa Lyn and Scott. Lee was named 
chairman of the Department of Oph¬ 
thalmology of Northwestern. At the 
dinner, Lee was also given special thanks 
for his work for the Alumni Fund. 
Stephen Krant is a plastic surgeon in 
La Jolla, California, and if things ever 
get slow could moonlight as an emcee, 
based on his performance in that role at 
our dinner. He was pinch-hitting for 
David Upton who orchestrated the 
reunion from the side lines but was 
unable to attend in person because of 
his bad back. Ellen Milstone and her 
husband, Leonard, and their children, 
Jenya, and Aaron, live in New Haven. 
Ellen practices dermatology with an 
interest in dermatopathology. Robert 
Marier and Joanne and their children, 
Alicia and Joanne, live in New Orleans. 
Bob is professor of medicine at LSU in 
infectious disease. Arnold Mazur and 
wife Nancy, live in Boston. Arnie attri¬ 
butes his youthfulness to his children, 
Scott and Sarah, as well as his specialty 
of college health and running. Lionel 
Nelson and wife, Elaine, and children, 
Amanda, Hilary and Alex, live in San 
Jose, California. Lionel specializes in 
ENT and head and neck surgery and is 
involved in medical politics as president 
of his local PSRO and VP of County 
Medical Society. Richard Pollis and 
wife, Victoria, live in Los Angeles. 
Richard practices orthopedic surgery 
with special interest in the spine. Dave 
Schulak lives in Tampa, Florida with 
his wife, Paula and daughter, Hilary. 
He is in partnership with Lutz Schlicke 
who, Dave tells us, mainly fishes, boats 
and occasionally practices. Gerald 
Smallberg practices neurology in Man¬ 
hattan and has his eye on Off Broad¬ 
way for the plays that he has written. 
Steve Webb and his wife, Dottie live in 
Rochester, New York with their child¬ 
ren, Becky, Mike, Katie, and Tommy. 
Steve practices pediatrics and was presi¬ 
dent of the Rochester Pediatric Society. 
Sandy Genser is a psychiatrist in D.C. 
and Ralph Falkenstein is an ophthal¬ 
mologist in Danbury. Both were present 
but we have no other information 
because they couldn’t manage to com¬ 
plete the questionnaire, although they 
could get it together to share the record 
for the longest marriages. 
Unfortunately, Elliot and Carol Liv- 
stone, who helped plan the dinner, were 
unable to attend. Elliot had undergone 
surgery but was doing well. He is 
leaving Yale to enter private practice in 
Florida. Mike Liebowitz and Rowena 
Korobkin did not attend but sent letters. 
Both are married. Rowena is in practice 
in San Francisco in pediatric neurology 
and Mike is in New York doing re¬ 
search in psychopharmacology. 
Those of you not here were remem¬ 
bered and talked about. The class net¬ 
work surprisingly was able to keep 
track of everyone one way or another. 
Although all present were happy with 
what we were doing in medicine, we 
were all concerned about the future of 
our profession. Several strategies for 
coping were suggested. Richard Pollis 
was still touting gold as he did at its 
high at our 10th reunion. Seth Charney 
from his experience in the Bay area was 
cautiously advising real estate. Dave 
Schulak analyzing the new hip pros- 
theses suggested that we consider 
rhodium. In the end we figured we 
would still mainly practice medicine as 
best we could and would return for our 
20th reunion happy but still pessimistic 
about the future of medicine as most 
likely all of our predecessors have done 




Our tenth reunion was held in New 
Haven during Medical Alumni Week¬ 
end on June 8 and 9. Despite the 100 
degree heat and 100 percent humidity, 
those of us able to attend enjoyed 
renewing old acquaintances.Several 
members of our class were fortunate to 
attend a reunion dinner at Casa Marra 
on Saturday. Kudos to Lenny Banco 
who made all the arrangements and 
even managed to come in under budget. 
Lenny is director of Pediatric Ambu¬ 
latory Services at Hartford Hospital 
(U.Conn.faculty). He and Liz have an 
8-year-old daughter, Ellie, and a 5- 
year-old son, Jonathan. Roger Emerson 
is an orthopedist at Mass. General and 
Cambridge Hospitals. He and Patricia 
have an 8-year-old daughter Caroline, 
and a 3-year-old son Christopher. Dan¬ 
iel Rosenthal is a radiologist at Mass. 
General. He and Ins wife Jacqueline 
have a 13-month-old daughter, Lillian. 
Irl Extein will soon (September I) be 
medical director of Psychiatric Institute 
of Del Ray (Fla.). He and Barbara have 
two or three children (depending on 
when you read this). 
Doug Berv is a psychiatrist in New 
Haven. He and his wife Cheryl have a 
young son. Ed Janosko. who has be¬ 
come an avid pilot, is a urologist in 
Greenville, North Carolina. Ron Neu¬ 
mann is associate professor of radiology 
and pathology at Yale. His wife, Maria, 
is also on Yale’s pathology faculty. 1 
am a geneticist based at San Francisco 
Kaiser. Carol and 1 have a 2 and a 
half-year-old son, Scott, and a 9 
month-old daughter, Catherine. 
Neil Blumberg is Blood Bank director 
at University of Rochester and Peter 
Buchin is a gastroenterologist in Man¬ 
hattan. Also up from New York for the 
day was Harry Shamoon with his wife 
and two sons. Bob Milstein is a psychi¬ 
atry resident at Yale. 
Many members of our class were 
unable to attend our reunion, but the 
following rumors were circulated; I apolo¬ 
gize for any inaccuracies. Jason Zie- 
lonka is in nuclear medicine in Mil¬ 
waukee. Boston is home to Dick Paster¬ 
nak, cardiologist; Jim Strom.nephrolo¬ 
gist; and Maisie Tam,dermatologist. 
Amy Schechter, pediatrician ; Bob 
Schecter, ophthalmologist; and Ross 
Tonkens are in the L A. area. Bob 
Hempton is a hand surgeon in San 
Diego. Fred Shessel is a urologist in 
Atlanta. 
The Pacific Northwest is home to 
Dick Howe (Oregon) and Carol Teitz, 
an orthopedist in Seattle. The San 
Francisco area finds Steve Arnold; 
Tom Munyer, Dani Goldwater, Rich 
Cazen, gastroenterologist; John 
Schrumpf, radiologist; David Ritvo, 
psychiatrist; and Marge Oda, ortho¬ 
pedist. Mike Gerber is a pediatrician in 
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Connecticut. Infectious Disease is the 
specialty of George Talbot in Philadel¬ 
phia and Andy Mayrer, who will soon 
be moving from New Haven to 
Baltimore. 
Information about other classmates 
is sketchy; some of you seem to be lost 
to follow-up. I hope to see or hear from 





No report received 
OTHER CLASS NOTES 
1943 
Ralph Alley received the degree Doctor 
of Science Honoris Causa from the 
Albany Medical College at commence¬ 
ment exercises in May. A member of 
the faculty since 1952, he is a clinical 
professor of surgery and former head 
of the Division of Thoracic Surgery at 
the Albany Medical Center. He was 
cited for his exemplary career in thor¬ 
acic surgery and for his many contri¬ 
butions to the field, both in scholarly 
publications and in innovative surgical 
techniques. 
1946 
Ruth Kempe and her husband, C. 
Henry Kempe (’48 HS) have written a 
book, “The Common Secret”, which 
deals with sexual abuse of children and 
adolescents. It considers the difficulties 
in coping with one’s personal feelings 
about the occurence of sexual child 
abuse which face all who have to deal 
with it: social workers, physicians, 
nurses, police, psychologists, teachers, 
the clergy, and the public. The frank 
but positive discussion of a subject 
once considered taboo helps explain 
the 200 percent increase in reported 
cases of sexual child abuse since 1976 
and sheds new light on the role pro¬ 
fessionals can play in this frightening 
dilemma. 
Robert Wagner has recently been ap¬ 
pointed director of the Cancer Center 
at the University of Virginia Medical 
Center in Charlottesville. He also will 
continue to serve as chairman of the 
Department of Microbiology. 
1950 
Sidney Lee has resigned as president of 
Michael Reese Hospital and professor 
of medicine at the University of Chicago 
to accept the appointment as president¬ 
elect of The Milbank Memorial Fund 
in New York City, effective in the fall of 
1984. He claims that this will be his last 
move. Sid’s two sons, Jonathan and 
Michael, will both be entering medical 
school this fall, at Georgetown and 
McGill respectively. 
Classmate Russell Anderson recently 
visited Sid at Michael Reese as the 
head of an Accreditation team for the 
Joint Commission on Accreditation of 
Hospitals. 
1951 
The 1983 American Journal of Ophthal¬ 
mology Lecture was delivered by Brad¬ 
ley Straatsma at the XIV Pan-American 
Congress in Lima, Peru. He spoke on 
“Cataracts — Clinical and Biochemical 
Correlations”and provided new insight 
to the biochemical nature of cataracts 
as it is related to the clinical appearance 
of the lens opacities. 
Dr. Straatsma is director of the Jules 
Stein Eye Institute, and professor and 
chairman of the Department of Oph¬ 
thalmology at the University of Califor¬ 
nia at Los Angeles School of Medicine. 
1953 
Thomas O. Gentsch.now clinical pro¬ 
fessor of surgery at the University of 
Miami School of Medicine and attend¬ 
ing surgeon at Miami Heart Institute, 
has been elected to Fellowship in the 
American College of Cardiology. 
1955 
Milton Corn was appointed medical 
director and chief of staff at the George- 
own University Hospital in Washing¬ 
ton, D.C.,effective July 1984. He will 
continue to serve as professor of medi¬ 
cine at the School of Medicine. 
James Nolan has been appointed gover¬ 
nor-elect of the American College of 
Physicians, U pstate New York Region. 
He is professor and chairman of the 
Department of Medicine at State Uni¬ 
versity of New York at Buffalo, w here 
he has been a member of the School of 
Medicine faculty for 21 years. 
Dr. Nolan is also director of the Erie 
County Medical Center’s Department 
of Medicine and chairman of the board 
and president of Research lor Health in 
Erie County, Inc. A Buffalo native. Dr. 
Nolan his wife and four children live on 
Burbank Drive in Snyder, New York. 
1957 
Joseph Pagano, director of the Line - 
berger Cancer Research Center at The 
U niversity of North Carolina School of 
Medicine, Chapel Hill, participated in 
the dedication of the Cancer Research 
Center’s new $9.4 million building in 
May. 
Clifford Reifler, medical director of 
Strong Memorial Hospital of the Uni¬ 
versity of Rochester Medical Center 
and director of the University Health 
Service, has been elected to membership 
in the American College of Physician 
Executives. Dr. Reifler’s selection was 
based on his “clinical excellence, formal 
management education preparation, 
and leadership excellence.” 
A member of the Rochester faculty 
since 1970. Dr. Reifler is professor of 
psychiatry, of health services, and of 
preventive, family and rehabilitation 
medicine. 
1961 
Kenneth Arndt has been appointed 
new chief editor of Archives of Derma¬ 
tology. In the announcement of his new 
position. Dr. Arndt was cited for his 
achievements, and it was noted that he 
is widely regarded throughout the pro¬ 
fession as one of the premier academic 
clinicians in dermatology in the country. 
“Dr. Arndt brings to his new position 
impressive credentials in medicine, 
medical journalism, and teaching. Al¬ 
though he is best know n for his pioneer¬ 
ing research in laser technology and for 
his authorship of the Manual of Derma - 
tologv Therapeutics — considered by 
physicians the world over to be the 
‘standard work'in dermatology — he is 
also a generalist with experience and 
expertise in a variety of areas . . . 
Archives of Dermatology recently ob¬ 
served its centennial year. The appoint¬ 
ment of Kenneth Arndt ensures the 
continued excellence of this prominent 
journal into its second century of publi¬ 
cation and marks a new era of vigorous 
leadership.” 
Earl Baker was elected to a two-year 
term as president-elect of the American 
Heart Association South Central 
Connecticut Chapter at the Associa¬ 
tion’s annual meeting in May. 
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This past March, Philip Felig was 
appointed president of the Sandoz Re - 
search Institute in East Hanover, New 
Jersey. This institute has been organized 
to facilitate closer interaction with aca¬ 
demic research centers throughout the 
country and broaden the base for future 
preclinical and clinical research at 
Sandoz. Dr. Felig, who has been a 
member of the Yale faculty for the last 
14 years, will continue his association 
with the School as a clinical professor 
of medicine. 
1965 
John Barchilon, now living in Califor¬ 
nia, wrote in April updating his most 
recent activities. He noted that: “I’ve 
always wanted a chance to see the 
country before moving out west, so I 
joined a practice management/locum 
tenens group based in North Carolina, 
and they sent me all over. It was a 
terrific experience, practicing in small 
towns in South Carolina, Georgia, 
northern Connecticut, Illinois, and Mon¬ 
tana — especially coming from Man¬ 
hattan," Now settled in Los Angeles, he 
divides his time between practicing 
sports medicine and writing. 
Between assignments last year, he 
was able to finish a novel, “The Crown 
Prince”, a story of love, war, and music 
based on the life of the legendary 
concert pianist Paul Wittgenstein. The 
novel set in Europe from the nineties 
through the twenties portrays kings, 
courtesans, soldiers, scoundrels, artists, 
and rabble rousers during these turbu¬ 
lent years. 
1966 
Henry Hanley, currently professorand 
head of the Section of Cardiology in 
the Department of Medicine at Louisi¬ 
ana State University, and chief of the 
Cardiology Section of the Medical Ser¬ 
vice at the Veterans Administration 
Medical Center in Shreveport has been 
elected to Fellowship in the American 
College of Cardiology. 
1967 
John Pastore is currently serving as 
secretary of the International Physicians 
for Prevention of Nuclear War and 
attended the organization’s Fourth 
Congress held in Helsinki, Finland this 
past spring. He is director of the St. 
Elizabeth’s Hospital of Boston and an 
associate professor of medicine at Tufts 
University School of Medicine. 
1969 
Elliot Livstone resigned from the Yale 
medical faculty in June and has opened 
his office for practice of gastroenterol¬ 
ogy in Riverview Professional Center, 
Sarasota, Florida. 
1971 
H. Steven Moffic, who is associate 
professor of psychiatry at Baylor 
College of Medicine, was awarded a 
fellowship by the American Jewish 
Committee to attend the annual Aca¬ 
demician’s Seminar in Israel, December 
20 to January 3, 1984. He was joined by 
his wife Rusti, who isa learningdisabil- 
ities specialist. The trip included 23 
American academicians and one other 
phsycian. Dr. Moffic’s particular area 
of research is in ethnic identity. After 
returning, he wrote two short pieces for 
the journal devoted to the seminar: 
“Singing for the Scholars: The Yiskor 
Service at Yad Vashem”and “From the 
Ivory Tower to the Dead Sea: The 
Genesis of a Seminar.” 
1972 
In response to Yale Medicine's request 
in our last issue for news about current 
activities of alumni, Roy Kaplan sent 
in the following: “I have been appointed 
chief. Division of Rheumatology at 
Mercy Hospital and Medical Center in 
San Diego; clinical assistant professor 
in the Department of Medicine at Uni¬ 
versity of California at San Diego 
Medical Center. I have also been reap¬ 
pointed chairman of the Medical and 
Scientific Committee of the San Diego 
Chapter of Arthritis Foundation for 
1984 and re-elected to the Board of 
Governors, San Diego Chapter, Arthri¬ 
tis Foundation.” 
1976 
Jerome Zeldis is one of five who were 
recently awarded Pfizer postdoctoral 
fellowships in the first annual Pfizer 
Fellowship competition. Following his 
internship and residency training in 
internal medicine at UCLA Medical 
Center, Dr. Zeldis, since 1981, has been 
a research fellow in medicine at Harvard 
and also a clinical research fellow in 
medicine at Massachusetts General Hos¬ 
pital. His postdoctoral research will 
examine, through molecular biological 
and recombinant DNA technologies, 
the induction of chronic hepatitis by 
hepatitis- B virus (HBV) and the associa¬ 
tion of H BV and H BV-related hepatitis 
with hepatocellular carcinoma. 
1978 
Arthur Gershkoff, who is a member of 
the attending staff of Magee Rehabilita¬ 
tion Hospital in Philadephia and direc¬ 
tor of its Chronic Pain Program, has 
been elected president of Magee’s medi¬ 
cal staff. In addition to his position at 
Magee, which is a regional lifetime 
resource center dedicated to improving 
the quality of life for the physically 
disabled. Dr. Gershkoff is an instructor 
and a consulting staff physician at 
Thomas Jefferson University’s Depart¬ 
ment of Rehabilitation Medicine. He 
has been the author and co-author of 
numerous presentations in the areas of 
pain, the chronically ill and spinal cord 
injury. 
Michael Owens has joined the Watts 
Health Foundation, Inc. as medical 
director of the Watts Health Center in 
Los Angeles. 
1980 
Jay Barahan is one of five winners of 
the Pfizer postdoctoral fellowships in 
the first annual Pfizer Fellowship com¬ 
petition. After interning at Hospital of 
St. Raphael in New Haven, he com¬ 
pleted his psychiatric residency training 
at Columbia College of Physicians and 
Surgeons and the New York State 
Psychiatric Institute. Since July of last 
year. Dr. Baraban has spent the elective 
period of his psychiatry residency in 
the laboratory of Dr. Solomon Snyder 
at Johns Hopkins and will conduct his 
postdoctoral research under Dr. Snyder. 
Pursuing his interests in novel mech¬ 
anisms whereby chemotherapies may 
relieve schizophrenic symptoms, he will 
study the allosteric modulation of dopa¬ 
mine receptors and its implications for 
the development of improved antipsy¬ 
chotic chemotherapies. 
1982 
Lynn Tanoue, serving her residency in 
medicine at Yale-New Haven Hospital, 
has been selected as the recipient of The 
Samuel D. Kushlan Award, which was 
inaugurated in 1969 and which is given 
annually to thejuniorassistant resident 
who has contributed the most to patient 
care during rotations through the Com¬ 
munity Medical Service. 
1983 
Eric Winer, a member of the house 
staff at Yale-New Haven Hospital in 
the Department of Medicine, has been 
selected as the recipient of The Samuel 
35 
D. Kushlan Award, annually given to 
the intern who has contributed the 
most to patient care during rotation 




John McGovern received an honorary 
degree from Florida State University at 
its commencement in April. Dr. 
McGovern was also the main speaker 
for the University’s commencement pro¬ 
gram. In May hedelivered the principal 
address and was awarded an honorary 
Doctorate of Laws degree at the spring 
commencement of Lamar University in 
Beaumont, Texas. 
1967 
Thomas Hansen has announced the 
opening of his office at 2 Church Street 
South in New Haven for the practice of 
dermatology. 
1971 
Thomas Koontz has been elected chair¬ 
man. Board of Trustees of the Medical 
Park Hospital in Winston-Salem, North 
Carolina. 
1972 
Fid ward McGuire has left Yale as pro¬ 
fessor of urology to become chairman 
of the Department of U rology at U niver- 
sity of Michigan Medical School. 
1982 
Warren F’agadau has been named by 
the Pan-American Association of Oph¬ 
thalmology to become the coordinator 
between North American and Latin 
American activities. In addition to his 
ideas for increasing membership, partici¬ 
pation and service in the PAAO, his 
primary goal is to increase the exchange 
of fellowships between the Americas. 
Dr. Fagadau is in practice in Dallas. 
PUBFIC HEAFTH 
1969 
Samuel Korper has been appointed 
director of the National Institutes of 
Health Division of Legislative Analysis. 
In his new position. Dr. Korper will be 
responsible for advising the N1H direc¬ 
tor and other senior NIH executive 
staff on legislative developments rele¬ 
vant to NIH programs and activities, 
the need for proposed changes in the 
statutory base of NIH activities, and 
development of new legislative pro¬ 
posals. Previously, Dr. Korper served 
as associate director for Legislation, 
Epidemiology, and the Environment in 
the Office of the Deputy Assistant 
Secretary for Health Research, Statis¬ 
tics, and Technology, OASH. 
1980 
Robert Levine has been appointed assis¬ 
tant administrator, University Hospital 
at New York University Medical Center. 
He was formerly director of the Faculty 
Practice Plan at Long Island Jewish 
-Hillside Medical Center. 
IN MEMOR1AM 
Max H. Ruby 
July 16,1983 
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CLASS OF 1984 
postgraduate appointments 
ALABAMA 
University of Alabama Medical Center, 
Birmingham 
John Gwin, Jr., General Surgery 
ARIZONA 
Tucson Hospitals, Tucson 
David Fillmore. Transitional 
CALIFORNIA 
Cedars-Sinai Medical Center, Los Angeles 
Steven Schick, Pathology 
Pacific Medical Center, San Francisco 
Charles Zacks, Ophthalmology 
UCLA Hospital and Clinics 
Abner Korn, Obstetrics and Gynecology 
University of California San Diego Affiliated 
Hospitals 
Robert Bookstein, Pathology 
Robert Winchell, General Surgery 
University of California Hospitals, 
San Francisco 
William Cimino, Orthopedic Surgery 
Linda Grais, Internal Medicine 
COLORADO 
University of Colorado Affiliated Hospitals, 
Denver 
John Babich, Internal Medicine 
Terri Richardson, Internal Medicine 
CONNECTICUT 
Middlesex Memorial Hospital, Middletown 
Roger Phillips, Family Practice 
Waterbury Hospital 
Paul Gagliardi, Medicine 
Yale-New Haven Medical Center 
David Astrachan, Surgery 
Leonard Bell Internal Medicine 
Mary Bogucki, Internal Medicine 
Michael Brines, Internal Medicine 
Sandra Castro, Pediatrics 
Terence Chen, Neurosurgery 
Arthur Duberg, Diagnostic Radiology 
Edward Duda, Internal Medicine 
Mariano Garcia Blanco, Postdoctoral 
Fellow, Molecular Biophysics and 
Biochemistry 
Bruce Haffty, Therapeutic Radiology 
Robert Havlik, General Surgery 
Ellen Heyneman, Pediatrics 
Sabra Jones, Orthopedic Surgery 
Jeffrey Katz, Internal Medicine 
Daniel Kolansky, Internal Medicine 
John Krystal, Psychiatry 
James Linakis, Pediatrics 
Dan Oren, Psychiatry 
Ronnie Rosenberg, Psychiatry 
Ana Salazar, General Surgery 
Stephen Sigal, Internal Medicine 
Paul Snyder, Surgery 
Kenichi Takeshita, Internal Medicine 
Diana Traquina, Surgery 
DISTRICT OF COLUMBIA 
Georgetown University Hospital 
Conrad Duncan, Obstetrics and Gynecology 
George Washington University Hospital 
Jill Ratain, Internal Medicine 
FLORIDA 
University of Florida Medical Center, 
Shands Hospital, Gainesville 
William Rios, Internal Medicine 
ILLINOIS 
University of Chicago Clinics 
Jessica Berman, Surgery 
Steven Gore, Internal Medicine 
Carolyn Johnston, Obstetrics 
and Gynecology 
MAINE 
Eastern Maine Medical Center, Bangor 
Connie Kreiss, Family Practice 
MARYLAND 
University of Maryland Hospital, Baltimore 
Deborah Arrindell, Pediatrics 
MASSACHUSETTS 
Beth Israel Hospital, Boston 
Paula Fracasso, Internal Medicine 
Dominic Pennachio, Jr., Internal Medicine 
Janet Rucker, Internal Medicine 
Robert Staszewski, Internal Medicine 
Boston City Hospital 
Douglas Webber, Internal Medicine 
Boston University Affilated Hospitals 
Geoffrey Ahern, Neurology 
Brigham and Women’s Hospital, Boston 
Scott Haig, General Surgery 
Donald Ingber, Research Fellow, Pathology 
Susan Tredwell. Obstetrics and Gynecology 
Children’s Hospital Medical Center, Boston 
Donald Ingber, Research Fellow, Surgery 
Massachusetts General Hospital, Boston 
Samuel Bern, General Surgery 
Troyen Brennan, Internal Medicine 
Juanita Merchant, Internal Medicine 
Massachusetts Institute of Technology, 
Cambridge 
Martin Yarmush, Research Associate, 
Chemical Engineering 
New England Medical Center Hospital, Boston 
Michael Simons, Internal Medicine 
Tufts University School of Medicine, Boston 
Theoharis Theoharides, Assistant Professor, 
of Biochemistry and Pharmacology 
MICHIGAN 
University of Michigan Affiliated Hospitals, 
Ann Arbor 
John Lane, Orthopedic Surgery 
MINNESOTA 
Mayo Graduate School of Medicine, Rochester 
Robert Arnold, Ophthalmology 
University of Minnesota Hospitals, 
Minneapolis 
Kenneth Rosenblum, General Surgery 
NEW YORK 
Bronx Municipal Hospital Center 
Robert Berkowitz, Medicine 
Saul Sadka, Diagnostic Radiology 
Maimonides Medical Center, New York 
Leon Eisikowitz, Internal Medicine 
Montefiore Hospital Center, New York 
Nelson Aaron, Pediatrics 
Mark Stein, Surgery 
Mount Sinai Hospital, New York 
Emilio Juncosa. Obstetrics and Gynecology 
New York Hospital, New York 
David Young, Pathology 
New York Hospital, 
Cornell-Westchester Division, White Plains 
Kim Gutner, Psychiatry 
Mark Servis, Psychiatry 
New York Infirmary, 
Beekman Downtown Hospital, New York 
Theodore Silver, Medicine 
New York University Medical Center, 
New York 
Alison Lindsay, Pediatrics 
Steven Sockin, Internal Medicine 
Presbyterian Hospital, New York 
Martha Arden, Pediatrics 
Maxwell Bloche, Internal Medicine 
Michel Kliot, Surgery 
Paul Rothman, Internal Medicine 
Rockefeller University, New York 
Kenneth Mackie, Research Fellow, 
Laboratory of Cellular and Molecular 
Neuroscience 
Roosevelt Hospital, New York 
Andrew Sternlicht, General Surgery 
State University, Kings County Hospital, 
Brooklyn 
Frederick Paola, Internal Medicine 
Strong Memorial Hospital, Rochester 
Richard Marottoli, Internal Medicine 
David Shrier, Surgery 
NORTH CAROLINA 
Duke University Medical Center, Durham 
Jerome Kim, Internal Medicine 
Richard Leff, Internal Medicine 
North Carolina Memorial Hospital, 
Chapel Hill 
Peter Arvan, Internal Medicine 
OHIO 
Case Western Reserve University Hospital, 
Cleveland 
Philip Krause, Internal Medicine 
Edwina Simmons, Obstetrics and Gynecology 
Valerie Stone, Obstetrics and Gynecology 
Cincinnati General Hospital 
David Binder, Emergency Medicine 
PENNSYLVANIA 
Albert Einstein Medical Center, Philadelphia 
Sharan Abdul-Rahman, Obstetrics and 
Gynecology 
Graduate Hospital, Philadelphia 
Kieran Cooper, Internal Medicine 
Hospital of the University of Pennsylvania, 
Philadelphia 
Margaret Lancefield, Internal Medicine 
William Palmer, Internal Medicine 
Aron Wahrman, Genera! Surgery 
Sharon Youcha, Obstetrics and Gynecology 
Lankenau Hospital, Philadelphia 
Helen Mrose, Medicine 
St. Christopher’s Hospital, Philadelphia 
Richard Rossin, Pediatrics 
Temple University Hospitals, Philadelphia 
Charles Abrams, Internal Medicine 
Jay Kostman, Internal Medicine 
Steven Porcelli, Internal Medicine 
Thomas Jefferson University Hospital, 
Philadelphia 
Joseph DeSantis, General Surgery 
RHODE ISLAND 
Miriam Hospital, Providence 
Cynthia Berry, Medicine 
TEXAS 
University of Texas Southwestern Affiliated 
Hospitals, Dallas 
Edward Dohring, Surgery 
WASHINGTON 
Univeristy of Washington Affiliated 
Hospitals, Seattle 
Joseph Chambers, Internal Medicine 
Barbara Coda, Anesthesiology 
Lori Rubens, Psychiatry 
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YALE ALUMNI IN MEDICINE 
N icholas P. R . Spinelli, M. D. '44, President 
Dwight F. Miller,M.D..’56, Vice-President 
Richard W. Breck.M.D.,’45,Secretary 
William L. Kissick. M.D.,‘57 M.P.H, ’59; 
Dr. P.H.,’6! , Past-President 
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Susan S. Addiss, M.P.H..’69 
J Roswell Gallagher, M.D , ’30 
Gilbert F. Hogan, M.D., ’57 
Thomas P. Kugelman, M.D., '60 
Richard T. Otis, M.D., ’49 
John O. Pastore, M.D., '67 
Ora K. Smith, M D., ’53 
Rebecca Soloman, M.D, ’39 
Lynne T. Tanoue, M.D., '82 
Muriel D. Wolfe, M.D . ’51 
Lowell I. Goodman, M.D.,’51, Chairman, 
Medical School Alumni Fund 
ABOUT THE COVER: 
The design was adapted from a Chinese hamster/human hybrid clone panel for assignment of human DNA 
sequences to human chromosomes (shown above) developed in the laboratory of Dr. Uta Francke, 
associate professor of human genetics and pediatrics. The human chromosomes present in each of the 17 
different Chinese hamster/human hybrid cell lines are indicated by black boxes. White boxes refer to 
human chromosomes that were not detected. The chromosomes indicated by hatched boxes were 
rearranged and only present in part. The crosses symbolize low frequency of chromosome. 
DNA from these hybrids was tested with cloned human DNA sequences that recognize restriction length 
polymorphic loci. Dark boxes on the right indicate presence of hybridizing sequences, a cross means weak 
hybridization and white boxes mean lack of hybridization. Based on concordant segregation in these 
hybrids the locus, thereafter called D14S1, was mapped to a region of chromosome 14, and the locus called 
DXYSI was mapped to the Y chromosome and to part of the X chromosome. 
Dr. Francke is a leader in the field of somatic cell genetics, recognized internationally for her elegant 
work in mapping human and mouse genes to specific chromosomal regions. Recently, she has pioneered in 
the study of chromosome abnormalities of human tumors and in the mapping of oncogenes. 
More about outstanding research in the Department of Human Genetics appears in an article beginning 
on page 6 of this issue. 
THE STATE OF OUR SCHOOL 
On September 9th, Dean Leon E. Rosen¬ 
berg convened the faculty in Mary S. 
Harkness Auditorium to deliver his 
first formal presentation to them on 
the “State of Our School”. The 
audience which filled the auditorium 
to capacity included two of his 
predecessors, Dr. Vernon W. 
Lippard, dean from 1952 to 1967, and 
Dr. Robert W. Berliner, who retired 
in June after serving eleven years as 
dean. The text of Dean Rosenberg's 
address and accompanying 
illustrations are printed in full on the 
following pages. 
Ladies and Gentlemen of the Faculty of the School of Medicine: I’m pleased to stand before you as your new dean. Not being 
superstitious, my pleasure is not lessened by assuming this post in 
“Orwell’s year” or by addressing you on the thirteenth of September, or 
by being the thirteenth dean of this institution. If anything should have 
daunted me about where I find myself today, it would have been the 
written and oral messages 1 received during the months after my appointment 
was announced. Of the nearly 300 letters 1 received (a volume which 
reminded me somewhat anxiously, of the national visibility of this deanship), 
more than 30 added words of concern, condolences, even grief to their 
congratulations. Several letters contained whole pages of jokes reveling in 
the foolishness of deans. A good friend said that the last good dean was 
Gunga Din because “at least he brought water to the troops.” Yet another 
advised me “not to let the bastards get me down,” but failed to tell me who 
the bastards were. Finally, so many of you asked me if I was really certain I 
wanted to be dean that 1 came to understand that many perceive this job as 
one to be taken on only by someone confused, intoxicated, or otherwise 
impaired. 
Why then do I stand here? My reasons are many: first, because I desire a 
new career challenge (and have a queasy feeling these days that I’ve found 
one); second, because I wish to learn more about Yale University, a place 
which has earned my enduring loyalty by understanding what phrases like 
“the academy,” or “academic freedom,” or “collegiality,” truly mean; third, 
because I have great admiration and respect for Bart Giamatti and Bill 
Brainard and believe they and their administration are committed to the 
good fortunes of their medical school; fourth, and foremost, because I 
consider it an enormous honor and privilege to be your leader — to be the 
dean of and for this distinguished faculty. 
I wonder, in fact, how many of you know that you are a member of a truly 
outstanding faculty, and that this school’s faculty has been distinguished for 
more than half a century. Whereas I abhore stiff-necked boasting or hubris, 
by individual or institution, I have long felt that this faculty has honed the 
virtues of modesty and self effacement to the point that they approach being 
vices. We have been so “low key” that our achievements have sometimes 
been invisible to ourselves and to the public. 
How many of you know that: 
• penicillin was first administered to a patient in this country by a Yale 
physician at the Yale-New Haven Hospital in 1942 
• that another Yale physician brought chemistry and biochemistry to the 
bedside in the 1940’s 
• that the first highly purified preparations of ACTH were prepared here 
in 1943 
• that cancer chemotherapy began here in the 1940’s with the introduction 
of nitrogen mustard for the treatment of Hodgkin’s disease 
• that a Yale biochemist first elucidated the mechanism of action of pepsin 
• that in 1951, a member of Yale’s 
poliomyelitis research unit illuminated 
the pathogenesis of polio by demonstrat¬ 
ing the virus in the blood stream early in 
the disease 
• that the discovery that fragments of 
an enzyme can reassociate to restore 
catalytic activity was made here 
• that the first newborn intensive care 
unit in this country was established here 
slightly more than 20 years ago. 
To those of you who say these things 
took place before your time, 1 ask how 
many of you are familiar with some of 
the more recent major achievements of 
this faculty: 
• the development of methods for the 
mapping of human genes to specific 
chromosomes 
• the discovery of suppressor T cells 
• the first demonstration of the role of 
cyclic nucleotides in neurotransmitter 
action 
•the initial description of Lyme disease, 
followed by elucidation of its spirochetal 
etiology and definition of effective anti- 
mirobial treatment 
• the discovery of biotinated nucleo¬ 
tides as multi-purpose gene probes 
•the development of one of the premier 
fetal medicine/prenatal diagnosis pro¬ 
grams in the world 
•the discovery that beta-blocking drugs 
are effective in the treatment of glaucoma 
This faculty has been recognized nation¬ 
ally and internationally for its research 
achievements. It currently contains one 
Nobel Laureate, 17 members of the 
National Academy of Sciences, 11 mem¬ 
bers of the American Academy of Arts 
and Sciences and nine members of the 
National Institute of Medicine. Its depart¬ 
mental programs in Physiology, Pharma¬ 
cology, Cell and Molecular Biology, and 
Biochemistry, each ranked among the 
top four in a recent survey of graduate 
departments. This is all part of our 
institutional heritage. We have a right to 
recall it in the hope that it will elevate our 
sights when we aim too low, and lessen 
our pain when we suffer institutional 
wounds. 
But being more comfortable with data 
presentation than with exhortation, let 
me tell you who make up this faculty and 
a bit about what we do. As can be seen 
from the bottom line on figure I, this 
faculty currently numbers 2,112; two- 
thirds are part-time and voluntary; and 
one-third full time. Of this full-time 
faculty, roughly one-third have tenure or 
its equivalent. This faculty has nearly 
doubled since 1972-73. Most of this 
growth has occurred in the voluntary 
faculty, reflecting expansion of ouraffilia- 
2 
tion program with community hospitals. 
The full-time faculty has increased by 
only about 18 percent since 1972 — this 
increase reflecting a gain in tenured 
academic faculty and in senior research 
faculty. Term faculty members have de¬ 
creased slightly. These numbers suggest 
that our full-time faculty is a bit “greyer” 
in 1984 than it was a decade ago, but not 
dangerously so. 1 am concerned, however, 
by the relatively slight increase in the 
number of women on our full-time fac¬ 
ulty. In 1972-73 women accounted for 11 
percent of the total full-time faculty. By 
1983-84, this number has risen to only 17 
percent. Clearly, the “gender gap” is 
closing here, but we still have some 
distance to go. The situation regarding 
Black faculty members is quite discour¬ 
aging; there has been essentially no 
growth since 1972 despite recruitment 
efforts. 
This large and diverse faculty does 
many things, but I’ll address only the 
traditional trio of activities — teaching, 
research and patient care — in that 
order. 
As can be seen in figure 2, we teach a 
diverse array of students, eight categories 
to be precise. In 1983-84, M.D. candidates, 
who numbered 417, accounted for only 
about one-quarter of the 1726 total 
students at this school, with about equal 
fractions coming from house officers 
and postdoctoral fellows. Over the past 
decade, as noted on the bottom line, 
total students here have increased by 
about 350 or by 25 percent. Nearly half 
of this increase has come in the postdoc¬ 
toral fellow category, and another third 
among house officers and Ph.D. candi¬ 
dates. These figures serve as a reminder 
that many ol us teach on a one-to-one 
figure 1 
basis in the laboratory or at the bedside, 
rather than in the more traditional class¬ 
room setting. In contrast, little growth 
has occurred among M.D. or M.D./ 
Ph.D. students. If, as some have said, the 
combined M.D./Ph.D. degree program 
represents the best hope of attracting 
M.D.’s to research careers, perhaps we 
should address ways of increasing their 
representation in our student body. 
None of us can afford to forget that 
teaching is a fundamental raison d’etre 
of this institution and that our students 
are our legacy. They are tomorrow’s 
medical scientists and clinicians. To them 
we entrust the proceeds of the research 
and clinical experience which we accumu¬ 
late over a lifetime’s work. Having said 
that, I have no precise way of knowing 
how well we do collectively as teachers 
or how much time we spend at it. Data of 
that sort are almost impossible to as¬ 
semble. Some of you are gifted educators, 
capable of inspiring vour students. Some 
others of you. sadly, give little to and get 
little from this endeavor. Most of us fall 
in the middle; we take our teaching 
responsibilities seriously and derive con¬ 
siderable reward therefrom. I am grateful 
to all of you who teach, and salute 
particularly the voluntary faculty who 
make such major contributions to the 
clinical teaching programs at Yale-New 
Haven Hospital and at the other hospitals 
with which we affiliate. 
The other raison d'etre for this school 
is to conduct research fundamental 
and applied — of the highest quality. 
Earlier I mentioned some of the historical 
highlights of this faculty’s research contri¬ 
butions and alluded to a few of the 
accolades received for such contributions. 
Let me emphasize now that the scientific 
FACULTY ROSTER 
Yale School of Medicine 
Number of Positions 
Full-Time Voluntary Total 
Year Tenure Term 
Senior 
Research 
1972-73 144 409 11 625 1189 
1975-76 181 371 14 942 1508 
1977-78 201 379 17 1108 1705 
1979-80 209 401 34 1254 1898 
1981-82 236 387 37 1350 2010 
1983-84 233 376 57 1446 2112 
figure 3 
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contributions of this faculty do not derive 
from stellar contributions of a few “stars” 
though stars we have. It is the collective 
effort I want to underscore. 
On the graph in figure 3 is plotted the 
research grant and contract income (in 
millions of dollars of direct costs) gener¬ 
ated by this school’s faculty annually 
since fiscal year 1973. Federal research 
and training grants, more than 90 percent 
of which are from the N1H, are shown in 
lines; non-federal grants are shown in 
dots. In 1973, our total income from 
these sources was 26 million dollars, 21 
million of which came from federal 
sources. Over the ensuing decade, this 
income more than doubled, reaching a 
total of 57 million in 1984. During this 
interval, federal and non-federal funds 
increased comparably the fractional 
contribution from federal sources being 
80 percent in 1973 and 79 percent in 
1984. This increased income is made 
more impressive by recognizing that it 
has occurred during an interval marked 
by a leveling off of the NIH budget and 
by more competition from the increasing 
figure 2 
number of applicants at a much larger 
number of medical schools. In 1973, this 
school ranked tenth nationally among 
medical schools as a recipient of total 
NIH research grants. In 1976, it was 
seventh, in 1980 third, and in each of the 
past two years, second. In 1973, our 
fractional share of NIH’s total grant 
awards to medical schools was 2.8 per¬ 
cent; by 1984 that had risen to 3.4 
percent. In the research training grant 
category, perhaps the most keenly com¬ 
petitive area of NIH funding, we have 
done even better ranking first nation¬ 
ally in each of the past four years. This 
impressive performance is not confined 
to any one part of the School. In 1984, 
339 of the 666 eligible full-time faculty 
(that is 51 percent of the total) were 
principle investigators on one or more 
externally funded grants; 157 of these 
PI ’s came from the basic science depart¬ 
ments where virtually all faculty were 
Pi’s. The remaining 210 Pi’s came from 
the clinical departments. 
Before leaving these encouraging data, 
let me show you one other piece. In 
figure 4, the direct cost income from 
research grants (dots on the graphs) is 
shown corrected for inflation (lines). In 
constant 1972 dollars, this school’s 
research grant income increased by 4.5 
million dollars or 27 percent over the 
interval shown. The number of individual 
Pi’s increased too — from 225 in 1973 to 
339 in 1984. Such real financial growth 
did not occur at most medical schools 
during this interval. It bears strong wit¬ 
ness to the vitality of our research 
capability. 
The great strength shown by this 
school’s research enterprise is matched 
by its clinical fortunes, which have pros- 
STUDENT ENROLLMENT 
Yale School of Medicine 
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pered and broadened in recent years. 
The major hospital in which our part- 
time and full-time faculty practice, Yale- 
Neu' Haven Hospital, is an institution 
regularly ranked among the top hospitals 
in the country. This hospital, our hospital, 
is now housed in an excellent new facility, 
and is led by a superb administrative 
team headed by Tom Smith. The mutually 
pivotal relationship between Yale-New 
Haven Hospital and the Yale School of 
Medicine cannot be overstated. Strength¬ 
ening this powerful, (if sometimes frus¬ 
trating and always complex) symbiotic 
partnership will be a central issue of my 
deanship. 
Some of you may not be aware of the 
array of other health care institutions 
with which this medical school affiliates 
(figure 5). We have major relationships 
with such local institutions as the West 
Haven Veteran’s Administration Medical 
Center, and the Connecticut Mental 
Health Center. We have important affili¬ 
ation agreements with no fewer than ten 
community hospitals in Connecticut and 
with an array of health maintenance 
organizations in our locale, including 
the Yale Health Plan, the Community 
Health Care Program,and the Hill Health 
Center. All of these are vital to the 
teaching mission of this school. In turn, 
our presence at these institutions en- 
1975-76 1977-78 1979-80 1981-82 1983-84 hances the quality of care provided there. 
Previously, 1 used some financial data 
to describe our faculty’s research program, 
recognizing, of course, that evaluating M.D. candidates 386 402 413 397 417 
M.D.-Ph.D. candidates 41 48 47 47 47 our research by counting dollars is as 
M.P.H. candidates 160 181 195 193 206 
spurious as appraising a lootball team 
by seeing how much its players weigh. 
Dr. P.H. candidates 10 6 5 8 7 Nonetheless, 1 think we learn something 
P.A. candidates 39 43 47 41 44 from such measuring, and I’ve done a bit 
Ph.D. candidates 150 160 167 185 208 
more ot it concerning our full-time 
House officers 317 321 332 339 360 
taculty s clinical activity. In 1 igure 6, I’ve 
plotted total income earned from medical 
Postdoctoral Fellows 275 318 361 390 437 services (i.e. patient billings and labora- 
Total 1378 1479 1567 1600 1726 
tory charges) in millions of dollars as an 
annual function. Between 1973 and 1984. 
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figure 5 
from 6.8 million to 46.4 millions (shown 
in dots), a nearly six-fold rise. When 
corrected for inflation, considerable real 
growth is seen as shown in lines on the 
graph. In constant dollars, however, the 
increase since 1973 is only three-fold. 
When examined critically, this apparently 
remarkable growth has many explana¬ 
tions. First, it reflects a completely over 
hauled and more efficient billing and col¬ 
lection program of the School’s Office 
of Professional Services. Second, nearly 
40 percent of the growth reflects billings 
by several hospital-based departments 
(Anesthesiology, Diagnostic Radiology, 
Therapeutic Radiology) which formerly 
billed their services through Yale-New 
Haven Hospital. Third, it reflects the 
introduction of a number of new tertiary 
TOTAL MEDICAL SERVICE INCOME 
BY FULL-TIME FACULTY 
YALE SCHOOL OF MEDICINE FY1973 TO FY1984 
ACTUAL AJVD COATSTALVr DOLLARS 
care services by the full-time faculty. 
Fourth, it reflects a modest increase in 
the number of full-time faculty engaged 
in some medical service activity. It is 
particularly worth noting that the 300 
percent increase in real medical service 
income between 1973 and 1984 was 
achieved with no increase in inpatients 
admitted to Yale-New Haven Hospital 
by full-time faculty and with only a 48 
percent increase in outpatients seen by 
this practicing group. 
In 1973, only 15 percent of the School’s 
total income was derived from medical 
services and no less than 67 percent from 
grants and contracts — a ratio which 
mortgaged our future far too much to 
the federal economy and political whim. 
In 1984, medical service income ac¬ 
counted for 31 percent of the total, and 
grants and contracts for 51 percent. 
Together, these two sources continue to 
account for 82 percent of the school’s 
income. This testimony to your collective, 
entrepreneurial efforts, I should add, is 
not unlike that found in many other 
prominent, research-intensive, private 
medical schools with large faculty-to- 
student ratios. 
Institutions like this one remember 
their past and assess their present to 
prepare for the future. We of the faculty 
and administration of the Yale School of 
Medicine have every reason to face the 
future with excitement and confidence. 
None of us can doubt the opportunities 
afforded by the exuberant, sometimes 
breathtaking, pace of advances in cell 
and molecular biology, genetics, immun¬ 
ology, and neuroscience — both for an 
enhanced understanding of human bio¬ 
logy and for new insights into the patho¬ 
genesis, diagnosis, treatment, or pre¬ 
vention of disease. None of us should 
doubt either the commitment or the 
capacity of this school to remain at the 
very top of this country’s medical institu¬ 
tions. My restless spirit has caused me, 
from time to time, to look hard at some 
other fine medical schools — to the 
northeast of us, and just to the south; 
slightly to the west of us, and far to the 
west. None, in my view, is as vital, as 
decent, or as sound as this school is. But 
if you join me in aspiring to be vibrant as 
well as vital, and to soar as well as be 
sound, then we must strive ever harder 
for excellence and be prepared for change. 
It is this challenge of change which I see 
as the major agenda item of my deanship, 
and it will take many forms. 
First, we must find new leadership for 
many of our academic units. As of July 
I, we have new chairmen in MB and B 
(Bill Konigsberg)and in Human Genetics 
(Carolyn Slayman), and I am negotiating 
actively with a candidate for the chair of 
Pharmacology. Search committees have 
recently been appointed to identify re¬ 
placements for chairmen in Dermatology, 
Psychiatry, and Surgery and next year, a 
new chairman in Neurology will be 
sought. Administration leadership, too, 
is changing. Sue Dorn has recently been 
appointed Director of an expanded 
Medical School Development Office, 
Bella Berson has been named director of 
our much used and much needed medical 
library, and we are seeking a head for a 
revamped and enlarged public infor¬ 
mation office. 
Second, we must strengthen (and in 
some cases) establish programs in critical 
or particularly exciting areas in which 
we have unusual potential or in which we 
are under-represented — molecular im¬ 
munology; neuroendocrinology; cancer 
biology with particular reference to the 
structure and function of oncogenes; 
clinical pharmacology; and the biomed¬ 
ical applications of computers and of 
nuclear magnetic resonance spectroscopy 
to mention a few. 
Third, we must appraise and, where 
necessary, modify our curriculum for 
medical students particularly, but for 
our many other student constituencies as 
well. We should not accept a medical 
school basic science curriculum which is 
either too dense or too ossified. Course 
hours should reflect where medicine is 
going, not merely where it has been. I see 
a core curriculum as essential, but that 
core needn't be rigidly assigned to depart¬ 
ments nor should it deny the opportunity 
for electives. I believe our students should, 
as part of their educational core, be 
exposed to information concerning the 
place of medicine in our society via such 
topics as: biomedical ethics; medico¬ 
legal issues; and the economics of health 
care - from the vantage of provider as 
well as patient. If three semesters is not 
sufficient time to do this part of our 
teaching well, then let us consider going 
back to four. That would result in com¬ 
pression of the clinical curriculum. But 
if, as many argue, the fourth year is being 
wasted because students devote too much 
time to finding a house staff position or 
to proving themselves as subinterns, 
such compression may not be a bad idea. 
Our country is filled with voices urging 
modification of and experi¬ 
mentation with medical education. We 
are too visible and too able a school to 
act as the control group. 
Fourth, we must add to and modify 
the physical facilities in which we carry 
out our functions. In this regard, change 
will be particularly dramatic: renovation 
of space in the Boardman Building for a 
4 
i 
much expanded Yale Eye Center; erection 
of a new Faculty Practice Plan build¬ 
ing on the corner of Howard and Daven¬ 
port Avenues to permit our clinical 
faculty to see outpatients in an appro¬ 
priate setting; construction of a Magnetic 
Resonance Center below the LC1 building 
to permit expansion of programs in 
metabolic research, diagnostic imaging, 
and macromolecular characterization; 
renovation of space in the Tompkins 
stack for our newly established Section 
of Molecular Neurobiology. The latter 
project is nearing completion; the other 
three are scheduled to begin within the 
next few months. Other construction 
plans are only a bit further into the 
future. The Yale Psychiatric Institute 
will bring its widely recognized facility 
for inpatient management of patients 
with severe emotional disturbances back 
to the medical center. The medical library 
will be enlarged and modified to become 
a vanguard facility of its kind. Finally, 
and crucially, we need to construct a new 
laboratory research building on our 
campus — probably where the tennis 
court now stands — to provide an oppor¬ 
tunity for much needed growth in our 
outstanding laboratory research enter¬ 
prise whose facilities have expanded 
little in the past decade. 
These changes, and many others un¬ 
mentioned or even unimagined, will re¬ 
quire time, energy, and resources. Please 
do not equate the word “resources” with 
money. The most important resource we 
have to accomplish what is needed is you 
the human resource that is this faculty. 
You have always been responsive - 
sometimes even heroic — in your contribu¬ 
tions to this school. All of you full or 
part time, paid or voluntary, M.D. or 
Ph. D., clinician or basic scientist - must 
be prepared to continue, even to increase, 
those contributions — not just to your 
own research programs, or your teaching 
commitments, or your patient care activi¬ 
ties, or your sections, or your depart¬ 
ments, but to the institution as a whole. 
The other critical resource needed to 
move ahead boldly is monetary. For two 
years, a development advisory committee 
composed of senior faculty and appointed 
by Dean Berliner, examined the Medical 
School’s resources with a particular eye 
to the future. It concluded that the 
continued greatness of this institution 
depends on a major infusion of funds. 
That conclusion was accepted by Presi¬ 
dent Giamatti and the Yale Corporation 
who have agreed that the University 
mount a major capital campaign on 
behalf of the School of Medicine the 
first such campaign in the School’s his¬ 
tory. Within a few months, that campaign 
will be launched officially. Here is where 
it stands as of now: 
• the target has been set at 125 million 
dollars and the campaign duration at 
five years 
• the major financial goals have been 
set: 40 million dollars for endowment 
funds; 40 million for erecting new facilities 
or modifying existing ones; the remainder 
for a variety of programmatic needs 
including increased student aid, funds 
for laboratory equipment replacement, 
and seeding new academic ventures 
• the campaign director. Sue Dorn, 
has been appointed and has recruited her 
campaign staff 
•a New York firm has been com¬ 
missioned to prepare the case statement 
for the campaign and initial drafts of the 
words and layout have already been 
received. Completion of the statement is 
expected before Christmas 
• two key advisory committess, one 
composed of faculty members and an¬ 
other of major volunteers, have been 
fashioned and their membership nearly 
completed 
• more than 12 million dollars in gifts 
or pledges are already in hand and a 
major gift for the library renovation is in 
the offing 
In announcing this campaign to the 
alumni of the School of Medicine in 
June 1984, President Giamatti said, “1 
expect this campaign to be launched 
during the next academic year. 1 expect 
to work diligently toward its goals and 
ask each of you in your own ways to 
do the same. This is an effort for all of us 
by all of us. And, I expect the campaign 
to succeed.” 1 share the President’s 
feelings and will do all 1 can to help this 
noble effort meet its goals and perhaps 
even surpass them. 
That, my friends and colleagues of the 
faculty, is my initial assessment of the 
state of our school. 1 have much to learn 
about being a dean, but 1 already sense 
that the most difficult aspect will be to 
step back from a myriad of day to day 
issues and think about the school as a 
whole. As 1 attempt to lead this institu¬ 
tion, to conduct this fine orchestra 
with its many-toned, multi-voiced sec¬ 
tions of bedside clinicians and bench 
researchers, of surgeons and physicians, 
of clerks and technicians, of students 
and alumni, of deans and managers — 1 
know what I’ll be listening for. It is a 
sound rich and mellow enough for all to 
appreciate, yet unique enough for even 
the most discerning ear to recognize. 
Achieving that sound will not only be 
gratifying for us, it will enrich all 
mankind. 
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Dean Rosenberg 
“. . . if you join me in aspiring 
to be vibrant as well as vital, 
and to soar as well as be 
sound, then we must strive 
ever harder for excellence and 
be prepared for change. It is 
this challenge of change 
which I see as the major 
agenda item of my deanship, 
and it will take many forms. ” 
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CONTINUING THE SEARCH 
FOR SOLUTIONS TO 
INHERITED DISEASES 
AND DISORDERS 
Under the direction of Dr. Leon E. Rosenberg, who was chairman since its founding 
in 1972 until his appointment as Dean in July, the Department of Human Genetics 
has assumed a leadership role in the application of basic genetic knowledge to the 
probelms of human illness. With Dr. Carolyn Slayman as chairman, the Department 
continues to focus on the identification and explanation of the basic biochemical and 
genetic mechanisms responsible for specific diseases, as well as on the study of new 
methods of disease detection and treatment of patients. 
by Nissa Simon 
More than 1,600 different human disorders are caused by abnormalities 
-coding errors - that occur in any one of tens of thousands of genes, 
each of which carries the genetic blueprint for a single protein. These 
seemingly minor departures from the normal chemistry of the gene result in mental 
retardation, physical deformity, metabolic disorders and a host of other inherited 
disorders, some insignificant, others disastrous. 
In recent years, scientists have learned to diagnose some of these problems before 
birth and to read the genetic code in an effort to avoid the tragic consequences of 
these diseases. Members of Yale’s Human Genetics Department are among those 
scientists working to assure that eventually as many infants as possible will be born 
free of the burden of genetic diseases. Four of these scientists approach the problem 
from different levels. Dr. Roy W. Breg, Jr., professor of human genetics and 
pediatrics, and director of the diagnostic cytogenetic laboratory, is studying genetic 
diseases at the level of chromosomes. Dr. Kenneth K. Kidd, associate professor of 
human genetics and psychiatry, is involved in the relatively new science of human 
gene mapping. Dr. Maurice J. Mahoney, professor of human genetics, pediatrics 
and obstetrics and gynecology, is working on ways of identifying genetic problems 
during fetal life. Dr. Margretta R. Seashore, associate professor of human genetics 
and pediatrics, and director of the genetic consultation service, is attempting to 
quantify the risk of genetic illness even before conception. 
I’HOIOS BY WILLIAM CARTER 
In the late 1960’s, Dr. Breg and a 
colleague were the first to demon¬ 
strate that cells from amniotic fluid 
could be cultured and used to diagnose 
genetic problems prenatally. By the 
mid-1970’s, amniocentesis was a routine 
procedure. It remains a major tool for 
diagnosing genetic defects. 
Dr. Breg now studies chromosomes 
associated with a variety of health 
problems. “One of the largest groups 
we work with consists of couples where 
the woman has had multiple spontan¬ 
eous abortions and couples where the 
woman gave birth to an infant with a 
birth defect or congenital malformation. 
“When I speak of birth defects or 
malformations, I include a spectrum of 
abnormalities such as mental retarda¬ 
tion, multiple physical abnormalities 
and problems of incomplete sex differen¬ 
tiation. Not all of these have a chromo¬ 
somal basis, but many do,” said Dr. 
Breg. His laboratory is also developing 
techniques to pinpoint chromosomal 
imbalances that cause multiple abor¬ 
tions, which will permit more accurate 
counseling. 
Chromosomes must be studied using 
cells that are alive and dividing because 
only during mitosis do they contract so 
that they can be stained and photo¬ 
graphed. One of the recent advances in 
cytogenetics allows the study of cells 
during earlier stages of mitosis. 
“Before 1970. we could identify chromo¬ 
somes only by their length and by the 
position of the centromere. In many 
cases, we couldn’t distinguish between 
chromosomes within a certain group 
that were similar in length and the 
position of their centromere. When 
new banding techniques came along, 
we could begin to see the patterns that 
are specific for each type of chromo¬ 
some. This improved our method of 
detecting various abnormalities. But 
we knew at the time that we were still 
not seeing some deletions and trans¬ 
locations. 
“We realized that we would be able 
to see more if the chromosomes were 
longer, before they contracted for divi¬ 
sion. But these long chromosomes are 
difficult to work with because there are 
so many overlaps and bends. Gradually, 
we’ve been learning to work with longer 
and longer chromosomes,” said Dr. 
Breg. “The trick is to get them to spread 
enough so they're reasonably separate, 
which makes them easier to work with. 
But there’s a limit, because if you 
spread them too much, the cell breaks 
and loses chromosomes. If they’re not 
spread enough, you can’t distinguish 
them. So we try to strike a balance. 
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Dr. Breg 
“I wish the chromosomes were as 
neatly lined up in the cells as they are 
after we stain them, photograph them, 
cut them out of the photograph individu¬ 
ally and then line them up for their 
portrait. In a textbook they look very 
tidy, but in actuality, they look more 
like a bowl of spaghetti,’’continued Dr. 
Breg. 
As its name implies, the diagnostic 
cytogenetics laboratory is primarily respon¬ 
sible for providing clinical services. 
Because the work is so painstaking, not 
many other laboratories offer this tech¬ 
nique as a diagnostic service. 
Dr. Breg foresees some kind of com¬ 
puter-assisted analysis to help locate 
which cells are dividing. “We also hope 
to get help from a computer-based 
image analysis system to analyze the 
800 to 1,000 different bands per set of 
chromosomes,” he said. “There are so 
many genes in chromosomes that no 
one knows how many there are alto¬ 
gether, but even the smallest chromo¬ 
some surely must have more than 100 
genes.” The problem of identifying these 
individual genes is the task of 
gene mapping, the specialty of 
Dr. Kidd. DNA molecules form a 
continuous strand in each chromosome 
and the only way to distinguish a gene 
from a ‘spacer’ DNA between genes is 
by identifying the information content. 
“It’s like taking the 26 letters of the 
English language, some spaces, a few 
commas, some semicolons, colons and 
periods and putting them all into a 
random string. Insert a sonnet by Shake¬ 
speare into the stringand then continue 
with the gibberish. Someone who didn’t 
know English wouldn’t be able to recog¬ 
nize that there was something in there 
that made sense. If you tried to analyze 
it by any criterion other than informa¬ 
tion content, you couldn’t do it,” said 
Dr. Kidd. 
“If you know how to translate the 
information into the meaning, that is, 
the function of the gene, then you can 
find the gene. But for many diseases we 
only know the clinical signs, we don’t 
know the controlling mechanism, there¬ 
fore we don’t know the responsible 
gene. So we look for markers,” Dr. 
Kidd continued. 
Recently, researchers learned how to 
use restriction enzymes to cut DNA 
fragments. This new technique has al¬ 
ready permitted the discovery of a 
marker for the Huntington’s disease 
gene and will be used to locate markers 
technically known as restriction 
fragment length polymorphisms 
(RFLPs) — for several thousand other 
inherited disorders. These markers are 
included in the spacer DNA and are 
genetically determined. 
Each of the more than 100 known 
different restriction enzymes cuts at its 
specific nucleotide sequence known as 
a recognition site. All humans have 
millions of these sites and some vary 
from person to person. Any given site 
that is sometimes present and sometimes 
absent on a specific chromosome can 
serve as a marker. In a given family, if 
one parent has one chromosome with 
the site and one without it, the inheri¬ 
tance pattern can be observed. “If the 
disease gene is located in the part of the 
DNA close to the marker, we can often 
determine which child in the family has 
inherited the disease gene by looking at 
the inheritance pattern of this closely 
linked marker,” said Dr. Kidd. 
Because there is no way yet of predic¬ 
ting the form of the marker that goes 
along with a specific disease gene in any 
family, (that is, whether or not the site 
is present) scientists now test several 
generations of large families with inheri¬ 
ted diseases. 
“I’m studying a family for a dominant¬ 
ly inherited genetic form of cancer. We 
have DNA samples for the entire family. 
We know who has the gene and who 
inherited it from whom. We can now 
test all of these genetic markers until we 
find one that segregates with the cancer. 
And that will tell us that we have found 
a marker that is close by on the same 
chromosome. It won’t give us the gene 
for the cancer, but if we’re close enough, 
we can use it for prenatal diagnosis,” 
said Dr. Kidd. 
“The most dramatic evidence of the 
explosion of knowledge in this field is 
the discovery of these DNA markers,” 
continued Dr. Kidd. “The first genetic 
polymorphism a common, normal 
variation — in humans was discovered 
in 1900, and that was the ABO blood 
group system. By the mid-1960s, bio¬ 
chemical stains and starch-gel electro¬ 
phoresis had been developed and quite 
a few more polymorphisms were found. 
Dr. Kidd 
By 1978, perhaps 100 had been dis¬ 
covered, but only about 20 of them 
were common enough to be good 
markers. Most of the others happened 
so infrequently that although they were 
polymorphisms, they weren’t useful. In 
1978, the first of the DNA polymor¬ 
phisms was discovered. By 1979, there 
were three that were known, mostly 
near the hemoglobin region. By 1981, 
we knew about 26 of them. Last summer, 
156 had been tabulated. No one has 
done a tabulation in the last year, but 
its probably close to 500 by now. The 
number is tripling each year.” 
All of these variants are inherited 
and it may be that as many as one out 
of every 100 base pairs in spacer DNA 
shows such a variation. That’s on the 
order of 3 X 107 potential markers. 
“They’re everywhere, all over the chro¬ 
mosomes,” continued Dr. Kidd. “Any¬ 
where anyone has looked, they’ve found 
polymorphisms. It's a whole new ball 
game.” 
Mapping the human genome is impor¬ 
tant because it is a necessary first step. 
“It will enable us to learn a phenomenal 
amount about human biology, what 
makes us what we are and how we 
function. We'll learn about human be¬ 
havioral disorders and psychiatric disor¬ 
ders. There are more genes active and 
devoted to the function of the brain 
than to any other part of the body. 
There may be 30,000 to 50,000 different 
genes required only for the functioning 
of the brain. These are genes that aren’t 
used in the fingernails or kidney or 
heart or muscles or bone. They are 
genes devoted only to the brain, geneti¬ 
cally the most complex part of the 
human body. So genes offer an exciting 
approach to finding out how the brain 
functions and how it goes awry,” con¬ 
cluded Dr. Kidd. Research at the level of genes 
and chromosomes done in lab¬ 
oratories like Dr. Breg’s and 
Dr. Kidd’s provides the kind of informa¬ 
tion used in clinical settings such as 
Drs. Mahoney and Seashore. 
“I’m involved in diagnosing disease 
during fetal life,” said Dr. Mahoney. 
“Asking questions about an unborn 
baby’s health has become such a com¬ 
mon elective procedure for pregnant 
women that we have to screen large 
groups of women to narrow the group 
to a manageable one. Then we apply 
more invasive or more expensive diag¬ 
nostic techniques where necessary.” 
These techniques include amniocen¬ 
tesis or chorionic villus biopsy, a new 
technique for obtaining fetal cells for 
Dr. Mahoney 
“We at Yale have a diverse 
faculty that looks at many 
aspects of human genetics and 
works together in a cooperative 
setting. The willingness to push 
forward and to be innovative 
have always been hallmarks of 
this department. We’re now at a 
period when we can see the 
possibility of some exciting 
therapies for genetic diseases, 
and we have people working 
actively in those directions. ” 
prenatal diagnosis. Dr. Mahoney is 
principal mvestiator at Yale in a four- 
year collaborative clinical trial asses¬ 
sing the safety and accuracy of chorionic 
villus biopsy. Six other medical centers 
in the country are participating in the 
study funded by the National Institute 
of Child Health and Human Develop¬ 
ment (NICH HD). 
Unlike amniocentesis, which relies 
on culturing fetal cells found in the 
amniotic fluid, chorionic villus biopsy 
samples fetal tissue directly through 
the cervix. The procedure provides a 
larger tissue sample than amniocentesis, 
can be done much earlier in pregnancy 
and gives faster results. 
Using a catheter and guided by ultra¬ 
sound, the physician suctions off a 
small plug of tissue from one or more 
villi, protrusions of the chorion. Where 
the villi grow and attach to the inner 
surface of the womb, the early chorion 
matures to form the placenta. Other 
villi grow into the membranous chorion, 
which lies outside the amnion as part of 
the fetal membranes. The tissue can be 
analyzed for defects immediately be¬ 
cause it constitutes a dense sample of 
rapidly dividing cells. 
Chorionic villus biopsy permits test¬ 
ing during the first three months of 
pregnancy and yields results within 
days, whereas amniocentesis is not rou¬ 
tinely performed before the 15th week 
of gestation and doesn't yield results 
for another two weeks. 
“To move prenatal diagnosis back 
from the middle of the second trimester 
to the eighth, ninth or tenth week of 
pregnancy has major benefits,” said 
Dr. Mahoney. “One of the major draw¬ 
backs of amniocentesis is that of having 
to face a second-trimester abortion 
decision if serious fetal disease is dis¬ 
covered. The possibility of obtaining 
that same information earlier in preg¬ 
nancy shifts the decision to a first- 
trimester abortion using suction aspira¬ 
tion. 
“The dangers of chorionic villus 
biopsy and the risks to both the unborn 
baby and the woman still must be 
established. It’s doubtful that the risks 
will be as low as those in amniocentesis. 
That will mean a significant decision. A 
pregnant woman will have to ask herself 
whether she wants an early diagnosis 
with a somewhat higher risk of mis¬ 
carriage or a later diagnosis with a low 
chance of losing the baby. At the 
moment, the risk estimates of mis- 
carriaae are in the ranee of two to five 
percent. We expect it to drop, just as 
the risks for amniocentesis dropped. 
But most of us doubt that the risks will 
soon be as low as those for amnio¬ 
centesis,” Dr. Mahoney said. Whereas Dr. Mahoney is con¬ 
cerned with early diagnosis 
of genetic diseases. Dr. Sea¬ 
shore attempts to identify the prospects 
of a genetic disease even before 
conception. 
“Most families come to see us because 
of a child who is mentally retarded or 
who has a birth defect,” she said. “The 
family wants to know why it happened, 
will it happen again with another child, 
and what will happen with this child. 
“We also have people come in who 
know that a family member suffers 
from what is believed to be a genetic 
condition and would like to know 
wheter it runs in the family. They may 
tell us about a brother who has muscular 
dystrophy, or an uncle who has hemo¬ 
philia, or a cousin who has epileptic 
seizures and they want to know if they 
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themselves or their children might have 
the disease.” 
The first thing Dr. Seashore does is 
attempt to confirm the diagnosis. “There 
are many different kinds of genetic 
problems and if we don't know the 
exact problem, we’re sunk. We have to 
corroborate the diagnosis ourselves, so 
it’s important that we’re diagnosticians 
as well as genetic counselors. 
“That may sound distrustful, and I 
certainly don’t mean to imply that we 
don’t trust the rest of the medical 
community, but we've all seen cases 
that on first blush look like one thing 
and then turn out to be something 
different,” Dr. Seashore explained. “In 
many cases scientific knowledge has 
progressed since the diagnosis was first 
made and there are now better tests and 
better ways of ascertaining just what 
Dr. Seashore 
kind of genetic problem it is. 
“Achondroplasia, for instance, is one 
of a group of diseases that have to be 
distinguished from one another. Hurler’s 
syndrome is now recognized to be one 
of at least ten different mucopolysac¬ 
charide storage diseases, some of which 
are inherited in a recessive way and one 
of which is inherited on the X chromo¬ 
some. Each has a different biochemical 
defect, so it's important to distinguish 
them for purposes of prenatal diagnosis. 
There are many examples of that kind 
of similarity and the more we learn, the 
more there seem to be. In fact, it’s 
almost become a rule that many things 
that look similar may be biochemically 
or genetically distinct,” she said. 
When patients come in to the clinic, 
the first person they see is the genetic 
counselor who also serves as clinic 
coordinator. She obtains the necessary 
medical records that tell what tests 
have been done. “We try not to do any 
more tests or x-rays than are absolutely 
necessary. It’s costly, sometimes uncom¬ 
fortable and perhaps, even risky for the 
patient,” said Dr. Seashore. 
During ensuing visits, the physician 
responsible for the diagnosis and care 
interprets the tests and explains the 
results. Once the family receives the 
needed information, they must then 
decide what to do. “They may decide 
this isn’t the time to have a child and 
would like to think about it for a while. 
Then they may come back in a couple 
of years and ask whether anything has 
changed or whether there's any new 
information. Or, they may decide to go 
ahead with a pregnancy,” said Dr. 
Seashore. “Then we arrange for prenatal 
diagnosis when that’s possible and the 
family wants it.” 
Another part of Dr. Seashore’s clini¬ 
cal service involves caring for children 
with inborn errors of metabolism. For 
instance, all infants in Connecticut are 
screened for PKU after birth. There are 
several different kinds of PKU, each of 
which requires a different treatment. 
One must be treated by dietary restric¬ 
tions; one doesn’t require treatment 
beyond the first few years of life, and 
yet another kind needs treatment with 
neurotransmitters and vitamin cofac¬ 
tors. “Within the first few weeks we can 
tell which kind of PKU it is,” said Dr. 
Seashore, “and treat it accordingly.” 
Dr. Seashore’s service is part of the 
Connecticut Genetic Services Program, 
a coordinated effort of Yale, the Univer¬ 
sity of Connecticut and the State Health 
Department. The consultation clinics 
are not all located at Yale. The Yale 
School of Medicine is also responsible 
for the supervision of three genetic 
counseling clinics at community hos¬ 
pitals in Danbury, Norwalk and Bridge¬ 
port. 
“Our center is also very active in the 
New England regional genetics group. 
Members from all over New England 
meet regularly to discuss new develop¬ 
ments and coordinate services,” said 
Dr. Seashore. “We can work together 
to try to help a family with members 
scattered throughout New England in¬ 
stead of having isolated groups trying 
to solve the problem separately.” 
Members of the Genetic Consultation 
Service have faculty appointments in 
the Department of Human Genetics. 
“We take our places as full members of 
the department in research and teach- 
ing,”said Dr. Seashore. “All of us feel a 
scholarly commitment to the academic 
part of the department. It’s exciting to 
work with basic scientists on a daily 
basis. And, having us around helps 
them see problems from a different 
perspective. 
“Teaching is an important part of 
our job. 1 feel a strong commitment to 
teaching and to helping students 
whether or not they eventually specialize 
in genetics,” she continued. “Although 
it doesn’t always seem obvious to pa¬ 
tients, we know that having people in 
training asking questions and seeking 
the latest information improves the 
level of care for patients.” 
What’s ahead? 
“We’ll get better at diagnosis. We're 
now able to identify finer chromosome 
structures so that we’ll improve our 
ability to locate genes, recognize them 
and identify mutations that we cannot 
now identify. We’ll get better at telling 
people whether or not they carry a 
specific gene that puts them at risk,” 
predicted Dr. Seashore. 
“What’s the next really big step? 
Manipulating a defective gene to make 
it work by fixing it or replacing it. We 
talk a lot about replacing the protein 
that’s missing because the gene is mal¬ 
functioning. But it’s clear that we have 
a great deal more ot learn about how to 
do that and we cannot go forward at all 
without a lot of very careful basic 
resarch,” Dr. Seashore concluded. 
“This is an exciting time in the 
history of medicine,”said Dr. Mahoney. 
“Knowledge of genetic disease is ex¬ 
ploding. We at Yale have a diverse 
faculty that looks at many different 
aspects of human genetics and works 
together in a cooperative setting. The 
willingness to push forward and to be 
innovative have always been hallmarks 
of this department. We’re now at a 
period where we can see the possibility 
of some exciting therapies for genetic 
diseases, and we have people working 









by Marje Noyes 
ome of the most remarkable 
progress in medicine over the 
past ten years has been made in 
the relatively young field of perinatol¬ 
ogy. Disorders caused by chromosomal 
abnormalities, as well as an increasing 
number of genetically transmitted dis¬ 
eases and structural abnormalities can 
be detected prenatally, and perinatolo¬ 
gists are beginning to be able to success¬ 
fully treat some of these disorders in 
utero. 
A number of advances in all aspects 
of this new field are due in large part to 
pioneering research by members of the 
Comprehensive Maternal Care Unit at 
Yale, which has been under the direction 
of Dr. John C. Hobbins, professor of 
obstetrics and gynecology and diagnos¬ 
tic radiology, since it was founded ten 
years ago. One of the leading fetal 
medicine/ perinatal diagnosis programs 
in the world, the Unit’s reputation is 
based on its contributions to the develop¬ 
ment of fetoscopy and other diagnostic 
procedures involving ultrasound, as 
well as for its superb care of mothers 
whose pregnancy is at risk. Their accom¬ 
plishments are the result of truly close 
collaboration with researchers in human 
genetics, diagnostic radiology, obstetrics 
and gynecology, pediatric cardiology 
and surgery. 
“Women come here literally from all 
over the world to find out if an illness 
or condition present in the family or a 
previous pregnancy will recur,” said 
Inge Venus, pointing to a large map of 
the world marked with colored pins in 
countries as far away as South Africa, 
the Fiji Islands, India and Europe. A 
clinical studies researcher in the Depart¬ 
ment of Obstetrics and Gynecology, 
Ms. Venus has been a member of the 
Unit’s staff since its beginning, and has 
witnessed the rapid advances in prenatal 
diagnosis which are giving parents op¬ 
tions unheard of as little as ten years 
ago. 
Twenty-seven in every thousand 
babies in the United States are 
born with some kind of defect, 
according to Dr. Hobbins. The Unit 
has the capability to accurately diag¬ 
nose, and in some cases, treat in utero 
from ten to 15 of those problems. 
Dr. Hobbins and Dr. Maurice J. 
Mahoney were leaders in the develop¬ 
ment of fetoscopy, a method of intra¬ 
uterine visualization requiring neither 
laparotomy nor general anesthesia, as 
well as new techniques combining fetos¬ 
copy and ultrasound, for fetal blood 
sampling and skin biopsy. These tech¬ 
niques have expanded the number of 
fetal problems that can be diagnosed 
by amniocentesis to include hemoglobin¬ 
opathies, deficiencies of certain clotting 
proteins, and other errors of meta¬ 
bolism, as well as congenital abnormal¬ 
ities occurring in repeated pregnancies, 
such as spina bifida cystica. 
Yale-New Haven is one of only tour 
or five medical centers in the U.S. to 
offer fetoscopy. “Our purpose is to 
avoid needless abortions,” explained 
Ms. Venus, who is responsible for 
reviewing the patients’genetic situation, 
and for giving them and their families 
necessary' information and support. “Be¬ 
fore fetoscopy, a couple at risk for a 
sex-linked disease such as hemophilia 
would have amniocentesis, and if they 
found the fetus was a male, they would 
automatically consider abortion,” she 
explained. “Sometimes these were per¬ 
fectly healthy babies. Fetoscopy saves 
these healthy fetuses.” 
Drs. Mahoney and Hobbins think of 
fetoscopy as more than a diagnostic 
tool. “1 think it will be part of the path 
to new therapeutics as well as diagnostic 
techniques - access to the unborn 
baby we never had before,” predicted 
Dr. Mahoney. 
Drs. Hobbins and Mahoney have 
collaborated on a number of procedures 
involving human genetic and diagnostic 
radiology techniques. They are currently 
participating in a nationwide study to 
test the accuracy as well as the risk 
factors of a new technique, chorionic 
villus biopsy, for obtaining fetal cells 
for prenatal diagnosis (See preceding 
article on the Department of Human 
Genetics —page 6). 
Literally hundreds of women are 
referred to the Unit from the New 
Haven area, and from all over the U.S. 
and abroad for testing for conditions 
ranging from Down’s syndrome to limb 
and structural abnormalities and ob¬ 
structive uropathy. The Unit is a major 
referral center for women suspected of 
bearing hydrocephalic fetuses, who 
come here to learn whether or not the 
condition can be treated prenatally; 
and it conducts one of the most active 
maternal serum alpha fetal protein 
screening programs in the nation. 
“We are able to definitely determine 
whether the fetus has a spinal defect, 
and if so, the size and precise location 
of that defect,’’explained Dr. Hobbins. 
“Indirectly, we are being asked what 
the quality of life is going to be for 
those babies. If the defect is low on the 
spine, there is a chance for surgical 
repair; if it is high, there is very consider¬ 
able risk for severe paralysis.” In collaboration with Dr. Charles 
Kleinman, associate professor of 
pediatrics and diagnostic radiology, 
the Unit has been at the forefront in 
developments in fetal cardiology. Cap¬ 
able of diagnosing a large number of 
fetal cardiac anomalies of the gross 
structure of the heart, they are also 
doing research in the diagnosis and 
treatment of cardiac function. 
Cardiac defects are a major problem 
affecting fetuses, according to Dr. Hob¬ 
bins. About eight in every 1.000 fetuses 
have a cardiac problem. 
For instance, fetal immune ideopathic 
hydrops has long been associated with 
interuterine death, with the exact cause 
unknown. “We found a cardiac reason 
in 13 of the first 16 patients referred to 
us with this diagnosis,” said Dr. Hob¬ 
bins. “The heart was structurally sound, 
but the beat was irregular, causing 
inadequate blood How, and eventually, 
an excessive buildup of fluids.” 
After typing the various fetal heart 
arrhythmias. Dr. Kleinman began treat¬ 
ing the condition by giving the mothers 
digitalis, or in more severe cases, similar 
but more effective newer drugs. “In a 
majority of cases, we were able to keep 
the fetus alive until it was mature 
enough to be delivered, and in some 
cases, we reversed the hydrops,” said 
Dr. Hobbins. 
A large portion of current research is 
directed toward monitoring fetal growth 
and nourishment, in an effort to circum¬ 
vent problems caused by living in an 
unsuitable or alien uterine environment. 
“We think the key may be fetal blood 
flow,”commented Dr. Hobbins. “There¬ 
fore, we are directing a large part of this 
research into evaluating blood flow in 
normal and in undergrown fetuses.” 
Dr. Hobbins and his colleagues have 
developed ways to measure the limbs, 
abdomen and head of fetuses, and even 
to determine their approximate weight, 
based on formulas designed in the 
Unit. These data, plus observations by 
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ultrasound of fetal behavior such as the 
character of movement, the r.e.m., 
breathing and the like, give clues as to 
whether or not the fetus is undernour¬ 
ished and suffering from relative as¬ 
phyxia or hypoxia. 
The fetal diagnosis program is a non¬ 
stop operation, starting early in the 
morning and going on well into the 
evening. At least 20 women are seen 
each day. The majority come only once 
or twice for diagnostic procedures and 
consultation, but others require further 
care, either on an outpatient or in¬ 
patient basis. The high-risk outpatient program 
is extremely active. There are 
special programs designed especi¬ 
ally for pregnant women who are dia¬ 
betics, as well as for those who are 
hypertensive or who are Rh sensitive or 
toxemic. 
“In the diabetes program we monitor 
both the fetal development and the 
blood sugar of the mother. We have 
spent a great deal of effort on developing 
ways to control the blood sugar level of 
the mothers in order to avert some of 
the problems that infants of diabetics 
are subject to,’’explained Dr. Hobbins. 
The survival rate of infants of diabetics 
has increased dramatically over the 
past ten years, as a result. A few years 
ago, perinatal mortality for infants of 
diabetic mothers was almost 50 percent; 
today, the survival rate for these babies 
is almost the same as those of non¬ 
diabetic mothers, according to Dr. Hob- 
bins. “Similarly, through research we 
are able to identify a certain population 
of women who are at risk for hypertension 
in pregnancy and intervene by pre¬ 
scribing medication and bedrest.” 
The new Maternal Special Care Unit 
was created for patients with acute 
complications of pregnancy - either a 
fetus at risk, or a mother with a serious 
illness such as pneumonia or liver dis¬ 
ease. Directed by Dr. Peter Grannum, 
assistant professor of obstetrics and 
gynecology, it is staffed 24 hours a day 
by a team of specially trained nurses 
who offer the kind of care that generates 
a great deal of enthusiastic fan mail 
from former patients. 
Because many of the infants born to 
high-risk mothers will spend some time 
in the Newborn Special Care Unit, the 
Maternal Special Care Unit is located 
adjacent not only to the prenatal diag¬ 
nostic facilities, but also to the Newborn 
Unit. Physicians of the Newborn staff 
have joint appointments in obstetrics 
and gynecology, and become involved 
in the care of their prospective patients 
several weeks prior to their delivery. 
“We consult with parents to tell them 
what to expect, and work closely with 
the staff of the Maternal Special Care 
Unit, as well as with others who may be 
involved, to coordinate the delivery,” 
said Dr. Richard Ehrenkranz, clinical 
director of the Newborn Special Care 
Unit. 
Dr. John Hobbins, left, and his 
colleagues are developing new 
procedures to obtain samples of 
fetal liver and kidney tissue and 
pure fetal blood. “The 
excitement comes in what 
geneticists like Dr. Mahoney can 
do with these samples, using 
new techniques to diagnose 
problems, such as cystic fibrosis, 
that have frustrated us, and 
ultimately, using some of these 
same tools to treat many more 
problems prenatally. ” 
Research and advances in pre¬ 
natal diagnosis and care aren’t 
limited to the third floor of the 
Yale-New Haven Hospital. Physicians 
come here from around the country to 
attend training courses given bi-monthly 
in ultrasonography. Every year, two or 
three postdoctoral fellows from medical 
institutions abroad come for a year or 
two for training or research. “Having 
visitors from other institutions creates 
a stimulating environment here,” said 
Dr. Hobbins. “This is a very exciting 
field to be in right now. We’re making 
progress — and we have a way to go.” 
Looking to the future, he described 
current research that seeks to find safe 
and accurate ways to obtain samples of 
fetal liver and kidney tissue, and a new 
procedure he is working on to obtain 
pure fetal blood. “The excitement comes 
in what geneticists like Dr. Mahoney 
can do with these samples, using new 
enzyme and DNA techniques, and leuk- 
age techniques to diagnose problems 
that have baffled us, such as cystic 
fibrosis and muscular dystrophy,” he 
said. “And, ultimately, using some of 
these same tools to treat many more 
problems prenatally. 
“For instance, it may well be possible 
to inject a clone of cells from a normal 
fetus into the blood stream or directly 
into the liver of a fetus who is dying 
because it is missing an enzyme,” he 
continued. “As a result, that fetus will 
start producing these cells, which will 
multiply and the tissue will regenerate. 
In time, normal genes will produce 
normal enzymes in that fetus.” 
Thus, one of the foremost prenatal 
diagnosis/fetal medicine programs in 
the world looks to the future in its 
research to improve not only the survival 
rate , but also the quality of of life for 
fetuses with severe problems. 
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After more than twenty years, 
ongoing research and the 
latest in technology combined 
with professionalism and 
dedication remain the heart 
of the first and one of the 
finest newborn intensive care 
units in the world. . . 
Despite the bright balloons floating above and the cuddly toys in every isolet, 
it is obvious at once that the mission here is extremely serious. Against a 
background of the insistent wails typical of newborns and the steady hum 
and beep of hi-tech life support systems, teams of nurses maintain a constant 
vigil over their tiny patients. 
A mother, scrubbed and gowned, lovingly feeds her baby, so fragile it 
hardly seems possible that he is able to take nourishment from the bottle. A 
doctor quietly consults with parents as they peer anxiously at their infant 
daughter, attached by many wires to monitoring equipment surrounding her 
isolet. The phone rings — and within minutes after the message is relayed, a 
crisis transport team is mobilized and on its way to bring in a critically ill 
newborn from a hospital 25 miles away. 
The first of its kind in the country, the 44-bed Newborn Special Care Unit 
has earned a reputation of outstanding research in the cause and treatment of 
critical problems affecting premature infants. It has served as a model for 
similar units in hospitals throughout the world. 
Almost 150 of the more than 1,000 infant patients last year were brought 
to the Unit from hospitals throughout Connecticut and from nearby states. 
Another 150 were born to high-risk mothers who were patients in Yale’s 
Maternal Special Care Unit. 
This prototype intensive and special care unit for prematures and 
newborns was founded in 1960 by Dr. Louis Gluck, who is now professor of 
pediatrics and reproductive medicine at the University of California, San 
Diego. “Knowing what constituted intensive care was difficult, lacking as we 
did, both guidance and precedent. Part of our work had to extend to the 
delivery room,” he wrote in an article in Yale New Haven on the occasion of 
the Unit’s twentieth anniversary.“We adapted existing adult and pediatric 
intensive care techniques to prematures and newborns. We developed 
transport procedures for patients from outlying hospitals and experimented 
with different architectural schemes, learning that babies received better care 
in large rooms rather than in the little cubicles prescribed by law. . .” 
During those first few years, the basis for intensive care for newborns 
slowly developed. “We knew little of electrical hazards or of sophisticated 
techniques,” said Dr. Gluck. 
In 1962, Dr. Edward Hon, one of the leaders in the development of 
electronic fetal monitoring, returned to the Yale Department of Obstetrics, 
and with Dr. Gluck, founded the first known perinatal unit with joint 
training of residents and fellows. 
“What incredible excitement there was in those days!” wrote Dr. Gluck. 
“Every day we developed more confidence and sophistication. This was 
infectious, and soon pediatric and obstetric residents began to appreciate the 
great opportunites of this new frontier: perinatal medicine.” 
Today, with Dr. Ian Gross, associate professor of pediatrics and obstetrics 
and gynecology, as director, and Dr. Richard Ehrenkranz, associate 
professor of pediatrics and obstetrics and gynecology, as clinical director, 
the Unit has a staff of four full-time physicians, four postdoctoral fellows 
and seven house officers. Ongoing nursing care is provided by a staff of 
almost eighty nurses under the direction of Jeryl Gagliardi, assistant clinical 
director of pediatrics. 
The largest tertiary neonatal center in 
Connecticut, the Newborn Special 
Care Unit is a referral center for 
critically ill newborns from nearby 
towns and cities in Rhode Island, 
New York and Massachusetts. Within 
a very short time, two members of a 
specially trained and equipped 
nursing team are mobilized to safely 
transport these infants to the Unit. 
The twelve-nurse transport team, 
on call 24hours a day, 365 days a 
year, is prepared to perform 
important life-supporting procedures 
including intubation, initiation of 
ventilatory assistance, and 
interpretation of x-rays, arterial 
blood gases and other clinical and 
















The population of patients on the 
Unit is quite different from that of 
twenty years ago, when babies stayed 
there until they were well enough to 
go home. 
“ We are much more of a critical 
care nursery now, ”said Jeryl 
Gagliardi, director of the nursing 
staff, who has been on the Unit since 
the beginning. 
As soon as they pass the critical 
phase, babies are transferred into a 
less intensive area of the Newborn 
Special Care Unit. Referral infants 
are returned to the hospital they came 
from once the level of care required is 
compatible with the care provided in 
the community hospital. 
Today families are encouraged to 
be active participants in their infant ’s 
care. This family involvement really 
has changed since 1962, when there 
were many restrictions governing 
what parents were allowed to do. “ We 
have become more and more liberal 
over the years, "commented Ms. 
Gagliardi. 
Parents are encouraged to visit 
even the most critically ill infants as 
often as they like, day and night. “ We 
even suggest they bring in their other 
children. If a mother and father are 
worried about the baby here, it's 
better for the siblings to see the sick 
baby, "she explained. “It helps them 
understand the source of their 
parents ’ worry. ” 
Nurturing, too, is encouraged. A 
rocking chair is by every isolet. 
Mothers can cuddle and feed their 
babies, and in time, even bath them. 
“As our understanding of the 
physiology of the very small 
premature infant has increased, we 
have become much more aware of the 
nutritional needs of these babies, ” 
observed Dr. Richard Ehrenkranz, 
associate professor of pediatrics and 
obstetrics and gynecology, and 
clinical director of the Unit. In 
collaboration with Barbara 
Ackerman, R.N., he has conducted 
research on human milk and on the 
ability of premature infants to absorb 
dietary nutrients. 
Their research has demonstrated 
that milk produced by mothers of 
preterm infants contains as much as 
20 percent more protein for four to 
six weeks after birth than does the 
milk of mothers of full term babies. 
Although it is not known precisely 
why this is, the extra protein may 
have a decided advantage for the 
growth of preterm babies who are fed 
their own mother's milk. In addition, 
this research has shown that preterm 
human milk changes as the duration 
of lactation increases, and that some 
nutrients, such as calcium and 
phosphorus, might not meet the 
nutritional needs of the growing 
premature infant. 
Coincidental to these findings is an 
increasing move toward feeding 
mother’s milk to premature infants — 
a trend some mothers feel is not only 
important to the health of their baby, 
but also important to the nurturing 
process. Milk is expressed by the 
mothers and stored in containers in 
the Unit’s freezer until the baby is 
able to be bottle fed. Then, it is given 
in the sequence in which the mother 
has expressed it. 
“Are we going to reach a limit in 
terms of the viability of very low 
birthweight infants?"pondered Dr. 
Ehrenkranz. 
During the last 20 years physicians 
and nurses in neonatology have 
witnessed some of the most dramatic 
changes in the recent history of 
medicine. Less than a decade ago, the 
survival rate of infants weighing two 
pounds was less than ten percent. 
Today, approximately 70 percent of 
these babies survive with a prognosis 
for a quality of life that is generally 
very good. 
“Now we care for infants who 
weigh one to one-and -a half- pounds. 
The survival rate for these infants is 
not very high— and some who 
survive have multiple problems. 
Those without multiple problems do 
very well, ” according to Dr. 
Ehrenkranz. “ This is due not only to 
refinements in technology, but also to 
our increased knowledge of the 
pathophysiology of the smaller and 
smaller infant. 
"The challenge today is how to 
improve their care — to better 
ventilate them, to nourish them, and 
to deal with or prevent problems 
technology sometimes cause, ”he 
added. “ The greatest challenge, 
ofcourse, is to prevent prematurity. ” 
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Research has contributed important 
new knowledge on a number of fronts 
in the care of premature infants. 
Much of the work at Yale has 
focussed on fetal lung development. 
Dr. Ian Gross, director of the Unit, 
(at left in photo below) is widely 
recognized for his research on 
respiratory distress syndrome, (RDS) 
a major problem of prematurity. The 
mortality rate for RDS has decreased 
dramatically in the last 20 years, due 
in large part to advances in the ability 
to ventilate premature infants until 
their lungs are capable of taking on 
the task. Nevertheless, prolonged 
ventilation causes chronic lung 
disease. RDS is also associated with 
an increased incidence of brain 
hemorrhage as well. 
RDS of the newborn is believed to 
be caused by immaturity of the fetal 
lung, particularly the pulmonary 
surfactant system. Research by Dr. 
Gross and his colleagues suggests that 
fetal lung development, including the 
maturation of the pulmonary 
surfactant system, is under multi- 
hormonal control. 
Tissue culture and animal studies 
have shown that some hormones act 
synergistically to promote the 
production of pulmonary surfactant 
during fetal life. This observation will 
soon be tested in a collaborative 
clinical trial involving Yale and three 
other major medical centers. It is 
hoped that administering a 
combination of hormones to women 
in premature labor, one day prior to 
delivery, will prevent the development 
of RDS in their offspring. 
“ You can V help getting involved when 
you take care of these babies and 
interact with their parents, ” observed 
Dr. Ehrenkranz, (above). “But it’s 
important to maintain a sense of 
objectivity so that when an infant 
doesn t do well or dies, one can ‘get 
back on the horse’, doing the best for 
other infants. ’’ 
“The rewards are the kids. Seeing 
them when they come back for visits 
one, two or three years later. They ’re 
great, ” he said. “I still correspond 
with twin boys I took care of ten 
years ago. They live in the mid-west 
now. ” 
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DR. PERKINS APPOINTED 
CHAIRMAN OF 
PHARMACOLOGY 
The Yale Corporation has appointed 
Dr. John P. Perkins professor and 
chairman of the Department of Pharma¬ 
cology, effective January 1, 1985. Wide¬ 
ly recognized as a superior administra¬ 
tor, teacher and researcher. Dr. Perkins 
has been professor and chairman of the 
Department of Pharmacology at the 
University of North Carolina School of 
Medicine in Chapel Hill, since 1977. 
“The appointment of John Perkins 
to chair the Department of Pharma¬ 
cology is extremely important to the 
School of Medicine," said Dean Leon 
E. Rosenberg. “He has demonstrated 
outstanding leadership during the past 
seven years as chairman of Pharma¬ 
cology at the University of North Caro¬ 
lina, while remaining among the na¬ 
tional and international leaders in his 
scientific field concerned with regulation 
of the adenylate cyclase system by 
hormones and neurotransmitters.” 
Dr. Perkins’ research is of broad 
pharmacological significance, particu¬ 
larly to studies of the neuronal and 
hormonal regulation of cardiac function 
and blood pressure, as well as for 
research on cancer cell growth. A gradu¬ 
ate of Arizona State University, where 
he received a B.S. degree in chemistry 
in 1960, and an M.S. degree in biochem¬ 
istry in 1962, he received his Ph.D. 
degree in pharmacology from Yale 
Univeristy in 1966. 
Following a postdoctoral fellowship 
in the Department of Biochemistry at 
the University of Washington in Seattle, 
he was appointed assistant professor of 
pharmacology at the U niversity of Color¬ 
ado Medical Center in Denver in 1968, 
and was promoted to associate professor 
in 1974. In addition to a Merck Faculty 
Development Award, he held a Re¬ 
search Career Development Award of 
the U.S. Public Health Service and the 
National Cancer Institute from 1972 
until 1977, when he was appointed 
professor and chairman of pharmaco¬ 
logy at the University of North Carolina. 
Dr. Perkins is co-founder of the 
Journal of Cyclic Nucleotide Research, 
and serves on the editorial boards of 
Molecular Pharmacology and the Jour¬ 
nal of Nucleotide Research. He is a 
member of the American Society for 
Pharmacology and Experimental Thera¬ 
peutics, the American Society for Bio¬ 
logical Chemists and the Association 
for Medical School Pharmacology. 
Dr. Perkins succeeds Dr. Alan C. 
Sartorelli, who has been chairman of 
the Department since 1977. A leading 
cancer investigator. Dr. Sartorelli was 
appointed director of the Yale Compre¬ 
hensive Cancer Center a year ago. 
Dr. Janerich 
Mrs Dorn 
FIRST ROBERT W. BERLINER 
PROFESSOR NAMED 
Dr. Barry L. Zaret, professor of medi¬ 
cine and diagnostic radiology, has been 
appointed the first Robert W. Berliner 
Professor of Internal Medicine. The 
Chair was created in honor of the 
former Dean of the School of Medicine 
on his retirement last June, in recogni¬ 
tion of his many contributions to sci¬ 
ence, to Yale and to this country. 
Internationally recognized for his 
pioneer research in nuclear cardiology 
and cardiac imaging and for his studies 
of heart function. Dr. Zaret is also chief 
of the Section of Cardiology at the 
School of Medicine and director of one 
of three NIH-sponsored core labora¬ 
tories in the U.S. for collaborative 
clinical trials of a new treatment of 
acute heart attack. The National Insti¬ 
tutes of Health awarded Yale $ 1.5 mil¬ 
lion for its participation in the trials. 
Dr. Zaret received his B.S. degree 
cum laude from Queens College in 
1962, and his M.D. degree from New 
York University School of Medicine in 
1966. Following internship and residen¬ 
cy at Bellevue Hospital, he was ap¬ 
pointed National Heart, Lung, Blood 
Institute Special Research Fellow in 
the Department of Medicine at The 
Johns Hopkins University School of 
Medicine from 1969 to 1971. Hejoined 
the Yale medical faculty as assistant 
professor of medicine in 1973, following 
two years of military duty as a major in 
the USAF Medical Corp. He was ap¬ 
pointed assistant professor of diagnostic 
radiology the next year, and was pro¬ 
moted to associate professor of medicine 
and diagnostic radiology in 1976. He 
was named professor in 1982. 
An associate editor of the Yearbook 
of Nuclear Medicine, Dr. Zaret serves 
on the editorial boards of several other 
professional journals, and is a fellow of 
the American College of Cardiology, 
the Council on Clinical Cardiology and 
the Council on Circulation of the Ameri¬ 
can Health Association. 
DR. JANERICH APPOINTED 
Dr. Dwight T. Janerich has been ap¬ 
pointed professor of epidemiology and 
cology), as well as associate director for 
cancer control and prevention at the 
Yale Comprehensive Cancer Center. In 
addition, he has been named director 
of the Connecticut State Tumor Regis¬ 
try, the oldest such registry in the 
United States. 
Widely recognized for his contribu¬ 
tions to knowledge of the epidemiology 
of cancer and birth defects. Dr. Janerich 
will be program director for training in 
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cancer epidemiology in the Department 
of Epidemiology and Public Health, 
and will coordinate the development of 
a cancer control research program of 
the Department and the Cancer Center. 
Prior to his appointment, he was adjunct 
professor of preventive and community 
medicine at Albany Medical College, 
Union University, and acting chairman 
of the Department of Epidemiology, 
School of Health Sciences, SUNY at 
Albany. 
A graduate of King’s College, Dr. 
Janerich received a D.D.S. degree from 
Temple University in 1963, and an 
M.P.H. degree from Harvard University 
in 1967. Most of his career to date has 
been as an epidemiologist with the New 
York State Health Department where 
he was appointed resident in 1965; 
director of epidemiology and population 
genetics of the Birth Defects Insitute in 
1968; director of the Bureau of Cancer 
Control in 1978; and acting director of 
the Division of Epidemiology, prior to 
his appointment in 1982 as Director of 
the Division of Community Health and 
Epidemioogy. 
Dr. Janerich is president of the Amer¬ 
ican College of Epidemiology and was 
president of the Society for Epidemio¬ 
logic Research in 1976-77. He is a 
member as well of the American Epi¬ 
demiology Society and of the American 
Public Health Association. 
Among numerous professional ap¬ 
pointments, Dr. Janerich is a member 
of the Breast Cancer Task Force of the 
National Cancer Institute, a charter 
board member of the American College 
of Epidemioogy, and an advisor to the 
National Institute of Child Health and 
Human Development. He is past presi¬ 
dent of the Society for Epidemiologic 
Research and of the American College 
of Epidemiology. 
PLANS ARE UNDERWAY FOR 
THE SCHOOL’S $125 MILLION 
FUND RAISING CAMPAIGN 
With the appointment last spring of 
Sue B. Dorn as Associate Vice-President 
and Director of Medical School Develop¬ 
ment, plans were initiated for the 
School’s major fund raising campaign. 
Three staff members have been ap¬ 
pointed Daniel W. Vecchitto, Carole 
L. Corbett, and Ann Pecora Diamond 
— and a distinguished volunteer leader¬ 
ship committee chaired by Dr. James 
G. Hirsh, ‘43S, has been formed. 
In announcing the $ 125 million cam¬ 
paign to the alumni last spring. Presi¬ 
dent A. Bartlett Giamatti noted that 
Mrs. Dorn is recognized as among the 
most outstanding institutional develop¬ 
ment officers in the country. Prior to 
her appointment as Vice-President and 
Director of Medical School Develop¬ 
ment, she served as Senior Development 
Officer for Yale University, and as 
Associate Director for Major Gifts during 
The Campaign for Yale. She has been a 
Vice-President for Resource Planning 
and Development at the Aspen Institute 
for Humanistic Studies and Vice-Presi¬ 
dent for Resource Development and 
Public Information at the Bank Street 
College of Education, as well as Director 
for Promotion, Executive Compensa¬ 
tion Service, the American Management 
Association. 
A graduate of Stanford University, 
Mrs. Dorn received an M.S. degree in 
special education from the Bank Street 
College of Education. She is a member 
of the National Resource Committee 
and Chairman of the Greater New 
York Special Gift Committee of Stan¬ 
ford University. In 1976, she was the 
first woman and the first eastern member 
of the Stanford alumni to receive the 
Gold Spike Award, the University’s 
highest award for outstanding volunteer 
service to the Alumni Fund. 
Prior to his appointment as Deputy 
Director of the Campaign for the School 
of Medicine, Daniel W. Vecchitto was 
Associate Director of Development for 
the School. A graduate, cum laude.oi 
Saint Michael’s College in Winooski, 
Vermont, he has been a coordinator of 
grants and planned giving for Saint 
Michael’s, as well as Director of Devel¬ 
opment at Merrimack College, North 
Andover, Massachusetts, and Associate 
Development Director of the Woods 
Hole Oceanographic Institution. 
Carole L. Corbett was Director of 
Development for the Illinois Masonic 
Medical Center, Chicago, from 1977 
until her appointment in June as Associ¬ 
ate Director for Medical School Devel¬ 
opment. In addition to development, 
she has been involved in broadcasting 
as Producer/ Director of Public Affairs 
Programming for Station WBBM- 
FM / CBS Radio and as Producer/ Direc¬ 
tor for WGN Continental Broadcasting 
Company, both in Chicago. Ms. Corbett 
attended Vassar College and the Univer¬ 
sity of California at Berkeley. 
Ann Pecora Diamond has been 
named Assistant Director of Medical 
School Development. A graduate of 
Syracuse University, she attended Colum¬ 
bia University, and received a B.S. 
degree in biology from the University 
of California, Los Angeles. She did 
graduate studies in cell biology at the 
Yale School of Medicine, and was an 
associate in research in the Department 
of Internal Medicine from 1979 until 
her appointment with the Development 
Office. 
The goal of the campaign is to raise 
$125 million: $33 million for facilities 
and equipment; $33 million for program 
and research, and $59 million for endow¬ 
ment. 
CHIEF NAMED FOR SECTION 
OF IMMUNOLOGY 
Dr. Philip Askenase has been appointed 
chief of the Section of Immunology, 
effective July 1, 1985. Well known for 
his studies in clinical immunology and 
in tropical medicine. Dr. Askenase has 
been a member of the Yale medical 
faculty since 1971. He succeeds Dr. 
John Dwyer, who has retired from 
Yale to return to his native Australia as 
chairman of the Department of Medi¬ 
cine at the University of New South 
Wales in Sidney. 
A graduate of Brown University, 
where he received a B. A. degree, magna 
cum laude in physics in 1961, Dr. 
Askenase received his M.D. degree 
cum laude from Yale University in 
1965. Following completion of intern¬ 
ship and residency in the Harvard 
Medical Unit and Thorndike Labora¬ 
tories at Boston City Hospital, he was 
appointed clinical associate in the Arth¬ 
ritis and Rheumatism Section, NIAMD, 
NIH. He was a British American Heart 
Fellow of the American Heart Associ¬ 
ation at London Hospital Medical Col¬ 
lege in London for a year prior to 
returning to the Yale School of Medicine 
in 1970 as a postdoctoral fellow in 
inflammatory diseases in the Section of 
Internal Medicine. He was appointed 
assistant professor of medicine the fol¬ 
lowing year, and associate professor in 
1975. 
In 1978-79, Dr. Askenase was a 
Visiting Scientist in the Immunoparis- 
itology Division of the National Insti¬ 
tute of Medical Research. London. He 
was appointed associate professor of 
the Yale Department of Pathology in 
1981, and the following year, he was 
named associate professor of medicine 
and pathology. 
Dr. Askenase is a member of a 
number of professional societies in¬ 
cluding the American Association of 
Immunologists, the British Society for 
Immunology, the Reticuloendothelial 
Society, and the American Federation 
for Clinical Research. 
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A CHAIRMAN IS NAMED FOR 
SECTION OF GROSS ANATOMY 
Dr. William B. Stewart, assistant profes¬ 
sor of surgery in the Sections of Ana¬ 
tomy and Neurosurgery has been ap¬ 
pointed chairman of the Section of 
Gross Anatomy. Recognized as an out¬ 
standing teacher. Dr. Stewart has been 
director of medical studies in the Section 
of Anatomy for the past two years. 
A graduate of the University of Illi¬ 
nois, he received his M.A. degree from 
Western Michigan University and his 
Ph.D degree in anatomy from Emory 
University. Dr. Stewart came to Yale in 
1976 as a NIH Postdoctoral Research 
Fellow in Physiology and Neurosurgery. 
He became a member of the faculty in 
1978 as a lecturer in gross anatomy. 
TWO MORE FACULTY NAMED 
JAVITS AWARD WINNERS 
Dr. Linda M. Bartoshuk and Dr. Wil¬ 
liam S. Cain have received Javits Neuro¬ 
science Awards of the National Institute 
of Neurological and Communicative 
Disorders and Stroke (NINCDS). Mem¬ 
bers of the scientific staff of the John B. 
Pierce Foundation and of the faculty of 
Epidemiology and Public Health, they 
are psychophysicists considered leaders 
in studies of chemosensory response to 
enviornmental stimuli. Dr. Bartoshuk’s 
research interest is taste sensation; Dr. 
Cain’s work focuses on olfactory per¬ 
ception. 
Over two million Americans suffer 
from a loss or impairment of the sense 
of taste or smell, according to a 
NINCDS report. Although the condi¬ 
tion is not generally considered life- 
threatening, scientists now realize that 
the chemical senses have considerable 
medical significance, according to Dr. 
Bartoshuk. 
In previous studies, she demonstrated 
that a subject’s ability to taste PTC 
(phenylthiocarbamine), a bitter subs¬ 
tance, was linked to a recessive gene, 
individuals with two recessive genes 
are relatively insensitive to the bitterness 
of PTC and are classified as “non¬ 
tasters”; those with one or more dom¬ 
inant genes are much more sensitive to 
the PTC and are called “tasters”. Ac¬ 
cording to Dr. Bartoshuk, 70 percent 
of all Americans are “tasters”. 
The $683,000 Javits Award will sup¬ 
port Dr. Bartoshuk’s studies of addi¬ 
tional compounds to characterize the 
differences between tasters and non¬ 
tasters She will also evaluate various 
aster receptors and determine their 
location on the tongue. 
Dr. Cam will apply his award ol 
$835,000 to the development of proced¬ 
ures to compare the olfactory and 
trigeminal sensitivity of individuals suf¬ 
fering from olfactory impairment or 
loss with that of people with a normal 
sense of smell. He will also work to 
develop ways to diagnose different types 
of olfactory impairment and loss. 
In addition. Dr. Cain will study the 
way in which individuals’perceptions 
of odors vary. This in turn will provide 
information about how to select items 
for clinical test of odor identification 
and offer a theoretical rationale for 
such tests, according to Dr. Cain. (More 
about Dr. Cain's work appears in the 
Fall 1980 issue of Yale Medicine.) 
Drs. Bartoshuk and Cain are the 
fifth and sixth members of the School 
of Medicine faculty to receive Javits 
Awards. The award honors NINCDS 
grantees who have achieved a distin¬ 
guished record of contributions in the 
field of neurological and communicative 
sciences and who are expected to be 
highly productive over the next seven 
years. 
FACULTY PRACTICE PLAN 
WILL HAVE A NEW BUILDING 
OF ITS OWN 
Plans are finalized and construction 
will begin soon of an ambulatory care 
facility that will consolidate clinics and 
offices of the Faculty Practice Plan 
which are currently scattered in 17 
locations throughout the Medical 
Center. “Such consolidation will en¬ 
hance patient convenience and provide 
opportunities not currently available 
for cost effectiveness,” according to 
Arthur G. Isack, executive director of 
the Plan. 
The four-story glass, concrete and 
brick building will be located on the 
southeast corner of Howard and Daven¬ 
port Avenues. With adjacent parking 
and a pedestrian bridge to the Hospital, 
the new facility will include specialty 
and consultative services, x-ray and 
laboratory services, and a pharmacy. It 
will not include hospital beds or one- 
day surgery facilities. 
The Yale Faculty Practice Plan was 
established in 1981 to bring together 
administrative, management and billing 
and collection activities of the existing 
clinical practice of the full-time faculty. 
Clinical practice, research and teaching 
are essential activities of a medical 
school, and the mission of the Plan is to 
enhance the academic responsibilities 
of the School by directly relating its 
clinical activities to teaching and 
research. 
The building of about 90,000 square 
feet will be constructed at an estimated 
cost of $9 million on land presently 
owned by the Hospital and used as part 
of a parking lot. 
A REGIONAL EYE CENTER AT 
YALE SOON TO BECOME A 
REALITY 
Ground breaking ceremonies were held 
on November 16 for the new Eye 
Center at Yale, A regional, national 
and international referral resource, the 
Center will be the only facility of its 
kind between Boston and New York 
for persons requiring diagnosis and 
treatment of eye disease. 
The $2.5 million project is the cul¬ 
mination of 23 years of planning by Dr. 
Marvin Sears, who has been chairman 
of the Department of Ophthalmology 
and Visual Science since it was founded 
in 1971. Under his leadership, the de¬ 
partment has earned a world-wide repu¬ 
tation for its significant contributions 
to the development of treatments for 
blinding eye diseases. 
The Eye Center will occupy the entire 
Boardman Building, which is being 
extensively renovated for the purpose. 
Centrally located in the Medical Center, 
and adjacent to the Department of 
Ophthalmology’s research labs, it will 
integrate patient care with basic research 
and teaching activities. 
With an entrance off Cedar Street, 
the first floor will include admissions 
and nurses offices and a general eye 
clinic; retinal and corneal diseases will 
be treated on the second Boor; and 
glaucoma and strabismus treatment 
centers will be located on the third 
floor. The Center will include two 
operating rooms for eye surgery, a 15- 
bed inpatient recovery unit and research 
laboratories. 
AN MR CENTER WILL BE BUILT 
UNDERGROUND ADJACENT TO 
THE LCI BUILDING 
Excavation is expected to start this 
spring for an underground addition to 
the LCI building to bring together 
Yale’s research and clinical activities in 
magnetic resonance technology, con¬ 
sidered one of the most important 
developments in medicine in this decade. 
The Magnetic Resonance Center, includ¬ 
ing offices, laboratories and patient 
care rooms, will be equipped with two 
whole body scanners, a small animal 
18 
instrument and a high field spectro¬ 
meter. The four magnets will have a 
combined strength of almost 450,000 
times that of the earth’s magnetic field, 
and will require special construction 
and shielding to contain their tremen¬ 
dous force. 
The MR Center will bring together 
distinguished scientists in the field in¬ 
cluding the directors, Dr. Robert Schul- 
man, recognized as one of the world 
leaders in MR studies of the brain, 
liver, kidney and heart; and Dr. Richard 
Greenspan, well known for his research 
in clinical MR imaging. Dr. John Gore, 
associate professor of diagnostic radio¬ 
logy, who helped develop the first 
whole-body scanner, is another of the 
group who will be exploring the great 
potential of this new technology. They 
will collaborate on basic and clinical 
MR studies with colleagues including 
Drs. Joseph Coleman and Ian Armitage 
of the Department of Molecular Bio¬ 
physics and Biochemistry. 
POSTDOCTORAL FELLOWS 
RECEIVE AWARDS 
Drs. Deborah Dyett and Gary Desir 
have been awarded Robert Wood John¬ 
son Foundation Minority Medical Fa¬ 
culty Awards. Graduates of the Class 
of 1980, Yale School of Medicine, Dr. 
Dyett and Dr. Desir are postdoctoral 
fellows in the Department of Internal 
Medicine. 
Dr. Dyett, who is a fellow in the 
laboratory of Dr. Stephen Malawista, 
chief of the Section of Rheumatology, 
received a grant of $120,000 for two 
years in support of her research to 
study the way in which neutrophils 
interpret messages and move, and how 
they release mediators of inflammation. 
Neutrophils are white blood cells impor¬ 
tant in protecting the body from infec¬ 
tion. They are also important in inflam¬ 
mation, and are responsible for much 
of the pain and discomfort of diseases 
such as rheumatoid arthritis and gout. 
“A better understanding of the inflam¬ 
matory process may open new thera¬ 
peutic avenues in the treatment of these 
and other inflammatory diseases,”said 
Dr. Dyett. A graduate of Harvard 
University, she received the John P. 
Peters Prize for an outstanding thesis, 
and the Henry J. Kaiser Family Founda¬ 
tion/National Medical Fellowship 
Merit Graduation Award in 1980. 
Dr. Desir is a fellow in nephrology in 
the laboratory of Dr. Fred Wright, 
professor of medicine and physiology. 
The Robert Wood Johnson Foundation 
awarded him $119,673 in support of his 
research to determine the mechanisms 
that account for potassium transport in 
the proximal tubule. “A detailed know¬ 
ledge of the mechanisms that account 
for ion transport could greatly enhance 
our understanding, and thereby our 
ability to treat many diseases,"said Dr. 
Desir. “It is noteworthy that the pro¬ 
cesses described in the kidney might 
pertain to other organs. Therefore our 
studies might be of general interest.” 
Dr. Desir received his B.A. degree 
magna cum laude from New York 
University, where he was elected to Phi 
Beta Kappa, and received the Univer¬ 
sity’s Founder’s Day Award in 1976. 
The Robert Wood Johnson Minority 
Medical Faculty Development Program 
seeks to increase the number of minority 
faculty who can encourage and foster 
the development of succeeding classes 
of minority physicians. It offers postdoc¬ 
toral research fellowships to minority 
physicians who have demonstrated 
superior academic and clinical skills 
and who are committed to careers in 
academic medicine and biomedical 
research. 
Cheung Lam King, Ph.D., a postdoc¬ 
toral associate in the Department of 
Pharmacology, has been awarded the 
first Leslie Warner Postdoctoral Fellow¬ 
ship of the Yale Comprehensive Cancer 
Center. 
Dr. King, who received his Ph.D. 
from the Graduate School of Biomedical 
Sciences at the University of Texas, is 
studying the induction of terminal differ¬ 
entiation on malignant keratinocytes 
and determination of the differential 
gene expression during cellular differen¬ 
tiation. His research is directed toward 
a new approach for cancer treatment, 
inducing malignant cells to differentiate 
to mature cells with low proliferative 
capacity, hopefully without major ef¬ 
fects on normal cells. 
The Leslie Warner Postdoctoral Fellow- 
ship was established from gifts given in 
memory of the former chairman of the 
board of General Telephone and Elec¬ 
tronics of Stamford, Connecticut. 
FACULTY NOTES 
Dr. Allen C. Steere, associate professor 
of medicine, received the Society 
Citation of the Infectious Diseases Soci¬ 
ety of America at its annual meeting in 
Washington, D.C. Dr. Steere was hon¬ 
ored for his recognition of Lyme disease 
as a new entity and for defining its 
epidemiology, clinical features, micro¬ 
biology, pathogenesis and treatment. 
Dr. Richard K. Root, former professor 
and vice president of the Department 
of Internal Medicine, now at the Seattle 
V.A. Medical Center, presented the 
award to Dr. Steere. 
“Besides defining this new infectious 
disease and all of its important aspects. 
Dr. Steere’s investigations have demon¬ 
strated the bright side of effective scienti¬ 
fic collaboration among investigators 
in the same lab or between different 
laboratories. In an age when competi¬ 
tion to get there first is the overriding 
concern of many, the dramatic value of 
this collaboration is a stirring reminder 
of how the quest for scientific truth 
should properly supersede personal no¬ 
toriety,’’said Dr. Root. “Appropriately, 
Dr. Steere has requested that his associ¬ 
ate investigators at Yale University 
also be named in this citation. These 
are Dr. Stephen E. Malawista, chief of 
the Section of Rheumatology in the 
Department of Internal Medicine, Dr. 
John A. Hardin and Dr. Joseph E. 
Craft, both members of the Section of 
Rheumatology, and Robert L. Grod- 
zicki and Elice Taylor, research associ¬ 
ates in the Section.” 
Dr. Arthur L. Horwich received a 1984 
Life and Health Insurance Medical 
Research Fund Award. One of six 
medical scientists to receive the award 
this year, he was recognized for his 
studies of the Expression of cDNA 
Encoding Human Ornithine Transcarba- 
mylase. Dr. Horwich is assistant pro¬ 
fessor of human genetics. 
The 1984 Heath Memorial Award was 
presented to Dr. Raymond Yesner at 
the Twenty-eighth Annual Clinical Con¬ 
ference of the University of Texas 
System Cancer Center. The award 
honors individuals who have made 
outstanding contributions to the better 
care of the cancer patient by the clinical 
application of basic cancer knowledge. 
Dr. Yesner, who is professor emeritus 
of pathology and director of Pathologic 
Anatomy, Laboratory Service at the 
West Haven VA Medical Center, is 
well known for his classification of 




At its 80th annual meeting held in 
Baltimore in December, the American 
Society of Tropical Medicine and Hy¬ 
giene awarded the Walter Reed Medal 
to Dr. Wilbur G. Downs in recognition 
of his outstanding work in the field of 
tropical medicine; and the Richard 
Moreland Taylor Award to Dr. Thomas 
H.G. Aitken for outstanding scientific 
contribution to the field over a signifi¬ 
cant period of time. 
Dr. Downs, clinical professor of epi¬ 
demiology, is recognized worldwide 
for his research on malaria and other 
diseases attributed to arthropod-borne 
viruses. A consultant to the World 
Health Organization for the East Afri¬ 
can Research Institute in Entebbe, 
Uganda since 1970, Dr. Downs was 
associate director of The Rockefeller 
Foundation from 1963 until 1971, and 
head of the Yale Arbovirus Research 
Unit from 1965 until 1971. In 1977, he 
was the recipient of the Richard More¬ 
land Taylor Award. 
Dr. Aitken, who is senior research 
scientist emeritus, has been a member 
of the Yale Arbovirus Research Unit 
since 1971. An entimologist and parisit- 
ologist, he is best known for his research 
on mosquito-transmitted viruses. 
Dr. Joseph F. Hoffman,Eugene Higgins 
Professor of Physiology, has received 
the Humboldt-Award in recognition of 
his past accomplishments in research 
and teaching. An authority on cellular 
and comparative physiology, best 
known for his investigations of the 
membrane transport processes. Dr. 
Hoffman, who is a member of the 
National Academy of Sciences and the 
American Academy of Arts and Sci¬ 
ences, is president-elect of the American 
Biophysical Society. The Humboldt- 
Award was established in Germany in 
1860 to enable academically trained, 
highly qualified persons of foreign na¬ 
tionality to carry out research in the 
Federal Republic of Germany. 
Dr. Edith Hsiung, professor of labora¬ 
tory medicine, has received an honorary 
degree from Hubei Medical College in 
the People's Republic of China. Dr. 
Hsiung recently conducted a virology 
workshop at the College, and was also 
invited to lecture at the Institute of 
Virology, Chinese National Center of 
Preventative Medicine in Beijing, Tien- 
jing Medical College, and at epidemic 
prevention stations in various cities in 
China. 
The New Jersey Chapter of the Ameri¬ 
can Diabetes Association has honored 
Dr. Ralph A. DeFronzo, associate pro¬ 
fessor of medicine, for his contributions 
over the past ten years to the advance¬ 
ment of diabetes research. Well known 
for his studies of diabetes. Dr. DeFronzo 
is co-author of “The Physician’s Guide 
to Type II Diabetes (NIDDM): Diag¬ 
nosis and Treatment” and the editor of 
a new journal. Diabetes/Metabolism 
Reviews. 
Dr.M.David Tilson, professor of sur¬ 
gery has been named a Surgical Traveler 
of the James IV Association of Sur¬ 
geons, Inc. The purpose of the Associa¬ 
tion is to foster the exchange of know¬ 
ledge among the distinguished surgeons 
of English-speaking countries through 
an honorarium to Surgical Travelers 
who have made outstanding contribu¬ 
tions to the art and science of surgery. 
BOOKS BY FACULTY 
“Continuity and Change in Art: The 
Development of Modes of Representa¬ 
tion”, by Sidney J. Blatt, profes¬ 
sor of psychiatry and psychology, in 
collaboration with Ethel S. Blatt. Law¬ 
rence Erlbaum Associates (1984). 
“Psychotherapeutic Management in the 
Day Program — Practices in Day 
Hospital Psychiatry”, by Jerzy E. 
Henisz, M.D., associate professor of 
psychiatry, with a foreward by Boris 
M. Astrachan,professor of psychiatry. 
Charles C. Thomas (Springfield, Ill.) 
1984. 194 pp, illus. 
“Psychotherapeutic Management on 
the Short-term Unit — Glimpses at 
Inpatient Psychiatry”, by Jerzy E. 
Henisz, M.D., associate professor of 
psychiatry, with a forward by Stephen 
Fleck, M.D., professor of psychiatry 
and public health.Charles C. Thomas 
(Springfield, 111)1981. 182 pp. 
VERNON WILLIAM LIPPARD.M.D. 
Dr. Vernon W. Lippard, dean emeritus 
and professor emeritus of pediatrics, 
died of a heart attack on December 22 
at his home in New Haven. He was 79 
years old. 
Few have had a more distinguished 
career in the field of medical education 
than Vernon Lippard, who served as 
dean of the Yale School of Medicine 
from 1952 to 1967. Before coming to 
Yale as dean, he taught at the Cornell 
Medical College, was associate dean at 
the College of Physicians and Surgeons 
of Columbia University, and was dean 
and professor of pediatrics at Louisiana 
State University and the University of 
Virginia in Charlottesville. 
Born in Marlborough, Massachu¬ 
setts, Dr. Lippard was a member of the 
class of 1926 at Yale’s Sheffield Scienti¬ 
fic School, and graduated from the 
School of Medicine in 1929. After 
training as a resident at the New York 
Nursery and Child’s Hospital and the 
New York Hospital, he conducted re¬ 
search on the development of immunity 
to infections in infancy and in 1939, 
directed the Commission on the Care 
of Crippled Children in New York 
City, one of the first health projects 
sponsored by the U.S. Children’s Bu¬ 
reau. Its report brought forcefully to 
the attention of the public the inefficien¬ 
cy and lack of coordination in treatment 
of children who had been paralyzed by 
poliomyelitis. 
In World War II, Dr. Lippard served 
in the Army Medical Corps in New 
Guinea, and the Phillipines. When the 
war ended, he held the rank of colonel 
and was stationed in Manilla as Chief 
of Medical Personnel. 
Dr. Lippard was active in national 
and international health affairs. In 1949, 
he conducted a study of health services 
in Italy under the auspices of the World 
Health Organization. As president of 
the Association of American Medical 
Colleges in 1954-55, and as a consultant 
to the Surgeon General of the U.S. 
Public Health Service, he led the move¬ 
ment for federal aid to medical educa¬ 
tion which resulted in increased produc¬ 
tion of physicians by American universi¬ 
ties and decreased dependence on gradu¬ 
ates of foreign medical schools. The 
University of Maryland awarded him 
the honorary degree of doctor of science 
in 1955. 
Under his leadership, the Yale School 
of Medicine experienced a fifteen year 
period of phenomenal growth. The 
faculty more than doubled in size. 
Three new academic departments were 
established. The annual budget grew 
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about five-fold, with a considerable 
increase in support from the federal 
government and foundations. The phys¬ 
ical plant underwent impressive expan¬ 
sion with the construction of new educa¬ 
tional and research facilities. Postgrad¬ 
uate educational programs and fellow¬ 
ships were greatly increased, as was the 
program of continuing education for 
practicing physicians. It was also at this 
time that the Yale-New Haven Medical 
Center was formally established. 
After retiring as dean. Dr. Lippard 
served as Assistant to the President for 
Medical Development. Following his 
retirement from the faculty in 1971, he 
remained active in the field of medical 
education in this country and abroad. 
He was a consultant to the Josiah 
Macy, Jr., Foundation on its programs 
to aid medical education in developing 
countries. He served on the boards of a 
number of organizations, including the 
National Fund for Medical Education 
and the William T. Grant Foundation. 
He also served on various advisory 
committees here and throughout the 
country. 
Dr. Lippard is survived by his wife, 
Margaret Isham Cross Lippard; a daugh¬ 
ter, Lucy Rowland Lippard; and a 
grandson, Ethan Ryman. 
It is suggested that memorial gifts, 
payable to Yale University, be sent to 
the Section of the History of Medicine, 
Yale School of Medicine, 333 Cedar 
Street, P.O.Box 3333, New Haven, 
Connecticut 06510. A.E. 
COURTNEYCRAIG BISHOP, M.D. 
Dr. Courtney C. Bishop, clinical profes¬ 
sor emeritus of surgery, died on January 
17 at his home in Wardsboro, Vermont. 
He was 79 years old. 
Dr. Bishop was born and raised in 
New Haven. He graduated from Yale 
College in 1926, and was awarded his 
M.D. degree from the Yale School of 
Medicine in 1930. He was a surgical 
house officer with Dr. Harvey Cushing 
at the Peter Bent Brigham Hospital in 
Boston. When Dr. Cushing retired in 
1932, Dr. Bishop moved to the New 
York Hospital to complete his residency 
under Dr. George Hoyer, then chairman 
of surgery. In 1938, he returned to New 
Haven and Yale, and was appointed to 
the staff of the New Haven Hospital, 
and a clinical instructor on the School 
of Medicine faculty. 
During World War II, Dr. Bishop 
served in the Army Medical Corps with 
the 39th General Hospital, the Yale 
Unit stationed in New Zealand and on 
Saipan. When the war ended, he was 
chief of the surgical service with the 
rank of lieutenant colonel, and in Novem¬ 
ber 1945, he returned to his practice 
and to his assignments at the Hospital 
and the School 
In the succeeding years, Dr. Bishop 
continued to serve both institutions in 
various capacities. In 1949, he was 
promoted to associate clinical professor 
of surgery and in 1958, to clinical 
professor. He had been appointed chief 
of surgery at the Grace-New Haven 
Community Hospital in 1953. When 
the community and University physi¬ 
cians merged into a single staff in 1960, 
Dr. Bishop was appointed chief of 
staff, a position in which he served with 
great distinction until his retirement in 
1973. 
For two decades he had worked 
tirelessly to improve cooperation be¬ 
tween the Hospital and the School of 
Medicine and between members of the 
full-time faculty and their colleagues in 
the community. In 1981, in honor of his 
long years of service to the Hospital, 
the Board of Directors dedicated the 
newly renovated conference room- in 
the Clinic Building in his honor. 
Dr. Bishop is survived by his wife, 
Eleanor Alcorn Bishop; two daughters, 
and grandchildren. A.E. 
ISIDORE SYDNEY FALK., PH.D. 
Isidore Sydney Falk, Ph.D., professor 
of public health (medical care) in the 
Department of Epidemiology and Public 
Health from 1960 to 1968, died in New 
Haven on October 4, 1984, after a brief 
illness. 
Dr. Falk’s distinguished career began 
when, after graduating from Yale in 
1923, he was appointed to the faculty of 
the University of Chicago. He left that 
position in 1927 to become the director 
of the first major analysis of the national 
medical care system in the U.S., the 
Committee on the Cost of Medical 
Care. This committee’s final report in 
1932, changed the history of health 
care in this country. The ideas advanced 
in this report of prepayment through 
some form of health insurance and of 
the advantages, in particular, of prepaid 
group practice medicine were areas in 
which Dr. Falk was to spend the rest of 
his life. 
He was active in the efforts to enact 
Social Security and subsequently 
served Presidents Roosevelt, Truman, 
and Eisenhower as Director of Research 
and Statistics for the Social Security 
Administration from 1941 to 1954. 
After his retirement from the Social 
Security Administration, he was advisor 
on Social and Health Services to the 
World Bank and a consultant to the 
Republic of Panama, the U.S. Canal 
Zone, and various other countries on 
health care and social security programs. 
He was a health services and medical 
care consultant to the United Steel 
Workers of America, where he assisted 
in the planning and development of a 
number of prepaid group medical plans 
in the United States and Canada. Yale 
University was fortunate in recruiting 
him in 1960 for the professorship in 
medical care. During his eight years at 
the school, this renowned man patiently 
opened to faculty, students and commun¬ 
ity leaders, the principles of medical 
care and health economics. Dr. Falk 
did not permit his reputation to erect a 
facade between him and his students, 
nor did he use his expertise as a platform 
for exhortation or polemics. 
After his retirement from Yale, Dr. 
Falk became the executive director of 
the Community Health Care Center 
Plan in New Haven, the first HMO in 
Connecticut, and a flourishing example 
of this new health care delivery system. 
He was decorated with the Congres¬ 
sional Selective Service Medal and 
received the 1973 Sedgwick Memorial 
Medal of the American Public Health 
Association. J.D.T. 
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MERRILL ABNER BARATZ, M.D. 
Merrill A. Baratz, M.D., associate clini¬ 
cal professor of pediatrics, died follow¬ 
ing an acute myocardial infarction on 
December 26, 1984. He was 63 years 
old at the time of his death. 
Born in New London, Connecticut 
in 1921, “Judge” Baratz received a 
bachelor’s degree from Johns Hopkins 
University, following which he enlisted 
in the Army Air Corps, quickly rising 
to the rank of major. He served in the 
European Theater as a B-17 pilot, 
participating in 35 missions. Upon his 
return, he enrolled in the University of 
Rochester School of Medicine from 
which he later graduated. 
Dr. Baratz came to Yale in 1950 to 
study pediatrics under Dr. Grover 
Powers, whose kindly, observant de¬ 
meanor was passed along to his trainee. 
Following internship and residency at 
the New Haven Hospital, he established 
a private practice in New Haven and 
spent the next 17 years at it. When the 
Yale Health Plan was being developed, 
he was recruited as its first pediatrician 
and served as senior member of its 
Department of Pediatrics from 1971 
until his death. 
A kind and gentle practitioner as 
well as observant and careful clinician, 
his philosophical approach to the art 
and practice of medicine was, indeed, 
as he expressed in an autobiographical 
sketch published in a Yale Health Plan 
consumer newsletter a year ago, “My 
interests have been the care of a patient 
as a person; a part of our general 
society... it is important to understand 
how the patient reacts to him or herself, 
to his or her family, to the stresses of his 
or her society. An illness is a mixture of 
physiological forces and effects of psycho¬ 
social stress.” 
Dr. Baratz was a fellow of the Ameri¬ 
can Academy of Pediatrics, a member 
of the executive board of the New 
Haven Pediatrics Society, and a former 
president of the Connecticut and the 
American Orchid Societies. He was 
also a fellow of Yale’s Trumbull College 
and long-time participant in study 
groups at the Yale Child Study Center. 
He is survived by his wife, Nancy 
Shemitz Baratz, a reference librarian in 
the Yale Medical Library, and by three 
children, Steven Baratz of Los Angeles, 
Susan Baratz of San Francisco, and 
Thomas Baratz, of Hamden. J.V.F. 
DONALD PETER GRANGER, M.D. 
On January 19, 1985, Dr. Donald P. 
Granger, associate clinical professor of 
neurology, died at age 55, following a 
lengthy illness. 
Dr. Granger was born in New York 
City on October 6, 1929. After graduat¬ 
ing from Antioch College, he attended 
the University of Pennsylvania School 
of Medicine, where he received his 
M.D. degree in 1954. He interned at the 
Cincinnati General Hospital and then 
served for two years in the U.S. Army 
in Korea. 
Following military service, he began 
his residency in neurology at the Univer- 
sity of Pennsylvania Hospital. In 1959, 
he came to Yale as a clinical fellow and 
in 1961, was appointed an instructor. 
He was engaged in private practice of 
neurology for the past 20 years and 
since 1964, was chief of neurology at 
the Bridgeport Hospital and the director 
of its electroencephalography labora¬ 
tory, which he had established. 
During this time he continued to be 
an active member of the part-time 
faculty and in 1974, was promoted to 
associate clinical professor. He was 
highly regarded as a clinical teacher by 
medical students and residents. 
Dr. Granger was a fellow of the 
American Academy of Neurology and 
a member of the American Electroen- 
cephalographic Society and the Ameri¬ 
can Epilepsy Society. He had served as 
chairman of the executive committee 
of the Board of Trustees of Antioch 
College. 
He was the husband of Susan Simon 
Granger, film and drama critic for 
radio station WICC in Bridgeport. In 
addition to his wife and mother, he 
leaves a daughter, Janet Granger; a 
son, Donald Granger, Jr.; and a brother. 
Dr. Richard Granger of New Haven. 
A.E. 
SPECIAL NOTICE TO ALUMNI 
Arrangements have been made for all 
medical school alumni to receive the 
Yale Alumni Magazine regularly. The 
cost of the first year’s subscription is 
being borne by the School of Medicine. 
The magazine, published eight times 
a year from October to June, previously 
was distributed only to Yale College 
alumni and others who subscribed. 
In accord with the efforts of the 
Association of Yale Alumni (AYA) to 
involve graduate and professional 
alumni more actively in Yale affairs, 
the Yale Alumni Magazine has increased 
coverage of events and people in the 
graduate and professional schools. We 
hope that you read the NMR article in 
the November issue. Future issues will 
contain additional news and article for 
the School of Medicine. 
ALUM%ws 
The Alumni in Medicine Column 
Notes front the President 
Nicholas P.R.Spinelli, M.D. 
TWO ALUMNI 
One has seen these two veteran alumni 
for decades: at medical school social 
events in New Haven or New York, and 
at scientific conferences to which alumni 
are invited. They have always responded 
when called. In younger days, they 
have functioned as members of our 
Association’s executive committee; been 
officers of this body; have offered sage 
counsel to members of our school’s 
administration when consulted. Their 
service has spanned the tenure of seven 
deans. Regardless of the time frame, 
theirs has been a youthful, thoughtful, 
vigorous presence. Myron Sallick cele¬ 
brated the 60th year anniversary of his 
graduation this past June; John Ogilvie 
enjoyed his 50th reunion the same 
weekend. 
To share the pleasure of their com¬ 
pany at these events is always an inspira¬ 
tion. The leadership of our alumni 
association struggles with the questions: 
what is our organization’s purpose? Its 
goals? How do we reach them? Pondering 
the intense loyalty, the unflagging dedi¬ 
cation of these two men is a source of 
wonder. What is the motivation, the 
driving force of these two men’s feelings, 
so vital to the accomplishment of any 
organization’s goal? 
Myron Sallick is a soft spoken, gentle 
man of gallant bearing. His eyes twinkle 
and he smiles often when he speaks, 
recollecting the experiences of the early 
years of his medical education. John 
Ogilvie is a solidly built, gregarious 
man with a full thatch of white hair 
crowning what could still be an under- 
graduate-football-player-figure. He is 
inquisitive; open; direct; eager. 
Both men have been practicing gener¬ 
al surgeons; Dr. Sallick in New York 
City, and Dr. Ogilvie still active in 
Stamford, Connecticut. Both have had 
successful careers, enjoying the accom¬ 
plishment and gratification of their 
professional objectives in surgery. 
Neither became outstandingly wealthy 
in doing it. Myron and John came to 
New Haven as poor students, dependent 
on Yale financial aid and part-time 
jobs for these goals to become possible. 
It has been an unvarying fact of life for 
six decades, it seems. Educational costs 
are always a quantum beyond the stu¬ 
dent’s financial reach. The need to help 
the qualified student find monetary 
resources is always a high priority of 
school administrations in every era. 
Reminiscing about their school days 
at Cedar Street many years ago comes 
easily and with enthusiasm to both 
men. It is remarkable how vivid and 
immediately accessible all of the details 
of these experiences are to them. The 
admission to medical school of both by 
an almost identical process, involving 
interviews with Dean Milton Winternitz 
in the presence of Miss Miriam Dasey, 
then registrar, is intriguing. Both these 
figures are now ledgends in the history 
of the Yale School of Medicine. The 
process of admission of these young 
men was both similar and relatively 
expeditiously decided. In both instances. 
Dr. Winternitz delivered the favorable 
judgement. The almost absurd simpli¬ 
city of administrative structure of this, 
then small medical school, is affecting. 
There were so many fewer students; 
such a small faculty; and a curriculum 
which was largely yet to come in the 
breadth and its complexity of our more 
modern time. The modern science and 
technologies of medicine were then 
about to unfold. Both men, with a kind 
of reverence, describe the career counsel¬ 
ling by the “great men of medicine” of 
the faculty, who thoughtfully guided 
them into their choosing surgery as a 
future direction. The names of Dr. Sam 
Harvey, Dr. Grover Powers, Dr. George 
Bloomer, among others, recur in their 
commentary; the “great men of medi¬ 
cine” — the motive forces among stu¬ 
dents then as now, as faculty, as role 
models. 
Was it the simpler time, with com¬ 
munications and student identification 
then an easier task, responsible for the 
emergence of such devoted graduates? 
One doubts that, because it was not a 
universal phenomenon among their 
peers. Also, one can find among gradu¬ 
ates in every decade since, behavior 
which identifies the “grateful” alum¬ 
nus/a, the doctor seeking to repay with 
service in many arenas for remembered 
privileges. One indeed can identify the 
Sallicks, the Ogilvies, among current 
students in Yale medicine. Their names 
differ and they are often the student 
leaders. They are in a sense “alumni” in 
transit. 
In the truest spirit of generosity, our 
old friends sought little in return after 
leaving Yale. Myron Sallick has one 
son who became a physician. “Not at 
Yale, incidentally, but I didn’t expect 
Yale had to accept him. He went to 
Cornell and has done very well.” Rich¬ 
ard Sallick is now on the Yale faculty 
and heads a department in a Yale 
affiliated hospital. John Ogilvie has 
four sons. “None wanted to become 
doctors and two wanted to go to Yale 
College. They did.” 
Both men, in their later years, were 
to add to the most generous of their 
gifts to their alma mater, themselves, 
material gifts as well. Dr. Sallick has 
bequeathed, for eventual transfer to 
Yale, the old homestead where his 
children were born. Dr. Ogilvie recently 
provided funds for the restoration of 
the old amphitheater in the Hope Build¬ 
ing (Dr. Sallick has described attending 
classes in the original as an undergradu¬ 
ate). When the dedication of this amphi¬ 
theater was commemorated with the 
placing of a plaque bearing his name 
last June, Dr. Ogilvie was overwhelmed 
by the “generosity of the gesture”. In 
both of them, modesty is not just an 
attitude but a passion. Their feelings 
perhaps are best paraphrased by the 
statement almost identically articulated 
by them both: “I can never repay Yale 
for what was given to me. What I have 
done, what I do for Yale now, is 
nothing compared to the opportunity 
the School gave me. I was exposed to 
the finest teachers of my time. I owe 
everything I did, or am, to Yale.” 
This dialogue was to be repeated this 
past June at reunion weekend. Fol¬ 
lowing the annual meeting of the Yale 
Alumni in Medicine, Dr. Leona Baum¬ 
gartner and her classmate. Dr. John 
Ogilvie, had just been awarded the 
Association’s first Distinguished Ser¬ 
vices Awards for alumni. Dr. Baum¬ 
gartner was expressing perplexity, a 
true sense of wonder, as though her 
diploma had been freshly awarded her. 
“I didn’t do anything. Yale did it all for 
me. I was given a great opportunity.” 
John Ogilvie nodded in energetic agree¬ 
ment. 
The opportunity for alumni to contri¬ 
bute, in ways other than financial, to 
the activities of the medical school in 
the years after graduation has been 
severely limited by the fragile organiza¬ 
tional structure of our alumni associa¬ 
tion. With the publication of our Direc¬ 
tory and with it, our ability to find 
where our alumni colleagues are, new 
opportunities for participation are tanta- 
lizingly possible. In the past, only those 
graduates within commuting distance 
of New Haven could be tapped for the 
committee functions which formed the 
larger part of non-reunion activities. 
Only they could participate in the oc¬ 
casional social activity on campus. The 
potential for development of regional 
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groups, thereby enhancing the possibil¬ 
ities of more varied alumni functions, is 
an imminent challenge. The reality of 
continuity in the character of the alumni- 
school relationship looms more pos¬ 
sible. School speakers might address 
regional graduates, thereby providing 
a more palpable sense of the school’s 
vitality, of where our school is now. 
The massive burgeoning of medical 
scientific knowledge is a present chal¬ 
lenge for the postgraduate to assimilate 
and maintain. The present and future 
physician is indeed becoming a docu¬ 
mented, life-long student. Can a given 
student be linked to a given University 
in this life-long quest? Will the word 
“Alumni” become synonymous with 
“on-going students”? How exciting if 
alumni-as-students could become part 
of such a creative process. 
Such conjecture renders even more 
seductive the portrait of our two alumni, 
our students of a simpler time. Their 
message to us, through the years, re¬ 
mains clear and lucid and germane: 
there is joy in achieving a professional 
goal in a learning institution of quality; 
in maintaining the links of communica¬ 
tion with such a medical school; and in 
working for the continued health of 
that institution assuring the same experi¬ 
ence to the countless students to come. 
Perhaps this “same experience” may 
serve the possible alumni-student of 
the future as well. 
CLASS NOTES 
1927 
In honor of Harry Zimmerman, chairman 
emeritus of the Department of Pathology 
at Montefiore Medical Center and pro¬ 
fessor emeritus of pathology at Albert 
Einstein College of Medicine, The Harry 
Zimmerman Chair in the Neurosciences 
has been established at Montefiore Med¬ 
ical Center in New York City. 
The endowed chair will be the foun¬ 
dation upon which Montefiore will build 
a S10 million Institute of Neurosciences, 
to combine under one roof, all the dis¬ 
ciplines involved in the study of the brain 
and the functioning of the central nervous 
system, including neuropathology, neu¬ 
rology, neurosurgery, neurochemistry, 
neuropharmacology, neurophysiology, 
and psychiatry. 
Dr. Zimmerman served on the faculties 
of Yale and of Columbia College of 
Physicians and Surgeons before going to 
Montiefiore in 1946. Over the years, he 
has trained hundreds of neuropatholo¬ 
gists, 137 of whom are now professors or 
department chairmen in this country, 
Japan, Israel and throughout many coun¬ 
tries of Europe. 
Among the many honors bestowed on 
Dr. Zimmerman is the Gold-Headed Cane 
of the American Association of Patholo¬ 
gists which he received in 1982. Created 
in 1919 to honor “a physician who repre¬ 
sents the highest ideals in medicine and 
pathology”, this award is the highest 
honor given to a pathologist, and has 
been awarded only 30 times since it was 
established. 
Now at 83, Dr. Zimmerman carries a 
full teaching-research-writing program 
at the Montefiore Medical Center as 
chairman emeritus of the Department of 
Pathology and he also has just completed 
a year as scientific adviser/coordinator 
for the eight symposia held to celebrate 
Montefiore's centennial. 
1947 
Robert Chase is the subject of an article 
in the fall 1984 issue of Stanford Medicine. 
It notes: “Dr. Robert Chase has nurtured 
the specialty of reconstructive hand sur¬ 
gery from its infancy to a fine-tuned 
microsurgical and biomechanics science. 
Along the way, he’s molded an image for 
himself among students, colleagues and 
patients that can’t be beat.” 
The article continues to describe Dr. 
Chase’s work: “His latest research project 
is bringing hand surgery into an era that 
could easily be mistaken for the stuff 
science fiction is made of. He is digitizing- 
-assigning numerical values—to cross sec¬ 
tions of each part of the hand. He’s 
entering all this information, obtained by 
photographing millimeter-thick slivers 
one at a time, into a computer. He is then 
able to call up a three-dimensional, mov¬ 
able image of the hand parts on the 
computer screen. He can move the parts 
of the hand, isolate them, or make them 
larger in order to study them in new ways. 
“ ‘By animating the hand we can study 
the relationship of one part to another, 
and the biomechanics of its function,’ he 
predicts. ‘Well be able to learn exactly 
what parts can be substituted for others 
for surgical repairs. We’ll also have the 
data that will allow us to construct artifi¬ 
cial parts that are closer akin to human 
parts. If we better understand how the 
hand works, we’re better able to duplicate 
it or substitute for it using robotic devices.’ ” 
1956 
At the 128th annual meeting of the 
Hawaii Medical Association William 
Hindle was installed as president. Dr. 
Hindle has been actively involved with 
Hawaii Medical Association affairs since 
1965, has been a member of numerous 
committees and has served as an Associ¬ 
ation officer since 1978. He is currently in 
private practice at Straub Clinic & 
Hospital, is an associate professor of 
obstetrics and gynecology at the Univer¬ 
sity of Hawaii School of Medicine and is 
very active with the American College of 
Obstetrics and Gynecology both locally 
and nationally. 
1957 
William Kissick was the keynote speaker 
at the Annual Meeting of the American 
Public Health Association in November. 
Dr. Kissick is The George Seckel 
Pepper Professor of Public Health and 
Preventive Medicine at the University of 
Pennsylvania School of Medicine. He is 
also professor of health care systems in 
The Wharton School as well as director 
of the Health Policy and Planning 
Program of the Leonard Davis Institute 
of Health Economics. 
Dr. Kissick has written on a wide range 
of issues such as training of public health 
professionals; planning and budgeting in 
health; cost/benefit in health planning; 
national health insurance; hospices and 
home care and multi-institutional delivery 
of services. He is currently completing a 
book entitled, “Who Shall Live? Who 
Shall Decide?: A Strategy for Health.” 
A brief note from Thomas O'Brien, who 
is living in Greenville, North Carolina, 
stated that he has been elected chief of 
staff for 1985 at the Pitt County Memorial 
Hospital, the teaching facility for East 
Carolina University School of Medicine. 
1962 
Michael Alderman was appointed as of 
September 1, to the position of chairman 
of the Department of Epidemiology and 
Social Medicine at Montefiore Medical 
Center and the Albert Einstein College of 
Medicine. The Department, now renamed 
and unified under Dr. Alderman’s leader¬ 
ship, was formerly known as the Depart¬ 
ment of Social Medicine at Montefiore 
and the Department of Community 
Health at Einstein. 
Prior to accepting his new position at 
Montefiore, Dr. Alderman was a pro¬ 
fessor in the Departments of Public 
Health and Medicine at Cornell University 
Medical College and an attending phy¬ 
sician at New York Hospital. 
He has developed programs in Jamaica 
and East Africa which reduced child 
mortality in those areas by more than 50 
percent; and in an urban setting, his 
pioneering research on hypertension con¬ 
trol at the work site, has brought a new 
understanding to the course of the 
disease and workers’ responses to treat¬ 
ment. From 1979 to 1983, he adminis¬ 
tered a Robert Wood Johnson Founda¬ 
tion National Grants Program to design, 
establish and evaluate community-based 
systems for the improvement of care 
for persons with chronic diseases. 
Dr. Alderman presently is chairman of 
the Board of Directors of the African 
Medical and Research Foundation and a 
consultant to the World Health Organiza¬ 
tion and the National Institutes of Health. 
1965 
Thomas Aoki is now at University of 
California, Davis where he has been 
appointed professor of internal medicine 
and chief of the Division of Endocrin¬ 
ology. Until his move to Davis, he was at 
the Joslin Diabetes Center in Boston 
where he was head of the Metabolism 
Section and associate professor of medi¬ 
cine at Harvard Medical School. 
In the announcement of his appoint¬ 
ment it was noted that Dr. Aoki’s research 
has focused on hormone-fuel interrela¬ 
tionships, especially the effects of the 
pancreatic polypeptide hormones, insulin 
and glucagon, on the transport and 
metabolism of low molecular weight sub¬ 
stances in peripheral tissues. In his most 
recent efforts with the artificial beta-cell 
(Biostator), he has demonstrated the 
inability of conventionally treated diabetic 
patients to both oxidize and store carbo¬ 
hydrates; however, with his unique treat¬ 
ment, he has managed to restore both 
functions in severely compromised type 1 
diabetic patients. 
1968 
As of November 1, Frank Lucente became 
chairman of the Department of Otolaryn¬ 
gology, Head and Neck Surgery at The 
New York Eye and Ear Infirmary. 
Dr. Tucente received his training in 
otolaryngology at Barnes Hospital under 
the late distinguished Dr. Joseph Ogura, 
completing his residency in 1974. From 
1974 to 1976 during military service, he 
was chief of the Department of Otolaryn¬ 
gology at the U.S. Public Health Service 
Hospital in Staten Island, New York. 
Also in 1974 he was appointed to the 
faculty of Mount Sinai School of Med¬ 
icine where he became professor this 
year. 
Dr. Lucente’s extensive teaching exper¬ 
ience has included several visiting lecture¬ 
ships, an annual course at the American 
Academy of Otolaryngology, and the 
Paige and William Black Post Graduate 
School of Medicine at Mount Sinai. For 
his contributions to the American Acad¬ 
emy of Otolaryngology’s educational 
program, he won the 1980 Honor Award. 
He has published numerous papers 
and books including two medical text¬ 
books, “Essentials of Otolaryngology” 
and “Diseases of the External Ear”, and 
is on the editorial board or is a reviewer 
for several major journals. In addition to 
being a member of many professional 
societies, he serves on a number of local 
and national committees. 
1973 
Michael Kaufman was elected to fellow¬ 
ship in the American Academy of Pedia¬ 
trics at a recent fall meeting of its executive 
board. To qualify as a fellow of the 
Academy, a pediatrician must have been 
certified as a fully-qualified specialist in 
the field of child health. Dr. Kaufman 
resides in Beverly Hills, California. 
1974 
Harry Shamoon has been elected to 
fellowship in The American College of 
Physicians and will be honored during 
the convocation ceremony at the College’s 
annual session in Washington, D.C., 
March 28-31, 1985. Dr. Shamoon, a 
specialist in endocrinology, is on the 
faculty of the Albert Einstein College of 
Medicine. He and his wife, Rona, and 
sons Evan, Mark and Michael, reside in 
Scarsdale, New York. 
HOUSE STAFF 
1946 
John McGovern has been elected a fellow 
of the Royal College of Physicians of 
London, England. Under a special bylaw 
of the Royal College of Physicians, 
fellowship may be conferred on “men and 
women of great distinction in medicine 
worldwide.... and their number must not 
exceed eight in any one year.” This year, 
fellowship was conferred upon six distin¬ 
guished physicians—two from France, 
one from Germany and three from the 
United States. The other two Americans 
honored are Dr. James Wyngaarden, 
director of the NIH, and Dr. Baruch 
Blumberg, 1976 Nobel Prize winner in 
Medicine. 
In Memoriam 
Joseph T. Eagan 
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1983 - 84 ALUMNI FUND REPORT 
FUND OFFICERS 1983-84 
Medical School Alumni Fund 
Lowell I. Goodman, '51, Chairman 
Malvin F. White,'39, Vice Chairman 
William K.McClelland,'47, Vice Chairman 
John L.Cieply,71, Vice Chairman 
J. Roswell Gallagher,'30 Bequest 
and Endowment Co-Chairman 
Samuel D.Kushlan,’35, Bequest 
and Endowment Co-Chairman, 
and Chairman, Former House Staff 
Public Health Alumni Fund 
Kathleen H. Howe,'56, Chairman 
MESSAGE FROM THE MEDICAL 
SCHOOL ALUMNI FUND CHAIRMAN 
The 1983-84 campaign ended with a grand total of $304,320 
— not quite reaching the $325,000 goal. However, the average 
gift from alumni of $152 compared to $143 the previous year, 
indicates a heightened awareness of our program which is to 
provide income for the Student Revolving Loan Fund. 
During the midpoint of our campaign we succeeded in 
earning the entire $50,000 Baumgartner Challenge award for 
new and increased gifts for student loans. This incentive plus 
over $77,000 from the reunion classes, gifts from non-reunion 
alumni, former house staff, parents and friends, contributed to 
our final total. 
I appreciate the efforts of the Bequest and Endowment 
chairmen, the chairman of the former house staff program, the 
vice chairmen, the 85 class agents, the reunion phonathon 
volunteers, and the student telephoners who contributed their 
time and energy to this worthwhile program. 
On behalf of the students and the school, I extend my sincere 
thanks to all the Fund’s loyal supporters. 
Lowell I. Goodman, '51 
A MESSAGE FROM THE DEAN 
During the eleven years I have been Dean, I have been 
impressed by the generosity of the alumni of the School of 
Medicine. Your prompt and enthusiastic response to Leona 
Baumgartner’s magnificent challenge gift this year is yet 
another example of your loyalty. 
Funds raised this year, amounting to $304,320, will be added 
to the Student Revolving Loan Fund. As you all know, helping 
our students meet the tremendous cost of medical education 
through scholarships and student loans is a high priority. 
Monies acquired through the Alumni Fund Campaign continue 
to be a mainstay in this effort. It is an important way for you to 
assure the quality of medical practice, research and teaching in 
the future. 
1 join the faculty and students in sending congratulations and 
appreciation to Lowell Goodman and the many volunteers who 
"■ c worked so hard on the 1983-84 Alumni Fund campaign, 
d to those of you who, through your continued interest and 
port, have made their fund raising goals a reality. 
Robert W. Berliner 
MESSAGE TO THE PUBLIC HEALTH GRADUATES 
AND FRIENDS 
This past year the proceeds of the 1983-84 Public Health 
Alumni Fund Campaign were designated the “Colin White 
Scholarship Fund" in honor of our popular professor of public 
health and statistics, who retired in June. 
The final total — nearly $44,000 contributed by 646 graduates 
represents 115 percent of the goal. This included funds 
earned as a result of the Leona Baumgartner challenge gift and 
over $5,000 raised by graduates in the New Haven area, who 
generously participated in two phonathons. 
Many thanks to the energetic agents and all of the Fund’s 
loyal supporters who made our campaign for 1983-84 the 
success it was. 
Jan A.J.Stolwijk 
Kathleen H. H owe 
MEMORIALS 
Deceased medical alumni (and friends) may be memorialized 
by a gift at any time to the Medical School Alumni Fund 
Endowment, in the name and class of the person so honored. 
The next-of-kin of a deceased medical alumnus/a is advised 
about this “In Memoriam Program” by mailing from New 
Haven some weeks after the School of Medicine receives 
notification of the death. The letter of information includes a 
copy of “The Testament of Remembrance” in which the names 
of all persons so memorialized are listed in the medical section 
by class, thus establishing a lasting memorial. Donors receive a 
personal penned note of appreciation from me. Your inquiries 
and interest are welcome at any time. 
In 1983-84, the Medical School Alumni Fund received 
$2,123 from 18 donors of In Memoriam gifts. Deceased alumni 
and friends so honored for the first time in 1983-84 were: 
Maurice Grozin '22 
Julius Weiner '29 
Paul Watson '30 
Roland T. Wehger '32 
Daniel Harvey '33 
Milton Rose '35 
W. Norman Sears '40 
Robert F. Dine’41 
John Taylor Adams '83 
James Wells 






















































MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION 
AGENT(S) 1982-3 
PARTICIPATION 
Edward Wakeman 56% 
William Cohen 57% 
Myron Sallick 63% 
Alice Whittier 67% 
Maxwell Bogin 50% 
Henry Fineberg 47% 
Harry Zimmerman "" 
Max Alpert 79% 
Paul McAlenney 71% 
J. Edward Flynn 65% 
Michael D’Amico 44% 
Henry Brill 43% 
Franklin Foote 76% 
John Ogilvie 50%, 
James Haralambie 52% 
George Hahn 35% 
David Dolowitz 53% 
Nelson Ordway 60%, 
Rebecca Solomon 53% 
James Ferguson 69% 
Charles Cheney 59% 
Walter Burdette 55% 
Jonathan Lanman 64% 
Dorothea Peck — 
S. Brownlee Brinkley 57% 
Nicholas Spinelli 67% 
Richard Breck 58% 
Charles Judd 66% 
T homas Whelan 
William Roy Breg 61% 
Paul Koehler 66% 
Daniel Elliott 58% 
David Frucht 62% 
Lowell Goodman 50% 
Harvey Young 43%) 
Vincent Gott 59% 
John Rose 80% 
Robert Kramer 53% 
John Gardner 53% 
Ronald Fishbein 68% 
Howard Minners 
Charles Hall 69% 
Paul Rudnick 
Asa Barnes 64% 
Muriel Wolf 
Roland Ingram Wo 
Thomas Kugelman 
Earl Baker 54% 
John R. Woodward 
Anoush Miridjanian 
A. Richard Pschirrer 47% 
Frank Hartman 
Craig Llewellyn 49%, 
William Houghton 64%, 
William Pratt 
David Hill 54%, 
Mary-Alice Houghton 62%, 
Henry Mann 
James Dowaliby 62% 
John Drews 
Anthony Lovell 
Frank Lucente OV7o 
Donald Lyman 
Lee Lampol 61% 
James Missett 42% 
John Cieply 58% 
Barbara Kinder 
Paul Lucky 53% 
David Baily 52% 
Lynne Liptay 
Jerrold Rosenbaum 
Peter Buchin 32% 
Daniel Passeri 24% 
Mary Jane Minkin 
Robert Taylor 26%, 
David Kreis 25% 
Ronald Vender 
Duke Cameron 20% 
Seth Powsner 
Thomas Smith 
1982-3 1983-4 1983-4 
AMOUNT PARTICIPATION AMOUNT 
$ 561 50%, $ 385 
634 67% 608 
2,400 86% 3,652 
(+ 118,000)* 
805 77% 960 
671 67% 546 
1,229 — — 
_ 56% 975 
2,795 73% 3,216 
1,572 90%, 1,612 
3,800 52% 2,446 
1,373 68% 1,901 
1,045 50% 1,366 
5,399° 74% 2,107 
2,703 61% 9,929° 
(+5,000)* 
2,276 58% 3,736 
3,275 47% 4,333 
1,590 48% 1,671 
2,360° 63% 1,100 
3,020 57% 3,231° 
4.369 65% 3,750 
3,331 64% 2,287 
1,789 61% 2,356 
10,107° — — 
_ 66% 2,915 
4,419° 47% 2,686 
7,086 74% 14,394° 
(+3,000)* 
3,590 60%, 3,350 
7,090 64% 7,021 
4,320 66% 4,918 
8,141° 51% 5,251 
4,169 52%, 5.829° 
3,688 58% 5,230 
5,515 45% 5,075 
3,845 46%, 5,035 
4,950° 56% 3,865 
6,172 65% 6,248° 
5,748 62% 4,712 
4,925 49% 6,275 
6,480 64%, 6,400 
10,550° 62% 5,065 
7,035 62% 10,115° 
8,550 66% 8,280 
4,645 49% 5,836 
4,790 47% 4,047 
5,770° 54% 5,715 
5,790 67% 8,670° 
5,710 38% 3,905 
3,680 63% 4,125 
4,975 76%, 6,596 
6,363° 54% 4,666 
(+20,000)° 
7.436 62% 7,948° 
2,795 49% 3,909 
6,262 51% 6,031 
3,208 44% 3,048 
3,709° 47% 3,515 
2,155 37% 1,970° 
933 21% 1.420 
1,325 30% 1,982 
1,351 36% 1,915 
915 26% 2,135 








1979 Michael Hausman 
Laurie Smaldon 
17% $ 770 20% $ 830 
1980 Eduardo Alfonso 
Mark Bernhardl 
17% 848 26% 830 
1981 Anthony Urbano 13% 665 19% 530 
1982 Muriel Cyrus 
Jed Gorlin 
Lynn Tanoue 
7% 105 14% 275 
1983 Michael Tom 
David Schwartz 
10% 255 
Alumni 50% $377,120(1) 48% $254,711(2) 
Former House Staff 18% 8,053 16% 7,095 
Parents & Friends 19%, 13,589 18% 11,652 
Interest & Miscellaneous 10,492 11,319 
gifts 
Baumgartner Match 39,811 19,542 
TOTAL 42% $449,065 40% 304.319 
1) includes $6,648 endowment income 
2) includes $7,474 endowment income 
RECORD REUNION GIFT BY CLASS OF 1944 
The report of annual giving for 1983-84 published in this issue 
of Yale Medicine lists the Class of 1944 as contributing $ 17,394 
on the occasion of the 40th anniversary of its graduation. 
Through errors in record keeping as class agent for 1944, this 
total is in error, and should read $21,697. Either figure 
represents a record for giving by a reunion class to the Yale 
Medical School Alumni Fund. Funds pledged by my class 
members for one reunion gift were in part given by some in ’82 - 
'83 and some in the ’84 -’85 periods. Totals for those off years 
will thereby be reported erroneously high, including as they do, 
some reunion year pledges. 
Pausing to analyze some aspects of this accomplishment is of 
interest: 
•This record was achieved by one of the smallest post WWII 
classes (44 graduates/41 living) and possibly one of the least 
affluent, then as now. 
• It required no gigantic effort on my or anyone’s part. Many 
economically stressed class members could contribute no¬ 
thing. Some contributions emerged from grateful patients of 
class members, a gesture of gratitude to their doctor. • 
•A major factor in the achievement was the planning of the gift 
over time (a two-year period); and the setting of a goal (a 
tentative $1,000 per alumnus/a -preposterous for some, far 
short of the possibilities for others). Now that the unexpected 
total is in, it is apparent that a more rational goal of $25,000 
could easily have been achieved. No pressure or last minute 
efforts were indulged. 
•The process engendered no huckstering, no breach of confiden¬ 
tiality. It was followed by one of the warmest, most successful 
reunion weekends we ever had. Sixty-five percent of the class 
attended. No one ever knew of the individual contribution of 
his classmates. 
•Without mention in speech or print, we contributed to one of 
the most vital causes our medical school — and every 
American medical school faces today; student financial 
aid The Revolving Student Loan Fund, in the current 
climate of medical education costs, has changed from a 
welcome assist to a vital life-line for so many students. The 
performance of my classmates, I believe, represents a mani¬ 
festation of the rising of consciousness of such need. 
This October, Chairman Lowell Goodman convened an organi¬ 
zational meeting to structure an advisory board of the Yale 
Medical School Alumni Fund, such as are now functioning in 
other professional schools at Yale. It will assist him as chairman 
to realize larger returns through such organizational effort, as 
have been realized where such boards function. As part of this 
organizational structure, I was appointed vice chairperson for 
reunions on the advisory board. 
I report this experience as class agent for my class because the 
simplicity of the process and the response of my classmates was 
so gratifying, and worthy of emulation by other classes. As vice 
chairman for reunions, I am ready to assist all appropriate 
agents for such a task. 
Finally, — and with apologies for my long-windedness — my 
salute to my extraordinary class! 
N.P.R. Spinelli, M.D., class agent, 1944 Med. 
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PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION 
LASS AGENT 1982-3 1982-83 1983-84 1983-84 
PARTICIPATION AMOUNT PARTICIPATION AMOUNT 
1923-1941 53% $1,844 58% $1,791 
(+1,000)* 
1942 Eric W Mood 50% 550 33% 265 
1943 Eric W. Mood 36% 390 31% 275 
1944 Eric W. Mood 33% 295 56% 270 
1945 — 31% 120 33% 130 
1946 — 22% 35 22% 65 
1947 — 39% 290 39% 265 
1948 Elizabeth Robinton 33% 720 39% 785 
1949 Elizabeth Robinton 33% 490 22% 440 
1950 Eric W Mood 52% 723 50% 790 
1951 Leonard F. Menczer 48% 635 - - 
Norton Chaucer - - 37% 565 
1952 Yolande F. Lyon 39% 730 39% 840 
1953 Milton Sisselman 40% 735 42% 860 
1954 Ruth Taber 29% 120 13% 70 
1955 Frances Ogasawara 43% 390 50% 535 
1956 David Boyd 32% 352 36% 555 
1957 Edward DeLouise 52% 422 48% 470 
1958 Thomas Flynn 21% 825 29% 765 
1959 Dorothy Wilson 33% 535 48% 945 
I960 Hannah Russell 33% 565 - - 
Else Schulze - - 54% 1,050 
1961 Gordon R. Beem 45% 410 - - 
William Slivka - - 43% 1,300 
1962 A. Kay Keiser 23% 70 10% 60 
1963 David Dolins 38% 650 33% 520 
1964 Estelle Siker 50% 1,025 29% 895 
1965 H. Patterson Harris 31% 540 29% 580 
1966 Allen Cohen 10% 200 24% 305 
1967 James Malloy 28% 1,260 36% 2,445 
1968 Arnold Saslow 46% 1,420 43% 1,475 
1969 Samuel Korper 28% 820 27% 1.450 
1970 Susan Balter 27% 1,330 35% 1,650 
1971 John Bihldorff 42% 1,500 53% 2,221 
1972 Daphne Gemmill 27% 650 - - 
Dorothy Lewis - - 34% 830 
1973 Judith Beatrice 22% 965 20% 820 
1974 Elizabeth Helming 40% 740 27% 695 
Karen Lindlors 
1975 Linda Broker 39% 1,666 35% 1,391 
1976 Elaine Anderson 36% 890 34% 1,560 
1977 Carroll Schilling 30% 960 - - 
Dorothy Rice - - 29% 1,390 
1978 Richard Poole 35% 1,400 38% 1,318 
1979 Ralph Tartaglione 40% 1,315 51% 2,420 
1980 Christina Quinn 25% 665 31% 1,020 
1981 Diane Goren 20% 645 33% 970 
Jill Goldwater 
1982 Michele Visconti 15% 320 26% 860 
Amy Wilson 
1983 Jeffrey Hughes - - 36% 805 
Mary Beth McNerney 
Alumni 36% 
Baumgartner Match 33% $31,532(1) $38,761(2) 
Interest & Miscellaneous 3,778 3,162 
gifts 1,262 1,755 
TOTAL 
33% $36,572 36% $43,678 
1) includes $50 endowment income 
2) includes $104 endowment income 
Contributors to the 
Medical School Alumni 
Fund 1983-84 
1906 
Charles R. Mitchell * 
1908 
Michael A. Parlato * 
1912 
Walter C. Tilden * 
1913 
Ralph E. Taylor * 
1919 
Willys M. Monroe * 
1920 
Oscar Brenner * 
1921 
Ella W Calhoun 
Joseph T. Eagan 
1922 
Maurice Grozin * 
Benedict R Harris 
Chester E. Hurwitz * 






Hyman Weinstein * 
1924 
John J. Batchelor 
D Anthony D’Esopo 
David M Raskind 
Myron A. Sallick 
Morris Slater 
Harold T Vogel 
1925 
Dorence S. Cowles 
Waldo F Desmond 
Henry W. Ferris 
William E. Hall 
Stanton K. Livingston 
Samuel Reback 
Welles A. Standish 
Alice A.S. Whittier 
Gonsalvo C. Williams 
Howard A Wood 
1926 
Stanton T Allison 
Maxwell Bogin 
William H Hahn * 




Joseph T. Matteis 
1927 
Milton B Berman 
Wallace R Bostwick * 
Henry Irwin Fineberg 
John M. Freiheit * 
Meyer Friedenson 
Edward E. Harkavy 
Albert Jablonsky 
Nathan Levy 
William C. Meredith 
Moses Rothberg 
Harry M Zimmerman 
1928 
Max Alpert 
Clement F. Batelli 
Berthold R Comeau 
Sheldon A Jacobson 
Edward P J Kearney 
Ralph E Knutti 
R Harold Lockhart 
Edward W. Ludwig * 
Nathan E. Ross 
Robert I Rubinstein 
John M Russell * 
Alvin A. Schaye * 
Lewis A. Scheucr 
• Deceased 
1929 
James Rae Arneill 
Frank H D’Andrea 
Charles J Epstein 
Robert A. Frisch 
Olive Gates 
George S. Goldman 
Alexander O Haff * 
John A. Hangen 
Harold J Harris 
Vernon W. Lippard 
Paul F. McAlenney 
Tony L Rakieten * 
William F Roth, Jr. * 
Russell B Scobie 
Benjamin Spock 
Robert Tennant 
Newell R. Washburn * 






Daniel N. Beers * 
Courtney Craig Bishop 
Charles A. Beck * 
Frederick Fitzherbert Boyce 
Vincent A. Doroszka 
Knox H. Finley 
J Edward Flynn 
J Roswell Gallagher 
Leonard Greenburg 
James C Hart 
Edmund L. Kitzmeyer 
Paul H Lavietes 
James M Lynch * 
Paul Watson * 
Amy Wilson 
Charles L. Wood 
1931 
Henry H. Briggs 
Benjamin Castleman * 
Michael D'Amico 
Richard L. Frank 
Helen R Gilmore 
Paul A. Harper 
Harold E. Harrison 
Morris Heller * 
Thomas C. Jaleski 
A Philip Lafrance 
Rhoda M. Mickey 
Nelson Newmark 
Sheldon Payne 
James W Reed 
Abraham J. Schechter 
1932 
Louis K. Alpert 
Henry Brill 
Frank Carroll 
Clement C. Clarke 
Robert M. Cushing 
Joseph P. Donnelly 
Lewis F. Foster 
Storer Plumer Humphreys 
Conrad R. Lam 
Arthur J. Present 
Elizabeth M. Ramsey 
Benjamin N. Tager 
Rudolph E. Vandeveer 
Myron E. Wegman 
Roland J. Wehger* 
1933 
Myron J Adams * 
Fred W Buse 
Warren P. Cordes 
Franklin M Foote 
Jack Greenberg 
George K Hirst 
Robert W Huntington 
Robert E. Kaufman 
Raymond E. Miller 
Ashley Pond 111 
Paul L. Saffo 
Sidney Stringer * 
John J Wolfe 
Francis M. Woods 
1934 
Leona Baumgartner 
James F Blades 
Joseph Budnitz 
Derick A. January 
Knowles B. Lawrence 
Theodore P Merrick 
Herbert C. Miller 
Edward T. O’Donnell 
John B Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
William R. Willard 
George Zalkan * 
1935 
George A. Carden 
Edward F. Falsey 
Sawnie R Gaston 
H Hoffman Groskloss 
James Quintin Haralambie 
W. Howard Horner 
Samuel D Kushlan 
Donald P. Morris 
Graham C. Newbury 
Norman E. Peatfield 
Norman P Rindge 
Milton Rose * 
Clark P. Searle 
Walter A.L, Thompson 
Samuel Zelman 
1936 
George Henderson Brown 
Lester W. Burket 
Nicholas D. D’Esopo 
Albert W. Diddle 
Franklin F Ferguson 
Margaret C.L. Gildea 
George D. Gross 
George A. Hahn 
Louise G Hutchins 
Philip M, Le Compte 
Donald F. Marshall 
Stephen F. Nagyfy 
Frederick A. Post 
Margaret Sommers 
Morris Tager 
Edgar W. Warren 
1937 
David A. Dolowitz 
D. Crosby Greene 
Wilbur D. Johnston 
Alfred E King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrill 
Charles W. Neuhardt 
Alan A. Rozen 
Morgan Sargent 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
Lucille R Wiepert 
1938 
Roy N. Barnett 
Henry L. Carideo 
S. Charles Kasdon 
Benjamin E. Lyons 
John J McGillicuddy 
Edward Nichols 
Nelson K. Ordway 
Edward W Pinkham 
James Radcliffe 
George E. Roberge 
Lester J. Wallman 
J. Richard Zahn 
1939 
Harold H Coppersmith 
Norman L. Cressy 
William H Druckemiller 
Robert G. Ernst 
John P. Ferguson 
Joseph B Forman 
S. Jerome Greenfield 
Paul E. Huston 
Nathaniel Kenigsberg 
Margaret A. Lennox 
James Peter Murphy 
Russell Nahigian 
Douglas S. Riggs 
Ernest L. Sarason 
Rebecca Z. Solomon 
Stuart S. Stevenson 
John D Tobin 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Jack S. Blaisdell 
Philip S Brezina 
Thaddeus S. Danowski 
Wynant Dean 
Richard E Dormont 
Robert M. Dunlap 
James F. Ferguson 
Eugene J. Fitzpatrick 
Henry D Humphrey 
H. Stuart Irons 
Donald G. Johnson 
Ira D LeFevre 
Paul D. MacLean 
Edward Martin 
William R. Oakes 
Maurice Ross 
Lee S. Sannella 
W. Norman Sears * 
Joseph E. Sokal 
J. Champneys Taylor 
Patricia E. Wanning 
John B. Wells 
Helen H. Woods 
1941 
Sophia H. Alway 
Robert H Areson 
W. Randal Bell 
Knute E. Berger 
William A. Carey 
Joseph P. Carson 
Charles B Cheney 
Herbert W. Diefendorf 
Robert Dine * 
Lloyd D. Flint 
John Franklin 
Robert L. Gilbert 
Frederick P Glike 
Sidney L. Lasell 
William Lee 
Bjorn Lih 
F. Eugene Martin 
Willys M. Monroe 
Malcolm C. Murfitt 
Edward B. O'Connell 
Robert W. Ollayos 




Eugene M. de Hostos 
James M. Bunce 
Walter J Burdette 
Robert E. Carroll 
Donald S. Childs 




Allan V.N. Goodyer 
Charles R. Harms 
William Harrison 
Wilson E. Hughes 
Leo Kellerman 
John R. Lincoln 
Patrick S. Mullins 
Dean Nichols * 
Samuel Ritvo 
Lois Knight Rogers 
Charles F. Scholhamer 
Richard W. Smith 
Edgar B Taft 
Maurice Tulin 
Irving Norman Wolfson 
1943 (March) 
Ralph D. Alley 
John R Brobeck 
Lycurgus M. Davey 
C. Thomas Flynn 
Gerard Fountain 
Jessamine R. Goerner 
R. Leonard Kemler 
Joseph P. Kriss 
Jonathan T. Lanman 
Dorothea R Peck 
Edward F. Rabe 
Earl J Rhoades 
Henry A. Reidel 
Bernard R Rowen 
Marcus E. Sanford 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Sophie Trent Stevens 
Oliver G Stonington 
Robert Lee Taylor 
Robert G. Turner 
Frederick A Waldron 
John J Weber 
Robert H Wyatt 
1943 (December) 
Richard N. Abbott 
John R Almklov 
David G Borden 
S Brownlee Brinkley 
Henry B Bruyn 
Thomas L. Bucky 
Jane B Cadbury 
Philip B. Chase 
Hunter H Comly 
Ronald W. Cooke 
Jean P Davis 
Joseph I. Epstein 
Fred M. Haddad 
Henry H Jones 
Joseph Keel 
Sawyer E. Medbury 
Ira A Rashkoff 
Donald W. Seldin 
Francis A. Spellman 
C. Wesley Watson 
1944 
Carl Andrews 
Edward J Conway 
John C. Coolidge 
George B Corcoran 
Frank W. Countryman 
Charles H. Crothers 
Lawrence G. Crowley 
John H Doherty 
Robert W Frelick 
Carol Goldenthal 
Howard B Hamilton 
Robert 1 Hinkley 
W Raymond James 
Ward S. Jenkins 
Edith M. Jurka 
Jerome J. Kaye 
John Weaver King 
Frederick F Krauskopf 
Ellen P. Mackenzie 
Elias J Marsh 
Katherine Hawley Martin 
Joseph Massaro 
A Reese Matteson 
Paul E. Molumphy 
Russell R. Monroe 
Lawrence K Pickett 
Laurence G Roth 
Haynes W. Sheppard 
Sarah P. Sherwood 
Nicholas P R. Spinelli 
Anthony J. Stone 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin W. Woodruff 
Rueben Zucker 
1945 
George Howard Allison 
A. John Anlyan 
Albert S. Atwood 
Frederic M. Blodgett 
Richard W Breck 
Louise H. Burr 
Alice Shepard Cary 
Sanford F. Cockerell 
Jay B Cohn 
Thomas P. Cotter 
Edward M. Daniels 
Richard R Dyer 
Robert S. Easton 
Sidney S. Feuerstein 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
Philip S. Good 
Herbert S. Harned 
Paul W. Hoffert 
O. Roger Hollan 
Hans R Huessy 
William L. Jenney 
William E. Laupus 
Raymond E. Lesser 
Mark McD Lindsey 
Charles E. McLean 
George W. Naumburg 
Fitzhugh C. Pannill 
Richard M. Peters 
Elliot R. Reiner 
Charles E. Sherwood 
1946 
Margaret J. Albrink 
Aaron T. Beck 
Sanfurd G. Bluestein 
Linus W. Cave 
James F. Cooney 
George C. Cusick 
Thomas A. Doe 
Edward F. Edinger 
H. Lambert Filer 
Gregory E. Flynn 
Martin E. Gordon 
Charles S. Judd 
Harold King 
Benjamin F. Kitchen 
Vincent J Longo 
Richard H. Mann 
Thomas J. Mathieu 
Hugh J. McLane 
Joe D Morris 
John H Morton 
John F. Neville 
Laura W. Neville 
Francis Reilly * 
David H. Riege 
Julian A. Sachs 
Donald P. Shedd 
Richard G. Sisson 
Colby S. Stearns 
R. Bruce Thayer 
Robert R. Wagner 
William P. Walsh 
William J. Wedemeyer 
Thomas J. Whelan 
Hugh R. Williams 
Elihu S. Wing 
1947 
George R Barnes 
Henry N. Blansfield 
Albert W. Bostrom 
John E. Bowers 
William Roy Breg 
John L. Cannon 
M. Richard Carlin 
John C. Carpenter 
Charles R. Cavanaugh 
Roland G. Chambers 
Robert Chase 
* Deceased 
Amoz I. Chernoff 
William F. Collins 
Robert P. Darrow 
Archie L. Dean 
Jean H. Dougherty 
Owen W. Doyle 
Franklin Harold Epstein 
Edward D. Foord 
Richard K. Friedlander 
Frank H. Horton 
Robert J. Kerin 
Don F. Kimmerhng 
Richard P. Levy 
Brock Lynch 
Victor A. Machcinski 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C Perry 
Edgar B. Phillips 
Olive E. Pitkin 
Irving Rudman 
Igor Tamm 
Patricia B Tudbury 
Ellis J. Van Slyck 
Laura B. Weed 
M. Henry Williams 
1948 
Russell J. Barrnett 
Edith M. Beck 
Allyn G. Bridge 
Richard Steele Buker 
Ruth E. Cortell 





B. Herold Griffith 
Sylvia Preston Griffiths 
Beatrix A. Hamburg 
Richard M. Hannah 
Ross R. Harcus 
W. Rayner Johnson 
Paul B. Koehler 
Robert E. Lempke 
Patrick J. McLaughlin 
John B. Morrison 
George P. Rostel 
Lewis P. Rowland 
Benjamin F. Rush 
Gabriel A. Saviano * 
Jerome H Shapiro 
Jessie Parkinson Spear 
Anne G. St. Goar 
Paul Woodbury Weld 
1949 
William G. Anlyan 
Alfred E. Bacon 
Henry W. Baird 
William D. Bevis 
Jonathan S. Bishop 
Thomas L. Chiffele 
Mary Pucci Couchman 
Phillip G. Couchman 
Peter R. Cunningham 
N. Joel Ehrenkranz 
Daniel W. Elliott 
Gunnar O. Eng 
Albert A. Fisk 
Paul S. Goldstein 
Frederic W. Gray 
Jackson Harris 
Robert C. Howard 
Orval 1 McKay 
Richard D. Otis 
Julian I Pichel 
Edmund L. Piper 
Charles L. Rennell 
Murray Z. Rosenberg 
Carl M. Russell 
William H. Sewell 
Raymond D. Sudarsky 
Martha Vaughan 
1950 
Russell N. Anderson 
Lyal D. Asay 
John E. Borowy 
William H Bucher 
Alvin Davis 
Claude W. Delia 
Kent Ellis 
Thomas J. Ferraro 
Daniel Fine 
Yvette F. Francis 
Carl A. Gagliardi 
Archie J. Golden 
Sidney S. Lee 
Janus C. Lindner 
Margaret S. Lyman 
Harry L McClelland 
John H. Meyers 
Orlando J. Miller 
Robert T. Sceery 
Cynia B. Shimm 
Jane B Shumway 
Martin Smith * 
Myra D. Tyler 
1951 
W. Robert Adams 
Frank R. Allen 
Thomas T. Amatruda 
Stanley D. Ardell 
Eleanor Clay Bigley 
John J. Egan 
Daniel X. Freedman 
Sidney S. Furst 
Ralph M. Gofstein 
Lowell 1. Goodman 
John T. Groel 
Robert N. Hamburger 
Carrold K. Iverson 
Jocelyn S. Malkin 
Paul D. Millikin 
Albert R. Mowlem 
Richard S. Munford 
Charles A. Nugent 
Jose Felix Patino 
Arthur A. Pava 
Majic S. Potsaid 
Robert G. Small 
William F. Stephenson 
William Taylor * 
Andrew S. Wong 
1952 
John W. Arnold 
Frank A. Carone 
Frank R. Coughlin 
Philip Gardner Deane 
Raymond S. Duff 
James R. Durham 
Robert P. Gerety 
William Joseph Johnson 
Thomas S. Kelly 
James Kent Luce 
N. Karle Mottet 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B Schultz 
Virginia Lee Swanson 
John H. Wagner 
Doris L. Wethers 
John L. Wolff 




Harold D. Bornstein 
Remi J. Cadoret 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
Louis R.M. Del Guercio 
James P. Dunn 
Vincent Lynn Gott 
Robert Emanuel Hamlisch 
A. Daniel Hauser 
George L. Hoffmann 
David Purdy Holman 
Peter Biggs Hukill 
Richard Robert Knowles 
Frederick Martin Lane 
Hildegard Mueller Leslie 
Preston Lee Leslie 
John Dutch Lord 
Robert N. Melnick 
Harvey Martin Peck 
Paul G. Quie 
Jose Ramirez-Rivera 
John C. Roberts 
Barbara F. Rosenburg 
Irwin K. Rosenburg 
Virginia C. Saft 
Howard Willis Smith 
Ora K. Smith 
Lynn Cortland Stoker 
Matthew Andrew Tandysh 
William Junior Vandervort 
William August Wilson 
1954 
Frank P Berg 
Richard J. Bouchard 
George N. Bowers 
John R. Cole 
William D. Cone 
Alan H. Covey 
Arthur C. Crovatto 
Donald D Davis 
Walter J. Freeman 
John A. Gariepy 
Edward J. Gerety 
Frank L. Gruskay 
Nicholas A. Halasz 
Katherine H. Halloran 
Robert P Hatch 
Walker R. Heap 
Eva H. Henriksen 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J.T. Joy 
Robert M. Keith 
Robert P. Knight 
Donald S. Kornfeld 
Harry C. Miller 
Paul N. Neufield 
William J. Paule 
Anthony V. Piccirillo 
Richard D Pullen 
Jacques M. Quen 
Edwin R. Ranzenhofer 
Earl D Rees 
John Keith Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
John W. Vosskuhler 
1955 
John B Atwater 
John C. Bailar 
George E. Becker 
Jerome Bobruff 
Douglas G. Boyden 
Irwin M. Braverman 
Edward Noel Brennan 
Padraic Burns 
Leo R. Cardillo 
Nicholas A. Coassin 
Edward D. Coppola * 
Milton Corn 
Pasquale James Costa 
John G. Daley 
Fred Wendell Doyle 
William O. Edward 
Leroy Engel 
F Robert Fekety 
Mahlon V.R. Freeman 
Barbara W. Gibson 
Rudolph J. Goerke 
Paul Gonick 
Ion Gresser 
John H. Hodge 
D Franklin Johnson 
Harry O. Kendall 
David R. Kessler 
Robert A. Kramer 
William E. Lattanzi 
Gilbert M.P. Leib 
Roger Lester 
Alexander Maitland 
Joseph S. McGuire 
Russel] Miller 
Robert C. Nodine 
James P. Nolan 
Sherwin B. Nuland 
Gloria C. Onque 
John C. Pace 
Robert H Peters 
Gregory Peterson 
Robert A. Reich 
Paul J Robinson 
F Brantley Scott 
Phillip W. Smith 
Alan A. Stone 
Alexander Zuckerbraun 
1956 
Alan E. Apfel 
Peter Bios 
Levon Z. Boyajian 
Thomas M Brown 
Rosalie A. Burns 
Joseph C. Cerny 
Edwin L. Child 
James C. Collias 
Donald J. Dalessio 
Chandler Dawson 
S. Evans Downing 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
Sumner Gochberg 
John Herd Hart 
William H. Hindle 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Preston C. Manning 
Dwight F. Miller 
Norman F. Moon 
Donald J. Nalebuff 
A. Frederick North 
David A. Page 
George W. Paulson 
Robert Lee Scheig 
James Scheuer 
Edward C. Senay 
Benjamin A. Shaver 
Donald William Sherrick 
Daniel R Silbert 
1957 
Donald Agostinelli 
Joseph S. Amenta 
Jack Norman Blechner 
Richard I Breuer 
Harry C Briggs 
John P Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold Dick Cross 
John D’Agostino 
Thomas H. Danaher 
James R. Dorr 
Harold J Fallon 
Robert E. Fishbein 
Ronald H, Fishbein 
Anthony L. Fons 
Elizabeth H. Forsyth 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Joyce D. Gryboski 
Gilbert F. Hogan 
Warren R. Johnson 
Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
George C. Knovick 
Jack Levin 
Bennett F. Markel 
Mark D. Marshall 
David E. Martin 
Howard A. Minners 
Robert K Modlin 
Hugh Lamson Moffet 
George Albert Nelson 
Herbert A. Newman 
Thomas Francis O'Brien 
Joseph S. Pagano 
Raymond E Phillips 
Clifford B Reifler 
Jesse G. Rubin 
Kenneth A. Simon 
Charles A. Slanetz 
Gilbert B. Solitare 
Robert W. Southworth 
Donald C. Stahl 
Arthur Taub 
William J. Waskowitz 
James G. Zimmer 
1958 
George K Aghajanian 
Joseph E. Angelo 
John P Arnot 
Gerard N. Burrow 
Benjamin Bursten 
David A. Carlson 
John A. Carlston 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Michael E. Fishman 
Peter A. Flynn 
Raymond A. Gaito 
John C. Gallagher 
Marcia Kraft Goin 
James Greenwald 
Charles A. Hall 
Michael Kashgarian 
Haskins K Kashima 
Jay Ward Kislak 
Theodore W Lieberman 
Myron Lotz 
Thomas J. Mauro 
Michael J. McCabe 
Leo T. McCallum 
William S. McClanahan 
Andrew Joseph McGowan 
John A. Merritt 
Albert Muggia 
Robert S. Neuwirth 
David W O’Keeffe 
Carol F. Phillips 
David M Pugh 
William B Radcliffe 
Paul A Rudnick 
Bruce H Sklarew 
Edward Lloyd Socolow 
Arlene Sweedler 
Raymond W Turner 
Margaret Smith Wenzel 
Joseph P. Wierzbinski 
John Patrick Wood 
Pauline B Wood 
1959 
Scott Ingram Allen 
Carol J Amick 
Robert M Amick 
Asa Barnes 
Francis A. Beer 
Jack F. Bowers 
William C. Butterfield 
Edward Call 
Sidney M Cohen 
Martin Colodzin 
Lyall S. Crary 
William L. Donegan 
Robert L. Fisher 
Robert J. Gonyea 
Gerald B. Gordon 
W Keith Hadley 
William H Heydorn Me 
C. Richard Hinckley 
Leonard Inker 
John J. Jasaitis 
Edvardas Kaminskas 
David W. Kingsbury 
Parry B. Larsen 
Myron S.S. Lee 
Kathryn Huxtable Lewis 
Daniel L. Macken 
James A. O'Neill 
Robert H. Ostbcrg 
Nicholas M Passarelli 
Charles A. Phillips 
John A. Poglinco 
Lincoln T. Potter 
James D. Prokop 
James R Ralph 
David Pardee Reed 
Joseph Douglas Robinson 
Joseph D. Saccio 
Marvin L. Schulman 
Marc D. Schwartz 
David B Skinner 
Sanford P. Solomon 
32 
James J. Stagnone 
Lisa A. Steiner 
John S. Strauss 
Leo H Von Euler 
Robert B Whitney 
Muriel D. Wolf 
1960 
Victor Altshul 
Alan W. Ames 
Jack D Barchas 
Donald P Buebendorf 
Thomas E. Carson 
Stanley M.K. Chung 
Jon E. Courtney 
March Enders 
Caldwell B. Esselstyn 
Warren H Fisher 
Paul Jay Friedman 
Alvin E. Friedman-Kien 
Eugene C. Gaenslen 
Gary Earl Gathman 
James 1 Gilman 
Sylvia D Grant 
Roland H Ingram 
Daniel M. Jones 
William S. Kaden 
Eric P Kindwall 
Frank J Kleeman 
Susan T. Kleeman 
Thomas P Kugelman 
Edward R. Lang 
Thomas L. Lincoln 
Edward Longo 
Eugene G McCarthy 
Donald L. Miller 
Richard G Morrill 
Allan W. Newcomb 
Buford l.. Nichols 
J Thomas Okin 
Fred Palace 
Jerrold M. Post 
Nancy Rolick Powell 
Martin L. Reite 
Albert Matthew Ross 
Daniel J Rubin 
John J. Schrogie 
Ross L. Snyder 
Fred Stargardter 
Constantine M Voyagis 
Robert C. Wallach 
May Yung-Fun Woo Wang 
1961 
Kenneth A. Arndt 
Earl L. Baker 
Albert A. Bechtoldt 
Robert S. Briggs 
David William Brook 
Orson R. Dee 
Paul David Deiter 
Ronald A. Dierwechter 
Jon Dudley Dorman 
Christopher Francis Durham 
John E. Fenn 
James M Giffin 
Edward C. Gilbert 
Robert Sterling Gillcash 
Louis D. Hunt 
Richard L. Keefe 
Robert Isaac Levy 
Hugh James Lurie 
David B Matloff 
Anoush Miridjanian 
Richard Allen Moore 
Norman 1 Moss 
John Pearce 
William M Rogoway 
Roy E. Ronke 
Stanley G. Schade 
John J. St. Andre 
Robert N. Taub 
Hugh C. Thompson 
Franklin H. Top 
David E Weaver 
Warren D. Widmann 
1962 
Michael H Alderman 
Charles B Anderson 
Frederic P. Anderson 
Dean E. Burgct 
Fredric K Cantor 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
John W. Foreman 
Leroy A. Forstrom 
Stephen John Fricker 
Anthony V. Furano 
John N. German 
John H Hageman 
John T. Harrington 
Patricia C. Hassakis 
Victor W. Hurst 
Walter Watson Karney 
Glenn L. Kelly 
David E. Knoop 
Alan D. Lieberson 
Manuel J. Lipson 
John P Lynch 
Malcolm A. Martin 
Stanley E. Matyszewski 
David J. McConnell 
William G. Meffert 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
A Richard Pschirrer 
James A.E. Spencer 
Larry Lee Stewart 
H. Oliver Stoutland 
Seth Thaler 
Sherwood Waldron 
William Farnsworth Weber 
1963 
Arthur Howard Acherman 
Miguel R. Alonso 
V Richard Back 
Charles W. Carl 
Theodore J Chu 
Gordon S. Cohen 
John E. Conte 
David F. Cross 
James S. Dalsimer 
Dudley Seth Danoff 
Andrew Edin 
John P. Eliopoulos 
B. Allen Flaxman 
David H. Fram 
William T. Friedewald 
Alexander R Gaudio 
Vincent F. Geremia 
Lee D. Goldberg 
Peter B Gregory 
Harold P Kaplan 
Constantine D. Kvropoulos 
William B Lehmann 
Craig H. Llewellyn 
Robert H Margulis 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R Pinnell 
Jay M Pomerantz 
Gene R. Profant 
Marvin R Skolnick 
Lee Bland Talner 
Thomas W. Tillack 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
Seth M Weingarten 
James G Wepsic 
Jerome Allen Winer 
Alfred J. Wise 
1964 
William A. Alonso 
Leland S Berger 
Philip Blume 
Anthony J Bravo 
Robert M Briggs 
William Virgil Brown 
Thomas A. Cardella 
Joseph F.J Curi 




Norman C. Fost 
Peter A. Gross 
John F.B. Haney 
Gene I Higashi 
Richard Hockman 
Lawrence Horwitz 
William J. Houghton 
William E. Kmght 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
Paul R Lightfoot 
Richard Murray Linburg 
Robert W. Lyons 
Andrew E. MacMahon 
William F. Matchett 
Thomas O. McCann 
Robert L. Mitchell 
Alan H. Morris 
James J. Murphy 
Donald A. O’Kieffe 
William B Pratt 
Stanley J. Rosenberg 
Jonathan J. Russ 
Norman Scher 
Robert L. Shelton 
Donald G. Skinner 
A. Thomas Snoke 
Lyall C. Stilp 





Susan A. Aoki 
Thomas T. Aoki 
Paul Balter 
Michael J. Cummings 
Carl Ellenberger 
David S. Fedson 
Robert 1. Finkel 
Frank J. Grady 
James K. Gude 
Reid R. Heffner 
Carl E. Hunt 
Virginia Burnham Johnson 
Robert H. Koehl 
Richard J Kozera 
Mark W. Lischner 
A. Lawrence Ossias 
Robertson Parkman 
John A. Parrish 
Robert L. Pickens 
Alan N. Rachleff 
William A. Renert 
Gene A. Robinson 
George B Rowland 
John H. Seashore 
Margretta Ann Reed Seashore 
Charles J. Semonsky 
David M. Shames 
Harlan Spitz 
E. James Stanley 
Bert Yuan-Shu Wong 
1966 
Benjamin F. Balme 
John D Baxter 
Patricia Bazemore 
Robert P. Bazemore 
Frank C. Bell 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Donald J. Cohen 
Thoburn Aaron Dadisman 
Joseph A. Donadio 
Robert E. Dragon 
Marvin A. Eisengart 
Jared M. Emery 
Robert N. Frank 
Robert C. George 
Jeffrey B Gluckman 
Stanley I Greenspan 
J McLeod Griffiss 
Robert A Gunn 
Stuart T. Hauser 
Jay G Hayden 
Mary Alice Houghton 
John B Howard 
Richard J Howard 
Bruce W Jackson 
Gordon R Kelly 
Neal Koss 
Stuart M Kotler 
David C. Law 
Lynne L. Levitsky 
Henry B Mann 
Robert L. McRoberts 
Harold Mellin 
John J. Mooney 
Edward J O'Keefe 
William D. Peterson 
James D. Slavin 
Parker J. Staples 
Gary L. Townsend 
Lee Van Lenten 
Joan T. Wayland 
Jon S. Wayland 
John W. Wickenden 
William B. Yeagley 
Arne S. Youngberg 
1967 
Daniel L. Arons 
Arthur L. Beaudet 
Arthur Walker Boddie 
Daniel J Booser 
Gary C. Burget 
William T. Cave 
Mary Williams Clark 
Cynthia Rapp Curry 
Marian C. Davidson 
James Lucius Davis 
James J. Dineen 
Alexander F. Dora 
James M. Dowaliby 
John A. Drews 
Peter R. Egbert 
Herbert W. Felsenfeld 
Melvin Victor Goldblat 
Richard J. Hart 
Richard L. Heppner 
Peter N. Herbert 
George P Herr 
David L. Ingram 
J Robert Kirkwood 
Melvyn Korobkin 
Carl E. Lane 
Anthony P. Lovell 
Stephen W. Miller 
William J. Mitchell 
Joseph L. Morris 
Jennifer Robinson Ntebyl 
John O Pastore 
William E. Perkins 
Brian F Rigney 
James J Robinson 
Marvin J. Rosser 
Robert 1 Roy 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith 
Helen L. Smits 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson 
Karen H. Toker 
George Tyler 
Robert A. Vogel 
Robert A. Vollero 
Joseph F Walter 
Martin Wand 
Robert J Winer 
Robert S.K Young 
lhor George Zachary 
Peter M. Zeman 
1968 
Julius H Anderson 
Joseph F. Andrews 
Philip L Barry 
Daniel I. Becker 
Donald R Coustan 
Robert G. Dillard 
Edward M. Druy 
Barbara Mayer Egbert 
Lamar Ekbladh 
Alan G. Finesilver 
William F. Flynn 
Richard A. Getnick 
Mark Gilbert Grand 
Leonard Grauer 
Kevin N Hennessey 
John R Hill 
Harry S. Holcomb 
Peter A. Kirkpatrick 
Jeffrey S. Lee 
Marc E. Lippman 
Peter A. Livingston 
Frank E. Lucenle 
Donald O. Lyman 
Rodrigo Martinez 
Harmon Michelson 
David P. Millett 
James B. Morris 
Margot Onek 
Jackson B E. Pickett 
Charles T. Post 
Joseph L. Renda 
Gordon H. Sasaki 
Jacob J. Schlesinger 
Bruce Stuart Schoenberg 
George F. Sheckleton 
Frederick C. Sherman 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
James L. Weiss 
Per Henrik Wickstrom 
1969 
Brian D. Altman 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
N. Roger Cooke 
Leo M. Cooney 
Richard J. Daly 
Charles A. Dinarello 
Douglas T. Domoto 
Ralph J. Falkenstein 
Gary S. Larnham 
Steven A. Frankel 
William H. Frazier 
Anna S. Gail 
Royal J. Gay 
David A. Geer 
Sander G. Genser 
Robert O. Gordon 
Steven M. Herzberg 
Thomas C. Howard 
Lee M Jampol 
Joel Mark Kaufman 
Paul H. Kelker 
John J. Kelly 
Rowena Korobkin 
Stephen Krant 
Michael R. Liebowitz 
Robert L. Marier 
Arnold F. Mazur 
Ellen B Milstone 
Thomas F. Minehan 
Bruce K. Nagel 
Lionel M. Nelson 
Deborah A. Putnam 
N. Burgess Record 
Joseph D. Robinson 
Joseph M. Rochford 
Dennis J. Rudzinski 
David J. Sahn 
Lutz H. Schlicke 
Adrian M. Schnall 
David J. Schulak 
Gerald J. Smallberg 
Michael S. Toren 
Robert J. Walat 
Stephen R Webb 
Steven C. White 
1970 
Elissa B. Arons 
Roger J Branson 
Henry Chessin 
Michael J. Chusid 
C. Norman Coleman 
Michael D Danzig 
James E. De Lano 
Margaret W. Delano 
Jonathan Ecker 
Bruce A. Fabric 
B. Graeme Fincke 
Thomas H. Gouge 
Paul C. Hessler 
Jay H. Hoofnagle 
Robert L. Janco 
Gerard T. Kennealy 
Ely A. Kirschner 
Mark A. Korsten 
Thomas L. Lewis 
Stephen Lipper 
Robert B. Litman 
Anne W. Lucky 
Jay W. Marks 
Leonard M. Milstone 
James R Missett 
William K. Mueller 
Bruce A. Reitz 
Robert M. Rosa 
Joel F. Rubinstein 
Dennis E. Shield 
Stuart S. Shorr 
Richard A. St. Onge 
Philip E. Steeves 
Ray W Tripp 
Brian Weiss 




Judith L. Bader 
Gregory W Bartha 
Laurie J. Bleicher 
Willard Cates 
Frederick L. Cohn 
Andrew D. Cook 
David Cossman 
Edward C. Cottle 
Michael Cynamon 
John S. Ebersole 
Leonard I. Eisenfeld 
Daniel E. Feldman 
Harvey Fernback 
Fred Finkelman 
Jared J. Gardner 
Michael J. Hart 
William W. Hay 
Richard E. Kaufman 
Robert M. Kessler 
Barbara K. Kinder 
William L. Krinsky 
David H Lippman 
Sten B. Lofgren 
Samuel S. Masters 
John C. Mills 
Patrick T. Mimhan 
Steven H. Moffic 
Richard Albert Moggio 
Martin Paris 
John A. Patti 
Barry Bruce Perlman 
Michael C. Piercey 
Anthony V. Proto 
Barry S. Rand 
Irving G. Raphael 
David M. Rinzler 
John Smiarowski 
James P. Southwick 
Jonathan W. Stewart 
Daniel R. Synkowski 
Richard D. Travers 
Yvonne E. Vaucher 
Paul A. Vignola 
Albert Carl Weihl 
Burns Woodward 
1972 
Robert D. Arbeit 
Michael A. Catalano 
Leonard H. Cohan 
Philip L. Cohen 
Gloria Cummings * 
Norman M. Dinerman 
William H. Druckemiller 
M. Fleix Freshwater 
John P Fulkerson 
Robert D. Glassman 
Dorothy M. Gohdes 
Bruce B. Haak 
Thomas L. Horn 
Vernon H Humbert 
Anthony H Jackson 
Jesse B Jupiter 
Frank M. Kahr 
Roy A. Kaplan 
David L. Kneapler 
Philip W. Lebowitz 
Theodore M. Levin 
Paul A. Lucky 
Harry L. Malech 
Jeffery S. Menkes 
Jerome H. Meyer 
Jorge A. Motta 
Edward J. Olinger 
Peter J Panzarino 
John N. Posch 
William L. Risser 
David H Romond 
Philip M. Rothfeld 
John S. Smolowe 
Frederick D. Stockwell 
Philip J. Weyman 
John D. Wright 
Michael W. Yogman 
1973 
David A. Adler 
David Nelson Bailey 
Mary Ann Brunstetter-Shafer 
Robert W Bucholz 
Marvin M. Chassin 
Joseph M Connors 
David L. Coulter 
Christopher M. Doran 
Joseph W. Eichenbaum 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert E. Galloway 
Lee Goldman 
Gary T. Grimes 
Jorge L. Hernandez 
Howard S. Honig 
David C. Johnson 
Andrew G. Kadar 
Lynne M Liptay 
George Lister 
Mark G.F. McCormick 
John F. McQuade 
Jerry Nagler 
Victor L. Pappoe 
David E. Peach 
David Pickar 
Robert J. Polackwich 
Charles F. Reynolds 
James S. Robertson 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
Joseph F. Simeone 
Michael E. Solin 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Marc A. Weinberg 
Richard S.K. Young 
Randall M. Zusman 
1974 
Irving M. Asher 
Leonard I. Banco 
Douglas A. Berv 
Bruce David Blumberg 
Neil Blumberg 
Peter J. Buchin 
Paul David 
Vincent A. Di Maria 
Roger H. Emerson 
Michael K. Eshelman 
Irl L. Extein 
Reginald K. Franklin 
Allan B. Friedland 
Michael A. Gerber 
David Grant 
Robert F. Hempton 
Ancil A. Jones 
Edward L. Marut 
Marjorie A.S. Oda 
Richard C Pasternak 
Andrew L. Ries 
David Z Ritvo 
Amy S. Schechter 
John D. Schrumpf 
Frederick S. Shessel 
Carol C. Teitz 
John Jones Thompson 
Jason S. Zielonka 
1975 
J. Edwin Atwood 
Ralph E. Binder 
Neil Blumberg 
Stanley W. Gale 
Isaac Hoch 
Kevin Kane 
Martin B Leon 
Richard J Loewenstein 
Hyman J. Milstein 
Mary Jane Minkin 
Robert G. Nankin 
Edwin G. Olson 
Vivia Reznik 
Philip J Rich 
Salvatore V. Romano 
Fred P Rosenfelt 
Robert S. Sandler 
Steven A. Schwartz 
Barbara J. Stoll 
George H Talbot 
Douglas R. Zusman 
1976 
Sarah S. Auchincloss 
Alfredo L. Axtmayer 
Peter B Bitterman 
Alan B Block 
Sharon L. Bonney 
Roger A. Boshes 
Randall D. Cebul 
Richard S. Childs 
John A. Elefteriades 
Geoffery Etherington 
Leonard Firestone 
Dennis M. Fisher 
Rose Hannah Goldman 
Glenn A. Gorlitsky 
Norman V. Kohn 
William J. Lederer 
William K. Levy 
George W. Luedke 
Douglas G. Mann 
Larry Markowitz 
Paul R Ramirez 
James L. Rosenzweig 
Mark C. Ruchman 
John T. Sladky 
Peter M. Ting 
Frank B Watkins 
John C. Wiles 
Carol M. Ziminski 
1977 
Marcia Clark Arem 
George Bolen 
John J Boronow 
Margery Buck Brenner 
Richard D. Bucholz 
Charles M. Bunke 
Christopher S. Clark 
John H. Cook 
Stuart Brian Dubin 
Marybeth Ezaki 
Susan Firestone 
James A. Fox 
Julia B. Frank 
Robert W. Hand 
Jeffrey Neal Hausfeld 
Bruce L. Innis 
Karen G. Kelly 
David J. Kreis 
Robert J. Mitchell 
Stephen N. Oesterle 
Alan S. Penziner 
Theodore M. Pitts 
Ricky M Schneider 
Simeon A. Schwartz 
Mark S. Smith 
Gail M. Sullivan 
Ronald J Vender 
Steven L. Warsof 
J. Douglas White 
Daniel Wohlgelernter 
1978 
Thomas T. Amatruda 
Richard J. Baron 
Joann N. Bodurtha 
Booker T. Bush 
Jesse M. Cedarbaum 
Henry R. Desmarais 
Eric B. Einstein 
Emily A. Fine 
Eugene Glenn Fong 
Stuart M. Forman 
Robert A. Gelfand 
Jerald D. Hansing 
Alexandra N Helper 
Robert Hershfield 
Cynthia S. Kretschmar 
Robert P. Lamberton 
Seth M Powsner 
Steven M. Shoum 
Donald C. Simonson 
Thomas Joseph Smith 
Rafael J. Tavares 
Stanley J. Tillinghast 
Marcia J. Wade 
Sharon R Weinstein 




Daniel M Bethencourt 
Richard D Bey 
David A Brenner 
Stuart L. Bursten 
Michael M. Chang 
Orlando Fernandez 
John Jay Gargus 
David E. Golan 
Bruce Halperin 
Jeffrey L. Kaine 
Michael K. Lindsay 
David E. Ness 
Jean Rosenthal 
Gary L. Schaer 
Cynthia Anne Sherman 
Jill A. Silverman 
John T. Woo 
Jeffrey Work 
1980 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R Aronson 
David Allen August 
Jay M. Baraban 
Mark S. Bernhardt 
Patricia Church Brown 
Stuart L. Bursten 
Forrest John Doud 
David M. Gaba 
Todd J Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Gary I. Greenwald 
Barry M. Kacinski 
Theodore W. Marcy 
Suzanne M. Matsui 
Cesar R Molina 
Steven Ira Rosenfeld 
Jane G. Schweitzer 
Jeffrey N. Siegel 
Leslie W. Sojka 
Marcia R, Taylor 
Maria L White Greenwald 
1981 
Cynthia B Aten 
Alicia Barela 
Sherri L. Brown 
Patricia A. Burke 
Colleen Bursten 
Christine M. Duranceau 
Louis Essandoh 
Jonathan M. Fine 
Judy E. Garber 
Robert S. Goldman 
Laurie J. Gordon 
Neil D. Gross 
Scott A. Hundahl 
Elliot Lach 
Barton N. Milestone 
Robert M. Milstein 
Robert B Portney 
Barbara A. Roach 
Susan C. Schachner 
Anthony M. Urbano 
John C. Wong 
1982 
Rise Maura Chait 
Keith L. Gladstien 
Liba E. Goldblum 
David Goldstein 
Jed B. Gorlin 
Patricia Kellner 
Kathleen Anne Nolan 
Dan B Odenheimer 
33 
Carrie A. Redlich 
Paula C. Schlesinger 
Henry J. Stern 
Albert L. Ungricht 
Stephanie Wolf-Rosenblum 
1983 
John T. Adams * 
George Bartzokis 
Elena Citkowitz 
Nancy Kraemer Crocker 
William Kadish 
Augusta S Roth 
Leonard B. Saltz 
Michael Silverberg 
Daniel M. Sosin 
Michael B. Tom 
Contributors to the 
Public Health Alumni 
Fund 1983-84 
1923 
Isidore S. Falk * 
Leonard Greenburg 
1927 
Alice S. Baldwin 
1929 
Gertrude S Boyle 
1930 





Edward B Bosworth 
Evelyn H Halpin 
Elizabeth Murphy 
Eunice Nickerson Tyler 
1934 
Ivai A Merchant 
lwao M, Moriyama 
Amy H. Wilson 
1935 




M Allen Pond 
1937 
Lidie V. Dyer 
Howard West 
William R. Willard 
1938 
Willard H. Boynton 
Richard K.C. Lee 
Katharine Hawley Martin 
Lucy S. Morgan 
Andrew S. Wong 
1939 
Carl T. Cohen 
James C. Hart 
Frances S. Miller 
1940 
Elizabeth H. Pitney 
1941 
Roslyn L. MacNish 
Alexander Witkow 
1942 
Henry F. Canby 
Charles D. Spangler 
1943 
Carolyn S. Kofflcr 
Eric W Mood 
Miriam H. Rohde 
Jane 1 White 
1944 
Massimo Calabrcsi 
Paul E. Gagnon 
Jean F. Heston 
l ily Berman Moslyn 
Jane Y. Parker 
• Deceased 
1945 
Roslyn R Bilford 
Naomi Barer Golden 
Joe B Graber 
Lois M. Jund 
Naomi Helen Kalajan 
1946 
Edith M Blakeley 
D. Patricia Nelson 
1947 
Sidney S. Chipman 
Clara E. Councell 
Anne E. Fulton 
Lillian L. Konick 
Raymond W. Leonard 
JoAnn S. Lewis 
Rosa Frances Montgomery 
Jean M Pinder 
Cecil G. Sheps 
1948 
Mary Margaret Fitzgerald 
Samuel S. Herman 
Barbara L. Holman 
Sylvia Johnson 
Beatrice H Kaasch 
Dorothea S. LaBelle 
Hiram Sibley 
1949 
Eleanor C. Connolly 
Edgar L. Geibel 
Hilda H. Kroeger 
Christine R Owre 
William B Parsons 
Elizabeth D Robinton 
1950 
Henry G. Brickman 
Ida M, Bucher 
Helen P. Cleary 
Jerome M. Glassman 
Eugene K. Harris 
Martha P Jayne 
Everette D Reese 
Frances K Reynolds 
Elizabeth M. Scully 
Nathan M. Simon 
John D Thompson 
1951 
Clarissa E. Boyd 
Norton G. Chaucer 
John W Gerdes 
Homer P. Hopkins 
Robert L Johnson 
George Kraus 
Leonard F Menczer 
Jessie Parkinson Spear 
Angelica Z. Sysesky 
Elizabeth Ulrich Throm 
Walter Wenkert 
1952 
Cahit H. Corbacioglu 
Howard Dunphy 
Virgina M. Good 
Joanna Adele Henry 
Malcolm C Hope 
Charles Holway Lawrence 
Sidney S. Lee 
Helen Kardys Loria 
Yolande F. Lyon 
Richard B. Ogrean 
Anne Barlow Ramsay 
Brena B. Wolff 
1953 
Jeanette Averill 
Harold Robert Bernshock 
Abraham Cutcher 
Cecilia Frances DiCicco 
Shirley L. Handler 
William H. Hermann 
Barbara J. Lee 
Laurence K. Rainsford 
Milton H Sissclman 
Donald N. Zehl 
1954 
Calvin P Hatcher 
Ruth M. Taber 
1955 
Constance T. Beemer 
Lester M. Bornstein 
Charline S. Buck 
Amy L. Cawley 
Isreal Gitlitz 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Ann Peverley 
Gerald Rosenblatt 
Daniel E. Ross 
1956 
David D Boyd 
Marvin H Burton 
John P Dowling 
Kathleen H Howe 
Paul C. Kaufman 
Floyd D Parrish 
Henry M. Parrish 
Alice M. Wagner 
1957 
Janet Beach 
Lee De Cady 
Edward R Delouise 
Sheldon Selig King 
Edna May Klutas 
William R Metzger 
Jerome R. Sapolsky 
Alice K. Smith 
Shirley T. Steidel 
Sylvia R Talbot 
Patricia A. Viscosi 
1958 
Helen H Davenport 
Thomas T. Flynn 
Patricia P Grimaila 
Fred M. Haddad 
Philip B. Hallen 
Chun-Lin Lai 
Edward H. Noroian 
Thomas P. Weil 
1959 
O. Wade Avant 
Rita Dingman 
Raymond S. Duff 
Bennett 1 Enowitch 
John T. Foster 
Folly Hofer 
William L. Kissick 
Erica J. Koehler 
Marvin A. Lavenhar 
John F O’Connor 
John S. Pullman 
Ellwyn D Spiker 
Kenneth J. Williams 
Dorothy M. Wilson 
1960 
Bruce A. Barron 
Gyla E. Brooks 
Kathryn L D’Amico 
Wouter Ekker 
Armin F. Funke 
Maxine Geeslin 
Rose A Iannotta 
Katherine Anna Keppel 
Lowell Stern Levin 
Salvatore Miano 
R John C. Pearson 
Hannah Clark Russell 
Else Niebuhr Schulze 
1961 
Nicholas G Alexiou 
Gordon R. Beem 
Mary S. Blackburn 
Martin Donabedian 
Alfred E. Fletcher 
Herbert Rubinstein 
Angela M. Russo 
William R. Slivka 
K Berridge Sohler 
1962 
Richard B. Blakney 
1963 
Dorothy Weichert Brockway 
David Dolins 
C. DuVe Florey 
Frank M Isbell 
Edward M Kenney 
Jean M. Maynard 
Samuel B Webb 
1964 
Elizabeth C. Beilis 
James J. Culhane 
Katherine Maria Detre 
Neal L. Maslan 
Theodore Rosenberg 
Estelle Siker 
Claudewell Sidney Thomas 
1965 
Robert M. Edwards 
H Patterson Harris 
James F. Jekel 
Michael E. Kove 
Peter J Levin 
Charlotte Miller 
Elliott A. Segal 
David S Weiner 
1966 
Allen Cohen 
Anne B Collart 
[Dorothy Noyes Kane Evans 
Diana B. Fischer 
Norman M. Gervais 
Jennifer L Kelsey 
Robert C. Lowrie 
1967 







Joseph F. Kukla 
Patricia D. Mail 
James M. Malloy 
Nancy Ruth Phillips 
Brigitte Prusoff 
Michael C. Quadland 
Bruce J Steinhardt 
Robert L. Woodward 
1968 
Glenda Davis Anderson 
Philip D. Cobb 
Sonia M. Colon 
Joseph L. Dorsey 
Robert R Everett 
L. Carol Fernow 
Carl R Fischer 
Susan F Klein 
Jean C. MacCorison 
John M. Patton 
Richard L. Petrelli 
Arnold R. Saslow 
Cornell Scott 
Doreen P Sharabati 
Elizabeth A. Small 
Martha F. Steel 
Sheila W. Wellington 
Barbara L. Yetka-Eisenberg 
1969 
Susan S. Addiss 
Vistor Crown 
E. Belle Evans 
Sharon A. Garcia 
Gerald R Harpel 
Sylvia N. Holtzberg 
Charles C. Jelfrey 
Samuel P. Korper 
Samuel D. Rowley 
Marva Serotkin 
Wanda Vierthaler 
Robert L Young 
1970 
Susan W. Balter 
Robert T. Beeman 
Arthur A. Berarducci 
Michael B Bracken 
Hamilton B Brown 
Shan Cretin 
Sabina M. Dunton 
Walter M. Gawlak 
Robert S. Gureasko 
J. Kevin Kinsella 
C.P. Noel McCarthy 
Anthony M. Orlando 
Peter Orris 
David A Pearson 
Nancy Norton Reitz 
Charlotte F. Schwartz 
Carol B. Von Stein 




Evelyn J. Bromet 
William F. Carey 
Willard Cates 
Katrina H. Clark 
Karen S. Cohen 
John A. Daeley 
Harvey Fernbach 
William P. Ferretti 
Anne-Marie A. Foltz 
Billie S. Hamblin 
Sara P. Hartman 
Wanda J. Hatmaker 
Mohamed Ismail Johnson 
William P. Koughan 
Catherine S. Lindenberg 
Mark J. Magenheim 
Joan L. Martinez 
Eugene S. Mayer 
Joseph S. McManus 
Nancy P. Mogielnicki 
Lloyd F. Novick 
Wan Hin Ooi 
David A. Osgood 
Carol L Paul 
Jane Silver 
Walter O. Spitzer 
David L. Stockton 
Judith Whitcomb 
1972 
Stephen B Baruch 
C. Gene Cayten 
Catherine A. Connolly 
Paul Finlayson 
Daphne Dej Gemmill 
Susanne Harris 
Jean T. Harrison 
Selby Campbell Jacobs 
Dorothy N. Lewis 
Steven M. Lipsius 
Sergio Ruschel 
Jo Ann K. Silverstein 
Raymond L. Sphar 
Laurence A. Tanner 
Joyce R. Waksman 
Carol H. Simpson Yee 
1973 
Emily M. Barclay 
Eva Danielsson Cohen 
Schula Russell Hobbs 
Chang S. Lao 
George A. Million 
Marjorie E. Nelson 
Gary Dean Sax 
Thomas J Stranova 
Irene Trowell-Harris 
Larry S. Webber 
Bonnie C. Yankaskas 
Carl J. Zack 
1974 
Gregory Belok 
Thomas A Benoit 
Carl A. Cappello 
J. Breckenridge Eagle 
Elizabeth M Helming 
Stanley E. Kilty 
Roberta Lawrence 
Karen K Lindfors 
Edward A. Martinez 
Shirley M. Pripstein 
Nils R Richardson 
Abigail L. Smith 
Myrna M. Weissman 
Bienvenido G. Yangco 
1975 
Clayton A Ajello 
Christine P. Antaya 
Edith N. Baum 
Ralph E. Binder 
Gerald E Bisbee 
Linda K. Broker 
George R. Curry 
4 
Hillary Demby 
Mary Frances Flynn 
Susan T. Gershman 
Elizabeth T. Hunter 
Mary F. Johnson 
Philip D. Kennedy 
James E. Knoben 
Kathy S. Kohn 
Nancy J. Kreiger 
Patrick W. Laskey 
Stuart L. Lefkowich 
Laurence F. McMahon 
Edward J. O’Neill 
Mary W. Palshaw 
Dale P. Sandler 
Edward V. Sargent 
Nancy E. Stroup 
Thomas J. Trudell 
Franziska U. Ulrich 
Audrey S. Weiner 
Marion Lee Wu 
1976 
Peter B Aaronson 
Elaine P. Anderson 
William F. Appicelli 
Catherine M. Boyle 
Kathleen Keenan Bucholz 
Frances L. De Peyster 
Agueda N. Deans 
Joanna M. Erikson 
Tim M. Ettenheim 
Gail lies Genvert 
Linda J. Goodhart 
Karen A. Gordon 
Janet Heinrich 
Frances Anne Kanach 
Robert T. Kauer 
Karen E. Me Clelland 
Gino A. Nalli 
Peter N. Peduzzi 
Ruth Fitch Quah 
James B Rokos 
Robert Risdon Schwarz 
Mary Jo Shepard 
Gladys A. Williams 
Thomas S. Wingardner 
1977 
Patrick F. Carone 
Steven R. Cohen 
Marsha E. Dunn 
Gerard J. Foley 
Paula Yaney Gambill 
Rhona Kantor Kershnar 
Teri J. Klein 
Ronald F. LaPensee 
Wendy K. Lefkowich 
Robert Walter Makuch 
Polly W. Marvin 
Kristin K. O’Connor 
Harris Pastides 
Linda Mendelsohn Pottern 
Dorothy A. Rice 
Lynne E. Rosenwald 
Abby Rothschild 
Anthony V. Sardinas 
Carroll Schilling 
Young S. Shin 
Barbara G. Smith 
Gail M. Sullivan 
Thomas H. Ulfelder 
Leon F. Vinci 
Judy Walrath 
1978 
David S. Abernethy 
Vijaya V. Bapat 
Kathleen M. Berman 
Alan B. Bloch 
Maura Carley 
Scott H. Flamm 
Robert H. Frazier 
Ann T. Freedman 
Janice F. Gold 
Cynthia R. Gross 
Olympia Hadjimichael 
Nancy G. Hildreth 
Stephen W. Hildreth 
David W. Houck 
Jean Crum Jones 
* Deceased 
Margaret Long Karis 
Roslyn 1. Liss 
Christopher M. Maylahn 
Barbara J. Mieras 
Marguerite Nelhgan 
Elizabeth L. Pantelick 
Trudee Parenteau 
Ellen J. Reifler 
Ellen D. Rothberg 
Irene Schapiro 
Robert E. Schwartz 
Roberta Jo Shapiro 
Gloria Shappy-Meickle 
Karen Wolchuck Sher 
Roberta Nancy Silbert 
Alan J. Siniscalshi 
Martyn R Smith 
Marie Squattrito 
Marie Stoeckel 
Bernadette S. Vissani 
Lucy Ellen Weiger 
1979 
Rosemary C. Baggish 
Virginia P. Bainbridge 
Gertrud S. Berkowitz 
Marianne Berwick 
Rhonda S. Besunder 
Marna P Borgstrom 
Maria A. Bautti 
Ralph J. Coburn 
James F. Consedine 
Richard T. D’Aquila 
Susan De Renzo 





Kathe P. Fox 
Judith B. Gancher 
Lucinda H. Gerson 
Debra Haffner 
Candice C. Haslegrave 
Bruce H. Heckman 
Karen G. Hellenbrand 
Catherine Hobbins-Norton 
Siu L. Hui 
Karen Kmetzo 
Paul Anthony Kowalski 
Benjamin Krevsky 
Renee S. Leary 
Jean-Fern Lian 
Bennett Myles Locke 
Mary Elizabeth Lorenzi 
Elizabeth Lee Luttgens 
Osvaldo Marrero 
William McCune 
Patricia J. Moore-Pastides 
Laure C. Nichols 
Anna M Reager 
Betty J. Reid 
Marcia C. Richardson 
Lisa K. Rosenfeld 
George B. Rowland 
William E. Schweizer 
Ralph Tartaglione 
Elizabeth Tedder 
Mary Jane A. Teta 




Gary J. Aboff 
Frederick R. Aronson 
Curtis S. Breslin 
Antoinette M. Brooke 
Richard L. Buck 
Sheila Conneen 
Diane L, Denis 
Phyllis F. Dower 
Audrey L. Fetter 
Beth M. Finkelstein 
Richard J. Frankosky 
Barbara H. Granger 
Ellen B Greif 
Samuel S. Hamilton 
Virginia S. Humphrey 
Helen E. Kelly 
Yee-Lean Lee 
Kathleen A. Lewis 
Merle J. Lewis 
Leroy F. Ludwig 
Anne E. Morrison 
Steven Morrow 
Jane Ungate O’Connor 
Susan L. Schwartz 
Jane T. Siegal 
Marsha L. Silverman 
Richard Gerard Stracqualursi 
Thomas A. Tobin 
Rhona Weiss 
Carolyn K. Wells 
Philip A. Witman 
Marie L. Zanotti 
Barbara A. Zappas 
1981 
Jean Adnopoz 
Nancy R. Angoff 
Nancy M. Blankenship-Wheeler 
Donna A. Brenn 
Rollin C. Chew 
Ann M. Dunbar 
Julia Eisenstein 
Kristen H. Forrest 
Richard T. Forsley 
Robert Fox 
Judy E. Garber 
Barbara A. Gaugler 
Marie F. Gavula 
Susan A. Hart 
Susan E. Jennings 
Jill L. Lapides 
Katherine M. McCormack 
Blackford Middleton 
Howard J. Newman 
Mary E. Papke 
Gerald W Robinson 
Marsha Thomas Rudov 
Elizabeth N. Shapiro 
Susan M. Stoecker 
Karin Swanson 
Keith D. Tait 
Joan H. Urquhart 
Kathy S. Vita 
Nancy Schlesinger Weiss 
Kathleen R. Yager 
Nancy C. Yedlin 
1982 
Jamie L. Amaral 
Jenny 1 Andrus 
Lynn A. Baden 
Francis L. Crowley 
Mary Desmond-Tait 
Kathleen K Devine 
Meryl Beth Gold 
James L. Hadler 
Nancy Pitt Hopkins 
Kim Fulmer Humphrey 
Leonard Kalm 
Christina H. Kohout 
Linda F. Me Caig 
William F. McKeon 
Constance A- Morris 
Jill A. Okrent 
Carolyn Xavier Orcutt 
Sally R. Rinaldi 
Dale Allan Rublee 
Lisa E. Stone 
Elizabeth S. Valalik 
Michele T. Visconti 
Sandra Michaelson Warren 
Daniel Wartenberg 
Amy B. Wilson 
1983 
Barbara W Abraham 
Gail Alexander 
Joseph Amatruda 
Dean S. Archibald 
Jeffrey R. Botwinick 
Patricia Charnas 
Peter A. Charpentier 
Benjamin Obi Chukwumah 
Eileen Conlon 
Mark L. Dembert 
Robert A. Duncan 
Susan Faris 
James N. Gaito 
Ellen M. Ginzler 
Judith S. Goldstein 
Halesteen Graham 
Daniel A. Graybill 
Nancy R Kellett 
Linda S. Leo 
Allen F. Levy 
Cynthia M. Maglaque 
Wendy L. McGill 
Shinsuke Morio 
Beverly Y. Nipper 
Suzanne Nutt 
Jeannee M. Parker 
Lynn Saint Germain 
Paul M Schur 
Ina L. Silverman 
James G. Uberti 
Marilyn F. Vine 
Vicki L. Wilson 
Nancy K Wright 
Fund 1983-84 
Former House Staff 
Frederick W. Ackroyd 
N. Erick Albert 
Ronald Angoff 
Adel H Ayoub 
Robert G. Bachand 
Ronald J. Baily 
Jane E. Barry 
Arnold M. Baskin 
Carl Bennett Bean 
Gregory Kent Bergey 
Kenneth R. Berv 
Mary C. Bibro 
Ralpph Daniel Bien 
Jacques L. Bonnet-Eymard 
Alan L. Breed 
David Brigati 
Marvin B. Brooks 
Bruce Burnham 
Thomas N. Byrne 
Dennis J. Card 
Victor Carpiniello 
J Richard Casuccio 
Whei C. Chang 
Richard Allen Chase 
Chang Song Choi 
Michael Chun 
James C. Cobey 
David L. Copen 
Alan R. Cote 
Robert E. Crootof 
F. Mitchell Cummins 
Harvey Davis 
Michael Martin Deren 
Richard K. Donabedian 
William R. Drucker 
Marlene R. Eckstein 
Stephen A. Edelstein 
Daniel S. Egbert 
Lawrence B. Eisenberg 
Malcolm Mitchell Ellison 
Alvan R. Feinstein 
Richard Webster Finner 
Morris A. Fiaum 
Norman H. Gahm 
George O Gelinas 
David M. Gershenson 
V Philip Glassman 
Nelson H. Goldberg 
Issac Goldrich 
William H. Greene 
Williard F. Greenwald 
Gordon W. Grundy 
Joseph Guaraldo 
William R Haas 
Seymour Haber 
Hedda Ann Litowitz Haning 
Stanley Hersh 
Thomas P Higgins 
Melvin Horowitz 
David Smith Hubbell 
Eric A. Hyson 
Robert Orville Jensen 
Robert M. Johnston 
Jill P. Karpel 
Bernard L. Kaye 
Michael W. Keith 
Stephen King 
Samuel C. Klagsbrun 
Lawerence E. Klein 
Thomas J. Koontz 
Eugene Kuchner 
Joel C. Labow 
Sheri J. Lagin 
Paul Julius Laube 
Douglas M. Levin 
Stanley B Levine 
Peter G. Levinson 
Arthur L. Levy 







Richard J. Maunder 
John P. McGovern 
William W. Merrill 
Paul R. Meyer 
Patrick E. Moriarty 
Dominic J. Nardi 
Seymour Cy Nash 
Richard A. Norton 
Ruth Eiko Oda 
Joseph Manuel Ortiz 
Raymond L. Osborne 
Robert L. Paltzik 
Gordon K. Phillips 
Donald C. Rankin 










Susan Lynn Schley 
Louis N. Scotti 
Richard Alan Selzer 
Howard Senter 
Thomas E. Shaffer 
Daniel W. Shapiro 
Ezra A. Sharp 
Vernon H. Sharp 
Joel Silidker 
Frederick N. Silverman 
Paul 1. Silverstein 
Ethan A H. Sims 
Leon G. Smith 
Richard 1. Staiman 
John G. Steciw 
Sturla Stefansson 
Elsa L. Stone 
Fred Leslie Strieker 
Herbert Tabor 
lmad F. Tabry 
Jared R. Tinklenberg 
Theodore Tyberg 
Daniel W. Van Heeckeren 
Douglas Viets 
Romulo L. Villar 
E. Maurice Wakeman 
Thomas A. Warthin 
Herbert Allan Wenner 
George Wharton 
Robert R White 
Robert J, Williamson 
Eiji Yanagisawa 
Michael Yaros 
Robert C. Young 
Andrew Zaruski 
Marvin Paul Zimmerman 
Richard Walter Zimmerman 
Lawrence H. Zingesser 
Louis Zinterhofer 
Contributors to the 
Medical School Alumni 
35 
Contributors to the 
Medical School Alumni 
Fund 1983-84 
Parents and Friends 
Kurt I. Altman 
Dr & Mrs. Dorrance 1 Anderson 
Stanley August 




Hormoz K Broumand 
Mr. & Mrs. Ormonde L Brown 
Hariet F Brown * 
Mr & Mrs. Richard S. Childs 
Chin S. Chung 
Evis J. Coda 
Mr. & Mrs. Sidney J. Cohen 
Willibald H Conzen 
Daniel W De Renzi 
Mr. & Mrs. Kenneth T. Doran 
William C Drennan 
Max Finkelman 
Jose M. Garcia-Madrid 
William J. German * 
Mrs. Harold Grant 
Myron Greengold 
Barbara J Guillette 
Kenneth H Gutner 
Murray Halperin 
Frederick W Heilman 
Carl Hirshfield 
Gloria F Holmes 
Jordan L Holtzman 
Harold Katz 
Kenneth P Kinney 
Boris Kliot 
Joseph Litchman 
Amy G. Lloyd 
Shizuo Matsui 
Mr. & Mrs. Victor M. Newman 
William G. O'Donnell 
Mary M. Olson 
Louis H. Orkin 
Samuel Perlman 
Dr & Mrs Levi V. Perry 
R Donald Reich 
Barry D Reznik 
Yolanda Rivero 
Mr. & Mrs. Irving Rosenberg 
Joel G Roth 
Robert L. Rowley * 
Mr & Mrs. Jack Saltz 
Harold & Frances Sampson 
Joseph Schlesinger 
Melvin L. Schwartz 
Arthur A. Shachner 
Antonio Siu 
Mr. & Mrs. Philip Soskis 
Mark L. Sternlicht 
Mrs. Leo Teitz 
Thomas M Tierney 
Pable Vazquez-Calcerra 
Mr. & Mrs. Milton Weinberg 
Jack Weingold 
James Wells * 
Tony Y. Wong 
Rosalyn Yarmush 
Mr & Mrs. Herman H Zusman 
Contributors to the 
Public Health Alumni 
Fund 1983-84 
Friends 
John C. Bailar 
Robert E. Brubaker 
Mr. & Mrs Norman W. Lindsey 
PLEASE MARK YOUR 
CALENDAR: The 1985 
Medical School Alumni 
Weekend and the 5-year 
Class Reunions will be 
held Friday, June 7 
through Saturday, June 8. 
Deceased 
Dear Fellow Alumni/ae: 
1 am extending an invitation to alumni/ae across the country to 
open their homes as hosts to Yale medical students who may be 
visiting your communities for residency interviews during their 
junior and senior years. The travel, bed and board costs for all 
students have become formidable at a time when education 
costs are approaching the outrageous. The student’s pause in 
any city is rarely more than 24 hours. 
As important as the economic advantage to the students, is 
the opportunity for alumni to meet the current medical student 
and to receive present perspectives of medical education at 
Yale. The value to the student of counselling by graduates in the 
“real world” is incalculable. Insights into the region you 
practice in, specialty needs there (or lack of same); the 
academic, social and cultural character of the community you 
have been a part of, are obvious data to be communicated. 
Please complete and return the form below if you could and 
would like to participate in this effort. Further details will be 
forthcoming upon receipt of your response. 
Sincerely yours, 
Nicholas P.R.Spinelli, M.D.,’44 
President, Association of Yale Alumni in Medicine 
Dear Alumni/ae: 
As you know, there is more to a residency program than 
working 100 hours per week in a hospital. As Yale alumni no 
longer practicing within the Yale community, you are a 
valuable resource to current students attempting to evaluate 
postgraduate programs in different regions of the country. As 
host to a Yale student overnight, you would provide the student 
with a broader perspective on residency programs in your area 
(both medical and geographic). In return, you can expect to 
meet some interesting people while learning about the changes 
at Yale since your graduation. I hope you will choose to 
participate in this network — it could make a big difference to 
one of us. 
Sincerely, 
Barry Weinstock 
President, Medical Student Council 
If you would like to participate in this effort, or would like more 
information about it, please complete and return the form 
below and return it to the Office of Student Affairs, Yale 
School of Medicine, 333 Cedar Street, New Haven, CT 06510, 
or call Howard Levitin, M.D., Dean of Students, (203) 
785-2644. 
Yes, I am willing to participate, and would like additional information about the program. 
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COVER: d raw ing from Osteographia or the Anatomy of the 
Bones, by William Cheselden, c. 1753, courtesy Yale 
Medical Historical Library. An article about research 
and treatment of bone disorders being done at Yale 
begins on page 8. 
A NEW ERA IN MEDICINE 
CAMPAIGN FOR THE SCHOOL OF MEDICINE 
—so far, gifts and commitments for the $125 million capital campaign total $32 million 
T. CHARLES ERICKSON 
Yale President A. Bartlett Giamatti, Dean Leon E. Rosenberg and 
Dr. James G. Hirsch, chairman of the Campaign National Volunteer 
Committee, announced the $ 125 million capital campaign for the 
School of Medicine at a gala reception on May 28. Two weeks later, 
they held a press conference to announce a gift of $8 million from 
Betsey Cushing Whitney for a major addition to the Yale Medical 
Library. 
by D. Helaine Patterson 
Students, physicians and scholars who use the Yale 
Medical Library daily may be aware that Dr. Harvey 
Cushing, the Sterling Professor of Neurology at Yale; Dr. 
Arnold C. Klebs, a bibliographer and incunabulist who 
lived in Basel, Switzerland; and Dr. John F. Fulton, 
Sterling Professor of Physiology at Yale, spearheaded 
efforts to establish the library that opened in 1941. 
Today, the physician-triumvirate, who referred to 
themselves as the Trinitarians, would be proud and 
happy to know about the exciting plans to expand and 
renovate the library plans that will move this already 
fine medical resource well into the 21st century. 
Betsey Cushing Whitney of Manhasset, New York, 
and her family have given $8 million to Yale University to 
construct a major addition to the Yale Medical Library. 
It is the largest single gift ever received by the medical 
school. 
Yale President A. Bartlett Giamatti announced the 
Whitney gift shortly after the University launched a $ 125 
million capital campaign to increase endowment and 
meet research and program needs for the School of 
Medicine. It is anticipated that the campaign will last five 
years. Gifts and commitments, including that of the 
Whitney family, now total $32 million. 
President Giamatti said that Yale will name the library 
the Harvey Cushing/John Hay Whitney Medical Library 
to recognize two great names in the history of Yale and 
medicine. They are, respectively Mrs. Whitney’s late 
father and husband. 
Dr. Harvey Cushing, an 1891 Yale College graduate 
and internationally known neurosurgeon who taught at 
Yale, collected the works of early anatomists and surgeons. 
His collection forms the cornerstone of the School’s 
historical library. 
Dr. Cushing possessed a keen interest in books and 
even mended volumes himself. He advocated locating the 
medical library near the hospital because medical students 
and interns had little leisure time to walk across town to 
the University Library. He was a prolific writer, and his 
diaries, correspondence and papers now fill his study 
recreated in the medical historical library. In 1926, his 
biography of Sir William Osier, a British physician, 
earned him a Pulitzer Prize. 
Dr. Cushing was married to Kate Crowell for more 
than 30 years. She took a great interest in her husband’s 
students and hosted teas for them at the medical school. 
John Hay Whitney, a 1926 graduate of Yale College, 
served as United States Ambassador to Great Britain 
from 1957 to 1961. On his return from England, Mr. 
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Betsey Cushing Whitney's gift — the largest single gift ever made to 
the Yale School of Medicine, will make possible the first major 
e xpansion and renovation of the Yale Medical Library in 44 years. 
Yale will name the library the Harvey Cushing I John Hay Whitney 
Medical Library to recognize two great names in the history of Yale 
and medicine. They are, respectively, Mrs. Whitney’s late father and 
husband. 
Bella Z. Berson, director of the Yale Medical Library, right, is 
explaining the model of the Medical Library addition to Dr. 
William Summers, professor of therapeutic radiology, molecular 
biophysics and biochemistry and human genetics. Plans call for an 
additional 20,000 net square feet — a 50 percent increase in space. 
1 ii > of the first tower level. This zone of light, is the seam between 
new structure and the old. It will create attractive places to read 
and study. 
Die Library will retain its Y-shape; however, the stem of the Y will 
be widened to gain additional space for staff and reader services. 
Entrance to the curved addition in the foreground will be through 
the Cushing Rotunda. 
Whitney became publisher and editor-in-chief of the New 
York Herald Tribune and Chairman of its Paris-based 
newspaper. The International Herald Tribune. 
His philanthropy helped shape higher education in the 
United States. In addition to substantial gifts to Yale, 
through the John Hay Whitney Foundation which he 
established in 1949, Mr. Whitney focused on the field of 
education and on supporting individuals from minority 
groups who sought to make educational, social and 
economic changes in their communities. Mr. Whitney 
served as a Fellow of the Yale Corporation from 1955 to 
1970, and as Senior Fellow of the Corporation from 1970 
to 1973. In 1977, the John Hay Whitney Professorship in 
the Humanities at Yale was established. 
“The magnificent gift of the Whitney family will help 
ensure that the medical library will continue to serve the 
scholarly needs of students, scholars and health profes¬ 
sionals at Yale and from all parts of the world,” said Mr. 
Giamatti, who expressed the University’s profound appre¬ 
ciation to the Whitney family. 
“With the explosion in biomedical information, the 
library is a primary resource used daily in sustaining the 
school’s high standards of quality to train physicians, 
conduct research and provide patient care,’’the president 
said. 
In planning the project — the library’s first major 
modification in 44 years — a task force of researchers, 
physicians, librarians, information specialists and a devel¬ 
opment officer prepared a comprehensive plan to address 
the library’s long-standing needs for additional space and 
ways to improve information access. Bella Z. Berson, 
associate University librarian and director of the Yale 
Medical Library, chaired the task force. 
“By expanding the medical library, we will address the 
critical requirements for more space, and the program 
also will incorporate new, innovative technology for 
meeting the information needs of students, faculty, 
researchers and clinicians,” Mrs. Berson said. “The 
library today has become a center for information access 
rather than simply a repository for information. In 
addition to gathering and maintaining information, the 
library also is faced with synthesizing the information, 
and automatic tools will help this process,” she explained. 
Computers will enhance the library’s traditional pro¬ 
gram and extend the collection beyond its books and 
materials to include broader reference resources. In 
addition, new technologies will be used to automate the 
traditional library functions of acquisitions, cataloguing 
and circulation. 
“The expansion and renovation will enable the library 
to bring books and readers together,” Mrs. Berson said. 
Plans call for adding to and rearranging book stacks, 
creating a new periodicals room for all current issues, 
doubling seats in the reserve book room and enlarging 
the information room to bring more of the reference 
materials together and to accommodate computer termi¬ 
nals. A room where scholars can use the internationally 
acclaimed history of medicine collection also will be 
added. 
The addition and renovation will provide 20,000 net 
square feet of space for books and readers, a 50 percent 
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increase in space. The library will retain its characteristic 
Y-shape; however, the stem of the Y will be widened to 
gain additional space for staff and reader services. The 
curved addition will be tucked between the arms of the Y, 
and visitors will enter it through the Cushing Rotunda. 
Tightwells and skylights will connect the existing library 
and the new addition, allowing light and spaciousness. 
The architects are Alexander Purves and Allan J. 
Dehar, both of New Haven. According to architect 
Purves, the design lor the library expansion has “a dual 
responsibility. On the one hand it must create urgently 
needed space for the growth and consolidation of the 
library’s collections and look forward to the most innova¬ 
tive technology in information retrieval. 
“At the same time, the design must look back to the 
traditional role of the library as a quiet place for reading 
and reflection . . .The new expansion maintains the 
architectural integrity of the older building while in¬ 
creasing its capacity in a form that supports and amplifies 
the original design.” 
Construction is expected to begin in the spring of 1986, 
and the project is scheduled to be completed in 1988. 
At the campaign kick-off on May 28, Dr. Teon E. 
Rosenberg, dean of the School of Medicine, told faculty 
and friends gathered in Freshmen Commons, “Our 
School of Medicine is among the best anywhere. By many 
different measures, the accomplishments of our faculty, 
staff and students place us in a preeminent position in the 
medical world. But this is not a time w hen any of us can 
feel secure that the future of our school is assured. 
“Competition from other institutions for human and 
financial resources is keener than ever. Confusion about 
the future of federal programs for biomedical research, 
training and health care is greater than ever,” said Dr. 
Rosenberg, a human genetics researcher and former 
department chairman who became dean in July 1984. 
“We can meet this competition and be insulated from 
this confusion only if this capital campaign is a success,” 
the dean added. “Funds generated by the captial campaign 
will enable the School to advance its strong biomedical 
programs.” 
The medical school has launched the capital campaign 
after a tw'o-year study by a faculty committee on the 
future of medicine at Yale. This committee, chaired by 
Dr. George Palade, Nobel laureate cell biologist, defined 
broad areas of needs for the Yale School of Medicine to 
advance biological knowledge and translate that know¬ 
ledge into preventive, diagnostic and therapeutic applica¬ 
tions. 
Dr. James G. Hirsch, president of the Josiah Macy, Jr. 
Foundation and successor trustee of the Yale Corporation, 
heads the 13-member volunteer committee that will guide 
the campaign. To raise this huge sum increasing the 
school's security and flexibility in the biomedical sciences 
is “a daunting challenge, but the cause is just, the 
ment is firm, the plans and timetable are well 
drawn. We shall succeed,” he said. 
Dean Rosenberg chairs the 10-member faculty cornmit- 
■>n the capital campaign. Sue B. Dorn, associate vice 
! tor development and director of the medical 
>! development office, directs the campaign. 
During the next five years, the school will seek gift 
support for the follow ing areas: 
— $59 million for endowment, including $29.5 million in 
unrestricted funds for the school’s activities; $22.5 million 
for endowed professorships, and $7 million for endowed 
fellowships. 
— $33 million for biomedical research programs in gene 
structure, molecular neurobiology, molecular oncology, 
neuroendocrinology, immunobiology, neuropsychophar¬ 
macology, clinical pharmacology, parasitology and tropi¬ 
cal medicine, pediatric medicine, neurologic diseases and 
toxicology. 
“Special efforts will be directed at obtaining start-up 
funds for Yale’s rapid entry into activities that promise an 
important return in new knowledge and technologies that 
will benefit all humanity,” Dr. Rosenberg said. 
— $33 million for facilities and equipment, including 
funds to build a Center for Molecular Medicine; funds to 
expand and renovate the medical library, and to modern¬ 
ize laboratories and support facilities. 
THE COMPLEAT CAMPAIGN 
What’s a campaign without a button? 
It’s unheard of nowadays. 
So the Yale School of Medicine’s 
development staff, triggered by an 
article on a female cartoonist in a 
student magazine. The New Journal, 
enlisted the talents of artist and 
humorist Sandra Boynton, the 1974 
Yale graduate who draws greeting 
cards. 
“With the button, we wanted 
everyone to join in the spirit of the 
campaign and support it to the fullest 
extent possible,” said Sue B. Dorn, 
associate vice president for 
development and director of medical 
school development. Faculty 
members, friends and guests who 
attended the University-wide 
campaign kick-off May 28 in the 
Freshman Commons, received the 
two- and -a half-inch button. 
“We hope that the medical school’s 
Capital Campaign will be just as 
successful as Sandra Boynton's 
career,” Mrs. Dorn said. —H P. 
a history of 
CHILD DEVELOPMENT AT YALE 
In evaluating a child, trainees in the Child Study Center are taught to look for healthy behavioral skills as well as 
developmental deficits. 
by David F. Musto, M.D. In the fall of 1911, the Dean of the Yale School 
of Medicine, Dr. George Blumer, assigned to a new 
faculty member one room, a table, and a chair in the 
Hope Building to start a Juvenile Psycho-Clinic. 
Here Dr. Arnold Gesell inaugurated at Yale services 
for emotionally disturbed children, as well as research 
into the normal development of children. Dr. Gesell’s 
contributions would grow in significance and reputation 
until the Yale Clinic of Child Development would 
become known worldwide and its publications translated 
into many languages even today. 
In 1930, a wing was added to the medical school’s 
building to house the many activities which had become 
established during the past two decades. The Clinic of 
Child Development flourished there, and the group was 
made a department in the School of Medicine, the first 
program in child development to receive that recognition 
by any medical school. 
The Child Study Center succeeded the Clinic of Child 
Development upon the retirement of Dr. Gesell in 1948. 
Located in the same quarters, but taking a more environ¬ 
mental and psychoanalytic approach to child develop¬ 
er. Musto is professor in the Child Study Center, psychiatry and the 
history of medicine. 
ment, the Child Study Center was established by Dr. 
Milton J.E. Senn. Dr. Senn was succeeded as director by 
Dr. Albert J. Solnit in 1966. The current director, Dr. 
Donald J. Cohen, followed Dr. Solnit in 1983. Thus, in 
the fall of 1986, clinical child development at Yale will 
celebrate its 75th anniversary. 
Prior to the Psycho-Clinic, New Haven was the site of 
active work to improve the lot of the mentally ill and to 
understand better the nature of mental illness. Clifford 
Beers, a recent Yale graduate who had published a 
moving account of his own mental illness, A Mind that 
Found Itself (1908), established with the aid of prominent 
local individuals the Connecticut Society for Mental 
Hygiene, a group which would grow eventually into the 
National and World Mental Health Associations. In New 
Haven, Beers catalyzed a great deal of latent interest in 
normal and deviant mental development and functioning. 
Within a year of the publication of Beers’ book, the 
National Committee for Mental Hygiene had been 
established. 
Dean Blumer accepted the chairmanship of the National 
Committee for Mental Hygiene’s Executive Committee. 
The head of Yale’s Sheffield School, Russell H. Chitten¬ 
den, chaired the Finance Committee, and the president 
and secretary of Yale served on the National Committee, 
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Dr. Arnold Gesell, 1951 (courtesy Yale University Archives) 
Formal child study at Yale began in 1911 under the leadership of 
Dr. Arnold Gesell, who founded the Yale Clinic for Child 
Development. The Clinic soon became known throughout the world 
for its detailed observation of children at different stages of 
development as well as for the innovative techniques, including 
photographs and films, it used to record them. At a time when the 
notion prevailed that environmental factors were solely responsible 
for the way a child developed, Dr. Gesell and his colleagues were 
able to present compelling evidence with their detailed 
documentation, that the way a child developed was in large measure 
a result of the pattern established by his or her biological 
constitution. 
along with James B. Angell, of the University of Michigan, 
whose son was later to become Yale’s president. Thus, 
when Gesell moved to New Haven, he joined a fostering 
environment. Gesell, while an assistant professor in the Department 
of Education, enrolled in the Yale School of 
Medicine and obtained his M.D. degree in 
1915. He did this to gain “familiarity with the 
physical basis and the physiological processes 
of life and growth.” His life’s work would be to achieve 
the goal expressed just before coming to Yale: “to make a 
thorough-going study of the developmental stages of 
childhood.”To accomplish this monumental task, Gesell 
introduced the use of the motion picture camera in the 
1920s, as well as still photography. He was able to map 
the developmental stages and publish the results in 
atlases of human behavior and development. His studies 
on the normative development of children gave parents a 
welcome guide to their own children’s progress. 
He saw a child's development proceeding from the 
pattern established by his or her biological constitution, 
'he environment might assist or retard this development, 
but the general trend was there to begin with. He saw as 
his primary task the accurate description of these stages 
of development. He differed radically from the behavior- 
ist position of J.B. Watson, who saw the child as being 
molded by life’s experience and the psychoanalytic view, 
which combined the biological and experimental norma¬ 
tive developmental pattern with the therapeutic effects of 
group and individual intervention. 
With Dr. Gesell’s retirement in 1948, Yale considered 
how best to continue a leadership role in child develop¬ 
ment and concluded to establish the Child Study Center. 
Dr. Milton J.E. Senn of Cornell University, a nationally 
prominent pediatrician with a psychoanalytic approach 
to child development, was chosen to be the first director. 
Dr. Senn expanded the training of psychiatrists and 
pediatricians in child development, inaugurated longi¬ 
tudinal studies of young families, and brought to Yale a 
series of investigators and teachers who would attain 
leadership in their fields. Dr. Sally Provence began her 
pioneering study of institutionalized children, and Drs. 
Ernst and Marianne Kris joined Dr. Senn in organizing a 
psychoanalytically oriented longitudinal study. Drs. 
Provence, Samuel Ritvo and Albert Solnit played a 
prominent role in the Yale Longitudinal Study and its 
10-year followup. 
Dr. Grover Powers, left, former chairman of the Department of 
Pediatrics, who was known for his sensitivity to child development, 
was chairman of the search committee that selected Dr. Milton 
Senn, right, to succeed Dr. Gesell on his retirement in 1948. Under 
Dr. Senn's guidance, the new unit, called the Yale Child Study 
Center, became a model clinical facility which offered unique 
opportunities for the teaching and training of students and 
professionals. 
Dr. Albert J. Solnit. director of the Center from 1966 to 1983. has 
collaborated with the late Dr. Anna Freud, left and Professor 
Joseph Goldstein of the Yale Law School to provide important 
guidelines, based on psychoanalysis, to assist professionals who are 
charged with making difficult decisions about child placement and 
custody. The results of their studies, published in two volumes, 
Beyond the Best Interests of the Child and Before the Best Interests 
of the Child, have generated controversy and discussion which have 
helped establish better means to understand and protect the child’s 
best interest and the family's integrity. With Drs. Freud and Solnit is 
Dr. Julian Ferholt, associate clinical professor in the Child Study 
Center, pediatrics and psychiatry. When Dr. Albert J. Solnit became director in 
1966, the Child Study Center had a broad 
program of child therapy, training of child 
psychiatrists, and action research in the 
primary settings in which children grow up, 
including the family, pediatric settings, schools and child 
care programs and institutions. Professor Edward Zigler, 
first director of the Federal Office of Child Development, 
has played a vital role in the sustained teaching and 
research collaboration of the Child Study Center and the 
Department of Psychology. Dr. Zigler, as a leading 
scholar and champion of mentally retarded childen and 
adults and as an academic leader in contributing to the 
definition and improvement of an effective national 
social policy for children, has played a vital role as a 
senior faculty member of the Child Study Center. 
Dr. James P. Comer began what would be a remarkable 
demonstration that inner-city schools can revive and 
tlourish. Yale law professor Joseph Cioldstein accepted a 
joint appointment at the Child Study Center, establishing 
links with the Law School which have led to a better 
understanding of the best interests of the child and the 
implications of custody for the child’s mental health. 
Child Study Center faculty have reflected its leadership 
role in scholarship and the dissemination of state-of-the- 
art knowledge through publications in scholarly journals 
and books as well as through the editorial leadership 
provided by Dr. Melvin Lewis as editor of the Journal of 
the American Academy of Child Psychiatry and Dr. 
Solnit as managing editor of The Psychoanalytic Study 
of the Child. 
Through the teaching and research of many of its 
faculty, the Child Study Center has gained recognition as 
a Center at which child psychoanalysis has flourished at 
the same time as more socially and biologically based 
studies have been carried out effectively. Under the current director. Dr. Donald J. 
Cohen, biochemical studies of childhood autism 
and other serious afflictions of children have 
greatly expanded, and a long-term goal of the 
Child Study Center, an inpatient unit within 
the Yale-New Haven Hospital, has become a reality. 
The Center approaches the 75th anniversary of child 
development studies at Yale with a range and depth of 
research and teaching about children unparalleled in it 
history. Major support for research and delivery of 
services has been provided by individuals and foundations 
—as well as by the Federal government which made 
possible an expansion of Child Study Center programs 
and space. It also made possible vital collaborative 
activities with the Departments of Pediatrics, Psychiatry 
and Psychology such as the Children’s Clinical Research 
Center in Child Development and the Bush Center in 
Child Development and Social Policy, directed by Dr. 
Zigler. These centers have improved the resources of the 
Child Study Center in maintaining multidisciplinary 
training and research programs that have gained national 
and international recognition. 
The present director is Dr. Donald J. Cohen, whose clinical and 
laboratory research into the biochemical origins of childhood autism 
and other major psychiatric disorders of childhood are widely 
recognized. Under his leadership, and in collaboration with the Yale- 
New Haven Hospital, a new Child Psychiatry In-Patient Service will 
open this summer as a national resource for the clinical investigation 
and treatment of children from pre-school years through adolescence 
with serious psychological disorders. 
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over the last decade there has been encouraging progress in 
TREATING DISORDERS OF BONES 
by Marje Noyes 
Many thousands of Americans of all ages are victims of skeletal disorders 
as a result of injury or disease. Until quite recently, they had to struggle 
with the pain and crippling effects of these disorders with little hope for 
relief. 
Without much fanfare, researchers have made considerable progress 
during the last decade in understanding how bone is formed, and in 
applying this important new knowledge to developing treatments for a 
number of serious bone disorders. Scientists at Yale have made important 
contributions in several areas to these advances. 
Musculoskeletal disorders represent one of the leading causes of 
health-related expenditures in the United States — an estimated 
$59 billion each year — second only to diseases of the circulatory 
system. They rank highest among all disease categories when almost any 
indicator of the quality of life is concerned; and for people in their 
working years — ages 18 to 65. musculoskeletal conditions are the leading 
cause of disability. 
While these disorders have an effect on people of all ages, the impact on 
the elderly population is especially severe. By far the most common and 
devastating affliction of the skeletal system is osteoporosis. 
An estimated 20,000 women die each year of complications caused by 
postmenopausal osteoporosis — a condition of progressive bone loss. 
Many are unaware they have the problem until they fall, often for no 
apparent reason, fracturing a hip or their spine. As the expected life span 
of the population increases, the problem is bound to become even more 
prevalent. 
Until recently, it was thought that once the initial rapid phase of 
postmenopausal bone loss occurred, the condition was irreversible. 
Research at Yale over the past ten years offers considerable evidence to 
the contrary. 
A number of theories had been advanced and discarded about the cause 
of osteoporosis, when in 1964, several investigators noted that bone is a 
very dynamic, constantly regenerating tissue: bone turnover, or remod¬ 
eling, follows a set pattern of resorption first, and then, new bone 
formation. This information led to a better understanding of the cause of 
osteoporosis — that is, a failure in the normal progression of the cycle 
from a resorption to a formation phase, which results in net bone loss. At 
about the same time, researchers also found that calcitonin, a naturally 
occurring hormone, is a powerful inhibitor of bone resorption. 
With this information, it was logical to assume that calcitonin therapy 
would increase net bone formation in osteoporosis patients. Studies in 
1971 proved to the contrary, that while calcitonin inhibits bone resorption, 
it also blocks bone formation. 
In 1974, Dr. Howard Rasmussen, professor of medicine and chief of 
the Section of Endocrinology, and the late Dr. Phillipe Bordier of the 
Hopital Lariboisiere in Paris, conducted one of the first demonstrations 
that suggested the possibility that progressive bone loss in elderly women 
can be reversed with medical therapy. Their hypothesis was to stimulate 
bone resorption, and at the same time, shorten the duration of resorption 
and allow formation to continue. The idea of stimulating resorption was 
considered heretical at the time, according to Dr. Rasmussen. 
He and his colleagues reasoned that, if its secretion was stimulated, the 
parathyroid hormone — the one agent known to increase the rate of bone 
remodeling could play an important role in the treatment of 
osteoporosis. By combining phosphate, which activates parathyroid 
hormone secretion, with calcitonin, they aimed their research towards 
minimizing bone resorption while maximizing bone reformation. 
The results were encouraging. In a double blind pilot study of 26 
women with osteoporosis who had experienced at least two major bone 
fractures. Dr. Rasmussen and his colleagues were able to demonstrate 
that the bone of elderly women is hormonally responsive and can, in fact, 
be stimulated to new formation. 
A second study, with modified calcitonin and phosphate therapy, was 
done at Yale by Dr. Robert Lang, a colleague of Dr. Rasmussen. This 
study showed that while the dense outer cortical bone responded 
positively to the combined therapy, there was little or no regeneration of 
the trabecular, inner spongy bone. 
Loss to the cortical bone can lead to hip fracture; loss to the inner bone 
can result in fracture of the spine. 
Clearly, the researchers were on the right track — only further 
refinements to the therapy were necessary. 
For the past fifteen years, first in Paris, and since 1977 at Yale, 
Dr. Roland Baron has been doing basic research on the cellular 
basis of bone remodeling. With his colleagues. Dr. Agnes Vignery 
and Dr. Mark Horowitz, he is recognized for important clinical work with 
bone biopsies, as well as for advanced basic research leading to a better 
understanding of the mechanisms involved in bone diseases. 
Their research, supported by four grants from the N1H totalling about 
$ 1 million for the next three years, seeks answers to such basic questions 
as how do bone cells differentiate? What exactly is their function at each 
stage of bone remodeling and how do they communicate with each other? 
How does a site that has been resorbed know that it has to be repaired and 
how does the precursor of the cell that is going to resorb the tissue know 
where to go and how much to resorb? Why does it stop when the exact 
amount has been resorbed? 
“All clinical problems involving the skeleton, whether they are 
endocrine-related, congenital or local problems such as arthritis or 
periodontal disease, or metastatic lesions, are mediated through these 
cells,” explained Dr. Baron. “If we understand how they work, we will 
have a more precise basis for designing effective therapies for major bone 
disease.” 
Drs. Baron, Horowitz and Vignery are studying the interface between 
bone and bone marrow. The precursors of bone cells, blood cells and cells 
of the immune system are located in bone marrow. “It has been known for 
a long time that wherever and whenever there is local inflammation, there 
is bone destruction,” Dr. Baron said. “One or more components of the 
inflammatory immune response has a side effect, which becomes, in fact, 
the main clinical problem — the activation of bone resorption. We 
became interested in trying to understand one aspect of the local 
regulation of bone cells by observing activities of cells in the immune 
system.” 
An important part of their research has zeroed in on the osteoclast 
activating factor (OAF), a lymphokine only recently associated with bone 
resorption. They have made significant progress in understanding the 
drawing of different bones from Osteographia or ihe Anatomy 
of the Bones by William Cheselden, c. 1753, courtesy Yale 
Medical Historical Library 
Paleopathologic specimens reveal that bone 
loss has been a problem for aging women since 
earliest times. The condition went virtually 
unnoticed in medical accounts until the mid- 
19th century, when physicians attributed the 
fact that more women over 50 fractured their 
hips and legs than did men the same age to the 
long skirts women wore, which caused them to 
trip and frequently fall. In (he last decade, new 
knowledge about bone formation has ted to 
research that may soon bring about vastly 
improved treatment of degenerative bone 
diseases such as menopausal osteoporosis. 
9 
Born in Tunis in 1944, Dr. Roland 
Baron was educated at the University of 
Paris where he received a Baccalaureate 
in experimental Sciences; a DDS, and a 
Ph.D. in oral biology. Following an 
academic career in oral biology in 
Paris, he came to the Yale School of 
Medicine in 1977 as an assistant 
professor of pathology. In 1979, he was 
appointed assistant professor of internal 
medicine and cell biology, and in 1982, 
he was promoted to associate professor 
of medicine and cell biology. 
He is intensely involved in research 
into bone cell biology and the 
pathophysiology and treatment of 
skeletal diseases. Current projects in 
which he and his colleagues are 
involved include studies of bone cell 
function and differentiation, the role of 
the immune system in bone remodeling; 
and the pathophysiology and treatment 
of osteoporosis, osteopetrosis and of 
renal osteodystrophy in children. 
cellular mechanisms involved in its local secretion. “We have been able to 
identify the cell that is responsible for OAF production — a helper T 
lymphocyte — and to demonstrate that OAF is secreted in the same 
manner as other lymphokines such as gamma interferon, but operates 
differently from the other activators at the bone level,” said Dr. Baron. 
The laboratory is now working on the purification of these products. 
“These findings have important implications for all diseases where 
there is local destruction of bone, including metastatic cancer in bone, 
arthritis and periodontal disease,” explained Dr. Baron. “In fact, they 
contribute significantly to the understanding of bone resorption and even 
to skeletal development and bone transplantation.” 
Based on these findings, Dr. Robert Lang is conducting a study to 
test a new therapy to increase bone mass in women with postmeno¬ 
pausal osteoporosis who have had bone fracture. This study, 
funded by a $100,000 grant from the NIH, will refine previous studies by 
Dr. Rasmussen and Dr. Lang, with the goal of increasing the regeneration 
of not only the cortical bone, but of the trabecular bone as well. 
“Basically, in this study, which like the earlier studies, involves combine 
calcitonin and phosphate therapy for 12 months, we will increase the 
frequency and amount of calcitonin dosage. Recent research has shown 
that more frequent dosages are necessary to turn off bone resorption,” 
explained Dr. Lang. 
This study will be further enhanced by interpretation of bone biopsies 
in Dr. Baron’s laboratory, where bone resorption and formation can be 
measured, and by a new procedure using CT scanning to measure bone 
density. Developed by Dr. Pamela Jensen, associate professor of 
diagnostic radiology, the system enables investigators to note even very 
subtle changes in bone mass, and has been extremely useful in following 
the progress of therapy in osteoporosis patients. 
The pilot study will also include nutritional counseling and an exercise 
program of weight-bearing activities. “Diet and exercise are extremely 
important factors in osteoporosis therapy,"said Dr. Lang. “Although we 
were unable to prevent trabecular bone loss in our previous study, most of 
the patients felt much better because they had been put on a diet and 
exercise program which was clearly helpful, not only for strengthening 
their muscles and bones, but also for their general well being. This is very I 
important.” 
Estrogen replacement therapy reduces the rapid loss of bone that 
occurs at the onset of menopause, but it is of little or no therapeutic value 
once osteoporosis is established. On the other hand, there are indications 
that good nutritional habits, including a diet high in calcium and low in 
animal protein, and regular exercise such as walking or bicycling, may 
slow down, and perhaps even reverse the degenerative process. 
“Most of the women we have seen in our studies have had very poor 
nutritional habits and do very little in the way of exercise,” commented 
Dr. Lang. 
If the present pilot study with calcitonin and phosphate proves 
successful in increasing bone formation in osteoporosis patients, the 
research will also benefit patients with other disorders resulting in bone 
loss, including renal diseases, primary biliary cirrhosis and other gastro¬ 
intestinal disorders. “We are very confident that within this decade we will 
have a treatment for increasing bone formation,” predicted Dr. Lang. “If 
we can achieve it in menopausal osteoporosis, there is every likelihood 
that we can do it for other conditions as well, perhaps with slight 
variations in therapy.” 
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Many thousands of Americans of all ages are victims of skeletal 
disorders as a result of injury or of diseases such as rheumatoid 
arthritis or bone cancer. Until quite recently, treatment alterna¬ 
tives for the crippling effects of these disorders were limited in scope, and 
provided little hope for relief. 
Recent advances in orthopedic research and practice holds promise for 
many of these patients. One of the most encouraging developments has 
been progress in the transplantation of human bone to replace injured or 
diseased segments of arms and legs. 
The Yale School of Medicine is at the forefront in developing 
techniques for the preservation and transplantation of major bones. The 
Yale-New Haven Medical Center is among few centers in the country 
which routinely bank and implant whole bones or large bone segments, as 
well as smaller, but equally important bone grafts. One or two such 
operations are performed here each month. About one-third are to 
replace bone segments compromised by tumors; the balance involve 
accident victims who have severely damaged a limb, and for patients 
undergoing reconstruction as a result of arthritis. 
Much of the research and its clinical application has been done by Dr. 
Gary Friedlaender. As his titles indicates, he is a leading expert on tissue 
transplantation, who neatly balances his activities in many of its issues. 
He is deeply involved in research, some of which is in collaboration with 
Dr. Roland Baron, to improve understanding of the biologic and 
immunological aspects of bone transplantation, and in studies of the 
effects of chemotherapy and radiation therapy on the skeleton; he is 
responsible for the clinical care of orthopedic patients; and he is totally 
committed to providing national resources for information and program¬ 
ming support of organ and tissue donation and transplantation. 
“About 100,000 Americans require bone transplants each year, yet less 
than five percent of these patients were able to benefit from the use of 
banked bone last year because there weren’t enough replacement bones 
available,” noted Dr. Friedlaender. Banked bone works well and avoids 
sacrifice of normal bone in patients to provide graft material for another 
site. Also, some people can’t donate their own bone graft because the size, 
shape or quantity required is not available or is too large to take from their 
own body. “There is a great need to communicate these facts to potential 
donors and their families,” continued Dr. Friedlaender. 
Advances in transplantation of bones began in the 1950’s, when it 
was observed that bone allograft immunogenicity was reduced by 
freezing. Both the clinical science and banking methodologies 
required for transplantation of large bones have been substantially 
improved since then, reflecting to a large extent new knowledge of bone 
graft biology, cryopreservation techniques, immunobiology and critical 
analysis for factors contributing to clinical results. 
While amputation of an arm or leg is devastating for persons of any age, 
it is particularly tragic for young people. This is one reason why progress 
in bone transplantation is so important. 
Metallic and plastic implants to replace arthritic or fractured hips have 
been used with some success for several years, but implants of these 
materials to replace large segments of bones of the leg have proven less 
than satisfactory because they are not stable and are increasingly prone to 
loosening, as well as to failure of materials after a time. Furthermore, they 
are especially vulnerable in the rough and tumble life typical of a 
youngster. 
Dr. Robert Lang, associate professor of 
medicine, has been involved in 
osteoporosis studies ever since he came 
to Yale in 1976 as assistant professor of 
medicine. A graduate of Rutgers 
College, he received his M.D. degree 
from Albany Medical College and 
completed his internship and residency 
in medicine at the Hospital of the 
University of Pennsylvania. From 1971 
to 1973, he was a NIAMDD trainee in 
metabolism at Washington University 
School of Medicine. 
In addition to his work in 
osteoporosis, he has done extensive 
research on the diagnosis and treatment 
of Paget’s disease — a disorder 
characterized by abnormal increase in 
bone resorption followed by rapid and 
disordered bone formation. He is also 
involved in metabolic studies of renal 
stones, as well as in studies of the 
effects of exercise on the endocrine and 
skeletal systems of women athletes. 
Dr. Gary E. Friedlaender, professor of 
surgery (orthopedics), is chief of the 
Section of Orthopedic Surgery, director 
of the Orthopedic Oncology and 
Transplantation Immunobiology 
Laboratory and founder and director of 
the Bone Bank at Yale. In addition, he 
is a founder and immediate past- 
president of the American Council of 
Transplantation (ACT)— a centralized 
national resource for information and 
programming support on organ and 
tissue donation and transplantation. He 
is also president of the American 
Association of Tissue Banks. 
A graduate of the University of 
Michigan, he received an M.D. from 
the University’s School of Medicine in 
1969. He first came to Yale in 1971 as 
an NIH postdoctoral research fellow in 
surgery, oncology and immunology, as 
well as a resident in orthopedic surgery. 
It was here that he first became 
interested in bone transplantation. In 
1982, he received the Kappa Delta 
Award for Outstanding Orthopaedic 
Research from the American Academy 
of Orthopaedic Surgeons and the 
Orthopaedic Research Society. 
When feasible, bone autografts — replacement with segments of the 
patient’s own bone — make the most viable and successful transplants, 
but the supply is necessarily limited. An alternative, under ongoing 
investigation by Dr. Friedlaender and his colleagues is that of the 
cadaveric allograft, which is replaced by host bone over a period of time. 
Virtually any bone suited to clinical application can be removed from 
cadavers, but generally, the long bones of the extremities, the pelvis, and 
the ribs are the most useful for this procedure. 
Effective bone banking is of the essence to the success of these 
transplants. “In order to support the challenging and innovative contem¬ 
porary approaches to limb sparing reconstructive surgery, as well as the 
need for bone grafts used to treat a wide variety of traumatic, degenerative 
and benign neoplastic skeletal disorders, it is necessary to establish a safe 
and effective source for allogeneic tissue,’’commented Dr. Friedlaender, a 
crusader for a systematic approach to donor selection, tissue removal and 
preservation methodology. 
Unlike organs which must be removed and transplanted almost 
immediately following death, bones and other tissues may be removed as 
long as 24 hours later, and stored for five years. At Yale, they are removed 
under sterile operating conditions, cleaned of muscle and dipped in 
gylcerol of dimethyl sulfoxide for cryoprotection before being placed in a 
plastic bag and wrapped in sterile cloth. They are stored in a freezer at -70 
degrees Fahrenheit until required for transplantation. Each specimen is 
x-rayed to record its size and anatomical shape. 
When bone grafts are not reconnected to a blood supply immediately, 
they are subjected to a complex process of revascularization and 
replacement known as “creeping substitution” — a predictable sequence 
of events including cell necrosis, revascularization, resorption and 
eventually, replacement. In bone graft procedures, the replacement bone 
segment is fitted in between undamaged existing bone. Once in place, the 
graft is invaded by blood vessels from the host site. This new blood supply 
carries the primitive mesenchyal cells of recipient site origin that 
differentiate into bone resorption and bone remodelling cells. 
Initially, the bone becomes weaker than the original, but within 
months, it begins to strengthen and to build new bone from the old. 
Within five to ten years, the body will replace most of the donated bone 
with its own, a process identical to the replacement of bone which 
normally occurs. 
Dr. Friedlaender has trained with and collaborated for several years 
with researchers in the Orthopedic Oncology Unit at Massachu¬ 
setts General Hospital in clinical studies of allograft transplanta¬ 
tions mostly for malignant or aggressive tumors. That group now has 
experience with 300 major transplants in patients who are from 11 to 69 
years old. 
The types of graft procedures included osteoarticular, in which an 
articular joint was included with the bony replacement part (the majority 
of transplantations); intercalary, in which the grait consisted only of a 
portion of the shaft of a long bone; and allograft, in combination with a 
joint prosthesis (most of these have been used for hip joint replacement). 
All of the patients have been carefully followed and to date none has 
shown what could be interpreted as a “rejection”. Furthermore, data 
suggest that the graft is incorporated and slowly replaced by the host after 
an initial period and that the prognosis for long retention and tunction of 
the implanted segment is reasonable, providing there are not problems of 
drawing of the six lowest ribs with 6th and 7th vertebra of back 
from the Anatomy of the Bones by William Cheselden, c. 1753, 
courtesy Yale Medical Historical Library 
The idea of transplantation of bones may have 
originated when, according to the Bible, a rib 
was removed from Adam to create Eve. There 
are numerous other references in literature and 
art to allogeneic and xenogeneic hybrids, 
including the canvasses of the 15th century 
masters, Fra Angelico and Bellini, showing 
Cosmos and Damian, the patron saints of 
medicine replacing the diseased leg of a light¬ 
skinned patient with that of a Moor. 
Today, through clinical and laboratory 
research at institutions including Vale, bone 
allografts are becoming an increasingly viable 
treatment for a number of bone disorders. 
infection or fracture early on. 
“We aren’t there yet. The system needs further study — but clearly, 
these early results suggest that continued research is definitely warranted,” 
said Dr. Friedlaender, who is principal investigator of a national, multi- 
institutional study of bone graft biology, banking immunology and 
clinical results. A major portion of the project will be to correlate the 
long-term follow-up clinical, x-ray and histological data with an assess¬ 
ment of humoral evidence of the immune response. It is hoped that these 
data will provide a means of selection of the best graft for each patient. 
“This may be the key to avoiding failures we now naively attribute to the 
immune reaction,“ explained Dr. Friedlaender. 
In summing up the work to date. Dr. Friedlaender emphasized the 
tremendous need to educate both physicians and the public to the need for 
donor tissue and organs. “With all of the advances in surgery, in drugs 
that reduce rejection and in the biological understanding of transplanta¬ 
tion, we’re getting to be in an increasingly better position to do more and 
more transplants. So, the current shortage of organ and tissues will 
become severe in the future,” concluded Dr. Friedlaender. 
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MORE THAN ONE MISSION 
Dr. Curtis L. Patton, Professor of Epidemiology (Microbiology) 
by Marje Noyes with Charles Eguagu 
Sitting in his office, which is absolutely packed with 
photographs and travel posters, and stacks of journals 
and papers piled precariously high. Dr. Curtis Patton 
discussed his career. It didn't take long for a visitor to 
figure out that, early on, he had carefully charted his 
course to accomodate a commitment to encourage 
young minority students to enter careers in science, along 
with his own strong attraction to research and teaching. 
A man of many interests and talents. Dr. Patton is first 
and foremost an established parasitologist who has 
provided important new' insights into the biology of 
African trypanosomes. He is as well, a distinguished 
educator who, in the words of a former postdoctoral 
student, is as committed to leading his students into 
unique career opportunities as he is to the advancement 
of tropical medicine. “It was a pleasure to study with 
him,” said Dr. Larry Ruben. 
Dr. Patton grew up in Birmingham, Alabama in a very 
supportive environment. His father, the principal of a 
local high school, and his mother, a music teacher, 
encouraged his curiosity, and by so doing had a profound 
influence on his educational and career decisions. He was 
a good student, who admits to occasional minor mischief 
along the way, and who graduated with honors from high 
school. 
At Fisk University, “the going was a lot rougher,” he 
recalled. A small, private, predominantly Black liberal 
arts school in Tennessee, Fisk provided extraordinary 
opportunities for scholarship as well as for leadership. It 
was later, though, as a graduate student at Michigan 
State University (where he received an M.S. degree in 
1961 and a Ph.D. degree in 1966), that Dr. Patton first 
became interested in parasitology. This interest was 
furthered at Rockefeller University, where as a guest 
investigator and Fellow from 1967 to 1970. he was 
exposed to the work of unusually talented scientists and 
other resources in biomedical research. 
“Yale offered an opportunity to continue some aspects 
of this experience,” he said, “and 1 was excited about the 
prospects of continuing my work here.” 
Soon after his appointment as assistant professor of 
microbiology in 1970, Dr. Patton received a U.S. Public 
Health Service Career Development Award which offered 
a tempting opportunity to be rid of administrative and 
teaching responsibilities to devote full time to his research. 
But, it didn't work out quite that way. 
“At the time, I was one of a very few Black faculty in 
the University. I felt an obligation and responsibility to 
een as a teacher as well as a researcher,” he explained, 
sides, I really enjoy teaching. Having bright, energetic 
iplc around, who may be naive about some of the 
As much of Dr. Patton’s teaching takes place in his 
laboratory as it does in classrooms and lecture halls. 
Above, he is conferring with, from left to right, Henry 
Rice, a second year medical student; Rollin Johnson, a 
doctoral student at Cambridge University, England; 
Sharon Usip, a research assistant; Sarah Schleck, a 
Ph. D. student; and Charles Eguagu, a Ph. D. student. 
problems you are most concerned with, provides an 
opportunity for looking at things in a very different way.” 
By teaching, he could also advance the cause for 
parasitology. “It is difficult to believe now when so 
much attention is being paid to tropical medicine at all 
levels but when I first came to Yale, the field was not 
regarded as either important or very interesting to many 
of the leading biomedical scientists,” explained Dr. 
Patton. For several years, as the only parasitologist in the 
entire University, he taught undergraduates as well as 
medical and public health students. (There are now three 
research groups studying parasitic organisms in the 
Department of Epidemiology and Public Health, and 
five others in the Departments of Medicine and Pharma¬ 
cology, as well as groups elsewhere in the University.) 
Today, much of his teaching takes place in his labora¬ 
tory on the eighth floor of the Laboratory of Epidemiology 
and Public Health, where studies on the cellular and 
molecular biology of African trypanosomes are focused 
on antigens that may be of importance in immune 
responses as well as to regulatory problems. 
“When an organism lives on or in another organism, it 
has to figure out how to get what it needs for its own 
well-being without being destroyed by its host," explained 
Dr. Patton. “We have the feeling that the interface 
between the membrane of the parasite and its host is most 
important in the host-parasite complex. To exist, the 
parasite must remove its life sustaining substances across 
the host membrane and across its own membrane into its 
body or cell — and it has to do this very skillfully, because 
the parasite membrane is also the site where host immune 
responses are most effective." 
In their research. Dr. Patton and his colleagues have 
isolated and characterized a calcium-binding protein, 
calmodulin, in trypanosomes. Similar to protein found in 
the host, calmodulin is present in all eukaryotic cells and 
is highly conserved throughout evolution. Although 
trypanosome calmodulin exhibits a high degree of amino 
acid sequence homology with the host protein, it is 
sufficiently different to be termed “unique”. Current 
evidence suggests that specific residues interact with 
receptor proteins and drugs. Some of these may be 
unique for trypanosomes, and thus useful in the develop¬ 
ment of novel, trypanosome-specific chemotherapies. 
This research recently received major grant support from 
the National Institutes of Health. 
In addition to being able to contribute new knowledge 
to the understanding of the immune responses and 
regulatory problems, there is the very real satisfaction of 
contributing basic knowledge which may eventually lead 
to the control of diseases which have for years devastated 
Third World populations. Trypanosomes, for instance, 
cause African sleeping sickness in humans, and in 
animals, they cause ngana, a disease which has all but 
eradicated cattle farming in many parts of Africa. 
“As important as these organisms are as research tools, 
from a humanistic view, they are even more important as 
agents of suffering, and they deserve intense study for this 
reason as well,” said Dr. Patton. 
Because of his reputation as an outstanding Yale 
scientist and educator. Dr. Patton has been asked to 
participate on perhaps more than his share of committees 
and review boards — especially those involved with 
minority students. Although time consuming, he regards 
these activities as stimulating and necessary. 
“There is a notion that Black students are not tradi¬ 
tionally interested in careers in science. The very first 
Black to receive a Ph.D. in the United States, Eduard 
Alexander Bouchet, received that degree in physics from 
Yale, when no more than a dozen Ph.D.’s had been 
awarded in the country — in the sciences or any other 
field for that matter,” said Dr. Patton. “Unfortunately, 
the percentage of Blacks in the sciences today is very 
low.” 
Taking a leadership role in trying to increase this 
percentage, he serves on committees at Yale as well as of 
the National Research Council and the National Institutes 
of Health. One of the most important of these is the NIH 
Committee for Minority Access for Research Careers, of 
which he was chairman. This committee, which spent 
considerable time visiting colleges and research institu¬ 
tions, reviewing curricula and the preparation necessary 
for developing careers in the biomedical sciences, has 
been influential in attracting a large number of minorities 
to the sciences. 
In seeking a career in science, Dr. Patton believes one 
has to be driven, but not necessarily obsessed with the 
notion that it is important to make a contribution to 
science and perhaps, indirectly, to the nation and the 
world. 
“Those of us who are driven probably find it most 
satisfactory to be in a place like Yale, which is an exciting 
environment for scientific pursuits,” he concluded. 
Although he claims he no longer is a “Champion on 
the squash and racquet ball courts ”, a pair of racquets 
are ready for action in a corner of Dr. Patton's office. 
And, by all accounts, he is an accomplished musician 
playing jazz as well as classical on the piano, clarinet 
and recorder. “After all, ” he quipped, “the son of a 
music teacher is simply not allowed not to play 
something. ” He also confesses he pretends he is writing 
the great American novel. “But 1 read the Book Review 
Section of The New York Times more than I write. I 
doubt very seriously that I'll ever appear on those 
pages. "And, in a rare moment, he relaxes in the 
garden of the Patton home with his daughter Lynne 
and wife Barbara, whom he met when they both were 
















IS APPOINTED TO 
RESEARCH CHAIR 
Dr. George K. Aghajanian has been 
appointed Foundations Fund for Re¬ 
search in Psychiatry Professor. A neuro¬ 
psychopharmacologist widely recog¬ 
nized for his studies on the effects of 
psychoactive drugs on the mammalian 
brain. Dr. Aghajanian has been profes¬ 
sor of psychiatry and pharmacology 
since 1974. 
Born in Beirut, Lebanon, Dr. Agha¬ 
janian has been at the Yale School of 
Medicine almost continuously since his 
graduation from Cornell University in 
1954; first as a medical student in the 
Class of 1958, then as an intern in the 
Department of Internal Medicine, and 
from 1959 to 1963, as a resident and 
postdoctoral fellow in the Department 
of Psychiatry. Following two years in 
the U.S. Army Medical Corps, Dr. 
Aghajanian returned to Yale as assis¬ 
tant professor in the Department of 
Psychiatry. He was promoted to associ¬ 
ate professor in 1968, and named associ¬ 
ate professor of psychiatry and pharma¬ 
cology in 1970. 
A recipient of the Efron Award of 
the American College of Neuropsycho¬ 
pharmacology in 1975, Dr. Aghajanian 
received the Scheele Medal and was 
co-winner of the Foundations Fund 
Research Prize, both in 1981. He is a 
member of a number of professional 
societies including the American Society 
for Pharmacology and Experimental 
Therapeutics, the Psychiatric Research 
Society and the Neurochemistry So¬ 
ciety. A fellow of the American College 
of Neuropsychopharmacology, he is 
also a member of the International 
Brain Research Organization. 
DR. HOLMES APPOINTED 
TO CHAIR 
Dr. Frederic L. Holmes has been named 
Avalon Foundation Professor of the 
History of Medicine. Dr. Holmes is 
internationally recognized as a leading 
scholar in the history of medicine and 
science, particularly in the fields of 
physiology and chemistry. He has been 
professor and chairman of the Section 
of the History of Medicine since it was 
established in 1977. 
A graduate of the Massachusetts 
Institute of Technology, Dr. Holmes 
received an M.A. degree in history and 
a Ph.D. degree in the history of science 
from Harvard University. While at 
Harvard, he received the Schumann 
Prize of the History of Science Society, 
which later also awarded him the Pfizer 
Prize. In 1978, the American Associa¬ 
tion for the History of Medicine pre¬ 
sented Dr. Holmes the William H. 
Welch Medal. He is the author of 
Claude Bernard and Animal Chemistry 
(Harvard University Press, 1974), and 
numerous articles on the history of 
medicine. 
The Avalon Foundation Professor¬ 
ship was established in 1962. The late 
Dr. Derek deSolla Price was the first 
and only incumbent prior to Dr. 
Holmes’ appointment. 
DIRECTOR OF GRANTS 
AND CONTRACTS 
APPOINTED 
Dr. Halvor G. Aaslestad has been 
appointed director of the Office of 
Grants and Contracts at the School of 
Medicine. An accomplished administra¬ 
tor with academic and scientific experi¬ 
ence as well. Dr. Aaslestad had been 
chief of the Biological Sciences Review 
Section, Referral and Review Branch 
of the Division of Research Grants at 
the National Institutes of Health, prior 
to his appointment. 
A graduate of Louisiana State Univer¬ 
sity, Dr. Aaslestad received an M.S. 
degree from Pennsylvania State Univer¬ 
sity and a Ph. D. degree from Louisiana 
State University, both in microbiology. 
He was a postdoctoral fellow at the 
U.S. Army Biological Laboratories 
from 1965 to 1968, when he was ap¬ 
pointed assistant professor of microbio¬ 
logy at the University of Georgia. From 
1973 to 1976, he was senior scientist in 
primate virology and special projects at 
the Frederick Cancer Research Institute, 
Frederick, Maryland. 
In 1976, Dr. Aaslestad was appointed 
executive secretary of a Special Study 
Section of the National Institutes of 
Health, and in 1981, he was named 
chief of the Biological Sciences Review 
Section of the Scientific Review 
Branch of NIH, a post he held until 
1984. 
Dr. Aaslestad, who received the NIH 
Quality Increase Award in 1980, is a 
member of the American Society for 
Microbiology, Sigma Xi, and the Na¬ 
tional Council of University Research 
Administrators. As director of Grants 
and Contracts Administration at the 
School of Medicine, he succeeds Francis 
L. Crowley, who resigned in January 
after twelve years to assume a position 
in the private sector. 
Miss Patterson Dr. Spinelli 
ASSOCIATE DEAN FOR 
MEDICAL EDUCATION 
AND STUDENT AFFAIRS 
IS NAMED 
Dr. Robert H. Gifford, professor of 
medicine, has been appointed associate 
dean for medical education and student 
affairs, effective July 1, 1985. Chief of 
Medical Service at the West Haven 
Veterans Administration Medical Cen¬ 
ter, Dr. Gifford is well known as an 
outstanding teacher. 
A graduate of Ohio Wesleyan Univer¬ 
sity, Dr. Gifford received his M.D. 
degree cum laudefrom Tufts University. 
Prior to coming to Yale-New Haven 
Medical Center in 1966 as a resident in 
medicine, he was director of medical 
programs in Bogota, Columbia for 
three years for the Peace Corps. He was 
appointed assistant professor of medi¬ 
cine in 1969, and promoted to associate 
professor of clinical medicine in 1972, 
and professor in 1976. Active on a 
number of committees in the School, 
including the Standing Committee on 
the Status of Women, he organized the 
Clinical Correlations course for first- 
and second-year students. 
As associate dean for student affairs. 
Dr. Gifford succeeds Dr. Howard Levi¬ 
tin, who has held that post since 1966. 
Dr. Levitin, who is professor of medi¬ 
cine, plans to continue his research in 
nephrology and teaching in medicine. 
DR. GENEL TO DIRECT 
OFFICE OF GOVERNMENT 
AND COMMUNITY 
AFFAIRS 
Dean Leon E. Rosenberg has an¬ 
nounced the appointment of Dr. Myron 
Genel as associate dean for govern 
mentand community affairs, effective 
July 1. Dr. Genel is professor of pedia¬ 
trics and program director of the Child¬ 
ren’s Clinical Research Center, as well 
as an authority on pediatric endocrinol¬ 
ogy and metabolism. 
In 1982, Dr. Genel was awarded a 
Robert Wood Johnson Health Policy 
Fellowship in the Institute of Medicine, 
National Academy of Sciences. As¬ 
signed to the Investigations and Over¬ 
sight Subcommittee of the House of 
Representatives Committee on Science 
and Technology, he was largely respon¬ 
sible for organizing the committee’s 
Congressional hearings on organ trans¬ 
plantation. As a result, he was involved 
in the drafting of corrective legislation 
which culminated in the introduction 
of a National Organ Transplant Act. 
A graduate of Moravian College, 
Bethlehem, Pennsylvania, Dr. Genel 
received his M.D. degree from the 
University of Pennsylvania in 1961. He 
had been a member of the faculty of the 
University of Pennsylvania School of 
Medicine prior to his appointment to 
the Yale medical faculty in 1971 as 
assistant professor of pediatrics, as well 
as program director of the Childrens’ 
Research Center and director of pedia¬ 
tric endocrinology. He was promoted 
to associate professor in 1976, and was 
named professor of pediatrics in 1981. 
A member of a number of profes¬ 
sional societies including the American 
Association for the Advancement of 
Science, the American Academy of 
Pediatrics, and the American Diabetes 
Association, Dr. Genel served as presi¬ 
dent of the Association of Program 
Directors of the General Clinical Re¬ 
search Centers of the N1H in 1981-82. 
In 1979, he was presented the Annual 
Award of the Connecticut Campaign 
Against Cooley’s Anemia, and was co¬ 
recipient of The Jonathan May Award 
of the American Diabetes Association 
— Connecticut Affiliate. 
As associate dean for government 
and community affairs. Dr. Genel suc¬ 
ceeds Louis J. Kaplan, who retired in 
March after serving in that office for 18 
years. 
DIRECTOR IS APPOINTED 
FOR ALUMNI AFFAIRS 
Dean Leon E. Rosenberg has appointed 
Dr. Nicholas P.R. Spinelli director of 
Alumni Affairs for the School of Medi¬ 
cine. Well known to alumni for his 
enthusiastic support of the school and 
participation in many alumni activities. 
Dr. Spinelli is an associate clinical 
professor of medicine in the Department 
of Internal Medicine, as well as pres¬ 
ident of the Executive Committee of 
the Association of Yale Alumni in 
Medicine. 
A graduate of Yale University, where 
he received a B.S. degree with high 
honors in 1941, Dr. Spinelli received 
his M.D. degree cum laude from the 
School of Medicine in 1944. During his 
academic career he was elected to Phi 
Beta Kappa, Sigma Xi and Alpha 
Omega Alpha honor societies. 
Following internship at Bridgeport 
Hospital, he served as a neuropsychi¬ 
atrist in the military service from 1945 
to 1947. On completion of his residency 
in internal medicine at the Veterans 
Administration Hospital in Newington, 
Connecticut, Dr. Spinelli entered pri¬ 
vate practice of internal medicine in 
Stratford. He has been senior attending 
physician since 1950, and director of 
medical education since 1960 at Bridge¬ 
port Hospital. In 1950, he was appointed 
clinical instructor in medicine in the 
School of Medicine, and was promoted 
to associate clinical professor in 1978. 
As an alumnus of the School, Dr. 
Spinelli has served on the Executive 
Committee of the Association of Yale 
Alumni in Medicine since 1970, and 
was vice president from 1977 until his 
election in 1981 as president. He has 
also been involved in the Yale Medical 
School Alumni Fund, as Class of 1944 
agent since 1950. 
D. Helaine Patterson has been ap¬ 
pointed director of the Office of Public 
Information of the School of Medicine, 
effective March 18. As director. Miss 
Patterson will coordinate and expand 
the public information program of the 
School involving the news media and 
publications. 
Prior to her appointment, she had 
been director of Medical Center Infor¬ 
mation Services at the University of 
Virginia Medical Center. From 1975 to 
1979, she served as director of University 
Information Services. She began her 
career as a general assignment reporter, 
then copy editor of the Free Lance - 
Star in Fredericksburg, Virginia. 
A graduate of Mary Washington 
College of the University of Virginia, 
Miss Patterson received an M.A. degree 
in public affairs journalism from Ameri¬ 
can University in 1974. She is a member 
of the Board of Directors for Camp 
Holiday Trails, a national, non-profit 
summer camp in Charlottesville, Vir¬ 
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DEAN AND CHAIRMAN 
OF NEUROANATOMY 
ELECTED TO NAS 
At its 122nd annual meeting in April 
the National Academy of Sciences an¬ 
nounced the election of 60 new mem¬ 
bers, including Dr. Leon E. Rosenberg, 
dean of the School and C.N.H.Long 
Professor of Human Genetics, and Dr. 
Pasko Rakic, Dorys McConnell Duberg 
Professor and chairman of the Section 
of Neuroanatomy. They were elected 
to the nation’s most distinguished organ¬ 
ization of scientists and engineers in 
recognition of their outstanding achieve¬ 
ments in original research. 
One of the nation’s leading geneticists. 
Dr. Rosenberg is known for his work in 
clinical genetics as well as for his contri¬ 
butions to new knowledge in inherited 
metabolic disorders. He helped establish 
the Department of Human Genetics 
and was its chairman from the time of 
its founding in 1972 until his appoint¬ 
ment as dean of the School in 1984. 
An alumnus of the University of 
Wisconsin where he received both a 
B.A. and an M.D. degree summa cum 
laude, he was awarded a Guggenheim 
Foundation Fellowship in 1972, and 
the following year the American Aca¬ 
demy of Pediatrics presented him the 
Borden Award for outstanding achieve¬ 
ments in research relating to infant 
nutrition and development of children. 
In 1982, the University of Wisconsin 
School of Medicine awarded him its 
Distinguished Alumni Citation, and 
that same year, he was elected to the 
Institute of Medicine of the NAS. 
Dr. Rakic is an internationally recog¬ 
nized leader in research on brain develop¬ 
ment. Although his research covers a 
broad range of developmental neuro¬ 
biology, he is best known for his investi¬ 
gation of the development of neuronal 
maturation, as well as for research on 
the development of the visual system 
and cerebellum in primates. His work 
has important implications for studies 
of the interaction of genetic and environ¬ 
mental factors governing human behav¬ 
ior and intelligence, as well as for 
understanding human disease. 
Born and educated in Yugoslavia, 
Dr. Rakic came to Yale in 1978 from 
Harvard, where he had been on the 
faculty since 1972. He was one of the 
f irst scientists to receive a Javits Neuro¬ 
science Award for distinguished contri¬ 
butions in the field of neurological and 
communicative disorders. 
The election of Dean Rosenberg and 
Dr. Rakic brings to 19 the number of 
distiguished Yale medical faculty in the 
1,453-member NAS. 
TWO ON FACULTY 
AWARDED PRESTIGIOUS 
RHEUMATISM AWARD 
The Ciba-Geigy-ILAR Rheumatism 
Prize, considered one of the most pres¬ 
tigious awards given for arthritis re¬ 
search, has been presented to Dr. Allen 
C. Steereand Dr. Stephen E. Malawista 
for their research on Lyme disease. The 
award, which is presented every four 
years, was presented to Drs. Steere and 
Malawista at the opening session of the 
X Vlth International Congresss of Rheu¬ 
matology in Sidney, Australia. 
Dr. Steere is associate professor of 
medicine and Dr. Malawista is professor 
of medicine and chief of the Section of 
Rheumatology in the Department of 
Internal Medicine. Theircontributions 
are considered unique since they not 
only identified Lyme disease as a specific 
disorder, but also demonstrated the 
organism responsible for it, and the 
vector that carries it. In addition, they 
alerted the medical community to ef¬ 
fective courses of treatment. Their inves¬ 
tigations may advance the understand¬ 
ing of other forms of rheumatic disease. 
“Dr. Steere and Dr. Malawista must 
be congratulated on a truly magnificent 
piece of medical detective work,” noted 
Dr. George E. Ehrlich, vice president 
of development, Ciba-Geigy Pharmaceu¬ 
ticals. “There are few examples in 
modern times of a single team accom¬ 
plishing so much in such an elegant 
way.” 
Lyme disease, a complex, multi-sys¬ 
tem infection, was first identified in 
1975 in Lyme, Connecticut by a team 
headed by Drs. Steere and Malawista. 
In the past few years, thousands of 
cases have been reported in 14 states, 
particularly in the northeast, midwest 
and California. 
The award, sponsored by the Ciba- 
Geigy Pharmaceutical Corporation of 
Summit, New Jersey, and the Interna¬ 
tional League Against Rheumatism, 
includes a prize of $27,000. 
DRS. STEVENS AND 
SHEPHERD RECEIVE 
JAVITS AWARDS 
In recognition of their outstanding 
research contributions to the neuro¬ 
sciences, Dr. Charles Stevens and Dr. 
Gordon Shepherd have received 1985 
davits Neuroscience Investigator 
Awards of the Nl H. 
Dr. Stevens, professor ol molecular 
neurobiology and physiology and chair¬ 
man of the Section of Molecular Neuro¬ 
biology, is widely recognized as one of 
the pioneers in the application of molecu¬ 
lar techniques to the study of the 
human brain. He received a davits 
Award of almost $ 1.3 million in support 
of his studies aimed at discovering how 
the brain's electrical activity nerve 
impulses and synaptic transmission 
arises through the operation of special 
proteins in nerve cells called “channels”. 
This research should ultimately lead to 
a better understanding of the actions of 
drugs that affect the brain, such as 
tranquillizers and antidepressants. 
Dr. Shepherd is professor of neuro¬ 
science in the Section of Neuroanatomy. 
The author of two acclaimed texts. 
Neurobiology and The Synaptic Organi¬ 
zation of the Brain, both published by 
Oxford University Press, he is well 
known for his studies on the structure 
and function of nervous tissue. 
He received a davits Award of almost 
$1.3 million in support of his research 
on the synaptic organization of the 
brain, using the vertebrate olfactory 
system as a model. The long-term ob¬ 
jective of these studies is to elucidate 
the structure and function of local 
circuits within the cortical regions of 
the vertebrate central nervous system. 
The results should provide a much 
clearer understanding of neuronal struc¬ 
ture-function relations within different 
cortical regions of the nervous system 
and provide insight into normal func¬ 
tions of microcircuits within the central 
nervous system, and abnormal functions 
related to epilepsy, schizophrenia and 
Alzheimer’s dementia. 
Drs. Stevens and Shepherd are the 
seventh and eighth members of the 
Yale faculty to receive these special 
awards honoring Senator dacob K. 
davits of New York. The N1H have 
designated the awards for investigators 
submitting regular research grant appli¬ 
cations for competitive review, who 
have a distinguished record of substan¬ 
tial contributions in some field of neuro¬ 
logical or communicative science and 
who can be expected to be highly 
productive over the next seven years. 
DR. TSIEN RECEIVES 
AWARDS FOR HEART 
RESEARCH 
Research on calcium channels and their 
role in the function of heart cells and 
neurons by Dr. Richard Tsien, professor 
of physiology, and his colleagues has 
recently been recognized by two distin¬ 
guished professional societies. The Inter¬ 
national Society for Heart Research 
has awarded Dr. Tsien its 1984/1985 
dournal of Molecular and Cellular Car¬ 
diology Award for outstanding research, 
and The Biophysical Society presented 
him the 1985 Kenneth S. Cole Memorial 
Award. 
Dr. Tsien is well known for his 
studies of calcium channels and their 
response to drugs that have important 
therapeutic effects on the cardiovascular 
system. Calcium channels are molecular 
pores in the cell membrane which in 
general, have the important role of 
linking electrical activity to other func¬ 
tions such as contraction or neuro¬ 
secretion. In the heart they are vital for 
the generation of the normal heart beat 
and can also be responsible for mal¬ 
function of the cardiovascular system, 
such as angina and cardiac arrhythmias. 
“Understanding the mechanisms of 
action of calcium channels is essential 
to the intelligent use of existing channel 
blocking drugs as well as to the develop¬ 
ment of new drugs to stimulate the 
heart,"explained Dr. Tsien. By singling 
out the activity of a single calcium 
channel among tens of thousands in the 
cell membranes. Dr. Tsien and his 
colleagues were able to study the mecha¬ 
nism of action of calcium channel 
inhibitors and calcium channel stimula¬ 
tors such as epinephrine. They have 
presented a new explanation for how 
calcium channels manage to pass cal¬ 
cium ions rapidly, yet very selectively. 
In both heart cells and nerve cells, they 
have discovered novel types of calcium 
channels, different from those previous¬ 
ly recognized. 
Working with Dr. Tsien in this re¬ 
search were Drs. Peter Hess, Jeffry 
Lansman, Aaron Fox and Martha 
Nowycky. 
FACULTY AND FELLOWS 
RECEIVE GRANTS FOR 
CANCER RESEARCH 
The American Cancer Society has 
awarded grants in support of cancer 
research by two members of the faculty, 
and six fellows and research associates 
have received grants from the Leukemia 
Society of America for their research. 
Dr. William N. Hait, assistant profes¬ 
sor of medicine (medical oncology), 
has received $162,500 from the ACS in 
two-year support of his search for new 
effective anticancer agents. Most effec¬ 
tive anticancer drugs act on DNA, 
inhibiting the cancer cell's ability to 
divide and grow by interfering with 
DNA metabolism. Dr. Hait is adopting 
a different approach. He has found 
that an increased concentration of a 
substance called cyclic AMP can inhibit 
the growth of certain malignant tissues, 
and is investigating drugs that will 
inhibit the enzyme PDE (cyclic 
nucleotide phosphdiesterase) which 
degrades cyclic AMP. In his research, 
PDE will be compared in leukemic 
versus normal tissue and then potent 
inhibitors to this enzyme will be investi¬ 
gated. 
A grant of $149,572 from the ACS 
will support research of Dr. John Lazo, 
associate professor of pharmacology, 
into improving the effectiveness of bleo¬ 
mycin, a potent antibiotic used clinically 
in treating some cancers, including 
squamous cell carcinoma and malignant 
lymphomas. Dr. Lazo’s research will 
involve testing the effectiveness of other 
members of the naturally occurring 
bleomycin family in an effort to find a 
variation of the substance which might 
improve the use of the drug. 
The Leukemia Society of America 
has awarded two-year fellowships to: 
Dr. Malgorzata Jastreboff, postdoctoral 
fellow in pharmacology, and Dr. Kim- 
iko Ishiguro, associate research scientist 
in pharmacology, for research in the 
development of potent anti-leukemic 
agents and techniques for administering 
and enhancing chemicals that kill malig¬ 
nant cells; and to Dr. Jill Lacy, a 
postdoctoral fellow in medical onco¬ 
logy, and Dr. Alan Waldman, postdoc¬ 
toral fellow in therapeutic radiology, 
for research on the understanding of 
normal cellular genetic mechanisms 
and how changes in certain genes in a 
cell can lead to malignancy. 
Also, to Dr. Hal Jenson, postdoctoral 
fellow in pediatrics and epidemiology, 
for his research on the process by which 
normal, healthy cells become malignant; 
and to Dr. William Brown, a postdoc¬ 
toral fellow in cell biology, for his 
investigation of the growth character¬ 
istics and requirements of both normal 
and abnormal cells. 
The six Yale researchers are among 
45 investigators receiving the Society’s 
awards this year. 
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A CENTER FOR 
RADIOLOGIC PHYSICS 
ESTABLISHED AT YALE 
The School of Medicine has received a 
S1.03 million contract from the National 
Cancer Institute to establish a Center 
for Radiological Physics (CRP). It is 
one of six such centers in the United 
States created by the NCI to ensure 
uniformly high quality of radiological 
physics serv ices in diagnostic and thera¬ 
peutic radiology at hospitals partici¬ 
pating in projects supported by its 
Division of Cancer Prevention and 
Control. 
The Yale CRP will serve as a resource 
for review, consultation and education 
to approximately 70 hospitals in the 
northeast, according to Dr. Robert J. 
Schulz, professor of radiology (radiologic 
physics), who is the director. Dr. Ravin- 
der Nath, associate professor of thera¬ 
peutic radiology (radiologic physics), is 
the associate director. 
“The purpose of the CRP at Yale is 
to develop methods and equipment for 
assessing the performance of radiation 
equipment by on-site visits as well as by 
mailed dosimetry kits,”said Dr. Schulz. 
“The goal of these review processes is 
to help the participating hospitals reach 
and maintain a uniformly high level of 
health care delivery that heretofore has 
not been possible.” 
About half of all cancer patients 
receive radiotherapy at some point in 
their treatment program. For 25 percent 
almost 200,000 patients a year radia¬ 
tion is the primary treatment, or is used 
in conjunction with other modalities in 
the primary treatment. Despite on¬ 
going improvement in treatment with 
combined modality therapy, tumors 
recur in some areas of the body in 
approximately 100,000 patients each 
year. 
These statistics are the basis for the 
NCI’s decision to establish the CRP 
program. “Success or failure of topical 
tumor control by radiotherapy can 
depend on the accuracy with which a 
prescription is fulfilled,” said Dr. 
Schulz. “Accurate equipment calibration, 
treatment planning and dosimetry are 
essential for the delivery of quality 
radiation therapy.” 
Through a telecommunications net¬ 
work developed by Dr. Schulz and his 
colleagues, the dosimetry service at 
Yale provides radiation treatment plan¬ 
ning for cancer patients in six hospitals 
in Connecticut and Massachusetts. The 
dosimetry training program in the De¬ 
partment of Therapeutic Radiology is 
the first, and one of only two such 
programs in the country. Each year, 
four trainees are instructed in the physics 
of ionizing radiations, radioactivity, 
radiation oncology and treatment plan¬ 
ning before taking positions in hospitals 
throughout the United States. 
BEAUMONT MEDICAL 
CLUB AWARDS FULTON 
PRIZE AND PRESENTS 
FULTON LECTURE 
At its final meeting of the year the 
Beaumont Medical Club presented the 
John F. Fulton Memorial Lecture and 
awarded the John F. Fulton Memorial 
Prize. Barbara Gutman Rosenkrantz, 
the 1985 Fulton Fellow presented the 
lecture, “MindingOther People’s Busi¬ 
ness: Claims for Public Health Between 
the Wars.” 
The Fulton Memorial Prize was pre¬ 
sented to William Gaillard, Class of 
1985, the outgoing president of the 
Nathan Smith Club, for his research 
paper “The Great Plague of Athens: 
Thucydides and the Bonds of Polity.” 
The Prize is awarded to the member of 
the Club whose research paper was 
considered the most outstanding contri¬ 
bution of the academic year. It was 
presented to Mr. Gaillard by Dr. Arthur 
Viseltear, associate professor of the 
history of medicine and public health, 
on behalf of the Section of the History 
of Medicine. “In presenting this prize, 
we not only honor its recipient, but 
perpetuate Dr. Fulton’s memory,’’said 
Dr. Viseltear. 
Barbara Gutman Rosenkrantz is 
professor and chairman of the Depart¬ 
ment of the History of Science at 
Harvard University. As the seventh 
Fulton Fellow of the Beaumont Medical 
cal Club, the distinguished medical 
historian was in residence at Yale Uni¬ 
versity from May 1-3, during which 
time she presented three lectures, includ¬ 
ing “The Conquest of the Great White 
Plague” presented at the last meeting of 
the year of the Nathan Smith Club. 
The Fulton Fellowship was founded 
by Dr. Bern Dibner, director of the 
Burndy Library, Norwalk, Connecticut 
to honor and perpetuate the memory of 
Dr. John F. Fulton. The Fellow is 
selected annually by a committee of the 
Beaumont Medical Club. 
NATHAN SMITH CLUB 
HONORS MRS. FULTON 
At the final meeting this year of the 
Nathan Smith Club, president William 
Gaillard. Class of 1985, announced the 
creation of the Lucia P. Fulton Fellow¬ 
ship to honor Mrs. Fulton “in appreci¬ 
ation for her ardent and enthusiastic 
support and unsurpassed hospitality 
over these many years.” Mrs. Fulton, 
the widow' of the late Dr. John F. 
Fulton, has traditionally invited mem¬ 
bers of the Nathan Smith Club to hold 
their final meeting of the year at her 
home, “Millrock.” 
The Nathan Smith Club is comprised 
of Yale medical students who meet 
throughout the academic year in the 
homes of faculty to discuss historical 
medical topics. Dr. Fulton served as its 
principal sponsor and advisor for many 
years. 
The outstanding student in the history 
of science and medicine will be selected 
by the club's officers to present his or 
her paper at the last meeting of the year 
as the Lucia P. Fulton Speaker, accord¬ 
ing to Mr. Gaillard. 
BOOKS BY FACULTY 
“T he Admirable Secrets of Physick & 
Chyrurgery” by Thomas Palmer; edited 
by Thomas R. Forbes, E. K. Hunt Profes¬ 
sor Emeritus of Anatomy, senior re¬ 
search scholar in the History of Medi¬ 
cine. Yale University Press (New Haven) 
1984. 
“Clinical Epidemiology”, by Alvan R. 
Feinstein, M. Dprofessor of medicine 
and epidemiology. W.B. Saunders, Co. 
(Philadelphia) 
“A Stranger in My House: Jews and 
Arabs in the West Bank”, by Walter 
Reich, M.D., lecturer in psychiatry. 
Holt Rhinehart and Winston (New 
York) 1984. 
“Mind, Brain, Body: Toward a Conver¬ 
gence of Psychoanalysis and Neuro¬ 
biology”, by Morton F. Reiser, M.D., 
professor and chairman of the Depart¬ 
ment of Psychiatry. Basic Books (New 
York) 1984- 228 pp„ illus. 
FACULTY NEWS 
Dr. Vincent A. Andriole, professor of 
medicine, has been elected a member of 
the Council of Infectious Disease Soci¬ 
ety. There are six elected councilors of 
this distinguished society with a mem¬ 
bership of over 3,000. 
At its annual meeting in April, the 
Association of University Programs in 
Health Administration awarded its 
highest recognition to Professor John 
D. Thompson for his contributions to 
the improvement of health services 
through management education. Profes¬ 
sor of public health (hospital administra¬ 
tion) and nursing administration, he is 
widely recognized as the co-developer 
of the diagnostic related group (DRG) 
system. The AUPHA has established 
the John D. Thompson Prize for health 
services research to be awarded to a 
young faculty member any where in the 
world who has published the most 
significant original research report dur¬ 
ing the past year. 
The American Urological Association 
presented its prestigious Hugh Hampton 
Young Award to Dr. Bernard Lytton, 
professor of surgery (urology). The 
award, which is co-sponsored by Bristol 
Laboratories and carries an honorarium 
of $2,000, is presented for outstanding 
contributions to the study of urinary 
tract disease. 
Dr. Robert M. Donaldson, David Paige 
Smith Professor of Medicine, has been 
named a Master of the American Col¬ 
lege of Physicians. A leading medical 
educator and investigator in gastroenter¬ 
ology, Dr. Donaldson’s contributions 
to internal medicine include research 
on cobalamine transport and the blind 
loop syndrome. 
The New Haven Foundation presented 
one of its eight 1984 Elm and Ivy 
Awards to Dr. James P. Comer for 
outstanding contributions toward im¬ 
proved relations between New Haven 
and Yale University. Dr. Comer, who 
is Maurice Falk Professor of Child 
Psychiatry and associate dean for stu¬ 
dents at the School of Medicine, was 
cited for his leadership in a major 
collaboration between the Yale Child 
Study Center and the New Haven 
public school system to help solve the 
problems of inner-city school education, 
especially in the elementary schools. 
In addition, the American Psychiatric 
Association presented its Agnes Purcell 
McGavin Award to Dr. Comer for his 
outstanding work related to the preven¬ 
tive aspects of the emotional disorders 
of childhood. 
Dr. James F. Jekel, C.E.—A. Winslow 
Professor of Public Health, has received 
a 1985-86 Fulbright Fellowship to assist 
the people of the Bahamas in the 
development of an epidemiological sur¬ 
veillance system to monitor the island's 
drug and teenage pregnancy problems. 
Selected by the U.S. Information Agen¬ 
cy and the Board of Foreign Scholar¬ 
ships, Dr. Jekel will help promote 
mutual understanding between the 
people of the U.S. and the Bahamas. 
In addition to receiving a Javits Award, 
Dr. Charles Stevens was one of ten 
recipients of the McKnight Awards for 
Research Projects. The award for 
$150,000 for a three-year period is in 
support of his research on “Neuromodu- 
latory Mechanisms of Information Stor¬ 
age.” The McKnight Awards support 
outstanding investigative programs by 
established neuroscientists and their 
associates to encourage them to direct 
more of their efforts toward developing 
new approaches to the understanding 
of memory and related diseases. 
Dr. Arthur Horwich is one of twelve 
physicians selected from a group of 86 
highly qualified applicants to receive a 
Hartford Fellowship from The John A. 
Hartford Foundation, Inc. of New 
York, which provides annual salary 
support of $35,000 for three years. An 
assistant professor of human genetics 
and pediatrics who has focused his 
research on inborn errors of metabo¬ 
lism, Dr. Horwich received the Life 
and Health Insurance Medical Research 
Fund Award last year for his studies of 
the Expression of cDNA Encoding 
Human Ornithine Transcarbamy lase. 
The Alzheimer’s Disease and Related 
Disorders Association, Inc. has pre¬ 
sented Dr. Amy F.T.Arnsten a 1985 
Allied Corporation/ADRDA Faculty 
Scholar Award. The award of $38,000 
annually for three years is intended to 
support faculty at the junior level who 
have demonstrated an ability for inde¬ 
pendent and innovative research in the 
causes or treatment of Alzheimer’s dis¬ 
ease and related disorders. Dr. Arnsten 
is an associate research scientist in the 
Section of Neuroanatomy. 
The Japan Society of Anesthesiology 
has made Dr. Nicholas M. Greene and 
Dr. Luke M. Kitahata honorary mem¬ 
bers in recognition of their many contri¬ 
butions to research in the field. Drs. 
Greene and Kitahata are professors 
and former chairmen of the Department 
of Anesthesiology. In addition. Dr. 
Greene has been awarded an honorary 
degree and appointed a Fellow of the 
Faculty of Anesthesists, Royal College 
of Surgeons, England. 
Dr. William Cain, professor of epidemio¬ 
logy (environmental health)and psycho¬ 
logy, has been voted president-elect of 
the New York Academy of Sciences. 
Dr. Cain, who is also a fellow of the 
John B. Pierce Foundation Laboratory, 
is well known for his studies of the 
olfactory system and for his research 
on the eflects of indoor air pollution on 
the sensory system. The New York 
Academy ot Sciences is an international 
membership organization of 50,000 sci¬ 
entists from the United States and 81 
foreign nations, representing every 
scientific discipline. 
Dr. Sara Rockwell, professor of re¬ 
search in therapeutic radiology, has 
been elected a Councilor-at-large of the 
Rad iation Research Society. The society 
is the major international society for 
research in radiation and its effects. 
On May 23, Dr. Myrna M.Weissman, 
professor of psychiatry and epidemi¬ 
ology and director of the Depression 
Research Unit, presented the Distin¬ 
guished Psychiatric Lecture at the Amer¬ 
ican Psychiatric Association’s annual 
meeting in Dallas. The title of her 
lecture was “Does Psychiatric Epidemi¬ 
ology Count for the Clinician?” 
Dr. Paul G. Barash, professor and 
chairman of the Department of Anesthe¬ 
siology, has been elected to a two-year 
term as president of the Society of 
Cardiovascular Anesthesiologists, a na¬ 
tional organization promoting research 
and clinical development in cardiovascu¬ 
lar and thoracic anesthesiology. 
Dr. Norman Talner, professor of pedia¬ 
trics and diagnostic radiology, served 
on the organizing committee for the 
2nd World Congress of Pediatric Cardi¬ 
ology, held in New York City, June 2-6. 
Several other Yale medical faculty gave 
invited presentations including Drs. 
George Lister, associate professor of 
pediatrics and anesthesiology; Charles 
Kieinman, associate professor of pedia¬ 
trics (cardiology) and diagnostic radio¬ 
logy; William Hellenbrand, associate 
professor of pediatrics; Ruth Whitte- 
more, clinical professor of pediatrics; 
William W.L. Glenn, Charles W. Ohse 
Professor of Surgery (cardiothoracic); 
and Gary Kopf, assistant professor of 
surgery (cardiothoracic). In addition, 
Drs. Michelle Moss and John Fahy, 
postdoctoral fellows and instructors in 
pediatrics, and Patricia A. Richard, 
nurse clinical instructor in pediatric 




MR. KAPLAN IS HONORED 
Over 100 friends and family gathered 
on March 31 in the Hope Building to 
honor Louis J. Kaplan on his retirement 
as Associate Dean for Community and 
Government Relations and Alumni 
Affairs. Guests included not only mem¬ 
bers of the Yale and Medical Center 
communities, but representatives of 
the local and state governments as 
well. Several who could not attend, 
including former deans Fredrick Red- 
lich and Lewis Thomas sent messages 
of congratulations and best wishes. 
Lou Kaplan came to Yale in 1967 as 
assistant to Dean Redlich for commun¬ 
ity affairs and government relations. In 
1974, he became Assistant Dean for 
Community and Government Relations 
and Alumni Affairs; and in 1979, he 
was appointed Associate Dean. He was 
also a lecturer in epidemiology and 
public health and psychiatry.. 
During his 18 years at Yale, he 
retained membership on boards of many 
city, community and Yale affiliated 
organizations. He was Communicator 
Lobbyist for the State of Connecticut 
as well as a key source and advisor for 
local, state and federal officials. 
Alumni of the School of Medicine 
perhaps know Mr. Kaplan best for his 
participation in many alumni activities 
including the Yale Medical School 
Alumni Fund, the Association of Yale 
Alumni in Medicine, and the Associa¬ 
tion of Yale Alumni Graduate and 
Professional School Committee. 
One colleague expressed the opinion 
of many when she said, “Lou’s talents 
and expertise will be sorely missed by 
his Yale family and friends.” 
CLASS NOTES 
1932 
Conrad Lam wrote on February 1 that 
he was leaving the following week to 
participate in a World Congress on 
Open Heart Surgery in Bombay, India. 
The Congress was being held to com¬ 
memorate 25 years of open heart surgery 
in that country. 
1934 
Edward T. O’Donnell was honored on 
November 6, 1984 by the Medical 
Society of Delaware on the 50th anniver¬ 
sary of his practice of pediatrics. In 
addition, the Wilmington Friends 
School honored Dr. O’Donnell with a 
reception marking his retirement after 
20 years as school physician. 
1939 
Douglass Walker has given Yale’s Trum¬ 
bull College a set of Wedgewood china 
depicting various Yale scenes. The china 
belonged to Dr. Stanhope Bayne-Jones, 
who was master of the college from 
1932to 1938 and who served as dean of 
the School of Medicine from 1935 to 
1940. 
As a medical student and also a 
proctor in one of the Howard Avenue 
dormitories, Douglass Walker came to 
know Dean Bayne-Jones quite well. 
Subsequently, as an Army medical 
officer in World War II, he worked 
with B.J. (a colonel and latera brigadier 
general) in the Surgeon General’s office. 
While Dr. Walker was on the faculty at 
the Johns Hopkins School of Medicine 
(1963-1970), he renewed his friendship 
with B.J., who had retired and was 
living in Washington where he was 
writinga history of preventive medicine 
in World War II. In 1970, when B.J. 
died, Mrs. Bayne-Jones gave the set of 
china to the Walkers. Through their 
thoughtful generosity, the china has 
now returned to Trumbull College. 
1941 
A foundation to promote and support 
medical research, education and patient 
care has been named in honor of John 
Franklin of Norfolk, Viriginia. The 
John Franklin Medical Foundation 
was dedicated on January 12. A plaque 
installed in the lobby of the foundation 
building reads in part, “Dr. Franklin 
has devoted his professional life to 
excellence in the practice of medicine 
and his personal life to the care and 
well-being of his patients, his family, 
his colleagues, and his community. He 
is held in the highest esteem both as a 
man and as a physician by all who have 
been privileged to know him.” 
A tribute to Dr. Franklin written by 
Willys Monroe, entitled “Salute to a 
Life of Excellence” was published in 
the May 1985 issue of Virginia Medical 
He reports as follows in the final para¬ 
graph of that article: 
“A few weeks after the dedication 
ceremony. Jack underwent a quadruple 
coronary artery bypass. While he came 
through the procedure with flying 
colors, he tells me that the enforced rest 
period postoperatively was so pleasant 
that he decided to retire from the 
practice of medicine on May 1. His 
presence on the medical scene will be 
sorely missed, but we wish him and 
Frannie much happiness, contentment 
and many more productive years among 
their children, grandchildren and a 
host of friends.” 
1949 
Martha Vaughan, Chief of the Labora¬ 
tory of Cellular Metabolism at the 
National Heart, Lung and Blood Insti¬ 
tute, has been elected a member of the 
National Academy of Sciences, the 
nation’s most distinguished organiza¬ 
tion of scientists. She was one of sixty 
scientists to be so honored this year. 
1953 
William Whalen of Willimantic was 
installed as the 148th president of the 
Connecticut State Medical Society at 
the annual meeting in May. Since 1959 
he has been staff surgeon and from 
1982 to 1984, chief of staff, at Windham 
Community Memorial Hospital. In 1983 
Dr. Whalen, an associate clinical pro¬ 
fessor of surgery at Yale, received the 
Edward B. Storer Award for Excellence 
in Surgical Teaching, which was pre¬ 
sented by the chief residents of Yale’s 
Department of Surgery. 
1955 
The American College of Physicians 
(ACP) has announced that James P. 
Nolan has assumed office as a Governor 
of the 60,000-member national medical 
specialty society. Elected locally. Dr. 
Nolan will hold his post as the ACP 
Governor of Upstate New York for 
four years. A specialist in internal 
medicine, he is professorand chairman 
of the Department of Medicine at the 
State University of New York at Buffalo. 
1962 
Norman Bass, professor and chairman 
of the Department of Neurology at the 
University of Kentucky College of Medi¬ 
cine, has been named dean of the 
Medical College of Georgia School of 
Medicine. 
1973 
Jerry Nagler, recently elected to fellow¬ 
ship in the American College of Physi¬ 
cians, was honored in March during 
the convocation ceremony at the Col¬ 
lege’s Annual Session in Washington, 
D.C. Dr. Nagler, who specializes in 
internal medicine and gastroenterology, 
has been a resident of New York City 
for twelve years and is on the staff of 
New York Hospital - Cornell Medical 
Center and Cornell University Medical 
College. 
1977 
John White of Bethesda, Maryland has 
been elected to fellowship in the Ameri¬ 
can College of Physicians. He received 
this honor in March, at the College’s 
Convocation ceremony at its Annual 
Session in Washington, D.C. Dr. White, 
a specialist in internal medicine and 
emergency medicine, is a resident of 
Bethesda and is on the staff of the 
Georgetown University Medical Center. 
Christine K.Carrico has been appointed 
director of the Pharmacological Sci¬ 
ences Program of the National Institute 
of General Medical Sciences (N1GMS), 
one of the National Institutes of Health. 
As director, she will provide leadership 
in the administration of a large program 
of research and research training grants 
in the pharmacological sciences, bio¬ 
related chemistry and anesthesiology. 
Dr. Carrico will also direct the Pharma¬ 
cology Research Associate Program. 
1983 
The American Academy of Family 
Physicians (AAFP) presented a $ 1,500 
award to Patricia Kellner in support of 
her graduate training in family practice. 
Dr. Kellner, who is a family practice 
resident at Case Western Reserve Uni¬ 
versity, Cleveland, is one of twenty 
selected from 170 candidates on the 
basis of scholastic achievement, leader¬ 
ship qualities and qualifications for, 
and interest in family practice. 
1984 
Martin Yarmush is one of two biomedi¬ 
cal scientists at Massachusetts Institute 
of Technology who have been selected 
as recipients of the first Markey Scholar 
Awards by the Lucille P. Markey Chari¬ 
table Trust. The awards which have 
been made to sixteen outstanding young 
researchers, will provide from $500,000 
to $700,000 support to each recipient 
over six to eight years. 
Dr. Yarmush, who received his Ph.D. 
in immunology/ biochemistry from The 
Rockefeller University in 1979, is a 
principal research associate in the De¬ 
partment of Chemical Engineering at 
MIT. His work involves experimental 
and theoretical studies in applied immun¬ 
ology and biochemical and biomedical 
engineering. Among his specific interests 
are immunological approaches to treat¬ 
ment of cancer and other chronic dis¬ 
eases, immunoadsorption for large-scale 
biomolecule purification, and develop¬ 
ment of an artificial pancreas and liver. 
HOUSE STAFF 
1975 
Richard Uauy wrote recently that as of 
March 1, he was to leave his position as 
head of the Clinical Nutrition Unit at 
the University of Chile to become associ¬ 
ate professor of pediatrics at the Univer- 
sity of Texas in Dallas for a three-year 
period. He noted that the chairman of 
this department is Dr. Joseph Warshaw, 





Andrew Scala writes that he received 
an appointment with the Dartmouth- 
Hitchcock Clinic in New Hampshire, 
as of December 1. He is associated with 
the Department of Internal Medicine, 




February 3, 1985 
M.DJ23 
Henry W. Ferris 
January 19,1985 
M.D/25 
Tzu Pei Chou 
December 6, 1984 
M.D.’25 
Robert B. Love 
November 19, 1984 
M.DJ26 
Herman H. Goldstein 
September 30, 1983 
M.D/27 
Berthold R. Comeau 
February 14, 1985 
M.D728 
Uno H. Helgesson 
October 28, 1978 
M.D728 
Courtney C. Bishop 
January 17, 1985 
M.D730 
Frank H. Couch 
January 17, 1985 
M.D730 
Morris Y. Krosnick 
February 24, 1985 
M.DAJO 
Gideon K. deForest 
March 11, 1985 
M.D732 
Michael L. Furcolow 
January 20, 1985 
M.D/34 
Leo P. Rosenthal 
August 4, 1984 
exP.H.‘37 
Richard J. Hinchey 
April 1, 1978 
M.P.H740 
Charles R. Harms 
March 3, 1985 
M.D'42 
James L. Bradley 
February 1, 1985 
M.D‘43 
Helen B. Ausley 
November 13, 1982 
M.P.H745 
Lorraine C. Patterson 
July 2, 1974 
M.P.H/49 
Albert L. Stone 
October 20, 1984 
M.D753 
Merrill A. Baratz 
December 26, 1984 
HS’54 
Edwin D. Harrington 
September 20, 1973 
M.P.H/54 
William C. Edwards 
October 28, 1983 
M.D.'59 
Karlen L. Paulay 
December 9, 1981 
M.D762 
William B. Yeagley 
January 3, 1985 
M.D766 
Joseph H. Zelson 
December 23, 1984 
HS‘69 
Thomas W. Jones 
December 20. 1977 
M.P.H.71 
Stephen R. Shell 
February 14, 1985 
HS‘80 
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CLASS OF 1985 
CALIFORNIA 
Harbor-UCLA Medical Center, Torrance 
Lisa Nelson-Robinson, Transitional 
Santa Monica Hospital 
Michael Gilbert, Family Practice 
UCLA Neuropsychiatric Institute 
Thomas Newton, Psychiatry 
University of California San Diego Affiliated 
Hospitals 
Jaime Arroyo, Internal Medicine 
Peter Rubin, Surgery 
Javier Vizosos, Obstetrics and Gynecology 
University of California (Irvine) Affiliated 
Hospitals 
Alice Chi, Internal Medicine 
University of California, San Francisco 
Sandra Wolin, Postdoctoral Fellow, 
Department of Biochemistry and Biophysics 
University of California Hospitals 
San Francisco 
Brent Moelleken, General Surgery 
Jon Nakamoto, Pediatrics 
Eric Poeschla, Internal Medicine 
Fong Wang, Pediatrics 
COLORADO 
University of Colorado Affiliated Hospitals, 
Denver 
Barry Bergquist, Internal Medicine 
Michael Johnson, Psychiatry 
Elizabeth Mason, Obstetrics and Gynecology 
Leslye Pennypacker, Internal Medicine 
CONNECTICUT 
Hartford Hospital 
Robert Smith, Transitional 
Hospital of St. Raphael, New Haven 
Ellen Rieur, Internal Medicine 
Norwalk Hospital 
Kimball Woodward, Internal Medicine 
Yale-New Haven Hospital 
David Birnkrant, Pediatrics 
Vance Brown, Internal Medicine 
JoAnne Burger, Pediatrics 
Jane Carter, Internal Medicine 
Jacqueline Gutmann, Obstetrics and 
Gynecology 
Susan Korrick, Internal Medicine 
Jonathan Lewin, Pediatrics 
Susan Moore, Internal Medicine 
Jeffery Morton, Therapeutic Radiology 
David Roberts, Internal Medicine 
Richard Ruiz, Surgery 
Reginald Sanders, Internal Medicine 
Mark Topazian, Internal Medicine 
Pablo Vazquez-Seoane, Surgery 
DISTRICT OF COLUMBIA 
Children’s Hospital 
Fred Santoro, Pediatrics 
George Washington University Hospital 
Shirley Lee, Internal Medicine 
Walter Reed Army Hospital 
Jennifer Calagan, Internal Medicine 
RESIDENCY POSITIONS 
ILLINOIS 
McGaw Medical Center-Northwestern 
University, Chicago 
Edward Tyau, General Surgery 
University of Chicago Clinics 
Greg Sachs, Internal Medicine 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
Peter Greene, General Surgery 
John Roberts, General Surgery 
MASSACHUSETTS 
Beth Israel Hospital, Boston 
Terri Cornelison, Obstetrics and Gynecology 
Virginia Huang, General Surgery 
Boston City Hospital 
Carol Farver, Internal Medicine 
Samuel Goos, Internal Medicine 
Angela Grant, Internal Medicine 
Robert Needlman, Pediatrics 
Brigham and W omen's Hospital, Boston 
Hingge Hsu, Internal Medicine 
John Merendino, Internal Medicine 
Collin Smikle, Obstetrics and Gvnecoogy 
Steven Warren, Surgery 
Cambridge Hospital 
Janice Blustein, Primary Care Medicine 
Joshua Sparrow, Transitional 
Eye Research Institute Retina Foundation, 
Boston 
Tina Tillis, Research Fellow, Ophthalmology 
Lemuel Shattuck Hospital, Boston 
Marie Hobart, Transitional 
Massachusetts General Hospital, Boston 
Richard Garber, Pediatrics 
Ted Love, Internal Medicine 
Joshua Schor, Internal Medicine 
McLean Hospital, Belmont 
Alec Bodkin, Psychiatry 
New England Deaconess Hospital, Boston 
Jeffrey Lowell, General Surgery 
New England Medical Center Hospital, Boston 
Brian Annex, Internal Medicine 
Anthony Marks, Internal Medicine 
MICHIGAN 
University of Michigan Affiliated Hospitals, 
Ann Arbor 
Janet Young, Diagnostic Radiology 
MINNESOTA 
University of Minnesota Hospital, Minneapolis 
Calixto Dimas, Diagnostic Radiology 
Richard Parker, Neurosurgery 
NEW YORK 
Maimonides Medical Center, Brooklyn 
Paul Roberts, Internal Medicine 
Millard Fillmore Hospital, Buffalo 
Barbara Guillette, Surgery 
Montefiore Hospital, Bronx 
Daniel Greenwald, General Surgery 
Mt. Sinai Hospital, New York 
Stafford Broumand, General Surgery 
Julie Danaher, Obstetrics and Gynecology 
Darlyne Johnson, Surgery 
Maria Rivera, Internal Medicine 
New York University Medical Center, New York 
Peter Chang Sing, Internal Medicine 
Presbyterian Hospital, New York 
Gail Mattson, General Surgery 
Roosevelt Hospital, New York 
Michael Behrman, General Surgery 
Strong Memorial Hospital, Rochester 
Lynn Mehlman, Internal Medicine 
State University of New York-Erie County 
Medical Center, Buffalo 
Timothy Tanner, Internal Medicine/ Pediatr 
The New York Hospital, New York 
Sara Cartmell, Obstetrics and Gynecology 
Robert Klitzman, Psychiatry 
Marnin Merrick, Internal Medicine 
Anne Regenstein, Obstetrics and Gynecolog 
NORTH CAROLINA 
Duke University Medical Center, Durham 
Bryan DeSouza, Neurosurgery 
Victor Hsu, Internal Medicine 
OHIO 
Case Western Reserve University-Cleveland 
Metropolitan General Hospital, Cleveland 
Guy Fish, Internal Medicine 
PENNSYLVANIA 
Children's Hospital, Philadelphia 
Sara Schutzman, Pediatrics 
Louis Tesoro, Pediatrics 
Graduate Hospital, Philadelphia 
Samuel Pesin, Internal Medicine 
Hospital of the University of Pennsylvania, 
Philadelphia 
Edward Savage, General Surgery 
Mark Shachner, General Surgery 
Timothy Shapiro. Internal Medicine 
Hospitals of the University Health Center of 
Pittsburgh 
William Gaillard, Pediatrics 
Robert Higgins, General Surgery 
Medical College of Pennsylvania, Philadelphia 
Ronald Lisan, Internal Medicine 
Pennsylvania Hospital, Philadelphia 
Robert Aronowitz, Internal Medicine 
Jane Mathisen, Obstetrics and Gvnecoogy 
Temple University Hospital, Philadelphia 
Stuart Isaacs, Internal Medicine 
Thomas Jefferson University Hospital, 
Philadelphia 
Guy Fried. Internal Medicine 
RHODE ISLAND 
Women and Infants Hospital, Providence 
Elizabeth Moy, Obstetrics and Gvnecoogy 
TEXAS 
Baylor University Medical Center, Dallas 
Peter Shile, Internal Medicine 
University of Texas Southwestern Affiliated 
Hospitals, Dallas 
Kathleen Maurer, Internal Medicine 
CANADA 
Royal Victoria Hospital, Montreal 
David Alwin, Internal Medicine 
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